EnsemblID;Name;Sequence;Comments;Phenotype;Chromosome;GeneSymbol;IsInheritanceKnown
ENSG00000187608;ISG15 ubiquitin-like modifier;NotRelevant;;Immunodeficiency 38, 616126 (3), Autosomal recessiveImmunodeficiency 38, 616126 (3);chr1;ISG15, G1P2, IFI15, IMD38;True
ENSG00000188157;Agrin;NotRelevant;;Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessiveMyasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3);chr1;AGRN, CMS8;True
ENSG00000186827;Tumor necrosis factor receptor superfamily, member 4;NotRelevant;mutation identified in 1 IMD16 family;?Immunodeficiency 16, 615593 (3), Autosomal recessive?Immunodeficiency 16, 615593 (3);chr1;TNFRSF4, TXGP1L, OX40, ACT35, IMD16;True
ENSG00000176022;UDP-Gal:beta-Gal beta-1,3-galactosyltransferase polypeptide 6;NotRelevant;;Ehlers-Danlos syndrome, spondylodysplastic type, 2, 615349 (3), Autosomal recessiveSpondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures, 271640 (3);chr1;B3GALT6, SEMDJL1, EDSSPD2;True
ENSG00000107404;Dishevelled 1 (homologous to Drosophila dsh);NotRelevant;;Robinow syndrome, autosomal dominant 2, 616331 (3), Autosomal dominantRobinow syndrome, autosomal dominant 2, 616331 (3);chr1;DVL1, DRS2;True
ENSG00000197785;ATPase family, AAA domain-containing, member 3A;NotRelevant;one family with AR inheritance reported;Harel-Yoon syndrome, 617183 (3), Autosomal recessive, Autosomal dominantHarel-Yoon syndrome, 617183 (3);chr1;ATAD3A, HAYOS;True
ENSG00000205090;Transmembrane protein 240;NotRelevant;;Spinocerebellar ataxia 21, 607454 (3), Autosomal dominantSpinocerebellar ataxia 21, 607454 (3);chr1;TMEM240, C1orf70, SCA21;True
ENSG00000078369;Guanine nucleotide-binding protein, beta polypeptide-1;NotRelevant;;Leukemia, acute lymphoblastic, somatic, 613065 (3)Mental retardation, autosomal dominant 42, 616973 (3);chr1;GNB1, MRD42;True
ENSG00000187730;Gamma-aminobutyric acid (GABA) A receptor, delta;NotRelevant;;{Epilepsy, generalized, with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant{Epilepsy, juvenile myoclonic, susceptibility to}, 613060 (3);chr1;GABRD, GEFSP5, EIG10, EJM7;True
ENSG00000157933;Avian sarcoma viral (v-ski) oncogene homolog;NotRelevant;formerly mapped to 1q22-q24;Shprintzen-Goldberg syndrome, 182212 (3), Autosomal dominantShprintzen-Goldberg syndrome, 182212 (3);chr1;SKI, SGS;True
ENSG00000157911;Peroxisome biogenesis factor 10;NotRelevant;;Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessivePeroxisome biogenesis disorder 6B, 614871 (3);chr1;PEX10, NALD, PBD6A, PBD6B;True
ENSG00000142611;PR domain-containing protein 16;NotRelevant;;Cardiomyopathy, dilated, 1LL, 615373 (3), Autosomal dominantLeft ventricular noncompaction 8, 615373 (3);chr1;PRDM16, MEL1, LVNC8, CMD1LL;True
ENSG00000235169;Small integral membrane protein 1;NotRelevant;;[Blood group, Vel system], 615264 (3), Autosomal recessive[Blood group, Vel system], 615264 (3);chr1;SMIM1, VEL;True
ENSG00000116198;Centrosomal protein, 104kD;NotRelevant;;Joubert syndrome 25, 616781 (3), Autosomal recessiveJoubert syndrome 25, 616781 (3);chr1;CEP104, GLYBP, KIAA0562, JBTS25;True
ENSG00000131697;Nephrocystin 4;NotRelevant;;Nephronophthisis 4, 606966 (3), Autosomal recessiveSenior-Loken syndrome 4, 606996 (3);chr1;NPHP4, SLSN4;True
ENSG00000116251;Ribosomal protein L22;NotRelevant;fused with AML1 in t(3;21);chr1;RPL22, EAP;False
ENSG00000187017;Espin, mouse, homolog of;NotRelevant;;Deafness, autosomal recessive 36, 609006 (3), Autosomal recessiveDeafness, neurosensory, without vestibular involvement, autosomal dominant (3);chr1;ESPN;True
ENSG00000171680;Pleckstrin homology domain- and RhoGEF domain-containing protein G5;NotRelevant;;Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessiveSpinal muscular atrophy, distal, autosomal recessive, 4, 611067 (3);chr1;PLEKHG5, KIAA0720, DSMA4, CMTRIC;True
ENSG00000171735;Calmodulin-binding transcription activator 1;NotRelevant;;Cerebellar ataxia, nonprogressive, with mental retardation, 614756 (3), Autosomal dominantCerebellar ataxia, nonprogressive, with mental retardation, 614756 (3);chr1;CAMTA1, KIAA0833, CANPMR;True
ENSG00000049246;Period, Drosophila, homolog of, 3;NotRelevant;mutation identified in 1 FASPS3 family;?Advanced sleep phase syndrome, familial, 3, 616882 (3), Autosomal dominant?Advanced sleep phase syndrome, familial, 3, 616882 (3);chr1;PER3, FASPS3;True
ENSG00000116288;Oncogene DJ-1;NotRelevant;;Parkinson disease 7, autosomal recessive early-onset, 606324 (3), Autosomal recessiveParkinson disease 7, autosomal recessive early-onset, 606324 (3);chr1;DJ1, PARK7;True
ENSG00000162426;Solute carrier family 45, member 1;NotRelevant;;Intellectual developmental disorder with neuropsychiatric features, 617532 (3), Autosomal recessiveIntellectual developmental disorder with neuropsychiatric features, 617532 (3);chr1;SLC45A1, DNB5, IDDNPF;True
ENSG00000142599;RE repeats-encoding gene;NotRelevant;;Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3), Autosomal dominantNeurodevelopmental disorder with or without anomalies of the brain, eye, or heart, 616975 (3);chr1;RERE, NEDBEH;True
ENSG00000074800;Enolase-1, alpha;NotRelevant;;Enolase deficiency (1)Enolase deficiency (1);chr1;ENO1, PPH, MPB1;False
ENSG00000049239;Hexose-6-phosphate dehydrogenase;NotRelevant;digenic triallelic mutations with HSD11B1;Cortisone reductase deficiency 1, 604931 (3), Autosomal recessiveCortisone reductase deficiency 1, 604931 (3);chr1;H6PD, GDH, G6PDH, CORTRD1;True
ENSG00000171608;Phosphatidylinositol 3-kinase, catalytic, 110kD, delta;NotRelevant;;Immunodeficiency 14, 615513 (3), Autosomal dominantImmunodeficiency 14, 615513 (3);chr1;PIK3CD, APDS, IMD14;True
ENSG00000173614;Nicotinamide nucleotide adenylyltransferase 1;NotRelevant;;Leber congenital amaurosis 9, 608553 (3), Autosomal recessiveLeber congenital amaurosis 9, 608553 (3);chr1;NMNAT1, NMNAT, PNAT1, LCA9;True
ENSG00000054523;Kinesin family member 1B;NotRelevant;mutation identified in 1 CMT2A1 family;?Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant{Neuroblastoma, susceptibility to, 1}, 256700 (3);chr1;KIF1B, CMT2A, CMT2A1, NBLST1;True
ENSG00000142655;Peroxisome biogenesis factor 14;NotRelevant;;Peroxisome biogenesis disorder 13A (Zellweger), 614887 (3), Autosomal recessivePeroxisome biogenesis disorder 13A (Zellweger), 614887 (3);chr1;PEX14, PBD13A;True
ENSG00000120948;TAR DNA-binding protein;NotRelevant;pseudogenes on 2, 6, 8, 13, 20;Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominantFrontotemporal lobar degeneration, TARDBP-related, 612069 (3);chr1;TARDBP, TDP43, ALS10;True
ENSG00000009724;Mannan-binding lectin serine protease 2;NotRelevant;;MASP2 deficiency, 613791 (3), Autosomal recessiveMASP2 deficiency, 613791 (3);chr1;MASP2;True
ENSG00000198793;Mechanistic target of rapamycin;NotRelevant;;Focal cortical dysplasia, type II, somatic, 607341 (3)Smith-Kingsmore syndrome, 616638 (3);chr1;MTOR, FRAP1, SKS;False
ENSG00000120942;UbiA prenyltransferase domain-containing protein 1;NotRelevant;;Corneal dystrophy, Schnyder type, 121800 (3), Autosomal dominantCorneal dystrophy, Schnyder type, 121800 (3);chr1;UBIAD1, TERE1, SCCD;True
ENSG00000116670;Mitotic arrest-deficient 2, S. cerevisiae, homolog-like 2;NotRelevant;mutation identified in 1 FANCV patient; pseudogene on 14q21-q23?Fanconi anemia, complementation group V, 617243 (3);chr1;MAD2L2, MAD2B, FANCV;False
ENSG00000177000;Methylenetetrahydrofolate reductase;NotRelevant;;Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive{Vascular disease, susceptibility to} (3);chr1;MTHFR;True
ENSG00000175206;Natriuretic peptide precursor A;NotRelevant;;Atrial fibrillation, familial, 6, 612201 (3), Autosomal dominantAtrial standstill 2, 615745 (3);chr1;NPPA, PND, ANP, ATFB6, ATRST2;True
ENSG00000083444;Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase);NotRelevant;;Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessiveEhlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3);chr1;PLOD1, LH1, LLH, EDSKCL1;True
ENSG00000116688;Mitofusin 2;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominantHereditary motor and sensory neuropathy VIA, 601152 (3);chr1;MFN2, KIAA0214, CMT2A2A, HMSN6A, CMT2A2B;True
ENSG00000048707;Vacuolar protein sorting 13, yeast, homolog of, D;NotRelevant;;Spinocerebellar ataxia, autosomal recessive 4, 607317 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 4, 607317 (3);chr1;VPS13D, SCAR4;True
ENSG00000162438;Chymotrypsin;NotRelevant;;{Pancreatitis, chronic, susceptibility to}, 167800 (3), Autosomal dominant{Pancreatitis, chronic, susceptibility to}, 167800 (3);chr1;CTRC, CLCR;True
ENSG00000186510;Chloride channel, kidney, A;NotRelevant;11kb from CLCNKB; simultaneous mutation in CLCNKA and CLCNKBBartter syndrome, type 4b, digenic, 613090 (3);chr1;CLCNKA;False
ENSG00000184908;Chloride channel, kidney, B;NotRelevant;unequal crossingover with CLCNKA;Bartter syndrome, type 3, 607364 (3), Autosomal recessiveBartter syndrome, type 4b, digenic, 613090 (3);chr1;CLCNKB;True
ENSG00000142627;Ephrin receptor EphA2;NotRelevant;;Cataract 6, multiple types, 116600 (3), Autosomal dominantCataract 6, multiple types, 116600 (3);chr1;EPHA2, ECK, CTPP1, CTPA, ARCC2, CTRCT6;True
ENSG00000159363;ATPase, type 13A2;NotRelevant;mutation identified in 1 family with CLN12;Kufor-Rakeb syndrome, 606693 (3), Autosomal recessiveSpastic paraplegia 78, autosomal recessive, 617225 (3);chr1;ATP13A2, PARK9, KRPPD, SPG78;True
ENSG00000117118;Succinate dehydrogenase complex, subunit B, iron sulfur (Ip);NotRelevant;1 of 2 polypeptides;Gastrointestinal stromal tumor, 606444 (3)Pheochromocytoma, 171300 (3);chr1;SDHB, SDH2, SDHIP, PGL4;False
ENSG00000142619;Peptidylarginine deiminase, type III;NotRelevant;;Uncombable hair syndrome, 191480 (3), Autosomal recessiveUncombable hair syndrome, 191480 (3);chr1;PADI3, UHS1;True
ENSG00000159339;Peptidylarginine deiminase, type IV;NotRelevant;;{Rheumatoid arthritis, susceptibility to}, 180300 (3){Rheumatoid arthritis, susceptibility to}, 180300 (3);chr1;PADI4, PADI5, PAD;False
ENSG00000276747;Peptidylarginine deiminase, type VI;NotRelevant;;Preimplantation embryonic lethality 2, 617234 (3), Autosomal recessivePreimplantation embryonic lethality 2, 617234 (3);chr1;PADI6, PREMBL2;True
ENSG00000009709;Paired box homeotic gene-7;NotRelevant;fused with FKHR in rhabdomyosarcoma;Rhabdomyosarcoma 2, alveolar, 268220 (3), Autosomal recessiveRhabdomyosarcoma 2, alveolar, 268220 (3);chr1;PAX7, RMS2;True
ENSG00000159423;Aldehyde dehydrogenase 4 family, member A1 (delta-1-pyrroline 5-carboxylate dehydrogenase);NotRelevant;;Hyperprolinemia, type II, 239510 (3), Autosomal recessiveHyperprolinemia, type II, 239510 (3);chr1;ALDH4A1, ALDH4, P5CDH;True
ENSG00000127463;Endoplasmic reticulum membrane protein complex, subunit 1;NotRelevant;;Cerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3), Autosomal recessiveCerebellar atrophy, visual impairment, and psychomotor retardation, 616875 (3);chr1;EMC1, KIAA0090, CAVIPMR;True
ENSG00000188257;Phospholipase A2, group IIA, platelets, synovial fluid;NotRelevant;;{Colorectal cancer}, 114500 (3), Autosomal dominant{Colorectal cancer}, 114500 (3);chr1;PLA2G2A, PLA2B, PLA2L, MOM1;True
ENSG00000127472;Phospholipase A2, group V;NotRelevant;;[Fleck retina, familial benign], 228980 (3), Autosomal recessive[Fleck retina, familial benign], 228980 (3);chr1;PLA2G5, FRFB;True
ENSG00000158828;PTEN-induced putative kinase 1;NotRelevant;;Parkinson disease 6, early onset, 605909 (3), Autosomal recessiveParkinson disease 6, early onset, 605909 (3);chr1;PINK1, PARK6;True
ENSG00000244038;Dolichyl-diphosphooligosaccharide-protein glycosyltransferase;NotRelevant;mutation (cmpd het) identified in 1 CDG1R patient;?Congenital disorder of glycosylation, type Ir, 614507 (3), Autosomal recessive?Congenital disorder of glycosylation, type Ir, 614507 (3);chr1;DDOST, OST, OST48, CDG1R;True
ENSG00000117298;Endothelin converting enzyme 1;NotRelevant;mutation identified in 1 HCAD patient;?Hirschsprung disease, cardiac defects, and autonomic dysfunction, 613870 (3), Autosomal dominant{Hypertension, essential, susceptibility to}, 145500 (3);chr1;ECE1;True
ENSG00000162551;Alkaline phosphatase, liver/bone/kidney;NotRelevant;;Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominantOdontohypophosphatasia, 146300 (3);chr1;ALPL, HOPS, TNSALP;True
ENSG00000142798;Heparan sulfate proteoglycan of basement membrane (perlecan);NotRelevant;;Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessiveSchwartz-Jampel syndrome, type 1, 255800 (3);chr1;HSPG2, PLC, SJS, SJA, SJS1;True
ENSG00000070831;Cell division cycle 42 (GTP-binding protein, 25kD);NotRelevant;;Takenouchi-Kosaki syndrome, 616737 (3), Autosomal dominantTakenouchi-Kosaki syndrome, 616737 (3);chr1;CDC42, TKS;True
ENSG00000162552;Wingless-type MMTV integration site family, member 4;NotRelevant;mutation identified in 1 SERKAL family;Mullerian aplasia and hyperandrogenism, 158330 (3), Autosomal dominantMullerian aplasia and hyperandrogenism, 158330 (3);chr1;WNT4, SERKAL;True
ENSG00000173372;Complement component 1, q subcomponent, A chain;NotRelevant;;C1q deficiency, 613652 (3), Autosomal recessiveC1q deficiency, 613652 (3);chr1;C1QA;True
ENSG00000159189;Complement component 1, q subcomponent, C chain;NotRelevant;;C1q deficiency, 613652 (3), Autosomal recessiveC1q deficiency, 613652 (3);chr1;C1QC, C1QG;True
ENSG00000173369;Complement component 1, q subcomponent, B chain;NotRelevant;;C1q deficiency, 613652 (3), Autosomal recessiveC1q deficiency, 613652 (3);chr1;C1QB;True
ENSG00000133216;eph tyrosine kinase 3 (ephrin receptor EphB2);NotRelevant;;{Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3){Prostate cancer/brain cancer susceptibility, somatic}, 603688 (3);chr1;EPHB2, EPHT3, DRT, ERK, PCBC, CAPB;False
ENSG00000004487;Lysine-specific demethylase 1A;NotRelevant;;Cleft palate, psychomotor retardation, and distinctive facial features, 616728 (3), Autosomal dominantCleft palate, psychomotor retardation, and distinctive facial features, 616728 (3);chr1;KDM1A, LSD1, AOF2, BHC110, KIAA0601, CPRF;True
ENSG00000142676;Ribosomal protein L11;NotRelevant;;Diamond-Blackfan anemia 7, 612562 (3), Autosomal dominantDiamond-Blackfan anemia 7, 612562 (3);chr1;RPL11, DBA7;True
ENSG00000117308;UDP galactose-4-epimerase;NotRelevant;;Galactose epimerase deficiency, 230350 (3), Autosomal recessiveGalactose epimerase deficiency, 230350 (3);chr1;GALE;True
ENSG00000117305;3-hydroxy-3-methylglutaryl-Coenzyme A lyase;NotRelevant;;HMG-CoA lyase deficiency, 246450 (3), Autosomal recessiveHMG-CoA lyase deficiency, 246450 (3);chr1;HMGCL;True
ENSG00000179163;Fucosidase, alpha-L- 1, tissue;NotRelevant;8cM distal to RH; pseudogene on 2q31-q32Fucosidosis, 230000 (3);chr1;FUCA1;False
ENSG00000158055;Grainyhead-like 3;NotRelevant;;Van der Woude syndrome 2, 606713 (3), Autosomal dominantVan der Woude syndrome 2, 606713 (3);chr1;GRHL3, SOM, TFCP2L4, VWS2;True
ENSG00000187010;Rhesus system D polypeptide;NotRelevant;;[Rh-negative blood type] (3)[Rh-negative blood type] (3);chr1;RHD;False
ENSG00000188672;Rhesus system C and E polypeptides;NotRelevant;?order: C-E-D;[Blood group, Rhesus] (3)[Blood group, Rhesus] (3);chr1;RHCE, RHNA;False
ENSG00000157978;Low density lipoprotein receptor adaptor protein 1;NotRelevant;;Hypercholesterolemia, familial, autosomal recessive, 603813 (3), Autosomal recessiveHypercholesterolemia, familial, autosomal recessive, 603813 (3);chr1;LDLRAP1, ARH, FHCB2, FHCB1;True
ENSG00000162430;Selenoprotein N;NotRelevant;;Muscular dystrophy, rigid spine, 1, 602771 (3), Autosomal recessiveMyopathy, congenital, with fiber-type disproportion, 255310 (3);chr1;SELENON, SEPN1, SELN, RSMD1, CFTD;True
ENSG00000158014;Solute carrier family 30 (zinc transporter), member 2;NotRelevant;;Zinc deficiency, transient neonatal, 608118 (3), Autosomal dominantZinc deficiency, transient neonatal, 608118 (3);chr1;SLC30A2, ZNT2, TNZD;True
ENSG00000117682;Dehydrodolichyl diphosphate synthase;NotRelevant;mutation identified in 1 CDG1BB patient;?Congenital disorder of glycosylation, type 1bb, 613861 (3), Autosomal recessiveRetinitis pigmentosa 59, 613861 (3);chr1;DHDDS, HDS, RP59, DEDSM;True
ENSG00000117713;AT rich interactive domain 1A, SWI-like;NotRelevant;;Coffin-Siris syndrome 2, 614607 (3), Autosomal dominantCoffin-Siris syndrome 2, 614607 (3);chr1;ARID1A, C1orf4, B120, SMARCF1, MRD14, CSS2;True
ENSG00000060642;Phosphatidylinositol glycan, class V;NotRelevant;;Hyperphosphatasia with mental retardation syndrome 1, 239300 (3), Autosomal recessiveHyperphosphatasia with mental retardation syndrome 1, 239300 (3);chr1;PIGV, HPMRS1;True
ENSG00000131910;Nuclear receptor subfamily 0, group B, member 2;NotRelevant;;Obesity, mild, early-onset, 601665 (3), Autosomal recessive, Autosomal dominant, MultifactorialObesity, mild, early-onset, 601665 (3);chr1;NR0B2, SHP;True
ENSG00000175707;Keratinocyte differentiation factor 1;NotRelevant;mutation identified in 1 ECTD12 family;?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type, 617337 (3), Autosomal dominant?Ectodermal dysplasia 12, hypohidrotic/hair/tooth/nail type, 617337 (3);chr1;KDF1, C1orf172, ECTD12;True
ENSG00000090020;Solute carrier family 9 (sodium/hydrogen exchanger), member 1 (antiporter, Na+/H+, amiloride sensitive);NotRelevant;mutation identified in 1 LIKNS family;?Lichtenstein-Knorr syndrome, 616291 (3), Autosomal recessive?Lichtenstein-Knorr syndrome, 616291 (3);chr1;SLC9A1, NHE1, APNH, LIKNS;True
ENSG00000142748;Ficolin 3;NotRelevant;;Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessiveImmunodeficiency due to ficolin 3 deficiency, 613860 (3);chr1;FCN3, HAKA1;True
ENSG00000126705;AT-hook DNA-binding motif-containing protein 1;NotRelevant;;Xia-Gibbs syndrome, 615829 (3), Autosomal dominantXia-Gibbs syndrome, 615829 (3);chr1;AHDC1, MRD25;True
ENSG00000198492;YTH N6-methyladenosine RNA-binding protein 2;NotRelevant;fused with AML1 in t(1;21);chr1;YTHDF2;False
ENSG00000159023;Erythrocyte surface protein band 4.1;NotRelevant;;Elliptocytosis-1, 611804 (3), Autosomal recessive, Autosomal dominantElliptocytosis-1, 611804 (3);chr1;EPB41, EL1;True
ENSG00000116353;Mitochondrial trans-2-enoyl-CoA reductase;NotRelevant;;Dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3), Autosomal recessiveDystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities, 617282 (3);chr1;MECR, NRBF1, DYTOABG;True
ENSG00000162512;Syndecan 3;NotRelevant;;{Obesity, association with}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial{Obesity, association with}, 601665 (3);chr1;SDC3, SYND3, SDCN;True
ENSG00000134644;Pumilio, Drosophila, homolog of, 1;NotRelevant;;Spinocerebellar ataxia 47, 617931 (3), Autosomal dominantSpinocerebellar ataxia 47, 617931 (3);chr1;PUM1, KIAA0099, SCA47;True
ENSG00000160050;Coiled-coil domain-containing protein 28B;NotRelevant;;{Bardet-Biedl syndrome 1, modifier of}, 209900 (3), Autosomal recessive, Digenic recessive{Bardet-Biedl syndrome 1, modifier of}, 209900 (3);chr1;CCDC28B, MGC1203;True
ENSG00000182866;Lymphocyte-specific protein tyrosine kinase;NotRelevant;LCK/TCRB fusion in leukemia; mutation identified in 1 IMD22 patient?Immunodeficiency 22, 615758 (3);chr1;LCK, IMD22;False
ENSG00000134684;Tyrosyl-tRNA synthetase;NotRelevant;;Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominantCharcot-Marie-Tooth disease, dominant intermediate C, 608323 (3);chr1;YARS, CMTDIC, TYRRS, YTS, YRS;True
ENSG00000121905;Hippocalcin, 23kD, Ca2+-binding protein;NotRelevant;;Dystonia 2, torsion, autosomal recessive, 224500 (3), Autosomal recessiveDystonia 2, torsion, autosomal recessive, 224500 (3);chr1;HPCA, DYT2;True
ENSG00000004455;Adenylate kinase-2, mitochondrial;NotRelevant;;Reticular dysgenesis, 267500 (3), Autosomal recessiveReticular dysgenesis, 267500 (3);chr1;AK2;True
ENSG00000189433;Gap junction protein, beta-4;NotRelevant;;Erythrokeratodermia variabilis et progressiva 2, 617524 (3), Autosomal dominantErythrokeratodermia variabilis et progressiva 2, 617524 (3);chr1;GJB4, CX30.3, EKVP2;True
ENSG00000188910;Gap junction protein, beta-3;NotRelevant;same YAC as GJA4;Deafness, autosomal dominant 2B, 612644 (3), Autosomal dominantErythrokeratodermia variabilis et progressiva 1, 133200 (3);chr1;GJB3, CX31, DFNA2B, EKVP1;True
ENSG00000116863;ADP-ribosylhydrolase-like 2;NotRelevant;;Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, 618170 (3), Autosomal recessiveNeurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures, 618170 (3);chr1;ADPRHL2, ARH3, CONDSIAS;True
ENSG00000171812;Collagen VIII, alpha-2 polypeptide;NotRelevant;;Corneal dystrophy, Fuchs endothelial, 1, 136800 (3), Autosomal dominantCorneal dystrophy, posterior polymorphous 2, 609140 (3);chr1;COL8A2, FECD1, PPCD2;True
ENSG00000119535;Colony-stimulating factor-3 receptor (granulocyte);NotRelevant;;Neutropenia, severe congenital, 7, autosomal recessive, 617014 (3), Autosomal recessiveNeutropenia, severe congenital, 7, autosomal recessive, 617014 (3);chr1;CSF3R, GCSFR, SCN7;True
ENSG00000163877;SMAD nuclear interacting protein 1;NotRelevant;;Psychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3), Autosomal recessivePsychomotor retardation, epilepsy, and craniofacial dysmorphism, 614501 (3);chr1;SNIP1, PMRED;True
ENSG00000169218;Roof plate-specific spondin, mouse, homolog of, 1;NotRelevant;;Palmoplantar hyperkeratosis and true hermaphroditism, 610644 (3), Autosomal recessivePalmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal, 610644 (3);chr1;RSPO1, FLJ40906;True
ENSG00000043514;tRNA isopentenyltransferase 1;NotRelevant;;Combined oxidative phosphorylation deficiency 35, 617873 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 35, 617873 (3);chr1;TRIT1, IPT, COXPD35;True
ENSG00000168389;Major facilitator superfamily domain-containing protein 2A;NotRelevant;;Microcephaly 15, primary, autosomal recessive, 616486 (3), Autosomal recessiveMicrocephaly 15, primary, autosomal recessive, 616486 (3);chr1;MFSD2A, MCPH15;True
ENSG00000131238;Palmitoyl-protein thioesterase 1;NotRelevant;;Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessiveCeroid lipofuscinosis, neuronal, 1, 256730 (3);chr1;PPT1, CLN1;True
ENSG00000084073;Zinc metalloproteinase STE24;NotRelevant;;Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessiveRestrictive dermopathy, lethal, 275210 (3);chr1;ZMPSTE24, FACE1, STE24, MADB;True
ENSG00000049089;Collagen IX, alpha-2 polypeptide;NotRelevant;mutation identified in1 STL5 family;Epiphyseal dysplasia, multiple, 2, 600204 (3), Autosomal dominantEpiphyseal dysplasia, multiple, 2, 600204 (3);chr1;COL9A2, EDM2, STL5;True
ENSG00000117013;Potassium voltage-gated channel, KQT-like subfamily, member 4;NotRelevant;;Deafness, autosomal dominant 2A, 600101 (3), Autosomal dominantDeafness, autosomal dominant 2A, 600101 (3);chr1;KCNQ4, DFNA2A;True
ENSG00000171793;Cytidine 5'-triphosphate synthetase 1;NotRelevant;;Immunodeficiency 24, 615897 (3), Autosomal recessiveImmunodeficiency 24, 615897 (3);chr1;CTPS1, CTPS, IMD24;True
ENSG00000127125;Phosphopantothenoylcysteine synthetase;NotRelevant;;Cardiomyopathy, dilated, 2C, 618189 (3), Autosomal recessiveCardiomyopathy, dilated, 2C, 618189 (3);chr1;PPCS, CMD2C;True
ENSG00000164007;Claudin 19;NotRelevant;;Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessiveHypomagnesemia 5, renal, with ocular involvement, 248190 (3);chr1;CLDN19, HOMG5;True
ENSG00000117385;Prolyl 3-hydroxylase 1;NotRelevant;;Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessiveOsteogenesis imperfecta, type VIII, 610915 (3);chr1;P3H1, LEPRE1, GROS1, OI8;True
ENSG00000164010;Erythroblast membrane-associated protein;NotRelevant;;[Blood group, Radin], 111620 (3)[Blood group, Scianna system], 111750 (3);chr1;ERMAP, SC, RD;False
ENSG00000117394;Solute carrier family 2 (facilitated glucose transporter), member 1;NotRelevant;probably in 1p33;Dystonia 9, 601042 (3), Autosomal dominant{Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3);chr1;SLC2A1, GLUT1, HTLVR, DYT18, PED, GLUT1DS, EIG12, DYT9, SDCHCN;True
ENSG00000117400;Myeloproliferative leukemia virus, homolog of;NotRelevant;;Myelofibrosis with myeloid metaplasia, somatic, 254450 (3)Thrombocytopenia, congenital amegakaryocytic, 604498 (3);chr1;MPL, TPOR, MPLV, THCYT2;False
ENSG00000198198;Seizure threshold 2, mouse, homolog of;NotRelevant;;Epileptic encephalopathy, early infantile, 18, 615476 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 18, 615476 (3);chr1;SZT2, KIAA0467, EIEE18;True
ENSG00000142949;Protein tyrosine phosphatase, receptor type, f polypeptide;NotRelevant;mutation identified in 1 BNAH2 family;?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3), Autosomal recessive?Breasts and/or nipples, aplasia or hypoplasia of, 2, 616001 (3);chr1;PTPRF, LAR, BNAH2;True
ENSG00000126091;ST3 beta-galactoside alpha-2,3-sialyltransferase 3;NotRelevant;mutation identified in 1 EIEE15 family;?Epileptic encephalopathy, early infantile, 15, 615006 (3), Autosomal recessiveMental retardation, autosomal recessive 12, 611090 (3);chr1;ST3GAL3, SIAT6, ST3GALII, MRT12, EIEE15;True
ENSG00000196517;Solute carrier family 6 (neurotransmitter transporter, glycine), member 9;NotRelevant;;Glycine encephalopathy with normal serum glycine, 617301 (3), Autosomal recessiveGlycine encephalopathy with normal serum glycine, 617301 (3);chr1;SLC6A9, GLYT1, GCENSG;True
ENSG00000117425;Patched, Drosophila, homolog of, 2;NotRelevant;;Basal cell carcinoma, somatic, 605462 (3)Medulloblastoma, somatic, 155255 (3);chr1;PTCH2;False
ENSG00000070785;Eukaryotic translation initiation factor 2B, subunit 3;NotRelevant;;Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessiveLeukoencephalopathy with vanishing white matter, 603896 (3);chr1;EIF2B3;True
ENSG00000126088;Uroporphyrinogen decarboxylase;NotRelevant;;Porphyria cutanea tarda, 176100 (3), Autosomal recessive, Autosomal dominantPorphyria, hepatoerythropoietic, 176100 (3);chr1;UROD;True
ENSG00000132781;MutY, E. coli, homolog of;NotRelevant;;Adenomas, multiple colorectal, 608456 (3), Autosomal recessiveGastric cancer, somatic, 613659 (3);chr1;MUTYH, MYH;True
ENSG00000132773;Target of EGR1;NotRelevant;;Pontocerebellar hypoplasia, type 7, 614969 (3), Autosomal recessivePontocerebellar hypoplasia, type 7, 614969 (3);chr1;TOE1, PCH7;True
ENSG00000132763;MMACHC gene;NotRelevant;;Methylmalonic aciduria and homocystinuria, cblC type, 277400 (3), Autosomal recessiveMethylmalonic aciduria and homocystinuria, cblC type, 277400 (3);chr1;MMACHC;True
ENSG00000117450;Peroxiredoxin 1;NotRelevant;pseudogene PAGB on 9p22;Methylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3), Autosomal recessiveMethylmalonic aciduria and homocystinuria, cblC type, digenic, 277400 (3);chr1;PRDX1, PRXI, PAGA, NKEFA;True
ENSG00000085998;Protein 0-mannose beta-1,2-N-acetylglucosaminyltransferase;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessiveRetinitis pigmentosa 76, 617123 (3);chr1;POMGNT1, MEB, MDDGA3, MDDGB3, MDDGC3, RP76, LGMDR15;True
ENSG00000085999;RAD54, S. cerevisiae, homolog-like;NotRelevant;;Adenocarcinoma, colonic, somatic (3){Breast cancer, invasive ductal}, 114480 (3);chr1;RAD54L, HR54, HRAD54;False
ENSG00000117480;Fatty acid amide hydrolase;NotRelevant;;{Drug addiction, susceptibility to}, 606581 (3){Drug addiction, susceptibility to}, 606581 (3);chr1;FAAH;False
ENSG00000162367;T-cell acute lymphocytic leukemia-1;NotRelevant;proximal to MYCL1;Leukemia, T-cell acute lymphocytic, somatic, 613065 (3)Leukemia, T-cell acute lymphocytic, somatic, 613065 (3);chr1;TAL1, TCL5, SCL;False
ENSG00000123473;SCL/TAL1-interrupting locus;NotRelevant;within about 250kb of SCL;Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessiveMicrocephaly 7, primary, autosomal recessive, 612703 (3);chr1;STIL, SIL, MCPH7;True
ENSG00000186790;Forkhead box E3;NotRelevant;;Anterior segment dysgenesis 2, multiple subtypes, 610256 (3), Autosomal recessive{Aortic aneurysm, familial thoracic 11, susceptibility to}, 617349 (3);chr1;FOXE3, FKHL12, ASMD, CTRCT34, ASGD2, AAT11;True
ENSG00000085840;Origin recognition complex, subunit 1, S. cerevisiae, homolog;NotRelevant;;Meier-Gorlin syndrome 1, 224690 (3), Autosomal recessiveMeier-Gorlin syndrome 1, 224690 (3);chr1;ORC1, ORC1L;True
ENSG00000162377;Cytochrome C oxidase assembly factor;NotRelevant;mutation identified in 1 COX4D patient;?Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial?Mitochondrial complex IV deficiency, 220110 (3);chr1;COA7, RESA1, SELRC1, C1orf163;True
ENSG00000116171;Sterol carrier protein-2;NotRelevant;mutation identified in 1 LKDMN patient;?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3), Autosomal recessive?Leukoencephalopathy with dystonia and motor neuropathy, 613724 (3);chr1;SCP2;True
ENSG00000157184;Carnitine palmitoyltransferase II;NotRelevant;formerly at 1p13;CPT II deficiency, infantile, 600649 (3), Autosomal recessive{Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3);chr1;CPT2, IIAE4;True
ENSG00000157193;Low density lipoprotein receptor-related protein 8 (Apolipoprotein E receptor 2);NotRelevant;;{Myocardial infarction, susceptibility to}, 608446 (3){Myocardial infarction, susceptibility to}, 608446 (3);chr1;LRP8, APOER2, MCI1;False
ENSG00000116133;24-dehydrocholesterol reductase;NotRelevant;;Desmosterolosis, 602398 (3), Autosomal recessiveDesmosterolosis, 602398 (3);chr1;DHCR24, KIAA0018;True
ENSG00000162399;Barttin;NotRelevant;;Bartter syndrome, type 4a, 602522 (3), Autosomal recessiveSensorineural deafness with mild renal dysfunction, 602522 (3);chr1;BSND;True
ENSG00000169174;Proprotein convertase, subtilisin/kexin-type, 9;NotRelevant;;Hypercholesterolemia, familial, 3, 603776 (3){Low density lipoprotein cholesterol level QTL 1}, 603776 (3);chr1;PCSK9, NARC1, HCHOLA3, FH3, LDLCQ1;False
ENSG00000157131;Complement component-8, alpha polypeptide;NotRelevant;;C8 deficiency, type I, 613790 (3), Autosomal recessiveC8 deficiency, type I, 613790 (3);chr1;C8A;True
ENSG00000021852;Complement component-8, beta polypeptide;NotRelevant;;C8 deficiency, type II, 613789 (3), Autosomal recessiveC8 deficiency, type II, 613789 (3);chr1;C8B;True
ENSG00000173406;Disabled, Drosophila, homolog 1;NotRelevant;;Spinocerebellar ataxia 37, 615945 (3), Autosomal dominantSpinocerebellar ataxia 37, 615945 (3);chr1;DAB1, SCA37;True
ENSG00000184292;Tumor-associated calcium signal transducer 2;NotRelevant;;Corneal dystrophy, gelatinous drop-like, 204870 (3), Autosomal recessiveCorneal dystrophy, gelatinous drop-like, 204870 (3);chr1;TACSTD2, TROP2, M1S1;True
ENSG00000162601;MYB-like, SWIRM, and MPN domains-containing protein 1;NotRelevant;;Bone marrow failure syndrome 4, 618116 (3), Autosomal recessiveBone marrow failure syndrome 4, 618116 (3);chr1;MYSM1, 2ADUB, KIAA1915, BMFS4;True
ENSG00000162599;Nuclear factor I/A;NotRelevant;;Brain malformations with or without urinary tract defects, 613735 (3), Isolated casesBrain malformations with or without urinary tract defects, 613735 (3);chr1;NFIA, BRMUTD;False
ENSG00000116641;Dedicator of cytokinesis 7;NotRelevant;;Epileptic encephalopathy, early infantile, 23, 615859 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 23, 615859 (3);chr1;DOCK7, KIAA1771, EIEE23;True
ENSG00000132855;Angiopoietin-like 3;NotRelevant;;Hypobetalipoproteinemia, familial, 2, 605019 (3), Autosomal recessiveHypobetalipoproteinemia, familial, 2, 605019 (3);chr1;ANGPTL3, ANGPT5, FHBL2;True
ENSG00000187140;Forkhead box D3;NotRelevant;;{Autoimmune disease, susceptibility to, 1}, 607836 (3), Autosomal dominant{Autoimmune disease, susceptibility to, 1}, 607836 (3);chr1;FOXD3, AIS1, VAMAS2;True
ENSG00000088035;Alg6, S. cerevisiae, homolog of;NotRelevant;;Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessiveCongenital disorder of glycosylation, type Ic, 603147 (3);chr1;ALG6, CDG1C;True
ENSG00000079739;Phosphoglucomutase-1;NotRelevant;distal to ACADM; formerly 1p22.1Congenital disorder of glycosylation, type It, 614921 (3);chr1;PGM1, GSD14, CDG1T;False
ENSG00000185483;Receptor tyrosine kinase-like orphan receptor 1;NotRelevant;mutation identified in 1 DFNB108 family;?Deafness, autosomal recessive 108, 617654 (3), Autosomal recessive?Deafness, autosomal recessive 108, 617654 (3);chr1;ROR1, NTRKR1;True
ENSG00000116675;DNAJ, E. coli, homolog of, subfamily C, member 6;NotRelevant;;Parkinson disease 19a, juvenile-onset, 615528 (3), Autosomal recessiveParkinson disease 19b, early-onset, 615528 (3);chr1;DNAJC6, DJC6, KIAA0473, PARK19;True
ENSG00000116678;Leptin receptor;NotRelevant;;Obesity, morbid, due to leptin receptor deficiency, 614963 (3)Obesity, morbid, due to leptin receptor deficiency, 614963 (3);chr1;LEPR, OBR, LEPRD;False
ENSG00000116704;Solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1;NotRelevant;;Schneckenbecken dysplasia, 269250 (3), Autosomal recessiveSchneckenbecken dysplasia, 269250 (3);chr1;SLC35D1, UGTREL7, KIAA0260, SHNKND;True
ENSG00000162594;Interleukin 23 receptor;NotRelevant;;{Inflammatory bowel disease 17, protection against}, 612261 (3){Psoriasis, protection against}, 605606 (3);chr1;IL23R, IBD17;False
ENSG00000116745;RPE65 retinoid isomerohydrolase;NotRelevant;;Leber congenital amaurosis 2, 204100 (3), Autosomal recessiveRetinitis pigmentosa 20, 613794 (3);chr1;RPE65, RP20, LCA2;True
ENSG00000116761;Cystathionine gamma-lyase;NotRelevant;previously assigned to chr.16;Cystathioninuria, 219500 (3), Autosomal recessiveHomocysteine, total plasma, elevated (3);chr1;CTH;True
ENSG00000116783;TNNI3-interacting kinase;NotRelevant;;Cardiac conduction disease with or without dilated cardiomyopathy, 616117 (3), Autosomal dominantCardiac conduction disease with or without dilated cardiomyopathy, 616117 (3);chr1;TNNI3K, CCDD;True
ENSG00000117054;Acyl-Coenzyme A dehydrogenase, C-4 to C-12 straight chain;NotRelevant;;Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessiveAcyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3);chr1;ACADM, MCAD;True
ENSG00000162614;Nexilin, rat, homolog of;NotRelevant;;Cardiomyopathy, dilated, 1CC, 613122 (3), Autosomal dominantCardiomyopathy, hypertrophic, 20, 613876 (3);chr1;NEXN, NELIN, CMD1CC, CMH20;True
ENSG00000142867;B-cell leukemia/lymphoma 10;NotRelevant;mutation identified in 1 IMD37 patient;?Immunodeficiency 37, 616098 (3), Autosomal recessive{Sezary syndrome, somatic}, (3);chr1;BCL10, IMD37;True
ENSG00000122482;Zinc finger protein 644;NotRelevant;;Myopia 21, autosomal dominant, 614167 (3), Autosomal dominantMyopia 21, autosomal dominant, 614167 (3);chr1;ZNF644, MYP21;True
ENSG00000162669;Hfm1, ATP-dependent DNA helicase, S. cerevisiae, homolog of;NotRelevant;;Premature ovarian failure 9, 615724 (3), Autosomal recessivePremature ovarian failure 9, 615724 (3);chr1;HFM1, MER3, POF9;True
ENSG00000137948;Bromodomain, testis-specific;NotRelevant;mutation identified in 1 SPGF21 patient;?Spermatogenic failure 21, 617644 (3), Autosomal recessive?Spermatogenic failure 21, 617644 (3);chr1;BRDT, SPGF21;True
ENSG00000174842;Glomulin;NotRelevant;;Glomuvenous malformations, 138000 (3), Autosomal dominantGlomuvenous malformations, 138000 (3);chr1;GLML, GVM, VMGLOM;True
ENSG00000162676;Growth factor independent 1;NotRelevant;mutation identified in 1 SCN2 patient and 1 NICINA patient;?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant?Neutropenia, severe congenital 2, autosomal dominant, 613107 (3);chr1;GFI1, ZNF163, SCN2;True
ENSG00000122406;Ribosomal protein L5;NotRelevant;;Diamond-Blackfan anemia 6, 612561 (3), Autosomal dominantDiamond-Blackfan anemia 6, 612561 (3);chr1;RPL5, DBA6;True
ENSG00000023909;Glutamate-cysteine ligase, modifier subunit;NotRelevant;;{Myocardial infarction, susceptibility to}, 608446 (3){Myocardial infarction, susceptibility to}, 608446 (3);chr1;GCLM, GLCLR;False
ENSG00000198691;ATP-binding transporter, retina-specific;NotRelevant;;Cone-rod dystrophy 3, 604116 (3){Macular degeneration, age-related, 2}, 153800 (3);chr1;ABCA4, ABCR, STGD1, FFM, RP19, CORD3, ARMD2;False
ENSG00000117528;ATP-binding cassette, subfamily D, member 3 (peroxisomal membrane protein 1, 70kD);NotRelevant;mutation identified in 1 CBAS5 family;?Bile acid synthesis defect, congenital, 5, 616278 (3), Autosomal recessive?Bile acid synthesis defect, congenital, 5, 616278 (3);chr1;ABCD3, PXMP1, PMP70, CBAS5;True
ENSG00000172339;Alg14, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 CMSWTA family;?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3), Autosomal recessive?Myasthenic syndrome, congenital, 15, without tubular aggregates, 616227 (3);chr1;ALG14, CMS15;True
ENSG00000188641;Dihydropyrimidine dehydrogenase;NotRelevant;;Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessiveDihydropyrimidine dehydrogenase deficiency, 274270 (3);chr1;DPYD, DPD;True
ENSG00000162688;Amylo-1,6-glucosidase, 4-alpha-glucanotransferase (glycogen debranching enzyme);NotRelevant;;Glycogen storage disease IIIa, 232400 (3), Autosomal recessiveGlycogen storage disease IIIb, 232400 (3);chr1;AGL, GDE;True
ENSG00000117620;Solute carrier family 35 (UDP-GlcNAc transporter), member 3;NotRelevant;mutation identified in 1 family;?Arthrogryposis, mental retardation, and seizures, 615553 (3), Autosomal recessive?Arthrogryposis, mental retardation, and seizures, 615553 (3);chr1;SLC35A3, AMRS;True
ENSG00000156876;SAS-6 centriolar assembly protein;NotRelevant;mutation identified in 1 MCPH14 family;?Microcephaly 14, primary, autosomal recessive, 616402 (3), Autosomal recessive?Microcephaly 14, primary, autosomal recessive, 616402 (3);chr1;SASS6, SAS6, MCPH14;True
ENSG00000137992;Dihydrolipoamide branched chain transacylase (E2 component of branched chain keto acid dehydrogenase complex);NotRelevant;pseudogene on 3q24;Maple syrup urine disease, type II, 248600 (3), Autosomal recessiveMaple syrup urine disease, type II, 248600 (3);chr1;DBT, BCATE2;True
ENSG00000079335;Cell division cycle 14, S. cerevisiae, homolog A;NotRelevant;;Deafness, autosomal recessive 32, with or without immotile sperm, 608653 (3), Autosomal recessiveDeafness, autosomal recessive 32, with or without immotile sperm, 608653 (3);chr1;CDC14A, DFNB32;True
ENSG00000181656;G protein-coupled receptor 88;NotRelevant;mutation identified in 1 COCPMR family;?Chorea, childhood-onset, with psychomotor retardation, 616939 (3), Autosomal recessive?Chorea, childhood-onset, with psychomotor retardation, 616939 (3);chr1;GPR88, STRG, COCPMR;True
ENSG00000060718;Collagen XI, alpha-1 polypeptide;NotRelevant;;Fibrochondrogenesis 1, 228520 (3), Autosomal recessive{Lumbar disc herniation, susceptibility to}, 603932 (3);chr1;COL11A1, STL2;True
ENSG00000185946;RNA-binding region-containing protein 3;NotRelevant;mutation identified in 1 IGHD5 family;?Growth hormone deficiency, isolated, type V, 618160 (3), Autosomal recessive?Growth hormone deficiency, isolated, type V, 618160 (3);chr1;RNPC3, SNRNP65, KIAA1839, IGHD5;True
ENSG00000085491;Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 24;NotRelevant;;Fontaine progeroid syndrome, 612289 (3), Autosomal dominantFontaine progeroid syndrome, 612289 (3);chr1;SLC25A24, SCAMC1;True
ENSG00000121957;G protein signaling modulator 2;NotRelevant;;Chudley-McCullough syndrome, 604213 (3), Autosomal recessiveChudley-McCullough syndrome, 604213 (3);chr1;GPSM2, LGN, PINS, DFNB82, CMCS;True
ENSG00000197780;TAF13 RNA polymerase II, TATA box-binding protein-associated factor, 18kD;NotRelevant;;Mental retardation, autosomal recessive 60, 617432 (3), Autosomal recessiveMental retardation, autosomal recessive 60, 617432 (3);chr1;TAF13, TAF2K, MRT60;True
ENSG00000031698;Seryl-tRNA synthetase;NotRelevant;mutation identified in 1 NEDMAS family;?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive?Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3);chr1;SARS, SERS, NEDMAS;True
ENSG00000134243;Sortilin;NotRelevant;;[Low density lipoprotein cholesterol level QTL6], 613589 (3), Autosomal dominant[Low density lipoprotein cholesterol level QTL6], 613589 (3);chr1;SORT1, NT3, LDLCQ6;True
ENSG00000065135;Guanine nucleotide-binding protein (G-protein), alpha-inhibiting activity polypeptide-3;NotRelevant;;Auriculocondylar syndrome 1, 602483 (3), Autosomal dominantAuriculocondylar syndrome 1, 602483 (3);chr1;GNAI3, ARCND1;True
ENSG00000134183;Guanine nucleotide-binding protein (G-protein), alpha-transducing (transducin) activity polypeptide-2;NotRelevant;;Achromatopsia 4, 613856 (3)Achromatopsia 4, 613856 (3);chr1;GNAT2, ACHM4;False
ENSG00000116337;Adenosine monophosphate deaminase-2, isoform L;NotRelevant;mutation identified in 1 SPG63 family;Pontocerebellar hypoplasia, type 9, 615809 (3), Autosomal recessivePontocerebellar hypoplasia, type 9, 615809 (3);chr1;AMPD2, SPG63, PCH9;True
ENSG00000156150;Aristaless-like homeobox 3;NotRelevant;;Frontonasal dysplasia 1, 136760 (3), Autosomal recessiveFrontonasal dysplasia 1, 136760 (3);chr1;ALX3, FND1;True
ENSG00000197106;Solute carrier family 6 (neurotransmitter transporter), member 17;NotRelevant;;Mental retardation, autosomal recessive 48, 616269 (3), Autosomal recessiveMental retardation, autosomal recessive 48, 616269 (3);chr1;SLC6A17, NTT4, MRT48;True
ENSG00000162775;One-twenty two protein (RNA binding motif protein 15;NotRelevant;ENSG00000162775;Megakaryoblastic leukemia, acute (2);chr1;RBM15, SPEN, OTT;False
ENSG00000177301;Potassium channel, voltage-gated, Shaker-related subfamily, member 2;NotRelevant;;Epileptic encephalopathy, early infantile, 32, 616366 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 32, 616366 (3);chr1;KCNA2, EIEE32;True
ENSG00000156171;Damage-regulated autophagy modulator 2;NotRelevant;;Cone-rod dystrophy 21, 616502 (3), Autosomal recessiveCone-rod dystrophy 21, 616502 (3);chr1;DRAM2, TMEM77, CORD21;True
ENSG00000171385;Potassium voltage-gated channel, Shal-related subfamily, member 3;NotRelevant;;Brugada syndrome 9, 616399 (3), Autosomal dominantSpinocerebellar ataxia 19, 607346 (3);chr1;KCND3, KCND3S, KCND3L, SCA19, SCA22, BRGDA9;True
ENSG00000134245;Wingless-type MMTV integration site family, member 2B;NotRelevant;;Diarrhea 9, 618168 (3), Autosomal recessiveDiarrhea 9, 618168 (3);chr1;WNT2B, WNT13, XWNT2;True
ENSG00000155380;Solute carrier family 16 (monocarboxylic acid transporters), member 1;NotRelevant;;Erythrocyte lactate transporter defect, 245340 (3), Autosomal dominantMonocarboxylate transporter 1 deficiency, 616095 (3);chr1;SLC16A1, MCT1, HHF7, MCT1D;True
ENSG00000198799;Leucine-rich repeats- and immunoglobulin-like domains-containing protein 2;NotRelevant;;Urofacial syndrome 2, 615112 (3), Autosomal recessiveUrofacial syndrome 2, 615112 (3);chr1;LRIG2, LIG2, KIAA0806, UFS2;True
ENSG00000134242;Protein tyrosine phosphatase, nonreceptor-type 22;NotRelevant;;{Diabetes, type 1, susceptibility to}, 222100 (3), Autosomal recessive{Systemic lupus erythematosus susceptibility to}, 152700 (3);chr1;PTPN22, PEP, PTPN8, LYP;True
ENSG00000134262;Adaptor-related protein complex 4, beta-1 subunit;NotRelevant;;Spastic paraplegia 47, autosomal recessive, 614066 (3), Autosomal recessiveSpastic paraplegia 47, autosomal recessive, 614066 (3);chr1;AP4B1, SPG47, CPSQ5;True
ENSG00000116748;Adenosine monophosphate deaminase-1, muscle;NotRelevant;;Myopathy due to myoadenylate deaminase deficiency, 615511 (3), Autosomal recessiveMyopathy due to myoadenylate deaminase deficiency, 615511 (3);chr1;AMPD1, MMDD;True
ENSG00000213281;Neuroblastoma RAS viral (v-ras) oncogene homolog;NotRelevant;cen-CD2-NGFB-NRAS;Colorectal cancer, somatic, 114500 (3)Thyroid carcinoma, follicular, somatic, 188470 (3);chr1;NRAS, ALPS4, NS6, CMNS, NCMS;False
ENSG00000134200;Thyroid-stimulating hormone, beta polypeptide;NotRelevant;centromeric to NGFB;Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessiveHypothyroidism, congenital, nongoitrous 4, 275100 (3);chr1;TSHB, CHNG4;True
ENSG00000134259;Nerve growth factor, beta;NotRelevant;same 310kb fragment as TSHB; order: cen-CD2-CD58-ATP1A1-NGF-TSHB-NRAS-telNeuropathy, hereditary sensory and autonomic, type V, 608654 (3);chr1;NGF, NGFB, HSAN5;False
ENSG00000173218;Vang-like 1;NotRelevant;;Caudal regression syndrome, 600145 (3), Autosomal dominant{Neural tube defects, susceptibility to}, 182940 (3);chr1;VANGL1, STBM2;True
ENSG00000118729;Calsequestrin, fast-twitch, skeletal muscle-2;NotRelevant;;Ventricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3), Autosomal recessiveVentricular tachycardia, catecholaminergic polymorphic, 2, 611938 (3);chr1;CASQ2;True
ENSG00000163399;ATPase, Na+K+ transporting, alpha-1 polypeptide;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3), Autosomal dominantCharcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3);chr1;ATP1A1, CMT2DD;True
ENSG00000116815;CD58 antigen (lymphocyte function-associated antigen 3);NotRelevant;?same as MSK1; gene cloned;chr1;CD58, LFA3;False
ENSG00000143061;Immunoglobulin superfamily, member 3;NotRelevant;mutation identified in 1 LCDD family;?Lacrimal duct defect, 149700 (3), Autosomal recessive?Lacrimal duct defect, 149700 (3);chr1;IGSF3, LCDD;True
ENSG00000092607;T-box 15;NotRelevant;;Cousin syndrome, 260660 (3), Autosomal recessiveCousin syndrome, 260660 (3);chr1;TBX15;True
ENSG00000116874;Tryptophanyl-tRNA synthetase 2;NotRelevant;;Neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3), Autosomal recessiveNeurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures, 617710 (3);chr1;WARS2, NEMMLAS;True
ENSG00000203859;Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase, type 2 (adrenal, gonadal);NotRelevant;;Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessiveAdrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3);chr1;HSD3B2;True
ENSG00000092621;Phosphoglycerate dehydrogenase;NotRelevant;;Neu-Laxova syndrome 1, 256520 (3), Autosomal recessivePhosphoglycerate dehydrogenase deficiency, 601815 (3);chr1;PHGDH, NLS1, PHGDHD;True
ENSG00000134240;3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2, mitochondrial;NotRelevant;;HMG-CoA synthase-2 deficiency, 605911 (3), Autosomal recessiveHMG-CoA synthase-2 deficiency, 605911 (3);chr1;HMGCS2;True
ENSG00000134250;Notch, Drosophila, homolog  of, 2;NotRelevant;;Alagille syndrome 2, 610205 (3), Autosomal dominantHajdu-Cheney syndrome, 102500 (3);chr1;NOTCH2, AGS2, HJCYS;True
ENSG00000131779;Peroxisome biogenesis 11B;NotRelevant;mutation identified in 1 PEX14B patient;?Peroxisome biogenesis disorder 14B, 614920 (3), Autosomal recessive?Peroxisome biogenesis disorder 14B, 614920 (3);chr1;PEX11B, PEX14B;True
ENSG00000265241;RNA-binding motif protein 8A;NotRelevant;pseudogene on chr.14;Thrombocytopenia-absent radius syndrome, 274000 (3), Autosomal recessiveThrombocytopenia-absent radius syndrome, 274000 (3);chr1;RBM8A, RBM8B, TAR, C1DELq21.1, DEL1q21.1;True
ENSG00000168509;Hemojuvelin;NotRelevant;between D1S442 and D1S2347;Hemochromatosis, type 2A, 602390 (3), Autosomal recessiveHemochromatosis, type 2A, 602390 (3);chr1;HJV, HFE2A;True
ENSG00000265107;Gap junction protein, alpha-5, 40kD (connexin 40);NotRelevant;;Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominantAtrial standstill, digenic (GJA5/SCN5A), 108770 (3);chr1;GJA5, CX40, ATFB11;True
ENSG00000121634;Gap junction membrane channel protein alpha-8 (connexin 50);NotRelevant;;Cataract 1, multiple types, 116200 (3), Autosomal dominantCataract 1, multiple types, 116200 (3);chr1;GJA8, CX50, CTRCT1, CZP1, CAE1;True
ENSG00000150337;Fc fragment of IgG, high affinity Ia, receptor for (CD64);NotRelevant;;[IgG receptor I, phagocytic, familial deficiency of] (3)[IgG receptor I, phagocytic, familial deficiency of] (3);chr1;FCGR1A, IGFR1, CD64;False
ENSG00000270882;H4 histone, family 2;NotRelevant;100-200 histone genes; some on chromosome 6 and 12, as well as perhaps 7;chr1;H4FN, H4F2;False
ENSG00000143368;Splicing factor 3B, subunit 4;NotRelevant;;Acrofacial dysostosis 1, Nager type, 154400 (3), Autosomal dominantAcrofacial dysostosis 1, Nager type, 154400 (3);chr1;SF3B4, SF3B49, SAP49, AFD1;True
ENSG00000136631;Vacuolar protein sorting 45, yeast, homolog of, A;NotRelevant;;Neutropenia, severe congenital, 5, autosomal recessive, 615285 (3), Autosomal recessiveNeutropenia, severe congenital, 5, autosomal recessive, 615285 (3);chr1;VPS45A, VPS45, SCN5;True
ENSG00000117360;Precursor mRNA-processing factor 3, S. cerevisiae, homolog of;NotRelevant;;Retinitis pigmentosa 18, 601414 (3), Autosomal dominantRetinitis pigmentosa 18, 601414 (3);chr1;PRPF3, HPRP3, RP18;True
ENSG00000143374;Threonyl-tRNA synthetase 2;NotRelevant;mutation identified in one COXPD21 family;?Combined oxidative phosphorylation deficiency 21, 615918 (3), Autosomal recessive?Combined oxidative phosphorylation deficiency 21, 615918 (3);chr1;TARS2, COXPD21;True
ENSG00000143369;Extracellular matrix protein-1;NotRelevant;;Urbach-Wiethe disease, 247100 (3), Autosomal recessiveUrbach-Wiethe disease, 247100 (3);chr1;ECM1, URBWD;True
ENSG00000143382;ADAMTS-like 4;NotRelevant;;Ectopia lentis et pupillae, 225200 (3), Autosomal recessiveEctopia lentis, isolated, autosomal recessive, 225100 (3);chr1;ADAMTSL4, TSRC1, ECTOL2;True
ENSG00000143387;Cathepsin K;NotRelevant;;Pycnodysostosis, 265800 (3), Autosomal recessivePycnodysostosis, 265800 (3);chr1;CTSK;True
ENSG00000143363;Prune exopolyphosphatase 1;NotRelevant;;Neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3), Autosomal recessiveNeurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies, 617481 (3);chr1;PRUNE1, DRES17, NMIHBA;True
ENSG00000143373;Zinc finger protein 687;NotRelevant;fused with AML1 in t(1;21)Paget disease of bone 6, 616833 (3);chr1;ZNF687, KIAA1441, PDB6;False
ENSG00000143390;Regulatory factor X, 5 (influences HLA class II expression);NotRelevant;;Bare lymphocyte syndrome, type II, complementation group C, 209920 (3), Autosomal recessiveBare lymphocyte syndrome, type II, complementation group E, 209920 (3);chr1;RFX5;True
ENSG00000143416;Selenium-binding protein 1;NotRelevant;;Extraoral halitosis due to MTO deficiency, 618148 (3), Autosomal recessiveExtraoral halitosis due to MTO deficiency, 618148 (3);chr1;SELENBP1, SP56, EHMTO;True
ENSG00000159377;Proteasome subunit, beta type, 4;NotRelevant;mutation identified in 1 PRAAS3 patient and 1 digenic family;?Proteasome-associated autoinflammatory syndrome 3 and digenic forms, 617591 (3), Autosomal recessive?Proteasome-associated autoinflammatory syndrome 3 and digenic forms, 617591 (3);chr1;PSMB4, PRAAS3;True
ENSG00000143442;POGO transposable element with ZNF domain;NotRelevant;;White-Sutton syndrome, 616364 (3), Autosomal dominantWhite-Sutton syndrome, 616364 (3);chr1;POGZ, KIAA0461, MRD37, WHSUS;True
ENSG00000143365;RAR-related orphan receptor C;NotRelevant;;Immunodeficiency 42, 616622 (3), Autosomal recessiveImmunodeficiency 42, 616622 (3);chr1;RORC, RORG, RZRG, IMD42;True
ENSG00000159450;Trichohyalin;NotRelevant;mutation identified in 1 UHS3 patient;?Uncombable hair syndrome 3, 617252 (3), Autosomal recessive?Uncombable hair syndrome 3, 617252 (3);chr1;TCHH, THH, THL, TRHY, UHS3;True
ENSG00000143631;Filaggrin;NotRelevant;;{Dermatitis, atopic, susceptibility to, 2}, 605803 (3){Dermatitis, atopic, susceptibility to, 2}, 605803 (3);chr1;FLG, ATOD2;False
ENSG00000143520;Filaggrin family, member 2;NotRelevant;;Peeling skin syndrome 6, 618084 (3), Autosomal recessivePeeling skin syndrome 6, 618084 (3);chr1;FLG2, IFPS, PSS6;True
ENSG00000203782;Loricrin;NotRelevant;;Vohwinkel syndrome with ichthyosis, 604117 (3), Autosomal dominantVohwinkel syndrome with ichthyosis, 604117 (3);chr1;LOR;True
ENSG00000143614;GATA zinc finger domain-containing protein 2B;NotRelevant;;Mental retardation, autosomal dominant 18, 615074 (3), Autosomal dominantMental retardation, autosomal dominant 18, 615074 (3);chr1;GATAD2B, KIAA1150, p68, MRD18;True
ENSG00000177954;Ribosomal protein S27;NotRelevant;mutation identified in 1 DBA17 patient;?Diamond-Blackfan anemia 17, 617409 (3), Autosomal dominant?Diamond-Blackfan anemia 17, 617409 (3);chr1;RPS27, MPS1, DBA17;True
ENSG00000143549;Tropomyosin 3;NotRelevant;TRK = chimera of TPM3 and NTRK1; NEM1 to 1q21-q23 by FdNemaline myopathy 1, autosomal dominant or recessive, 609284 (3);chr1;TPM3, NEM1, CFTD, CAPM1;True
ENSG00000143575;HCLS1-associated protein X1;NotRelevant;;Neutropenia, severe congenital 3, autosomal recessive, 610738 (3), Autosomal recessiveNeutropenia, severe congenital 3, autosomal recessive, 610738 (3);chr1;HAX1, SCN3;True
ENSG00000160712;Interleukin-6 receptor;NotRelevant;IL6R-like gene on chr.9;[Interleukin 6, serum level of, QTL], 614752 (3)[Interleukin-6 receptor, soluble, serum level of, QTL], 614689 (3);chr1;IL6R, IL6RQ, IL6Q;False
ENSG00000160716;Cholinergic receptor, nicotinic, beta polypeptide-2;NotRelevant;linked to AMY in mouse;Epilepsy, nocturnal frontal lobe, 3, 605375 (3)Epilepsy, nocturnal frontal lobe, 3, 605375 (3);chr1;CHRNB2, EFNL3;False
ENSG00000160710;Adenosine deaminase, RNA-specific;NotRelevant;;Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessiveDyschromatosis symmetrica hereditaria, 127400 (3);chr1;ADAR, DRADA, DSH, DSRAD, IFI4, G1P1, AGS6;True
ENSG00000163344;Phosphomevalonate kinase;NotRelevant;;Porokeratosis 1, multiple types, 175800 (3), Autosomal dominantPorokeratosis 1, multiple types, 175800 (3);chr1;PMVK, PMK, POROK1;True
ENSG00000160688;Flavin adenine dinucleotide synthetase, S. cerevisiae, homolog of;NotRelevant;;Lipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3), Autosomal recessiveLipid storage myopathy due to flavin adenine dinucleotide synthetase deficiency, 255100 (3);chr1;FLAD1, FADS, LSMFLAD;True
ENSG00000179085;Dolichyl-phosphate mannosyltransferase 3;NotRelevant;;Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15, 612937 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle), type C, 15, 612937 (3);chr1;DPM3, CDG1O;True
ENSG00000185499;Mucin 1, transmembrane;NotRelevant;5cM proximal to SPTA1;Medullary cystic kidney disease 1, 174000 (3), Autosomal dominantMedullary cystic kidney disease 1, 174000 (3);chr1;MUC1, PUM, MCKD1;True
ENSG00000177628;Glucosidase, acid beta;NotRelevant;pseudogene GBAP ~16kb 3' to GBA;Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive{Parkinson disease, late-onset, susceptibility to}, 168600 (3);chr1;GBA;True
ENSG00000176444;CDC-like kinase 2;NotRelevant;near GDLD and PRKAA2; conflicting assignment 1q21;chr1;CLK2;False
ENSG00000143627;Pyruvate kinase, liver and RBC type;NotRelevant;;Adenosine triphosphate, elevated, of erythrocytes, 102900 (3), Autosomal dominantPyruvate kinase deficiency, 266200 (3);chr1;PKLR, PK1;True
ENSG00000160752;Farnesyl diphosphate synthase;NotRelevant;;Porokeratosis 9, multiple types, 616631 (3), Autosomal dominantPorokeratosis 9, multiple types, 616631 (3);chr1;FDPS, FPS, POROK9;True
ENSG00000116539;ash1 (absent, small, or homeotic), Drosophila, homolog of;NotRelevant;;Mental retardation, autosomal dominant 52, 617796 (3), Autosomal dominantMental retardation, autosomal dominant 52, 617796 (3);chr1;ASH1L, KIAA1420, ASH1, MRD52;True
ENSG00000125459;Misato 1, mitochondrial distribution and morphology regulator;NotRelevant;;Myopathy, mitochondrial, and ataxia, 617675 (3), Autosomal recessive, Autosomal dominantMyopathy, mitochondrial, and ataxia, 617675 (3);chr1;MSTO1, MMYAT;True
ENSG00000163374;YY1 associated protein 1;NotRelevant;;Grange syndrome, 602531 (3), Autosomal recessiveGrange syndrome, 602531 (3);chr1;YY1AP1, YAP, HCCA2, GRNG;True
ENSG00000143622;Ric-like protein without CAAX motif 1;NotRelevant;;Noonan syndrome 8, 615355 (3), Autosomal dominantNoonan syndrome 8, 615355 (3);chr1;RIT1, RIT, ROC1, NS8;True
ENSG00000116584;RHO guanine nucleotide exchange factor 2;NotRelevant;mutation identified in 1 NEDMHM family;?Neurodevelopmental disorder with midbrain and hindbrain malformations, 617523 (3), Autosomal recessive?Neurodevelopmental disorder with midbrain and hindbrain malformations, 617523 (3);chr1;ARHGEF2, GEFH1, KIAA0651, NEDMHM;True
ENSG00000116586;Late endosomal/lysosomal adaptor, MAPK and MTOR activator 2;NotRelevant;;Immunodeficiency due to defect in MAPBP-interacting protein, 610798 (3), Autosomal recessiveImmunodeficiency due to defect in MAPBP-interacting protein, 610798 (3);chr1;LAMTOR2, MAPBPIP, p14;True
ENSG00000160789;Lamin A/C;NotRelevant;;Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominantRestrictive dermopathy, lethal, 275210 (3);chr1;LMNA, LMN1, EMD2, FPLD2, CMD1A, HGPS;True
ENSG00000196189;Semaphorin 4A;NotRelevant;;Cone-rod dystrophy 10, 610283 (3), Autosomal recessiveRetinitis pigmentosa 35, 610282 (3);chr1;SEMA4A, SEMB, RP35, CORD10;True
ENSG00000163382;NAD(P)HX epimerase;NotRelevant;;Encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3), Autosomal recessiveEncephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 617186 (3);chr1;NAXE, APOA1BP, AIBP, PEBEL;True
ENSG00000143294;Papillary renal cell carcinoma, translocation-associated;NotRelevant;t(X;1)(p11Renal cell carcinoma, papillary, 605074 (3);chr1;PRCC, RCCP1;False
ENSG00000198400;Neurotrophic tyrosine kinase, receptor, type 1;NotRelevant;TRK = chimera of TPM3 and NTRK1;Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessiveMedullary thyroid carcinoma, familial, 155240 (3);chr1;NTRK1, TRKA, MTC;True
ENSG00000163554;Spectrin, alpha, erythrocytic-1;NotRelevant;17cM proximal to FY;Elliptocytosis-2, 130600 (3), Autosomal dominantSpherocytosis, type 3, 270970 (3);chr1;SPTA1, EL2, SPH3, HS3, HPP;True
ENSG00000213088;Atypical chemokine receptor 1 (Duffy antigen receptor for chemokines);NotRelevant;by A, 1q22-q23;[Blood group, Duffy system], 110700 (3), Autosomal recessive, Autosomal dominant{Malaria, vivax, protection against}, 611162 (3);chr1;ACKR1, DARC, FY, GPD, WBCQ1;True
ENSG00000132703;Amyloid P component, serum;NotRelevant;probably close to CRP;{?Amyloidosis, secondary, susceptibility to} (1){?Amyloidosis, secondary, susceptibility to} (1);chr1;APCS, SAP;False
ENSG00000143315;Phosphatidylinositol glycan, class M;NotRelevant;;Glycosylphosphatidylinositol deficiency, 610293 (3), Autosomal recessiveGlycosylphosphatidylinositol deficiency, 610293 (3);chr1;PIGM;True
ENSG00000177807;Potassium inwardly-rectifying channel, subfamily J, member 10;NotRelevant;;Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessiveSESAME syndrome, 612780 (3);chr1;KCNJ10, SESAME;True
ENSG00000018625;ATPase, Na+K+ transporting, alpha-2 polypeptide;NotRelevant;;Alternating hemiplegia of childhood 1, 104290 (3), Autosomal dominantMigraine, familial hemiplegic, 2, 602481 (3);chr1;ATP1A2, FHM2, MHP2;True
ENSG00000143318;Calsequestrin, fast-twitch, skeletal muscle-1;NotRelevant;;Myopathy, vacuolar, with CASQ1 aggregates, 616231 (3), Autosomal dominantMyopathy, vacuolar, with CASQ1 aggregates, 616231 (3);chr1;CASQ1, VMCQA;True
ENSG00000132716;DDB1- and CUL4-associated factor 8;NotRelevant;mutation identified in 1 GAN2 family;?Giant axonal neuropathy 2, autosomal dominant, 610100 (3), Autosomal dominant?Giant axonal neuropathy 2, autosomal dominant, 610100 (3);chr1;DCAF8, WDR42A, GAN2;True
ENSG00000162735;Peroxisome biogenesis factor 19 (peroxisomal farnesylated protein);NotRelevant;;Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessivePeroxisome biogenesis disorder 12A (Zellweger), 614886 (3);chr1;PEX19, PXF, HK33, D1S2223E, PBD12A;True
ENSG00000122218;Coatomer protein complex, subunit alpha;NotRelevant;;{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3), Autosomal dominant{Autoimmune interstitial lung, joint, and kidney disease}, 616414 (3);chr1;COPA, AILJK;True
ENSG00000162736;Nicastrin;NotRelevant;;Acne inversa, familial, 1, 142690 (3), Autosomal dominantAcne inversa, familial, 1, 142690 (3);chr1;NCSTN;True
ENSG00000162738;Vang-like 2 (loop-tail, mouse, homolog of);NotRelevant;;Neural tube defects, 182940 (3), Autosomal dominantNeural tube defects, 182940 (3);chr1;VANGL2, LTAP;True
ENSG00000122223;CD244 antigen;NotRelevant;;{Rheumatoid arthritis, susceptibility to}, 180300 (3){Rheumatoid arthritis, susceptibility to}, 180300 (3);chr1;CD244, NAIL, NKR2B4, SLAMF4;False
ENSG00000158773;Upstream transcription factor 1;NotRelevant;;{Hyperlipidemia, familial combined, susceptibility to}, 602491 (3){Hyperlipidemia, familial combined, susceptibility to}, 602491 (3);chr1;USF1, HYPLIP1;False
ENSG00000143217;Nectin 4;NotRelevant;;Ectodermal dysplasia-syndactyly syndrome 1, 613573 (3), Autosomal recessiveEctodermal dysplasia-syndactyly syndrome 1, 613573 (3);chr1;NECTIN 4, PVRL4, PRR4, EDSS1;True
ENSG00000143222;Ubiquitin-fold modifier-conjugating enzyme 1;NotRelevant;;Neurodevelopmental disorder with spasticity and poor growth, 618076 (3), Autosomal recessiveNeurodevelopmental disorder with spasticity and poor growth, 618076 (3);chr1;UFC1, NEDSG;True
ENSG00000143224;Protoporphyrinogen oxidase;NotRelevant;;Porphyria variegata, 176200 (3), Autosomal dominantPorphyria variegata, 176200 (3);chr1;PPOX;True
ENSG00000158864;NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kD;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 6, 618228 (3)Mitochondrial complex I deficiency, nuclear type 6, 618228 (3);chr1;NDUFS2, MC1DN6;False
ENSG00000158874;Apolipoprotein A-II;NotRelevant;;Apolipoprotein A-II deficiency (3){Hypercholesterolemia, familial, modifier of}, 143890 (3);chr1;APOA2;False
ENSG00000158887;Myelin protein zero;NotRelevant;;Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominantRoussy-Levy syndrome, 180800 (3);chr1;MPZ, CMT1B, CMTDID, DSS, CHN2;True
ENSG00000143252;Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kD;NotRelevant;;Gastrointestinal stromal tumor, 606764 (3), Autosomal dominant, Isolated casesParagangliomas 3, 605373 (3);chr1;SDHC, PGL3;True
ENSG00000143226;Fc fragment of IgG, low affinity IIa, receptor for (CD32);NotRelevant;FCG2 and FCG3 within 250kb;{Lupus nephritis, susceptibility to}, 152700 (3), Autosomal dominant{Pseudomonas aeruginosa, susceptibility to chronic infection by, in cystic fibrosis}, 219700 (3);chr1;FCGR2A, IGFR2, CD32;True
ENSG00000203747;Fc fragment of IgG, low affinity III, receptor for (CD16);NotRelevant;FCGR2A and FCGR3A within 250kb antigen;Immunodeficiency 20, 615707 (3), Autosomal recessiveImmunodeficiency 20, 615707 (3);chr1;FCGR3A, CD16, IGFR3, IMD20;True
ENSG00000162747;Fc fragment of IgG, low affinity IIIb, receptor for;NotRelevant;;Neutropenia, alloimmune neonatal (3)Neutropenia, alloimmune neonatal (3);chr1;FCGR3B;False
ENSG00000072694;Fc fragment of IgG, low affinity IIb, receptor for;NotRelevant;;{Malaria, resistance to}, 611162 (3){Systemic lupus erythematosus, susceptibility to}, 152700 (3);chr1;FCGR2B, CD32;False
ENSG00000118217;Activating transcription factor-6;NotRelevant;;Achromatopsia 7, 616517 (3), Autosomal recessiveAchromatopsia 7, 616517 (3);chr1;ATF6, ACHM7;True
ENSG00000162733;Discoidin domain receptor family, member 2;NotRelevant;;Spondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3), Autosomal recessiveSpondylometaepiphyseal dysplasia, short limb-hand type, 271665 (3);chr1;DDR2, NTRKR3, TKT;True
ENSG00000143248;Regulator of G protein signaling-5;NotRelevant;;[Blood pressure regulation QTL], 145500 (2), Multifactorial[Blood pressure regulation QTL], 145500 (2);chr1;RGS5;False
ENSG00000185630;Pre-B cell leukemia transcription factor-1;NotRelevant;pseudogene PBXP1 on chr.3;Congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3), Autosomal dominantCongenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay, 617641 (3);chr1;PBX1, CAKUHED;True
ENSG00000143183;Transmembrane and coiled-coil domains protein 1;NotRelevant;;Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3), Autosomal recessiveCraniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3);chr1;TMCO1, CFSMR;True
ENSG00000198821;CD247 antigen;NotRelevant;mutation identified in one IMD25 patient;?Immunodeficiency 25, 610163 (3), Autosomal recessive?Immunodeficiency 25, 610163 (3);chr1;CD247, CD3Z, TCRZ, IMD25;True
ENSG00000143199;Adenylyl cyclase 10, soluble;NotRelevant;;{Hypercalciuria, absorptive, susceptibility to}, 143870 (3), Autosomal dominant{Hypercalciuria, absorptive, susceptibility to}, 143870 (3);chr1;ADCY10, SAC, HCA2;True
ENSG00000143178;T-box 19;NotRelevant;;Adrenocorticotropic hormone deficiency, 201400 (3), Autosomal recessiveAdrenocorticotropic hormone deficiency, 201400 (3);chr1;TBX19;True
ENSG00000143153;ATPase, Na+K+ transporting, beta-1 polypeptide;NotRelevant;;[Blood pressure regulation QTL], 145500 (2), Multifactorial[Blood pressure regulation QTL], 145500 (2);chr1;ATP1B1;False
ENSG00000117479;Solute carrier family 19 (thiamine transporter), member 2;NotRelevant;;Thiamine-responsive megaloblastic anemia syndrome, 249270 (3), Autosomal recessiveThiamine-responsive megaloblastic anemia syndrome, 249270 (3);chr1;SLC19A2, THTR1, TRMA, THMD1;True
ENSG00000198734;Coagulation factor V (proaccelerin, labile factor);NotRelevant;Order: F5-GRMP-LYAM1-ELAM1 in 300kb segment;{Budd-Chiari syndrome}, 600880 (3), Autosomal recessive{Thrombophilia, susceptibility to, due to factor V Leiden}, 188055 (3);chr1;F5, THPH2, RPRGL1;True
ENSG00000174175;Selectin P (granulocyte membrane protein, 140kD;NotRelevant;ENSG00000174175;in same 300kb segment as LYAM1, ELAM1;chr1;SELP, GRMP;False
ENSG00000120370;Golgin, RAB6-interacting;NotRelevant;;Geroderma osteodysplasticum, 231070 (3), Autosomal recessiveGeroderma osteodysplasticum, 231070 (3);chr1;GORAB, SCYL1BP1, NTKLBP1, GO;True
ENSG00000116132;Paired-related homeobox gene 1;NotRelevant;;Agnathia-otocephaly complex, 202650 (3), Autosomal recessive, Autosomal dominantAgnathia-otocephaly complex, 202650 (3);chr1;PRRX1, PMX1, PHOX1, AGOTC;True
ENSG00000007933;Flavin-containing monooxygenase 3;NotRelevant;;Trimethylaminuria, 602079 (3), Autosomal recessiveTrimethylaminuria, 602079 (3);chr1;FMO3, TMAU;True
ENSG00000034971;Myocilin (trabecular meshwork-induced glucocorticoid response protein);NotRelevant;;Glaucoma 1A, primary open angle, 137750 (3), Autosomal dominantGlaucoma 1A, primary open angle, 137750 (3);chr1;MYOC, TIGR, GLC1A, JOAG, GPOA;True
ENSG00000010165;EEF1A lysine and N-terminal methyltransferase;NotRelevant;mutation identified in 1 family;?{Deafness, autosomal recessive 26, modifier of}, 605429 (3), Autosomal dominant?{Deafness, autosomal recessive 26, modifier of}, 605429 (3);chr1;EEF1AKNMT, METTL13, FEAT, KIAA0859, DFNB26M;True
ENSG00000135845;Phosphatidylinositol glycan, class C;NotRelevant;;Glycosylphosphatidylinositol biosynthesis defect 16, 617816 (3), Autosomal recessiveGlycosylphosphatidylinositol biosynthesis defect 16, 617816 (3);chr1;PIGC, GPI2, GPIBD16, MRT62;True
ENSG00000117560;Fas ligand (TNF superfamily, member 6);NotRelevant;;Autoimmune lymphoproliferative syndrome, type IB, 601859 (3), Autosomal dominant{Lung cancer, susceptibility to}, 211980 (3);chr1;FASLG, TNFSF6, APT1LG1, FASL, ALPS1B;True
ENSG00000117586;Tumor necrosis factor ligand superfamily, member 4;NotRelevant;;{Myocardial infarction, susceptibility to}, 608446 (3){Myocardial infarction, susceptibility to}, 608446 (3);chr1;TNFSF4, GP34, OX4OL;False
ENSG00000117593;Aspartyl-tRNA synthetase 2;NotRelevant;;Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessiveLeukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3);chr1;DARS2, ASPRS. LBSL;True
ENSG00000117601;Antithrombin III;NotRelevant;~17cM distal to FY;Thrombophilia due to antithrombin III deficiency, 613118 (3), Autosomal recessive, Autosomal dominantThrombophilia due to antithrombin III deficiency, 613118 (3);chr1;SERPINC1, AT3, AT3D, THPH7;True
ENSG00000143322;Abelson murine leukemia viral (v-abl) oncogene homolog 2 (arg, Abelson-related gene);NotRelevant;fused with ETV6 in AML;Leukemia, acute myeloid, with eosinophilia (1)Leukemia, acute myeloid, with eosinophilia (1);chr1;ABL2, ABLL, ARG;False
ENSG00000116218;Podocin;NotRelevant;modifies phenotype of NPHS1 mutations to FSGS;Nephrotic syndrome, type 2, 600995 (3), Autosomal recessiveNephrotic syndrome, type 2, 600995 (3);chr1;PDCN, NPHS2, SRN1;True
ENSG00000143337;Torsin A-interacting protein 1;NotRelevant;mutation identified in 1 MRRSDC family;?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures, 617072 (3), Autosomal recessive?Muscular dystrophy, autosomal recessive, with rigid spine and distal joint contractures, 617072 (3);chr1;TOR1AIP1, LAP1, LAP1B, LGMD2Y;True
ENSG00000121454;LIM homeo box gene 4;NotRelevant;fused to IGH in ALL;Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominantPituitary hormone deficiency, combined, 4, 262700 (3);chr1;LHX4, CPHD4;True
ENSG00000143324;Xenotropic and polytropic retrovirus receptor;NotRelevant;;Basal ganglia calcification, idiopathic, 6, 616413 (3), Autosomal dominantBasal ganglia calcification, idiopathic, 6, 616413 (3);chr1;XPR1, SYG1, IBGC6;True
ENSG00000135821;Glutamate-ammonia ligase (glutamine synthase);NotRelevant;pseudogene on chr.9;Glutamine deficiency, congenital, 610015 (3), Autosomal recessiveGlutamine deficiency, congenital, 610015 (3);chr1;GLUL, GLNS;True
ENSG00000135828;Ribonuclease L (2',5'-oligoisoadenylate synthetase-dependent);NotRelevant;;Prostate cancer 1, 601518 (3), Autosomal dominantProstate cancer 1, 601518 (3);chr1;RNASEL, RNS4, PRCA1, HPC1;True
ENSG00000058085;Laminin, gamma-2 (nicein, 100kD;NotRelevant;3918;ENSG00000058085Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3);chr1;LAMC2, LAMNB2, LAMB2T;False
ENSG00000116701;Neutrophil cytosolic factor-2, 65kD;NotRelevant;;Chronic granulomatous disease due to deficiency of NCF-2, 233710 (3), Autosomal recessiveChronic granulomatous disease due to deficiency of NCF-2, 233710 (3);chr1;NCF2;True
ENSG00000198860;tRNA splicing endonuclease 15, S. cerevisiae, homolog of;NotRelevant;;Pontocerebellar hypoplasia, type 2F, 617026 (3), Autosomal recessivePontocerebellar hypoplasia, type 2F, 617026 (3);chr1;TSEN15, SEN15, C1orf19, PCH2F;True
ENSG00000143341;Hemicentin (fibulin 6);NotRelevant;;{Macular degeneration, age-related, 1}, 603075 (3), Autosomal dominant{Macular degeneration, age-related, 1}, 603075 (3);chr1;HMCN1, FBLN6, FIBL6, ARMD1;True
ENSG00000116690;Proteoglycan 4 (megakaryocyte stimulating factor;NotRelevant;ENSG00000116690;Camptodactyly-arthropathy-coxa vara-pericarditis syndrome, 208250 (3);chr1;PRG4, CACP, MSF, SZP, HAPO;False
ENSG00000116711;Phospholipase A2, group IVA, cytosolic;NotRelevant;;Phospholipase A2, group IV A, deficiency of (3)Phospholipase A2, group IV A, deficiency of (3);chr1;PLA2G4A, PLA2G4;False
ENSG00000134371;Cell division cycle protein 73, S. cerevisiae, homolog of;NotRelevant;;Hyperparathyroidism, familial primary, 145000 (3), Autosomal dominantParathyroid carcinoma, 608266 (3);chr1;CDC73, HRPT2, C1orf28;True
ENSG00000162687;Potassium channel, subfamily T, member 2;NotRelevant;mutation identified in 1 EIEE57 patient;?Epileptic encephalopathy, early infantile, 57, 617771 (3), Autosomal dominant?Epileptic encephalopathy, early infantile, 57, 617771 (3);chr1;KCNT2, SLICK, EIEE57;True
ENSG00000000971;Complement factor H;NotRelevant;;Basal laminar drusen, 126700 (3), Autosomal dominant{Macular degeneration, age-related, 4}, 610698 (3);chr1;CFH, HF1, HUS, ARMD4, AHUS1;True
ENSG00000116785;Complement factor H-related 3;NotRelevant;;{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3), Autosomal recessive, Autosomal dominant{Macular degeneration, age-related, reduced risk of}, 603075 (3);chr1;CFHR3, FHR3, HLF4, CFHL3;True
ENSG00000244414;Complement factor H-related 1;NotRelevant;;{Hemolytic uremic syndrome, atypical, susceptibility to}, 235400 (3), Autosomal recessive, Autosomal dominant{Macular degeneration, age-related, reduced risk of}, 603075 (3);chr1;CFHR1, FHR1, HFL1, CFHL1;True
ENSG00000134389;Complement factor H-related 5;NotRelevant;;Nephropathy due to CFHR5 deficiency, 614809 (3), Autosomal dominantNephropathy due to CFHR5 deficiency, 614809 (3);chr1;CFHR5, CFHL5, FHR5, CFHR5D;True
ENSG00000143278;Coagulation factor XIII, B polypeptide;NotRelevant;;Factor XIIIB deficiency, 613235 (3), Autosomal recessiveFactor XIIIB deficiency, 613235 (3);chr1;F13B;True
ENSG00000066279;Abnormal spindle-like, microcephaly-associated;NotRelevant;;Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessiveMicrocephaly 5, primary, autosomal recessive, 608716 (3);chr1;ASPM, MCPH5;True
ENSG00000134376;Crumbs, Drosophila, homolog of, 1;NotRelevant;;Leber congenital amaurosis 8, 613835 (3)Retinitis pigmentosa-12, 600105 (3);chr1;CRB1, RP12, LCA8;False
ENSG00000081237;Protein tyrosine phosphatase, receptor type, c polypeptide;NotRelevant;;{Hepatitis C virus, susceptibility to}, 609532 (3){Hepatitis C virus, susceptibility to}, 609532 (3);chr1;PTPRC, CD45, LCA;False
ENSG00000118193;Kinesin family member 14;NotRelevant;mutation identified in 1 MKS12 family;?Meckel syndrome 12, 616258 (3), Autosomal recessiveMicrocephaly 20, primary, autosomal recessive, 617914 (3);chr1;KIF14, KIAA0042, MKS12, MCPH20;True
ENSG00000118197;DEAD box polypeptide 59;NotRelevant;;Orofaciodigital syndrome V, 174300 (3), Autosomal recessiveOrofaciodigital syndrome V, 174300 (3);chr1;DDX59, OFD5;True
ENSG00000163362;Innate immunity activator;NotRelevant;;{Inflammatory bowel disease 29}, 618077 (3){Inflammatory bowel disease 29}, 618077 (3);chr1;INAVA, C1orf106, IBD29;False
ENSG00000081248;Calcium channel, voltage-dependent, L type, alpha 1S subunit;NotRelevant;in mouse, mutation causes muscular dysgenesis;Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant{Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3);chr1;CACNA1S, CACNL1A3, CCHL1A3, TTPP1, HOKPP1;True
ENSG00000081277;Plakophilin-1;NotRelevant;;Ectodermal dysplasia/skin fragility syndrome, 604536 (3)Ectodermal dysplasia/skin fragility syndrome, 604536 (3);chr1;PKP1;False
ENSG00000118194;Troponin-T2, cardiac;NotRelevant;;Cardiomyopathy, dilated, 1D, 601494 (3), Autosomal dominantLeft ventricular noncompaction 6, 601494 (3);chr1;TNNT2, CMH2, CMD1D, RCM3, LVNC6;True
ENSG00000077152;Ubiquitin-conjugating enzyme E2T;NotRelevant;;Fanconi anemia, complementation group T, 616435 (3), Autosomal recessiveFanconi anemia, complementation group T, 616435 (3);chr1;UBE2T, HSPC150, FANCT;True
ENSG00000143858;Synaptotagmin-2;NotRelevant;;Myasthenic syndrome, congenital, 7, presynaptic, 616040 (3), Autosomal dominantMyasthenic syndrome, congenital, 7, presynaptic, 616040 (3);chr1;SYT2, CMS7, MYSPC;True
ENSG00000117139;Lysine-specific demethylase 5B;NotRelevant;;Mental retardation, autosomal recessive 65, 618109 (3), Autosomal recessiveMental retardation, autosomal recessive 65, 618109 (3);chr1;KDM5B, JARID1B, PUT1, PLU1, RBBP2H1A, MRT65;True
ENSG00000133048;Chitinase 3-like 1 (cartilage glycoprotein-39);NotRelevant;;{Asthma-related traits, susceptibility to, 7}, 611960 (3){Schizophrenia, susceptibility to}, 181500 (3);chr1;CHI3L1, GP39, YKL40, ASRT7;False
ENSG00000133063;Chitotriosidase;NotRelevant;;[Chitotriosidase deficiency], 614122 (3), Autosomal recessive[Chitotriosidase deficiency], 614122 (3);chr1;CHIT, CHITD;True
ENSG00000182004;Small nuclear ribonucleoprotein polypeptide E;NotRelevant;;Hypotrichosis 11, 615059 (3), Autosomal dominantHypotrichosis 11, 615059 (3);chr1;SNRPE, HYPT11;True
ENSG00000143839;Renin;NotRelevant;~24cM distal to AT3;[Hyperproreninemia] (3)[Hyperproreninemia] (3);chr1;REN, HNFJ2;False
ENSG00000170498;KISS1 metastasis suppressor;NotRelevant;mutation identified in 1 HH13 family;?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3), Autosomal recessive?Hypogonadotropic hypogonadism 13 with or without anosmia, 614842 (3);chr1;KISS1, HH13;True
ENSG00000158615;Protein phosphatase 1, regulatory subunit 15B;NotRelevant;;Microcephaly, short stature, and impaired glucose metabolism 2, 616817 (3), Autosomal recessiveMicrocephaly, short stature, and impaired glucose metabolism 2, 616817 (3);chr1;PPP1R15B, CREP, MSSGM2;True
ENSG00000184144;Contactin 2 (transiently-expressed axonal glycoprotein);NotRelevant;1 family identified with mutation;?Epilepsy, myoclonic, familial adult, 5, 615400 (3), Autosomal recessive?Epilepsy, myoclonic, familial adult, 5, 615400 (3);chr1;CNTN2, TAX, TAX1, FAME5;True
ENSG00000133059;Dual serine/threonine and tyrosine protein kinase;NotRelevant;;Congenital anomalies of kidney and urinary tract 1, 610805 (3), Autosomal dominantSpastic paraplegia 23, 270750 (3);chr1;DSTYK, KIAA0472, RIP5, DUSTYPK, CAKUT1, SPG23;True
ENSG00000136634;Interleukin-10;NotRelevant;;{Graft-versus-host disease, protection against}, 614395 (3){Rheumatoid arthritis, progression of}, 180300 (3);chr1;IL10, CSIF, GVHDS;False
ENSG00000196352;CD55 antigen (blood group Cromer);NotRelevant;;[Blood group Cromer], 613793 (3), Autosomal recessive[Blood group Cromer], 613793 (3);chr1;CD55, DAF, CROM, CHAPLE;True
ENSG00000117322;Complement component (3d/Epstein-Barr virus) receptor-2;NotRelevant;;Immunodeficiency, common variable, 7, 614699 (3), Autosomal recessive{Systemic lupus erythematosus, susceptibility to, 9}, 610927 (3);chr1;CR2, C3DR, SLEB9, CVID7;True
ENSG00000203710;Complement component (3b/4b) receptor-1;NotRelevant;;[Blood group, Knops system], 607486 (3){Malaria, severe, resistance to}, 611162 (3);chr1;CR1, C3BR;False
ENSG00000117335;Membrane cofactor protein (CD46, trophoblast-lymphocyte cross-reactive antigen);NotRelevant;;{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3), Autosomal recessive, Autosomal dominant{Hemolytic uremic syndrome, atypical, susceptibility to, 2}, 612922 (3);chr1;MCP, CD46, AHUS2;True
ENSG00000196878;Laminin, beta-3 (nicein, 125kD;NotRelevant;3914;ENSG00000196878Epidermolysis bullosa, junctional, non-Herlitz type, 226650 (3);chr1;LAMB3, AI1A;False
ENSG00000117594;Hydroxysteroid, 11-beta, dehydrogenase 1;NotRelevant;digenic triallelic mutations with H6PD;Cortisone reductase deficiency 2, 614662 (3), Autosomal dominantCortisone reductase deficiency 2, 614662 (3);chr1;HSD11B1, HSD11, HSD11L, CORTRD2;True
ENSG00000117595;Interferon regulatory factor 6;NotRelevant;OFC6 in enhancer 5' of IRF6;{Orofacial cleft 6}, 608864 (3), Isolated cases{Orofacial cleft 6}, 608864 (3);chr1;IRF6, VWS, LPS, PIT, PPS1, OFC6;False
ENSG00000143469;Synaptotagmin 14;NotRelevant;mutation identified in 1 SCAR11 family;?Spinocerebellar ataxia, autosomal recessive 11, 614229 (3), Autosomal recessive?Spinocerebellar ataxia, autosomal recessive 11, 614229 (3);chr1;SYT14, SCAR11;True
ENSG00000143473;Potassium voltage-gated channel, subfamily H, member 1 (ether-a-go-go, drosophila, homolog of);NotRelevant;;Temple-Baraitser syndrome, 611816 (3), Autosomal dominantZimmermann-Laband syndrome 1, 135500 (3);chr1;KCNH1, EAG, TMBTS, ZLS1;True
ENSG00000198570;Retinal degeneration 3, mouse, homolog of;NotRelevant;;Leber congenital amaurosis 12, 610612 (3), Autosomal recessiveLeber congenital amaurosis 12, 610612 (3);chr1;RD3, LCA12, C1orf36;True
ENSG00000117650;Never in mitosis gene a-related kinase 2;NotRelevant;pseudogenes on chr. 2, 14, and 22; mutation identified in 1 family?Retinitis pigmentosa 67, 615565 (3);chr1;NEK2, RP67;False
ENSG00000162769;Feline leukemia virus subgroup C receptor 1;NotRelevant;;Ataxia, posterior column, with retinitis pigmentosa, 609033 (3), Autosomal recessiveAtaxia, posterior column, with retinitis pigmentosa, 609033 (3);chr1;FLVCR1, AXPC1, PCARP;True
ENSG00000152104;Protein tyrosine phosphatase, nonreceptor-type, 14;NotRelevant;;Choanal atresia and lymphedema, 613611 (3), Autosomal recessiveChoanal atresia and lymphedema, 613611 (3);chr1;PTPN14, PEZ, CATLPH;True
ENSG00000117724;Centromere autoantigen F, 400kD;NotRelevant;;Stromme syndrome, 243605 (3), Autosomal recessiveStromme syndrome, 243605 (3);chr1;CENPF, CILD31, STROMS;True
ENSG00000042781;Usherin;NotRelevant;;Retinitis pigmentosa 39, 613809 (3)Usher syndrome, type 2A, 276901 (3);chr1;USH2A, RP39;False
ENSG00000092969;Transforming growth factor, beta-2;NotRelevant;;Loeys-Dietz syndrome 4, 614816 (3), Autosomal dominantLoeys-Dietz syndrome 4, 614816 (3);chr1;TGFB2, LDS4;True
ENSG00000196660;Solute carrier family 30 (zinc transporter), member 10;NotRelevant;;Hypermanganesemia with dystonia 1, 613280 (3), Autosomal recessiveHypermanganesemia with dystonia 1, 613280 (3);chr1;SLC30A10, ZNT10, HMNDYT1;True
ENSG00000136628;Glutamyl-prolyl-tRNA synthetase;NotRelevant;;Leukodystrophy, hypomyelinating, 15, 617951 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 15, 617951 (3);chr1;EPRS, PARS, HLD15;True
ENSG00000067704;Isoleucyl-tRNA synthetase 2;NotRelevant;mutation identified in 1 CAGSSS family;?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive?Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3);chr1;IARS2, CAGSSS;True
ENSG00000118873;RAB3 GTPase-activating protein (noncatalytic) subunit 2;NotRelevant;;Martsolf syndrome, 212720 (3), Autosomal recessiveWarburg micro syndrome 2, 614225 (3);chr1;RAB3GAP2, RAB3GAP150, p150, KIAA0839, WARBM2;True
ENSG00000187554;Toll-like receptor-5;NotRelevant;;{Legionnaire disease, susceptibility to}, 608556 (3){Systemic lupus erythematosus, susceptibility to, 1}, 601744 (3);chr1;TLR5, TIL3, SLEB1, MELIOS;False
ENSG00000162923;WD repeat-containing protein 26;NotRelevant;;Skraban-Deardorff syndrome, 617616 (3), Autosomal dominantSkraban-Deardorff syndrome, 617616 (3);chr1;WDR26, SKDEAS;True
ENSG00000143815;Lamin B receptor;NotRelevant;;Greenberg skeletal dysplasia, 215140 (3), Autosomal recessivePelger-Huet anomaly, 169400 (3);chr1;LBR, PHA, PHASK;True
ENSG00000143819;Epoxide hydroxylase 1, microsomal xenobiotic;NotRelevant;mutation identified in 1 FHCA patient;?Hypercholanemia, familial, 607748 (3), Autosomal recessive?Hypercholanemia, familial, 607748 (3);chr1;EPHX1;True
ENSG00000143811;Pyrroline-5-carboxylate reductase 2;NotRelevant;;Leukodystrophy, hypomyelinating, 10, 616420 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 10, 616420 (3);chr1;PYCR2, HLD10;True
ENSG00000143801;Presenilin 2;NotRelevant;;Alzheimer disease-4, 606889 (3), Autosomal dominantCardiomyopathy, dilated, 1V, 613697 (3);chr1;PSEN2, AD4, STM2, CMD1V;True
ENSG00000163050;AARF domain-containing kinase 3;NotRelevant;;Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessiveCoenzyme Q10 deficiency, primary, 4, 612016 (3);chr1;ADCK3, COQ8, CABC1, SCAR9, ARCA2, COQ10D4;True
ENSG00000143761;ADP-ribosylation factor-1;NotRelevant;;Periventricular nodular heterotopia 8, 618185 (3), Autosomal dominantPeriventricular nodular heterotopia 8, 618185 (3);chr1;ARF1, PVNH8;True
ENSG00000198835;Gap junction protein, gamma-2 (47kD);NotRelevant;;Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessiveSpastic paraplegia 44, autosomal recessive, 613206 (3);chr1;GJC2, GJA12, CX47, PMLDAR, HLD2, SPG44, LMPHM3;True
ENSG00000181873;IBA57, S. cerevisiae, homolog of;NotRelevant;;Multiple mitochondrial dysfunctions syndrome 3, 615330 (3), Autosomal recessiveMultiple mitochondrial dysfunctions syndrome 3, 615330 (3);chr1;IBA57, C1orf69, MMDS3, SPG74;True
ENSG00000143632;Actin, alpha-1, skeletal muscle;NotRelevant;mutation identified in 1 SHPM family;Myopathy, actin, congenital, with cores, 161800 (3), Autosomal recessive, Autosomal dominantNemaline myopathy 3, autosomal dominant or recessive, 161800 (3);chr1;ACTA1, ASMA, NEM3, CFTD1, SHPM;True
ENSG00000069248;Nucleoporin, 133kD;NotRelevant;;Nephrotic syndrome, type 18, 618177 (3), Autosomal recessiveNephrotic syndrome, type 18, 618177 (3);chr1;NUP133, NPHS18;True
ENSG00000135775;Component of oligomeric golgi complex 2;NotRelevant;mutation identified in 1 CDG2Q patient;?Congenital disorder of glycosylation, type IIq, 617395 (3), Autosomal recessive?Congenital disorder of glycosylation, type IIq, 617395 (3);chr1;COG2, LDLC, CDG2Q;True
ENSG00000135744;Angiotensinogen;NotRelevant;;{Hypertension, essential, susceptibility to}, 145500 (3), Multifactorial{Preeclampsia, susceptibility to} (3);chr1;AGT, SERPINA8;False
ENSG00000173409;ARV1, S. cerevisiae, homolog of;NotRelevant;;Epileptic encephalopathy, early infantile, 38, 617020 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 38, 617020 (3);chr1;ARV1, EIEE38;True
ENSG00000116906;Glyceronephosphate O-acyltransferase;NotRelevant;;Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessiveRhizomelic chondrodysplasia punctata, type 2, 222765 (3);chr1;GNPAT, DHAPAT, RCDP2;True
ENSG00000010072;SprT-like N-terminal domain protein;NotRelevant;;Ruijs-Aalfs syndrome, 616200 (3), Autosomal recessiveRuijs-Aalfs syndrome, 616200 (3);chr1;SPRTN, DVC1, C1orf124, RJALS;True
ENSG00000135766;Egl9, C. elegans, homolog of, 1;NotRelevant;;Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant[Hemoglobin, high altitude adaptation], 609070 (3);chr1;EGLN1, PHD2, HIFPH2, C1orf12, ZMYND6, SM20, ECYT3, HALAH;True
ENSG00000162946;Disrupted in schizophrenia 1;NotRelevant;;{Schizophrenia 9, susceptibility to}, 604906 (3){Schizophrenia 9, susceptibility to}, 604906 (3);chr1;DISC1, SCZD9;False
ENSG00000168275;Cytochrome c oxidase assembly factor 6;NotRelevant;;Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3), Autosomal recessiveCardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 4, 616501 (3);chr1;COA6, C1orf31, CEMCOX4;True
ENSG00000168264;Interferon regulatory factor 2-binding protein 2;NotRelevant;mutation identified in 1 CVID14 family;?Immunodeficiency, common variable, 14, 617765 (3), Autosomal dominant?Immunodeficiency, common variable, 14, 617765 (3);chr1;IRF2BP2, CVID14;True
ENSG00000284770;Tubulin-specific chaperone E;NotRelevant;;Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessiveKenny-Caffey syndrome, type 1, 244460 (3);chr1;TBCE, KCS, KCS1, HRD, PEAMO;True
ENSG00000162885;Beta-1,3-N-acetylgalactosaminyltransferase 2;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 11, 615181 (3);chr1;B3GALNT2, MGC39558, MDDGA11;True
ENSG00000143669;Lysosomal trafficking regulator;NotRelevant;;Chediak-Higashi syndrome, 214500 (3), Autosomal recessiveChediak-Higashi syndrome, 214500 (3);chr1;LYST, CHS1;True
ENSG00000186197;EDAR-associated death domain;NotRelevant;;Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominantEctodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3);chr1;EDARADD, ED3, EDA3, ECTD11B, ECTD11A;True
ENSG00000077522;Actinin, alpha-2;NotRelevant;;Cardiomyopathy, dilated, 1AA, with or without LVNC, 612158 (3), Autosomal dominantCardiomyopathy, hypertrophic, 23, with or without LVNC, 612158 (3);chr1;ACTN2, CMD1AA, CMH23;True
ENSG00000116984;5-methyltetrahydrofolate-homocysteine methyltransferase 1;NotRelevant;;Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3);chr1;MTR, HMAG;True
ENSG00000198626;Ryanodine receptor-2 (cardiac);NotRelevant;;Arrhythmogenic right ventricular dysplasia 2, 600996 (3), Autosomal dominantVentricular tachycardia, catecholaminergic polymorphic, 1, 604772 (3);chr1;RYR2, VTSIP, ARVD2, ARVC2;True
ENSG00000133019;Cholinergic receptor, muscarinic, 3;NotRelevant;mutation identified in 1 PBS family;?Prune belly syndrome, 100100 (3), Autosomal recessive?Prune belly syndrome, 100100 (3);chr1;CHRM3, PBS, EGBRS;True
ENSG00000155816;Formin 2;NotRelevant;;Mental retardation, autosomal recessive 47, 616193 (3), Autosomal recessiveMental retardation, autosomal recessive 47, 616193 (3);chr1;FMN2, MRT47;True
ENSG00000180875;Gremlin 2 homolog, cystine knot superfamily;NotRelevant;;Tooth agenesis, selective, 9, 617275 (3), Autosomal dominantTooth agenesis, selective, 9, 617275 (3);chr1;GREM2, PRDC, STHAG9;True
ENSG00000091483;Fumarate hydratase;NotRelevant;;Fumarase deficiency, 606812 (3), Autosomal recessiveLeiomyomatosis and renal cell cancer, 150800 (3);chr1;FH, HLRCC, MCUL1, FMRD;True
ENSG00000054282;Serologically defined colon cancer antigen 8;NotRelevant;;Bardet-Biedl syndrome 16, 615993 (3), Autosomal recessiveSenior-Loken syndrome 7, 613615 (3);chr1;SDCCAG8, CCCAP, SLSN7, BBS16;True
ENSG00000117020;v-Akt murine thymoma viral oncogene homolog 3;NotRelevant;;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3), Autosomal dominantMegalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2, 615937 (3);chr1;AKT3, PKBG, MPPH2;True
ENSG00000179456;Zinc finger and BTB domain containing 18;NotRelevant;;Mental retardation, autosomal dominant 22, 612337 (3), Autosomal dominantMental retardation, autosomal dominant 22, 612337 (3);chr1;ZBTB18, ZNF238, RP58, MRD22;True
ENSG00000203667;Cytochrome c oxidase 20, S. cerevisiae, homolog of;NotRelevant;;Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, MitochondrialMitochondrial complex IV deficiency, 220110 (3);chr1;COX20, FAM36A;True
ENSG00000153187;Heterogeneous nuclear ribonucleoprotein U;NotRelevant;;Epileptic encephalopathy, early infantile, 54, 617391 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 54, 617391 (3);chr1;HNRNPU, HNRPU, SAFA, EIEE54;True
ENSG00000162711;NLR family, pyrin domain containing 3;NotRelevant;;CINCA syndrome, 607115 (3), Autosomal dominantMuckle-Wells syndrome, 191900 (3);chr1;NLRP3, CIAS1, FCU, FCAS1, NALP3, PYPAF1, DFNA34, KEFH;True
ENSG00000115705;Thyroid peroxidase;NotRelevant;;Thyroid dyshormonogenesis 2A, 274500 (3), Autosomal recessiveThyroid dyshormonogenesis 2A, 274500 (3);chr2;TPO, TPX, TDH2A;True
ENSG00000130508;Peroxidasin, Drosophila, homolog of;NotRelevant;;Anterior segment dysgenesis 7, with sclerocornea, 269400 (3), Autosomal recessiveAnterior segment dysgenesis 7, with sclerocornea, 269400 (3);chr2;PXDN, D2S448E, KIAA0230, PRG2, PXN, COPOA, ASGD7;True
ENSG00000186487;Myelin transcription factor 1-like;NotRelevant;;Mental retardation, autosomal dominant 39, 616521 (3), Autosomal dominantMental retardation, autosomal dominant 39, 616521 (3);chr2;MYT1L, KIAA1106, MRD39;True
ENSG00000171853;Trafficking protein particle complex, subunit 12;NotRelevant;;Encephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3), Autosomal recessiveEncephalopathy, progressive, early-onset, with brain atrophy and spasticity, 617669 (3);chr2;TRAPPC12, TTC15, PEBAS;True
ENSG00000171865;Ribonuclease H1;NotRelevant;pseudogenes on chr. 17 and chr.1;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3), Autosomal recessiveProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2, 616479 (3);chr2;RNASEH1, PEOB2;True
ENSG00000171863;Ribosomal protein S7;NotRelevant;;Diamond-Blackfan anemia 8, 612563 (3), Autosomal dominantDiamond-Blackfan anemia 8, 612563 (3);chr2;RPS7, DBA8;True
ENSG00000118004;Collectin 11;NotRelevant;;3MC syndrome 2, 265050 (3), Autosomal recessive3MC syndrome 2, 265050 (3);chr2;COLEC11, CLK1, 3MC2;True
ENSG00000176887;SRY (sex-determining region Y)-box 11;NotRelevant;;Mental retardation, autosomal dominant 27, 615866 (3), Autosomal dominantMental retardation, autosomal dominant 27, 615866 (3);chr2;SOX11, MRD27;True
ENSG00000134313;Kinase D-interacting substrate, 220kD;NotRelevant;;Spastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3), Autosomal dominantSpastic paraplegia, intellectual disability, nystagmus, and obesity, 617296 (3);chr2;KIDINS220, ARMS, SINO;True
ENSG00000151694;A disintegrin and metalloproteinase domain 17;NotRelevant;mutation identified in 1 NISBD1 family;?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3), Autosomal recessive?Inflammatory skin and bowel disease, neonatal, 1, 614328 (3);chr2;ADAM17, TACE, NISBD1;True
ENSG00000172059;Kruppel-like factor 11;NotRelevant;;Maturity-onset diabetes of the young, type VII, 610508 (3)Maturity-onset diabetes of the young, type VII, 610508 (3);chr2;KLF11, TIEG2, FKLF1, FKLF, MODY7;False
ENSG00000115758;Ornithine decarboxylase-1;NotRelevant;pseudogene ODCP on 7q31-qter;{Colonic adenoma recurrence, reduced risk of}, 114500 (3), Autosomal dominant{Colonic adenoma recurrence, reduced risk of}, 114500 (3);chr2;ODC1;True
ENSG00000134324;Lipin 1;NotRelevant;related to LSL;Myoglobinuria, acute recurrent, autosomal recessive, 268200 (3), Autosomal recessiveMyoglobinuria, acute recurrent, autosomal recessive, 268200 (3);chr2;LPIN1;True
ENSG00000151779;Neuroblastoma-amplified sequence;NotRelevant;;Infantile liver failure syndrome 2, 616483 (3), Autosomal recessiveShort stature, optic nerve atrophy, and Pelger-Huet anomaly, 614800 (3);chr2;NBAS, NAG, SOPH, ILFS2;True
ENSG00000134323;Oncogene NMYC;NotRelevant;proximal to APOB;Feingold syndrome 1, 164280 (3), Autosomal dominantFeingold syndrome 1, 164280 (3);chr2;MYCN, NMYC, ODED, MODED;True
ENSG00000118965;WD repeat-containing protein 35;NotRelevant;;Cranioectodermal dysplasia 2, 613610 (3), Autosomal recessiveShort-rib thoracic dysplasia 7 with or without polydactyly, 614091 (3);chr2;WDR35, NAOFEN, KIAA1336, CED2, SRTD7;True
ENSG00000132031;Matrilin 3;NotRelevant;mutation identified in 1 SEMDM family;Epiphyseal dysplasia, multiple, 5, 607078 (3), Autosomal dominant{Osteoarthritis susceptibility 2}, 140600 (3);chr2;MATN3, EDM5, HOA, OS2;True
ENSG00000084674;Apolipoprotein B (including Ag(x) antigen);NotRelevant;1 gene for liver apo-B100 and gut apo-B48; Ag linkedHypobetalipoproteinemia, 615558 (3);chr2;APOB, FLDB, LDLCQ4;False
ENSG00000138031;Adenylate cyclase-3;NotRelevant;;{Obesity, susceptibility to, BMIQ19}, 617885 (3), Autosomal recessive{Obesity, susceptibility to, BMIQ19}, 617885 (3);chr2;ADCY3, BMIQ19;True
ENSG00000115138;Proopiomelanocortin (adrenocorticotropin/beta-lipotropin);NotRelevant;;Obesity, adrenal insufficiency, and red hair due to POMC deficiency, 609734 (3), Autosomal recessive{Obesity, early-onset, susceptibility to}, 601665 (3);chr2;POMC, OBAIRH;True
ENSG00000119772;DNA methyltransferase 3A;NotRelevant;;Acute myeloid leukemia, somatic, 601626 (3)Tatton-Brown-Rahman syndrome, 615879 (3);chr2;DNMT3A, TBRS;False
ENSG00000143970;Additional sex combs-like 2;NotRelevant;;Shashi-Pena syndrome, 617190 (3), Autosomal dominantShashi-Pena syndrome, 617190 (3);chr2;ASXL2, KIAA1685, SHAPNS;True
ENSG00000084754;Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/ enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit;NotRelevant;;Fatty liver, acute, of pregnancy, 609016 (3), Autosomal recessiveTrifunctional protein deficiency, 609015 (3);chr2;HADHA, MTPA;True
ENSG00000138029;Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase /enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit;NotRelevant;;Trifunctional protein deficiency, 609015 (3), Autosomal recessiveTrifunctional protein deficiency, 609015 (3);chr2;HADHB;True
ENSG00000157856;Dynein regulatory complex, subunit 1, Chlamydomonas, homolog of;NotRelevant;;Ciliary dyskinesia, primary, 21, 615294 (3), Autosomal recessiveCiliary dyskinesia, primary, 21, 615294 (3);chr2;DRC1, CCDC164, C2orf39, CILD21;True
ENSG00000115155;Otoferlin;NotRelevant;symbolized DFNB6 by authors;Auditory neuropathy, autosomal recessive, 1, 601071 (3), Autosomal recessiveDeafness, autosomal recessive 9, 601071 (3);chr2;OTOF, DFNB9, NSRD9, AUNB1;True
ENSG00000171303;Potassium channel, subfamily K, member 3;NotRelevant;;Pulmonary hypertension, primary, 4, 615344 (3), Autosomal dominantPulmonary hypertension, primary, 4, 615344 (3);chr2;KCNK3, TASK, PPH4;True
ENSG00000084693;AATP/GTP-binding protein-like 5;NotRelevant;;Retinitis pigmentosa 75, 617023 (3), Autosomal recessiveRetinitis pigmentosa 75, 617023 (3);chr2;AGBL5, CCP5, RP75;True
ENSG00000138030;Ketohexokinase (fructokinase);NotRelevant;;[Fructosuria], 229800 (3), Autosomal recessive[Fructosuria], 229800 (3);chr2;KHK;True
ENSG00000084774;CAD trifunctional protein of pyrimidine biosynthesis;NotRelevant;;Epileptic encephalopathy, early infantile, 50, 616457 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 50, 616457 (3);chr2;CAD, CDG1Z, EIEE50;True
ENSG00000115204;Mpv17 transgene, mouse, glomerulosclerosis, homolog of;NotRelevant;;Mitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3), Autosomal recessiveMitochondrial DNA depletion syndrome 6 (hepatocerebral type), 256810 (3);chr2;MPV17, MTDPS6;True
ENSG00000115211;Eukaryotic translation initiation factor 2B, subunit 4;NotRelevant;;Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessiveOvarioleukodystrophy, 603896 (3);chr2;EIF2B4;True
ENSG00000163795;Zinc finger protein 513;NotRelevant;mutation identified in 1 RP58 family;?Retinitis pigmentosa 58, 613617 (3), Autosomal recessive?Retinitis pigmentosa 58, 613617 (3);chr2;ZNF513, RP58;True
ENSG00000138002;Intraflagellar transport 172, Chlamydomonas, homolog of;NotRelevant;;Retinitis pigmentosa 71, 616394 (3), Autosomal recessiveShort-rib thoracic dysplasia 10 with or without polydactyly, 615630 (3);chr2;IFT172, SLB, KIAA1179, SRTD10, RP71;True
ENSG00000084734;Glucokinase (hexokinase 4) regulatory protein;NotRelevant;;[Fasting plasma glucose level QTL 5], 613463 (3)[Fasting plasma glucose level QTL 5], 613463 (3);chr2;GCKR, GKRP, FGQTL5;False
ENSG00000213639;Protein phosphatase-1, catalytic subunit, beta isoform;NotRelevant;;Noonan syndrome-like disorder with loose anagen hair 2, 617506 (3), Autosomal dominantNoonan syndrome-like disorder with loose anagen hair 2, 617506 (3);chr2;PPP1CB, NSLH2;True
ENSG00000179270;Chromosome 2 open reading frame 71;NotRelevant;;Retinitis pigmentosa 54, 613428 (3)Retinitis pigmentosa 54, 613428 (3);chr2;C2orf71;False
ENSG00000171094;Anaplastic lymphoma kinase (Ki-1);NotRelevant;;{Neuroblastoma, susceptibility to, 3}, 613014 (3){Neuroblastoma, susceptibility to, 3}, 613014 (3);chr2;ALK, NBLST3;False
ENSG00000158125;Xanthine dehydrogenase (xanthine oxidase);NotRelevant;;Xanthinuria, type I, 278300 (3), Autosomal recessiveXanthinuria, type I, 278300 (3);chr2;XDH, XAN1;True
ENSG00000277893;Steroid-5-alpha-reductase, alpha polypeptide-2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha-2);NotRelevant;;Pseudovaginal perineoscrotal hypospadias, 264600 (3), Autosomal recessivePseudovaginal perineoscrotal hypospadias, 264600 (3);chr2;SRD5A2;True
ENSG00000021574;Spastin;NotRelevant;;Spastic paraplegia 4, autosomal dominant, 182601 (3), Autosomal dominantSpastic paraplegia 4, autosomal dominant, 182601 (3);chr2;SPAST, SPG4;True
ENSG00000091106;NLR family, caspase recruitment domain-containing 4;NotRelevant;mutation identified in 1 FCAS4 family;Autoinflammation with infantile enterocolitis, 616050 (3), Autosomal dominantAutoinflammation with infantile enterocolitis, 616050 (3);chr2;NLRC4, CARD12, CLAN, IPAF, AIFEC, FCAS4;True
ENSG00000138061;Cytochrome P450, subfamily I, dioxin-inducible, polypeptide 1;NotRelevant;;Anterior segment dysgenesis 6, multiple subtypes, 617315 (3)Glaucoma 3A, primary open angle, congenital, juvenile, or adult onset, 231300 (3);chr2;CYP1B1, GLC3A, ASGD6;False
ENSG00000115904;Son of sevenless, Drosophila, homolog of, 1;NotRelevant;mutation identified in 1 GINGF1 family;?Fibromatosis, gingival, 1, 135300 (3), Autosomal dominantNoonan syndrome 4, 610733 (3);chr2;SOS1, GINGF, GF1, HGF, NS4;True
ENSG00000162882;3-hydroxyanthranilate 3,4-dioxygenase;NotRelevant;;Vertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3), Autosomal recessiveVertebral, cardiac, renal, and limb defects syndrome 1, 617660 (3);chr2;HAAO, VCRL1;True
ENSG00000138036;Dynein, cytoplasmic 2, light intermediate chain 1;NotRelevant;;Short-rib thoracic dysplasia 15 with polydactyly, 617088 (3), Autosomal recessiveShort-rib thoracic dysplasia 15 with polydactyly, 617088 (3);chr2;DYNC2LI1, D2LIC, LIC3, SRTD15;True
ENSG00000138075;ATP-binding cassette, subfamily G, member 5;NotRelevant;;Sitosterolemia, 210250 (3), Autosomal recessiveSitosterolemia, 210250 (3);chr2;ABCG5;True
ENSG00000143921;ATP-binding cassette, subfamily G, member 8;NotRelevant;;{Gallbladder disease 4}, 611465 (3){Gallbladder disease 4}, 611465 (3);chr2;ABCG8, GBD4;False
ENSG00000138095;Leucine-rich PPR motif-containing protein;NotRelevant;;Leigh syndrome, French-Canadian type, 220111 (3), Autosomal recessiveLeigh syndrome, French-Canadian type, 220111 (3);chr2;LRPPRC, LRP130, LSFC;True
ENSG00000138079;Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters), member 1;NotRelevant;;Cystinuria, 220100 (3), Autosomal recessive, Autosomal dominantCystinuria, 220100 (3);chr2;SLC3A1, ATR1, D2H, NBAT;True
ENSG00000138078;Prolyl endopeptidase-like;NotRelevant;;Myasthenic syndrome, congenital, 22, 616224 (3), Autosomal recessiveMyasthenic syndrome, congenital, 22, 616224 (3);chr2;PREPL, KIAA0436, CMS22;True
ENSG00000138083;Sine oculis homeo box, Drosophila, homolog of, 3;NotRelevant;;Holoprosencephaly 2, 157170 (3), Autosomal dominantSchizencephaly, 269160 (3);chr2;SIX3, HPE2;True
ENSG00000116016;Endothelial PAS domain protein 1;NotRelevant;;Erythrocytosis, familial, 4, 611783 (3)Erythrocytosis, familial, 4, 611783 (3);chr2;EPAS1, MOP2, HIF2A, ECYT4;False
ENSG00000119878;Cystine-rich PDZ binding protein;NotRelevant;;Short stature with microcephaly and distinctive facies, 615789 (3), Autosomal recessiveShort stature with microcephaly and distinctive facies, 615789 (3);chr2;CRIPT, SSMDF;True
ENSG00000180398;Multiple coagulation factor deficiency protein 2;NotRelevant;;Factor V and factor VIII, combined deficiency of, 613625 (3)Factor V and factor VIII, combined deficiency of, 613625 (3);chr2;MCFD2, F5F8D2;False
ENSG00000068724;Tetratricopeptide repeat domain 7A;NotRelevant;;Gastrointestinal defects and immunodeficiency syndrome, 243150 (3), Autosomal recessiveGastrointestinal defects and immunodeficiency syndrome, 243150 (3);chr2;TTC7A, TTC7, KIAA1140, MINAT, GIDID;True
ENSG00000143933;Calmodulin-2;NotRelevant;;Long QT syndrome 15, 616249 (3), Autosomal dominantLong QT syndrome 15, 616249 (3);chr2;CALM2, LQT15;True
ENSG00000119888;Epithelial cellular adhesion molecule;NotRelevant;previously assigned to 4q;Colorectal cancer, hereditary nonpolyposis, type 8, 613244 (3)Diarrhea 5, with tufting enteropathy, congenital, 613217 (3);chr2;EPCAM, ACSTD1, TROP1, M4S1, MIC18, DIAR5, HNPCC8;False
ENSG00000095002;mutS, E. coli, homolog of, 2;NotRelevant;;Colorectal cancer, hereditary nonpolyposis, type 1, 120435 (3), Autosomal dominantMuir-Torre syndrome, 158320 (3);chr2;MSH2, COCA1, FCC1, HNPCC1;True
ENSG00000116062;MutS, E. coli, homolog of, 6;NotRelevant;0.5 Mb from MSH2;Colorectal cancer, hereditary nonpolyposis, type 5, 614350 (3), Autosomal dominantMismatch repair cancer syndrome, 276300 (3);chr2;MSH6, GTBP, HNPCC5;True
ENSG00000138081;F-box only protein 11;NotRelevant;?2p16;Intellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3), Autosomal dominantIntellectual developmental disorder with dysmorphic facies and behavioral abnormalities, 618089 (3);chr2;FBXO11, FBX11, VIT1, PRMT9, IDDFBA;True
ENSG00000138039;Luteinizing hormone/choriogonadotropin receptor;NotRelevant;;Leydig cell adenoma, somatic, with precocious puberty, 176410 (3)Precocious puberty, male, 176410 (3);chr2;LHCGR, LHR, LCGR;False
ENSG00000170820;Follicle stimulating hormone receptor;NotRelevant;;Ovarian dysgenesis 1, 233300 (3), Autosomal recessiveOvarian response to FSH stimulation, 276400 (3);chr2;FSHR, ODG1;True
ENSG00000179915;Neurexin 1;NotRelevant;;Pitt-Hopkins-like syndrome 2, 614325 (3), Autosomal recessive{Schizophrenia, susceptibility to, 17}, 614332 (3);chr2;NRXN1, PTHSL2, SCZD17;True
ENSG00000115355;Coiled-coil domain-containing protein 88A;NotRelevant;mutation identified in 1 PEHOL family;?PEHO syndrome-like, 617507 (3), Autosomal recessive?PEHO syndrome-like, 617507 (3);chr2;CCDC88A, KIAA1212, HKRP1, GIRDIN, APE, GIV, PEHOL;True
ENSG00000138035;Polyribonucleotide nucleotidyltransferase 1;NotRelevant;;Combined oxidative phosphorylation deficiency 13, 614932 (3), Autosomal recessiveDeafness, autosomal recessive 70, 614934 (3);chr2;PNPT1, OLD35, COXPD13, DFNB70;True
ENSG00000115380;EGF-containing fibulin-like extracellular matrix protein 1 (fibrillin-like);NotRelevant;;Doyne honeycomb degeneration of retina, 126600 (3), Autosomal dominantDoyne honeycomb degeneration of retina, 126600 (3);chr2;EFEMP1, FBNL, DHRD;True
ENSG00000115392;PHD finger protein 9;NotRelevant;;Fanconi anemia, complementation group L, 614083 (3), Autosomal recessiveFanconi anemia, complementation group L, 614083 (3);chr2;PHF9, FANCL;True
ENSG00000119866;B-cell CLL/lymphoma 11A;NotRelevant;;Dias-Logan syndrome, 617101 (3), Autosomal dominantDias-Logan syndrome, 617101 (3);chr2;BCL11A, CTIP1, EVI9, KIAA1809, DILOS;True
ENSG00000162928;Peroxisome biogenesis factor 13 (peroxin 13);NotRelevant;;Peroxisome biogenesis disorder 11A (Zellweger), 614883 (3), Autosomal recessivePeroxisome biogenesis disorder 11B, 614885 (3);chr2;PEX13, ZWS, NALD, PBD11A, PBD11B;True
ENSG00000170264;Family with sequence similarity 161, member A;NotRelevant;;Retinitis pigmentosa 28, 606068 (3)Retinitis pigmentosa 28, 606068 (3);chr2;FAM161A, RP28;False
ENSG00000115504;EH domain-binding protein 1;NotRelevant;;{Prostate cancer, hereditary, 12}, 611868 (3){Prostate cancer, hereditary, 12}, 611868 (3);chr2;EHBP1, KIAA0903, HPC12;False
ENSG00000143951;WD repeat-containing planar cell polarity effector;NotRelevant;mutation identified in 1 BBS15 family and 1 CHDTHP patient;?Bardet-Biedl syndrome 15, 615992 (3), Autosomal recessive?Congenital heart defects, hamartomas of tongue, and polysyndactyly, 217085 (3);chr2;WDPCP, C2orf86, BBS15, CHDTHP;True
ENSG00000115902;Solute carrier family 1 (glutamate/neutral amino acid transporter), member 4;NotRelevant;;Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3), Autosomal recessiveSpastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3);chr2;SLC1A4, SATT, ASCT1, SPATCCM;True
ENSG00000169604;Anthrax toxin receptor 1;NotRelevant;mutation identified in 1 HCI patient;GAPO syndrome, 230740 (3), Autosomal recessive{?Hemangioma, capillary infantile, susceptibility to}, 602089 (3);chr2;ANTXR1, TEM8, ATR, GAPO;True
ENSG00000198380;Glutamine-fructose-6-phosphate transaminase;NotRelevant;;Myasthenia, congenital, 12, with tubular aggregates, 610542 (3), Autosomal recessiveMyasthenia, congenital, 12, with tubular aggregates, 610542 (3);chr2;GFPT1, GFAT1, GFPT1L, MSLG, CMS12, CMSTA1;True
ENSG00000169599;NFU1 iron-sulfur cluster scaffold, S. cerevisiae, homolog of;NotRelevant;;Multiple mitochondrial dysfunctions syndrome 1, 605711 (3), Autosomal recessiveMultiple mitochondrial dysfunctions syndrome 1, 605711 (3);chr2;NFU1, HIRIP, MMDS1;True
ENSG00000116001;TIA1 cytotoxic granule-associated RNA-binding protein;NotRelevant;;Welander distal myopathy, 604454 (3), Autosomal recessive, Autosomal dominantWelander distal myopathy, 604454 (3);chr2;TIA1, WDM;True
ENSG00000183733;Factor in germline alpha, mouse, homolog of;NotRelevant;;Premature ovarian failure 6, 612310 (3), Autosomal dominantPremature ovarian failure 6, 612310 (3);chr2;FIGLA, POF6;True
ENSG00000116031;CD207 antigen;NotRelevant;mutation identified in 1 patient;[?Birbeck granule deficiency], 613393 (3)[?Birbeck granule deficiency], 613393 (3);chr2;CD207, LANGERIN, CLEC4K;False
ENSG00000116039;ATPase, H+ transporting, lysosomal, beta polypeptide, 58kD (vacuolar proton pump, subunit 3);NotRelevant;;Renal tubular acidosis with deafness, 267300 (3), Autosomal recessiveRenal tubular acidosis with deafness, 267300 (3);chr2;ATP6B1, VPP3;True
ENSG00000124370;Methylmalonyl-CoA epimerase;NotRelevant;;Methylmalonyl-CoA epimerase deficiency, 251120 (3), Autosomal recessiveMethylmalonyl-CoA epimerase deficiency, 251120 (3);chr2;MCEE;True
ENSG00000135636;Dysferlin;NotRelevant;;Miyoshi muscular dystrophy 1, 254130 (3), Autosomal recessiveMyopathy, distal, with anterior tibial onset, 606768 (3);chr2;DYSF, LGMDR2, MMD1;True
ENSG00000003137;Cytochrome P450, subfamily XXVIB, polypeptide 1;NotRelevant;;Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3)Craniosynostosis with radiohumeral fusions and other skeletal and craniofacial anomalies, 614416 (3);chr2;CYP26B1, CYP26A2, P450RAI2, RHFCA;False
ENSG00000116096;Sepiapterin reductase;NotRelevant;;Dystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3), ?Autosomal dominant, Autosomal recessiveDystonia, dopa-responsive, due to sepiapterin reductase deficiency, 612716 (3);chr2;SPR;True
ENSG00000116127;Alstrom syndrome gene;NotRelevant;;Alstrom syndrome, 203800 (3), Autosomal recessiveAlstrom syndrome, 203800 (3);chr2;ALMS1, ALSS, KIAA0328;True
ENSG00000144034;TP53RK-binding protein;NotRelevant;;Galloway-Mowat syndrome 5, 617731 (3), Autosomal recessiveGalloway-Mowat syndrome 5, 617731 (3);chr2;TPRKB, GAMOS5;True
ENSG00000124356;STAM binding protein;NotRelevant;;Microcephaly-capillary malformation syndrome, 614261 (3), Autosomal recessiveMicrocephaly-capillary malformation syndrome, 614261 (3);chr2;STAMBP, AMSH, MICCAP;True
ENSG00000163017;Actin, gamma-2, smooth muscle, enteric;NotRelevant;;Visceral myopathy, 155310 (3), Autosomal dominantVisceral myopathy, 155310 (3);chr2;ACTG2, ACTA3, VSCM;True
ENSG00000114956;Deoxyguanosine kinase, mitochondrial;NotRelevant;;Mitochondrial DNA depletion syndrome 3 (hepatocerebral type), 251880 (3), Autosomal recessiveProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 4, 617070 (3);chr2;DGUOK, DGK, MTDPS3, PEOB4, NCPH;True
ENSG00000163170;BolA, E. coli, homolog of, 3;NotRelevant;;Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3), Autosomal recessiveMultiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia, 614299 (3);chr2;BOLA3, MMDS2;True
ENSG00000204843;Dynactin 1 (p150, glued, Drosophila, homolog of);NotRelevant;;{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominant{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3);chr2;DCTN1, HMN7B;True
ENSG00000115275;Mannosyl-oligosaccharide glucosidase;NotRelevant;;Congenital disorder of glycosylation, type IIb, 606056 (3), Autosomal recessiveCongenital disorder of glycosylation, type IIb, 606056 (3);chr2;MOGS, GCS1, CDG2B;True
ENSG00000115317;HTRA serine peptidase 2;NotRelevant;;3-methylglutaconic aciduria, type VIII, 617248 (3), Autosomal recessive{Parkinson disease 13}, 610297 (3);chr2;HTRA2, OMI, PARK13, PRSS25, MGCA8;True
ENSG00000066032;Catenin, alpha-2 (cadherin-associated protein, related);NotRelevant;;Cortical dysplasia, complex, with other brain malformations 9, 618174 (3), Autosomal recessiveCortical dysplasia, complex, with other brain malformations 9, 618174 (3);chr2;CTNNA2, CAPR, CTNR, CDCBM9;True
ENSG00000163541;Succinate-CoA ligase, alpha subunit;NotRelevant;;Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3), Autosomal recessiveMitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria), 245400 (3);chr2;SUCLG1, SUCLA1, MTDPS9;True
ENSG00000115459;ELMO/CED12 domain-containing protein 3;NotRelevant;one family identified with mutation;?Deafness, autosomal recessive 88, 615429 (3), Autosomal recessive?Deafness, autosomal recessive 88, 615429 (3);chr2;ELMOD3, RBED1, DFNB88;True
ENSG00000115486;Gamma-glutamyl carboxylase;NotRelevant;;Pseudoxanthoma elasticum-like disorder with multiple coagulation factor deficiency, 610842 (3)Vitamin K-dependent clotting factors, combined deficiency of, 1, 277450 (3);chr2;GGCX, VKCFD1;False
ENSG00000168878;Pulmonary surfactant-associated protein B, 18kD;NotRelevant;;Surfactant metabolism dysfunction, pulmonary, 1, 265120 (3), Autosomal recessiveSurfactant metabolism dysfunction, pulmonary, 1, 265120 (3);chr2;SFTPB, SFTB3, SMDP1;True
ENSG00000115525;Sialyltransferase 9;NotRelevant;;Salt and pepper developmental regression syndrome, 609056 (3), Autosomal recessiveSalt and pepper developmental regression syndrome, 609056 (3);chr2;SIAT9, ST3GALV, SPDRS;True
ENSG00000068654;Polymerase I, RNA, subunit A;NotRelevant;;Acrofacial dysostosis, Cincinnati type, 616462 (3), Autosomal dominantAcrofacial dysostosis, Cincinnati type, 616462 (3);chr2;POLR1A, RPA194, AFDCIN;True
ENSG00000068615;Receptor expression-enhancing protein 1;NotRelevant;mutation identified in 1 HMN5B family;?Neuronopathy, distal hereditary motor, type VB, 614751 (3), Autosomal dominantSpastic paraplegia 31, autosomal dominant, 610250 (3);chr2;REEP1, C2orf23, SPG31, HMN5B;True
ENSG00000153563;CD8 antigen, alpha polypeptide  (p32);NotRelevant;distal to IGK;CD8 deficiency, familial, 608957 (3), Autosomal recessiveCD8 deficiency, familial, 608957 (3);chr2;CD8A;True
ENSG00000172071;Eukaryotic translation initiation factor 2-alpha kinase 3;NotRelevant;;Wolcott-Rallison syndrome, 226980 (3), Autosomal recessiveWolcott-Rallison syndrome, 226980 (3);chr2;EIF2AK3, PEK, PERK, WRS;True
ENSG00000153574;Ribose 5-phosphate isomerase A;NotRelevant;mutation identified in 1 RPAID patient;?Ribose 5-phosphate isomerase deficiency, 608611 (3), Autosomal recessive?Ribose 5-phosphate isomerase deficiency, 608611 (3);chr2;RPIA, RPI, RPIAD;True
ENSG00000274286;Adrenergic, alpha-2B-, receptor;NotRelevant;;Epilepsy, myoclonic, familial adult, 2, 607876 (3), Autosomal dominantEpilepsy, myoclonic, familial adult, 2, 607876 (3);chr2;ADRA2B, ADRA2L1, FAME2;True
ENSG00000135956;Transmembrane protein 127;NotRelevant;;{Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant{Pheochromocytoma, susceptibility to}, 171300 (3);chr2;TMEM127;True
ENSG00000144028;Small nuclear ribonucleoprotein 200kD (U5);NotRelevant;;Retinitis pigmentosa 33, 610359 (3), Autosomal dominantRetinitis pigmentosa 33, 610359 (3);chr2;SNRNP200, ASCC3L1, KIAA0788, RP33;True
ENSG00000121152;Non-SMC condensin I complex subunit H;NotRelevant;mutation identified in 1 MCPH23 patient;?Microcephaly 23, primary, autosomal recessive, 617985 (3), Autosomal recessive?Microcephaly 23, primary, autosomal recessive, 617985 (3);chr2;NCAPH, CAPH, BRRN1, MCPH23;True
ENSG00000114988;LMAN2-like protein;NotRelevant;mutation identified in 1 MRT52 family;?Mental retardation, autosomal recessive, 52, 616887 (3), Autosomal recessive?Mental retardation, autosomal recessive, 52, 616887 (3);chr2;LMAN2L, VIPL, MRT52;True
ENSG00000158158;Cyclin M4;NotRelevant;;Jalili syndrome, 217080 (3), Autosomal recessiveJalili syndrome, 217080 (3);chr2;CNNM4, ACDP4;True
ENSG00000115085;Zeta-chain associated protein kinase, 70kD (syk-related tyrosine kinase);NotRelevant;;Autoimmune disease, multisystem, infantile-onset, 2, 617006 (3), Autosomal recessiveImmunodeficiency 48, 269840 (3);chr2;ZAP70, SRK, ADMIO2, IMD48;True
ENSG00000168658;von Willebrand factor A domain-containing protein 3B;NotRelevant;mutation identified in 1 SCAR22 family;?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3), Autosomal recessive?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3);chr2;VWA3B, SCAR22;True
ENSG00000144191;Cyclic nucleotide-gated channel, alpha-3;NotRelevant;;Achromatopsia 2, 216900 (3), Autosomal recessiveAchromatopsia 2, 216900 (3);chr2;CNGA3, CNG3, ACHM2;True
ENSG00000183513;Cytochrome c oxidase assembly factor 5;NotRelevant;mutation identified in 1 CEMCOX3 family;?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3), Autosomal recessive?Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 3, 616500 (3);chr2;COA5, C2orf64, PET191, CEMCOX3;True
ENSG00000135951;Testis-specific protein 10;NotRelevant;mutation identified in 1 SPGF26;?Spermatogenic failure 26, 617961 (3), Autosomal recessive?Spermatogenic failure 26, 617961 (3);chr2;TSGA10, SPGF26;True
ENSG00000144182;Lipoyltransferase 1;NotRelevant;;Lipoyltransferase 1 deficiency, 616299 (3), Autosomal recessiveLipoyltransferase 1 deficiency, 616299 (3);chr2;LIPT1, LIPT1D;True
ENSG00000115665;Solute carrier family 5 (choline transporter), member 7;NotRelevant;;Myasthenic syndrome, congenital, 20, presynaptic, 617143 (3), Autosomal recessiveNeuronopathy, distal hereditary motor, type VIIA, 158580 (3);chr2;SLC5A7, CHT1, HMN7A, CMS20;True
ENSG00000153201;RAN-binding protein 2;NotRelevant;;{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3), Autosomal dominant{Encephalopathy, acute, infection-induced, 3, susceptibility to}, 608033 (3);chr2;RANBP2, NUP358, ANE1, IIAE3;True
ENSG00000135960;Ectodysplasin 1, anhidrotic receptor (downless, mouse, homolog of);NotRelevant;;Ectodermal dysplasia 10A, hypohidrotic/hair/nail type, autosomal dominant, 129490 (3), Autosomal dominant[Hair morphology 1, hair thickness], 612630 (3);chr2;EDAR, DL, ED3, EDA3, HRM1, ECTD10A, ECTD10B;True
ENSG00000144061;Nephrocystin;NotRelevant;;Joubert syndrome 4, 609583 (3), Autosomal recessiveSenior-Loken syndrome-1, 266900 (3);chr2;NPHP1, NPH1, SLSN1, JBTS4;True
ENSG00000169679;Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of (mitotic checkpoint gene BUB1);NotRelevant;;Colorectal cancer with chromosomal instability, somatic (3)Colorectal cancer with chromosomal instability, somatic (3);chr2;BUB1;False
ENSG00000153208;Mer tyrosine kinase protooncogene;NotRelevant;;Retinitis pigmentosa 38, 613862 (3), Autosomal recessiveRetinitis pigmentosa 38, 613862 (3);chr2;MERTK, RP38;True
ENSG00000169607;Cytoskeleton-associated protein 2-like;NotRelevant;;Filippi syndrome, 272440 (3), Autosomal recessiveFilippi syndrome, 272440 (3);chr2;CKAP2L, RADMIS;True
ENSG00000125538;Interleukin-1, beta;NotRelevant;within 430kb of IL1RN, IL1A;{Gastric cancer risk after H. pylori infection}, 137215 (3), Autosomal dominant{Gastric cancer risk after H. pylori infection}, 137215 (3);chr2;IL1B;True
ENSG00000136695;Interleukin 36 receptor antagonist;NotRelevant;;Psoriasis 14, pustular, 614204 (3), Autosomal recessivePsoriasis 14, pustular, 614204 (3);chr2;IL36RN, IL1F5, FIL1D, IL1HY1, IL1RP3, PSORP, PSORS14;True
ENSG00000136689;Interleukin-1 receptor antagonist;NotRelevant;;{Gastric cancer risk after H. pylori infection}, 137215 (3), Autosomal dominant{Microvascular complications of diabetes 4}, 612628 (3);chr2;IL1RN, MVCD4, DIRA;True
ENSG00000125618;Paired box homeotic gene-8;NotRelevant;;Hypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3), Autosomal dominantHypothyroidism, congenital, due to thyroid dysgenesis or hypoplasia, 218700 (3);chr2;PAX8;True
ENSG00000115107;Six-transmembrane epithelial antigen of prostate 3;NotRelevant;mutation identified in 1 AHMIO2 family;?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3), Autosomal dominant?Anemia, hypochromic microcytic, with iron overload 2, 615234 (3);chr2;STEAP3, TSAP6, AHMIO2;True
ENSG00000074047;GLI-Kruppel family member GLI2 (oncogene GLI2);NotRelevant;;Culler-Jones syndrome, 615849 (3), Autosomal dominantHoloprosencephaly 9, 610829 (3);chr2;GLI2, HPE9, CJS;True
ENSG00000264229;RNA, U4, small nuclear, AT-AC form;NotRelevant;;Microcephalic osteodysplastic primordial dwarfism, type I, 210710 (3), Autosomal recessiveRoifman syndrome, 616651 (3);chr2;RNU4ATAC, U4ATAC, MOPD1, TALS, RFMN;True
ENSG00000136732;Glycophorin C;NotRelevant;;[Blood group, Gerbich], 616089 (3){Malaria, resistance to}, 611162 (3);chr2;GYPC, GE, GPC;False
ENSG00000136717;Box-dependent MYC-interacting protein-1 (amphiphysin-like);NotRelevant;;Centronuclear myopathy 2, 255200 (3), Autosomal recessiveCentronuclear myopathy 2, 255200 (3);chr2;BIN1, AMPHL, CNM2;True
ENSG00000163161;Excision-repair cross-complementing rodent repair deficiency, complementation group 3;NotRelevant;;Trichothiodystrophy 2, photosensitive, 616390 (3), Autosomal recessiveXeroderma pigmentosum, group B, 610651 (3);chr2;ERCC3, XPB, TTD2;True
ENSG00000115718;Protein C (inactivator of coagulation factors Va and VIIIa);NotRelevant;;Thrombophilia due to protein C deficiency, autosomal dominant, 176860 (3), Autosomal dominantThrombophilia due to protein C deficiency, autosomal recessive, 612304 (3);chr2;PROC, PC, THPH3, THPH4;True
ENSG00000072163;LIM and senescent cell antigen-like domains 2;NotRelevant;mutation identified in 1 LGMD2W family;?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue, 616827 (3), Autosomal recessive?Muscular dystrophy, autosomal recessive, with cardiomyopathy and triangular tongue, 616827 (3);chr2;LIMS2, PINCH2, MDRCMTT;True
ENSG00000136720;Heparan sulfate 6-O-sulfotransferase 1;NotRelevant;;{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3), Autosomal dominant{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3);chr2;HS6ST1, HS6ST, HH15;True
ENSG00000136710;Coiled-coil domain-containing protein 115;NotRelevant;;Congenital disorder of glycosylation, type IIo, 616828 (3), Autosomal recessiveCongenital disorder of glycosylation, type IIo, 616828 (3);chr2;CCDC115, CCP1, CDG2O;True
ENSG00000136698;Cryptic protein;NotRelevant;;Heterotaxy, visceral, 2, autosomal, 605376 (3), Autosomal dominantHeterotaxy, visceral, 2, autosomal, 605376 (3);chr2;CFC1, CRYPTIC, HTX2;True
ENSG00000075886;Tubulin, alpha-3D;NotRelevant;;Keratoconus 9, 617928 (3), Autosomal dominantKeratoconus 9, 617928 (3);chr2;TUBA3D, KTCN9;True
ENSG00000115839;RAB3 GTPase-activating protein, catalytic subunit;NotRelevant;;Warburg micro syndrome 1, 600118 (3), Autosomal recessiveWarburg micro syndrome 1, 600118 (3);chr2;RAB3GAP1, WARBM1, P130;True
ENSG00000115850;Lactase (lactase-phlorizin hydrolase);NotRelevant;;Lactase deficiency, congenital, 223000 (3), Autosomal recessiveLactase deficiency, congenital, 223000 (3);chr2;LCT, LAC, LPH;True
ENSG00000076003;Minichromosome maintenance deficient (mis5, S. pombe) 6;NotRelevant;mutations in introns 9 and 13;Lactase persistence/nonpersistence, 223100 (3), Autosomal dominantLactase persistence/nonpersistence, 223100 (3);chr2;MCM6;True
ENSG00000115866;Aspartyl tRNA synthetase;NotRelevant;;Hypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3), Autosomal recessiveHypomyelination with brainstem and spinal cord involvement and leg spasticity, 615281 (3);chr2;DARS, HBSL, HBSL;True
ENSG00000121966;Chemokine (C-X-C motif) receptor 4 (neuropeptide Y receptor Y3);NotRelevant;;Myelokathexis, isolated (3)WHIM syndrome, 193670 (3);chr2;CXCR4, D2S201E, NPY3R, WHIMS;False
ENSG00000150540;Histamine N-methyltransferase;NotRelevant;;{Asthma, susceptibility to}, 600807 (3), Autosomal dominant{Asthma, susceptibility to}, 600807 (3);chr2;HNMT, MRT51;True
ENSG00000115919;Kynureninase;NotRelevant;mutation identified in 1 KYNUU family;?Hydroxykynureninuria, 236800 (3), Autosomal recessiveVertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3);chr2;KYNU, KYNUU, VCRL2;True
ENSG00000169554;Zinc finger E box-binding homeobox 2;NotRelevant;;Mowat-Wilson syndrome, 235730 (3), Autosomal dominantMowat-Wilson syndrome, 235730 (3);chr2;ZEB2, ZFHX1B, SMADIP1, SIP1;True
ENSG00000115947;Origin recognition complex, subunit 4, S. cerevisiae, homolog of;NotRelevant;;Meier-Gorlin syndrome 2, 613800 (3), Autosomal recessiveMeier-Gorlin syndrome 2, 613800 (3);chr2;ORC4, ORC4L;True
ENSG00000204406;Methyl-CpG-binding domain protein 5;NotRelevant;;Mental retardation, autosomal dominant 1, 156200 (3), Autosomal dominantMental retardation, autosomal dominant 1, 156200 (3);chr2;MBD5, KIAA1461, MRD1;True
ENSG00000168280;Kinesin family member 5C;NotRelevant;;Cortical dysplasia, complex, with other brain malformations 2, 615282 (3), Autosomal dominantCortical dysplasia, complex, with other brain malformations 2, 615282 (3);chr2;KIF5C, NKHC2, CDCBM2;True
ENSG00000168288;Chromosome 2 open reading frame 25;NotRelevant;;Homocystinuria, cblD type, variant 1, 277410 (3), Autosomal recessiveMethylmalonic aciduria, cblD type, variant 2, 277410 (3);chr2;C2orf25, MMADHC;True
ENSG00000183091;Nebulin;NotRelevant;;Nemaline myopathy 2, autosomal recessive, 256030 (3), Autosomal recessiveNemaline myopathy 2, autosomal recessive, 256030 (3);chr2;NEB, NEM2;True
ENSG00000182389;Calcium channel, voltage-dependent, beta 4 subunit;NotRelevant;;{Epilepsy, idiopathic generalized, susceptibility to, 9}, 607682 (3), Autosomal dominant{Epilepsy, juvenile myoclonic, susceptibility to, 6}, 607682 (3);chr2;CACNB4, EJM6, EA5, EIG9;True
ENSG00000115159;Glycerol-3-phosphate dehydrogenase 2 (mitochondrial);NotRelevant;pseudogene on 19;{Diabetes, type 2, susceptibility to}, 125853 (3), Autosomal dominant{Diabetes, type 2, susceptibility to}, 125853 (3);chr2;GPD2;True
ENSG00000115170;Activin A receptor, type I;NotRelevant;;Fibrodysplasia ossificans progressiva, 135100 (3), Autosomal dominantFibrodysplasia ossificans progressiva, 135100 (3);chr2;ACVR1, ACVRLK2, ALK2, FOP;True
ENSG00000115221;Integrin, beta-6;NotRelevant;;Amelogenesis imperfecta, type IH, 616221 (3), Autosomal recessiveAmelogenesis imperfecta, type IH, 616221 (3);chr2;ITGB6, AI1H;True
ENSG00000136535;T-box, brain, 1;NotRelevant;;Intellectual developmental disorder with autism and speech delay, 606053 (3), Autosomal dominantIntellectual developmental disorder with autism and speech delay, 606053 (3);chr2;TBR1, IDDAS;True
ENSG00000115263;Glucagon;NotRelevant;;[?Hyperproglucagonemia] (1)[?Hyperproglucagonemia] (1);chr2;GCG;False
ENSG00000115267;Interferon induced with helicase C domain 1;NotRelevant;;Aicardi-Goutieres syndrome 7, 615846 (3), Autosomal dominantSingleton-Merten syndrome 1, 182250 (3);chr2;IFIH1, MDA5, AGS7, SGMRT1;True
ENSG00000153253;Sodium channel, voltage-gated, type III, alpha polypeptide;NotRelevant;;Epilepsy, familial focal, with variable foci 4, 617935 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 62, 617938 (3);chr2;SCN3A, FFEVF4, EIEE62;True
ENSG00000136531;Sodium channel, voltage-gated, type II, alpha subunit;NotRelevant;4 related genes on chr.2;Epileptic encephalopathy, early infantile, 11, 613721 (3), Autosomal dominantSeizures, benign familial infantile, 3, 607745 (3);chr2;SCN2A, SCN2A1, BFIC3, EIEE11, BFIS3, BFNIS;True
ENSG00000115339;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3;NotRelevant;;Tumoral calcinosis, hyperphosphatemic, familial, 1, 211900 (3), Autosomal recessiveTumoral calcinosis, hyperphosphatemic, familial, 1, 211900 (3);chr2;GALNT3, HHS, HFTC1;True
ENSG00000123607;Tetratricopeptide repeat domain 21B;NotRelevant;;Nephronophthisis 12, 613820 (3), Autosomal recessive, Autosomal dominantShort-rib thoracic dysplasia 4 with or without polydactyly, 613819 (3);chr2;TTC21B, THM1, NPHP12, SRTD4, ATD4;True
ENSG00000144285;Sodium channel, voltage-gated, type I, alpha polypeptide;NotRelevant;;Epilepsy, generalized, with febrile seizures plus, type 2, 604403 (3), Autosomal dominantMigraine, familial hemiplegic, 3, 609634 (3);chr2;SCN1A, GEFSP2, SMEI, FEB3A, EIEE6, FHM3;True
ENSG00000169432;Sodium channel, voltage-gated, type IX, alpha subunit;NotRelevant;;{Dravet syndrome, modifier of}, 607208 (3), Autosomal dominant{Dravet syndrome, modifier of}, 607208 (3);chr2;SCN9A, NENA, PN1, FEB3B, GEFSP7, SFNP, HSAN2D;True
ENSG00000073734;ATP-binding cassette, subfamily B, member 11 (bile salt export pump);NotRelevant;;Cholestasis, benign recurrent intrahepatic, 2, 605479 (3), Autosomal recessiveCholestasis, progressive familial intrahepatic 2, 601847 (3);chr2;ABCB11, BSEP, SPGP, PFIC2, BRIC2;True
ENSG00000081479;Low density lipoprotein-related protein 2;NotRelevant;;Donnai-Barrow syndrome, 222448 (3), Autosomal recessiveDonnai-Barrow syndrome, 222448 (3);chr2;LRP2, DBS;True
ENSG00000163093;BBS gene 5;NotRelevant;;Bardet-Biedl syndrome 5, 615983 (3), Autosomal recessiveBardet-Biedl syndrome 5, 615983 (3);chr2;BBS5;True
ENSG00000239474;Kelch-like family member 41;NotRelevant;;Nemaline myopathy 9, 615731 (3), Autosomal recessiveNemaline myopathy 9, 615731 (3);chr2;KLHL41, KBTBD10, SARCOSIN, NEM9;True
ENSG00000128683;Glutamate decarboxylase-1, brain, 67kD;NotRelevant;mutation identified in 1 CPSQ1 family;?Cerebral palsy, spastic quadriplegic, 1, 603513 (3), Autosomal recessive?Cerebral palsy, spastic quadriplegic, 1, 603513 (3);chr2;GAD1, SCP, CPSQ1;True
ENSG00000115827;DDB1- and CUL4-associated factor 17;NotRelevant;;Woodhouse-Sakati syndrome, 241080 (3), Autosomal recessiveWoodhouse-Sakati syndrome, 241080 (3);chr2;DCAF17, C20orf37;True
ENSG00000115840;Solute carrier family 25 (mitochondrial carrier, Aralar), member 12;NotRelevant;;Epileptic encephalopathy, early infantile, 39, 612949 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 39, 612949 (3);chr2;SLC25A12, ARALAR, EIEE39;True
ENSG00000091409;Integrin, alpha-6;NotRelevant;;Epidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3), Autosomal recessiveEpidermolysis bullosa, junctional, with pyloric stenosis, 226730 (3);chr2;ITGA6;True
ENSG00000091436;Leucine zipper- and sterile alpha motif-containing kinase;NotRelevant;;Centronuclear myopathy 6 with fiber-type disproportion, 617760 (3), Autosomal recessiveSplit-foot malformation with mesoaxial polydactyly, 616890 (3);chr2;ZAK, MLTK, MRK, SFMMP, CNM6;True
ENSG00000144354;Cell division cycle-associated 7;NotRelevant;;Immunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3), Autosomal recessiveImmunodeficiency-centromeric instability-facial anomalies syndrome 3, 616910 (3);chr2;CDCA7, JPO1, ICF3;True
ENSG00000115935;WAS/WASL-interacting protein family, member 1;NotRelevant;mutation identified in 1 WAS2 patient;?Wiskott-Aldrich syndrome 2, 614493 (3)?Wiskott-Aldrich syndrome 2, 614493 (3);chr2;WIPF1, WASPIP, WIP, WAS2;False
ENSG00000138435;Cholinergic receptor, nicotinic, alpha polypeptide-1, muscle;NotRelevant;;Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessiveMyasthenic syndrome, congenital, 1B, fast-channel, 608930 (3);chr2;CHRNA1, ACHRD, CMS1B, CMS1A;True
ENSG00000128656;Chimerin 1 (GTPase-activating protein, rho, 2);NotRelevant;;Duane retraction syndrome 2, 604356 (3)Duane retraction syndrome 2, 604356 (3);chr2;CHN1, CHN, ARHGAP2, RHOGAP2, DURS2;False
ENSG00000144320;Lunapark;NotRelevant;;Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3), Autosomal recessiveNeurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3);chr2;LNPK, KIAA1715, NEDEHCC;True
ENSG00000128714;Homeo box-D13;NotRelevant;mutation identified in 1 BDSD family;Brachydactyly, type D, 113200 (3), Autosomal dominantSynpolydactyly 1, 186000 (3);chr2;HOXD13, HOX4I, SPD1, BDSD;True
ENSG00000128710;Homeo box-D10;NotRelevant;;Charcot-Marie-Tooth disease, foot deformity of, 192950 (3), Autosomal dominantVertical talus, congenital, 192950 (3);chr2;HOXD10, HOX4D;True
ENSG00000116044;Nuclear factor, erythroid-derived 2-like 2;NotRelevant;;Immunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3), Autosomal dominantImmunodeficiency, developmental delay, and hypohomocysteinemia, 617744 (3);chr2;NFE2L2, NRF2, IMDDHH;True
ENSG00000018510;Alkylglycerone-phosphate synthase;NotRelevant;;Rhizomelic chondrodysplasia punctata, type 3, 600121 (3), Autosomal recessiveRhizomelic chondrodysplasia punctata, type 3, 600121 (3);chr2;AGPS, ADHAPS, RCDP3;True
ENSG00000128655;Phosphodiesterase 11A;NotRelevant;;Pigmented nodular adrenocortical disease, primary, 2, 610475 (3), Autosomal dominantPigmented nodular adrenocortical disease, primary, 2, 610475 (3);chr2;PDE11A, PDE11A1, PDE11A2, PDE11A3, PPNAD2;True
ENSG00000180228;Protein kinase, interferon-inducible double-stranded RNA-dependent activator;NotRelevant;;Dystonia 16, 612067 (3), Autosomal recessiveDystonia 16, 612067 (3);chr2;PRKRA, PACT, RAX, DYT16;True
ENSG00000204311;Pejvakin;NotRelevant;;Deafness, autosomal recessive 59, 610220 (3), Autosomal recessiveDeafness, autosomal recessive 59, 610220 (3);chr2;PJVK, DFNB59;True
ENSG00000155657;Titin;NotRelevant;;Cardiomyopathy, dilated, 1G, 604145 (3)Tibial muscular dystrophy, tardive, 600334 (3);chr2;TTN, CMD1G, TMD, LGMDR10, MPRM, HMERF, SALMY;False
ENSG00000188452;Ceramide kinase-like;NotRelevant;;Retinitis pigmentosa 26, 608380 (3)Retinitis pigmentosa 26, 608380 (3);chr2;CERKL, RP26;False
ENSG00000162992;Neurogenic differentiation 1;NotRelevant;;{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent}, 125853 (3);chr2;NEUROD1, NIDDM;True
ENSG00000162998;Frizzled-related protein;NotRelevant;;{Osteoarthritis susceptibility 1}, 165720 (3), Multifactorial{Osteoarthritis susceptibility 1}, 165720 (3);chr2;FRZB, FRZB1, SRFP3, OS1;False
ENSG00000188738;Fibrous sheath-interacting protein 2;NotRelevant;;Spermatogenic failure 34, 618153 (3), Autosomal recessiveSpermatogenic failure 34, 618153 (3);chr2;FSIP2, SPGF34;True
ENSG00000168542;Collagen III, alpha-1 polypeptide;NotRelevant;in same 35kb segment as COL5A2;Ehlers-Danlos syndrome, vascular type, 130050 (3), Autosomal dominantEhlers-Danlos syndrome, vascular type, 130050 (3);chr2;COL3A1, EDSVASC;True
ENSG00000204262;Collagen V, alpha-2 polypeptide;NotRelevant;very close to COL3A1;Ehlers-Danlos syndrome, classic type, 2, 130010 (3), Autosomal dominantEhlers-Danlos syndrome, classic type, 2, 130010 (3);chr2;COL5A2, EDSCL2;True
ENSG00000138449;Solute carrier family 40 (iron-regulated transporter), member 1;NotRelevant;;Hemochromatosis, type 4, 606069 (3), Autosomal dominantHemochromatosis, type 4, 606069 (3);chr2;SLC40A1, SLC11A3, FPN1, IREG1, HFE4;True
ENSG00000138379;Growth differentiation factor-8 (myostatin);NotRelevant;;Muscle hypertrophy, 614160 (3)Muscle hypertrophy, 614160 (3);chr2;GDF8, MSTN, MSLHP;False
ENSG00000198130;3-hydroxyisobutyryl-CoA hydrolase;NotRelevant;;3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3), Autosomal recessive3-hydroxyisobutryl-CoA hydrolase deficiency, 250620 (3);chr2;HIBCH;True
ENSG00000115415;Signal transducer and activator of transcription-1;NotRelevant;;Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3), Autosomal dominantImmunodeficiency 31C, autosomal dominant, 614162 (3);chr2;STAT1, CANDF7, IMD31A, IMD31B, IMD31C;True
ENSG00000138378;Signal transducer and activator of transcription-4;NotRelevant;;{Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3){Systemic lupus erythematosus, susceptibility to, 11}, 612253 (3);chr2;STAT4, SLEB11;False
ENSG00000138411;HECT, C2, and WW domains-containing E3 ubiquitin-protein ligase 2;NotRelevant;;Neurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3), Autosomal dominantNeurodevelopmental disorder with hypotonia, seizures, and absent language, 617268 (3);chr2;HECW2, NEDL2, KIAA1301, NDHSAL;True
ENSG00000197121;Post-GPI attachment to proteins 1;NotRelevant;;Mental retardation, autosomal recessive 42, 615802 (3), Autosomal recessiveMental retardation, autosomal recessive 42, 615802 (3);chr2;PGAP1, MRT42;True
ENSG00000115524;Splicing factor 3B, subunit 1;NotRelevant;;Myelodysplastic syndrome, somatic, 614286 (3)Myelodysplastic syndrome, somatic, 614286 (3);chr2;SF3B1, SF3B155, SAP155, MDS;False
ENSG00000144381;Heat-shock 60kD protein 1;NotRelevant;;Leukodystrophy, hypomyelinating, 4, 612233 (3), Autosomal recessiveSpastic paraplegia 13, autosomal dominant, 605280 (3);chr2;HSPD1, SPG13, HSP60, HLD4;True
ENSG00000247626;Methionyl-tRNA synthetase 2;NotRelevant;mutation identified in 1 COXPD25 family;?Combined oxidative phosphorylation deficiency 25, 616430 (3), Autosomal recessiveSpastic ataxia 3, autosomal recessive, 611390 (3);chr2;MARS2, SPAX3, COXPD25;True
ENSG00000119042;Special AT-rich sequence-binding protein 2;NotRelevant;;Glass syndrome, 612313 (3), Autosomal dominantGlass syndrome, 612313 (3);chr2;SATB2, KIAA1034, GLSS;True
ENSG00000119013;NADH-ubiquinone oxidoreductase 1 beta subcomplex, 3;NotRelevant;pseudogenes on chr. 1, 9, and 14;Mitochondrial complex I deficiency, nuclear type 25, 618246 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 25, 618246 (3);chr2;NDUFB3, MC1DN25;True
ENSG00000003400;Caspase 10, apoptosis-related cysteine protease;NotRelevant;;Autoimmune lymphoproliferative syndrome, type II, 603909 (3), Autosomal dominantLymphoma, non-Hodgkin, somatic, 605027 (3);chr2;CASP10, MCH4, ALPS2;True
ENSG00000064012;Caspase 8, apoptosis-related cysteine protease;NotRelevant;mutation identified in 1 ALPS2B family;?Autoimmune lymphoproliferative syndrome, type IIB, 607271 (3), Autosomal recessive{Lung cancer, protection against}, 211980 (3);chr2;CASP8, MCH5, ALPS2B;True
ENSG00000155755;Transmembrane protein 237;NotRelevant;;Joubert syndrome 14, 614424 (3), Autosomal recessiveJoubert syndrome 14, 614424 (3);chr2;TMEM237, ALS2CR4, JBTS14;True
ENSG00000003393;Alsin;NotRelevant;;Amyotrophic lateral sclerosis 2, juvenile, 205100 (3), Autosomal recessiveSpastic paralysis, infantile onset ascending, 607225 (3);chr2;ALS2, ALSJ, PLSJ, IAHSP;True
ENSG00000116030;Small ubiquitin-like modifier 1;NotRelevant;mutation identified in 1 OFC10 patient;?Orofacial cleft 10, 613705 (3), Isolated cases?Orofacial cleft 10, 613705 (3);chr2;SUMO1, UBL1, SMT3, OFC10;False
ENSG00000204217;Bone morphogenetic receptor, type II;NotRelevant;;Pulmonary hypertension, familial primary, 1, with or without HHT, 178600 (3), Autosomal dominantPulmonary venoocclusive disease 1, 265450 (3);chr2;BMPR2, PPH1, POVD1;True
ENSG00000163599;Cytotoxic T-lymphocyte-associated serine esterase-4;NotRelevant;;Autoimmune lymphoproliferative syndrome, type V, 616100 (3), Autosomal dominant{Systemic lupus erythematosus, susceptibility to}, 152700 (3);chr2;CTLA4, IDDM12, CELIAC3, ALPS5;True
ENSG00000163600;Inducible costimulator;NotRelevant;;Immunodeficiency, common variable, 1, 607594 (3), Autosomal recessiveImmunodeficiency, common variable, 1, 607594 (3);chr2;ICOS, AILIM, CVID1;True
ENSG00000023228;NADH dehydrogenase (ubiquinone) Fe-S protein 1, 75kD;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 5, 618226 (3)Mitochondrial complex I deficiency, nuclear type 5, 618226 (3);chr2;NDUFS1, MC1DN5;False
ENSG00000118246;FAST kinase domains 2;NotRelevant;mutation identified in 1 family;?Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial?Mitochondrial complex IV deficiency, 220110 (3);chr2;FASTKD2, KIAA0971;True
ENSG00000118260;cAMP-response element-binding protein-1;NotRelevant;fusion gene with EWSR1;Histiocytoma, angiomatoid fibrous, somatic, 612160 (3)Histiocytoma, angiomatoid fibrous, somatic, 612160 (3);chr2;CREB1;False
ENSG00000118231;Crystallin, gamma D;NotRelevant;;Cataract 4, multiple types, 115700 (3), Autosomal dominantCataract 4, multiple types, 115700 (3);chr2;CRYGD, CRYG4, CTRCT4, CACA, CCA3, PCC;True
ENSG00000163254;Crystallin, gamma C;NotRelevant;;Cataract 2, multiple types, 604307 (3), Autosomal dominantCataract 2, multiple types, 604307 (3);chr2;CRYGC, CRYG3, CTRCT2, CCL;True
ENSG00000182187;Crystallin, gamma B;NotRelevant;;Cataract 39, multiple types, autosomal dominant, 615188 (3), Autosomal dominantCataract 39, multiple types, autosomal dominant, 615188 (3);chr2;CRYGB, CRYG2, CTRCT39;True
ENSG00000138413;Isocitrate dehydrogenase, soluble;NotRelevant;;{Glioma, susceptibility to, somatic}, 137800 (3){Glioma, susceptibility to, somatic}, 137800 (3);chr2;IDH1;False
ENSG00000115020;Phosphatidylinositol kinase, FYVE-finger containing;NotRelevant;;Corneal fleck dystrophy, 121850 (3), Autosomal dominantCorneal fleck dystrophy, 121850 (3);chr2;PIKFYVE, PIP5K3;True
ENSG00000144406;Unc-80 homolog, NALCN activator;NotRelevant;;Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3), Autosomal recessiveHypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3);chr2;UNC80, C2orf21, KIAA1843;True
ENSG00000021826;Carbamoyl-phosphate synthetase 1, mitochondrial;NotRelevant;urea cycle enzyme;Carbamoylphosphate synthetase I deficiency, 237300 (3), Autosomal recessive{Venoocclusive disease after bone marrow transplantation} (3);chr2;CPS1, PHN;True
ENSG00000178568;Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 4;NotRelevant;;Amyotrophic lateral sclerosis 19, 615515 (3), Autosomal dominantAmyotrophic lateral sclerosis 19, 615515 (3);chr2;ERBB4, HER4, ALS19;True
ENSG00000138376;BRCA1-associated RING domain 1;NotRelevant;;{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation{Breast cancer, susceptibility to}, 114480 (3);chr2;BARD1;True
ENSG00000144452;ATP-binding cassette, subfamily A, member 12;NotRelevant;;Ichthyosis, congenital, autosomal recessive 4A, 601277 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 4B (harlequin), 242500 (3);chr2;ABCA12, ARCI4A, ARCI4B, ICR2B, LI2;True
ENSG00000138363;5-aminoimidazole-4-carboxyamide ribonucleotide formyltransferase/IMP cyclohydrolase;NotRelevant;;AICA-ribosiduria due to ATIC deficiency, 608688 (3), Autosomal recessiveAICA-ribosiduria due to ATIC deficiency, 608688 (3);chr2;ATIC, PURH, AICAR;True
ENSG00000115414;Fibronectin-1;NotRelevant;;Glomerulopathy with fibronectin deposits 2, 601894 (3), Autosomal dominantSpondylometaphyseal dysplasia, corner fracture type, 184255 (3);chr2;FN1, FN, LETS, FNZ, GFND2, SMDCF;True
ENSG00000138375;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily A-like;NotRelevant;;Schimke immunoosseous dysplasia, 242900 (3), Autosomal recessiveSchimke immunoosseous dysplasia, 242900 (3);chr2;SMARCAL1, HARP, SIOD;True
ENSG00000163464;Chemokine, CXC motif, receptor 1;NotRelevant;;{AIDS, slow progression to}, 609423 (3){AIDS, slow progression to}, 609423 (3);chr2;CXCR1, IL8RA;False
ENSG00000127838;Myofibrillogenesis regulator 1;NotRelevant;;Paroxysmal nonkinesigenic dyskinesia 1, 118800 (3), Autosomal dominantParoxysmal nonkinesigenic dyskinesia 1, 118800 (3);chr2;MR1, TAHCCP2, KIPP1184, BRP17, PNKD1, FPD1, PDC, DYT8;True
ENSG00000018280;Solute carrier family 11 (proton-coupled divalent metal ion transporter), member 1;NotRelevant;within 220 kb of VIL1;{Buruli ulcer, susceptibility to}, 610446 (3){Mycobacterium tuberculosis, susceptibility to infection by}, 607948 (3);chr2;NRAMP1, NRAMP, SLC11A1;False
ENSG00000074582;bcs1, S. cerevisiae, homolog-like;NotRelevant;;Bjornstad syndrome, 262000 (3), Autosomal recessiveMitochondrial complex III deficiency, nuclear type 1, 124000 (3);chr2;BCS1L, FLNMS, GRACILE, BJS, PTD, MC3DN1;True
ENSG00000135929;Cytochrome P450, subfamily XXVIIA, polypeptide 1 (sterol 27-hydroxylase);NotRelevant;;Cerebrotendinous xanthomatosis, 213700 (3), Autosomal recessiveCerebrotendinous xanthomatosis, 213700 (3);chr2;CYP27A1, CYP27, CTX;True
ENSG00000135925;Wingless-type MMTV integration site family, member 10A;NotRelevant;;Odontoonychodermal dysplasia, 257980 (3), Autosomal recessiveTooth agenesis, selective, 4, 150400 (3);chr2;WNT10A, SSPS, STHAG4, OODD;True
ENSG00000163499;Crystallin, beta A2;NotRelevant;mutation identified in 1 CTRCT42 family;?Cataract 42, 115900 (3), Autosomal dominant?Cataract 42, 115900 (3);chr2;CRYBA2, CTRCT42;True
ENSG00000163501;Indian hedgehog;NotRelevant;;Acrocapitofemoral dysplasia, 607778 (3), Autosomal recessiveBrachydactyly, type A1, 112500 (3);chr2;IHH, BDA1;True
ENSG00000187736;Nonhomologous end-joining factor 1;NotRelevant;;Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3)Severe combined immunodeficiency with microcephaly, growth retardation, and sensitivity to ionizing radiation, 611291 (3);chr2;NHEJ1, XLF;False
ENSG00000115657;ATP-binding cassette, subfamily B, member 6;NotRelevant;;[Blood group, Langereis system], 111600 (3)[Blood group, Langereis system], 111600 (3);chr2;ABCB6, MTABC3, MCOPCB7, LAN, DUH3, PSHK2;False
ENSG00000127824;Tubulin, alpha-4A;NotRelevant;;Amyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3), Autosomal dominantAmyotrophic lateral sclerosis 22 with or without frontotemporal dementia, 616208 (3);chr2;TUBA4A, TUBA1, ALS22;True
ENSG00000135924;DnaJ, E. coli, homolog of, subfamily B, member 2 (heat-shock protein, DNAJ-like 1);NotRelevant;;Spinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3), Autosomal recessiveSpinal muscular atrophy, distal, autosomal recessive, 5, 614881 (3);chr2;DNAJB2, HSJ1, HSPF3, DSMA5;True
ENSG00000175084;Desmin;NotRelevant;1 family with LGMD2R identified with mutation;Cardiomyopathy, dilated, 1I, 604765 (3)Scapuloperoneal syndrome, neurogenic, Kaeser type, 181400 (3);chr2;DES, CMD1I, MFM1, SCPNK;False
ENSG00000072195;SPEG complex locus;NotRelevant;;Centronuclear myopathy 5, 615959 (3), Autosomal recessiveCentronuclear myopathy 5, 615959 (3);chr2;SPEG, APEG1, CNM5;True
ENSG00000144591;GDP-mannose pyrophosphorylase A;NotRelevant;;Alacrima, achalasia, and mental retardation syndrome, 615510 (3), Autosomal recessiveAlacrima, achalasia, and mental retardation syndrome, 615510 (3);chr2;GMPPA, AAMR;True
ENSG00000124006;Obscurin-like 1;NotRelevant;;3-M syndrome 2, 612921 (3)3-M syndrome 2, 612921 (3);chr2;OBSL1, KIAA0657, 3M2;False
ENSG00000135903;Paired box homeotic gene-3;NotRelevant;;Craniofacial-deafness-hand syndrome, 122880 (3), Autosomal dominantWaardenburg syndrome, type 3, 148820 (3);chr2;PAX3, WS1, HUP2, CDHS, WS3;True
ENSG00000116120;Phenylalanine-tRNA synthetase-like, beta subunit;NotRelevant;mutation identified in 1 NEDBLLA patient;?Neurodevelopmental disorder with brain, liver, and lung abnormalities, 618007 (3), Autosomal recessive?Neurodevelopmental disorder with brain, liver, and lung abnormalities, 618007 (3);chr2;FARSLB, FRSB, NEDBLLA;True
ENSG00000152056;Adaptor-related protein complex 1, sigma-3 subunit;NotRelevant;;{Psoriasis 15, pustular, susceptibility to}, 616106 (3), Autosomal dominant{Psoriasis 15, pustular, susceptibility to}, 616106 (3);chr2;AP1S3, PSORS15;True
ENSG00000135900;Mitochondrial ribosomal protein L44;NotRelevant;Mutation identified in 1 family;?Combined oxidative phosphorylation deficiency 16, 615395 (3), Autosomal recessive?Combined oxidative phosphorylation deficiency 16, 615395 (3);chr2;MRPL44, COXPD16;True
ENSG00000135919;Protease inhibitor 7 (protease nexin I);NotRelevant;near MYL1; ?COPD susceptibility;chr2;PI7, PN1, SERPINE2;False
ENSG00000036257;Cullin 3;NotRelevant;;Pseudohypoaldosteronism, type IIE, 614496 (3), Autosomal dominantPseudohypoaldosteronism, type IIE, 614496 (3);chr2;CUL3, PHA2E;True
ENSG00000169047;Insulin receptor substrate-1;NotRelevant;;{Coronary artery disease, susceptibility to} (3){Diabetes mellitus, noninsulin-dependent}, 125853 (3);chr2;IRS1;False
ENSG00000081052;Collagen IV, alpha-4 polypeptide;NotRelevant;head-to-head with COL4A4 in same YAC;Alport syndrome, autosomal recessive, 203780 (3), Autosomal recessiveHematuria, familial benign (3);chr2;COL4A4;True
ENSG00000169031;Collagen IV, alpha-3 polypeptide (Goodpasture antigen);NotRelevant;noncollagenous domain = Goodpasture antigen;Alport syndrome, autosomal dominant, 104200 (3), Autosomal dominantHematuria, benign familial, 141200 (3);chr2;COL4A3;True
ENSG00000168958;Mitochondrial fission factor;NotRelevant;;Encephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3), Autosomal recessiveEncephalopathy due to defective mitochondrial and peroxisomal fission 2, 617086 (3);chr2;MFF, C2orf33, EMPF2;True
ENSG00000168955;Transmembrane 4 L6 family, member 20;NotRelevant;;{Specific language impairment 5}, 615432 (3), Autosomal dominant{Specific language impairment 5}, 615432 (3);chr2;TM4SF20, SLI5;True
ENSG00000135917;Solute carrier family 19 (folate transporter), member 3;NotRelevant;;Thiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3), Autosomal recessiveThiamine metabolism dysfunction syndrome 2 (biotin- or thiamine-responsive encephalopathy type 2), 607483 (3);chr2;SLC19A3, THMD2, BBGD;True
ENSG00000153827;Thyroid hormone receptor interactor 12;NotRelevant;;Mental retardation, autosomal dominant 49, 617752 (3), Autosomal dominantMental retardation, autosomal dominant 49, 617752 (3);chr2;TRIP12, MRD49;True
ENSG00000135899;SP110 nuclear body protein (interferon-induced protein 41, 30kD;NotRelevant;ENSG00000135899;{Mycobacterium tuberculosis, susceptibility to}, 607948 (3);chr2;SP110, IFI41, IFI75, VODI;False
ENSG00000135931;Armadillo repeat-containing protein 9;NotRelevant;;Joubert syndrome 30, 617622 (3), Autosomal recessiveJoubert syndrome 30, 617622 (3);chr2;ARMC9, KIAA1868, JBTS30;True
ENSG00000156973;Phosphodiesterase 6D, cGMP-specific, rod, delta;NotRelevant;mutation identified in 1 JBTS22 family;?Joubert syndrome 22, 615665 (3), Autosomal recessive?Joubert syndrome 22, 615665 (3);chr2;PDE6D, JBTS22;True
ENSG00000144535;Dis3 mitotic control, S. cerevisiae, homolog-like 2;NotRelevant;;Perlman syndrome, 267000 (3), Autosomal recessivePerlman syndrome, 267000 (3);chr2;DIS3L2, PRLMNS;True
ENSG00000163295;Alkaline phosphatase, intestinal;NotRelevant;close to ALPP; proximal to PAX3;chr2;ALPI;False
ENSG00000171551;Endothelin-converting enzyme-like 1;NotRelevant;;Arthrogryposis, distal, type 5D, 615065 (3), Autosomal recessiveArthrogryposis, distal, type 5D, 615065 (3);chr2;ECEL1, XCE, DA5D;True
ENSG00000237412;Protease, serine, 56;NotRelevant;;Microphthalmia, isolated 6, 613517 (3), Autosomal recessiveMicrophthalmia, isolated 6, 613517 (3);chr2;PRSS56, MCOP6;True
ENSG00000135902;Cholinergic receptor, nicotinic, delta polypeptide;NotRelevant;mutation identified in 1 CMS3A patient and 1 CMS3C family;Multiple pterygium syndrome, lethal type, 253290 (3), Autosomal recessiveMyasthenic syndrome, congenital, 3B, fast-channel, 616322 (3);chr2;CHRND, ACHRD, SCCMS, CMS3A, CMS3B, CMS3C;True
ENSG00000196811;Cholinergic receptor, nicotinic, gamma polypeptide;NotRelevant;tightly linked to CHRND by RE;Escobar syndrome, 265000 (3), Autosomal recessiveMultiple pterygium syndrome, lethal type, 253290 (3);chr2;CHRNG, ACHRG;True
ENSG00000204120;GRB10-interacting GYF protein 2;NotRelevant;;{Parkinson disease 11}, 607688 (3){Parkinson disease 11}, 607688 (3);chr2;GIGYF2, KIAA0642, PARK11;False
ENSG00000115474;Potassium inwardly-rectifying channel, subfamily J, member 13;NotRelevant;;Leber congenital amaurosis 16, 614186 (3), Autosomal recessiveSnowflake vitreoretinal degeneration, 193230 (3);chr2;KCNJ13, SVD, LCA16;True
ENSG00000085978;Autophagy 16-like 1;NotRelevant;;{Inflammatory bowel disease (Crohn disease) 10}, 611081 (3){Inflammatory bowel disease (Crohn disease) 10}, 611081 (3);chr2;ATG16L1, APG16L, IBD10;False
ENSG00000130561;S-antigen;NotRelevant;ENSG00000130561;Retinitis pigmentosa 47, 613758 (3);chr2;SAG, RP47;False
ENSG00000241635;UDP glycosyltransferase 1 family, polypeptide A1;NotRelevant;;[Bilirubin, serum level of, QTL1], 601816 (3)[Gilbert syndrome], 143500 (3);chr2;UGT1A1, UGT1, GNT1, BILIQTL1;False
ENSG00000163359;Collagen VI, alpha-3 polypeptide;NotRelevant;close to CRBP1;Bethlem myopathy 1, 158810 (3), Autosomal recessive, Autosomal dominantUllrich congenital muscular dystrophy 1, 254090 (3);chr2;COL6A3, DYT27, BTHLM1, UCMD1;True
ENSG00000115648;Melanophilin;NotRelevant;;Griscelli syndrome, type 3, 609227 (3), Autosomal recessiveGriscelli syndrome, type 3, 609227 (3);chr2;MLPH;True
ENSG00000132326;Period, Drosophila, homolog of, 2;NotRelevant;;Advanced sleep phase syndrome, familial, 1, 604348 (3), Autosomal dominantAdvanced sleep phase syndrome, familial, 1, 604348 (3);chr2;PER2, FASPS1, KIAA0347;True
ENSG00000204104;TNF receptor-associated factor 3-interacting protein 1;NotRelevant;;Senior-Loken syndrome 9, 616629 (3), Autosomal recessiveSenior-Loken syndrome 9, 616629 (3);chr2;TRAF3IP1, MIPT3, SLSN9;True
ENSG00000233608;Twist, Drosophila, homolog of, 2 (dermis-expressed protein 1, mouse, homolog of);NotRelevant;;Ablepharon-macrostomia syndrome, 200110 (3), Autosomal dominantFocal facial dermal dysplasia 3, Setleis type, 227260 (3);chr2;TWIST2, DERMO1, SETLSS, FFDD3, BBRSAY, AMS;True
ENSG00000130414;NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 10;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 22, 618243 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 22, 618243 (3);chr2;NDUFA10, MC1DN22;True
ENSG00000142330;Calpain-10;NotRelevant;;{Diabetes mellitus, noninsulin-dependent 1}, 601283 (3){Diabetes mellitus, noninsulin-dependent 1}, 601283 (3);chr2;CAPN10, NIDDM1;False
ENSG00000130294;Kinesin family member 1A;NotRelevant;incorrectly assigned to chr.9;Mental retardation, autosomal dominant 9, 614255 (3), Autosomal dominantSpastic paraplegia 30, autosomal recessive, 610357 (3);chr2;KIF1A, ATSV, UNC104, SPG30, HSN2C, MRD9;True
ENSG00000172482;Alanine-glyoxylate aminotransferase, liver-specific peroxisomal;NotRelevant;;Hyperoxaluria, primary, type 1, 259900 (3), Autosomal recessiveHyperoxaluria, primary, type 1, 259900 (3);chr2;AGXT, SPAT;True
ENSG00000180902;D-2-hydroxyglutarate dehydrogenase;NotRelevant;;D-2-hydroxyglutaric aciduria, 600721 (3), Autosomal recessiveD-2-hydroxyglutaric aciduria, 600721 (3);chr2;D2HGDH, D2HGD;True
ENSG00000188389;Programmed cell death 1;NotRelevant;;{Multiple sclerosis, disease progression, modifier of}, 126200 (3), Multifactorial{Systemic lupus erythematosus, susceptibility to, 2}, 605218 (3);chr2;PDCD1, SLEB2;False
ENSG00000072756;tRNA nucleotidyltransferase, CCA-adding, 1;NotRelevant;pseudogenes on chromosomes 1 and 22;Retinitis pigmentosa and erythrocytic microcytosis, 616959 (3), Autosomal recessiveSideroblastic anemia with B-cell immunodeficiency, periodic fevers, and developmental delay, 616084 (3);chr3;TRNT1, SIFD, RPEM;True
ENSG00000113851;Cereblon;NotRelevant;between D3S3525 and D3S1560;Mental retardation, autosomal recessive 2, 607417 (3), Autosomal recessiveMental retardation, autosomal recessive 2, 607417 (3);chr3;CRBN, MRT2;True
ENSG00000144455;Sulfatase-modifying factor-1;NotRelevant;;Multiple sulfatase deficiency, 272200 (3), Autosomal recessiveMultiple sulfatase deficiency, 272200 (3);chr3;SUMF1, FGE;True
ENSG00000150995;Inositol 1,4,5-triphosphate receptor, type 1;NotRelevant;;Gillespie syndrome, 206700 (3), Autosomal recessive, Autosomal dominantSpinocerebellar ataxia 29, congenital nonprogressive, 117360 (3);chr3;ITPR1, SCA15, SCA16, SCA29;True
ENSG00000182533;Caveolin-3;NotRelevant;within 7-10kb of OXTR;Cardiomyopathy, familial hypertrophic, 192600 (3), Autosomal dominantRippling muscle disease, 606072 (3);chr3;CAV3, LQT9, MPDT, RMD2;True
ENSG00000180914;Oxytocin receptor;NotRelevant;3p25 by others; within 7-10kb of CAV3;chr3;OXTR;False
ENSG00000168137;SET domain-containing protein 5;NotRelevant;;Mental retardation, autosomal dominant 23, 615761 (3), Autosomal dominantMental retardation, autosomal dominant 23, 615761 (3);chr3;SETD5, KIAA1757;True
ENSG00000163719;Myotubularin-related protein 14;NotRelevant;;{Centronuclear myopathy, autosomal, modifier of}, 160150 (3), Autosomal dominant{Centronuclear myopathy, autosomal, modifier of}, 160150 (3);chr3;MTMR14, C3orf29, HJUMPY;True
ENSG00000156983;Bromodomain- and PHD finger-containing protein 1, 140kD;NotRelevant;;Intellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3), Autosomal dominantIntellectual developmental disorder with dysmorphic facies and ptosis, 617333 (3);chr3;BRPF1, BR140, IDDDFP;True
ENSG00000114026;8-hydroxyguanine DNA glycosylase;NotRelevant;;Renal cell carcinoma, clear cell, somatic, 144700 (3)Renal cell carcinoma, clear cell, somatic, 144700 (3);chr3;OGG1;False
ENSG00000187288;Cell death-inducing DFFA-like effector C;NotRelevant;1 patient identified with mutation;?Lipodystrophy, familial partial, type 5, 615238 (3), Autosomal recessive?Lipodystrophy, familial partial, type 5, 615238 (3);chr3;CIDEC, FSP27, CIDE3, FPLD5;True
ENSG00000171135;Jagunal, Drosophila, homolog of, 1;NotRelevant;;Neutropenia, severe congenital, 6, autosomal recessive, 616022 (3), Autosomal recessiveNeutropenia, severe congenital, 6, autosomal recessive, 616022 (3);chr3;JAGN1, SCN6;True
ENSG00000163702;Interleukin 17 receptor C;NotRelevant;;Candidiasis, familial, 9, 616445 (3), Autosomal recessiveCandidiasis, familial, 9, 616445 (3);chr3;IL17RC, IL17RL, CANDF9;True
ENSG00000163703;Cysteine-rich protein with EGF-like domains 1;NotRelevant;;Atrioventricular septal defect, partial, with heterotaxy syndrome, 606217 (3), Autosomal dominant{Atrioventricular septal defect, susceptibility to, 2}, 606217 (3);chr3;CRELD1, AVSD2;True
ENSG00000144554;Fanconi anemia, complementation group D2;NotRelevant;;Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessiveFanconi anemia, complementation group D2, 227646 (3);chr3;FANCD2, FANCD, FACD, FAD;True
ENSG00000134086;VHL gene;NotRelevant;;Erythrocytosis, familial, 2, 263400 (3), Autosomal recessivevon Hippel-Lindau syndrome, 193300 (3);chr3;VHL;True
ENSG00000157017;Ghrelin;NotRelevant;;{Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial{Obesity, susceptibility to}, 601665 (3);chr3;GHRL;True
ENSG00000157087;ATPase, Ca++ transporting, plasma membrane, 2;NotRelevant;;{Deafness, autosomal recessive 12, modifier of}, 601386 (3), Autosomal recessive{Deafness, autosomal recessive 12, modifier of}, 601386 (3);chr3;ATP2B2, PMCA2;True
ENSG00000157103;Solute carrier family 6 (neurotransmitter transporter, GABA), member 1;NotRelevant;;Myoclonic-atonic epilepsy, 616421 (3), Autosomal dominantMyoclonic-atonic epilepsy, 616421 (3);chr3;SLC6A1, GABATR, MAE;True
ENSG00000157152;Synapsin II;NotRelevant;;{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant{Schizophrenia, susceptibility to}, 181500 (3);chr3;SYN2;True
ENSG00000132170;Peroxisome proliferator activated receptor, gamma;NotRelevant;PPARG1, PPARG2 from same gene;Carotid intimal medial thickness 1, 609338 (3){Diabetes, type 2}, 125853 (3);chr3;PPARG, PPARG1, PPARG2, CIMT1, GLM1;False
ENSG00000154743;tRNA splicing endonuclease 2, S. cerevisiae, homolog of;NotRelevant;;Pontocerebellar hypoplasia type 2B, 612389 (3), Autosomal recessivePontocerebellar hypoplasia type 2B, 612389 (3);chr3;TSEN2, SEN2, PCH2B;True
ENSG00000132155;Oncogene RAF1;NotRelevant;;Cardiomyopathy, dilated, 1NN, 615916 (3), Autosomal dominantNoonan syndrome 5, 611553 (3);chr3;RAF1, CRAF, NS5, CMD1NN;True
ENSG00000154764;Wingless-type MMTV integration site family, member 7A;NotRelevant;;Fuhrmann syndrome, 228930 (3), Autosomal recessiveUlna and fibula, absence of, with severe limb deficiency, 276820 (3);chr3;WNT7A;True
ENSG00000170876;Transmembrane protein 43;NotRelevant;;Arrhythmogenic right ventricular dysplasia 5, 604400 (3), Autosomal dominantEmery-Dreifuss muscular dystrophy 7, AD, 614302 (3);chr3;TMEM43, ARVD5, ARVC5, EDMD7;True
ENSG00000154767;XPC gene;NotRelevant;;Xeroderma pigmentosum, group C, 278720 (3), Autosomal recessiveXeroderma pigmentosum, group C, 278720 (3);chr3;XPC, XPCC;True
ENSG00000154781;Coiled-coil domain-containing protein 174;NotRelevant;;Hypotonia, infantile, with psychomotor retardation, 616816 (3), Autosomal recessiveHypotonia, infantile, with psychomotor retardation, 616816 (3);chr3;CCDC174, HSPC212, IHPM;True
ENSG00000206561;Collagenic tail of endplate acetylcholinesterase;NotRelevant;;Myasthenic syndrome, congenital, 5, 603034 (3), Autosomal recessiveMyasthenic syndrome, congenital, 5, 603034 (3);chr3;COLQ, EAD, CMS5;True
ENSG00000169814;Biotinidase;NotRelevant;;Biotinidase deficiency, 253260 (3), Autosomal recessiveBiotinidase deficiency, 253260 (3);chr3;BTD;True
ENSG00000092345;Deleted in azoospermia-like;NotRelevant;?founding member of DAZ gene family;{Spermatogenic failure, susceptibility to} (3){Spermatogenic failure, susceptibility to} (3);chr3;DAZL, DAZH, SPGYLA;False
ENSG00000129810;Shugoshin-like 1;NotRelevant;;Chronic atrial and intestinal dysrhythmia, 616201 (3), Autosomal recessiveChronic atrial and intestinal dysrhythmia, 616201 (3);chr3;SGOL1, SGO, SGO1, CAID;True
ENSG00000174748;Ribosomal protein L15;NotRelevant;mutation identified in 1 family;?Diamond-Blackfan anemia 12, 615550 (3), Autosomal dominant?Diamond-Blackfan anemia 12, 615550 (3);chr3;RPL15, DBA12;True
ENSG00000151090;Thyroid hormone receptor, beta (avian erythroblastic leukemia viral (v-erb-a) oncogene homolog-2);NotRelevant;;Thyroid hormone resistance, 188570 (3), Autosomal dominantThyroid hormone resistance, selective pituitary, 145650 (3);chr3;THRB, ERBA2, THR1, PRTH;True
ENSG00000077092;Retinoic acid receptor, beta polypeptide;NotRelevant;= HAP = HBV-activated protein;Microphthalmia, syndromic 12, 615524 (3), Autosomal recessive, Autosomal dominantMicrophthalmia, syndromic 12, 615524 (3);chr3;RARB, HAP, MCOPS12;True
ENSG00000151092;N-glycanase 1;NotRelevant;;Congenital disorder of deglycosylation, 615273 (3), Autosomal recessiveCongenital disorder of deglycosylation, 615273 (3);chr3;NGLY1, PNG1, CDDG, CDG1V;True
ENSG00000163513;Transforming growth factor, beta receptor II, 70-80kD;NotRelevant;;Colorectal cancer, hereditary nonpolyposis, type 6, 614331 (3)Loeys-Dietz syndrome 2, 610168 (3);chr3;TGFBR2, HNPCC6, AAT3, MFS2, LDS2;False
ENSG00000163527;STT3B, subunit of the oligosaccharyltransferase complex (catalytic);NotRelevant;mutation identified in 1 family;?Congenital disorder of glycosylation, type Ix, 615597 (3), Autosomal recessive?Congenital disorder of glycosylation, type Ix, 615597 (3);chr3;STT3B, SIMP, CDG1X;True
ENSG00000152642;Glycerol-3-phosphate dehydrogenase 1-like;NotRelevant;;Brugada syndrome 2, 611777 (3)Brugada syndrome 2, 611777 (3);chr3;GPD1L, KIAA0089;False
ENSG00000170266;Galactosidase, beta-1;NotRelevant;3p14.2-p11 excluded;GM1-gangliosidosis, type I, 230500 (3), Autosomal recessiveMucopolysaccharidosis type IVB (Morquio), 253010 (3);chr3;GLB1, MPS4B;True
ENSG00000170275;Cartilage-associated protein;NotRelevant;;Osteogenesis imperfecta, type VII, 610682 (3), Autosomal recessiveOsteogenesis imperfecta, type VII, 610682 (3);chr3;CRTAP, CASP, OI7;True
ENSG00000076242;mutL, E. coli, homolog of, 1;NotRelevant;;Colorectal cancer, hereditary nonpolyposis, type 2, 609310 (3)Muir-Torre syndrome, 158320 (3);chr3;MLH1, COCA2, HNPCC2;False
ENSG00000187091;Phospholipase C, delta-1;NotRelevant;;Nail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3), Autosomal recessive, Autosomal dominantNail disorder, nonsyndromic congenital, 3, (leukonychia), 151600 (3);chr3;PLCD1, NDNC3;True
ENSG00000008226;Deleted in lung and esophageal cancer 1;NotRelevant;;Esophageal cancer, 133239 (1), Autosomal dominantLung cancer, 211980 (1);chr3;DLEC1, DLC1;True
ENSG00000172936;Myeloid differentiation primary response gene 88;NotRelevant;;Macroglobulinemia, Waldenstrom, somatic, 153600 (3)Pyogenic bacterial infections, recurrent, due to MYD88 deficiency, 612260 (3);chr3;MYD88, MYD88D;False
ENSG00000114739;Activin A receptor, type IIB;NotRelevant;;Heterotaxy, visceral, 4, autosomal, 613751 (3)Heterotaxy, visceral, 4, autosomal, 613751 (3);chr3;ACVR2B, ACTRIIB, HTX4;False
ENSG00000183873;Sodium channel, voltage-gated, type V, alpha polypeptide;NotRelevant;;Atrial fibrillation, familial, 10, 614022 (3), Autosomal dominant{Sudden infant death syndrome, susceptibility to}, 272120 (3);chr3;SCN5A, LQT3, VF1, HB1, SSS1, CMD1E, CDCD2;True
ENSG00000185313;Sodium channel, voltage-gated, type X, alpha subunit;NotRelevant;;Episodic pain syndrome, familial, 2, 615551 (3), Autosomal dominantEpisodic pain syndrome, familial, 2, 615551 (3);chr3;SCN10A, FEPS2;True
ENSG00000168356;Sodium channel, voltage-gated, type XI, alpha subunit;NotRelevant;;Episodic pain syndrome, familial, 3, 615552 (3), Autosomal dominantNeuropathy, hereditary sensory and autonomic, type VII, 615548 (3);chr3;SCN11A, HSAN7, FEPS3;True
ENSG00000168329;Chemokine (C-X3-C) receptor 1 (G protein-coupled receptor-13);NotRelevant;;{Coronary artery disease, resistance to}, 607339 (3){Rapid progression to AIDS from HIV1 infection}, 609423 (3);chr3;CX3CR1, GPR13, V28;False
ENSG00000144659;Solute carrier family 25, member 38;NotRelevant;;Anemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3), Autosomal recessiveAnemia, sideroblastic, 2, pyridoxine-refractory, 205950 (3);chr3;SLC25A38, SIDBA2;True
ENSG00000168028;Ribosomal protein SA;NotRelevant;;Asplenia, isolated congenital, 271400 (3), Autosomal dominantAsplenia, isolated congenital, 271400 (3);chr3;RPSA, LAMR1, LAMBR, ICAS;True
ENSG00000168036;Catenin (cadherin-associated protein), beta 1, 88kD;NotRelevant;;Colorectal cancer, somatic, 114500 (3)Pilomatricoma, somatic, 132600 (3);chr3;CTNNB1, MRD19, EVR7;False
ENSG00000182606;Trafficking protein, kinesin-binding 1;NotRelevant;;Epileptic encephalopathy, early infantile, 68, 618201 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 68, 618201 (3);chr3;TRAK1, OIP106, KIAA1042, EIEE68;True
ENSG00000157119;Kelch-like 40;NotRelevant;;Nemaline myopathy 8, autosomal recessive, 615348 (3)Nemaline myopathy 8, autosomal recessive, 615348 (3);chr3;KLHL40, SYRP, KBTBD5, NEM8;True
ENSG00000144647;Protein O-mannose beta-1,2-N-acetylglucosaminyltransferase 2;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies, type A, 8, 614830 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle) type C, 8, 618135 (3);chr3;POMGNT2, GTDC2, C3orf39, AGO61, MDDGA8, MDDGC8;True
ENSG00000160746;Anoctamin 10;NotRelevant;;Spinocerebellar ataxia, autosomal recessive 10, 613728 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 10, 613728 (3);chr3;ANO10, TMEM16K, SCAR10;True
ENSG00000011198;Abhydrolase domain containing 5;NotRelevant;;Chanarin-Dorfman syndrome, 275630 (3), Autosomal recessiveChanarin-Dorfman syndrome, 275630 (3);chr3;ABHD5, CGI58, IECN2, NCIE2;True
ENSG00000011376;Leucyl-tRNA synthetase, mitochondrial;NotRelevant;mutation identified in 1 HLASA patient;?Hydrops, lactic acidosis, and sideroblastic anemia, 617021 (3), Autosomal recessivePerrault syndrome 4, 615300 (3);chr3;LARS2, PRLTS4, HLASA;True
ENSG00000163817;X transporter protein 3;NotRelevant;;Hyperglycinuria, 138500 (3), Autosomal dominantIminoglycinuria, digenic, 242600 (3);chr3;SLC6A20, XT3;True
ENSG00000163818;Leucine zipper transcription factor-like 1;NotRelevant;;Bardet-Biedl syndrome 17, 615994 (3), Autosomal recessiveBardet-Biedl syndrome 17, 615994 (3);chr3;LZTFL1, BBS17;True
ENSG00000163820;FYVE and coiled-coil domain containing 1;NotRelevant;;Cataract 18, autosomal recessive, 610019 (3), Autosomal recessiveCataract 18, autosomal recessive, 610019 (3);chr3;FYCO1, CATC2, CTRCT18;True
ENSG00000121807;Chemokine (C-C) receptor 2;NotRelevant;;{HIV infection, susceptibility/resistance to} (3){HIV infection, susceptibility/resistance to} (3);chr3;CCR2, CMKBR2;False
ENSG00000160791;Chemokine (C-C) receptor 5;NotRelevant;;{Diabetes mellitus, insulin-dependent, 22}, 612522 (3){West nile virus, susceptibility to}, 610379 (3);chr3;CCR5, CMKBR5, CCCKR5, IDDM22;False
ENSG00000241186;Teratocarcinoma-derived growth factor-1;NotRelevant;;Forebrain defects (3)Forebrain defects (3);chr3;TDGF1;False
ENSG00000181585;Transmembrane inner ear-expressed gene;NotRelevant;;Deafness, autosomal recessive 6, 600971 (3), Autosomal recessiveDeafness, autosomal recessive 6, 600971 (3);chr3;TMIE, DFNB6;True
ENSG00000160808;Myosin, light polypeptide-3, alkali;NotRelevant;ENSG00000160808;Cardiomyopathy, hypertrophic, 8, 608751 (3);chr3;MYL3, CMH8;False
ENSG00000160801;Parathyroid hormone receptor-1;NotRelevant;;Chondrodysplasia, Blomstrand type, 215045 (3), Autosomal recessiveMetaphyseal chondrodysplasia, Murk Jansen type, 156400 (3);chr3;PTHR1, PTHR, PFE;True
ENSG00000160796;Neurobeachin-like 2;NotRelevant;;Gray platelet syndrome, 139090 (3), Autosomal recessiveGray platelet syndrome, 139090 (3);chr3;NBEAL2, KIAA0540, GPS, BDPLT4;True
ENSG00000181555;SET domain-containing protein 2;NotRelevant;;Luscan-Lumish syndrome, 616831 (3), Autosomal dominantLuscan-Lumish syndrome, 616831 (3);chr3;SETD2, SET2, HYPB, HBP231, KIAA1732, LLS;True
ENSG00000132153;DEAH box polypeptide 30;NotRelevant;;Neurodevelopmental disorder with severe motor impairment and absent language, 617804 (3), Autosomal dominantNeurodevelopmental disorder with severe motor impairment and absent language, 617804 (3);chr3;DHX30, DDX30, RETCOR, KIAA0890, NEDMIAL;True
ENSG00000213689;3' repair exonuclease 1;NotRelevant;;Aicardi-Goutieres syndrome 1, dominant and recessive, 225750 (3), Autosomal recessive, Autosomal dominant{Systemic lupus erythematosus, susceptibility to}, 152700 (3);chr3;TREX1, AGS1, CRV, HERNS;True
ENSG00000114270;Collagen VII, alpha-1 polypeptide;NotRelevant;;EBD inversa, 226600 (3), Autosomal recessiveTransient bullous of the newborn, 131705 (3);chr3;COL7A1, NDNC8;True
ENSG00000178537;Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20 (carnitine-acylcarnitine translocase);NotRelevant;pseudogene on 6p12;Carnitine-acylcarnitine translocase deficiency, 212138 (3), Autosomal recessiveCarnitine-acylcarnitine translocase deficiency, 212138 (3);chr3;SLC25A20, CACT, CAC;True
ENSG00000178057;NADH dehydrogenase 1 alpha subcomplex, assembly factor 3;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 18, 618240 (3)Mitochondrial complex I deficiency, nuclear type 18, 618240 (3);chr3;NDUFAF3, MC1DN18;False
ENSG00000178035;Inosine-5'-monophosphate dehydrogenase, type II;NotRelevant;;[IMPDH2 enzyme activity, variation in], 617995 (3)[IMPDH2 enzyme activity, variation in], 617995 (3);chr3;IMPDH2, IMPD2;False
ENSG00000198218;Glutamine-rich protein 1;NotRelevant;;Ververi-Brady syndrome, 617982 (3), Autosomal dominantVerveri-Brady syndrome, 617982 (3);chr3;QRICH1, VERBRAS;True
ENSG00000172053;Glutaminyl-tRNA synthetase;NotRelevant;;Microcephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3), Autosomal recessiveMicrocephaly, progressive, seizures, and cerebral and cerebellar atrophy, 615760 (3);chr3;QARS, GLNRS, MSCCA;True
ENSG00000172037;Laminin, beta-2 (laminin S);NotRelevant;;Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3)Pierson syndrome, 609049 (3);chr3;LAMB2, LAMS, NPHS5;False
ENSG00000185909;Kelch domain-containing protein 8B;NotRelevant;;{Hodgkin lymphoma, susceptibility to}, 236000 (3), Autosomal recessive{Hodgkin lymphoma, susceptibility to}, 236000 (3);chr3;KLHDC8B, CHL;True
ENSG00000233276;Glutathione peroxidase-1;NotRelevant;?pseudogene on 3p11-p12;Hemolytic anemia due to glutathione peroxidase deficiency, 614164 (1), Autosomal recessiveHemolytic anemia due to glutathione peroxidase deficiency, 614164 (1);chr3;GPX1, GPXD;True
ENSG00000145020;Aminomethyltransferase (glycine cleavage system protein T);NotRelevant;;Glycine encephalopathy, 605899 (3), Autosomal recessiveGlycine encephalopathy, 605899 (3);chr3;AMT, NKH, GCE;True
ENSG00000173402;Dystrophin-associated glycoprotein-1;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 9, 616538 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle), type C, 9, 613818 (3);chr3;DAG1, DAG, MDDGC9, MDDGA9, LGMDR16;True
ENSG00000173540;GDP-mannose pyrophosphorylase B;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 14, 615350 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle), type C, 14, 615352 (3);chr3;GMPPB, KIAA1851, MDDGA14, MDDGB14, MDDGC14, LGMDR19;True
ENSG00000183763;TRAF-interacting protein;NotRelevant;;Seckel syndrome 9, 616777 (3), Autosomal recessiveSeckel syndrome 9, 616777 (3);chr3;TRAIP, TRIP, RNF206, SCKL9;True
ENSG00000164078;Macrophage stimulating 1 receptor (c-met-related tyrosine kinase);NotRelevant;;{Nasopharyngeal carcinoma, susceptibility to, 3}, 617075 (3), Autosomal dominant{Nasopharyngeal carcinoma, susceptibility to, 3}, 617075 (3);chr3;MST1R, RON, NPCA3;True
ENSG00000114349;Guanine nucleotide-binding protein (G protein), alpha-transducing (transducin) activity polypeptide-1;NotRelevant;;Night blindness, congenital stationary, autosomal dominant 3, 610444 (3), Autosomal dominantNight blindness, congenital stationary, type 1G, 616389 (3);chr3;GNAT1, CSNBAD3, CSNB1G;True
ENSG00000114353;Guanine nucleotide-binding protein (G protein), alpha-inhibiting activity polypeptide-2;NotRelevant;on 12p13-p12, GNAI2L;Pituitary ACTH-secreting adenoma (3)Ventricular tachycardia, idiopathic, 192605 (3);chr3;GNAI2, GNAI2B, GIP;False
ENSG00000114378;Hyaluronoglucosaminidase 1;NotRelevant;mutation identified in 1 MPS9 patient;?Mucopolysaccharidosis type IX, 601492 (3), Autosomal recessive?Mucopolysaccharidosis type IX, 601492 (3);chr3;HYAL1, MPS9;True
ENSG00000068028;RAS association domain family protein 1;NotRelevant;epigenetically inactivated;Lung cancer, 211980 (2), Autosomal recessiveLung cancer, 211980 (2);chr3;RASSF1;True
ENSG00000004838;Zinc finger MYND domain-containing protein 10;NotRelevant;;Ciliary dyskinesia, primary, 22, 615444 (3), Autosomal recessiveCiliary dyskinesia, primary, 22, 615444 (3);chr3;ZMYND10, BLU;True
ENSG00000114388;Npr2, S. cerevisiae, homolog of;NotRelevant;;Epilepsy, familial focal, with variable foci 2, 617116 (3), Autosomal dominantEpilepsy, familial focal, with variable foci 2, 617116 (3);chr3;NPR2L, NPRL2, FFEVF2;True
ENSG00000114737;Cytokine inducible SH2-containing protein;NotRelevant;;{Bacteremia, susceptibility to}, 614383 (3){Tuberculosis, susceptibility to}, 607948 (3);chr3;CISH, BACTS2;False
ENSG00000114738;Mitogen-activated protein kinase-activated protein kinase-3;NotRelevant;mutation identified in 1 MDPT3 family;?Macular dystrophy, patterned, 3, 617111 (3), Autosomal dominant?Macular dystrophy, patterned, 3, 617111 (3);chr3;MAPKAP3, 3PK, MDPT3;True
ENSG00000243989;Aminoacylase-1;NotRelevant;;Aminoacylase 1 deficiency, 609924 (3), Autosomal recessiveAminoacylase 1 deficiency, 609924 (3);chr3;ACY1, ACY1D;True
ENSG00000164087;POC1 centriolar protein, Chlamydomonas, homolog of, A;NotRelevant;;Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3), Autosomal recessiveShort stature, onychodysplasia, facial dysmorphism, and hypotrichosis, 614813 (3);chr3;POC1A, PIX2, SOFT;True
ENSG00000168237;Glycerate kinase;NotRelevant;;D-glyceric aciduria, 220120 (3), Autosomal recessiveD-glyceric aciduria, 220120 (3);chr3;GLYCTK, GLYCTK1;True
ENSG00000114841;Dynein, axonemal, heavy chain-1;NotRelevant;mutation identified in 1 CILD37 family;?Ciliary dyskinesia, primary, 37, 617577 (3), Autosomal recessiveSpermatogenic failure 18, 617576 (3);chr3;DNAH1, HL11, DNAHC1, HDHC7, SPGF18, CILD37;True
ENSG00000163930;BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase);NotRelevant;;Tumor predisposition syndrome, 614327 (3), Autosomal dominantTumor predisposition syndrome, 614327 (3);chr3;BAP1, TPDS;True
ENSG00000114854;Troponin-C1, slow;NotRelevant;;Cardiomyopathy, dilated, 1Z, 611879 (3)Cardiomyopathy, hypertrophic, 13, 613243 (3);chr3;TNNC1, CMD1Z, CMH13;False
ENSG00000055955;Inter-alpha (globulin) inhibitor, H4 polypeptide;NotRelevant;;{Hypercholesterolemia, susceptibility to}, 143890 (3), Autosomal dominant{Hypercholesterolemia, susceptibility to}, 143890 (3);chr3;ITIH4, PK120, ITIHL1;True
ENSG00000163933;RFT1, S. cerevisiae, homolog of;NotRelevant;;Congenital disorder of glycosylation, type In, 612015 (3), Autosomal recessiveCongenital disorder of glycosylation, type In, 612015 (3);chr3;RFT1, CDG1N;True
ENSG00000163932;Protein kinase C, delta;NotRelevant;mutation identified in 1 family;Autoimmune lymphoproliferative syndrome, type III, 615559 (3), Autosomal recessiveAutoimmune lymphoproliferative syndrome, type III, 615559 (3);chr3;PRKCD, CVID9, ALPS3;True
ENSG00000163931;Transketolase;NotRelevant;;Short stature, developmental delay, and congenital heart defects, 617044 (3), Autosomal recessiveShort stature, developmental delay, and congenital heart defects, 617044 (3);chr3;TKT, SDDHD;True
ENSG00000157388;Calcium channel, voltage-dependent, L type, alpha 1D subunit;NotRelevant;;Primary aldosteronism, seizures, and neurologic abnormalities, 615474 (3), Autosomal dominantSinoatrial node dysfunction and deafness, 614896 (3);chr3;CACNA1D, CACNL1A2, CCHL1A2, SANDD, PASNA;True
ENSG00000114251;Wingless-type MMTV integration site family, member 5A;NotRelevant;;Robinow syndrome, autosomal dominant 1, 180700 (3), Autosomal dominantRobinow syndrome, autosomal dominant 1, 180700 (3);chr3;WNT5A;True
ENSG00000144730;Interleukin 17, receptor D (Sef, zebrafish, homolog of);NotRelevant;;Hypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3), Autosomal recessive, Autosomal dominantHypogonadotropic hypogonadism 18 with or without anosmia, 615267 (3);chr3;IL17RD, SEF, HH18;True
ENSG00000163666;Homeo box gene expressed in ES cells;NotRelevant;;Growth hormone deficiency with pituitary anomalies, 182230 (3), Autosomal recessive, Autosomal dominantSeptooptic dysplasia, 182230 (3);chr3;HESX1, RPX, CPHD5;True
ENSG00000157500;Adaptor protein containing PH domain, PTB domain, and leucine zipper motif 1;NotRelevant;;{Maturity-onset diabetes of the young, type 14}, 616511 (3), Autosomal dominant{Maturity-onset diabetes of the young, type 14}, 616511 (3);chr3;APPL1, APPL, MODY14;True
ENSG00000136068;Filamin B;NotRelevant;;Atelosteogenesis, type I, 108720 (3), Autosomal dominantSpondylocarpotarsal synostosis syndrome, 272460 (3);chr3;FLNB, SCT, AOI, LRS1;True
ENSG00000163687;Deoxyribonuclease I-like 3;NotRelevant;;Systemic lupus erythematosus 16, 614420 (3), Autosomal recessiveSystemic lupus erythematosus 16, 614420 (3);chr3;DNASE1L3, SLEB16;True
ENSG00000168291;Pyruvate dehydrogenase, E1 beta polypeptide;NotRelevant;;Pyruvate dehydrogenase E1-beta deficiency, 614111 (3)Pyruvate dehydrogenase E1-beta deficiency, 614111 (3);chr3;PDHB, PDHBD;False
ENSG00000168306;Acyl-Coenzyme A oxidase 2, branched chain;NotRelevant;;Bile acid synthesis defect, congenital, 6, 617308 (3), Autosomal recessiveBile acid synthesis defect, congenital, 6, 617308 (3);chr3;ACOX2, BRCACOX, CBAS6;True
ENSG00000163635;Ataxin 7;NotRelevant;;Spinocerebellar ataxia 7, 164500 (3), Autosomal dominantSpinocerebellar ataxia 7, 164500 (3);chr3;ATXN7, SCA7, OPCA3;True
ENSG00000144741;Solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26;NotRelevant;;Combined oxidative phosphorylation deficiency 28, 616794 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 28, 616794 (3);chr3;SLC25A26, SAMC, COXPD28;True
ENSG00000163378;EGF domain-specific O-linked N-acetylglucosamine transferase;NotRelevant;;Adams-Oliver syndrome 4, 615297 (3), Autosomal recessiveAdams-Oliver syndrome 4, 615297 (3);chr3;EOGT, EOGT1, C3orf64, AOS4;True
ENSG00000163380;Leiomodin 3;NotRelevant;;Nemaline myopathy 10, 616165 (3), Autosomal recessiveNemaline myopathy 10, 616165 (3);chr3;LMOD3, NEM10;True
ENSG00000187098;Microphthalmia-associated transcription factor;NotRelevant;;COMMAD syndrome, 617306 (3), Autosomal recessive{Melanoma, cutaneous malignant, susceptibility to, 8}, 614456 (3);chr3;MITF, WS2A, CMM8, COMMAD;True
ENSG00000114861;Forkhead box P1;NotRelevant;;Mental retardation with language impairment and with or without autistic features, 613670 (3), Autosomal dominantMental retardation with language impairment and with or without autistic features, 613670 (3);chr3;FOXP1, QRF1;True
ENSG00000163421;Prokineticin 2;NotRelevant;;Hypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3), Autosomal dominantHypogonadotropic hypogonadism 4 with or without anosmia, 610628 (3);chr3;PROK2, PK2, BV8, HH4;True
ENSG00000185008;Roundabout, Drosophila, homolog of, 2;NotRelevant;;Vesicoureteral reflux 2, 610878 (3)Vesicoureteral reflux 2, 610878 (3);chr3;ROBO2, SAX3, KIAA1568;False
ENSG00000114480;Glycogen branching enzyme;NotRelevant;;Glycogen storage disease IV, 232500 (3), Autosomal recessivePolyglucosan body disease, adult form, 263570 (3);chr3;GBE1, GSD4, APBD;True
ENSG00000083937;CHMP family, member 2B;NotRelevant;;Amyotrophic lateral sclerosis 17, 614696 (3), Autosomal dominantDementia, familial, nonspecific, 600795 (3);chr3;CHMP2B, DMT1, VPS2B, ALS17;True
ENSG00000064835;POU domain, class 1, transcription factor 1 (Pit1, growth hormone factor 1);NotRelevant;;Pituitary hormone deficiency, combined, 1, 613038 (3), Autosomal recessive, Autosomal dominantPituitary hormone deficiency, combined, 1, 613038 (3);chr3;POU1F1, PIT1, CPHD1;True
ENSG00000184500;Protein S, alpha;NotRelevant;pseudogene PROSP contiguous on chr.3;Thrombophilia due to protein S deficiency, autosomal dominant, 612336 (3), Autosomal dominantThrombophilia due to protein S deficiency, autosomal recessive, 614514 (3);chr3;PROS1, THPH5, THPH6;True
ENSG00000169379;ADP-ribosylation factor-like 13B;NotRelevant;;Joubert syndrome 8, 612291 (3), Autosomal recessiveJoubert syndrome 8, 612291 (3);chr3;ARL13B, ARL2L1, JBTS8;True
ENSG00000113966;ADP-ribosylation factor-like 6;NotRelevant;mutation identified in 1 RPS55 family;{Bardet-Biedl syndrome 1, modifier of}, 209900 (3), Autosomal recessive, Digenic recessive{Bardet-Biedl syndrome 1, modifier of}, 209900 (3);chr3;ARL6, BBS3, RP55;True
ENSG00000080819;Coproporphyrinogen oxidase;NotRelevant;;Coproporphyria, 121300 (3), Autosomal dominantHarderoporphyria, 121300 (3);chr3;CPOX;True
ENSG00000036054;TBC1 domain family, member 23;NotRelevant;;Pontocerebellar hypoplasia, type 11, 617695 (3), Autosomal recessivePontocerebellar hypoplasia, type 11, 617695 (3);chr3;TBC1D23, PCH11;True
ENSG00000114354;TRK-fused gene;NotRelevant;fused with NR4A3 or NTRK1; mutation identified in 1 SPG57 familyHereditary motor and sensory neuropathy, Okinawa type, 604484 (3);chr3;TFG, HMSNP, SPG57;False
ENSG00000081148;Interphotoreceptor matrix proteoglycan 2;NotRelevant;;Macular dystrophy, vitelliform, 5, 616152 (3), Autosomal dominantRetinitis pigmentosa 56, 613581 (3);chr3;IMPG2, IPM200, RP56, VMD5;True
ENSG00000174173;tRNA methyltransferase 10, S. cerevisiae, homolog of, C;NotRelevant;;Combined oxidative phosphorylation deficiency 30, 616974 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 30, 616974 (3);chr3;TRMT10C, RG9MTD1, MRPP1, COXPD30;True
ENSG00000114446;Intraflagellar transport 57, chlamydomonas, homolog of (HIP1 protein interactor);NotRelevant;mutation identified in 1 OFD18 family;?Orofaciodigital syndrome XVIII, 617927 (3), Autosomal recessive?Orofaciodigital syndrome XVIII, 617927 (3);chr3;IFT57, ESRRBL1, HIPPI, OFD18;True
ENSG00000153283;CD96 antigen;NotRelevant;;C syndrome, 211750 (3), Autosomal dominantC syndrome, 211750 (3);chr3;CD96, TACTILE;True
ENSG00000206530;Cilia- and flagella-associated protein 44;NotRelevant;mutation identified in 1 SPGF20 patient;?Spermatogenic failure 20, 617593 (3), Autosomal recessive?Spermatogenic failure 20, 617593 (3);chr3;CFAP44, WDR52, SPGF20;True
ENSG00000114573;ATPase, H+ transporting, V1 subunit A;NotRelevant;;Cutis laxa, autosomal recessive, type IID, 617403 (3), Autosomal recessiveEpileptic encephalopathy, infantile or early childhood, 3, 618012 (3);chr3;ATP6V1A, HO68, ARCL2D, IECEE3;True
ENSG00000151577;Dopamine receptor D3;NotRelevant;;{Essential tremor, hereditary, 1}, 190300 (3), Autosomal dominant{Schizophrenia, susceptibility to}, 181500 (3);chr3;DRD3, ETM1, FET1;True
ENSG00000181722;Zinc finger and BTB-domain containing 20;NotRelevant;;Primrose syndrome, 259050 (3), Autosomal dominantPrimrose syndrome, 259050 (3);chr3;ZBTB20, ZNF288, DPZF, PRIMS;True
ENSG00000031081;Rho GTPase-activating protein 31;NotRelevant;;Adams-Oliver syndrome 1, 100300 (3), Autosomal dominantAdams-Oliver syndrome 1, 100300 (3);chr3;ARHGAP31, CDGAP, KIAA1204, AOS1;True
ENSG00000163389;Protein O-glucosyltransferase 1;NotRelevant;mutation identified in 1 LGMDR21 family;Dowling-Degos disease 4, 615696 (3), Autosomal dominantDowling-Degos disease 4, 615696 (3);chr3;POGLUT1, CLP46, KTELC1, RUMI, C3orf9, DDD4, LGMDR21;True
ENSG00000113845;Translocase of inner mitochondrial membrane domain-containing protein 1;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 31, 618251 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 31, 618251 (3);chr3;TIMMDC1, C3orf1, MC1DN31;True
ENSG00000113924;Homogentisate 1,2-dioxygenase (homogentisate oxidase);NotRelevant;;Alkaptonuria, 203500 (3), Autosomal recessiveAlkaptonuria, 203500 (3);chr3;HGD, AKU;True
ENSG00000173226;IQ motif-containing protein B1;NotRelevant;;Senior-Loken syndrome 5, 609254 (3), Autosomal recessiveSenior-Loken syndrome 5, 609254 (3);chr3;IQCB1, NPHP5, KIAA0036;True
ENSG00000145103;Immunoglobulin-like domain-containing receptor 1;NotRelevant;;Deafness, autosomal recessive 42, 609646 (3), Autosomal recessiveDeafness, autosomal recessive 42, 609646 (3);chr3;ILDR1, DFNB42;True
ENSG00000036828;Calcium-sensing receptor;NotRelevant;15cM from RHO;{Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3){Epilepsy idiopathic generalized, susceptibility to, 8}, 612899 (3);chr3;CASR, HHC1, PCAR1, FIH, EIG8, HYPOC1;False
ENSG00000121552;Cystatin A (stefin A);NotRelevant;;Peeling skin syndrome 4, 607936 (3), Autosomal recessivePeeling skin syndrome 4, 607936 (3);chr3;CSTA, STFA, STF1, AREI, PSS4;True
ENSG00000138463;Disrupted in renal carcinoma 2;NotRelevant;t(2;3)(q35Renal cell carcinoma, 144700 (1);chr3;DIRC2, RCC4;False
ENSG00000173175;Adenylate cyclase-5;NotRelevant;;Dyskinesia, familial, with facial myokymia, 606703 (3), Autosomal dominantDyskinesia, familial, with facial myokymia, 606703 (3);chr3;ADCY5, FDFM;True
ENSG00000065534;Myosin-light-polypeptide kinase;NotRelevant;pseudogene on 3p13;Aortic aneurysm, familial thoracic 7, 613780 (3), Autosomal dominantAortic aneurysm, familial thoracic 7, 613780 (3);chr3;MYLK, MLCK, AAT7;True
ENSG00000160145;Kalirin;NotRelevant;;{Coronary heart disease, susceptibility to, 5}, 608901 (3){Coronary heart disease, susceptibility to, 5}, 608901 (3);chr3;KALRN, HAPIP, DUO, CHDS5;False
ENSG00000114491;Uridine monophosphate synthetase (orotate phosphoribosyl transferase and orotidine-5'-decarboxylase);NotRelevant;;Orotic aciduria, 258900 (3), Autosomal recessiveOrotic aciduria, 258900 (3);chr3;UMPS, OPRT;True
ENSG00000163848;Zinc finger protein-148;NotRelevant;;Global developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3), Autosomal dominantGlobal developmental delay, absent or hypoplastic corpus callosum, and dysmorphic facies, 617260 (3);chr3;ZNF148, ZFP148, GDACCF;True
ENSG00000159650;Urocanase domain-containing protein 1;NotRelevant;mutation identified in 1 UROCD patient;?Urocanase deficiency, 276880 (3), Autosomal recessive?Urocanase deficiency, 276880 (3);chr3;UROC1, UROCD;True
ENSG00000073111;Minichromosome maintenance deficient, S. cerevisiae, 2, homolog of (mitotin);NotRelevant;mutation identified in 1 DFNA70 family;?Deafness, autosomal dominant 70, 616968 (3), Autosomal dominant?Deafness, autosomal dominant 70, 616968 (3);chr3;MCM2, CDCL1, DFNA70;True
ENSG00000058262;Sec61 translocon, alpha-1 subunit;NotRelevant;;Hyperuricemic nephropathy, familial juvenile, 4, 617056 (3), Autosomal dominantHyperuricemic nephropathy, familial juvenile, 4, 617056 (3);chr3;SEC61A1, SEC61, HNFJ4;True
ENSG00000179348;GATA-binding protein-2;NotRelevant;;Emberger syndrome, 614038 (3), Autosomal dominant{Myelodysplastic syndrome, susceptibility to}, 614286 (3);chr3;GATA2, DCML, MONOMAC, IMD21;True
ENSG00000075785;Ras-associated protein RAB7;NotRelevant;;Charcot-Marie-Tooth disease, type 2B, 600882 (3), Autosomal dominantCharcot-Marie-Tooth disease, type 2B, 600882 (3);chr3;RAB7, CMT2B, PSN;True
ENSG00000177646;Acyl-CoA dehydrogenase family, member 9;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 20, 611126 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 20, 611126 (3);chr3;ACAD9, MC1DN20;True
ENSG00000169704;Glycoprotein IX, platelet;NotRelevant;;Bernard-Soulier syndrome, type C, 231200 (3), Autosomal recessiveBernard-Soulier syndrome, type C, 231200 (3);chr3;GP9;True
ENSG00000169714;CCHC-type zinc finger nucleic acid-binding protein;NotRelevant;;Myotonic dystrophy 2, 602668 (3), Autosomal dominantMyotonic dystrophy 2, 602668 (3);chr3;CNBP, ZNF9, CNBP1, DM2, PROMM;True
ENSG00000163913;Intraflagellar transport 122, homolog of;NotRelevant;;Cranioectodermal dysplasia 1, 218330 (3), Autosomal recessiveCranioectodermal dysplasia 1, 218330 (3);chr3;IFT122, WDR10, CED1;True
ENSG00000163914;Rhodopsin (opsin 2);NotRelevant;;Night blindness, congenital stationary, autosomal dominant 1, 610445 (3)Retinitis punctata albescens, 136880 (3);chr3;RHO, RP4, OPN2, CSNBAD1;True
ENSG00000170893;Thyrotropin-releasing hormone;NotRelevant;;Thyrotropin-releasing hormone deficiency, 275120 (1), Autosomal recessiveThyrotropin-releasing hormone deficiency, 275120 (1);chr3;TRH;True
ENSG00000017260;ATPase, Ca(2+)-sequestering;NotRelevant;;Hailey-Hailey disease, 169600 (3), Autosomal dominantHailey-Hailey disease, 169600 (3);chr3;ATP2C1, BCPM, HHD;True
ENSG00000114686;Mitochondrial ribosomal protein L3;NotRelevant;;Combined oxidative phosphorylation deficiency 9, 614582 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 9, 614582 (3);chr3;MRPL3, MRL3, COXPD9;True
ENSG00000081307;Ubiquitin-like modifier activating enzyme 5;NotRelevant;mutation identified in 1 SCAR24 family;Epileptic encephalopathy, early infantile, 44, 617132 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 44, 617132 (3);chr3;UBA5, UBE1DC1, EIEE44, SCAR24;True
ENSG00000113971;Nephrocystin 3;NotRelevant;;Meckel syndrome 7, 267010 (3), Autosomal recessiveRenal-hepatic-pancreatic dysplasia 1, 208540 (3);chr3;NPHP3, NPH3, RHPD1, MKS7;True
ENSG00000170819;Beaded filament structural protein 2 (cytoskeletal protein, 49 kD);NotRelevant;;Cataract 12, multiple types, 611597 (3), Autosomal dominantCataract 12, multiple types, 611597 (3);chr3;BFSP2, CP49, CP47, CTRCT12;True
ENSG00000091513;Transferrin;NotRelevant;;Atransferrinemia, 209300 (3), Autosomal recessiveAtransferrinemia, 209300 (3);chr3;TF, TFQTL1;True
ENSG00000174640;Solute carrier organic anion transporter family, member 2A1;NotRelevant;;Hypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3), Autosomal recessiveHypertrophic osteoarthropathy, primary, autosomal recessive 2, 614441 (3);chr3;SLCO2A1, OATP2A1, PGT, SLC21A2, PHOAR2;True
ENSG00000182923;Centrosomal protein, 63kD;NotRelevant;mutation identified in 1 family;?Seckel syndrome 6, 614728 (3), Autosomal recessive?Seckel syndrome 6, 614728 (3);chr3;CEP63, SCKL6;True
ENSG00000174611;Kyphoscoliosis peptidase;NotRelevant;;Myopathy, myofibrillar, 7, 617114 (3), Autosomal recessiveMyopathy, myofibrillar, 7, 617114 (3);chr3;KY, MFM7;True
ENSG00000114054;Propionyl Coenzyme A carboxylase, beta polypeptide;NotRelevant;pccB complementation group;Propionicacidemia, 606054 (3), Autosomal recessivePropionicacidemia, 606054 (3);chr3;PCCB;True
ENSG00000118007;Stromal antigen 1;NotRelevant;;Mental retardation, autosomal dominant 47, 617635 (3), Autosomal dominantMental retardation, autosomal dominant 47, 617635 (3);chr3;STAG1, MRD47;True
ENSG00000158163;DAZ-interacting zinc finger protein 1-like;NotRelevant;;Polycystic kidney disease 5, 617610 (3), Autosomal recessivePolycystic kidney disease 5, 617610 (3);chr3;DZIP1L, DZIP2, PKD5;True
ENSG00000183770;Forkhead transcription factor FOXL2;NotRelevant;;Blepharophimosis, epicanthus inversus, and ptosis, type 1, 110100 (3), Autosomal dominantPremature ovarian failure 3, 608996 (3);chr3;FOXL2, BPES, BPES1, PFRK, POF3;True
ENSG00000175110;Mitochondrial ribosomal protein S22;NotRelevant;;Combined oxidative phosphorylation deficiency 5, 611719 (3), Autosomal recessiveOvarian dysgenesis 7, 618117 (3);chr3;MRPS22, C3orf5, COXPD5, ODG7;True
ENSG00000184432;Coatomer protein complex, subunit beta-2;NotRelevant;mutation identified in 1 MCPH19 family;?Microcephaly 19, primary, autosomal recessive, 617800 (3), Autosomal recessive?Microcephaly 19, primary, autosomal recessive, 617800 (3);chr3;COPB2, MCPH19;True
ENSG00000175054;Ataxia-telangiectasia and Rad3-related (FRAP-related protein-1);NotRelevant;mutation identified in 1 FCTCS family;?Cutaneous telangiectasia and cancer syndrome, familial, 614564 (3), Autosomal dominantSeckel syndrome 1, 210600 (3);chr3;ATR, FRP1, SCKL1, FCTCS;True
ENSG00000175040;Carbohydrate sulfotransferase-2 (GlcNAc-6-O-sulfotransferase;NotRelevant;ENSG00000175040;mapped by FISH to 7q31;chr3;CHST2;False
ENSG00000181804;Solute carrier family 9 (sodium/hydrogen exchanger), member A9;NotRelevant;mutation identified in 1 family;{?Autism susceptibility 16}, 613410 (3){?Autism susceptibility 16}, 613410 (3);chr3;SLC9A9, AUTS16;False
ENSG00000152952;Procollagen-lysine, 2-oxoglutarate 5-dioxygenase (lysine hydroxylase) 2;NotRelevant;;Bruck syndrome 2, 609220 (3), Autosomal recessiveBruck syndrome 2, 609220 (3);chr3;PLOD2, LH2, TLH, BRKS2;True
ENSG00000152977;Zic family, member 1;NotRelevant;;Craniosynostosis 6, 616602 (3), Autosomal dominantCraniosynostosis 6, 616602 (3);chr3;ZIC1, CRS6;True
ENSG00000144891;Angiotensin receptor 1;NotRelevant;;{Hypertension, essential}, 145500 (3), Multifactorial{Hypertension, essential}, 145500 (3);chr3;AGTR1, AGTR1A, AT2R1;False
ENSG00000163754;Glycogenin 1;NotRelevant;mutation identified in 1 GSD15 patient;?Glycogen storage disease XV, 613507 (3), Autosomal recessivePolyglucosan body myopathy 2, 616199 (3);chr3;GYG1, GSD15;True
ENSG00000163755;HPS gene 3;NotRelevant;;Hermansky-Pudlak syndrome 3, 614072 (3), Autosomal recessiveHermansky-Pudlak syndrome 3, 614072 (3);chr3;HPS3;True
ENSG00000047457;Ceruloplasmin;NotRelevant;~15cM from TF;Cerebellar ataxia, 604290 (3), Autosomal recessive[Hypoceruloplasminemia, hereditary], 604290 (3);chr3;CP;True
ENSG00000163646;Clarin 1;NotRelevant;frequent in Finland; ?digenic interaction with MYO7AUsher syndrome, type 3A, 276902 (3);chr3;CLRN1, USH3A, USH3, RP61;False
ENSG00000169313;Purinergic receptor P2Y, G protein-coupled, 12;NotRelevant;;Bleeding disorder, platelet-type, 8, 609821 (3), Autosomal recessiveBleeding disorder, platelet-type, 8, 609821 (3);chr3;P2RY12, P2Y12, BDPLT8;True
ENSG00000196549;Membrane metallo-endopeptidase (common acute lymphocytic leukemia antigen);NotRelevant;mutation identified in 1 SCA43 family;Charcot-Marie-Tooth disease, axonal, type 2T, 617017 (3), Autosomal recessive, Autosomal dominantCharcot-Marie-Tooth disease, axonal, type 2T, 617017 (3);chr3;MME, CD10, CALLA, NEP, CMT2T, SCA43;True
ENSG00000169359;Solute carrier family 33 (acetyl-CoA transporter), member 1;NotRelevant;;Congenital cataracts, hearing loss, and neurodegeneration, 614482 (3), Autosomal recessiveSpastic paraplegia 42, autosomal dominant, 612539 (3);chr3;SLC33A1, ACATN, AT1, SPG42, CCHLND;True
ENSG00000178053;Myeloid leukemia factor-1;NotRelevant;;Leukemia, acute myeloid, 601626 (1), Autosomal dominant, Somatic mutationLeukemia, acute myeloid, 601626 (1);chr3;MLF1;True
ENSG00000168827;Mitochondrial elongation factor G1;NotRelevant;;Combined oxidative phosphorylation deficiency 1, 609060 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 1, 609060 (3);chr3;GFM1, EFG1, GFM, COXPD1;True
ENSG00000068885;Intraflagellar transport 80, Chlamydomonas, homolog of;NotRelevant;;Short-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3), Autosomal recessiveShort-rib thoracic dysplasia 2 with or without polydactyly, 611263 (3);chr3;IFT80, KIAA1374, WDR56, SRTD2, ATD2;True
ENSG00000169255;UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase 3;NotRelevant;;[Blood group, P1PK system, P(k) phenotype], 111400 (3)[Blood group, globoside system], 615021 (3);chr3;B3GALT3, GLCT3, GLOB;False
ENSG00000090402;Sucrase-isomaltase;NotRelevant;;Sucrase-isomaltase deficiency, congenital, 222900 (3), Autosomal recessiveSucrase-isomaltase deficiency, congenital, 222900 (3);chr3;SI;True
ENSG00000114200;Butyrylcholinesterase;NotRelevant;distal to CP, TF;{Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}, 617936 (3){Apnea, postanesthetic, susceptibility to, due to BCHE deficiency}, 617936 (3);chr3;BCHE, CHE1, BCHED;False
ENSG00000114209;Programmed cell death 10;NotRelevant;;Cerebral cavernous malformations 3, 603285 (3)Cerebral cavernous malformations 3, 603285 (3);chr3;PDCD10, TFAR15, CCM3;False
ENSG00000163536;Protease inhibitor 12;NotRelevant;;Encephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3), Autosomal dominantEncephalopathy, familial, with neuroserpin inclusion bodies, 604218 (3);chr3;SERPINI1, PI12;True
ENSG00000085276;MDS1 and EVS1 complex locus;NotRelevant;;Radioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3), Autosomal dominantRadioulnar synostosis with amegakaryocytic thrombocytopenia 2, 616738 (3);chr3;MECOM, EVI1, RUSAT2;True
ENSG00000277925;Telomerase RNA component;NotRelevant;;{Aplastic anemia}, 614743 (3), Autosomal dominant{Pulmonary fibrosis, idiopathic, susceptibility to}, 614743 (3);chr3;TERC, TRC3, TR, DKCA1, PFBMFT2;True
ENSG00000013293;Solute carrier family 7, member 14;NotRelevant;;Retinitis pigmentosa 68, 615725 (3), Autosomal recessiveRetinitis pigmentosa 68, 615725 (3);chr3;SLC7A14, KIAA1613, RP68;True
ENSG00000163581;Solute carrier family 2 (facilitated glucose transporter), member 2;NotRelevant;;{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent}, 125853 (3);chr3;SLC2A2, GLUT2;True
ENSG00000154310;TRAF2-and NCK-interacting kinase;NotRelevant;;Mental retardation, autosomal recessive 54, 617028 (3), Autosomal recessiveMental retardation, autosomal recessive 54, 617028 (3);chr3;TNIK, KIAA0551, MRT54;True
ENSG00000075651;Phospholipase D1, phosphatidylcholine-specific;NotRelevant;;Cardiac valvular defect, developmental, 212093 (3), Autosomal recessiveCardiac valvular defect, developmental, 212093 (3);chr3;PLD1, CVDD;True
ENSG00000121853;Growth hormone secretagogue receptor;NotRelevant;;Growth hormone deficiency, isolated partial, 615925 (3), Autosomal recessive, Autosomal dominantGrowth hormone deficiency, isolated partial, 615925 (3);chr3;GHSR, GHDP;True
ENSG00000144962;Spermatogenesis-associated protein 16;NotRelevant;mutation identified in 1 SPGF6 family;?Spermatogenic failure 6, 102530 (3), Autosomal recessive?Spermatogenic failure 6, 102530 (3);chr3;SPATA16, SPGF6;True
ENSG00000177565;Transducin-beta-like 1 receptor 1;NotRelevant;;Mental retardation, autosomal dominant 41, 616944 (3), Autosomal dominantPierpont syndrome, 602342 (3);chr3;TBL1XR1, TBLR1, IRA1, C21, MRD41;True
ENSG00000121879;Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide;NotRelevant;;Breast cancer, somatic, 114480 (3)Ovarian cancer, somatic, 167000 (3);chr3;PIK3CA, CLOVE, MCAP, MCM, MCMTC, CWS5, CLAPO;False
ENSG00000114450;Guanine nucleotide-binding protein, beta-4;NotRelevant;;Charcot-Marie-Tooth disease, dominant intermediate F, 615185 (3), Autosomal dominantCharcot-Marie-Tooth disease, dominant intermediate F, 615185 (3);chr3;GNB4, CMTD1F;True
ENSG00000284862;Coiled-coil domain-containing protein 39;NotRelevant;;Ciliary dyskinesia, primary, 14, 613807 (3)Ciliary dyskinesia, primary, 14, 613807 (3);chr3;CCDC39;False
ENSG00000205981;DnaJ (Hsp40) homolog, subfamily C, member 19 (translocase of inner mitochondrial membrane 14, yeast, homolog of);NotRelevant;;3-methylglutaconic aciduria, type V, 610198 (3), Autosomal recessive3-methylglutaconic aciduria, type V, 610198 (3);chr3;DNAJC19, TIM14;True
ENSG00000181449;SRY (sex determining region Y)-box 2;NotRelevant;;Microphthalmia, syndromic 3, 206900 (3), Autosomal dominantOptic nerve hypoplasia and abnormalities of the central nervous system, 206900 (3);chr3;SOX2, MCOPS3;True
ENSG00000078070;3-Methylcrotonyl-CoA carboxylase 1;NotRelevant;;3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3), Autosomal recessive3-Methylcrotonyl-CoA carboxylase 1 deficiency, 210200 (3);chr3;MCCC1, MCCA;True
ENSG00000114796;Kelch-like 24;NotRelevant;;Epidermolysis bullosa simplex, generalized, with scarring and hair loss, 617294 (3), Autosomal dominantEpidermolysis bullosa simplex, generalized, with scarring and hair loss, 617294 (3);chr3;KLHL24, KRIP6, EBSSH;True
ENSG00000145191;Eukaryotic translation initiation factor 2B, subunit 5;NotRelevant;;Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessiveOvarioleukodystrophy, 603896 (3);chr3;EIF2B5, LVWM, CACH, CLE;True
ENSG00000161202;Dishevelled 3 (homologous to Drosophila dsh);NotRelevant;;Robinow syndrome, autosomal dominant 3, 616894 (3), Autosomal dominantRobinow syndrome, autosomal dominant 3, 616894 (3);chr3;DVL3, DRS3;True
ENSG00000214160;Alg3, S. cerevisiae, homolog of;NotRelevant;;Congenital disorder of glycosylation, type Id, 601110 (3), Autosomal recessiveCongenital disorder of glycosylation, type Id, 601110 (3);chr3;ALG3, NOT56L, CDGS4, CDG1D;True
ENSG00000114867;Eukaryotic translation initiation factor 4 gamma, 1;NotRelevant;amplified in squamous cell lung cancer;{Parkinson disease 18}, 614251 (3), Autosomal dominant{Parkinson disease 18}, 614251 (3);chr3;EIF4G1, EIF4G, PARK18;True
ENSG00000114859;Chloride channel-2;NotRelevant;;{Epilepsy, idiopathic generalized, susceptibility to, 11}, 607628 (3), Autosomal dominant{Epilepsy, juvenile myoclonic, susceptibility to, 8}, 607628 (3);chr3;CLCN2, EGMA, ECA2, EGI11, EJM8, LKPAT, HALD2;True
ENSG00000090534;Thrombopoietin (megakaryocyte growth and development factor);NotRelevant;;Thrombocythemia 1, 187950 (3), Autosomal dominantThrombocythemia 1, 187950 (3);chr3;THPO, MGDF, MPLLG, TPO, THCYT1;True
ENSG00000113790;Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase;NotRelevant;mutation identified in 1 family;?Fanconi renotubular syndrome 3, 615605 (3), Autosomal dominant?Fanconi renotubular syndrome 3, 615605 (3);chr3;EHHADH, PBFE, LBFP, FRTS3;True
ENSG00000163898;Lipase H;NotRelevant;;Hypotrichosis 7, 604379 (3), Autosomal recessiveWoolly hair, autosomal recessive 2 with or without hypotrichosis, 604379 (3);chr3;LIPH, LAH2, ARWH2, HYPT7;True
ENSG00000073792;Insulin-like growth factor 2 mRNA-binding protein 2;NotRelevant;;{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3);chr3;IGF2BP2, IMP2;True
ENSG00000213139;Crystallin, gamma S;NotRelevant;;Cataract 20, multiple types, 116100 (3), Autosomal dominantCataract 20, multiple types, 116100 (3);chr3;CRYGS, CRYG8, CTRCT20;True
ENSG00000090520;DNAJ/HSP40 homolog, subfamily B, member 11;NotRelevant;;Polycystic kidney disease 6 with or without polycystic liver disease, 618061 (3), Autosomal dominantPolycystic kidney disease 6 with or without polycystic liver disease, 618061 (3);chr3;DNAJB11, HEDJ, DJ9, ABBP2, PKD6;True
ENSG00000145192;Alpha-2HS-glycoprotein;NotRelevant;mutation identified in 1 APMR1 family;?Alopecia-mental retardation syndrome 1, 203650 (3), Autosomal recessive?Alopecia-mental retardation syndrome 1, 203650 (3);chr3;AHSG, APMR1;True
ENSG00000113905;Histidine-rich glycoprotein;NotRelevant;;Thrombophilia due to HRG deficiency, 613116 (3), Autosomal dominantThrombophilia due to elevated HRG, 613116 (1);chr3;HRG, THPH11;True
ENSG00000113889;Kininogen 1;NotRelevant;;[High molecular weight kininogen deficiency], 228960 (3), Autosomal recessive[Kininogen deficiency], 228960 (3);chr3;KNG1, KNG;True
ENSG00000181092;Adipocyte-, C1q-, and collagen domain-containing;NotRelevant;;Adiponectin deficiency, 612556 (3)Adiponectin deficiency, 612556 (3);chr3;ADIPOQ, APM1, GBP28, ADIPQTL1;False
ENSG00000127241;Mannan-binding lectin serine protease-1 (C4/C2 activating component of Ra-reactive factor);NotRelevant;;3MC syndrome 1, 257920 (3), Autosomal recessive3MC syndrome 1, 257920 (3);chr3;MASP1, CRARF, 3MC1;True
ENSG00000113916;B-cell CLL/lymphoma-6;NotRelevant;;Lymphoma, B-cell, 109565 (2)Lymphoma, B-cell (2);chr3;BCL6;False
ENSG00000145012;Lipoma-preferred-partner gene;NotRelevant;fused with HMGIC in lipoma; fused with MLL in leukemiaLipoma (3);chr3;LPP;False
ENSG00000073282;Tumor protein p63 (tumor protein p73-like);NotRelevant;;ADULT syndrome, 103285 (3), Autosomal dominantSplit-hand/foot malformation 4, 605289 (3);chr3;TP63, TP73L, KET, EEC3, SHFM4, LMS, RHS, OFC8;True
ENSG00000090530;Prolyl 3-hydroxylase 2;NotRelevant;;Myopia, high, with cataract and vitreoretinal degeneration, 614292 (3), Autosomal recessiveMyopia, high, with cataract and vitreoretinal degeneration, 614292 (3);chr3;P3H2, LEPREL1, MCVD;True
ENSG00000163347;Claudin 1;NotRelevant;;Ichthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3), Autosomal recessiveIchthyosis, leukocyte vacuoles, alopecia, and sclerosing cholangitis, 607626 (3);chr3;CLDN1, SEMP1, ILVASC;True
ENSG00000113946;Claudin 16 (paracellin 1);NotRelevant;;Hypomagnesemia 3, renal, 248250 (3), Autosomal recessiveHypomagnesemia 3, renal, 248250 (3);chr3;CLDN16, PCLN1, HOMG3;True
ENSG00000152492;Coiled-coil domain-containing protein 50;NotRelevant;mutation identified in 1 DFNA44 family;?Deafness, autosomal dominant 44, 607453 (3), Autosomal dominant?Deafness, autosomal dominant 44, 607453 (3);chr3;CCDC50, C3orf6, DFNA44;True
ENSG00000114279;Fibroblast growth factor-12;NotRelevant;;Epileptic encephalopathy, early infantile, 47, 617166 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 47, 617166 (3);chr3;FGF12, FHF1, EIEE47;True
ENSG00000198836;Optic atrophy 1 gene;NotRelevant;mutation identified in 1 MTDPS14 family;Behr syndrome, 210000 (3), Autosomal recessive{Glaucoma, normal tension, susceptibility to}, 606657 (3);chr3;OPA1, NTG, NPG, BERHS, MTDPS14;True
ENSG00000072274;Transferrin receptor;NotRelevant;;Immunodeficiency 46, 616740 (3), Autosomal recessiveImmunodeficiency 46, 616740 (3);chr3;TFRC, TFR, CD71, IMD46;True
ENSG00000161217;Phosphate cytidylyltransferase 1, choline, alpha isoform;NotRelevant;;Spondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3), Autosomal recessiveSpondylometaphyseal dysplasia with cone-rod dystrophy, 608940 (3);chr3;PCYT1A, CTPCT, PCYT1, SMDCRD;True
ENSG00000213123;TCTEX1 domain-containing protein 2;NotRelevant;;Short-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3), Autosomal recessiveShort-rib thoracic dysplasia 17 with or without polydactyly, 617405 (3);chr3;TCTEX1D2, SRTD17;True
ENSG00000163961;RING finger protein 168;NotRelevant;;RIDDLE syndrome, 611943 (3), Autosomal recessiveRIDDLE syndrome, 611943 (3);chr3;RNF168;True
ENSG00000174007;Centrosomal protein, 19kD;NotRelevant;mutation identified in 1 family;Morbid obesity and spermatogenic failure, 615703 (3), Autosomal recessiveMorbid obesity and spermatogenic failure, 615703 (3);chr3;CEP19, C3orf34, MOSPGF;True
ENSG00000145016;RUN domain and cysteine-rich domain containing, Beclin 1-interacting protein;NotRelevant;mutation identified in 1 family;?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3), Autosomal recessive?Spinocerebellar ataxia, autosomal recessive 15, 615705 (3);chr3;RUBCN, RUBICON, KIAA0226, SCAR15;True
ENSG00000182899;Ribosomal protein L35A;NotRelevant;previous assignment to chr.18 in error;Diamond-Blackfan anemia 5, 612528 (3), Autosomal dominantDiamond-Blackfan anemia 5, 612528 (3);chr3;RPL35A, DBA5;True
ENSG00000131127;Zinc finger protein-141 (clone pHZ-44);NotRelevant;1 family identified with mutation;?Polydactyly, postaxial, type A6, 615226 (3), Autosomal recessive?Polydactyly, postaxial, type A6, 615226 (3);chr4;ZNF141, D4S90, PAPA6;True
ENSG00000174227;Phosphatidylinositol glycan anchor biosynthesis class G protein;NotRelevant;;Mental retardation, autosomal recessive 53, 616917 (3), Autosomal recessiveMental retardation, autosomal recessive 53, 616917 (3);chr4;PIGG, GPI7, MRT53;True
ENSG00000133256;Phosphodiesterase-6B, cGMP-specific, rod, beta;NotRelevant;;Night blindness, congenital stationary, autosomal dominant 2, 163500 (3), Autosomal dominantRetinitis pigmentosa-40, 613801 (3);chr4;PDE6B, PDEB, RP40, CSNBAD2;True
ENSG00000168993;Complexin 1;NotRelevant;;Epileptic encephalopathy, early infantile, 63, 617976 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 63, 617976 (3);chr4;CPLX1, CPX1, EIEE63;True
ENSG00000145217;Solute carrier family 26 (sulfate transporter), member 1;NotRelevant;mutation identified in 1 CAON patient;?Nephrolithiasis, calcium oxalate, 167030 (3), Autosomal recessive?Nephrolithiasis, calcium oxalate, 167030 (3);chr4;SLC26A1, SAT1, CAON;True
ENSG00000127415;Iduronidase, alpha-L-;NotRelevant;;Mucopolysaccharidosis Ih, 607014 (3), Autosomal recessiveMucopolysaccharidosis Is, 607016 (3);chr4;IDUA, IDA;True
ENSG00000178222;Ring finger protein 212;NotRelevant;;Recombination rate QTL 1, 612042 (3)Recombination rate QTL 1, 612042 (3);chr4;RNF212, ZHP3;False
ENSG00000159692;C-terminal binding protein 1;NotRelevant;;Hypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3), Autosomal dominantHypotonia, ataxia, developmental delay, and tooth enamel defect syndrome, 617915 (3);chr4;CTBP1, HADDTS;True
ENSG00000163945;UV-stimulated scaffold protein A;NotRelevant;;UV-sensitive syndrome 3, 614640 (3), Autosomal recessiveUV-sensitive syndrome 3, 614640 (3);chr4;UVSSA, KIAA1530, UVSS3;True
ENSG00000068078;Fibroblast growth factor receptor-3;NotRelevant;;Achondroplasia, 100800 (3), Autosomal dominantThanatophoric dysplasia, type II, 187601 (3);chr4;FGFR3, ACH;True
ENSG00000185818;N-acetyltransferase 8-like;NotRelevant;mutation identified in 1 patient;?N-acetylaspartate deficiency, 614063 (3), Autosomal recessive?N-acetylaspartate deficiency, 614063 (3);chr4;NAT8L, CML3, NACED;True
ENSG00000087266;SH3-domain binding protein 2;NotRelevant;;Cherubism, 118400 (3), Autosomal dominantCherubism, 118400 (3);chr4;SH3BP2, CRPM;True
ENSG00000087274;Adducin-1, alpha;NotRelevant;;{Hypertension, essential, salt-sensitive}, 145500 (3), Multifactorial{Hypertension, essential, salt-sensitive}, 145500 (3);chr4;ADD1;False
ENSG00000197386;Huntingtin;NotRelevant;distal to D4S10;Huntington disease, 143100 (3), Autosomal dominantLopes-Maciel-Rodan syndrome, 617435 (3);chr4;HTT, HD, IT15, LOMARS;True
ENSG00000175920;Downstream of tyrosine kinase 7;NotRelevant;mutation identified in 1 FADS family;?Fetal akinesia deformation sequence, 208150 (3), Autosomal recessiveMyasthenic syndrome, congenital, 10, 254300 (3);chr4;DOK7, C4orf25, CMS10;True
ENSG00000163956;Low density lipoprotein-related protein-associated protein 1 (alpha-2-macroglobulin receptor-associated protein 1);NotRelevant;;Myopia 23, autosomal recessive, 615431 (3), Autosomal recessiveMyopia 23, autosomal recessive, 615431 (3);chr4;LRPAP1, A2MRAP, MYP23;True
ENSG00000184160;Adrenergic, alpha-2C-, receptor;NotRelevant;linked to D4S10;{Congestive heart failure and beta-blocker response, modifier of} (3){Congestive heart failure and beta-blocker response, modifier of} (3);chr4;ADRA2C, ADRA2L2;False
ENSG00000163132;Muscle segment homeo box, Drosophila, homolog of, 1 (homeo box 7);NotRelevant;;Ectodermal dysplasia 3, Witkop type, 189500 (3), Autosomal dominantTooth agenesis, selective, 1, with or without orofacial cleft, 106600 (3);chr4;MSX1, HOX7, HYD1, OFC5, STHAG1, ECTD3;True
ENSG00000173040;EVC2 (limbin) gene;NotRelevant;;Ellis-van Creveld syndrome, 225500 (3), Autosomal recessiveWeyers acrofacial dysostosis, 193530 (3);chr4;EVC2, LBN, WAD;True
ENSG00000072840;EVC gene;NotRelevant;mutation identified in 1 WAD patient;Ellis-van Creveld syndrome, 225500 (3), Autosomal recessiveEllis-van Creveld syndrome, 225500 (3);chr4;EVC;True
ENSG00000109501;Wolframin;NotRelevant;mutation identified in 1 CTRCT41 family;?Cataract 41, 116400 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent, association with}, 125853 (3);chr4;WFS1, WFRS, WFS, DFNA6, DFNA14, DFNA38, WFSL, CTRCT41;True
ENSG00000215612;Homeo box (H6 family) 1;NotRelevant;;Oculoauricular syndrome, 612109 (3), Autosomal recessiveOculoauricular syndrome, 612109 (3);chr4;HMX1, H6;True
ENSG00000109667;Solute carrier family 2 (facilitated glucose transporter), member 9;NotRelevant;;Hypouricemia, renal, 2, 612076 (3), Autosomal recessive, Autosomal dominant{Uric acid concentration, serum, QTL 2}, 612076 (3);chr4;SLC2A9, GLUT9, UAQTL2;True
ENSG00000169676;Dopamine receptor D5;NotRelevant;pseudogenes on 2p11 and 1q21;{Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3), Autosomal dominant{Blepharospasm, primary benign}, 606798 (3);chr4;DRD5, DRD1B, DRD1L2;True
ENSG00000157869;Ras-associated protein 28;NotRelevant;;Cone-rod dystrophy 18, 615374 (3), Autosomal recessiveCone-rod dystrophy 18, 615374 (3);chr4;RAB28, CORD18;True
ENSG00000109705;Bagpipe homeo box, Drosophila, homolog of;NotRelevant;;Spondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3), Autosomal recessiveSpondylo-megaepiphyseal-metaphyseal dysplasia, 613330 (3);chr4;NKX3-2, BAPX1, SMMD;True
ENSG00000048342;Coiled-coil and C2 domains-containing protein 2A;NotRelevant;;COACH syndrome, 216360 (3), Autosomal recessiveMeckel syndrome 6, 612284 (3);chr4;CC2D2A, KIAA1345, MKS6;True
ENSG00000007062;Prominin 1;NotRelevant;;Cone-rod dystrophy 12, 612657 (3)Stargardt disease 4, 603786 (3);chr4;PROM1, PROML1, AC133, RP41, CORD12, CD133, MCDR2, STGD4;False
ENSG00000169762;Transmembrane anterior posterior transformation 1;NotRelevant;;Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3), Autosomal recessiveOsteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type, 616897 (3);chr4;TAPT1, CMVFR, OCLSBG;True
ENSG00000151552;Quinoid dihydropteridine reductase;NotRelevant;;Hyperphenylalaninemia, BH4-deficient, C, 261630 (3), Autosomal recessiveHyperphenylalaninemia, BH4-deficient, C, 261630 (3);chr4;QDPR, DHPR;True
ENSG00000109610;Superoxide dismutase-3, extracellular;NotRelevant;;[Superoxide dismutase, elevated extracellular] (3)[Superoxide dismutase, elevated extracellular] (3);chr4;SOD3;False
ENSG00000109618;O-phosphoserine tRNA-selenocysteine tRNA synthase;NotRelevant;;Pontocerebellar hypoplasia type 2D, 613811 (3), Autosomal recessivePontocerebellar hypoplasia type 2D, 613811 (3);chr4;SEPSECS, SLA, LP, PCH2D;True
ENSG00000157765;Solute carrier family 34 (sodium/phosphate cotransporter), member 2;NotRelevant;;Pulmonary alveolar microlithiasis, 265100 (3), Autosomal recessivePulmonary alveolar microlithiasis, 265100 (3);chr4;SLC34A2;True
ENSG00000168214;Recombination signal-binding protein 1 for kappa J region;NotRelevant;pseudogenes at 9q13, 9p13, and 3q25;Adams-Oliver syndrome 3, 614814 (3), Autosomal dominantAdams-Oliver syndrome 3, 614814 (3);chr4;RBPJ, RBPSUH, IGKJRB1, AOS3;True
ENSG00000174125;Toll-like receptor-1;NotRelevant;;{Leprosy, protection against}, 613223 (3){Leprosy, susceptibility to, 5}, 613223 (3);chr4;TLR1, TIL. LPRS5;False
ENSG00000157796;WD repeat-containing protein 19;NotRelevant;mutation identified in 1 CED4 family and 1 SRTD5 family;?Cranioectodermal dysplasia 4, 614378 (3), Autosomal recessiveSenior-Loken syndrome 8, 616307 (3);chr4;WDR19, SRTD5, ATD5, NPHP13, CED4;True
ENSG00000121897;Lipoic acid synthase;NotRelevant;;Hyperglycinemia, lactic acidosis, and seizures, 614462 (3), Autosomal recessiveHyperglycinemia, lactic acidosis, and seizures, 614462 (3);chr4;LIAS, PDHLD, HGCLAS;True
ENSG00000154277;Ubiquitin C-terminal esterase L1;NotRelevant;mutation identified in 1 PARK5 family;{?Parkinson disease 5, susceptibility to}, 613643 (3){?Parkinson disease 5, susceptibility to}, 613643 (3);chr4;UCHL1, PARK5, SPG79, NDGOA;False
ENSG00000109132;Paired mesoderm homeo box 2B;NotRelevant;;Central hypoventilation syndrome, congenital, with or without Hirschsprung disease, 209880 (3), Autosomal dominant{Neuroblastoma, susceptibility to, 2}, 613013 (3);chr4;PHOX2B, NBPHOX, PMX2B, NBLST2, CCHS;True
ENSG00000014824;Solute carrier family 30 (zinc transporter), member 9;NotRelevant;mutation identified in 1 BILAPES family;?Birk-Landau-Perez syndrome, 617595 (3), Autosomal recessive?Birk-Landau-Perez syndrome, 617595 (3);chr4;SLC30A9, C4orf1, HUEL, BILAPES;True
ENSG00000215203;Glutaredoxin, cysteine-rich, 1;NotRelevant;;Deafness, autosomal recessive 25, 613285 (3), Autosomal recessiveDeafness, autosomal recessive 25, 613285 (3);chr4;GRXCR1;True
ENSG00000151806;GTPase, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 EIEE40 family;?Epileptic encephalopathy, early infantile, 40, 617065 (3), Autosomal recessive?Epileptic encephalopathy, early infantile, 40, 617065 (3);chr4;GUF1, EF4, EIEE40;True
ENSG00000151834;Gamma-aminobutyric acid (GABA) A receptor, alpha-2;NotRelevant;;{Alcohol dependence, susceptibility to}, 103780 (3), Multifactorial{Alcohol dependence, susceptibility to}, 103780 (3);chr4;GABRA2;False
ENSG00000109158;Gamma-aminobutyric acid (GABA) A receptor, alpha-4;NotRelevant;cluster with GABRA2, B1, G1; ?involved in autism;chr4;GABRA4;False
ENSG00000163288;Gamma-aminobutyric acid (GABA) A receptor, beta-1;NotRelevant;;Epileptic encephalopathy, early infantile, 45, 617153 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 45, 617153 (3);chr4;GABRB1, EIEE45;True
ENSG00000145244;Corin, serine peptidase;NotRelevant;;Preeclampsia/eclampsia 5, 614595 (3)Preeclampsia/eclampsia 5, 614595 (3);chr4;CORIN, CRN, TMPRSS10, ATC2, PEE5;False
ENSG00000198515;Cyclic nucleotide gated channel, alpha 1;NotRelevant;;Retinitis pigmentosa 49, 613756 (3)Retinitis pigmentosa 49, 613756 (3);chr4;CNGA1, CNCG1, RP49;False
ENSG00000163069;Sarcoglycan, beta (43kD dystrophin-associated glycoprotein);NotRelevant;;Muscular dystrophy, limb-girdle, autosomal recessive 4, 604286 (3), Autosomal recessiveMuscular dystrophy, limb-girdle, autosomal recessive 4, 604286 (3);chr4;SGCB, LGMDR4;True
ENSG00000109220;Cysteine-rich hydrophobic domain 2 (Brx-like gene translocated in leukemia);NotRelevant;;{Leukemia, acute myeloid}, 601626 (3), Autosomal dominant, Somatic mutation{Leukemia, acute myeloid}, 601626 (3);chr4;CHIC2, BTL;True
ENSG00000134853;Platelet-derived growth factor receptor, alpha polypeptide;NotRelevant;same 700bp segment as KIT; fused to BCR or FIP1L1Hypereosinophilic syndrome, idiopathic, resistant to imatinib, 607685 (3);chr4;PDGFRA;False
ENSG00000157404;Hardy-Zuckerman 4 feline sarcoma (v-kit) oncogene;NotRelevant;same 700bp segment as PDGFRA;Gastrointestinal stromal tumor, familial, 606764 (3), Autosomal dominant, Isolated casesPiebaldism, 172800 (3);chr4;KIT, PBT, MASTC;True
ENSG00000128052;Kinase insert domain receptor;NotRelevant;?mutant in TAPVR1;Hemangioma, capillary infantile, somatic, 602089 (3){Hemangioma, capillary infantile, susceptibility to}, 602089 (3);chr4;KDR;False
ENSG00000128039;Steroid 5-alpha-reductase 3;NotRelevant;;Congenital disorder of glycosylation, type Iq, 612379 (3), Autosomal recessiveKahrizi syndrome, 612713 (3);chr4;SRD5A3, SRD5A2L, CDG1Q, KRIZI;True
ENSG00000134851;Transmembrane protein 165;NotRelevant;;Congenital disorder of glycosylation, type IIk, 614727 (3), Autosomal recessiveCongenital disorder of glycosylation, type IIk, 614727 (3);chr4;TMEM165, FT27, CDG2K;True
ENSG00000174799;Centrosomal protein, 135kD;NotRelevant;;Microcephaly 8, primary, autosomal recessive, 614673 (3), Autosomal recessiveMicrocephaly 8, primary, autosomal recessive, 614673 (3);chr4;CEP135, KIAA0635, MCPH8;True
ENSG00000128050;Phosphoribosylaminoimidazole carboxylase;NotRelevant;bifunctional enzyme; ade-D;chr4;PAICS, AIRC;False
ENSG00000174780;Signal recognition particle, 72kD;NotRelevant;;Bone marrow failure syndrome 1, 614675 (3), Autosomal dominantBone marrow failure syndrome 1, 614675 (3);chr4;SRP72, BMFS1;True
ENSG00000128040;Serine protease inhibitor, Kazal-type, 2;NotRelevant;mutation identified in 1 SPGF29 family;?Spermatogenic failure 29, 618091 (3), Autosomal recessive?Spermatogenic failure 29, 618091 (3);chr4;SPINK2, SPGF29;True
ENSG00000084093;RE1-silencing transcription factor;NotRelevant;;Fibromatosis, gingival, 5, 617626 (3), Autosomal dominant{Wilms tumor 6, susceptibility to}, 616806 (3);chr4;REST, NRSF, WT6, GINGF5, HGF5;True
ENSG00000163453;Insulin-like growth factor-binding protein-7;NotRelevant;;Retinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3), Autosomal recessiveRetinal arterial macroaneurysm with supravalvular pulmonic stenosis, 614224 (3);chr4;IGFBP7, MAC25, RAMSVPS;True
ENSG00000205678;Trans-2,3-enoyl-CoA reductase-like protein;NotRelevant;;Ventricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3), Autosomal recessiveVentricular tachycardia, catecholaminergic polymorphic, 3, 614021 (3);chr4;TECRL, TERL, SRD5A2L2, GPSN2L, CPVT3;True
ENSG00000109163;Gonadotropin-releasing hormone receptor;NotRelevant;placed at 4q12 or 4q13 by some;Hypogonadotropic hypogonadism 7 without anosmia, 146110 (3), Autosomal recessiveHypogonadotropic hypogonadism 7 without anosmia, 146110 (3);chr4;GNRHR, LHRHR, HH7;True
ENSG00000197888;UDP-glucuronyltransferase, family 2, beta-17;NotRelevant;;{Bone mineral density QTL 12, osteoporosis}, 612560 (3){Bone mineral density QTL 12, osteoporosis}, 612560 (3);chr4;UGT2B17, BMND12;False
ENSG00000171195;Mucin 7, salivary;NotRelevant;;{Asthma, protection against}, 600807 (3), Autosomal dominant{Asthma, protection against}, 600807 (3);chr4;MUC7;True
ENSG00000187689;Amelotin;NotRelevant;mutation identified in 1 AI3B family;?Amelogenesis imperfecta, type IIIB, 617607 (3), Autosomal dominant?Amelogenesis imperfecta, type IIIB, 617607 (3);chr4;AMTN, AI3B;True
ENSG00000178522;Ameloblastin;NotRelevant;mutation identified in 1 AI1F family;Amelogenesis imperfecta, type IF, 616270 (3), Autosomal recessiveAmelogenesis imperfecta, type IF, 616270 (3);chr4;AMBN, AI1F;True
ENSG00000132464;Enamelin;NotRelevant;;Amelogenesis imperfecta, type IB, 104500 (3), Autosomal dominantAmelogenesis imperfecta, type IC, 204650 (3);chr4;ENAM, AIH2, AI1C;True
ENSG00000080493;Solute carrier family 4, sodium bicarbonate cotransporter, member 4;NotRelevant;;Renal tubular acidosis, proximal, with ocular abnormalities, 604278 (3), Autosomal recessiveRenal tubular acidosis, proximal, with ocular abnormalities, 604278 (3);chr4;SLC4A4, NBC1, KNBC;True
ENSG00000156140;A Disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 3;NotRelevant;mutation identified in 1 HKLLS3 family;?Hennekam lymphangiectasia-lymphedema syndrome 3, 618154 (3), Autosomal recessive?Hennekam lymphangiectasia-lymphedema syndrome 3, 618154 (3);chr4;ADAMTS3, HKLLS3;True
ENSG00000163631;Albumin;NotRelevant;linked to GC;Analbuminemia, 616000 (3)[Dysalbuminemic hyperthyroxinemia], 615999 (3);chr4;ALB, ANALBA, FDAH;False
ENSG00000081051;Alpha-fetoprotein;NotRelevant;order: 5'-ALB-3'--5'-AFP-3';Alpha-fetoprotein deficiency, 615969 (3), Autosomal recessive[Hereditary persistence of alpha-fetoprotein], 615970 (3);chr4;AFP, HPAFP, AFPD;True
ENSG00000163739;Chemokine, C-X-C, ligand 1 (GRO1 oncogene;NotRelevant;ENSG00000163739;apparently cluster of 3 GRO genes;chr4;CXCL1, GRO1, MGSA;False
ENSG00000174792;Odontogenesis-associated phosphoprotein;NotRelevant;;Amelogenesis imperfecta, type IIA4, 614832 (3), Autosomal recessiveAmelogenesis imperfecta, type IIA4, 614832 (3);chr4;ODAPH, C4orf26;True
ENSG00000169245;Chemokine, C-X-C motif, ligand 10 (interferon-inducible cytokine IP-10);NotRelevant;?involved in monocytic leukemia with t(4;11)(q21;chr4;CXCL10, INP10;False
ENSG00000138760;Scavenger receptor class B, member 2;NotRelevant;;Epilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3), Autosomal recessiveEpilepsy, progressive myoclonic 4, with or without renal failure, 254900 (3);chr4;SCARB2, CD36L2, LIMPII, AMRF, EPM4;True
ENSG00000138759;FRAS1 gene;NotRelevant;;Fraser syndrome 1, 219000 (3), Autosomal recessiveFraser syndrome 1, 219000 (3);chr4;FRAS1, FRASRS1;True
ENSG00000163297;Anthrax toxin receptor 2;NotRelevant;;Hyaline fibromatosis syndrome, 228600 (3), Autosomal recessiveHyaline fibromatosis syndrome, 228600 (3);chr4;ANTXR2, CMG2, HFS;True
ENSG00000152784;PR domain-containing protein 8;NotRelevant;mutation identified in 1 EPM10 family;?Epilepsy, progressive myoclonic, 10, 616640 (3), Autosomal recessive?Epilepsy, progressive myoclonic, 10, 616640 (3);chr4;PRDM8, EPM10;True
ENSG00000138675;Fibroblast growth factor-5;NotRelevant;;Trichomegaly, 190330 (3), Autosomal recessiveTrichomegaly, 190330 (3);chr4;FGF5, TCMGLY;True
ENSG00000152795;Heterogeneous nuclear ribonucleoprotein D-like protein;NotRelevant;;Muscular dystrophy, limb-girdle, autosomal dominant 3, 609115 (3), Autosomal dominantMuscular dystrophy, limb-girdle, autosomal dominant 3, 609115 (3);chr4;HNRNPDL, HNRPDL, JKTBP, LGMDD3;True
ENSG00000173085;CoQ2, S. cerevisiae, homolog of (parahydroxybenzoate-polyprenyltransferase, mitochondrial);NotRelevant;;Coenzyme Q10 deficiency, primary, 1, 607426 (3), Autosomal recessive{Multiple system atrophy, susceptibility to}, 146500 (3);chr4;COQ2, COQ10D1, MSA1;True
ENSG00000163625;WD repeat- and FYVE domain-containing protein 3;NotRelevant;mutation identified in 1 MCPH18 family;?Microcephaly 18, primary, autosomal dominant, 617520 (3), Autosomal dominant?Microcephaly 18, primary, autosomal dominant, 617520 (3);chr4;WDFY3, ALFY, BCHS, MCPH18;True
ENSG00000152591;Dentin sialophosphoprotein;NotRelevant;;Deafness, autosomal dominant 39, with dentinogenesis, 605594 (3), Autosomal dominantDentinogenesis imperfecta, Shields type III, 125500 (3);chr4;DSPP, DPP, DGI1, DFNA39, DTDP2;True
ENSG00000152592;Dentin matrix acidic phosphoprotein;NotRelevant;;Hypophosphatemic rickets, AR, 241520 (3), Autosomal recessiveHypophosphatemic rickets, AR, 241520 (3);chr4;DMP1, ARHR, ARHP;True
ENSG00000118762;Polycystin-2;NotRelevant;;Polycystic kidney disease 2, 613095 (3), Autosomal dominantPolycystic kidney disease 2, 613095 (3);chr4;PKD2;True
ENSG00000118777;ATP-binding cassette, subfamily G, member 2;NotRelevant;;[Junior blood group system], 614490 (3)[Uric acid concentration, serum, QTL1], 138900 (3);chr4;ABCG2, BCRP, ABCP, UAQTL1, GOUT1;False
ENSG00000163644;Protein phosphatase, PP2C domain-containing, 1K;NotRelevant;mutation identified in 1 MSUDMV family;?Maple syrup urine disease, mild variant, 615135 (3)?Maple syrup urine disease, mild variant, 615135 (3);chr4;PPM1K, PP2CM, PTMP, MSUDMV;False
ENSG00000255072;Phosphatidylinositol glycan, class Y;NotRelevant;;Hyperphosphatasia with mental retardation syndrome 6, 616809 (3), Autosomal recessiveHyperphosphatasia with mental retardation syndrome 6, 616809 (3);chr4;PIGY, HPMRS6;True
ENSG00000145335;Synuclein, alpha (non A4 component of amyloid precursor);NotRelevant;;Dementia, Lewy body, 127750 (3), Autosomal dominantParkinson disease 4, 605543 (3);chr4;SNCA, NACP, PARK1, PARK4;True
ENSG00000152208;Glutamate receptor, ionotropic, delta-2;NotRelevant;;Spinocerebellar ataxia, autosomal recessive 18, 616204 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 18, 616204 (3);chr4;GRID2, SCAR18;True
ENSG00000163104;SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily A, DEAD/H box-containing, 1;NotRelevant;;Adermatoglyphia, 136000 (3), Autosomal dominantBasan syndrome, 129200 (3);chr4;SMARCAD1, KIAA1122, ETL1, HEL1, ADERM, BASNS;True
ENSG00000138696;Bone morphogenetic protein receptor, type IB;NotRelevant;;Acromesomelic dysplasia, Demirhan type, 609441 (3), Autosomal recessiveBrachydactyly, type A2, 112600 (3);chr4;BMPR1B, ALK6, AMDD, BDA2, BDA1D;True
ENSG00000138698;RAP1, GTP-GDP dissociation stimulator 1;NotRelevant;fusion partner with NUP98 in ALL;Lymphocytic leukemia, acute T-cell (3)Lymphocytic leukemia, acute T-cell (3);chr4;RAP1GDS1;False
ENSG00000151247;Eukaryotic translation initiation factor 4E;NotRelevant;pseudogene on 20;{Autism, susceptibility to, 19}, 615091 (3){Autism, susceptibility to, 19}, 615091 (3);chr4;EIF4E, EIF4EL1, AUTS19;False
ENSG00000196616;Alcohol dehydrogenase IB (class I), beta polypeptide;NotRelevant;;{Aerodigestive tract cancer, squamous cell, alcohol-related, protection against}, 103780 (3), Multifactorial{Alcohol dependence, protection against}, 103780 (3);chr4;ADH1B, ADH2;False
ENSG00000248144;Alcohol dehydrogenase IC (class I), gamma polypeptide;NotRelevant;;{Alcohol dependence, protection against}, 103780 (3), Multifactorial{Parkinson disease, susceptibility to}, 168600 (3);chr4;ADH1C, ADH3;False
ENSG00000145331;tRNA methyltransferase 10, S. cerevisiae, homolog of, A;NotRelevant;;Microcephaly, short stature, and impaired glucose metabolism 1, 616033 (3), Autosomal recessiveMicrocephaly, short stature, and impaired glucose metabolism 1, 616033 (3);chr4;TRMT10A, RG9MTD2, MSSGM1;True
ENSG00000138823;Microsomal triglyceride transfer protein, 88kD;NotRelevant;;Abetalipoproteinemia, 200100 (3), Autosomal recessive{Metabolic syndrome, protection against}, 605552 (3);chr4;MTP;True
ENSG00000138814;Protein phosphatase-3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha);NotRelevant;;Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development, 618265 (3)Epileptic encephalopathy, infantile or early childhood, 1, 617711 (3);chr4;PPP3CA, PPP2B, CALNA, CNA1, IECEE1, ACCIID;False
ENSG00000138821;Solute carrier family 39 (zinc transporter), member 8;NotRelevant;;Congenital disorder of glycosylation, type IIn, 616721 (3), Autosomal recessiveCongenital disorder of glycosylation, type IIn, 616721 (3);chr4;SLC39A8, BIGM103, CDG2N;True
ENSG00000109320;Nuclear factor of kappa light chain gene enhancer in B-cells 1 (p105);NotRelevant;;Immunodeficiency, common variable, 12, 616576 (3), Autosomal dominantImmunodeficiency, common variable, 12, 616576 (3);chr4;NFKB1, CVID12;True
ENSG00000109323;Mannosidase, beta A, lysosomal;NotRelevant;linked in mouse to Adl-3;Mannosidosis, beta, 248510 (3), Autosomal recessiveMannosidosis, beta, 248510 (3);chr4;MANBA, MANB1;True
ENSG00000145354;CDGSH iron sulfur domain protein 2;NotRelevant;;Wolfram syndrome 2, 604928 (3), Autosomal recessiveWolfram syndrome 2, 604928 (3);chr4;CISD2, WFS2, ZCD2, ERIS;True
ENSG00000138778;Centromere autoantigen E, 312kD;NotRelevant;mutation identified in 1 MCPH13 family;?Microcephaly 13, primary, autosomal recessive, 616051 (3), Autosomal recessive?Microcephaly 13, primary, autosomal recessive, 616051 (3);chr4;CENPE, MCPH13;True
ENSG00000169836;Tachykinin receptor 3;NotRelevant;;Hypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3), Autosomal recessiveHypogonadotropic hypogonadism 11 with or without anosmia, 614840 (3);chr4;TACR3, NK3R, HH11;True
ENSG00000168769;TET oncogene family, member 2;NotRelevant;;Myelodysplastic syndrome, somatic, 614286 (3)Myelodysplastic syndrome, somatic, 614286 (3);chr4;TET2, KIAA1546, MDS;False
ENSG00000138777;Pyrophosphatase, inorganic, 2;NotRelevant;mutation identified in 1 SCFAI family;?Sudden cardiac failure, alcohol-induced, 617223 (3), Autosomal recessiveSudden cardiac failure, infantile, 617222 (3);chr4;PPA2, SCFI, SCFAI;True
ENSG00000145348;TBC1 domain-containing kinase;NotRelevant;;Hypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3), Autosomal recessiveHypotonia, infantile, with psychomotor retardation and characteristic facies 3, 616900 (3);chr4;TBCK, IHPRF3;True
ENSG00000164022;ARS-interacting multifunctional protein 1;NotRelevant;;Leukodystrophy, hypomyelinating, 3, 260600 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 3, 260600 (3);chr4;AIMP1, SCYE1, EMAP2, EMAPII, HLD3;True
ENSG00000155016;Cytochrome P450, family 2, subfamily U, polypeptide 1;NotRelevant;;Spastic paraplegia 56, autosomal recessive, 615030 (3), Autosomal recessiveSpastic paraplegia 56, autosomal recessive, 615030 (3);chr4;CYP2U1, SPG56;True
ENSG00000138796;L-3-hydroxyacyl-CoA dehydrogenase, short chain;NotRelevant;;3-hydroxyacyl-CoA dehydrogenase deficiency, 231530 (3), Autosomal recessiveHyperinsulinemic hypoglycemia, familial, 4, 609975 (3);chr4;HADHSC, SCHAD, HHF4;True
ENSG00000138795;Lymphoid enhancer-binding factor-1;NotRelevant;;Sebaceous tumors, somatic (3)Sebaceous tumors, somatic (3);chr4;LEF1;False
ENSG00000188517;Collagen, type XXV, alpha-1 polypeptide;NotRelevant;;Fibrosis of extraocular muscles, congenital, 5, 616219 (3), Autosomal recessiveFibrosis of extraocular muscles, congenital, 5, 616219 (3);chr4;COL25A1, CLAC, CFEOM5;True
ENSG00000205403;Complement factor I;NotRelevant;40kb distal to EGF;Complement factor I deficiency, 610984 (3), Autosomal recessive{Macular degeneration, age-related, 13, susceptibility to}, 615439 (3);chr4;CFI, FI, AHUS3, ARMD13;True
ENSG00000183423;Leucine-rich repeat, immunoglobulin-like, and transmembrane domains-containing protein 3;NotRelevant;;Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3), Autosomal recessiveNight blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3);chr4;LRIT3, FIGLER4, CSNB1F;True
ENSG00000138798;Epidermal growth factor (urogastrone);NotRelevant;linked to ADH3; cen-ADH3-EGF-IL2-qterHypomagnesemia 4, renal, 611718 (3);chr4;EGF, URG, HOMG4;False
ENSG00000164093;Paired-like homeodomain transcription factor-2;NotRelevant;;Anterior segment dysgenesis 4, 137600 (3), Autosomal dominantRing dermoid of cornea, 180550 (3);chr4;PITX2, IDG2, RIEG1, RGS, IGDS2, ASGD4;True
ENSG00000174720;La ribonucleoprotein domain family, member 7;NotRelevant;;Alazami syndrome, 615071 (3), Autosomal recessiveAlazami syndrome, 615071 (3);chr4;LARP7, PIP7S, ALAZS;True
ENSG00000145362;Ankyrin-2, nonerythrocytic;NotRelevant;;Cardiac arrhythmia, ankyrin-B-related, 600919 (3), Autosomal dominantLong QT syndrome 4, 600919 (3);chr4;ANK2, LQT4;True
ENSG00000164099;Protease, serine, 12;NotRelevant;;Mental retardation, autosomal recessive 1, 249500 (3), Autosomal recessiveMental retardation, autosomal recessive 1, 249500 (3);chr4;PRSS12, BSSP3, MRT1;True
ENSG00000150961;Sec24-related gene family, member D;NotRelevant;;Cole-Carpenter syndrome 2, 616294 (3), Autosomal recessiveCole-Carpenter syndrome 2, 616294 (3);chr4;SEC24D, KIAA0755, CLCRP2;True
ENSG00000172399;Myozenin 2;NotRelevant;;Cardiomyopathy, hypertrophic, 16, 613838 (3), Autosomal dominantCardiomyopathy, hypertrophic, 16, 613838 (3);chr4;MYOZ2, CMH16;True
ENSG00000138738;PR domain-containing protein 5;NotRelevant;;Brittle cornea syndrome 2, 614170 (3), Autosomal recessiveBrittle cornea syndrome 2, 614170 (3);chr4;PRDM5, BCS2;True
ENSG00000164111;Annexin A5 (endonexin II);NotRelevant;;{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3), Autosomal dominant{Pregnancy loss, recurrent, susceptibility to, 3}, 614391 (3);chr4;ANXA5, ENX2, RPRGL3;True
ENSG00000123737;Exosome component 9;NotRelevant;;Pontocerebellar hypoplasia, type 1D, 618065 (3), Autosomal recessivePontocerebellar hypoplasia, type 1D, 618065 (3);chr4;EXOSC9, PMSCL1, PCH1D;True
ENSG00000138686;BBS7 gene;NotRelevant;;Bardet-Biedl syndrome 7, 615984 (3), Autosomal recessiveBardet-Biedl syndrome 7, 615984 (3);chr4;BBS7;True
ENSG00000138741;Transient receptor potential cation channel, subfamily C, member 3;NotRelevant;mutation identified in one SCA41 patient;?Spinocerebellar ataxia 41, 616410 (3), Autosomal dominant?Spinocerebellar ataxia 41, 616410 (3);chr4;TRPC3, TRP3, SCA41;True
ENSG00000138688;KIAA1109 gene;NotRelevant;;Alkuraya-Kucinskas syndrome, 617822 (3), Autosomal recessiveAlkuraya-Kucinskas syndrome, 617822 (3);chr4;KIAA1109, ALKKUCS;True
ENSG00000138684;Interleukin 21;NotRelevant;mutation identified in 1 CVID11 patient;?Immunodeficiency, common variable, 11, 615767 (3), Autosomal recessive?Immunodeficiency, common variable, 11, 615767 (3);chr4;IL21, CVID11;True
ENSG00000181004;BBS12 gene;NotRelevant;1Mb centromeric to BBS;Bardet-Biedl syndrome 12, 615989 (3), Autosomal recessiveBardet-Biedl syndrome 12, 615989 (3);chr4;BBS12, FLJ35630, C4orf24;True
ENSG00000145375;Spermatogenesis-associated protein 5;NotRelevant;;Epilepsy, hearing loss, and mental retardation syndrome, 616577 (3), Autosomal recessiveEpilepsy, hearing loss, and mental retardation syndrome, 616577 (3);chr4;SPATA5, SPAF, EHLMRS;True
ENSG00000196159;FAT tumor suppressor, Drosophila, homolog of, 4;NotRelevant;;Hennekam lymphangiectasia-lymphedema syndrome 2, 616006 (3), Autosomal recessiveVan Maldergem syndrome 2, 615546 (3);chr4;FAT4, VMLDS2, HKLLS2;True
ENSG00000164066;Inturned, Drosophila, homolog of;NotRelevant;mutation identified in 1 SRTD20 patient and 1 OFD17 patient;?Orofaciodigital syndrome XVII, 617926 (3), Autosomal recessive?Short-rib thoracic dysplasia 20 with polydactyly, 617925 (3);chr4;INTU, KIAA1284, PDZK6, SRTD20, OFD17;True
ENSG00000142731;Polo-like kinase 4 (serine/threonine protein kinase-18);NotRelevant;;Microcephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3), Autosomal recessiveMicrocephaly and chorioretinopathy, autosomal recessive, 2, 616171 (3);chr4;PLK4, STK18, SAK, MCCRP2;True
ENSG00000164073;Major facilitator superfamily domain-containing protein 8;NotRelevant;;Ceroid lipofuscinosis, neuronal, 7, 610951 (3), Autosomal recessiveMacular dystrophy with central cone involvement, 616170 (3);chr4;MFSD8, MGC33302, CLN7, CCMD;True
ENSG00000164134;N-alpha-acetyltransferase 15, NatA auxiliary subunit;NotRelevant;;Mental retardation, autosomal dominant 50, 617787 (3), Autosomal dominantMental retardation, autosomal dominant 50, 617787 (3);chr4;NAA15, NARG1, NATH, MRD50;True
ENSG00000172007;Ras-associated protein RAB33B;NotRelevant;;Smith-McCort dysplasia 2, 615222 (3), Autosomal recessiveSmith-McCort dysplasia 2, 615222 (3);chr4;RAB33B, SMC2;True
ENSG00000109424;Uncoupling protein 1 (mitochondrial, proton carrier);NotRelevant;;{Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial{Obesity, susceptibility to}, 601665 (3);chr4;UCP1;True
ENSG00000109458;Grb2-associated binding protein 1;NotRelevant;mutation identified in 1 family;?Deafness, autosomal recessive 26, 605428 (3), Autosomal recessive?Deafness, autosomal recessive 26, 605428 (3);chr4;GAB1, DFNB26;True
ENSG00000197465;Glycophorin E;NotRelevant;tandem: 5'-GYPA-GYPB-GYPE-3'; ?4q31.1;chr4;GYPE, GPE;False
ENSG00000250361;Glycophorin B;NotRelevant;;[Blood group, Ss], 111740 (3){Malaria, resistance to}, 611162 (3);chr4;GYPB, SS;False
ENSG00000170180;Glycophorin A;NotRelevant;;[Blood group, MNSs system], 111300 (3){Malaria, resistance to}, 611162 (3);chr4;GYPA, MN, GPA;False
ENSG00000151611;MMAA gene;NotRelevant;;Methylmalonic aciduria, vitamin B12-responsive, 251100 (3), Autosomal recessiveMethylmalonic aciduria, vitamin B12-responsive, 251100 (3);chr4;MMAA;True
ENSG00000151617;Endothelin receptor type A;NotRelevant;;Mandibulofacial dysostosis with alopecia, 616367 (3), Autosomal dominant{Migraine, resistance to}, 157300 (3);chr4;EDNRA, MFDA;True
ENSG00000151623;Nuclear receptor subfamily 3, group C, member 2 (mineralocorticoid receptor;NotRelevant;ENSG00000151623;Pseudohypoaldosteronism type I, autosomal dominant, 177735 (3);chr4;NR3C2, MLR, MCR;True
ENSG00000198589;Lipopolysaccharide-responsive, beige-like anchor protein;NotRelevant;;Immunodeficiency, common variable, 8, with autoimmunity, 614700 (3), Autosomal recessiveImmunodeficiency, common variable, 8, with autoimmunity, 614700 (3);chr4;LRBA, LBA, CDC4L, CVID8;True
ENSG00000181541;MAB21, C. elegans, homolog-like 2;NotRelevant;;Microphthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3), Autosomal recessive, Autosomal dominantMicrophthalmia/coloboma and skeletal dysplasia syndrome, 615877 (3);chr4;MAB21L2, MCSKS14;True
ENSG00000109686;SH3 domain protein 19;NotRelevant;fused with AML1 in t(4;21);chr4;SH3D19, EBP;False
ENSG00000109654;Tripartite motif-containing protein 2;NotRelevant;;Charcot-Marie-Tooth disease, type 2R, 615490 (3), Autosomal recessiveCharcot-Marie-Tooth disease, type 2R, 615490 (3);chr4;TRIM2, KIAA0517, CMT2R;True
ENSG00000137462;Toll-like receptor-2;NotRelevant;;{Colorectal cancer, susceptibility to}, 114500 (3), Autosomal dominant{Mycobacterium tuberculosis, susceptibility to}, 607948 (3);chr4;TLR2, TIL4;True
ENSG00000171564;Fibrinogen, beta polypeptide;NotRelevant;4q31 by A; proximal to GYPB/GYPAHypofibrinogenemia, congenital, 202400 (3);chr4;FGB;False
ENSG00000171560;Fibrinogen, alpha polypeptide;NotRelevant;;Afibrinogenemia, congenital, 202400 (3), Autosomal recessiveHypodysfibrinogenemia, congenital, 616004 (3);chr4;FGA;True
ENSG00000171557;Fibrinogen, gamma polypeptide;NotRelevant;linked to MN;Afibrinogenemia, congenital, 202400 (3), Autosomal recessiveHypofibrinogenemia, congenital, 202400 (3);chr4;FGG;True
ENSG00000121207;Lecithin retinol acyltransferase;NotRelevant;;Leber congenital amaurosis 14, 613341 (3), Autosomal recessiveRetinitis pigmentosa, juvenile, 613341 (3);chr4;LRAT, LCA14;True
ENSG00000164116;Guanylate cyclase 1, soluble, alpha 3;NotRelevant;;Moyamoya 6 with achalasia, 615750 (3), Autosomal recessiveMoyamoya 6 with achalasia, 615750 (3);chr4;GUCY1A3, GUC1A3, GUCSA3, MYMY6;True
ENSG00000151790;Tryptophan oxygenase;NotRelevant;mutation identified in 1 HYPTRP patient;[?Hypertryptophanemia], 600627 (3), Autosomal recessive[?Hypertryptophanemia], 600627 (3);chr4;TDO2, TPH2, TRPO, HYPTRP;True
ENSG00000109738;Glycine receptor, beta subunit;NotRelevant;;Hyperekplexia 2, 614619 (3), Autosomal recessiveHyperekplexia 2, 614619 (3);chr4;GLRB, HKPX2;True
ENSG00000171503;Electron transfer flavoprotein:ubiquinone oxidoreductase;NotRelevant;;Glutaric acidemia IIC, 231680 (3), Autosomal recessiveGlutaric acidemia IIC, 231680 (3);chr4;ETFDH, MADD;True
ENSG00000109756;Rap guanine nucleotide exchange factor 2;NotRelevant;mutation identified in 1 FAME7 patient;?Epilepsy, familial adult myoclonic, 7, 618075 (3)?Epilepsy, familial adult myoclonic, 7, 618075 (3);chr4;RAPGEF2, NRAPGEP, RAGEF, KIAA0313;False
ENSG00000052802;Methylsterol monooxygenase 1;NotRelevant;;Microcephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3), Autosomal recessiveMicrocephaly, congenital cataract, and psoriasiform dermatitis, 616834 (3);chr4;MSMO1, SC4MOL, ERG25, MCCPD;True
ENSG00000038295;Tolloid-like 1;NotRelevant;;Atrial septal defect 6, 613087 (3), Autosomal dominantAtrial septal defect 6, 613087 (3);chr4;TLL1, TLL, ASD6;True
ENSG00000129116;Palladin, mouse, homolog of;NotRelevant;;{Pancreatic cancer, susceptibility to, 1}, 606856 (3){Pancreatic cancer, susceptibility to, 1}, 606856 (3);chr4;PALLD, KIAA0992, PNCA1;False
ENSG00000137601;Never in mitosis gene A-related kinase 1;NotRelevant;1 patient showed heterozygous NEK2 and DYNC2H1 mutations;{Amyotrophic lateral sclerosis, susceptibility to, 24}, 617892 (3){Amyotrophic lateral sclerosis, susceptibility to, 24}, 617892 (3);chr4;NEK1, SRTD6, SRPS2A, ALS24;False
ENSG00000164120;Hydroxyprostaglandin dehydrogenase 15-(NAD);NotRelevant;;Cranioosteoarthropathy, 259100 (3), Autosomal recessiveHypertrophic osteoarthropathy, primary, autosomal recessive 1, 259100 (3);chr4;HPGD, PGDH1, PHOAR1;True
ENSG00000150630;Vascular endothelial growth factor C;NotRelevant;;Lymphatic malformation 4, 615907 (3), Autosomal dominantLymphatic malformation 4, 615907 (3);chr4;VEGFC, VRP, LMPHM4;True
ENSG00000038002;Aspartylglucosaminidase;NotRelevant;;Aspartylglucosaminuria, 208400 (3), Autosomal recessiveAspartylglucosaminuria, 208400 (3);chr4;AGA;True
ENSG00000218336;Teneurin transmembrane protein 3;NotRelevant;;Microphthalmia, isolated, with coloboma 9, 615145 (3), Autosomal recessiveMicrophthalmia, isolated, with coloboma 9, 615145 (3);chr4;TENM3, ODZ3, TNM3, KIAA1455, MCOPCB9;True
ENSG00000168538;Trafficking protein particle complex, subunit 11;NotRelevant;;Muscular dystrophy, limb-girdle, autosomal recessive 18, 615356 (3), Autosomal recessiveMuscular dystrophy, limb-girdle, autosomal recessive 18, 615356 (3);chr4;TRAPPC11, C4orf41, LGMDR18;True
ENSG00000164306;Coiled-coil domain containing 111;NotRelevant;;Myopia 22, autosomal dominant, 615420 (3), Autosomal dominantMyopia 22, autosomal dominant, 615420 (3);chr4;CCDC111, MYP22;True
ENSG00000151729;Solute carrier family 25 (mitochondrial carrier) member 4 (adenine nucleotide translocator-1, skeletal muscle);NotRelevant;;Mitochondrial DNA depletion syndrome 12A (cardiomyopathic type) AD, 617184 (3), Autosomal dominantProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 2, 609283 (3);chr4;SLC25A4, ANT1, T1, PEO3, PEO2, MTDPS12A, PEOA2;True
ENSG00000109775;UFM1-specific peptidase 2;NotRelevant;mutation identified in 1 BHD family;?Hip dysplasia, Beukes type, 142669 (3), Autosomal dominant?Spondyloepimetaphyseal dysplasia, Di Rocco type, 617974 (3);chr4;UFSP2, C4orf20, BHD, SEMDDR;True
ENSG00000164342;Toll-like receptor-3;NotRelevant;;{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 2}, 613002 (3), Autosomal recessive, Autosomal dominant{HIV1 infection, resistance to}, 609423 (3);chr4;TLR3, IIAE2;True
ENSG00000145476;Cytochrome P450, family 4, subfamily V, polypeptide 2;NotRelevant;;Bietti crystalline corneoretinal dystrophy, 210370 (3), Autosomal recessiveBietti crystalline corneoretinal dystrophy, 210370 (3);chr4;CYP4V2, BCD;True
ENSG00000164344;Kallikrein B plasma 1 (Fletcher factor);NotRelevant;similar to F11;Fletcher factor (prekallikrein) deficiency, 612423 (3), Autosomal recessiveFletcher factor (prekallikrein) deficiency, 612423 (3);chr4;KLKB1, KLK3, PKKD;True
ENSG00000088926;Coagulation factor XI (plasma thromboplastin antecedent);NotRelevant;not closely linked to MNS;Factor XI deficiency, autosomal dominant, 612416 (3)Factor XI deficiency, autosomal recessive, 612416 (3);chr4;F11;True
ENSG00000073578;Succinate dehydrogenase complex, subunit A, flavoprotein;NotRelevant;copy on 3q29;Cardiomyopathy, dilated, 1GG, 613642 (3)Paragangliomas 5, 614165 (3);chr5;SDHA, SDH1, SDHF, CMD1GG, PGL5;False
ENSG00000066230;Solute carrier family 9 (sodium/hydrogen exchanger), member 3;NotRelevant;pseudogene on chr.10;Diarrhea 8, secretory sodium, congenital, 616868 (3), Autosomal recessiveDiarrhea 8, secretory sodium, congenital, 616868 (3);chr5;SLC9A3, NHE3, DIAR8;True
ENSG00000071539;Thyroid hormone receptor interactor 13;NotRelevant;;Mosaic variegated aneuploidy syndrome 3, 617598 (3), Autosomal recessiveMosaic variegated aneuploidy syndrome 3, 617598 (3);chr5;TRIP13, 16E1BP, MVA3;True
ENSG00000174358;Solute carrier family 6 (neurotransmitter transporter), member 19;NotRelevant;;Hartnup disorder, 234500 (3), Autosomal recessiveIminoglycinuria, digenic, 242600 (3);chr5;SLC6A19, HND;True
ENSG00000164362;Telomerase reverse transcriptase;NotRelevant;deleted in cri du chat;{Dyskeratosis congenita, autosomal dominant 2}, 613989 (3), Autosomal recessive, Autosomal dominant{Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1}, 614742 (3);chr5;TERT, TCS1, EST2, DKCA2, DKCB4, PFBMFT1, CMM9;True
ENSG00000142319;Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3;NotRelevant;;{Nicotine dependence, protection against}, 188890 (3){Nicotine dependence, protection against}, 188890 (3);chr5;SLC6A3, DAT1, PKDYS1;False
ENSG00000145494;NADH dehydrogenase (ubiquinone) Fe-S protein 6, 13kD;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 9, 618232 (3)Mitochondrial complex I deficiency, nuclear type 9, 618232 (3);chr5;NDUFS6, MC1DN9;False
ENSG00000037474;NOP2/SUN RNA methyltransferase family, member 2;NotRelevant;;Mental retardation, autosomal recessive 5, 611091 (3), Autosomal recessiveMental retardation, autosomal recessive 5, 611091 (3);chr5;NSUN2, TRM4, SAKI, MISU, MRT5;True
ENSG00000124275;Methionine synthase reductase;NotRelevant;;Homocystinuria-megaloblastic anemia, cbl E type, 236270 (3), Autosomal recessive{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3);chr5;MTRR;True
ENSG00000150753;chaperonin containing TCP1, subunit 5 (epsilon);NotRelevant;;Neuropathy, hereditary sensory, with spastic paraplegia, 256840 (3), Autosomal recessiveNeuropathy, hereditary sensory, with spastic paraplegia, 256840 (3);chr5;CCT5, KIAA0098, CCTE;True
ENSG00000039139;Dynein, axonemal, heavy chain 5;NotRelevant;;Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3)Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3);chr5;DNAH5, HL1, PCD, CILD3;False
ENSG00000038382;Triple functional domain;NotRelevant;;Mental retardation, autosomal dominant 44, 617061 (3), Autosomal dominantMental retardation, autosomal dominant 44, 617061 (3);chr5;TRIO, MRD44;True
ENSG00000154124;OTU deubiquitinase with linear linkage specificity;NotRelevant;;Autoinflammation, panniculitis, and dermatosis syndrome, 617099 (3), Autosomal recessiveAutoinflammation, panniculitis, and dermatosis syndrome, 617099 (3);chr5;OTULIN, FAM105B, GUM, AIPDS;True
ENSG00000154122;Ank, mouse, homolog of;NotRelevant;;Chondrocalcinosis 2, 118600 (3), Autosomal dominantCraniometaphyseal dysplasia, 123000 (3);chr5;ANKH, HANK, ANK, CMDJ, CCAL2, CPPDD;True
ENSG00000154153;Family with sequence similarity 134, member B;NotRelevant;;Neuropathy, hereditary sensory and autonomic, type IIB, 613115 (3), Autosomal recessiveNeuropathy, hereditary sensory and autonomic, type IIB, 613115 (3);chr5;FAM134B, HSAN2B;True
ENSG00000113389;Natriuretic peptide receptor C;NotRelevant;;?Hypertension, salt-resistant (1)?Hypertension, salt-resistant (1);chr5;NPR3, ANPRC;False
ENSG00000164175;Solute carrier family 45, member 2;NotRelevant;;Albinism, oculocutaneous, type IV, 606574 (3)[Skin/hair/eye pigmentation 5, dark/light eyes], 227240 (3);chr5;SLC45A2, MATP, AIM1, SHEP5, OCA4;False
ENSG00000242110;Alpha-methylacyl-CoA racemase;NotRelevant;;Alpha-methylacyl-CoA racemase deficiency, 614307 (3), Autosomal recessiveBile acid synthesis defect, congenital, 4, 214950 (3);chr5;AMACR, CBAS4, AMACRD;True
ENSG00000168724;DNAJ/HSP40 homolog, subfamily C, member 21;NotRelevant;;Bone marrow failure syndrome 3, 617052 (3), Autosomal recessiveBone marrow failure syndrome 3, 617052 (3);chr5;DNAJC21, DNAJA5, BMFS3;True
ENSG00000113492;Alanine-glyoxylate aminotransferase 2;NotRelevant;;[Beta-aminoisobutyric acid, urinary excretion of], 210100 (3), Autosomal recessive[Beta-aminoisobutyric acid, urinary excretion of], 210100 (3);chr5;AGXT2, AGT2, BAIBA;True
ENSG00000113494;Prolactin receptor;NotRelevant;mutation identified in 1 family with HPRL;?Hyperprolactinemia, 615555 (3), Autosomal dominantMultiple fibroadenomas of the breast, 615554 (3);chr5;PRLR, MFAB, HPRL;True
ENSG00000168685;Interleukin-7 receptor;NotRelevant;;Severe combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3), Autosomal recessiveSevere combined immunodeficiency, T-cell negative, B-cell/natural killer cell-positive type, 608971 (3);chr5;IL7R, IL7RA, CD127;True
ENSG00000152620;NAD kinase 2, mitochondrial;NotRelevant;mutation identified in 1 DECRD family;?2,4-dienoyl-CoA reductase deficiency, 616034 (3), Autosomal recessive?2,4-dienoyl-CoA reductase deficiency, 616034 (3);chr5;NADK2, C5orf33, DECRD;True
ENSG00000079215;Solute carrier family 1 (glial high affinity glutamate transporter), member 3;NotRelevant;;Episodic ataxia, type 6, 612656 (3), Autosomal dominantEpisodic ataxia, type 6, 612656 (3);chr5;SLC1A3, EAAT1, EA6;True
ENSG00000164190;Nipped-B-like (delangin);NotRelevant;;Cornelia de Lange syndrome 1, 122470 (3), Autosomal dominantCornelia de Lange syndrome 1, 122470 (3);chr5;NIPBL, CDLS1;True
ENSG00000197603;Ciliogenesis and planar polarity effector 1;NotRelevant;;Joubert syndrome 17, 614615 (3), Autosomal recessiveOrofaciodigital syndrome VI, 277170 (3);chr5;CPLANE1, C5orf42, JBTS17, OFD6;True
ENSG00000113569;Nucleoporin, 155kD;NotRelevant;mutation identified in 1 ATFB15 family;?Atrial fibrillation 15, 615770 (3), Autosomal recessive?Atrial fibrillation 15, 615770 (3);chr5;NUP155, KIAA0791, ATFB15;True
ENSG00000168621;Glial cell line derived neurotrophic factor;NotRelevant;;Central hypoventilation syndrome, 209880 (3), Autosomal dominant{Pheochromocytoma, modifier of}, 171300 (3);chr5;GDNF, HSCR3;True
ENSG00000113594;Leukemia inhibitory factor receptor;NotRelevant;;Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3), Autosomal recessiveStuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome, 601559 (3);chr5;LIFR, STWS, SWS, SJS2;True
ENSG00000145623;Oncostatin M receptor;NotRelevant;;Amyloidosis, primary localized cutaneous, 1, 105250 (3), Autosomal dominantAmyloidosis, primary localized cutaneous, 1, 105250 (3);chr5;OSMR, OSMRB, PLCA1;True
ENSG00000082074;FYN-binding protein;NotRelevant;;Thrombocytopenia 3, 273900 (3), Autosomal recessiveThrombocytopenia 3, 273900 (3);chr5;FYB, SLAP130, ADAP, THC3;True
ENSG00000113600;Complement component-9;NotRelevant;;C9 deficiency, 613825 (3){Macular degeneration, age-related, 15, susceptibility to}, 615591 (3);chr5;C9, C9D, ARMD15;False
ENSG00000112936;Complement component-7;NotRelevant;;C7 deficiency, 610102 (3)C7 deficiency, 610102 (3);chr5;C7;False
ENSG00000039537;Complement component-6;NotRelevant;;C6 deficiency, 612446 (3)Combined C6/C7 deficiency (3);chr5;C6;False
ENSG00000083720;3-oxoacid CoA transferase 1;NotRelevant;;Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3)Succinyl CoA:3-oxoacid CoA transferase deficiency, 245050 (3);chr5;OXCT1, OXCT, SCOT;False
ENSG00000112964;Growth hormone receptor;NotRelevant;;Growth hormone insensitivity, partial, 604271 (3), Autosomal dominant{Hypercholesterolemia, familial, modifier of}, 143890 (3);chr5;GHR, GHIP;True
ENSG00000112992;Nicotinamide nucleotide transhydrogenase;NotRelevant;;Glucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3), Autosomal recessiveGlucocorticoid deficiency 4, with or without mineralocorticoid deficiency, 614736 (3);chr5;NNT, GCCD4;True
ENSG00000070193;Fibroblast growth factor-10;NotRelevant;;Aplasia of lacrimal and salivary glands, 180920 (3), Autosomal dominantLADD syndrome, 149730 (3);chr5;FGF10;True
ENSG00000164588;Hyperpolarization-activated cyclic nucleotide-gated potassium channel 1;NotRelevant;;Epileptic encephalopathy, early infantile, 24, 615871 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 24, 615871 (3);chr5;HCN1, BCNG1, EIEE24;True
ENSG00000016082;ISL1 transcription factor, LIM/homeodomain (islet-1);NotRelevant;between D5S395 and D5S407; proximal 5q;chr5;ISL1;False
ENSG00000164171;Integrin, alpha-2 (CD49B;NotRelevant;3673;ENSG00000164171?Glycoprotein Ia deficiency, 614200 (1);chr5;ITGA2, CD49B, BR, BDPLT9;False
ENSG00000164172;Molybdenum cofactor synthesis-2;NotRelevant;;Molybdenum cofactor deficiency B, 252160 (3), Autosomal recessiveMolybdenum cofactor deficiency B, 252160 (3);chr5;MOCS2, MPTS, MOCODB;True
ENSG00000164258;NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kD (NADH-coenzyme Q reductase);NotRelevant;;Mitochondrial complex I deficiency, nuclear type 1, 252010 (3), Autosomal recessive, X-linked dominant, MitochondrialMitochondrial complex I deficiency, nuclear type 1, 252010 (3);chr5;NDUFS4, AQDQ, MC1DN1;True
ENSG00000169271;Heat-shock 27kD protein 3;NotRelevant;mutation identified in 1 HMN2C family;?Neuronopathy, distal hereditary motor, type IIC, 613376 (3), Autosomal dominant?Neuronopathy, distal hereditary motor, type IIC, 613376 (3);chr5;HSPB3, HSPL27, HMN2C, DHMN2C;True
ENSG00000152669;Cyclin O;NotRelevant;;Ciliary dyskinesia, primary, 29, 615872 (3), Autosomal recessiveCiliary dyskinesia, primary, 29, 615872 (3);chr5;CCNO, UNG2, CILD29;True
ENSG00000164509;Interleukin 31 receptor A;NotRelevant;mutation identified in 1 PLCA2 patient;?Amyloidosis, primary localized cutaneous, 2, 613955 (3), Autosomal dominant?Amyloidosis, primary localized cutaneous, 2, 613955 (3);chr5;IL31RA, GLMR, GPL, PLCA2;True
ENSG00000095015;Mitogen-activated protein kinase kinase kinase 1;NotRelevant;;46XY sex reversal 6, 613762 (3), Autosomal dominant46XY sex reversal 6, 613762 (3);chr5;MAP3K1, MEKK1, MEKK, SRXY6;True
ENSG00000113448;Phosphodiesterase-4D, cAMP-specific (dunce, Drosophila, homolog of, phosphodiesterase-E3);NotRelevant;;Acrodysostosis 2, with or without hormone resistance, 614613 (3), Autosomal dominant{Stroke, susceptibility to, 1}, 606799 (3);chr5;PDE4D, DPDE3, STRK1, ACRDYS2;True
ENSG00000049167;Excision repair cross-complementing rodent repair deficiency, complementation group 8;NotRelevant;;Cockayne syndrome, type A, 216400 (3), Autosomal recessiveUV-sensitive syndrome 2, 614621 (3);chr5;ERCC8, CKN1, CSA, UVSS2;True
ENSG00000164182;NADH dehydrogenase 1 alpha subcomplex, assembly factor 2;NotRelevant;pseudogene on chr.2;Mitochondrial complex I deficiency, nuclear type 10, 618233 (3)Mitochondrial complex I deficiency, nuclear type 10, 618233 (3);chr5;NDUFAF2, NDUFA12L, MMTN, B17.2L, MC1DN10;False
ENSG00000130449;Zinc finger SWIM domain-containing protein 6;NotRelevant;;Acromelic frontonasal dysostosis, 603671 (3), Autosomal dominantNeurodevelopmental disorder with movement abnormalities, abnormal gait, and autistic features, 617865 (3);chr5;ZSWIM6, KIAA1577, AFND, NEDMAGA;True
ENSG00000068796;Kinesin, heavy chain, 2;NotRelevant;;Cortical dysplasia, complex, with other brain malformations 3, 615411 (3), Autosomal dominantCortical dysplasia, complex, with other brain malformations 3, 615411 (3);chr5;KIF2A, CDCBM3;True
ENSG00000178394;5-hydroxytryptamine (serotonin) receptor-1A;NotRelevant;;Periodic fever, menstrual cycle dependent, 614674 (3), Autosomal dominantPeriodic fever, menstrual cycle dependent, 614674 (3);chr5;HTR1A, ADRB2RL1, PFMCD;True
ENSG00000153015;CWC27 spliceosome-associated protein, X. cerevisiae, homolog of;NotRelevant;;Retinitis pigmentosa with or without skeletal anomalies, 250410 (3), Autosomal recessiveRetinitis pigmentosa with or without skeletal anomalies, 250410 (3);chr5;CWC27, SDCCAG10, RPSKA;True
ENSG00000145675;Phosphatidylinositol 3-kinase, regulatory, 1;NotRelevant;mutation identified in 1 AGM7 family;?Agammaglobulinemia 7, autosomal recessive, 615214 (3), Autosomal recessiveSHORT syndrome, 269880 (3);chr5;PIK3R1, GRB1, AGM7, SHORT, IMD36;True
ENSG00000152939;Marvel domain-containing protein 2 (tricellulin);NotRelevant;;Deafness, autosomal recessive 49, 610153 (3), Autosomal recessiveDeafness, autosomal recessive 49, 610153 (3);chr5;MARVELD2, MARVD2, TRIC, DFNB49;True
ENSG00000197822;Occludin;NotRelevant;;Pseudo-TORCH syndrome 1, 251290 (3), Autosomal recessivePseudo-TORCH syndrome 1, 251290 (3);chr5;OCLN, BLCPMG, PTORCH1;True
ENSG00000205571;Survival of motor neuron 2, centromeric;NotRelevant;;{Spinal muscular atrophy, type III, modifier of}, 253400 (3), Autosomal recessive{Spinal muscular atrophy, type III, modifier of}, 253400 (3);chr5;SMN2;True
ENSG00000172062;Survival of motor neuron 1, telomeric;NotRelevant;;Spinal muscular atrophy-1, 253300 (3), Autosomal recessiveSpinal muscular atrophy-4, 271150 (3);chr5;SMN1, SMA1, SMA2, SMA3, SMA4;True
ENSG00000145734;B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB;NotRelevant;mutation identified in 1 DFNB112 family;?Deafness, autosomal recessive 112, 618257 (3), Autosomal recessive?Deafness, autosomal recessive 112, 618257 (3);chr5;BDP1, TFNR, DFNB112;True
ENSG00000131844;3-Methylcrotonyl-CoA carboxylase 2;NotRelevant;;3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3), Autosomal recessive3-Methylcrotonyl-CoA carboxylase 2 deficiency, 210210 (3);chr5;MCCC2, MCCB;True
ENSG00000164326;Cocaine- and amphetamine-regulated transcript prepropeptide;NotRelevant;mutation identified in 1 family;{?Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial{?Obesity, susceptibility to}, 601665 (3);chr5;CARTPT, CART;True
ENSG00000049860;Hexosaminidase B, beta polypeptide;NotRelevant;;Sandhoff disease, infantile, juvenile, and adult forms, 268800 (3), Autosomal recessiveSandhoff disease, infantile, juvenile, and adult forms, 268800 (3);chr5;HEXB;True
ENSG00000113161;3-hydroxy-3-methylglutaryl-Coenzyme A reductase;NotRelevant;ENSG00000113161;[Statins, attenuated cholesterol lowering by] (3);chr5;HMGCR, LDLCQ3;False
ENSG00000113163;COL4A3-binding protein (ceramide transporter);NotRelevant;;Mental retardation, autosomal dominant 34, 616351 (3), Autosomal dominantMental retardation, autosomal dominant 34, 616351 (3);chr5;COL4A3BP, GPBP, CERT, MRD34;True
ENSG00000113231;Phosphodiesterase 8B;NotRelevant;;Pigmented nodular adrenocortical disease, primary, 3, 614190 (3)Striatal degeneration, autosomal dominant, 609161 (3);chr5;PDE8B, PPNAD3, ADSD;True
ENSG00000132842;Adaptor-related protein complex 3, beta 1 subunit (adaptin, beta-3a);NotRelevant;;Hermansky-Pudlak syndrome 2, 608233 (3), Autosomal recessiveHermansky-Pudlak syndrome 2, 608233 (3);chr5;AP3B1, ADTB3A, HPS2;True
ENSG00000113273;Arylsulfatase B;NotRelevant;;Mucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3), Autosomal recessiveMucopolysaccharidosis type VI (Maroteaux-Lamy), 253200 (3);chr5;ARSB, MPS6;True
ENSG00000132837;Dimethylglycine dehydrogenase;NotRelevant;;Dimethylglycine dehydrogenase deficiency, 605850 (3), Autosomal recessiveDimethylglycine dehydrogenase deficiency, 605850 (3);chr5;DMGDH, DMGDHD;True
ENSG00000228716;Dihydrofolate reductase;NotRelevant;;Megaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3), Autosomal recessiveMegaloblastic anemia due to dihydrofolate reductase deficiency, 613839 (3);chr5;DHFR;True
ENSG00000113318;mutS, E. coli, homolog of, 3;NotRelevant;5' to DHFR;Endometrial carcinoma, somatic, 608089 (3)Familial adenomatous polyposis 4, 617100 (3);chr5;MSH3, FAP4;False
ENSG00000186468;Ribosomal protein S23;NotRelevant;;Brachycephaly, trichomegaly, and developmental delay, 617412 (3), Autosomal dominantBrachycephaly, trichomegaly, and developmental delay, 617412 (3);chr5;RPS23, BTDD, MCINS;True
ENSG00000152422;X-ray repair, complementing defective, repair in Chinese hamster cells-4;NotRelevant;between D5S427 and D5S401;Short stature, microcephaly, and endocrine dysfunction, 616541 (3), Autosomal recessiveShort stature, microcephaly, and endocrine dysfunction, 616541 (3);chr5;XRCC4, SSMED;True
ENSG00000038427;Versican (chondroitin sulfate proteoglycan-2);NotRelevant;;Wagner syndrome 1, 143200 (3), Autosomal dominantWagner syndrome 1, 143200 (3);chr5;VCAN, CSPG2, WGN, WGN1, ERVR;True
ENSG00000145715;RAS p21 protein activator 1 (GTPase activating protein);NotRelevant;;Basal cell carcinoma, somatic, 605462 (3)Capillary malformation-arteriovenous malformation 1, 608354 (3);chr5;RASA1, GAP, CMAVM1, PKWS;False
ENSG00000081189;MADS box transcription enhancer factor 2, polypeptide C (myocyte enhancer factor 2C);NotRelevant;;Chromosome 5q14.3 deletion syndrome, 613443 (4), Autosomal dominantMental retardation, stereotypic movements, epilepsy, and/or cerebral malformations, 613443 (3);chr5;MEF2C, C5DELq14.3, DEL5q14.3;True
ENSG00000164199;Adhesion G protein-coupled receptor V1;NotRelevant;mutation identified in 1 FEB4 family;?Febrile seizures, familial, 4, 604352 (3), Autosomal dominantUsher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3);chr5;ADGRV1, GPR98, MASS1, VLGR1, KIAA0686, FEB4, USH2C;True
ENSG00000175745;Nuclear receptor subfamily 2, group F, member 1 (transcription factor COUP 1);NotRelevant;;Bosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3), Autosomal dominantBosch-Boonstra-Schaaf optic atrophy syndrome, 615722 (3);chr5;NR2F1, TFCOUP1, ERBAL3, EAR3, BBSOAS;True
ENSG00000198677;Tetratricopeptide repeat domain 37;NotRelevant;;Trichohepatoenteric syndrome 1, 222470 (3), Autosomal recessiveTrichohepatoenteric syndrome 1, 222470 (3);chr5;TTC37, KIAA0372;True
ENSG00000175426;Proprotein convertase subtilisin/kexin type 1;NotRelevant;;Obesity with impaired prohormone processing, 600955 (3), Autosomal recessive{Obesity, susceptibility to, BMIQ12}, 612362 (3);chr5;PCSK1, NEC1, PC1, PC3, BMIQ12;True
ENSG00000153113;Calpastatin;NotRelevant;;Peeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3), Autosomal recessivePeeling skin with leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, 616295 (3);chr5;CAST, PLACK;True
ENSG00000153922;Chromodomain helicase DNA binding protein-1;NotRelevant;;Pilarowski-Bjornsson syndrome, 617682 (3), Autosomal dominantPilarowski-Bjornsson syndrome, 617682 (3);chr5;CHD1, PILBOS;True
ENSG00000164209;Solute carrier family 25, member 46;NotRelevant;;Neuropathy, hereditary motor and sensory, type VIB, 616505 (3), Autosomal recessiveNeuropathy, hereditary motor and sensory, type VIB, 616505 (3);chr5;SLC25A46, HMSN6B;True
ENSG00000134987;WD repeat-containing protein 36;NotRelevant;;Glaucoma 1, open angle, G, 609887 (3)Glaucoma 1, open angle, G, 609887 (3);chr5;WDR36, TAWDRP, GLC1G;False
ENSG00000134982;Adenomatous polyposis coli;NotRelevant;150kb distal to MCC;Adenoma, periampullary, somatic (3)Hepatoblastoma, somatic, 114550 (3);chr5;APC, GS, FPC, BTPS2;False
ENSG00000171444;Mutated in colorectal cancers;NotRelevant;;Colorectal cancer, somatic, 114500 (3)Colorectal cancer, somatic, 114500 (3);chr5;MCC;False
ENSG00000152503;Tripartite motif-containing protein 36;NotRelevant;mutation identified in 1 ANPH patient;?Anencephaly, 206500 (3), Autosomal recessive?Anencephaly, 206500 (3);chr5;TRIM36, RBCC728, ANPH;True
ENSG00000133835;Hydroxysteroid (17-beta) dehydrogenase 4;NotRelevant;;D-bifunctional protein deficiency, 261515 (3), Autosomal recessivePerrault syndrome 1, 233400 (3);chr5;HSD17B4, PRLTS1;True
ENSG00000113083;Lysyl oxidase;NotRelevant;;Aortic aneurysm, familial thoracic 10, 617168 (3), Autosomal dominantAortic aneurysm, familial thoracic 10, 617168 (3);chr5;LOX, AAT10;True
ENSG00000061455;PR domain-containing protein 6;NotRelevant;;Patent ductus arteriosus 3, 617039 (3), Autosomal dominantPatent ductus arteriosus 3, 617039 (3);chr5;PRDM6, PRISM, PDA3;True
ENSG00000168944;Centrosomal protein, 120kD;NotRelevant;;Joubert syndrome 31, 617761 (3), Autosomal recessiveShort-rib thoracic dysplasia 13 with or without polydactyly, 616300 (3);chr5;CEP120, CCDC100, SRTD13, JBTS31;True
ENSG00000164904;Aldehyde dehydrogenase 7 family, member A1 (antiquitin 1);NotRelevant;;Epilepsy, pyridoxine-dependent, 266100 (3), Autosomal recessiveEpilepsy, pyridoxine-dependent, 266100 (3);chr5;ALDH7A1, ATQ1, EPD, PDE;True
ENSG00000113368;Lamin B1;NotRelevant;;Leukodystrophy, adult-onset, autosomal dominant, 169500 (3), Autosomal dominantLeukodystrophy, adult-onset, autosomal dominant, 169500 (3);chr5;LMNB1, ADLD;True
ENSG00000145794;Multiple epidermal growth factor-like domains 10;NotRelevant;;Myopathy, areflexia, respiratory distress, and dysphagia, early-onset, 614399 (3), Autosomal recessiveMyopathy, areflexia, respiratory distress, and dysphagia, early-onset, mild variant, 614399 (3);chr5;MEGF10, KIAA1780, EMARDD;True
ENSG00000138829;Fibrillin-2;NotRelevant;;Contractural arachnodactyly, congenital, 121050 (3), Autosomal dominantMacular degeneration, early-onset, 616118 (3);chr5;FBN2, CCA, EOMD;True
ENSG00000169567;Histidine triad nucleotide-binding protein 1 (protein kinase C inhibitor 1);NotRelevant;;Neuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3), Autosomal recessiveNeuromyotonia and axonal neuropathy, autosomal recessive, 137200 (3);chr5;HINT1, PRKCNH1, NMAN;True
ENSG00000186687;LYR motif-containing protein 7;NotRelevant;;Mitochondrial complex III deficiency, nuclear type 8, 615838 (3), Autosomal recessiveMitochondrial complex III deficiency, nuclear type 8, 615838 (3);chr5;LYRM7, MZM1L, MC3DN8;True
ENSG00000164398;Acyl-CoA synthetase long-chain family member 6;NotRelevant;;Myelodysplastic syndrome (3)Myelogenous leukemia, acute (3);chr5;ACSL6, FACL6, ACS2;False
ENSG00000164399;Interleukin-3;NotRelevant;9kb from CSF2; order: cen-5'IL3-5'CF2-qter;chr5;IL3;False
ENSG00000072682;Procollagen-proline, 2-oxoglutarate-4-dioxygenase, alpha subunit, isoform 2;NotRelevant;;Myopia 25, autosomal dominant, 617238 (3), Autosomal dominantMyopia 25, autosomal dominant, 617238 (3);chr5;P4HA2, MYP25;True
ENSG00000131435;LIM domain protein ril;NotRelevant;;{Osteoporosis, susceptibility to}, 166710 (3), Autosomal dominant{Osteoporosis, susceptibility to}, 166710 (3);chr5;RIL;True
ENSG00000197208;Solute carrier family 22 (organic cation transporter), member 4;NotRelevant;;{Rheumatoid arthritis, susceptibility to}, 180300 (3){Rheumatoid arthritis, susceptibility to}, 180300 (3);chr5;SLC22A4, OCTN1;False
ENSG00000197375;Solute carrier, family 22 (organic cation transporter), member 5;NotRelevant;;Carnitine deficiency, systemic primary, 212140 (3), Autosomal recessiveCarnitine deficiency, systemic primary, 212140 (3);chr5;SLC22A5, OCTN2, CDSP, SCD;True
ENSG00000125347;Interferon regulatory factor-1;NotRelevant;;Gastric cancer, somatic, 613659 (3)Nonsmall cell lung cancer, somatic, 211980 (3);chr5;IRF1, MAR;False
ENSG00000113522;RAD50, S. cerevisiae, homolog of;NotRelevant;;Nijmegen breakage syndrome-like disorder, 613078 (3)Nijmegen breakage syndrome-like disorder, 613078 (3);chr5;RAD50, NBSLD;False
ENSG00000169194;Interleukin-13;NotRelevant;;{Allergic rhinitis, susceptibility to}, 607154 (3){Asthma, susceptibility to}, 600807 (3);chr5;IL13, ALRH, BHR1;False
ENSG00000164404;Growth/differentiation factor 9;NotRelevant;mutation identified in 1 patient;?Premature ovarian failure 14, 618014 (3), Autosomal recessive?Premature ovarian failure 14, 618014 (3);chr5;GDF9, POF14;True
ENSG00000164405;Ubiquinol-cytochrome c reductase, complex III subunit VII, 9.5kD;NotRelevant;;Mitochondrial complex III deficiency, nuclear type 4, 615159 (3), Autosomal recessiveMitochondrial complex III deficiency, nuclear type 4, 615159 (3);chr5;UQCRQ, QPC, MC3DN4;True
ENSG00000072364;AF4/FMR2 family, member 4;NotRelevant;;CHOPS syndrome, 616368 (3), Autosomal dominantCHOPS syndrome, 616368 (3);chr5;AFF4, AF5Q31, CHOPS;True
ENSG00000119048;Ubiquitin-conjugating enzyme E2B (RAD6 homolog);NotRelevant;;?Male infertility (1)?Male infertility (1);chr5;UBE2B, RAD6B;False
ENSG00000152700;Sar1a, S. cerevisiae, homolog 2;NotRelevant;;Chylomicron retention disease, 246700 (3), Autosomal recessiveChylomicron retention disease, 246700 (3);chr5;SAR1B, CMRD, SARA2, ANDD;True
ENSG00000069011;Paired-like homeodomain transcription factor-1;NotRelevant;;Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly, 119800 (3), Autosomal dominantLiebenberg syndrome, 186550 (4);chr5;PITX1, PTX1, BFT, POTX, CCF, LBNBG;True
ENSG00000120708;Transforming growth factor, beta-induced, 68kD;NotRelevant;;Corneal dystrophy, Avellino type, 607541 (3), Autosomal dominantCorneal dystrophy, lattice type IIIA, 608471 (3);chr5;TGFBI, CSD2, CDGG1, CSD, BIGH3, CDG2, EBMD;True
ENSG00000146021;Kelch-like 3;NotRelevant;;Pseudohypoaldosteronism, type IID, 614495 (3), Autosomal recessive, Autosomal dominantPseudohypoaldosteronism, type IID, 614495 (3);chr5;KLHL3, PHA2D;True
ENSG00000120729;Myotilin (titin immunoglobulin domain protein);NotRelevant;;Myopathy, myofibrillar, 3, 609200 (3), Autosomal dominantMyopathy, spheroid body, 182920 (3);chr5;MYOT, TTOD, MFM3;True
ENSG00000132563;Receptor expression-enhancing protein 2;NotRelevant;mutation identified in 1 family each SPG72 AR and AD;?Spastic paraplegia 72, autosomal dominant, 615625 (3), Autosomal recessive, Autosomal dominant?Spastic paraplegia 72, autosomal recessive, 615625 (3);chr5;REEP2, C5orf19, SPG72;True
ENSG00000113013;Heat-shock 70kD protein-9 (mortalin);NotRelevant;;Anemia, sideroblastic, 4, 182170 (3), Autosomal dominantEven-plus syndrome, 616854 (3);chr5;HSPA9, HSPA9B, MOT2, GRP75, EVPLS, SIDBA4;True
ENSG00000044115;Catenin (cadherin-associated protein), alpha 1, 102kD;NotRelevant;;Macular dystrophy, patterned, 2, 608970 (3), Autosomal dominantMacular dystrophy, patterned, 2, 608970 (3);chr5;CTNNA1, MDPT2;True
ENSG00000120725;Sil1, S. cerevisiae, homolog of;NotRelevant;;Marinesco-Sjogren syndrome, 248800 (3), Autosomal recessiveMarinesco-Sjogren syndrome, 248800 (3);chr5;SIL1, BAP, MSS;True
ENSG00000015479;Matrin 3;NotRelevant;;Amyotrophic lateral sclerosis 21, 606070 (3), Autosomal dominantAmyotrophic lateral sclerosis 21, 606070 (3);chr5;MATR3, MPD2, ALS21;True
ENSG00000184584;Transmembrane protein 173;NotRelevant;;STING-associated vasculopathy, infantile-onset, 615934 (3), Autosomal dominantSTING-associated vasculopathy, infantile-onset, 615934 (3);chr5;TMEM173, STING, MPYS, SAVI;True
ENSG00000185129;Purine-rich element binding protein A;NotRelevant;;Mental retardation, autosomal dominant 31, 616158 (3), Autosomal dominantMental retardation, autosomal dominant 31, 616158 (3);chr5;PURA, PUR1, MRD31;True
ENSG00000113070;Heparin-binding EGF-like growth factor (diphtheria toxin receptor);NotRelevant;;{Diphtheria, susceptibility to} (1){Diphtheria, susceptibility to} (1);chr5;HBEGF, DTR, DTSF, HEGFL;False
ENSG00000131495;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2 (8kD, B8);NotRelevant;;Mitochondrial complex I deficiency, nuclear type 13, 618235 (3)Mitochondrial complex I deficiency, nuclear type 13, 618235 (3);chr5;NDUFA2, MC1DN13;False
ENSG00000170445;Histidyl-tRNA synthetase;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2W, 616625 (3), Autosomal dominantUsher syndrome type 3B, 614504 (3);chr5;HARS, USH3B, CMT2W;True
ENSG00000112855;Histidyl-tRNA synthetase 2;NotRelevant;mutation identified in 1 PRLTS2 family;?Perrault syndrome 2, 614926 (3), Autosomal recessive?Perrault syndrome 2, 614926 (3);chr5;HARS2, HARSL, HARSR, HO3, PRLTS2;True
ENSG00000131504;Diaphanous, Drosophila, homolog of, 1;NotRelevant;;Deafness, autosomal dominant 1, 124900 (3), Autosomal dominantSeizures, cortical blindness, microcephaly syndrome, 616632 (3);chr5;DIAPH1, DFNA1, LFHL1, SCBMS;True
ENSG00000113555;Protocadherin 12 (cadherin, vascular endothelial, 2);NotRelevant;;Microcephaly, seizures, spasticity, and brain calcification, 251280 (3), Autosomal recessiveMicrocephaly, seizures, spasticity, and brain calcification, 251280 (3);chr5;PCDH12, VECAD2, PCDH12;True
ENSG00000187678;Sprouty, Drosophila, homolog of;NotRelevant;;Hypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3), Autosomal dominantHypogonadotropic hypogonadism 17 with or without anosmia, 615266 (3);chr5;SPRY4, HH17;True
ENSG00000145819;RHO GTPase-activating protein 26;NotRelevant;;Leukemia, juvenile myelomonocytic, somatic, 607785 (3)Leukemia, juvenile myelomonocytic, somatic, 607785 (3);chr5;ARHGAP26, GRAF;False
ENSG00000113580;Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor);NotRelevant;;Glucocorticoid resistance, 615962 (3), Autosomal dominantGlucocorticoid resistance, 615962 (3);chr5;NR3C1, GCR, GRL, GCRST;True
ENSG00000204928;Glutaredoxin, cysteine-rich, 2;NotRelevant;mutation identified in 1 DFNB101 family;?Deafness, autosomal recessive 101, 615837 (3), Autosomal recessive?Deafness, autosomal recessive 101, 615837 (3);chr5;GRXCR2, DFNB101;True
ENSG00000133706;Leucyl-tRNA synthetase;NotRelevant;mutation identified in 1 family;?Infantile liver failure syndrome 1, 615438 (3), Autosomal recessive?Infantile liver failure syndrome 1, 615438 (3);chr5;LARS, LFIS, ILFS1;True
ENSG00000091010;POU domain, class 4, transcription factor-3;NotRelevant;;Deafness, autosomal dominant 15, 602459 (3), Autosomal dominantDeafness, autosomal dominant 15, 602459 (3);chr5;POU4F3, BRN3C;True
ENSG00000156475;Protein phosphatase 2, regulatory subunit B, beta;NotRelevant;;Spinocerebellar ataxia 12, 604326 (3), Autosomal dominantSpinocerebellar ataxia 12, 604326 (3);chr5;PPP2R2B;True
ENSG00000164266;Serine protease inhibitor, Kazal type I (pancreatic secretory trypsin inhibitor);NotRelevant;;{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3), Autosomal recessive, Autosomal dominant{Fibrocalculous pancreatic diabetes, susceptibility to}, 608189 (3);chr5;SPINK1, PSTI, PCTT, TATI, TCP;True
ENSG00000164265;Secretoglobin, family 3A, member 2 (uteroglobin-related protein 1);NotRelevant;;{Asthma, susceptibility to}, 600807 (3), Autosomal dominant{Asthma, susceptibility to}, 600807 (3);chr5;SCGB3A2, UGRP1;True
ENSG00000133710;Serine protease inhibitor, Kazal type, 5;NotRelevant;;Netherton syndrome, 256500 (3), Autosomal recessiveNetherton syndrome, 256500 (3);chr5;SPINK5, LEKTI;True
ENSG00000145868;F-box only protein 38;NotRelevant;;Neuronopathy, distal hereditary motor, type IID, 615575 (3), Autosomal dominantNeuronopathy, distal hereditary motor, type IID, 615575 (3);chr5;FBXO38, FBX38, MOKA, HMN2D;True
ENSG00000169252;Adrenergic, beta-2-, receptor, surface;NotRelevant;;{Asthma, nocturnal, susceptibility to}, 600807 (3), Autosomal dominant{Obesity, susceptibility to}, 601665 (3);chr5;ADRB2;True
ENSG00000169247;SH3 domain and tetratricopeptide repeat domain 2;NotRelevant;;Charcot-Marie-Tooth disease, type 4C, 601596 (3), Autosomal recessiveMononeuropathy of the median nerve, mild, 613353 (3);chr5;SH3TC2, KIAA1985, MNMN;True
ENSG00000155846;Peroxisome proliferator-activated receptor-gamma, coactivator 1, beta;NotRelevant;;{Obesity, variation in}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial{Obesity, variation in}, 601665 (3);chr5;PPARGC1B, PGC1B, PERC;True
ENSG00000132915;Phosphodiesterase-6A, cGMP-specific, rod, alpha;NotRelevant;;Retinitis pigmentosa 43, 613810 (3)Retinitis pigmentosa 43, 613810 (3);chr5;PDE6A, PDEA, RP43;False
ENSG00000155850;Solute carrier family 26 (sulfate transporter), member 2 (diastrophic dysplasia sulfate transporter);NotRelevant;distal to APC;Achondrogenesis Ib, 600972 (3), Autosomal recessiveEpiphyseal dysplasia, multiple, 4, 226900 (3);chr5;SLC26A2, DTD, DTDST, D5S1708, EDM4;True
ENSG00000182578;Colony-stimulating factor-1 receptor;NotRelevant;ENSG00000182578;FMS2 is 5' endLeukoencephalopathy, diffuse hereditary, with spheroids, 221820 (3);chr5;CSF1R, FMS, HDLS;False
ENSG00000113721;Platelet-derived growth factor receptor, beta polypeptide;NotRelevant;fusion gene with ETV6, HIP1, RABPT5, or H4 in chronic myeloproliferative disorders;Basal ganglia calcification, idiopathic, 4, 615007 (3), Autosomal dominantPremature aging syndrome, Penttinen type, 601812 (3);chr5;PDGFRB, PDGFR, IBGC4, IMF1, PENTT, KOGS;True
ENSG00000070808;Calcium/calmodulin-dependent protein kinase II-alpha;NotRelevant;mutation identified in 1 MRT63 family;Mental retardation, autosomal dominant 53, 617798 (3), Autosomal dominantMental retardation, autosomal dominant 53, 617798 (3);chr5;CAMK2A, KIAA0968, CAMKA, MRD53, MRT63;True
ENSG00000070814;Treacle;NotRelevant;prox. to SPARC;Treacher Collins syndrome 1, 154500 (3), Autosomal dominantTreacher Collins syndrome 1, 154500 (3);chr5;TCOF1, MFD1, TCS1;True
ENSG00000164587;Ribosomal protein S14;NotRelevant;;Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3)Macrocytic anemia, refractory, due to 5q deletion, somatic, 153550 (3);chr5;RPS14, EMTB;False
ENSG00000070614;N-deacetylase/N-sulfotransferase (heparan sulfate-N-deacetylase/N-sulfotransferase);NotRelevant;;Mental retardation, autosomal recessive 46, 616116 (3), Autosomal recessiveMental retardation, autosomal recessive 46, 616116 (3);chr5;NDST1, HSST, MRT46;True
ENSG00000237693;Immunity-related GTPase family, M;NotRelevant;;{Inflammatory bowel disease (Crohn disease) 19}, 612278 (3){Mycobacterium tuberculosis, protection against}, 607948 (3);chr5;IRGM, LRG47, IFI1, IBD19;False
ENSG00000196743;GM2 ganglioside activator protein;NotRelevant;pseudogene on chr.3;GM2-gangliosidosis, AB variant, 272750 (3), Autosomal recessiveGM2-gangliosidosis, AB variant, 272750 (3);chr5;GM2A;True
ENSG00000186335;Solute carrier family 36 (proton/amino acid symporter), member 2;NotRelevant;;Hyperglycinuria, 138500 (3), Autosomal dominantIminoglycinuria, digenic, 242600 (3);chr5;SLC36A2, PAT2;True
ENSG00000086570;Fat tumor suppressor, Drosophila, homolog of, 2;NotRelevant;;Spinocerebellar ataxia 45, 617769 (3), Autosomal dominantSpinocerebellar ataxia 45, 617769 (3);chr5;FAT2, MEGF1, SCA45;True
ENSG00000113140;Osteonectin (secreted protein, acidic, cysteine-rich);NotRelevant;;Osteogenesis imperfecta, type XVII, 616507 (3), Autosomal recessiveOsteogenesis imperfecta, type XVII, 616507 (3);chr5;SPARC, ON, OI17;True
ENSG00000145888;Glycine receptor, alpha-1 polypeptide;NotRelevant;;Hyperekplexia 1, 149400 (3), Autosomal recessive, Autosomal dominantHyperekplexia 1, 149400 (3);chr5;GLRA1, STHE, HKPX1;True
ENSG00000170624;Sarcoglycan, delta (35kD dystrophin-associated glycoprotein);NotRelevant;mutant in Syrian hamster cardiomyopathy;Cardiomyopathy, dilated, 1L, 606685 (3)Muscular dystrophy, limb-girdle, autosomal recessive 6, 601287 (3);chr5;SGCD, SGD, LGMDR6, CMD1L;True
ENSG00000113263;T-cell-specific tyrosine kinase;NotRelevant;ENSG00000113263;Lymphoproliferative syndrome 1, 613011 (3);chr5;ITK, EMT, LPFS1;False
ENSG00000055163;Cytoplasmic FMRP interacting protein 2;NotRelevant;;Epileptic encephalopathy, early infantile, 65, 618008 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 65, 618008 (3);chr5;CYFIP2, EIEE65;True
ENSG00000172548;NIPA-like domain-containing 4;NotRelevant;;Ichthyosis, congenital, autosomal recessive 6, 612281 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 6, 612281 (3);chr5;NIPAL4, ICHYN, ARCI6;True
ENSG00000113302;Interleukin-12B (natural killer cell stimulatory factor-2, cytotoxic lymphocyte maturation factor-2, p40);NotRelevant;between GLR1 and GABRA1;Immunodeficiency 29, mycobacteriosis, 614890 (3), Autosomal recessiveImmunodeficiency 29, mycobacteriosis, 614890 (3);chr5;IL12B, NKSF2, IMD29;True
ENSG00000145864;Gamma-aminobutyric acid (GABA) A receptor, beta-2;NotRelevant;;Epileptic encephalopathy, infantile or early childhood, 2, 617829 (3), Autosomal dominantEpileptic encephalopathy, infantile or early childhood, 2, 617829 (3);chr5;GABRB2, ICEE2;True
ENSG00000022355;Gamma-aminobutyric acid (GABA) A receptor, alpha-1;NotRelevant;in same 200kb as GABRG2;{Epilepsy, childhood absence, susceptibility to, 4}, 611136 (3){Epilepsy, juvenile myoclonic, susceptibility to, 5}, 611136 (3);chr5;GABRA1, EJM5, ECA4, EIEE19;False
ENSG00000113327;Gamma-aminobutyric acid (GABA) A receptor, gamma-2;NotRelevant;in alpha/beta/gamma cluster;{Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3), Autosomal dominant{Epilepsy, childhood absence, susceptibility to, 2}, 607681 (3);chr5;GABRG2, GEFSP3, CAE2, ECA2;True
ENSG00000072571;Hyaluronan-mediated motility receptor (RHAMM);NotRelevant;;{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation{Breast cancer, susceptibility to}, 114480 (3);chr5;HMMR;True
ENSG00000113645;WW, C2, and coiled-coil domain-containing 1;NotRelevant;;[Memory, enhanced, QTL], 615602 (3)[Memory, enhanced, QTL], 615602 (3);chr5;WWC1, KIBRA, KIAA0869, MEMRYQTL;False
ENSG00000113643;Arginyl-tRNA synthetase;NotRelevant;;Leukodystrophy, hypomyelinating, 9, 616140 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 9, 616140 (3);chr5;RARS, HLD9;True
ENSG00000134516;Dedicator of cytokinesis 2;NotRelevant;;Immunodeficiency 40, 616433 (3), Autosomal recessiveImmunodeficiency 40, 616433 (3);chr5;DOCK2, IMD40;True
ENSG00000168269;Forkhead box I1;NotRelevant;some patients have digenic mutations with SLC26A4;Enlarged vestibular aqueduct, 600791 (3), Autosomal recessiveEnlarged vestibular aqueduct, 600791 (3);chr5;FOXI1, FKHL10, FREAC6;True
ENSG00000145936;Potassium large conductance calcium-activated channel, subfamily M, beta member 1;NotRelevant;;{Hypertension, diastolic, resistance to}, 608622 (3), Autosomal dominant{Hypertension, diastolic, resistance to}, 608622 (3);chr5;KCNMB1;True
ENSG00000181163;Nucleophosmin 1 (nucleolar phosphoprotein B23, numatrin);NotRelevant;fused with RARA in APL;Leukemia, acute myeloid, somatic, 601626 (3)Leukemia, acute myeloid, somatic, 601626 (3);chr5;NPM1;False
ENSG00000174705;SH3 and PX domains-containing protein 2B;NotRelevant;;Frank-ter Haar syndrome, 249420 (3), Autosomal recessiveFrank-ter Haar syndrome, 249420 (3);chr5;SH3PXD2B, TKS4, KIAA1295, FTHS;True
ENSG00000113719;Endoplasmic reticulum-golgi intermediate compartment protein 1;NotRelevant;mutation identified in 1 AMCN family;?Arthrogryposis multiplex congenita, neurogenic type, 208100 (3), Autosomal recessive?Arthrogryposis multiplex congenita, neurogenic type, 208100 (3);chr5;ERGIC1, ERGIC32, KIAA1181, AMCN;True
ENSG00000183072;NK2 homeobox-5 gene;NotRelevant;near border with 5q35;Atrial septal defect 7, with or without AV conduction defects, 108900 (3), Autosomal dominantVentricular septal defect 3, 614432 (3);chr5;NKX2-5, NKX2E, CSX, CHNG5, VSD3, HLHS2;True
ENSG00000120149;msh, Drosophila, homeo box homolog of, 2;NotRelevant;;Craniosynostosis 2, 604757 (3), Autosomal dominantParietal foramina with cleidocranial dysplasia, 168550 (3);chr5;MSX2, CRS2, HOX8;True
ENSG00000074317;Synuclein, beta;NotRelevant;;Dementia, Lewy body, 127750 (3), Autosomal dominantDementia, Lewy body, 127750 (3);chr5;SNCB;True
ENSG00000160867;Fibroblast growth factor receptor-4;NotRelevant;distal to DRD1;{Cancer progression/metastasis} (3){Cancer progression/metastasis} (3);chr5;FGFR4;False
ENSG00000165671;Nuclear receptor binding SET domain protein 1;NotRelevant;fusion gene with NUP98 in AML;Leukemia, acute myeloid, 601626 (1), Autosomal dominant, Somatic mutationSotos syndrome 1, 117550 (3);chr5;NSD1, ARA267, STO, SOTOS1;True
ENSG00000131183;Solute carrier family 34 (sodium phosphate cotransporter), member 1;NotRelevant;mutation identified in 1 FRTS2 family;?Fanconi renotubular syndrome 2, 613388 (3), Autosomal recessiveNephrolithiasis/osteoporosis, hypophosphatemic, 1, 612286 (3);chr5;SLC34A1, SLC17A2, NPT2, NPHLOP1, FRTS2, HCINF2;True
ENSG00000131187;Coagulation factor XII (Hageman factor);NotRelevant;;Angioedema, hereditary, type III, 610618 (3), Autosomal dominantFactor XII deficiency, 234000 (3);chr5;F12, HAF, HAE3;True
ENSG00000183258;DEAD/H box 41;NotRelevant;;{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3), Autosomal dominant{Myeloproliferative/lymphoproliferative neoplasms, familial (multiple types), susceptibility to}, 616871 (3);chr5;DDX41, ABS, MPLPF;True
ENSG00000027847;Beta-1,4-galactosyltransferase 7;NotRelevant;;Ehlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3), Autosomal recessiveEhlers-Danlos syndrome, spondylodysplastic type, 1, 130070 (3);chr5;B4GALT7, XGALT1, XGPT1, EDSSPD1;True
ENSG00000175325;Prophet of Pit1, paired-like homeodomain transcription factor;NotRelevant;;Pituitary hormone deficiency, combined, 2, 262600 (3), Autosomal recessivePituitary hormone deficiency, combined, 2, 262600 (3);chr5;PROP1, CPHD2;True
ENSG00000145912;Nucleolar protein family A, member 2;NotRelevant;;Dyskeratosis congenita, autosomal recessive 2, 613987 (3), Autosomal recessiveDyskeratosis congenita, autosomal recessive 2, 613987 (3);chr5;NOLA2, NHP2, DKCB2;True
ENSG00000175309;5-phosphohydroxy-L-lysine phospho-lyase;NotRelevant;mutation identified in 1 PHLU patient;[?Phosphohydroxylysinuria], 615011 (3)[?Phosphohydroxylysinuria], 615011 (3);chr5;PHYKPL, AGXT2L2, PHLU;False
ENSG00000113262;Glutamate receptor, metabotropic, 6;NotRelevant;;Night blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3), Autosomal recessiveNight blindness, congenital stationary (complete), 1B, autosomal recessive, 257270 (3);chr5;GRM6, MGLUR6, CSNB1B;True
ENSG00000087116;A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 2 (procollagen I N-proteinase);NotRelevant;;Ehlers-Danlos syndrome, dermatosparaxis type, 225410 (3), Autosomal recessiveEhlers-Danlos syndrome, dermatosparaxis type, 225410 (3);chr5;ADAMTS2, NPI, EDSDERMS;True
ENSG00000213316;Leukotriene C4 synthase;NotRelevant;;Leukotriene C4 synthase deficiency, 614037 (1), Autosomal recessiveLeukotriene C4 synthase deficiency, 614037 (1);chr5;LTC4S;True
ENSG00000161011;Sequestosome 1;NotRelevant;;Frontotemporal dementia and/or amyotrophic lateral sclerosis 3, 616437 (3), Autosomal dominantPaget disease of bone 3, 167250 (3);chr5;SQSTM1, P62, PDB3, FTDALS3, NADGP, DMRV;True
ENSG00000037280;fms-related tyrosine kinase-4 (vascular endothelial growth factor receptor 3);NotRelevant;;Hemangioma, capillary infantile, somatic, 602089 (3)Lymphatic malformation 1, 153100 (3);chr5;FLT4, VEGFR3, PCL, LMPHM1;False
ENSG00000137265;Interferon regulatory factor-4;NotRelevant;dysregulated in t(6;14)[Skin/hair/eye pigmentation, variation in, 8], 611724 (3);chr6;IRF4, LSIRF, SHEP8;False
ENSG00000054598;Forkhead, Drosophila, homolog-like 7;NotRelevant;;Anterior segment dysgenesis 3, multiple subtypes, 601631 (3), Autosomal dominantAxenfeld-Rieger syndrome, type 3, 602482 (3);chr6;FOXC1, FKHL7, FREAC3, IRID1, RIEG3, ASGD3;True
ENSG00000124570;Protease inhibitor 6 (placental thrombin inhibitor);NotRelevant;mutation identified in 1 DFNB91 family;?Deafness, autosomal recessive 91, 613453 (3), Autosomal recessive?Deafness, autosomal recessive 91, 613453 (3);chr6;SERPINB6, PI6, PTI, SPI3, DFNB91;True
ENSG00000124588;NAD(P)H dehydrogenase, quinone 2 (NAD(P)H menadione oxidoreductase-1, dioxin-inducible-2);NotRelevant;;{?Breast cancer susceptibility}, 114480 (1), Autosomal dominant, Somatic mutation{?Breast cancer susceptibility}, 114480 (1);chr6;NQO2, NMOR2;True
ENSG00000137275;Receptor-interacting serine/threonine kinase 1;NotRelevant;;Immunodeficiency 57, 618108 (3), Autosomal recessiveImmunodeficiency 57, 618108 (3);chr6;RIPK1, RIP1, RIP, IMD57;True
ENSG00000137267;Tubulin, beta-2A;NotRelevant;;Cortical dysplasia, complex, with other brain malformations 5, 615763 (3), Autosomal dominantCortical dysplasia, complex, with other brain malformations 5, 615763 (3);chr6;TUBB2A, CDCBM5;True
ENSG00000137285;Tubulin, beta-2B;NotRelevant;TUBB2A is 70kb telomeric to TUBB2B;Cortical dysplasia, complex, with other brain malformations 7, 610031 (3), Autosomal dominantCortical dysplasia, complex, with other brain malformations 7, 610031 (3);chr6;TUBB2B, CDCBM7;True
ENSG00000214113;LYR motif-containing protein 4;NotRelevant;mutation identified in 1 family;?Combined oxidative phosphorylation deficiency 19, 615595 (3), Autosomal recessive?Combined oxidative phosphorylation deficiency 19, 615595 (3);chr6;LYRM4, ISD11, C6orf149, COXPD19;True
ENSG00000145982;Phenylalanyl-tRNA synthetase 2, mitochondrial;NotRelevant;;Combined oxidative phosphorylation deficiency 14, 614946 (3), Autosomal recessiveSpastic paraplegia 77, autosomal recessive, 617046 (3);chr6;FARS2, FARS1, COXPD14, SPG77;True
ENSG00000124491;Coagulation factor XIII, A polypeptide;NotRelevant;;Factor XIIIA deficiency, 613225 (3), Autosomal recessive{Venous thrombosis, protection against}, 188050 (3);chr6;F13A1, F13A;True
ENSG00000096696;Desmoplakin;NotRelevant;splice variants result in DP I and DP II;Arrhythmogenic right ventricular dysplasia 8, 607450 (3), Autosomal dominantSkin fragility-woolly hair syndrome, 607655 (3);chr6;DSP, KPPS2, PPKS2, DCWHKTA;True
ENSG00000137203;Transcription factor AP-2 alpha (activating enhancer-binding protein 2 alpha);NotRelevant;;Branchiooculofacial syndrome, 113620 (3), Autosomal dominantBranchiooculofacial syndrome, 113620 (3);chr6;TFAP2A, AP2TF, BOFS;True
ENSG00000111846;Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme;NotRelevant;previously assigned to 9q21;Adult i phenotype without cataract, 110800 (3), Autosomal dominant[Blood group, Ii], 110800 (3);chr6;GCNT2, Ii, CTRCT13;True
ENSG00000111837;Male germ cell-associated kinase;NotRelevant;;Retinitis pigmentosa 62, 614181 (3), Autosomal recessiveRetinitis pigmentosa 62, 614181 (3);chr6;MAK, RP62;True
ENSG00000124827;Glial cells missing, Drosophila, homolog of, 2;NotRelevant;;Hyperparathyroidism 4, 617343 (3), Autosomal dominantHypoparathyroidism, familial isolated, 146200 (3);chr6;GCM2, GCMB, HRPT4;True
ENSG00000078401;Endothelin-1;NotRelevant;;Auriculocondylar syndrome 3, 615706 (3), Autosomal recessive{High density lipoprotein cholesterol level QTL 7} (3);chr6;EDN1, ARCND3, QME, HDLCQ7;True
ENSG00000145979;TBC1 domain family, member 7;NotRelevant;;Macrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3), Autosomal recessiveMacrocephaly/megalencephaly syndrome, autosomal recessive, 248000 (3);chr6;TBC1D7, PIG51, TBC7, MGCPH;True
ENSG00000047579;Dystrobrevin-binding protein 1 (dysbindin);NotRelevant;;Hermansky-Pudlak syndrome 7, 614076 (3), Autosomal recessiveHermansky-Pudlak syndrome 7, 614076 (3);chr6;DTNBP1, HPS7;True
ENSG00000124788;Ataxin-1;NotRelevant;;Spinocerebellar ataxia 1, 164400 (3), Autosomal dominantSpinocerebellar ataxia 1, 164400 (3);chr6;ATXN1, ATX1, SCA1;True
ENSG00000187566;NHL repeat-containing 1 gene (malin);NotRelevant;;Epilepsy, progressive myoclonic 2B (Lafora), 254780 (3), Autosomal recessiveEpilepsy, progressive myoclonic 2B (Lafora), 254780 (3);chr6;NHLRC1, EPM2A, EPM2B;True
ENSG00000137364;Thiopurine S-methyltransferase;NotRelevant;;{Thiopurines, poor metabolism of, 1}, 610460 (3), Autosomal recessive{Thiopurines, poor metabolism of, 1}, 610460 (3);chr6;TPMT, TPMTD;True
ENSG00000124795;DEK oncogene;NotRelevant;fused with CAN in t(6;9)Leukemia, acute nonlymphocytic (2);chr6;DEK, D6S231E;False
ENSG00000146038;Doublecortin domain-containing protein 2;NotRelevant;mutation identified in 1 DFNB66 family;?Deafness, autosomal recessive 66, 610212 (3), Autosomal recessiveSclerosing cholangitis, neonatal, 617394 (3);chr6;DCDC2, RU2, KIAA1154, NPHP19, DFNB66, NSC;True
ENSG00000112294;Succinic semialdehyde dehydrogenase;NotRelevant;;Succinic semialdehyde dehydrogenase deficiency, 271980 (3), Autosomal recessiveSuccinic semialdehyde dehydrogenase deficiency, 271980 (3);chr6;ALDH5A1, SSADH;True
ENSG00000111802;Tyrosyl-DNA phosphodiesterase 2;NotRelevant;;Spinocerebellar ataxia, autosomal recessive 23, 616949 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 23, 616949 (3);chr6;TDP2, TTRAP;True
ENSG00000112312;Geminin;NotRelevant;;Meier-Gorlin syndrome 6, 616835 (3), Autosomal dominantMeier-Gorlin syndrome 6, 616835 (3);chr6;GMNN, MGORS6;True
ENSG00000111913;RHO family interacting cell polarization regulator 2;NotRelevant;mutation identified in 1 DFNB104 family;?Deafness, autosomal recessive 104, 616515 (3), Autosomal recessive?Deafness, autosomal recessive 104, 616515 (3);chr6;RIPOR2, FAM65B, C6orf32, KIAA0386, PL48, DFNB104;True
ENSG00000124564;Solute carrier family 17 (sodium phosphate cotransporter), member 3;NotRelevant;;{Gout susceptibility 4}, 612671 (3), Autosomal dominant{Gout susceptibility 4}, 612671 (3);chr6;SLC17A3, NPT4, UAQTL4, GOUT4;True
ENSG00000010704;Hemochromatosis gene;NotRelevant;;{Alzheimer disease, susceptibility to}, 104300 (3), Autosomal dominant{Porphyria variegata, susceptibility to}, 176200 (3);chr6;HFE, HLA-H, HFE1, MVCD7, TFQTL2;True
ENSG00000168298;Histone 1, H1e;NotRelevant;;Rahman syndrome, 617537 (3), Autosomal dominantRahman syndrome, 617537 (3);chr6;HIST1H1E, H1F4, RMNS;True
ENSG00000204701;Olfactory receptor, family 2, subfamily J, member 3;NotRelevant;;[C3HEX, ability to smell], 615082 (3), Autosomal dominant[C3HEX, ability to smell], 615082 (3);chr6;OR2J3, C3HEXS;True
ENSG00000204655;Myelin-oligodendrocyte glycoprotein;NotRelevant;60kb telomeric to HLA-F; mutation identified in 1 NRCLP7 family?Narcolepsy 7, 614250 (3);chr6;MOG, NRCLP7;False
ENSG00000204644;Zinc finger protein 57, mouse, homolog of;NotRelevant;;Diabetes mellitus, transient neonatal, 1, 601410 (3)Diabetes mellitus, transient neonatal, 1, 601410 (3);chr6;ZFP57, TNDM1;False
ENSG00000204632;HLA-G histocompatibility antigen, class I;NotRelevant;;{Asthma, susceptibility to}, 600807 (2), Autosomal dominant{Asthma, susceptibility to}, 600807 (2);chr6;HLA-G;True
ENSG00000206503;Major histocompatibility complex, class I, A;NotRelevant;;{Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3){Hypersensitivity syndrome, carbamazepine-induced, susceptibility to}, 608579 (3);chr6;HLA-A;False
ENSG00000196230;Tubulin, beta polypeptide;NotRelevant;;Cortical dysplasia, complex, with other brain malformations 6, 615771 (3), Autosomal dominantSymmetric circumferential skin creases, congenital, 1, 156610 (3);chr6;TUBB, TUBB5, M40, CDCBM6, CSCSC1;True
ENSG00000137411;Valyl-tRNA synthetase 2;NotRelevant;;Combined oxidative phosphorylation deficiency 20, 615917 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 20, 615917 (3);chr6;VARS2, KIAA1885, COXPD20;True
ENSG00000204539;Corneodesmosin;NotRelevant;;Hypotrichosis 2, 146520 (3), Autosomal dominantPeeling skin syndrome 1, 270300 (3);chr6;CDSN, HTSS1, HYPT2, PSS1;True
ENSG00000204531;Pou domain, class 5, transcription factor 1 (octamer-binding transcription factor 3);NotRelevant;OTF3L on 12; ?related pseudogene on chr.8;chr6;POU5F1, OTF3, OCT3;False
ENSG00000204525;Major histocompatibility complex, class I, C;NotRelevant;;{HIV-1 viremia, susceptibility to}, 609423 (3){Psoriasis susceptibility 1}, 177900 (3);chr6;HLA-C, PSORS1;False
ENSG00000234745;Major histocompatibility complex, class I, B;NotRelevant;;{Abacavir hypersensitivity, susceptibility to} (3){Toxic epidermal necrolysis, susceptibility to}, 608579 (3);chr6;HLA-B, SPDA1;False
ENSG00000204498;Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 1;NotRelevant;;{Rheumatoid arthritis, susceptibility to}, 180300 (3){Rheumatoid arthritis, susceptibility to}, 180300 (3);chr6;NFKBIL1;False
ENSG00000226979;Lymphotoxin alpha (formerly tumor necrosis factor beta);NotRelevant;cen-DR-21OH-C4-BF-C2-TNF-LTA-HLA-B;{Leprosy, susceptibility to, 4}, 610988 (3){Psoriatic arthritis, susceptibility to}, 607507 (3);chr6;LTA, TNFB;False
ENSG00000232810;Tumor necrosis factor (cachectin);NotRelevant;5'-LTA--TNF-3' in 7kb segment (pter-cen); 210kb from HLA-B{Septic shock, susceptibility to} (3);chr6;TNF, TNFA;False
ENSG00000204475;Natural cytotoxicity triggering receptor 3;NotRelevant;;{Malaria, mild, susceptibility to}, 609148 (3){Malaria, mild, susceptibility to}, 609148 (3);chr6;NCR3, 1C7, NKP30, CD337, MALS;False
ENSG00000204420;G6B protein;NotRelevant;mutation identified in 1 THAMY family;?Thrombocytopenia, anemia, and myelofibrosis, 617441 (3), Autosomal recessive?Thrombocytopenia, anemia, and myelofibrosis, 617441 (3);chr6;G6B, C6orf25, THAMY;True
ENSG00000204410;MutS, E. coli, homolog of, 5;NotRelevant;mutation identified in POF13 family;?Premature ovarian failure 13, 617442 (3), Autosomal recessive?Premature ovarian failure 13, 617442 (3);chr6;MSH5, POF13;True
ENSG00000204394;Valyl-tRNA synthetase;NotRelevant;;Neurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3), Autosomal recessiveNeurodevelopmental disorder with microcephaly, seizures, and cortical atrophy, 617802 (3);chr6;VARS, VARS1, G7A, VARS2, NDMSCA;True
ENSG00000204386;Neuraminidase 1 (lysosomal sialidase;NotRelevant;ENSG00000204386;Sialidosis, type II, 256550 (3);chr6;NEU1, NEU, SIAL1;False
ENSG00000204385;Solute carrier family 44, member 4;NotRelevant;mutation identified in 1 DFNA72 family;?Deafness, autosomal dominant 72, 617606 (3), Autosomal dominant?Deafness, autosomal dominant 72, 617606 (3);chr6;SLC44A4, CTL4, C6orf29, DFNA72;True
ENSG00000166278;Complement component-2;NotRelevant;no crossover with BF;C2 deficiency, 217000 (3), Autosomal recessive{Macular degeneration, age-related, 14, reduced risk of}, 615489 (3);chr6;C2, ARMD14;True
ENSG00000243649;Complement factor B;NotRelevant;mutation identified in 1 CFBD family;?Complement factor B deficiency, 615561 (3){Macular degeneration, age-related, 14, reduced risk of}, 615489 (3);chr6;CFB, BF, GBG, AHUS4, ARMD14, CFBD;False
ENSG00000204351;Superkiller viralicidic activity 2, S. cerevisiae, homolog, like;NotRelevant;;Trichohepatoenteric syndrome 2, 614602 (3), Autosomal recessiveTrichohepatoenteric syndrome 2, 614602 (3);chr6;SKIV2L, SKI2, SKI2W, THES2;True
ENSG00000244731;Complement component-4A;NotRelevant;order:  HLA-B, C2, BF, C4A, C4B, CYP21, DR;[Blood group, Rodgers], 614374 (3)[Blood group, Rodgers], 614374 (3);chr6;C4A, C4S, C4AD;False
ENSG00000224389;Complement component-4B;NotRelevant;10kb from C4S;C4B deficiency, 614379 (3)C4B deficiency, 614379 (3);chr6;C4B, C4F, C4BD;False
ENSG00000231852;Cytochrome P450, subfamily XXIA, polypeptide 2 (steroid 21-hydroxylase);NotRelevant;linked to C2, C4, BF; 2 loci, A and BHyperandrogenism, nonclassic type, due to 21-hydroxylase deficiency, 201910 (3);chr6;CYP21A2, CYP21, CA21H;False
ENSG00000168477;Tenascin XB;NotRelevant;;Ehlers-Danlos syndrome, classic-like, 1, 606408 (3), Autosomal recessiveVesicoureteral reflux 8, 615963 (3);chr6;TNXB, TNX, TNXB1, TNXBS, TNXB2, EDSCLL1, VUR8;True
ENSG00000204290;Butyrophilin-like protein 2;NotRelevant;;{Sarcoidosis, susceptibility to, 2}, 612387 (3), Autosomal dominant{Sarcoidosis, susceptibility to, 2}, 612387 (3);chr6;BTNL2, SS2;True
ENSG00000196126;Major histocompatibility complex, class II, DR beta-1;NotRelevant;;{Multiple sclerosis, susceptibility to, 1}, 126200 (3), Multifactorial{Sarcoidosis, susceptibility to, 1}, 181000 (3);chr6;HLA-DRB1, SS1;False
ENSG00000196735;Major histocompatibility complex, class II, DQ alpha-1;NotRelevant;;{Celiac disease, susceptibility to}, 212750 (3), Autosomal recessive, Multifactorial{Celiac disease, susceptibility to}, 212750 (3);chr6;HLA-DQA1, CELIAC1;True
ENSG00000179344;Major histocompatibility complex, class II, DQ beta-1;NotRelevant;;{Celiac disease, susceptibility to}, 212750 (3), Autosomal recessive, Multifactorial{Multiple sclerosis, susceptibility to, 1}, 126200 (3);chr6;HLA-DQB1, CELIAC1;True
ENSG00000204267;Transporter 2, ATP-binding cassette, subfamily B;NotRelevant;tel-TAP1-LMP2-LMP1-TAP2-cen;Bare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3), Autosomal recessiveBare lymphocyte syndrome, type I, due to TAP2 deficiency, 604571 (3);chr6;TAP2, ABCB3, PSF2, RING11;True
ENSG00000204264;Proteasome subunit, beta type, 8 (large multifunctional protease-7);NotRelevant;between TAP1 and TAP2;Proteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3), Autosomal recessiveProteasome-associated autoinflammatory syndrome 1 and digenic forms, 256040 (3);chr6;PSMB8, LMP7, RING10, JMP, NKJO, ALDD, PRAAS1;True
ENSG00000168394;Transporter 1, ATP-binding cassette, subfamily B;NotRelevant;~7kb telomeric to TAP2;Bare lymphocyte syndrome, type I, 604571 (3), Autosomal recessiveBare lymphocyte syndrome, type I, 604571 (3);chr6;TAP1, ABCB2, RING4, PSF1;True
ENSG00000240065;Proteasome subunit, beta type, 9;NotRelevant;mutation identified in 1 digenic family;?Proteasome-associated autoinflammatory syndrome 3, digenic, 617591 (3), Autosomal recessive?Proteasome-associated autoinflammatory syndrome 3, digenic, 617591 (3);chr6;PSMB9, LMP2, RING12, PRAAS3;True
ENSG00000223865;Major histocompatibility complex, class II, DP beta-1;NotRelevant;;{Beryllium disease, chronic, susceptibility to} (3){Beryllium disease, chronic, susceptibility to} (3);chr6;HLA-DPB1;False
ENSG00000204248;Collagen XI, alpha-2 polypeptide;NotRelevant;45kb centromeric of HLA-DPB2; 3'--5'-cenOtospondylomegaepiphyseal dysplasia, autosomal recessive, 215150 (3);chr6;COL11A2, DFNA13, DFNB53, FBCG2, OSMEDA, OSMEDB;True
ENSG00000231925;TAP-binding protein (tapasin);NotRelevant;;Bare lymphocyte syndrome, type I, 604571 (3), Autosomal recessiveBare lymphocyte syndrome, type I, 604571 (3);chr6;TAPBP, TPSN;True
ENSG00000197283;Synaptic Ras GTPase activating protein 1;NotRelevant;;Mental retardation, autosomal dominant 5, 612621 (3), Autosomal dominantMental retardation, autosomal dominant 5, 612621 (3);chr6;SYNGAP1, MRD5;True
ENSG00000096433;Inositol 1,4,5-triphosphate receptor, type 3;NotRelevant;;{Diabetes, type 1, susceptibility to}, 222100 (2), Autosomal recessive{Diabetes, type 1, susceptibility to}, 222100 (2);chr6;ITPR3;True
ENSG00000137288;Ubiquinol-cytochrome c reductase complex assembly factor 2;NotRelevant;;Mitochondrial complex III deficiency, nuclear type 7, 615824 (3), Autosomal recessiveMitochondrial complex III deficiency, nuclear type 7, 615824 (3);chr6;UQCC2, C6orf126, M19, MC3DN7;True
ENSG00000161904;LEM domain-containing protein 2;NotRelevant;;Cataract 46, juvenile-onset, 212500 (3), Autosomal recessiveCataract 46, juvenile-onset, 212500 (3);chr6;LEMD2, NET25, CTRCT42;True
ENSG00000137309;High-mobility group AT-hook 1;NotRelevant;;{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3);chr6;HMGA1, HMGIY;True
ENSG00000124614;Ribosomal protein S10;NotRelevant;;Diamond-Blackfan anemia 9, 613308 (3), Autosomal dominantDiamond-Blackfan anemia 9, 613308 (3);chr6;RPS10, DBA9;True
ENSG00000112039;Fanconi anemia, complementation group E gene;NotRelevant;;Fanconi anemia, complementation group E, 600901 (3), Autosomal recessiveFanconi anemia, complementation group E, 600901 (3);chr6;FANCE, FACE;True
ENSG00000112041;Tubby-like protein-1;NotRelevant;;Leber congenital amaurosis 15, 613843 (3), Autosomal recessiveRetinitis pigmentosa 14, 600132 (3);chr6;TULP1, RP14, LCA15;True
ENSG00000096060;FK506-binding protein 5;NotRelevant;;{Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3){Major depressive disorder and accelerated response to antidepressant drug treatment}, 608516 (3);chr6;FKBP5, FKBP51;False
ENSG00000197753;LHFP-like protein 5;NotRelevant;;Deafness, autosomal recessive 67, 610265 (3), Autosomal recessiveDeafness, autosomal recessive 67, 610265 (3);chr6;LHFPL5, TMHS, DFNB67;True
ENSG00000112053;Solute carrier family 26 (sulfate transporter), member 8;NotRelevant;;Spermatogenic failure 3, 606766 (3), Autosomal dominantSpermatogenic failure 3, 606766 (3);chr6;SLC26A8, TAT1, SPGF3;True
ENSG00000180316;Patatin-like phospholipase domain-containing protein 1;NotRelevant;;Ichthyosis, congenital, autosomal recessive 10, 615024 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 10, 615024 (3);chr6;PNPLA1, ARCI10;True
ENSG00000124615;Molybdenum cofactor synthesis-1;NotRelevant;;Molybdenum cofactor deficiency A, 252150 (3), Autosomal recessiveMolybdenum cofactor deficiency A, 252150 (3);chr6;MOCS1, MOCODA;True
ENSG00000095970;Triggering receptor expressed on myeloid cells 2;NotRelevant;;Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, 618193 (3)Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 2, 618193 (3);chr6;TREM2, PLOSL2;False
ENSG00000048545;Guanylate cyclase activator 1A, retina;NotRelevant;;Cone dystrophy-3, 602093 (3), Autosomal dominantCone-rod dystrophy 14, 602093 (3);chr6;GUCA1A, GCAP, COD3, CORD14;True
ENSG00000112599;Guanylate cyclase activator 1B, retina;NotRelevant;;Retinitis pigmentosa 48, 613827 (3)Retinitis pigmentosa 48, 613827 (3);chr6;GUCA1B, GCAP2, GUCA2, RP48;False
ENSG00000112619;Peripherin 2, mouse, homolog of;NotRelevant;digenic RP with ROM1;Choroidal dystrophy, central areolar 2, 613105 (3), Autosomal dominantRetinitis punctata albescens, 136880 (3);chr6;PRPH2, DS, RP7, PRPH, AVMD, AOFMD, CACD2, MDBS1;True
ENSG00000137161;Canopy 3, zebrafish, homolog of;NotRelevant;;Epileptic encephalopathy, early infantile, 60, 617929 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 60, 617929 (3);chr6;CNPY3, TNRC5, PRAT4A, ERDA5, EIEE60;True
ENSG00000124713;Glycine N-methyltransferase;NotRelevant;;Glycine N-methyltransferase deficiency, 606664 (3), Autosomal recessiveGlycine N-methyltransferase deficiency, 606664 (3);chr6;GNMT;True
ENSG00000124587;Peroxisomal biogenesis factor 6 (peroxisomal AAA-type ATPase 1);NotRelevant;;Heimler syndrome 2, 616617 (3), Autosomal recessivePeroxisome biogenesis disorder 4B, 614863 (3);chr6;PEX6, PXAAA1, PAF2, PBD4A, PDB4B, HMLR2;True
ENSG00000112640;Protein phosphatase-2, regulatory subunit B (B56), delta isoform;NotRelevant;;Mental retardation, autosomal dominant 35, 616355 (3), Autosomal dominantMental retardation, autosomal dominant 35, 616355 (3);chr6;PPP2R5D, MRD35;True
ENSG00000044090;Cullin 7;NotRelevant;;3-M syndrome 1, 273750 (3), Autosomal recessive3-M syndrome 1, 273750 (3);chr6;CUL7, 3M1;True
ENSG00000171453;Polymerase I, RNA, subunit C;NotRelevant;;Leukodystrophy, hypomyelinating, 11, 616494 (3), Autosomal recessiveTreacher Collins syndrome 3, 248390 (3);chr6;POLR1C, RPA39, RPA40, RPAC1, RPA5, TCS3, HLD11;True
ENSG00000170734;Polymerase, DNA, eta;NotRelevant;;Xeroderma pigmentosum, variant type, 278750 (3), Autosomal recessiveXeroderma pigmentosum, variant type, 278750 (3);chr6;POLH, XPV;True
ENSG00000172432;GTP-binding protein 2;NotRelevant;;Jaberi-Elahi syndrome, 617988 (3), Autosomal recessiveJaberi-Elahi syndrome, 617988 (3);chr6;GTPBP2, JABELS;True
ENSG00000172426;Radial spoke head 9, Chlamydomonas, homolog of;NotRelevant;;Ciliary dyskinesia, primary, 12, 612650 (3)Ciliary dyskinesia, primary, 12, 612650 (3);chr6;RSPH9, CILD12;False
ENSG00000112715;Vascular endothelial growth factor;NotRelevant;;{Microvascular complications of diabetes 1}, 603933 (3){Microvascular complications of diabetes 1}, 603933 (3);chr6;VEGF, MVCD1;False
ENSG00000124608;Alanyl-tRNA synthetase 2;NotRelevant;;Combined oxidative phosphorylation deficiency 8, 614096 (3), Autosomal recessiveLeukoencephalopathy, progressive, with ovarian failure, 615889 (3);chr6;AARS2, KIAA1270, MTALARS, COXPD8, LKENP;True
ENSG00000124813;Runt-related transcription factor 2;NotRelevant;;Cleidocranial dysplasia, 119600 (3), Autosomal dominantMetaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly, 156510 (3);chr6;RUNX2, CBFA1, PEBP2A1, AML3, CCD, CLCD;True
ENSG00000112782;Chloride intracellular channel 5;NotRelevant;mutation identified in 1 DFNB103 family;?Deafness, autosomal recessive 103, 616042 (3), Autosomal recessive?Deafness, autosomal recessive 103, 616042 (3);chr6;CLIC5, DFNB103;True
ENSG00000146070;Phospholipase A2, group VII (platelet-activating factor acetylhydrolase);NotRelevant;;{Asthma, susceptibility to}, 600807 (3), Autosomal dominant{Atopy, susceptibility to}, 147050 (3);chr6;PLA2G7, PAFAH, PAFAD;True
ENSG00000198087;CD2-associated protein;NotRelevant;;Glomerulosclerosis, focal segmental, 3, 607832 (3)Glomerulosclerosis, focal segmental, 3, 607832 (3);chr6;CD2AP, CMS;False
ENSG00000146085;Methylmalonyl Coenzyme A mutase;NotRelevant;;Methylmalonic aciduria, mut(0) type, 251000 (3), Autosomal recessiveMethylmalonic aciduria, mut(0) type, 251000 (3);chr6;MUT, MCM;True
ENSG00000112077;Rhesus blood group-associated glycoprotein;NotRelevant;;Anemia, hemolytic, Rh-null, regulator type, 268150 (3), Autosomal dominantOverhydrated hereditary stomatocytosis, 185000 (3);chr6;RHAG, RH50A, OHST, RHNR;True
ENSG00000008196;Transcription factor AP-2 beta (activating enhancer-binding protein 2 beta);NotRelevant;;Char syndrome, 169100 (3), Autosomal dominantPatent ductus arteriosus 2, 617035 (3);chr6;TFAP2B, CHAR, PDA2;True
ENSG00000170927;Fibrocystin;NotRelevant;;Polycystic kidney disease 4, with or without hepatic disease, 263200 (3), Autosomal recessivePolycystic kidney disease 4, with or without hepatic disease, 263200 (3);chr6;FCYT, PKHD1, ARPKD, PKD4;True
ENSG00000112116;Interleukin 17F;NotRelevant;mutation identified in 1 CANDF6 family;?Candidiasis, familial, 6, autosomal dominant, 613956 (3)?Candidiasis, familial, 6, autosomal dominant, 613956 (3);chr6;IL17F, ML1, CANDF6;True
ENSG00000096093;EF hand domain (C-terminal)-containing 1;NotRelevant;;{Epilepsy, juvenile absence, susceptibility to, 1}, 607631 (3), Autosomal dominant{Myoclonic epilepsy, juvenile, susceptibility to, 1}, 254770 (3);chr6;EFHC1, FLJ10466, EJM1, JAE, EJA1;True
ENSG00000112144;Intestinal cell kinase;NotRelevant;;Endocrine-cerebroosteodysplasia, 612651 (3), Autosomal recessive{Epilepsy, juvenile myoclonic, susceptibility to, 10}, 617924 (3);chr6;ICK, MRK, KIAA0936, ECO, EJM10;True
ENSG00000012660;Elongation of very long chain fatty acids-like 5;NotRelevant;;Spinocerebellar ataxia 38, 615957 (3), Autosomal dominantSpinocerebellar ataxia 38, 615957 (3);chr6;ELOVL5, HELO1, SCA38;True
ENSG00000001084;Glutamate-cysteine ligase, catalytic subunit;NotRelevant;;Hemolytic anemia due to gamma-glutamylcysteine synthetase deficiency, 230450 (3), Autosomal recessive{Myocardial infarction, susceptibility to}, 608446 (3);chr6;GCLC, GLCLC;True
ENSG00000151914;Dystonin (bullous pemphigoid antigen 1);NotRelevant;?mutation identified in 1 HSAN6 family;Epidermolysis bullosa simplex, autosomal recessive 2, 615425 (3), Autosomal recessiveEpidermolysis bullosa simplex, autosomal recessive 2, 615425 (3);chr6;DST, BPAG1, DMH, D6S1101, HSAN6, EBSB2;True
ENSG00000112210;Ras-associated protein RAB23;NotRelevant;;Carpenter syndrome, 201000 (3), Autosomal recessiveCarpenter syndrome, 201000 (3);chr6;RAB23;True
ENSG00000188107;Eyes shut, Drosophila, homolog of;NotRelevant;;Retinitis pigmentosa 25, 602772 (3), Autosomal recessiveRetinitis pigmentosa 25, 602772 (3);chr6;EYS, RP25;True
ENSG00000168216;LMBR1 domain-containing protein 1;NotRelevant;;Methylmalonic aciduria and homocystinuria, cblF type, 277380 (3), Autosomal recessiveMethylmalonic aciduria and homocystinuria, cblF type, 277380 (3);chr6;LMBRD1, LMBD1, NESI, MAHCF;True
ENSG00000112280;Collagen IX, alpha-1 polypeptide;NotRelevant;mutation identified in 1 EDM6 family;?Epiphyseal dysplasia, multiple, 6, 614135 (3), Autosomal dominantStickler syndrome, type IV, 614134 (3);chr6;COL9A1, EDM6, STL4;True
ENSG00000079841;Regulating synaptic membrane exocytosis 1;NotRelevant;;Cone-rod dystrophy 7, 603649 (3)Cone-rod dystrophy 7, 603649 (3);chr6;RIMS1, RIM1, RIM, KIAA0340, CORD7;False
ENSG00000185760;Potassium channel, voltage-gated, KQT-like subfamily, member 5;NotRelevant;;Mental retardation, autosomal dominant 46, 617601 (3), Autosomal dominantMental retardation, autosomal dominant 46, 617601 (3);chr6;KCNQ5, MRD46;True
ENSG00000203908;KH domain containing 3-like, subcortical maternal complex member;NotRelevant;;Hydatidiform mole, recurrent, 2, 614293 (3), Autosomal recessiveHydatidiform mole, recurrent, 2, 614293 (3);chr6;KHDC3L, C6orf221, ECAT1, HYDM2;True
ENSG00000135297;Mitochondrial translation optimization 1, S. cerevisiae, homolog of;NotRelevant;;Combined oxidative phosphorylation deficiency 10, 614702 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 10, 614702 (3);chr6;MTO1, COXPD10;True
ENSG00000119899;Solute carrier family 17 (sodium phosphate), member 5;NotRelevant;;Salla disease, 604369 (3), Autosomal recessiveSialic acid storage disorder, infantile, 269920 (3);chr6;SLC17A5, SIASD, SLD;True
ENSG00000111799;Collagen, type XII, alpha-1;NotRelevant;mutation identified in 1 UCMD2 family;Bethlem myopathy 2, 616471 (3), Autosomal dominantBethlem myopathy 2, 616471 (3);chr6;COL12A1, UCMD2, BTHLM2, EDSMYP;True
ENSG00000196586;Myosin VI;NotRelevant;;Deafness, autosomal dominant 22, 606346 (3), Autosomal dominantDeafness, autosomal recessive 37, 607821 (3);chr6;MYO6, DFNA22, DFNB37;True
ENSG00000112706;Interphotoreceptor matrix proteoglycan-1;NotRelevant;;Macular dystrophy, vitelliform, 4, 616151 (3), Autosomal dominantMacular dystrophy, vitelliform, 4, 616151 (3);chr6;IMPG1, IPM150, VMD4;True
ENSG00000146247;Pleckstrin homology domain-interacting protein;NotRelevant;;Developmental delay, intellectual disability, obesity, and dysmorphic features, 617991 (3), Autosomal dominantDevelopmental delay, intellectual disability, obesity, and dysmorphic features, 617991 (3);chr6;PHIP, DIDOD;True
ENSG00000135338;Lebercilin;NotRelevant;;Leber congenital amaurosis 5, 604537 (3)Leber congenital amaurosis 5, 604537 (3);chr6;LCA5, C6orf152;False
ENSG00000118402;Elongation of very long chain fatty acids 4;NotRelevant;;Ichthyosis, spastic quadriplegia, and mental retardation, 614457 (3), Autosomal recessiveStargardt disease 3, 600110 (3);chr6;ELOVL4, ADMD, STGD2, STGD3, ISQMR, SCA34;True
ENSG00000083123;Branched chain keto acid dehydrogenase E1, beta polypeptide;NotRelevant;;Maple syrup urine disease, type Ib, 248600 (3), Autosomal recessiveMaple syrup urine disease, type Ib, 248600 (3);chr6;BCKDHB, E1B;True
ENSG00000112773;Terminal nucleotidyltransferase 5A;NotRelevant;;Osteogenesis imperfecta, type XVIII, 617952 (3), Autosomal recessiveOsteogenesis imperfecta, type XVIII, 617952 (3);chr6;TENT5A, FAM46A, C6orf37, OI18;True
ENSG00000013375;Phosphoglucomutase-3 (N-acetylglucosamine-phosphate mutase 1);NotRelevant;;Immunodeficiency 23, 615816 (3), Autosomal recessiveImmunodeficiency 23, 615816 (3);chr6;PGM3, AGM1, IMD23;True
ENSG00000203877;Ripply2, zebrafish, homolog of;NotRelevant;mutation identified in 1 SCDO6 family;?Spondylocostal dysostosis 6, 616566 (3), Autosomal recessive?Spondylocostal dysostosis 6, 616566 (3);chr6;RIPPLY2, C6orf59, SCDO6;True
ENSG00000135324;Melanocortin 2 receptor accessory protein 2;NotRelevant;mutation identified in 1 BMIQ18 individual;{?Obesity, susceptibility to, BMIQ18}, 615457 (3), Autosomal dominant{?Obesity, susceptibility to, BMIQ18}, 615457 (3);chr6;MRAP2, C6orf117, BMIQ18;True
ENSG00000112837;T-box 18;NotRelevant;;Congenital anomalies of kidney and urinary tract 2, 143400 (3), Autosomal dominantCongenital anomalies of kidney and urinary tract 2, 143400 (3);chr6;TBX18, CAKUT2;True
ENSG00000135318;5' nucleotidase, ecto (CD73);NotRelevant;;Calcification of joints and arteries, 211800 (3), Autosomal recessiveCalcification of joints and arteries, 211800 (3);chr6;NT5E, NT5;True
ENSG00000135317;Sorting nexin 14;NotRelevant;;Spinocerebellar ataxia, autosomal recessive 20, 616354 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 20, 616354 (3);chr6;SNX14, SCAR20;True
ENSG00000164414;Solute carrier family 35 (CMP-sialic acid transporter), member 1;NotRelevant;;Congenital disorder of glycosylation, type IIf, 603585 (3), Autosomal recessiveCongenital disorder of glycosylation, type IIf, 603585 (3);chr6;SLC35A1, CST, CDG2F;True
ENSG00000146282;Arginyl-tRNA synthetase 2;NotRelevant;;Pontocerebellar hypoplasia, type 6, 611523 (3), Autosomal recessivePontocerebellar hypoplasia, type 6, 611523 (3);chr6;RARS2, RARSL, PCH6;True
ENSG00000135341;Mitogen-activated protein kinase kinase kinase 7;NotRelevant;;Cardiospondylocarpofacial syndrome, 157800 (3), Autosomal dominantFrontometaphyseal dysplasia 2, 617137 (3);chr6;MAP3K7, TAK1, CSCF, FMD2;True
ENSG00000123545;NADH dehydrogenase 1 alpha subcomplex, assembly factor 4;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 15, 618237 (3)Mitochondrial complex I deficiency, nuclear type 15, 618237 (3);chr6;NDUFAF4, HRPAP20, C6orf66, MC1DN15;False
ENSG00000112234;F-box and leucine-rich repeat protein 4;NotRelevant;;Mitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3), Autosomal recessiveMitochondrial DNA depletion syndrome 13 (encephalomyopathic type), 615471 (3);chr6;FBXL4, FBL4, MTDPS13;True
ENSG00000112246;Single-minded, Drosophila, homolog of, 1;NotRelevant;;Obesity, severe, 601665 (3), Autosomal recessive, Autosomal dominant, MultifactorialObesity, severe, 601665 (3);chr6;SIM1;True
ENSG00000164418;Glutamate receptor, ionotropic, kainate 2;NotRelevant;;Mental retardation, autosomal recessive, 6, 611092 (3), Autosomal recessiveMental retardation, autosomal recessive, 6, 611092 (3);chr6;GRIK2, GLUR6, MRT6;True
ENSG00000085382;HECT domain- and ankyrin repeat-containing E3 ubiquitin protein ligase 1;NotRelevant;;Spastic paraplegia and psychomotor retardation with or without seizures, 616756 (3), Autosomal recessiveSpastic paraplegia and psychomotor retardation with or without seizures, 616756 (3);chr6;HACE1, KIAA1320, SPPRS;True
ENSG00000112276;Blood vessel epicardial substance;NotRelevant;mutation identified in 1 CARICK family;?Cardiac arrhythmia with increased serum creatine kinase, 616812 (3), Autosomal recessive?Cardiac arrhythmia with increased serum creatine kinase, 616812 (3);chr6;BVES, HBVES, POPDC1, CARICK;True
ENSG00000057663;Autophagy 5, S. cerevisiae, homolog of;NotRelevant;mutation identified in one SCAR25 family;?Spinocerebellar ataxia, autosomal recessive 25, 617584 (3), Autosomal recessive?Spinocerebellar ataxia, autosomal recessive 25, 617584 (3);chr6;ATG5, APG5, APG5L, ASP, SCAR25;True
ENSG00000130347;Reticulon 4-interacting protein 1;NotRelevant;;Optic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3), Autosomal recessiveOptic atrophy 10 with or without ataxia, mental retardation, and seizures, 616732 (3);chr6;RTN4IP1, NIMP, OPA10;True
ENSG00000272398;CD24 antigen;NotRelevant;pseudogenes at 15q21-q22; Yq11;chr6;CD24;False
ENSG00000164494;Prenyl diphosphate synthase, subunit 2;NotRelevant;;Coenzyme Q10 deficiency, primary, 3, 614652 (3), Autosomal recessiveCoenzyme Q10 deficiency, primary, 3, 614652 (3);chr6;PDSS2, DLP1, C6orf210, COQ10D3;True
ENSG00000112320;Sine oculis-binding protein, Drosophila, homolog of;NotRelevant;;Mental retardation, anterior maxillary protrusion, and strabismus, 613671 (3), Autosomal recessiveMental retardation, anterior maxillary protrusion, and strabismus, 613671 (3);chr6;SOBP, JXC1, MRAMS;True
ENSG00000025796;Sec63, S. cerevisiae, homolog of;NotRelevant;;Polycystic liver disease 2, 617004 (3), Autosomal dominantPolycystic liver disease 2, 617004 (3);chr6;SEC63, PCLD2;True
ENSG00000081087;Osteopetrosis associated transmembrane protein 1 (grey-lethal, mouse, homolog of);NotRelevant;;Osteopetrosis, autosomal recessive 5, 259720 (3), Autosomal recessiveOsteopetrosis, autosomal recessive 5, 259720 (3);chr6;OSTM1, GL, OPTB5;True
ENSG00000112335;Sorting nexin 3;NotRelevant;t(6;13)(q21;chr6;SNX3;False
ENSG00000135535;CD164 antigen;NotRelevant;mutation identified in 1 DFNA66 family;?Deafness, autosomal dominant 66, 616969 (3), Autosomal dominant?Deafness, autosomal dominant 66, 616969 (3);chr6;CD164, DFNA66;True
ENSG00000112365;Zinc finger- and BTB domain-containing protein 24;NotRelevant;;Immunodeficiency-centromeric instability-facial anomalies syndrome 2, 614069 (3), Autosomal recessiveImmunodeficiency-centromeric instability-facial anomalies syndrome 2, 614069 (3);chr6;ZBTB24, PATZ2, ZNF450, KIAA0441, ICF2;True
ENSG00000112367;Fig4, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 BTOP family;Amyotrophic lateral sclerosis 11, 612577 (3), Autosomal dominantYunis-Varon syndrome, 216340 (3);chr6;FIG4, KIAA0274, SAC3, ALS11, YVS, BTOP;True
ENSG00000056972;TRAF3-interacting protein 2;NotRelevant;mutation identified in 1 family with CANDF8;?Candidiasis, familial, 8, 615527 (3), Autosomal recessive{Psoriasis susceptibility 13}, 614070 (3);chr6;TRAF3IP2, C6orf5, ACT1, CIKS, C6orf4, C6orf6, PSORS13, CANDF8;True
ENSG00000112761;Wnt-1 inducible signaling pathway protein 3;NotRelevant;;Arthropathy, progressive pseudorheumatoid, of childhood, 208230 (3), Autosomal recessiveSpondyloepiphyseal dysplasia tarda with progressive arthropathy, 208230 (3);chr6;WISP3, PPAC, PPD;True
ENSG00000112769;Laminin, alpha-4;NotRelevant;;Cardiomyopathy, dilated, 1JJ, 615235 (3), Autosomal dominantCardiomyopathy, dilated, 1JJ, 615235 (3);chr6;LAMA4, LAMA3, CMD1JJ;True
ENSG00000123500;Collagen X, alpha-1 polypeptide;NotRelevant;;Metaphyseal chondrodysplasia, Schmid type, 156500 (3), Autosomal dominantMetaphyseal chondrodysplasia, Schmid type, 156500 (3);chr6;COL10A1;True
ENSG00000111817;Dermatan sulfate epimerase;NotRelevant;;Ehlers-Danlos syndrome, musculocontractural type 2, 615539 (3), Autosomal recessiveEhlers-Danlos syndrome, musculocontractural type 2, 615539 (3);chr6;DSE, SART2, EDSMC2;True
ENSG00000189241;Y-encoded testis-specific protein-like;NotRelevant;;Sudden infant death with dysgenesis of the testes syndrome, 608800 (3), Autosomal recessiveSudden infant death with dysgenesis of the testes syndrome, 608800 (3);chr6;TSPYL1, TSPYL, SIDDT;True
ENSG00000111834;Radial spoke head 4, Chlamydomonas, homolog of, A;NotRelevant;;Ciliary dyskinesia, primary, 11, 612649 (3)Ciliary dyskinesia, primary, 11, 612649 (3);chr6;RSPH4A, CILD11;False
ENSG00000185002;Regulatory factor X, 6;NotRelevant;;Mitchell-Riley syndrome, 615710 (3), Autosomal recessiveMitchell-Riley syndrome, 615710 (3);chr6;RFX6, RFXDC1, MTCHRS;True
ENSG00000153989;Nuclear undecaprenyl pyrophosphate synthase 1, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 CDG1AA family;?Congenital disorder of glycosylation, type 1aa, 617082 (3), Autosomal recessiveMental retardation, autosomal dominant 55, with seizures, 617831 (3);chr6;NUS1, NGBR, C6orf68, CDG1AA, MRD55;True
ENSG00000198523;Phospholamban;NotRelevant;;Cardiomyopathy, dilated, 1P, 609909 (3)Cardiomyopathy, hypertrophic, 18, 613874 (3);chr6;PLN, PLB, CMD1P, CMH18;False
ENSG00000111877;Minichromosome maintenance complex component 9;NotRelevant;;Ovarian dysgenesis 4, 616185 (3), Autosomal recessiveOvarian dysgenesis 4, 616185 (3);chr6;MCM9, MCMDC1, ODG4;True
ENSG00000152661;Gap junction protein, alpha-1, 43kD (connexin 43);NotRelevant;pseudogene on chr.5;Atrioventricular septal defect 3, 600309 (3), Autosomal dominantSyndactyly, type III, 186100 (3);chr6;GJA1, CX43, ODDD, SDTY3, ODOD, HSS, AVSD3, HLHS1, CMDR, EKVP3;True
ENSG00000186439;Triadin;NotRelevant;;Ventricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3), Autosomal recessiveVentricular tachycardia, catecholaminergic polymorphic, 5, with or without muscle weakness, 615441 (3);chr6;TRDN, TDN, CPVT5;True
ENSG00000196569;Laminin, alpha-2 (merosin);NotRelevant;;Muscular dystrophy, congenital, merosin deficient or partially deficient, 607855 (3), Autosomal recessiveMuscular dystrophy, limb-girdle, autosomal recessive 23, 618138 (3);chr6;LAMA2, LAMM, MDC1A;True
ENSG00000118520;Arginase, liver;NotRelevant;;Argininemia, 207800 (3), Autosomal recessiveArgininemia, 207800 (3);chr6;ARG1;True
ENSG00000112282;Mediator complex subunit 23;NotRelevant;;Mental retardation, autosomal recessive 18, 614249 (3), Autosomal recessiveMental retardation, autosomal recessive 18, 614249 (3);chr6;MED23, MRT18;True
ENSG00000197594;Ectonucleotide pyrophosphatase/phosphodiesterase 1 (Ly-41 antigen, mouse, homolog of);NotRelevant;;Arterial calcification, generalized, of infancy, 1, 208000 (3), Autosomal recessive{Obesity, susceptibility to}, 601665 (3);chr6;ENPP1, PDNP1, NPPS, M6S1, PCA1, ARHR2, COLED;True
ENSG00000112299;Vanin 1;NotRelevant;;[High density lipoprotein cholesterol level QTL 8] (3)[High density lipoprotein cholesterol level QTL 8] (3);chr6;VNN1, HDLCQ8;False
ENSG00000112319;Eyes absent, Drosophila, homolog of, 4;NotRelevant;mutation identified in 1 CMD1J family;?Cardiomyopathy, dilated, 1J, 605362 (3), Autosomal dominantDeafness, autosomal dominant 10, 601316 (3);chr6;EYA4, DFNA10, CMD1J;True
ENSG00000118513;Avian myeloblastosis viral (v-myb) oncogene homolog;NotRelevant;;{T-cell acute lymphoblastic leukemia} (3){T-cell acute lymphoblastic leukemia} (3);chr6;MYB;False
ENSG00000135541;Abelson helper integration site 1;NotRelevant;;Joubert syndrome 3, 608629 (3), Autosomal recessiveJoubert syndrome 3, 608629 (3);chr6;AHI1;True
ENSG00000112357;Peroxisomal biogenesis factor-7;NotRelevant;;Peroxisome biogenesis disorder 9B, 614879 (3), Autosomal recessiveRhizomelic chondrodysplasia punctata, type 1, 215100 (3);chr6;PEX7, RCDP1, PBD9B;True
ENSG00000027697;Immune interferon, receptor for;NotRelevant;;{H. pylori infection, susceptibility to}, 600263 (3){Tuberculosis, susceptibility to}, 607948 (3);chr6;IFNGR1, IMD27A, IMD27B;False
ENSG00000118503;Tumor necrosis factor-alpha-induced protein 3;NotRelevant;;Autoinflammatory syndrome, familial, Behcet-like, 616744 (3), Autosomal dominantAutoinflammatory syndrome, familial, Behcet-like, 616744 (3);chr6;TNFAIP3, A20, OTUD7C, AISBL;True
ENSG00000135597;RALBP1-associated EPS domain-containing protein 1;NotRelevant;mutation identified in 1 NBIA7 family;?Neurodegeneration with brain iron accumulation 7, 617916 (3), Autosomal recessive?Neurodegeneration with brain iron accumulation 7, 617916 (3);chr6;REPS1, NBIA7;True
ENSG00000164442;CBP/p300-interacting transactivator, with glu/asp-rich C-terminal domain, 2;NotRelevant;?pseudogene on 1q22;Atrial septal defect 8, 614433 (3), Autosomal dominantVentricular septal defect 2, 614431 (3);chr6;CITED2, MRG1, P35SRJ, VSD2, ASD8;True
ENSG00000112414;Adhesion G protein-coupled receptor G6;NotRelevant;;Lethal congenital contracture syndrome 9, 616503 (3), Autosomal recessiveLethal congenital contracture syndrome 9, 616503 (3);chr6;ADGRG6, PR126, VIGR, LCCS9;True
ENSG00000010818;Human immunodeficiency virus type I enhancer-binding protein-2;NotRelevant;;Mental retardation, autosomal dominant 43, 616977 (3), Autosomal dominantMental retardation, autosomal dominant 43, 616977 (3);chr6;HIVEP2, MRD43;True
ENSG00000034693;Peroxisomal biogenesis factor-3;NotRelevant;mutation identified in 1 PBD10B patient;Peroxisome biogenesis disorder 10A (Zellweger), 614882 (3), Autosomal recessivePeroxisome biogenesis disorder 10A (Zellweger), 614882 (3);chr6;PEX3, PBD10A, PBD10B;True
ENSG00000118495;Pleomorphic adenoma gene-like 1 (ZAC tumor suppressor);NotRelevant;relaxed imprinting in TNDM;{Diabetes mellitus, transient neonatal}, 601410 (1){Diabetes mellitus, transient neonatal}, 601410 (1);chr6;PLAGL1, ZAC, LOT1;False
ENSG00000135604;Syntaxin-11;NotRelevant;;Hemophagocytic lymphohistiocytosis, familial, 4, 603552 (3), Autosomal recessiveHemophagocytic lymphohistiocytosis, familial, 4, 603552 (3);chr6;STX11, FHL4, HPLH4, HLH4;True
ENSG00000112425;Laforin;NotRelevant;;Epilepsy, progressive myoclonic 2A (Lafora), 254780 (3), Autosomal recessiveEpilepsy, progressive myoclonic 2A (Lafora), 254780 (3);chr6;EPM2A, MELF, EPM2;True
ENSG00000152822;Glutamate receptor, metabotropic, 1;NotRelevant;;Spinocerebellar ataxia 44, 617691 (3), Autosomal dominantSpinocerebellar ataxia, autosomal recessive 13, 614831 (3);chr6;GRM1, MGLUR1, GRM1A, SCAR13, SCA44;True
ENSG00000055208;Tak1 (MAP3K7) binding protein 2;NotRelevant;;Congenital heart defects, nonsyndromic, 2, 614980 (3), Autosomal dominantCongenital heart defects, nonsyndromic, 2, 614980 (3);chr6;TAB2, MAP3K7IP2, KIAA0733, CHTD2;True
ENSG00000177688;Small ubiquitin-like modifier 4;NotRelevant;;{Diabetes mellitus, insulin-dependent, 5}, 600320 (3){Diabetes mellitus, insulin-dependent, 5}, 600320 (3);chr6;SUMO4, IDDM5;False
ENSG00000009765;Iodotyrosine deiodinase;NotRelevant;;Thyroid dyshormonogenesis 4, 274800 (3), Autosomal recessiveThyroid dyshormonogenesis 4, 274800 (3);chr6;IYD, DEHAL1, TDH4;True
ENSG00000155906;Required for meiotic nuclear division 1, S. cerevisiae, homolog of;NotRelevant;;Combined oxidative phosphorylation deficiency 11, 614922 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 11, 614922 (3);chr6;RMND1, COXPD11;True
ENSG00000091831;Estrogen receptor 1;NotRelevant;;{Atherosclerosis, susceptibility to} (3){Myocardial infarction, susceptibility to}, 608446 (3);chr6;ESR1, ESR, ESTRR;False
ENSG00000131018;Spectrin repeat-containing nuclear envelope protein 1 (nesprin 1);NotRelevant;;Emery-Dreifuss muscular dystrophy 4, autosomal dominant, 612998 (3), Autosomal dominantSpinocerebellar ataxia, autosomal recessive 8, 610743 (3);chr6;SYNE1, KIAA0796, KIAA1756, KIAA1262, SCAR8, EDMD4;True
ENSG00000049618;AT-rich interaction domain-containing protein 1B;NotRelevant;;Coffin-Siris syndrome 1, 135900 (3), Autosomal dominantCoffin-Siris syndrome 1, 135900 (3);chr6;ARID1B, BAF250B, KIAA1235, MRD12, CSS1;True
ENSG00000122335;Serine active site-containing protein 1;NotRelevant;;3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3), Autosomal recessive3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome, 614739 (3);chr6;SERAC1, MEGDEL;True
ENSG00000272047;General transcription factor IIH, polypeptide 5;NotRelevant;;Trichothiodystrophy 3, photosensitive, 616395 (3)Trichothiodystrophy 3, photosensitive, 616395 (3);chr6;GTF2H5, TTD3, TFB5, C6orf175, TTDA;False
ENSG00000130363;Radial spoke head 3, Chlamydomonas, homolog of;NotRelevant;;Ciliary dyskinesia, primary, 32, 616481 (3), Autosomal recessiveCiliary dyskinesia, primary, 32, 616481 (3);chr6;RSPH3, RSHL2, RSP3, CILD32;True
ENSG00000112096;Superoxide dismutase-2, mitochondrial;NotRelevant;;{Microvascular complications of diabetes 6}, 612634 (3){Microvascular complications of diabetes 6}, 612634 (3);chr6;SOD2, MNSOD, MVCD6;False
ENSG00000120437;Acetyl-Coenzyme A acetyltransferase 2 (acetoacetyl Coenzyme A thiolase);NotRelevant;encoded on strand opposite TCP1;?ACAT2 deficiency, 614055 (1), Isolated cases?ACAT2 deficiency, 614055 (1);chr6;ACAT2;False
ENSG00000120438;T-complex locus TCP-1;NotRelevant;tightly linked to PLG; ~15cM proximal to TCP10;chr6;TCP1;False
ENSG00000197081;Insulin-like growth factor-2 receptor (mannose-6-phosphate receptor, cation-independent);NotRelevant;behaves as a tumor suppressor;Hepatocellular carcinoma, somatic, 114550 (3)Hepatocellular carcinoma, somatic, 114550 (3);chr6;IGF2R, MPRI;False
ENSG00000198670;Apolipoprotein Lp(a);NotRelevant;absent in mice;{Coronary artery disease, susceptibility to} (1){Coronary artery disease, susceptibility to} (1);chr6;LPA;False
ENSG00000122194;Plasminogen;NotRelevant;20cM from TCP10A;Dysplasminogenemia, 217090 (3), Autosomal recessivePlasminogen deficiency, type I, 217090 (3);chr6;PLG;True
ENSG00000185345;Parkin;NotRelevant;shares 5' regulatory region and both 3' UTRs with PACRG;Adenocarcinoma of lung, somatic, 211980 (3){Leprosy, susceptibility to}, 607572 (3);chr6;PRKN, PARK2, PDJ, LPRS2;False
ENSG00000112541;Phosphodiesterase 10A;NotRelevant;;Dyskinesia, limb and orofacial, infantile-onset, 616921 (3), Autosomal recessiveStriatal degeneration, autosomal dominant, 616922 (3);chr6;PDE10A, IOLOD, ADSD2;True
ENSG00000164458;Brachyury, mouse, homolog of;NotRelevant;;{Neural tube defects, susceptibility to}, 182940 (3), Autosomal dominant{Neural tube defects, susceptibility to}, 182940 (3);chr6;T, TFT, SAVA;True
ENSG00000060762;Brain protein 44-like;NotRelevant;;Mitochondrial pyruvate carrier deficiency, 614741 (3), Autosomal recessiveMitochondrial pyruvate carrier deficiency, 614741 (3);chr6;BRP44L, MPC1, MPYCD;True
ENSG00000026297;Ribonuclease T2;NotRelevant;;Leukoencephalopathy, cystic, without megalencephaly, 612951 (3), Autosomal recessiveLeukoencephalopathy, cystic, without megalencephaly, 612951 (3);chr6;RNASET2, RNASE6PL;True
ENSG00000213066;Fibroblast growth factor receptor-1 oncogene partner;NotRelevant;fusion gene with ZNF198, CEP1, and FGFR1;Myeloproliferative disorder, 605392 (2)Myeloproliferative disorder (2);chr6;FGFR1OP, FOP;False
ENSG00000112562;Secreted modular calcium-binding protein 2;NotRelevant;;Dentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3), Autosomal recessiveDentin dysplasia, type I, with microdontia and misshapen teeth, 125400 (3);chr6;SMOC2, SMAP2, DTDP1;True
ENSG00000186340;Thrombospondin 2;NotRelevant;;{Lumbar disc herniation, susceptibility to}, 603932 (3){Lumbar disc herniation, susceptibility to}, 603932 (3);chr6;THBS2;False
ENSG00000130023;Endoplasmic reticulum membrane-associated RNA degradation protein;NotRelevant;;?Periventricular nodular heterotopia 6, 615544 (3), Autosomal dominant?Periventricular nodular heterotopia 6, 615544 (3);chr6;ERMARD, C6orf70, PVNH6;True
ENSG00000112592;TATA box binding protein;NotRelevant;;{Parkinson disease, susceptibility to}, 168600 (3), Isolated cases, Multifactorial{Parkinson disease, susceptibility to}, 168600 (3);chr6;TBP, SCA17, HDL4;False
ENSG00000177706;Family with sequence similarity 20, member C;NotRelevant;;Raine syndrome, 259775 (3), Autosomal recessiveRaine syndrome, 259775 (3);chr7;FAM20C, DMP4;True
ENSG00000164818;Dynein axonemal assembly factor 5;NotRelevant;;Ciliary dyskinesia, primary, 18, 614874 (3), Autosomal recessiveCiliary dyskinesia, primary, 18, 614874 (3);chr7;DNAAF5, HEATR2, CILD18;True
ENSG00000002822;Mitotic arrest-deficient 1, yeast, homolog-like 1;NotRelevant;;Lymphoma, somatic (3)Prostate cancer, somatic, 176807 (3);chr7;MAD1L1, TXBP181;False
ENSG00000106003;Lunatic fringe;NotRelevant;mutation identified in 1 SDO3 family;?Spondylocostal dysostosis 3, autosomal recessive, 609813 (3)?Spondylocostal dysostosis 3, autosomal recessive, 609813 (3);chr7;LFNG, SCDO3;True
ENSG00000106009;BRCA1-associated ATM activator 1;NotRelevant;;Neurodevelopmental disorder with cerebellar atrophy and with or without seizures, 618056 (3), Autosomal recessiveRigidity and multifocal seizure syndrome, lethal neonatal, 614498 (3);chr7;BRAT1, BAAT1, C7orf27, RMFSL, NEDCAS;True
ENSG00000106012;IQ domain-containing protein E;NotRelevant;mutation identified in 1 PAPA7 family;?Polydactyly, postaxial, type A7, 617642 (3), Autosomal recessive?Polydactyly, postaxial, type A7, 617642 (3);chr7;IQCE, KIAA1023, PAPA7;True
ENSG00000198286;Caspase recruitment domain-containing protein 11;NotRelevant;;B-cell expansion with NFKB and T-cell anergy, 616452 (3), Autosomal dominantImmunodeficiency 11B with atopic dermatitis, 617638 (3);chr7;CARD11, CARMA1, BIMP3, PPBL, BENTA, IMD11A;True
ENSG00000242802;Adaptor-related protein complex 5, zeta-1 subunit;NotRelevant;;Spastic paraplegia 48, autosomal recessive, 613647 (3), Autosomal recessiveSpastic paraplegia 48, autosomal recessive, 613647 (3);chr7;AP5Z1, KIAA0415, SPG48;True
ENSG00000075624;Actin, beta;NotRelevant;~20 pseudogenes also; mutation identified in twin DJO patientsBaraitser-Winter syndrome 1, 243310 (3);chr7;ACTB, BRWS1;False
ENSG00000011275;RING finger protein 216;NotRelevant;;Cerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3), Autosomal recessiveCerebellar ataxia and hypogonadotropic hypogonadism, 212840 (3);chr7;RNF216, TRIAD3, ZIN, CAHH;True
ENSG00000122512;Postmeiotic segregation increased, S. cerevisiae, 2, homolog of;NotRelevant;;Colorectal cancer, hereditary nonpolyposis, type 4, 614337 (3)Mismatch repair cancer syndrome, 276300 (3);chr7;PMS2, PMSL2, HNPCC4;False
ENSG00000106305;Aminoacyl tRNA synthetase complex-interacting multifunctional protein 2;NotRelevant;;Leukodystrophy, hypomyelinating, 17, 618006 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 17, 618006 (3);chr7;AIMP2, JTV1, HLD17;True
ENSG00000136238;Ras-related C3 botulinum toxin substrate 1;NotRelevant;;Mental retardation, autosomal dominant 48, 617751 (3), Autosomal dominantMental retardation, autosomal dominant 48, 617751 (3);chr7;RAC1, MRD48;True
ENSG00000106415;Glucocorticoid-induced transcript 1;NotRelevant;;{Glucocorticoid therapy, response to}, 614400 (3){Glucocorticoid therapy, response to}, 614400 (3);chr7;GLCCI1, TSSN1, GCTR;False
ENSG00000106460;Transmembrane protein 106B;NotRelevant;;Leukodystrophy, hypomyelinating, 16, 617964 (3), Autosomal dominantLeukodystrophy, hypomyelinating, 16, 617964 (3);chr7;TMEM106B, HLD16;True
ENSG00000214960;Isoprenoid synthase domain-containing protein;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 7, 614643 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle), type C, 7, 616052 (3);chr7;ISPD, MDDGA7, MDDGC7, LGMDR20;True
ENSG00000122691;TWIST, Drosophila, homolog of, 1;NotRelevant;;Craniosynostosis 1, 123100 (3), Autosomal dominantSweeney-Cox syndrome, 617746 (3);chr7;TWIST1, ACS3, SCS, CRS1, SWCOS;True
ENSG00000105877;Dynein, axonemal, heavy chain-11;NotRelevant;;Ciliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3), Autosomal recessiveCiliary dyskinesia, primary, 7, with or without situs inversus, 611884 (3);chr7;DNAH11, DNAHC11, CILD7, DNAHBL;True
ENSG00000136244;Interleukin-6 (interferon, beta-2);NotRelevant;;{Crohn disease-associated growth failure}, 266600 (3), Multifactorial{Rheumatoid arthritis, systemic juvenile}, 604302 (3);chr7;IL6, IFNB2, BSF2, HSF, HGF;False
ENSG00000122591;Hyccin;NotRelevant;;Leukodystrophy, hypomyelinating, 5, 610532 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 5, 610532 (3);chr7;FAM126A, DRCTNNB1A, HLD5;True
ENSG00000122550;Kelch-like 7;NotRelevant;;Cold-induced sweating syndrome 3, 617055 (3), Autosomal recessiveRetinitis pigmentosa 42, 612943 (3);chr7;KLHL7, RP42, CISS3;True
ENSG00000136235;Glycoprotein NMB;NotRelevant;;Amyloidosis, primary localized cutaneous, 3, 617920 (3), Autosomal recessiveAmyloidosis, primary localized cutaneous, 3, 617920 (3);chr7;GPNMB, PLCA3;True
ENSG00000105928;Gasdermin E;NotRelevant;;Deafness, autosomal dominant 5, 600994 (3), Autosomal dominantDeafness, autosomal dominant 5, 600994 (3);chr7;GSDME, DFNA5;True
ENSG00000172115;Cytochrome C, somatic;NotRelevant;;Thrombocytopenia 4, 612004 (3), Autosomal dominantThrombocytopenia 4, 612004 (3);chr7;CYCS, CYC, THC4;True
ENSG00000122566;Heterogeneous nuclear ribonucleoprotein A2/B1;NotRelevant;mutation identified in 1 family;?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3)?Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2, 615422 (3);chr7;HNRPA2B1, IBMPFD2;False
ENSG00000086300;Sorting nexin 10;NotRelevant;;Osteopetrosis, autosomal recessive 8, 615085 (3), Autosomal recessiveOsteopetrosis, autosomal recessive 8, 615085 (3);chr7;SNX10, OPTB8;True
ENSG00000105991;Homeo box-A1;NotRelevant;;Athabaskan brainstem dysgenesis syndrome, 601536 (3)Bosley-Salih-Alorainy syndrome, 601536 (3);chr7;HOXA1, HOX1F, BSAS;False
ENSG00000105996;Homeobox A2;NotRelevant;mutation identified in 1 MCOHICP family;Microtia with or without hearing impairment (AD), 612290 (3), Autosomal recessive, Autosomal dominantMicrotia with or without hearing impairment (AD), 612290 (3);chr7;HOXA2, MCOHI;True
ENSG00000078399;Homeo box-A9;NotRelevant;homolog of Drosophila Abd-B; fused to NUP98 in myeloid leukemia;chr7;HOXA9, HOX1G;False
ENSG00000005073;Homeo box-A11;NotRelevant;;Radioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3), Autosomal dominantRadioulnar synostosis with amegakaryocytic thrombocytopenia 1, 605432 (3);chr7;HOXA11, HOX1I, RUSAT1;True
ENSG00000106031;Homeo box-A13;NotRelevant;;Guttmacher syndrome, 176305 (3), Autosomal dominantHand-foot-uterus syndrome, 140000 (3);chr7;HOXA13, HOX1J;True
ENSG00000106080;FK506-binding protein 14;NotRelevant;;Ehlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3), Autosomal recessiveEhlers-Danlos syndrome, kyphoscoliotic type, 2, 614557 (3);chr7;FKBP14, EDSKSCL2;True
ENSG00000106105;Glycyl-tRNA synthetase;NotRelevant;;Charcot-Marie-Tooth disease, type 2D, 601472 (3), Autosomal dominantNeuropathy, distal hereditary motor, type VA, 600794 (3);chr7;GARS, SMAD1, CMT2D, HMN5;True
ENSG00000240583;Aquaporin-1 (channel-forming integral protein, 28kD);NotRelevant;;[Aquaporin-1 deficiency], 110450 (3)[Blood group, Colton], 110450 (3);chr7;AQP1, CHIP28, CO;False
ENSG00000106128;Growth hormone releasing hormone receptor;NotRelevant;;Growth hormone deficiency, isolated, type IV, 618157 (3)Growth hormone deficiency, isolated, type IV, 618157 (3);chr7;GHRHR, GHRFR, IGHD4;False
ENSG00000154678;Phosphodiesterase 1C;NotRelevant;mutation identified in 1 DFNA74 family;?Deafness, autosomal dominant 74, 618140 (3), Autosomal dominant?Deafness, autosomal dominant 74, 618140 (3);chr7;PDE1C, HCAM3, DFNA74;True
ENSG00000106341;G-substrate;NotRelevant;;{Hypercholesterolemia, susceptibility to}, 143890 (3), Autosomal dominant{Hypercholesterolemia, susceptibility to}, 143890 (3);chr7;GSBS;True
ENSG00000122643;5' nucleotidase, cytosolic IIIA (uridine 5' monophosphate hydrolase 1);NotRelevant;pseudogenes on chr.4 and chr.7;Anemia, hemolytic, due to UMPH1 deficiency, 266120 (3), Autosomal recessiveAnemia, hemolytic, due to UMPH1 deficiency, 266120 (3);chr7;NT5C3A, NT5C3, UMPH1, PSN1;True
ENSG00000164610;RP9 gene (pim1-associated protein, mouse, homolog of);NotRelevant;mutation identified in 1 patient;?Retinitis pigmentosa 9, 180104 (3), Autosomal dominant?Retinitis pigmentosa 9, 180104 (3);chr7;RP9, PAP1;True
ENSG00000122507;Parathyroid hormone-responsive B1 gene;NotRelevant;;Bardet-Biedl syndrome 9, 615986 (3), Autosomal recessiveBardet-Biedl syndrome 9, 615986 (3);chr7;PTHB1, BBS9;True
ENSG00000164619;BMP binding endothelial regulator;NotRelevant;;Diaphanospondylodysostosis, 608022 (3), Autosomal recessiveDiaphanospondylodysostosis, 608022 (3);chr7;BMPER, CV2;True
ENSG00000187258;Neuropeptide S receptor 1;NotRelevant;;{Asthma, susceptibility to, 2}, 608584 (3){Asthma, susceptibility to, 2}, 608584 (3);chr7;NPSR1, GPR154, GPRA, VRR1, PGR14, ASRT2;False
ENSG00000164532;T-box 20;NotRelevant;;Atrial septal defect 4, 611363 (3)Atrial septal defect 4, 611363 (3);chr7;TBX20, ASD4;False
ENSG00000011426;Actin-binding protein anillin;NotRelevant;;Focal segmental glomerulosclerosis 8, 616032 (3), Autosomal dominantFocal segmental glomerulosclerosis 8, 616032 (3);chr7;ANLN, FSFS8;True
ENSG00000086288;NME/NM23 family member 8;NotRelevant;;Ciliary dyskinesia, primary, 6, 610852 (3), Autosomal recessiveCiliary dyskinesia, primary, 6, 610852 (3);chr7;NME8, TXNDC3, SPTRX2, CILD6;True
ENSG00000106483;Secreted frizzled-related protein 4;NotRelevant;;Pyle disease, 265900 (3), Autosomal recessivePyle disease, 265900 (3);chr7;SFRP4, FRPHE, PYL;True
ENSG00000106536;POU domain, class 6, transcription factor 2;NotRelevant;;{Wilms tumor susceptibility-5}, 601583 (3), Autosomal dominant, Somatic mutation{Wilms tumor susceptibility-5}, 601583 (3);chr7;POU6F2, WTSL, WT5;True
ENSG00000065883;Cyclin-dependent kinase 13;NotRelevant;;Congenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3), Autosomal dominantCongenital heart defects, dysmorphic facial features, and intellectual developmental disorder, 617360 (3);chr7;CDK13, CDC2L5, CHED, CHDFIDD;True
ENSG00000168303;M-phase specific PLK1 interacting protein;NotRelevant;;Trichothiodystrophy 4, nonphotosensitive, 234050 (3), Autosomal recessiveTrichothiodystrophy 4, nonphotosensitive, 234050 (3);chr7;MPLKIP, C7orf11, ABHS, TTDN1, TTD4;True
ENSG00000175600;Chromosome 7 open reading frame 10;NotRelevant;;Glutaric aciduria III, 231690 (3), Autosomal recessiveGlutaric aciduria III, 231690 (3);chr7;C7orf10, GA3;True
ENSG00000106571;GLI-Kruppel family member GLI3 (oncogene GLI3);NotRelevant;amplified in glioblastoma;Greig cephalopolysyndactyly syndrome, 175700 (3), Autosomal dominant{Hypothalamic hamartomas, somatic}, 241800 (3);chr7;GLI3, PAPA, PAPB;True
ENSG00000106605;Biliverdin reductase A;NotRelevant;;Hyperbiliverdinemia, 614156 (3), Autosomal recessive, Autosomal dominantHyperbiliverdinemia, 614156 (3);chr7;BLVRA;True
ENSG00000164708;Phosphoglycerate mutase, muscle form;NotRelevant;;Glycogen storage disease X, 261670 (3), Autosomal recessiveGlycogen storage disease X, 261670 (3);chr7;PGAM2, PGAMM, GSD10;True
ENSG00000106624;AE-binding protein 1;NotRelevant;;Ehlers-Danlos syndrome, classic-like, 2, 618000 (3), Autosomal recessiveEhlers-Danlos syndrome, classic-like, 2, 618000 (3);chr7;AEBP1, ACLP;True
ENSG00000106633;Glucokinase (hexokinase-4);NotRelevant;proximal to TCRB;Diabetes mellitus, noninsulin-dependent, late onset, 125853 (3), Autosomal dominantMODY, type II, 125851 (3);chr7;GCK, HHF3;True
ENSG00000058404;Calcium/calmodulin-dependent protein kinase II-beta;NotRelevant;;Mental retardation, autosomal dominant 54, 617799 (3), Autosomal dominantMental retardation, autosomal dominant 54, 617799 (3);chr7;CAMK2B, MRD54;True
ENSG00000015520;NPC1-like 1;NotRelevant;;[Ezetimibe, nonresponse to], 617966 (3)[Low density lipoprotein cholesterol level QTL 7], 617966 (3);chr7;NPC1L1, LDLCQ7;False
ENSG00000105953;Oxoglutarate dehydrogenase, lipoamide (alpha-ketoglutarate dehydrogenase);NotRelevant;;Alpha-ketoglutarate dehydrogenase deficiency, 203740 (1), Autosomal recessiveAlpha-ketoglutarate dehydrogenase deficiency, 203740 (1);chr7;OGDH;True
ENSG00000136280;Malcavernin;NotRelevant;;Cerebral cavernous malformations-2, 603284 (3), Autosomal dominantCerebral cavernous malformations-2, 603284 (3);chr7;C7orf22, CCM2, MGC4067;True
ENSG00000164742;Adenylate cyclase-1, brain;NotRelevant;mutation identified in 1 DFNB44 family;?Deafness, autosomal recessive 44, 610154 (3), Autosomal recessive?Deafness, autosomal recessive 44, 610154 (3);chr7;ADCY1, DFNB44;True
ENSG00000158683;Polycystin 1L1;NotRelevant;;Heterotaxy, visceral, 8, autosomal, 617205 (3), Autosomal recessiveHeterotaxy, visceral, 8, autosomal, 617205 (3);chr7;PKD1L1, HTX8;True
ENSG00000185811;Ikaros family zinc finger 1;NotRelevant;fused with BCL6 in DLBL;Immunodeficiency, common variable, 13, 616873 (3), Autosomal dominantImmunodeficiency, common variable, 13, 616873 (3);chr7;IKZF1, ZNFN1A1, IK1, LYF1, CVID13;True
ENSG00000132437;DOPA decarboxylase (aromatic L-amino acid decarboxylase);NotRelevant;;Aromatic L-amino acid decarboxylase deficiency, 608643 (3), Autosomal recessiveAromatic L-amino acid decarboxylase deficiency, 608643 (3);chr7;DDC;True
ENSG00000146648;Epidermal growth factor receptor;NotRelevant;same as oncogene ERBB; mutation identified in 1 NISBD2 family{Nonsmall cell lung cancer, susceptibility to}, 211980 (3);chr7;EGFR, NISBD2;False
ENSG00000146733;Phosphoserine phosphatase;NotRelevant;;Phosphoserine phosphatase deficiency, 614023 (3), Autosomal recessivePhosphoserine phosphatase deficiency, 614023 (3);chr7;PSPH, PSP, PSPHD;True
ENSG00000106153;Coiled-coil-helix-coiled-coil-helix domain-containing protein 2;NotRelevant;;Parkinson disease 22, autosomal dominant, 616710 (3), Autosomal dominantParkinson disease 22, autosomal dominant, 616710 (3);chr7;CHCHD2, PARK22;True
ENSG00000169919;Glucuronidase, beta-;NotRelevant;;Mucopolysaccharidosis VII, 253220 (3), Autosomal recessiveMucopolysaccharidosis VII, 253220 (3);chr7;GUSB, MPS7;True
ENSG00000126522;Argininosuccinate lyase;NotRelevant;;Argininosuccinic aciduria, 207900 (3), Autosomal recessiveArgininosuccinic aciduria, 207900 (3);chr7;ASL;True
ENSG00000243335;Potassium channel tetramerization domain containing 7;NotRelevant;;Epilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3), Autosomal recessiveEpilepsy, progressive myoclonic 3, with or without intracellular inclusions, 611726 (3);chr7;KCTD7, EPM3, CLN14;True
ENSG00000126524;SBDS gene;NotRelevant;;{Aplastic anemia, susceptibility to}, 609135 (3){Aplastic anemia, susceptibility to}, 609135 (3);chr7;SBDS, SDS;False
ENSG00000158321;KIAA0442 gene;NotRelevant;translocation break at 7q11.2;Mental retardation, autosomal dominant 26, 615834 (3), Autosomal dominantMental retardation, autosomal dominant 26, 615834 (3);chr7;KIAA0442, MRD26;True
ENSG00000049540;Elastin;NotRelevant;;Cutis laxa, autosomal dominant, 123700 (3), Autosomal dominantSupravalvar aortic stenosis, 185500 (3);chr7;ELN, SVAS, ADCL1;True
ENSG00000158517;Neutrophil cytosolic factor-1, 47kD;NotRelevant;;Chronic granulomatous disease due to deficiency of NCF-1, 233700 (3), Autosomal recessiveChronic granulomatous disease due to deficiency of NCF-1, 233700 (3);chr7;NCF1;True
ENSG00000127946;Huntingtin interacting protein-1;NotRelevant;;{Prostate cancer, progression of}, 176807 (1), Autosomal dominant{Prostate cancer, progression of}, 176807 (1);chr7;HIP1;True
ENSG00000127948;Cytochrome P450 oxidoreductase;NotRelevant;;Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis, 201750 (3), Autosomal recessiveDisordered steroidogenesis due to cytochrome P450 oxidoreductase, 613571 (3);chr7;POR;True
ENSG00000146701;Malate dehydrogenase, mitochondrial;NotRelevant;;Epileptic encephalopathy, early infantile, 51, 617339 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 51, 617339 (3);chr7;MDH2, EIEE51;True
ENSG00000106211;Heat-shock 27kD protein-1;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2F, 606595 (3), Autosomal dominantNeuropathy, distal hereditary motor, type IIB, 608634 (3);chr7;HSPB1, HSP27, CMT2F, HMN2B;True
ENSG00000170027;Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma isoform;NotRelevant;;Epileptic encephalopathy, early infantile, 56, 617665 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 56, 617665 (3);chr7;YWHAG, EIEE56;True
ENSG00000188372;Zona pellucida glycoprotein-3 (sperm receptor);NotRelevant;;Oocyte maturation defect 3, 617712 (3), Autosomal dominantOocyte maturation defect 3, 617712 (3);chr7;ZP3, ZP3A, ZP3B, OOMD3;True
ENSG00000127947;Protein tyrosine phosphatase, nonreceptor-type, 12;NotRelevant;;Colon cancer, somatic, 114500 (3)Colon cancer, somatic, 114500 (3);chr7;PTPN12, PTPG1;False
ENSG00000187391;Membrane-associated guanylate kinase, WW and PDZ domains-containing, 2;NotRelevant;;Nephrotic syndrome, type 15, 617609 (3), Autosomal recessiveNephrotic syndrome, type 15, 617609 (3);chr7;MAGI2, AIP1, KIAA0705, NPHS15;True
ENSG00000135218;CD36 antigen (collagen type I);NotRelevant;;{Coronary heart disease, susceptibility to, 7}, 610938 (3){Malaria, cerebral, susceptibility to}, 611162 (3);chr7;CD36, CHDS7, BDPLT10;False
ENSG00000019991;Hepatic growth factor;NotRelevant;;Deafness, autosomal recessive 39, 608265 (3), Autosomal recessiveDeafness, autosomal recessive 39, 608265 (3);chr7;HGF, DFNB39;True
ENSG00000186472;Piccolo, mouse, homolog of;NotRelevant;mutation identified in 1 PCHD3 family;?Pontocerebellar hypoplasia, type 3, 608027 (3), Autosomal recessive?Pontocerebellar hypoplasia, type 3, 608027 (3);chr7;PCLO, PCH3;True
ENSG00000170381;Semaphorin 3E;NotRelevant;mutation identified in 1 CHARGE patient;?CHARGE syndrome, 214800 (3), Autosomal dominant?CHARGE syndrome, 214800 (3);chr7;SEMA3E, SEMAH, KIAA0331;True
ENSG00000075213;Semaphorin 3A;NotRelevant;;{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3), Autosomal dominant{Hypogonadotropic hypogonadism 16 with or without anosmia}, 614897 (3);chr7;SEMA3A, SEMAD, COLL1, HH16;True
ENSG00000005471;ATP-binding cassette, subfamily B, member 4 (P-glycoprotein-3/multiple drug resistance-3);NotRelevant;within 500kb of MDR1;Cholestasis, intrahepatic, of pregnancy, 3, 614972 (3), Autosomal recessive, Autosomal dominantGallbladder disease 1, 600803 (3);chr7;ABCB4, PGY3, MDR3, ICP3;True
ENSG00000085563;ATP-binding cassette, subfamily B, member 1 (P-glycoprotein-1/multiple drug resistance-1);NotRelevant;;{Colchicine resistance}, 120080 (3){Inflammatory bowel disease 13}, 612244 (3);chr7;ABCB1, PGY1, MDR1, IBD13, CLCs;False
ENSG00000008277;A disintegrin and metalloproteinase domain 22;NotRelevant;mutation identified in 1 EIEE61 patient;?Epileptic encephalopathy, early infantile, 61, 617933 (3), Autosomal recessive?Epileptic encephalopathy, early infantile, 61, 617933 (3);chr7;ADAM22, EIEE61;True
ENSG00000105792;Cilia- and flagella-associated protein 69;NotRelevant;;Spermatogenic failure 24, 617959 (3), Autosomal recessiveSpermatogenic failure 24, 617959 (3);chr7;CFAP69, C7orf63, SPGF24;True
ENSG00000127914;A-kinase anchor protein 9;NotRelevant;mutation identified in 1 LQT11 family;?Long QT syndrome-11, 611820 (3), Autosomal dominant?Long QT syndrome-11, 611820 (3);chr7;AKAP9, YOTIAO, AKAP450;True
ENSG00000001631;KREV interaction trapped 1;NotRelevant;;Cavernous malformations of CNS and retina, 116860 (3), Autosomal dominantHyperkeratotic cutaneous capillary-venous malformations associated with cerebral capillary malformations, 116860 (3);chr7;CCM1, CAM, KRIT1;True
ENSG00000157259;GATA zinc finger domain-containing protein 1;NotRelevant;mutation identified in 1 GATAD1 family;?Cardiomyopathy, dilated, 2B, 614672 (3), Autosomal recessive?Cardiomyopathy, dilated, 2B, 614672 (3);chr7;GATAD1, ODAG, CMD2B;True
ENSG00000127980;Peroxisome biogenesis factor-1;NotRelevant;;Heimler syndrome 1, 234580 (3), Autosomal recessivePeroxisome biogenesis disorder 1B (NALD/IRD), 601539 (3);chr7;PEX1, ZWS1, PBD1A, PBD1B, HMLR1;True
ENSG00000105810;Cyclin-dependent kinase 6;NotRelevant;mutation identified in 1 MCPH12 family;?Microcephaly 12, primary, autosomal recessive, 616080 (3), Autosomal recessive?Microcephaly 12, primary, autosomal recessive, 616080 (3);chr7;CDK6, PLSTIRE, MCPH12;True
ENSG00000205413;Sterile alpha motif domain-containing protein 9;NotRelevant;;MIRAGE syndrome, 617053 (3), Autosomal dominantTumoral calcinosis, familial, normophosphatemic, 610455 (3);chr7;SAMD9, NFTC, MIRAGE;True
ENSG00000177409;Sterile alpha motif domain-containing 9-like;NotRelevant;;Ataxia-pancytopenia syndrome, 159550 (3), Autosomal dominantAtaxia-pancytopenia syndrome, 159550 (3);chr7;SAMD9L, ATXPC;True
ENSG00000004948;Calcitonin receptor;NotRelevant;not deleted in Williams syndrome;{Osteoporosis, postmenopausal, susceptibility}, 166710 (3), Autosomal dominant{Osteoporosis, postmenopausal, susceptibility}, 166710 (3);chr7;CALCR, CRT;True
ENSG00000164692;Collagen I, alpha-2 polypeptide;NotRelevant;~17cM from CF;Ehlers-Danlos syndrome, arthrochalasia type, 2, 617821 (3), Autosomal dominant{Osteoporosis, postmenopausal}, 166710 (3);chr7;COL1A2, EDSCV, EDSARTH2;True
ENSG00000127990;Sarcoglycan, epsilon;NotRelevant;pseudogene on 2q21; maternally imprintedDystonia-11, myoclonic, 159900 (3);chr7;SGCE, DYT11;False
ENSG00000005421;Paraoxonase-1;NotRelevant;;{Coronary artery disease, susceptibility to} (3){Organophosphate poisoning, sensitivity to} (3);chr7;PON1, PON, ESA, MVCD5;False
ENSG00000105854;Paraoxonase-2;NotRelevant;;{Coronary artery disease, susceptibility to} (3){Coronary artery disease, susceptibility to} (3);chr7;PON2;False
ENSG00000004864;Solute carrier family 25 (mitochondrial carrier, citrin), member 13;NotRelevant;;Citrullinemia, adult-onset type II, 603471 (3), Autosomal recessiveCitrullinemia, type II, neonatal-onset, 605814 (3);chr7;SLC25A13, CTLN2;True
ENSG00000105880;Distal-less homeo box-5;NotRelevant;mutation identified in 1 family;?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3), Autosomal recessive?Split-hand/foot malformation 1 with sensorineural hearing loss, 220600 (3);chr7;DLX5, SHFM1D;True
ENSG00000006128;Tachykinin 1 (substance K;NotRelevant; neuropeptide gamma; tachykinin 2);chr7;TAC1, TAC2, NKNA;False
ENSG00000070669;Asparagine synthetase;NotRelevant;temperature sensitive G1 mutant;Asparagine synthetase deficiency, 615574 (3), Autosomal recessiveAsparagine synthetase deficiency, 615574 (3);chr7;ASNS, ASNSD;True
ENSG00000130429;Actin-related protein 2/3 complex, subunit 1B;NotRelevant;;Platelet abnormalities with eosinophilia and immune-mediated inflammatory disease, 617718 (3), Autosomal recessivePlatelet abnormalities with eosinophilia and immune-mediated inflammatory disease, 617718 (3);chr7;ARPC1B, ARC41, PLTEID;True
ENSG00000106258;Cytochrome P450, subfamily IIIA, polypeptide 5;NotRelevant;;{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3), Multifactorial{Hypertension, salt-sensitive essential, susceptibility to}, 145500 (3);chr7;CYP3A5, P450PCN3;False
ENSG00000166526;Zinc finger protein-3;NotRelevant;?relation to ZNF4, ZNF5; previous assignment to Chr.5;chr7;ZNF3;False
ENSG00000221838;Adaptor-related protein complex 4, mu-1 subunit;NotRelevant;;Spastic paraplegia 50, autosomal recessive, 612936 (3), Autosomal recessiveSpastic paraplegia 50, autosomal recessive, 612936 (3);chr7;AP4M1, SPG50, CPSQ3;True
ENSG00000106290;TAF6 RNA polymerase II, TATA box-binding protein-associated factor, 80kD;NotRelevant;;Alazami-Yuan syndrome, 617126 (3), Autosomal recessiveAlazami-Yuan syndrome, 617126 (3);chr7;TAF6, TAF2E, TAFII80, ALYUS;True
ENSG00000066923;Stromalin 3;NotRelevant;;Premature ovarian failure 8, 615723 (3), Autosomal recessivePremature ovarian failure 8, 615723 (3);chr7;STAG3, POF8;True
ENSG00000106327;Transferrin receptor 2;NotRelevant;;Hemochromatosis, type 3, 604250 (3), Autosomal recessiveHemochromatosis, type 3, 604250 (3);chr7;TFR2, HFE3;True
ENSG00000130427;Erythropoietin;NotRelevant;mutation identified in 1 DBAL family;?Diamond-Blackfan anemia-like, 617911 (3), Autosomal recessive{Microvascular complications of diabetes 2}, 612623 (3);chr7;EPO, MVCD2, ECYT5, DBAL;True
ENSG00000196411;Ephrin receptor EphB4 (hepatoma transmembrane kinase);NotRelevant;;Capillary malformation-arteriovenous malformation 2, 618196 (3), Autosomal dominantLymphatic malformation 7, 617300 (3);chr7;EPHB4, HTK, MYK1, HFASD, CMAVM2, LMPHM7;True
ENSG00000087085;Acetylcholinesterase (YT blood group);NotRelevant;blood group YT (112100) = epitope of ACHE;[Blood group, Yt system], 112100 (3)[Blood group, Yt system], 112100 (3);chr7;ACHE, YT;False
ENSG00000106366;Plasminogen activator inhibitor, type I;NotRelevant;;Plasminogen activator inhibitor-1 deficiency, 613329 (3), Autosomal recessive, Autosomal dominant{Transcription of plasminogen activator inhibitor, modulator of} (3);chr7;PAI1, PLANH1, SERPINE1;True
ENSG00000106367;Adaptor-related protein complex 1, sigma 1 subunit;NotRelevant;;MEDNIK syndrome, 609313 (3), Autosomal recessiveMEDNIK syndrome, 609313 (3);chr7;AP1S1, CLAPS1, AP19, MEDNIK;True
ENSG00000106397;Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (lysyl hydroxylase 3);NotRelevant;previously assigned to 7q36;Lysyl hydroxylase 3 deficiency, 612394 (3), Autosomal recessiveLysyl hydroxylase 3 deficiency, 612394 (3);chr7;PLOD3, LH3;True
ENSG00000105819;Peptidase, mitochondrial processing, beta;NotRelevant;;Multiple mitochondrial dysfunctions syndrome 6, 617954 (3), Autosomal recessiveMultiple mitochondrial dysfunctions syndrome 6, 617954 (3);chr7;PMPCB, MPPB;True
ENSG00000170615;Solute carrier family 26, member 5;NotRelevant;mutation identified in 1 DFNB61 family;?Deafness, autosomal recessive 61, 613865 (3), Autosomal recessive?Deafness, autosomal recessive 61, 613865 (3);chr7;SLC26A5, PRES, DFNB61;True
ENSG00000189056;Reelin;NotRelevant;;{Epilepsy, familial temporal lobe, 7}, 616436 (3), Autosomal dominant{Epilepsy, familial temporal lobe, 7}, 616436 (3);chr7;RELN, RL, LIS2, ETL7;True
ENSG00000164597;Component of oligomeric golgi complex 5;NotRelevant;;Congenital disorder of glycosylation, type IIi, 613612 (3)Congenital disorder of glycosylation, type IIi, 613612 (3);chr7;COG5, GOLTC1, GTC90, CDG2I;False
ENSG00000091137;Solute carrier family 26 (sulfate transporter), member 4;NotRelevant;some patients have digenic mutations with FOXI1;Deafness, autosomal recessive 4, with enlarged vestibular aqueduct, 600791 (3), Autosomal recessivePendred syndrome, 274600 (3);chr7;SLC26A4, PDS, DFNB4, EVA, TDH2B;True
ENSG00000091138;Solute carrier family 26 (sulfate transporter), member 3;NotRelevant;5' and close to PDS;Diarrhea 1, secretory chloride, congenital, 214700 (3), Autosomal recessiveDiarrhea 1, secretory chloride, congenital, 214700 (3);chr7;SLC26A3, DRA, CLD;True
ENSG00000091140;Dihydrolipoamide dehydrogenase (E3 component of pyruvate dehydrogenase complex, 2-oxo-glutarate complex);NotRelevant;;Dihydrolipoamide dehydrogenase deficiency, 246900 (3), Autosomal recessiveDihydrolipoamide dehydrogenase deficiency, 246900 (3);chr7;DLD, LAD, PHE3, DLDD;True
ENSG00000091136;Laminin, beta-1;NotRelevant;;Lissencephaly 5, 615191 (3), Autosomal recessiveLissencephaly 5, 615191 (3);chr7;LAMB1, LIS5;True
ENSG00000135241;Patatin-like phospholipase domain-containing protein 8;NotRelevant;mutation identified in 1 MMLA family;?Mitochondrial myopathy with lactic acidosis, 251950 (3), Autosomal recessive?Mitochondrial myopathy with lactic acidosis, 251950 (3);chr7;PNPLA8, MMLA;True
ENSG00000154415;Protein phosphatase 1, regulatory subunit 3A;NotRelevant;;Insulin resistance, severe, digenic, 125853 (3), Autosomal dominantInsulin resistance, severe, digenic, 125853 (3);chr7;PPP1R3A, PPP1R3;True
ENSG00000128573;Forkhead box P2;NotRelevant;;Speech-language disorder-1, 602081 (3), Autosomal dominantSpeech-language disorder-1, 602081 (3);chr7;FOXP2, SPCH1, TNRC10, CAGH44;True
ENSG00000105974;Caveolin-1;NotRelevant;mutation identified in 1 CGL3 family; mutation identified in 1 LCCNS familyPulmonary hypertension, primary, 3, 615343 (3);chr7;CAV1, BSCL3, CGL3, PPH3, LCCNS;False
ENSG00000105976;Oncogene MET;NotRelevant;mutation identified in 1 DFNB97 family;?Deafness, autosomal recessive 97, 616705 (3), Autosomal recessive{Osteofibrous dysplasia, susceptibility to}, 607278 (3);chr7;MET, DFNB97, OSFD;True
ENSG00000001626;Cystic fibrosis transmembrane conductance regulator (ATP-binding cassette, subfamily C, member 7);NotRelevant;distal and 5' to MET;{Bronchiectasis with or without elevated sweat chloride 1, modifier of}, 211400 (3), Autosomal dominant{Pancreatitis, hereditary}, 167800 (3);chr7;CFTR, ABCC7, CF, MRP7;True
ENSG00000106025;Tetraspanin 12;NotRelevant;;Exudative vitreoretinopathy 5, 613310 (3), Autosomal dominantExudative vitreoretinopathy 5, 613310 (3);chr7;TSPAN12, NET2, EVR5;True
ENSG00000008311;Alpha-aminoadipic semialdehyde synthase;NotRelevant;;Hyperlysinemia, 238700 (3), Autosomal recessiveSaccharopinuria, 268700 (1);chr7;AASS;True
ENSG00000128610;FEZ family zinc finger protein 1;NotRelevant;;Hypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3), Autosomal recessiveHypogonadotropic hypogonadism 22, with or without anosmia, 616030 (3);chr7;FEZF1, FEZ, ZNF312B, HH22;True
ENSG00000128519;Taste receptor type 2, member 16;NotRelevant;;[Beta-glycopyranoside tasting], (3) {Alcohol dependence, susceptibility to}, 617956 (3)[Beta-glycopyranoside tasting], 617956 (3) {Alcohol dependence, susceptibility to}, 103780 (3);chr7;TAS2R16, T2R16, BGLPT;False
ENSG00000128513;Protection of telomeres 1;NotRelevant;;{Glioma susceptibility 9}, 616568 (3), Autosomal dominant{Melanoma, cutaneous malignant, susceptibility to, 10}, 615848 (3);chr7;POT1, CMM10, GLM9;True
ENSG00000106331;Paired box homeotic gene-4;NotRelevant;;{Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3), Autosomal recessive, Autosomal dominant{Diabetes mellitus, ketosis-prone, susceptibility to}, 612227 (3);chr7;PAX4, MODY9, KPD;True
ENSG00000174697;Leptin (murine obesity homolog);NotRelevant;in mouse cen-Cola-2-Met-ob-Cpa-Tcrb-tel;Obesity, morbid, due to leptin deficiency, 614962 (3), Autosomal recessiveObesity, morbid, due to leptin deficiency, 614962 (3);chr7;LEP, OB, LEPD;True
ENSG00000106344;RNA-binding motif protein 28;NotRelevant;mutation identified in 1 ANES family;?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3), Autosomal recessive?Alopecia, neurologic defects, and endocrinopathy syndrome, 612079 (3);chr7;RBM28, ANES;True
ENSG00000106348;Inosine-5'-monophosphate dehydrogenase, type I;NotRelevant;pseudogene on 16p13.13;Leber congenital amaurosis 11, 613837 (3)Retinitis pigmentosa 10, 180105 (3);chr7;IMPDH1, RP10, LCA11;False
ENSG00000128617;Blue cone pigment (opsin 1, short-wave-sensitive);NotRelevant;;Colorblindness, tritan, 190900 (3), Autosomal dominantColorblindness, tritan, 190900 (3);chr7;OPN1SW, BCP, CBT;True
ENSG00000128591;Filamin C (actin-binding protein-280);NotRelevant;;Cardiomyopathy, familial hypertrophic, 26 (3)Myopathy, myofibrillar, 5, 609524 (3);chr7;FLNC, FLN2, ABPA, ABPL, MFM5, MPD4, CMH26, RCM5;False
ENSG00000128604;Interferon regulatory factor 5;NotRelevant;;{Inflammatory bowel disease 14}, 612245 (3){Systemic lupus erythematosus, susceptibility to, 10}, 612251 (3);chr7;IRF5, IBD14, SLEB10;False
ENSG00000064419;Transportin 3;NotRelevant;;Muscular dystrophy, limb-girdle, autosomal dominant 2, 608423 (3), Autosomal dominantMuscular dystrophy, limb-girdle, autosomal dominant 2, 608423 (3);chr7;TNPO3, TRNSR, LGMDD2;True
ENSG00000128602;Smoothened, Drosophila, homolog of;NotRelevant;;Basal cell carcinoma, somatic, 605462 (3)Curry-Jones syndrome, somatic mosaic, 601707 (3);chr7;SMOH, SMO, CRJS;False
ENSG00000199158;Micro RNA 96;NotRelevant;;Deafness, autosomal dominant 50, 613074 (3), Autosomal dominantDeafness, autosomal dominant 50, 613074 (3);chr7;MIR96, MIRN96, DFNA50;True
ENSG00000106477;Centrosomal protein, 41kD;NotRelevant;;Joubert syndrome 15, 614464 (3), Autosomal recessiveJoubert syndrome 15, 614464 (3);chr7;CEP41, TSGA14, JBTS15;True
ENSG00000172331;2,3-bisphosphoglycerate mutase;NotRelevant;;Erythrocytosis due to bisphosphoglycerate mutase deficiency, 222800 (3), Autosomal recessiveErythrocytosis due to bisphosphoglycerate mutase deficiency, 222800 (3);chr7;BPGM;True
ENSG00000155561;Nucleoporin, 205kD;NotRelevant;mutation identified in 1 NPHS13 family;?Nephrotic syndrome, type 13, 616893 (3)?Nephrotic syndrome, type 13, 616893 (3);chr7;NUP205, C7orf14, KIAA0225, NPHS13;False
ENSG00000122787;Bile acid synthesis defect, congenital, 2;NotRelevant;;Bile acid synthesis defect, congenital, 2, 235555 (3), Autosomal recessiveBile acid synthesis defect, congenital, 2, 235555 (3);chr7;AKR1D1, SRD5B1, CBAS2;True
ENSG00000105929;ATPase, H+ transporting, V0 subunit a4;NotRelevant;;Renal tubular acidosis, distal, autosomal recessive, 602722 (3)Renal tubular acidosis, distal, autosomal recessive, 602722 (3);chr7;ATP6V0A4, ATP6N1B, VPP2, RTA1C, RTADR;True
ENSG00000059377;Thromboxane A synthase 1, platelet;NotRelevant;;Ghosal hematodiaphyseal syndrome, 231095 (3), Autosomal recessiveGhosal hematodiaphyseal syndrome, 231095 (3);chr7;TBXAS1, GHOSAL, CYP5, BDPLT14;True
ENSG00000157764;Murine sarcoma viral (v-raf) oncogene homolog B1;NotRelevant;pseudogene BRAF2 on Xq13 or 7q;Adenocarcinoma of lung, somatic, 211980 (3)Noonan syndrome 7, 613706 (3);chr7;BRAF, NS7;False
ENSG00000006530;Acylglycerol kinase;NotRelevant;;Cataract 38, autosomal recessive, 614691 (3), Autosomal recessiveSengers syndrome, 212350 (3);chr7;AGK, MULK, MTDPS10, CATC5, CTRCT38;True
ENSG00000214102;Wee1, S. pombe, homolog of, 2;NotRelevant;;Oocyte maturation defect 5, 617996 (3), Autosomal recessiveOocyte maturation defect 5, 617996 (3);chr7;WEE2, WEE1B, OOMD5;True
ENSG00000257138;Taste receptor, type 2, member 38;NotRelevant;;[Phenylthiocarbamide tasting], 171200 (3), Autosomal dominant[Phenylthiocarbamide tasting], 171200 (3);chr7;TAS2R38, T2R61, PTC, THIOT;True
ENSG00000204983;Protease, serine, 1 (trypsin 1);NotRelevant;8 trypsinogen genes embedded in TCRB locus;Pancreatitis, hereditary, 167800 (3), Autosomal dominantTrypsinogen deficiency, 614044 (1);chr7;PRSS1, TRY1;True
ENSG00000275896;Protease, serine, 2 (trypsin 2);NotRelevant;;{Pancreatitis, chronic, protection against}, 167800 (3), Autosomal dominant{Pancreatitis, chronic, protection against}, 167800 (3);chr7;PRSS2, TRY2;True
ENSG00000165125;Transient receptor potential cation channel, subfamily V, member 6;NotRelevant;;Hyperparathyroidism, transient neonatal, 618188 (3), Autosomal recessiveHyperparathyroidism, transient neonatal, 618188 (3);chr7;TRPV6, ECAC2, CAT1, CATL, HRPTTN;True
ENSG00000197993;Kell blood group;NotRelevant;;[Blood group, Kell], 110900 (3)[Blood group, Kell], 110900 (3);chr7;KEL;False
ENSG00000188037;Chloride channel-1, skeletal muscle;NotRelevant;;Myotonia congenita, dominant, 160800 (3), Autosomal dominantMyotonia levior, recessive (3);chr7;CLCN1;True
ENSG00000146904;eph tyrosine kinase 1 (erythropoietin-producing hepatoma amplified sequence;NotRelevant;2041;ENSG00000146904;chr7;EPHA1, EPHT1;False
ENSG00000106410;Newborn ovary homeobox, mouse, homolog of;NotRelevant;;Premature ovarian failure 5, 611548 (3), Autosomal dominantPremature ovarian failure 5, 611548 (3);chr7;NOBOX, POF5;True
ENSG00000196511;Thiamine pyrophosphokinase;NotRelevant;;Thiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3), Autosomal recessiveThiamine metabolism dysfunction syndrome 5 (episodic encephalopathy type), 614458 (3);chr7;TPK1, THMD5;True
ENSG00000174469;Contactin-associated protein-like 2;NotRelevant;;{Autism susceptibility 15}, 612100 (3){Autism susceptibility 15}, 612100 (3);chr7;CNTNAP2, CASPR2, NRXN4, CDFE, AUTS15, PTHSL1;False
ENSG00000106462;Enhancer of zeste, Drosophila, homolog of, 2;NotRelevant;pseudogene on 21q22;Weaver syndrome, 277590 (3), Autosomal dominantWeaver syndrome, 277590 (3);chr7;EZH2, EZH1, WVS;True
ENSG00000055118;Potassium voltage-gated channel, subfamily H, member 2 (human ether-a-go-go-related gene);NotRelevant;;Long QT syndrome 2, 613688 (3), Autosomal dominant{Long QT syndrome 2, acquired, susceptibility to}, 613688 (3);chr7;KCNH2, LQT2, HERG, SQT1;True
ENSG00000164867;Nitric oxide synthase 3, endothelial cell;NotRelevant;;{Alzheimer disease, late-onset, susceptibility to}, 104300 (3), Autosomal dominant{Placental abruption} (3);chr7;NOS3;True
ENSG00000164885;Cyclin-dependent kinase 5;NotRelevant;mutation identified in 1 LIS7 family;?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3), Autosomal recessive?Lissencephaly 7 with cerebellar hypoplasia, 616342 (3);chr7;CDK5, LIS7;True
ENSG00000146926;Ankyrin repeat- and SOCS box-containing protein 10;NotRelevant;;Glaucoma 1, open angle, F, 603383 (3)Glaucoma 1, open angle, F, 603383 (3);chr7;ASB10, GLC1F;False
ENSG00000106617;Protein kinase, AMP-activated, noncatalytic, gamma-2;NotRelevant;;Cardiomyopathy, hypertrophic 6, 600858 (3), Autosomal dominantWolff-Parkinson-White syndrome, 194200 (3);chr7;PRKAG2, WPWS, CMH6;True
ENSG00000055609;Lysine (K)-specific methyltransferase 2C;NotRelevant;;Kleefstra syndrome 2, 617768 (3), Autosomal dominantKleefstra syndrome 2, 617768 (3);chr7;KMT2C, MLL3, KIAA1506, KLEFS2;True
ENSG00000196584;X-ray repair, complementing defective, repair in Chinese hamster cells-2;NotRelevant;mutation identified in 1 FANCU patient;?Fanconi anemia, complementation group U, 617247 (3), Autosomal recessive?Fanconi anemia, complementation group U, 617247 (3);chr7;XRCC2, FANCU;True
ENSG00000130226;Dipeptidylpeptidase VI;NotRelevant;;Mental retardation, autosomal dominant 33, 616311 (3){Ventricular fibrillation, paroxysmal familial, 2}, 612956 (3);chr7;DPP6, VF2, MRD33;True
ENSG00000164690;Sonic hedgehog;NotRelevant;separate from TPT1;Holoprosencephaly 3, 142945 (3), Autosomal dominantSingle median maxillary central incisor, 147250 (3);chr7;SHH, HPE3, HLP3, SMMCI, MCOPCB5;True
ENSG00000105983;Limb region 1, mouse, homolog of;NotRelevant;;Acheiropody, 200500 (3), Autosomal recessiveTriphalangeal thumb-polysyndactyly syndrome, 174500 (3);chr7;LMBR1, ACHP, C7orf2, PPD2, THYP, LSS;True
ENSG00000130675;Motor neuron and pancreas homeobox 1;NotRelevant;;Currarino syndrome, 176450 (3), Autosomal dominantCurrarino syndrome, 176450 (3);chr7;MNX1, HLXB9, HOXHB9, SCRA1;True
ENSG00000105993;DNAJ/HSP40 homolog, subfamily B, member 6;NotRelevant;;Muscular dystrophy, limb-girdle, autosomal dominant 1, 603511 (3), Autosomal dominantMuscular dystrophy, limb-girdle, autosomal dominant 1, 603511 (3);chr7;DNAJB6, MRJ, DJ4, LGMDD1;True
ENSG00000126870;WD repeat containing protein 60;NotRelevant;;Short-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3), Autosomal recessiveShort-rib thoracic dysplasia 8 with or without polydactyly, 615503 (3);chr7;WDR60, SRTD8, SRPS6;True
ENSG00000182372;CLN8 gene;NotRelevant;;Ceroid lipofuscinosis, neuronal, 8, 600143 (3), Autosomal recessiveCeroid lipofuscinosis, neuronal, 8, Northern epilepsy variant, 610003 (3);chr8;CLN8, EPMR;True
ENSG00000104728;Rho guanine nucleotide exchange factor 10;NotRelevant;mutation identified in 1 SNCV family;?Slowed nerve conduction velocity, AD, 608236 (3), Autosomal dominant?Slowed nerve conduction velocity, AD, 608236 (3);chr8;ARHGEF10, KIAA0294, SNCV;True
ENSG00000147316;Microcephalin;NotRelevant;genetic heterogeneity;Microcephaly 1, primary, autosomal recessive, 251200 (3), Autosomal recessiveMicrocephaly 1, primary, autosomal recessive, 251200 (3);chr8;MCPH1;True
ENSG00000147324;Malignant fibrous histiocytoma-amplified sequences with leucine-rich tandem repeats-1;NotRelevant;;Malignant fibrous histiocytoma, 605352 (2)Malignant fibrous histiocytoma (2);chr8;MFHAS1, MASL1;False
ENSG00000183638;RP1-like protein 1;NotRelevant;;Occult macular dystrophy, 613587 (3), Autosomal dominantOccult macular dystrophy, 613587 (3);chr8;RP1L1;True
ENSG00000136573;BLK nonreceptor tyrosine kinase;NotRelevant;;Maturity-onset diabetes of the young, type 11, 613375 (3), Autosomal dominantMaturity-onset diabetes of the young, type 11, 613375 (3);chr8;BLK, MODY11;True
ENSG00000136574;GATA-binding protein-4;NotRelevant;mutations identified in 1 TACHD family;Atrial septal defect 2, 607941 (3), Autosomal dominantVentricular septal defect 1, 614429 (3);chr8;GATA4, ASD2, VSD1, TACHD, TOF;True
ENSG00000079459;Farnesyl-diphosphate farnesyltransferase 1 (squalene synthase);NotRelevant;;Squalene synthase deficiency, 618156 (3)Squalene synthase deficiency, 618156 (3);chr8;FDFT1, DGPT, SQSD;False
ENSG00000164733;Cathepsin B (regulatory element, cis-acting, enhancer upstream of CTSB, included);NotRelevant;KWE due to duplication upstream of CTSB that disrupts a cis-acting regulatory element;Keratolytic winter erythema, 148370 (4), Autosomal dominantKeratolytic winter erythema, 148370 (4);chr8;CTSB, CPSB, RECEUP;True
ENSG00000164741;Deleted in liver cancer 1;NotRelevant;;Colorectal cancer, somatic, 114500 (3)Colorectal cancer, somatic, 114500 (3);chr8;DLC1;False
ENSG00000104723;Tumor suppressor candidate 3;NotRelevant;;Mental retardation, autosomal recessive 7, 611093 (3), Autosomal recessiveMental retardation, autosomal recessive 7, 611093 (3);chr8;TUSC3, M33, D8S1992, MRT7, MRT22;True
ENSG00000038945;Macrophage scavenger receptor;NotRelevant;~11cM distal to LPL;Barrett esophagus/esophageal adenocarcinoma, 614266 (3)Barrett esophagus/esophageal adenocarcinoma, 614266 (3);chr8;MSR1, SCARA1, SRA;False
ENSG00000078579;Fibroblast growth factor-20;NotRelevant;mutation identified in 1 RHDA2 family;?Renal hypodysplasia/aplasia 2, 615721 (3), Autosomal recessive?Renal hypodysplasia/aplasia 2, 615721 (3);chr8;FGF20, RHDA2;True
ENSG00000155975;Vacuolar protein sorting 37A;NotRelevant;;Spastic paraplegia 53, autosomal recessive, 614898 (3), Autosomal recessiveSpastic paraplegia 53, autosomal recessive, 614898 (3);chr8;VPS37A, HCRP1, SPG53;True
ENSG00000104213;Platelet-derived growth factor receptor-like;NotRelevant;;Colorectal cancer, somatic, 114500 (3)Hepatocellular cancer, somatic, 114550 (3);chr8;PDGFRL, PDGRL, PRLTS;False
ENSG00000104763;N-acylsphingosine amidohydrolase (acid ceramidase) 1;NotRelevant;;Farber lipogranulomatosis, 228000 (3), Autosomal recessiveSpinal muscular atrophy with progressive myoclonic epilepsy, 159950 (3);chr8;ASAH1, AC, SMAPME;True
ENSG00000156006;Arylamine N-acetyltransferase-2;NotRelevant;acetylation polymorphism;[Acetylation, slow], 243400 (3), Autosomal recessive[Acetylation, slow], 243400 (3);chr8;NAT2, AAC2;True
ENSG00000175445;Lipoprotein lipase;NotRelevant;;Combined hyperlipidemia, familial, 144250 (3), Autosomal dominant[High density lipoprotein cholesterol level QTL 11] (3);chr8;LPL, LIPD, HDLCQ11;True
ENSG00000147416;ATPase, H+ transporting, V1 subunit B2;NotRelevant;;Deafness, congenital, with onychodystrophy, autosomal dominant, 124480 (3), Autosomal dominantZimmermann-Laband syndrome 2, 616455 (3);chr8;ATP6V1B2, ATP6B2, VPP3, DOOD, ZLS2;True
ENSG00000061337;Leucine zipper, putative tumor suppressor 1;NotRelevant;;Esophageal squamous cell carcinoma, 133239 (3), Autosomal dominantEsophageal squamous cell carcinoma, 133239 (3);chr8;LZTS1, F37, FEZ1;True
ENSG00000158815;Fibroblast growth factor 17;NotRelevant;;Hypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3), Autosomal dominantHypogonadotropic hypogonadism 20 with or without anosmia, 615270 (3);chr8;FGF17, HH20;True
ENSG00000168453;Hairless, mouse, homolog of;NotRelevant;;Alopecia universalis, 203655 (3), Autosomal recessiveHypotrichosis 4, 146550 (3);chr8;HR, AU, MUHH1, HYPT4;True
ENSG00000168484;Surfactant, pulmonary-associated protein C (pulmonary surfactant apoprotein-2, SP-C);NotRelevant;;Surfactant metabolism dysfunction, pulmonary, 2, 610913 (3), Autosomal dominantSurfactant metabolism dysfunction, pulmonary, 2, 610913 (3);chr8;SFTPC, SFTP2, SMDP2;True
ENSG00000168487;Bone morphogenetic protein-1;NotRelevant;1kb 3' to SFTP2;Osteogenesis imperfecta, type XIII, 614856 (3), Autosomal recessiveOsteogenesis imperfecta, type XIII, 614856 (3);chr8;BMP1, OI13;True
ENSG00000104635;Solute carrier family 39 (zinc transporter), member 14;NotRelevant;mutation identified in 1 HCTN family;Hypermanganesemia with dystonia 2, 617013 (3), Autosomal recessiveHypermanganesemia with dystonia 2, 617013 (3);chr8;SLC39A14, ZIP14, KIAA0062, HMNDYT2, HCIN;True
ENSG00000008853;Rho-related BTB domain-containing protein 2;NotRelevant;;Epileptic encephalopathy, early infantile, 64, 618004 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 64, 618004 (3);chr8;RHOBTB2, DBC2, KIAA0717, EIEE64;True
ENSG00000120889;Tumor necrosis factor receptor superfamily, member 10B;NotRelevant;;Squamous cell carcinoma, head and neck, 275355 (3), Autosomal recessiveSquamous cell carcinoma, head and neck, 275355 (3);chr8;TNFRSF10B, DR5, TRAILR2;True
ENSG00000180053;NK2, Drosophila, homolog of, 6;NotRelevant;;Conotruncal heart malformations, 217095 (3)Persistent truncus arteriosus, 217095 (3);chr8;NKX2-6, CSX2, CTHM;False
ENSG00000277586;Neurofilament, light polypeptide;NotRelevant;;Charcot-Marie-Tooth disease, dominant intermediate G, 617882 (3), Autosomal dominantCharcot-Marie-Tooth disease, type 2E, 607684 (3);chr8;NEFL, CMT2E, CMT1F, CMTDIG;True
ENSG00000147437;Gonadotropin-releasing hormone-1 (luteinizing-releasing hormone);NotRelevant;mutation identified in 1 HH12 family;?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3), Autosomal recessive?Hypogonadotropic hypogonadism 12 with or without anosmia, 614841 (3);chr8;GNRH1, LNRH, HH12;True
ENSG00000120903;Cholinergic receptor, nicotinic, alpha polypeptide-2;NotRelevant;;Epilepsy, nocturnal frontal lobe, type 4, 610353 (3), Autosomal dominantEpilepsy, nocturnal frontal lobe, type 4, 610353 (3);chr8;CHRNA2;True
ENSG00000120915;Epoxide hydrolase 2, cytoplasmic;NotRelevant;;{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3), Autosomal dominant{Hypercholesterolemia, familial, due to LDLR defect, modifier of}, 143890 (3);chr8;EPHX2;True
ENSG00000120885;Clusterin (complement lysis inhibitor, SP-40,40;NotRelevant;CLU;1191;chr8;CLU, CLI, SGP2, TRPM2;False
ENSG00000171320;Establishment of cohesion 1, S. cerevisiae, homolog of, 2;NotRelevant;;Roberts syndrome, 268300 (3), Autosomal recessiveSC phocomelia syndrome, 269000 (3);chr8;ESCO2;True
ENSG00000012232;Exostosin-like 3;NotRelevant;;Immunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3), Autosomal recessiveImmunoskeletal dysplasia with neurodevelopmental abnormalities, 617425 (3);chr8;EXTL3, EXTR1, ISDNA;True
ENSG00000197265;General transcription factor IIE, polypeptide 2, beta subunit, 34kD;NotRelevant;;Trichothiodystrophy 6, nonphotosensitive, 616943 (3), Autosomal recessiveTrichothiodystrophy 6, nonphotosensitive, 616943 (3);chr8;GTF2E2, TTD6;True
ENSG00000104687;Glutathione reductase;NotRelevant;;Hemolytic anemia due to glutathione reductase deficiency (1)Hemolytic anemia due to glutathione reductase deficiency (1);chr8;GSR;False
ENSG00000133863;Testis-expressed gene 15;NotRelevant;;Spermatogenic failure 25, 617960 (3), Autosomal recessiveSpermatogenic failure 25, 617960 (3);chr8;TEX15, SPGF25;True
ENSG00000165392;DNA helicase, RecQ-like 2;NotRelevant;;Werner syndrome, 277700 (3), Autosomal recessiveWerner syndrome, 277700 (3);chr8;RECQL2, RECQ3, WRN;True
ENSG00000157168;Neuregulin 1 (heregulin, alpha, 45kD;NotRelevant;ENSG00000157168;{?Schizophrenia, susceptibility to}, 603013 (1);chr8;NRG1, HGL, HRGA, ARIA;False
ENSG00000129696;TELO2-interacting protein 2;NotRelevant;;Mental retardation, autosomal recessive 39, 615541 (3), Autosomal recessiveMental retardation, autosomal recessive 39, 615541 (3);chr8;TTI2, C8orf41, MRT39;True
ENSG00000147475;Endoplasmic reticulum lipid raft-associated protein 2;NotRelevant;;Spastic paraplegia 18, autosomal recessive, 611225 (3), Autosomal recessiveSpastic paraplegia 18, autosomal recessive, 611225 (3);chr8;ERLIN2, SPFH2, C8orf2, SPG18;True
ENSG00000147471;Proline synthetase cotranscribed, bacteria, homolog of;NotRelevant;;Epilepsy, early-onset, vitamin B6-dependent, 617290 (3), Autosomal recessiveEpilepsy, early-onset, vitamin B6-dependent, 617290 (3);chr8;PROSC, EPVB6D;True
ENSG00000188778;Adrenergic, beta-3-, receptor;NotRelevant;;{Obesity, susceptibility to}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial{Obesity, susceptibility to}, 601665 (3);chr8;ADRB3;True
ENSG00000147465;Steroidogenic acute regulatory protein;NotRelevant;;Lipoid adrenal hyperplasia, 201710 (3), Autosomal recessiveLipoid adrenal hyperplasia, 201710 (3);chr8;STAR;True
ENSG00000085788;DDHD domain-containing protein 2;NotRelevant;;Spastic paraplegia 54, autosomal recessive, 615033 (3), Autosomal recessiveSpastic paraplegia 54, autosomal recessive, 615033 (3);chr8;DDHD2, KIAA0725, SPG54;True
ENSG00000147548;Nuclear receptor-binding SET domain protein 3;NotRelevant;pseudogene on 17q21; fusion partner with NUP98 in AML;chr8;NSD3, WHSC1L1;False
ENSG00000077782;Fibroblast growth factor receptor-1 (fms-related tyrosine kinase-2);NotRelevant;fused with BCR, CEP1, FOP, FIM in hematologic malignancies;Encephalocraniocutaneous lipomatosis, 613001 (3), Somatic mosaicismTrigonocephaly 1, 190440 (3);chr8;FGFR1, FLT2, OGD, KAL2, HH2, HRTFDS, ECCL;False
ENSG00000168615;A disintegrin and metalloproteinase domain 9;NotRelevant;;Cone-rod dystrophy 9, 612775 (3)Cone-rod dystrophy 9, 612775 (3);chr8;ADAM9, MDC9, MCMP, CORD9;False
ENSG00000029534;Ankyrin-1, erythrocytic;NotRelevant;;Spherocytosis, type 1, 182900 (3), Autosomal dominantSpherocytosis, type 1, 182900 (3);chr8;ANK1, SPH1;True
ENSG00000083168;K(lysine) acetyltransferase 6A;NotRelevant;;Mental retardation, autosomal dominant 32, 616268 (3), Autosomal dominantMental retardation, autosomal dominant 32, 616268 (3);chr8;KAT6A, MYST3, MOZ, ZNF220, MRD32;True
ENSG00000104368;Plasminogen activator, tissue type;NotRelevant;;Hyperfibrinolysis, familial, due to increased release of PLAT, 612348 (1)Thrombophilia, familial, due to decreased release of PLAT, 612348 (1);chr8;PLAT, TPA;False
ENSG00000104365;Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, beta;NotRelevant;;Immunodeficiency 15A, 618204 (3), Autosomal dominantImmunodeficiency 15B, 615592 (3);chr8;IKBKB, NFKBIKB, IMD15B, IMD15A;True
ENSG00000168575;Solute carrier family 20, phosphate transporter, member 2 (murine leukemia virus, amphotropic, receptor for);NotRelevant;;Basal ganglia calcification, idiopathic, 1, 213600 (3), Autosomal dominantBasal ganglia calcification, idiopathic, 1, 213600 (3);chr8;SLC20A2, MLVAR, GLVR2, IBGC1;True
ENSG00000131931;THAP domain-containing protein 1;NotRelevant;;Dystonia 6, torsion, 602629 (3), Autosomal dominantDystonia 6, torsion, 602629 (3);chr8;THAP1, DYT6;True
ENSG00000120925;RING finger protein 170;NotRelevant;;Ataxia, sensory, 1, autosomal dominant, 608984 (3), Autosomal dominantAtaxia, sensory, 1, autosomal dominant, 608984 (3);chr8;RNF170, SNAX1;True
ENSG00000185900;Protein-O-mannose kinase;NotRelevant;mutation in 1 MDDGC12 family has been reported;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 12, 615249 (3);chr8;POMK, SGK196, MDDGA12, MDDGC12;True
ENSG00000165102;Heparan-alpha-glucosaminide N-acetyltransferase;NotRelevant;;Mucopolysaccharidosis type IIIC (Sanfilippo C), 252930 (3), Autosomal recessiveRetinitis pigmentosa 73, 616544 (3);chr8;HGSNAT, TMEM76, MPS3C, RP73;True
ENSG00000253729;Protein kinase, DNA-activated, catalytic polypeptide (hyperradiosensitivity of murine SCID mutation, complementing-1);NotRelevant;;Immunodeficiency 26, with or without neurologic abnormalities, 615966 (3), Autosomal recessiveImmunodeficiency 26, with or without neurologic abnormalities, 615966 (3);chr8;PRKDC, HYRC1, DNPK1, IMD26;True
ENSG00000104738;Minichromosome maintenance deficient, S. cerevisiae, homolog of, 4;NotRelevant;;Immunodeficiency 54, 609981 (3), Autosomal recessiveImmunodeficiency 54, 609981 (3);chr8;MCM4, NKGCD, NKCD, IMD54;True
ENSG00000019549;snail, Drosophila, homolog of, 2 (Neural crest transcription factor SLUG);NotRelevant;;Piebaldism, 172800 (3), Autosomal dominantWaardenburg syndrome, type 2D, 608890 (3);chr8;SNAI2, SLUG, WS2D;True
ENSG00000023287;RB1-inducible coiled-coil 1;NotRelevant;;Breast cancer, somatic, 114480 (3)Breast cancer, somatic, 114480 (3);chr8;RB1CC1, CC1, KIAA0203;False
ENSG00000164736;SRY-box 17;NotRelevant;;Vesicoureteral reflux 3, 613674 (3), Autosomal dominantVesicoureteral reflux 3, 613674 (3);chr8;SOX17, VUR3;True
ENSG00000104237;Oxygen-regulated photoreceptor protein-1 (retinitis pigmentosa-1);NotRelevant;;Retinitis pigmentosa 1, 180100 (3), Autosomal recessive, Autosomal dominantRetinitis pigmentosa 1, 180100 (3);chr8;RP1, ORP1;True
ENSG00000181690;Pleomorphic adenoma gene 1;NotRelevant;fused with CTNNB1 in SGPA;Adenomas, salivary gland pleomorphic, somatic, 181030 (3)Adenomas, salivary gland pleomorphic, somatic, 181030 (3);chr8;PLAG1, SGPA, PSA;False
ENSG00000104331;Inositol monophosphatase domain-containing protein 1;NotRelevant;;Chondrodysplasia with joint dislocations, GPAPP type, 614078 (3), Autosomal recessiveChondrodysplasia with joint dislocations, GPAPP type, 614078 (3);chr8;IMPAD1, GPAPP, IMPA3;True
ENSG00000178538;Carbonic anhydrase VIII;NotRelevant;;Cerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3), Autosomal recessiveCerebellar ataxia and mental retardation with or without quadrupedal locomotion 3, 613227 (3);chr8;CA8, CALS, CARP, CAMRQ3;True
ENSG00000171316;Chromodomain helicase DNA binding protein 7;NotRelevant;;CHARGE syndrome, 214800 (3), Autosomal dominantHypogonadotropic hypogonadism 5 with or without anosmia, 612370 (3);chr8;CHD7, HH5;True
ENSG00000198363;Aspartate beta-hydroxylase (junctin;NotRelevant;ENSG00000198363;Traboulsi syndrome, 601552 (3);chr8;ASPH, HAAH, FDLAB;False
ENSG00000137561;Tocopherol, alpha, transfer protein;NotRelevant;;Ataxia with isolated vitamin E deficiency, 277460 (3), Autosomal recessiveAtaxia with isolated vitamin E deficiency, 277460 (3);chr8;TTPA, TTP1, AVED;True
ENSG00000172817;Cytochrome P450, subfamily VIIB (oxysterol 7-alpha-hydroxylase), polypeptide 1;NotRelevant;;Bile acid synthesis defect, congenital, 3, 613812 (3), Autosomal recessiveSpastic paraplegia 5A, autosomal recessive, 270800 (3);chr8;CYP7B1, CBAS3, SPG5A;True
ENSG00000104218;Centrosome spindle pole-associated protein 1;NotRelevant;;Joubert syndrome 21, 615636 (3), Autosomal recessiveJoubert syndrome 21, 615636 (3);chr8;CSPP1, CSPP, JBTS21;True
ENSG00000165078;Carboxypeptidase A6;NotRelevant;;Epilepsy, familial temporal lobe, 5, 614417 (3), Autosomal recessive, Autosomal dominantFebrile seizures, familial, 11, 614418 (3);chr8;CPA6, CPAH, ETL5, FEB11;True
ENSG00000104313;Eyes absent, Drosophila, homolog of, 1;NotRelevant;mutation identified in 1 OFC1 family;Anterior segment anomalies with or without cataract, 602588 (3), Autosomal dominantBranchiootorenal syndrome 1, with or without cataracts, 113650 (3);chr8;EYA1, BOR, BOS1, OFC1;True
ENSG00000104321;Transient receptor potential cation channel, subfamily A, member 1 (ankyrin-like protein with transmembrane domains 1);NotRelevant;mutation identified in 1 FEPS1 family;?Episodic pain syndrome, familial, 1, 615040 (3), Autosomal dominant?Episodic pain syndrome, familial, 1, 615040 (3);chr8;TRPA1, ANKTM1, FEPS1;True
ENSG00000175606;Transmembrane protein 70;NotRelevant;;Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3), Autosomal recessiveMitochondrial complex V (ATP synthase) deficiency, nuclear type 2, 614052 (3);chr8;TMEM70, MC5DN2;True
ENSG00000104369;Junctophilin 1;NotRelevant;mutation identified in 1 CMT2K family;?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3), Autosomal recessive, Autosomal dominant?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K, 607831 (3);chr8;JPH1, JP1, CMT2K;True
ENSG00000104381;Ganglioside-induced differentiation-associated protein 1;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2K, 607831 (3), Autosomal recessive, Autosomal dominantCharcot-Marie-Tooth disease, type 4A, 214400 (3);chr8;GDAP1, CMT4A, CMT2K, CMTRIA;True
ENSG00000091656;Zinc finger homeobox 4;NotRelevant;;?Ptosis, congenital, 178300 (2), Autosomal dominant?Ptosis, congenital, 178300 (2);chr8;ZFHX4, ZFH4;True
ENSG00000164751;Peroxisome biogenesis factor 2;NotRelevant;;Peroxisome biogenesis disorder 5A (Zellweger), 614866 (3), Autosomal recessivePeroxisome biogenesis disorder 5B, 614867 (3);chr8;PEX2, PAF1, PMP35, PBD5A, PBD5B, PXMP3;True
ENSG00000133731;Inositol(myo)-1(or 4)-monophosphatase-1;NotRelevant;;Mental retardation, autosomal recessive 59, 617323 (3), Autosomal recessiveMental retardation, autosomal recessive 59, 617323 (3);chr8;IMPA1, MRT59;True
ENSG00000104267;Carbonic anhydrase II;NotRelevant;CA1, CA2 linked in monkey and mouse;Osteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3), Autosomal recessiveOsteopetrosis, autosomal recessive 3, with renal tubular acidosis, 259730 (3);chr8;CA2;True
ENSG00000170289;Cyclic nucleotide-gated channel, beta-3;NotRelevant;;Achromatopsia 3, 262300 (3), Autosomal recessiveMacular degeneration, juvenile, 248200 (3);chr8;CNGB3, ACHM3, ACHM1;True
ENSG00000104320;Nibrin;NotRelevant;;Aplastic anemia, 609135 (3)Nijmegen breakage syndrome, 251260 (3);chr8;NBN, NBS1;False
ENSG00000155100;OTU domain-containing protein 6B;NotRelevant;;Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3), Autosomal recessiveIntellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies, 617452 (3);chr8;OTUD6B, DUBA5, IDDFSDA;True
ENSG00000079102;unt-related transcription factor 1, translocated to, 1, cyclin D-related;NotRelevant;fused with AML1 in t(8;21);chr8;RUNX1T1, CBFA2T1, AML1T1, ETO;False
ENSG00000188343;Family with sequence similarity 92, member A;NotRelevant;mutation identified in 1 PAPA9 family;?Polydactyly, postaxial, type A9, 618219 (3), Autosomal recessive?Polydactyly, postaxial, type A9, 618219 (3);chr8;FAM92A, FAM92A1, PAPA9;True
ENSG00000164953;Transmembrane protein 67 (meckelin);NotRelevant;mutation identified in 1 RHYNS patient;{Bardet-Biedl syndrome 14, modifier of}, 615991 (3), Autosomal recessive{Bardet-Biedl syndrome 14, modifier of}, 615991 (3);chr8;TMEM67, MKS3, JBTS6, NPHP11;True
ENSG00000164951;Pyruvate dehydrogenase phosphatase catalytic subunit 1;NotRelevant;;Pyruvate dehydrogenase phosphatase deficiency, 608782 (3), Autosomal recessivePyruvate dehydrogenase phosphatase deficiency, 608782 (3);chr8;PDP1, PPM2C, PDPC;True
ENSG00000197275;RAD54, S. cerevisiae, homolog of, B;NotRelevant;;Colon cancer, somatic, 114500 (3)Lymphoma, non-Hodgkin, somatic, 605027 (3);chr8;RAD54B;False
ENSG00000104413;Epithelial splicing regulatory protein 1;NotRelevant;mutation identified in 1 DFNB109 family;?Deafness, autosomal recessive 109, 618013 (3), Autosomal recessive?Deafness, autosomal recessive 109, 618013 (3);chr8;ESRP1, RMB35A, DFNB109;True
ENSG00000156170;NADH dehydrogenase (ubiquinone) complex I, assembly factor 6;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 17, 612392 (3)Mitochondrial complex I deficiency, nuclear type 17, 612392 (3);chr8;NDUFAF6, C8orf38, MC1DN17;False
ENSG00000156172;Chromosome 8 open reading frame 37;NotRelevant;;Bardet-Biedl syndrome 21, 617406 (3), Autosomal recessiveRetinitis pigmentosa 64, 614500 (3);chr8;C8orf37, CORD16, RP64, BBS21;True
ENSG00000156466;Growth/differentiation factor 6;NotRelevant;;Klippel-Feil syndrome 1, autosomal dominant, 118100 (3), Autosomal dominantMultiple synostoses syndrome 4, 617898 (3);chr8;GDF6, MCOP4, KFS1, MCOPCB6, LCA17, SYNS4;True
ENSG00000156467;Ubiquinol-cytochrome c reductase binding protein;NotRelevant;;Mitochondrial complex III deficiency, nuclear type 3, 615158 (3), Autosomal recessiveMitochondrial complex III deficiency, nuclear type 3, 615158 (3);chr8;UQCRB, UQBP, QPC, MC3DN3;True
ENSG00000156471;Phosphatidylserine synthase 1;NotRelevant;;Lenz-Majewski hyperostotic dwarfism, 151050 (3), Autosomal dominantLenz-Majewski hyperostotic dwarfism, 151050 (3);chr8;PTDSS1, PSS1, KIAA0024, LMHD;True
ENSG00000104356;Processing of precursor 1, S. cerevisiae, homolog of;NotRelevant;;Anauxetic dysplasia 2, 617396 (3), Autosomal recessiveAnauxetic dysplasia 2, 617396 (3);chr8;POP1, ANXD2;True
ENSG00000132549;Vacuolar protein sorting 13, yeast, homolog of, B;NotRelevant;;Cohen syndrome, 216550 (3), Autosomal recessiveCohen syndrome, 216550 (3);chr8;VPS13B, KIAA0532, COH1;True
ENSG00000104450;Sperm-associated antigen-1;NotRelevant;;Ciliary dyskinesia, primary, 28, 615505 (3), Autosomal recessiveCiliary dyskinesia, primary, 28, 615505 (3);chr8;SPAG1, CILD28;True
ENSG00000083307;Grainyhead-like 2;NotRelevant;;Corneal dystrophy, posterior polymorphous, 4, 618031 (3), Autosomal dominantEctodermal dysplasia/short stature syndrome, 616029 (3);chr8;GRHL2, TFCP2L3, DFNA28, ECTDS, PPCD4;True
ENSG00000048392;Ribonucleotide reductase M2 B, TP53 inducible;NotRelevant;;Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy), 612075 (3), Autosomal recessiveProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 5, 613077 (3);chr8;RRM2B, P53R2, PEOA5, MTDPS8A, MTDPS8B;True
ENSG00000164930;Frizzled, Drosophila, homolog of, 6;NotRelevant;;Nail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3), Autosomal recessiveNail disorder, nonsyndromic congenital, 10, (claw-shaped nails), 614157 (3);chr8;FZD6, NDNC10;True
ENSG00000164932;Collagen triple-helix repeat-containing protein 1;NotRelevant;;Barrett esophagus/esophageal adenocarcinoma, 614266 (3)Barrett esophagus/esophageal adenocarcinoma, 614266 (3);chr8;CTHRC1;False
ENSG00000164933;Solute carrier family 25 (mitochondrial carrier, folate), member 32;NotRelevant;mutation identified in 1 RREI patient;?Exercise intolerance, riboflavin-responsive, 616839 (3), Autosomal recessive?Exercise intolerance, riboflavin-responsive, 616839 (3);chr8;SLC25A32, MFT, RREI;True
ENSG00000147647;Dihydropyrimidinase;NotRelevant;;Dihydropyrimidinuria, 222748 (3), Autosomal recessiveDihydropyrimidinuria, 222748 (3);chr8;DPYS, DHP;True
ENSG00000169946;Zinc finger protein, multitype 2 (friend of GATA2);NotRelevant;;Diaphragmatic hernia 3, 610187 (3)Tetralogy of Fallot, 187500 (3);chr8;ZFPM2, FOG2, DIH3, SRXY9;False
ENSG00000147655;R-spondin family, member 2;NotRelevant;mutation identified in 1 HHRRD family;?Humerofemoral hypoplasia with radiotibial ray deficiency, 618022 (3), Autosomal recessiveTetraamelia syndrome 2, 618021 (3);chr8;RSPO2, CRISTIN2, TETAMS2, HHRRD;True
ENSG00000174417;Thyrotropin-releasing hormone receptor;NotRelevant;;Thyrotropin-releasing hormone resistance, generalized (3)Thyrotropin-releasing hormone resistance, generalized (3);chr8;TRHR;False
ENSG00000104447;Zinc finger transcription factor TRPS1;NotRelevant;;Trichorhinophalangeal syndrome, type I, 190350 (3), Autosomal dominantTrichorhinophalangeal syndrome, type III, 190351 (3);chr8;TRPS1;True
ENSG00000164754;Rad21, S. pombe, homolog of;NotRelevant;mutation identified in 1 MGS family;Cornelia de Lange syndrome 4, 614701 (3), Autosomal dominantCornelia de Lange syndrome 4, 614701 (3);chr8;RAD21, SCC1, NXP1, KIAA0078, CDLS4, MGS;True
ENSG00000164756;Solute carrier family 30 (zinc transporter), member 8;NotRelevant;;{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3);chr8;SLC30A8, ZNT8;True
ENSG00000182197;Exostosin 1;NotRelevant;distal to TRPS1;Chondrosarcoma, 215300 (3), Autosomal recessiveExostoses, multiple, type 1, 133700 (3);chr8;EXT1;True
ENSG00000177570;Sterile alpha motif domain containing 12;NotRelevant;;Epilepsy, familial adult myoclonic, 1, 601068 (3), Autosomal dominantEpilepsy, familial adult myoclonic, 1, 601068 (3);chr8;SAMD12;True
ENSG00000164761;Tumor necrosis factor receptor superfamily, member 11B (osteoprotegerin);NotRelevant;;Paget disease of bone 5, juvenile-onset, 239000 (3), Autosomal recessivePaget disease of bone 5, juvenile-onset, 239000 (3);chr8;TNFRSF11B, OPG, OCIF, PDB5;True
ENSG00000184374;Collectin 10;NotRelevant;;3MC syndrome 3, 248340 (3), Autosomal recessive3MC syndrome 3, 248340 (3);chr8;COLEC10, CLL1, 3MC3;True
ENSG00000064313;TAF2 RAN polymerase II, TATA box-binding protein-associated factor, 150kD;NotRelevant;;Mental retardation, autosomal recessive 40, 615599 (3), Autosomal recessiveMental retardation, autosomal recessive 40, 615599 (3);chr8;TAF2, TAF2B, TAFII150, CIF150, MRT40;True
ENSG00000170881;RING finger protein 139;NotRelevant;;Renal cell carcinoma, 144700 (3)Renal cell carcinoma, 144700 (3);chr8;RNF139, TRC8, RCA1;False
ENSG00000147684;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 9 (22kD, B22);NotRelevant;mutation identified in 1 MC1DN24 family;?Mitochondrial complex I deficiency, nuclear type 24, 618245 (3), Autosomal recessive?Mitochondrial complex I deficiency, nuclear type 24, 618245 (3);chr8;NDUFB9, UQOR22, MC1DN24;True
ENSG00000164961;WASH complex, subunit 5;NotRelevant;;Ritscher-Schinzel syndrome 1, 220210 (3), Autosomal recessiveSpastic paraplegia 8, autosomal dominant, 603563 (3);chr8;WSHC5, KIAA0196, SPG8, RTSC1;True
ENSG00000156831;Non-SMC element 2, S. cerevisiae, homolog of;NotRelevant;;Seckel syndrome 10, 617253 (3), Autosomal recessiveSeckel syndrome 10, 617253 (3);chr8;NSMCE2, NSE2, MMS21;True
ENSG00000136997;Avian myelocytomatosis viral (v-myc) oncogene homolog;NotRelevant;cen-5'-3'-ter;Burkitt lymphoma, 113970 (3), Isolated casesBurkitt lymphoma, 113970 (3);chr8;MYC;False
ENSG00000184156;Potassium voltage-gated channel, KQT-like subfamily, member 3;NotRelevant;;Seizures, benign neonatal, 2, 121201 (3), Autosomal dominantSeizures, benign neonatal, 2, 121201 (3);chr8;KCNQ3, EBN2, BFNC2;True
ENSG00000129295;Leucine-rich repeat-containing protein 6;NotRelevant;;Ciliary dyskinesia, primary, 19, 614935 (3), Autosomal recessiveCiliary dyskinesia, primary, 19, 614935 (3);chr8;LRRC6, LRTP, CILD19;True
ENSG00000042832;Thyroglobulin;NotRelevant;distal to MYC;{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3){Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3);chr8;TG, AITD3, TDH3;False
ENSG00000104419;N-myc downstream-regulated gene 1;NotRelevant;;Charcot-Marie-Tooth disease, type 4D, 601455 (3), Autosomal recessiveCharcot-Marie-Tooth disease, type 4D, 601455 (3);chr8;NDRG1, HMSNL, CMT4D;True
ENSG00000066827;Zinc finger gene in autoimmune thyroid disease 1;NotRelevant;;{Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3){Autoimmune thyroid disease, susceptibility to, 3}, 608175 (3);chr8;ZFAT1, ZNF406, AITD3;False
ENSG00000169427;Potassium channel, subfamily K, member 9;NotRelevant;;Birk-Barel mental retardation dysmorphism syndrome, 612292 (3)Birk-Barel mental retardation dysmorphism syndrome, 612292 (3);chr8;KCNK9, TASK3;False
ENSG00000167632;Trafficking protein particle complex 9;NotRelevant;;Mental retardation, autosomal recessive 13, 613192 (3), Autosomal recessiveMental retardation, autosomal recessive 13, 613192 (3);chr8;TRAPPC9, NIBP, KIAA1882, MRT13;True
ENSG00000126233;Secreted LY6/uPAR-related protein 1;NotRelevant;;Meleda disease, 248300 (3), Autosomal recessiveMeleda disease, 248300 (3);chr8;SLURP1, MDM;True
ENSG00000160882;Cytochrome P450, subfamily XIB, polypeptide 1 (11-beta-hydroxylase;NotRelevant;ENSG00000160882;chimeric CYP11B1/CYP11B2 gene = anti-Lepore-likeAldosteronism, glucocorticoid-remediable, 103900 (3);chr8;CYP11B1, P450C11, FHI;False
ENSG00000179142;Cytochrome P450, subfamily XIB, polypeptide 2;NotRelevant;;Aldosterone to renin ratio raised (3){Low renin hypertension, susceptibility to} (3);chr8;CYP11B2;False
ENSG00000277494;Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1;NotRelevant;;Hyperlipoproteinemia, type 1D, 615947 (3), Autosomal recessiveHyperlipoproteinemia, type 1D, 615947 (3);chr8;GPIHBP1, HYPL1D;True
ENSG00000182759;v-MAF avian musculoaponeurotic fibrosarcoma oncogene homolog A;NotRelevant;;Insulinomatosis and diabetes mellitus, 147630 (3), Autosomal dominantInsulinomatosis and diabetes mellitus, 147630 (3);chr8;MAFA, RIPE3B1, INSDM;True
ENSG00000180921;Family with sequence similarity 83, member H;NotRelevant;;Amelogenesis imperfecta, type IIIA, 130900 (3), Autosomal dominantAmelogenesis imperfecta, type IIIA, 130900 (3);chr8;FAM83H, AI3A;True
ENSG00000179950;Poly-U-binding splicing factor, 60kD;NotRelevant;;Verheij syndrome, 615583 (3), Autosomal dominantVerheij syndrome, 615583 (3);chr8;PUF60, FIR, SIAHBP1, VRJS;True
ENSG00000178209;Plectin 1;NotRelevant;mutation identified in 1 EBSND family;Epidermolysis bullosa simplex with muscular dystrophy, 226670 (3), Autosomal recessiveMuscular dystrophy, limb-girdle, autosomal recessive 17, 613723 (3);chr8;PLEC1, PLEC, PLTN, EBS1, LGMDR17, EBSOG, EBSPA, EBSMD, EBSND;True
ENSG00000178814;5-oxoprolinase (ATP-hydrolyzing);NotRelevant;;5-oxoprolinase deficiency, 260005 (3), Autosomal recessive, Autosomal dominant5-oxoprolinase deficiency, 260005 (3);chr8;OPLAH, OPLAHD;True
ENSG00000197858;Glycophosphatidylinositol anchor attachment protein 1;NotRelevant;;Glycosylphosphatidylinositol biosynthesis defect 15, 617810 (3), Autosomal recessiveGlycosylphosphatidylinositol biosynthesis defect 15, 617810 (3);chr8;GPAA1, GAA1, GPIBD15;True
ENSG00000179091;Cytochrome c1;NotRelevant;;Mitochondrial complex III deficiency, nuclear type 6, 615453 (3), Autosomal recessiveMitochondrial complex III deficiency, nuclear type 6, 615453 (3);chr8;CYC1, MC3DN6;True
ENSG00000185000;Diacylglycerol O-acyltransferase 1;NotRelevant;mutation identified in 1 DIAR7 family;?Diarrhea 7, protein-losing enteropathy type, 615863 (3), Autosomal recessive?Diarrhea 7, protein-losing enteropathy type, 615863 (3);chr8;DGAT1, ARGP1, DIAR7;True
ENSG00000185803;Solute carrier family 52, riboflavin transporter, member 2;NotRelevant;;Brown-Vialetto-Van Laere syndrome 2, 614707 (3), Autosomal recessiveBrown-Vialetto-Van Laere syndrome 2, 614707 (3);chr8;SLC52A2, GPR172A, GPCR41, PAR1, FLJ11856, BVVLS2;True
ENSG00000147804;Solute carrier family 36 (zinc transporter), member 4;NotRelevant;;Acrodermatitis enteropathica, 201100 (3), Autosomal recessiveAcrodermatitis enteropathica, 201100 (3);chr8;SLC39A4, ZIP4;True
ENSG00000160957;DNA helicase, RecQ-like 4;NotRelevant;;Baller-Gerold syndrome, 218600 (3), Autosomal recessiveRothmund-Thomson syndrome, 268400 (3);chr8;RECQL4, RTS, RECQ4;True
ENSG00000107099;Dedicator of cytokinesis 8;NotRelevant;;Hyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3), Autosomal recessiveHyper-IgE recurrent infection syndrome, autosomal recessive, 243700 (3);chr9;DOCK8;True
ENSG00000107104;KN motif- and ankyrin repeat domain-containing protein 1;NotRelevant;;Cerebral palsy, spastic quadriplegic, 2, 612900 (3)Cerebral palsy, spastic quadriplegic, 2, 612900 (3);chr9;KANK1, KANK, ANKRD15, KIAA0172, CPSQ2;False
ENSG00000080503;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2;NotRelevant;;Nicolaides-Baraitser syndrome, 601358 (3), Autosomal dominantNicolaides-Baraitser syndrome, 601358 (3);chr9;SMARCA2, SNF2L2, NCBRS;True
ENSG00000147852;Very low density lipoprotein receptor;NotRelevant;;Cerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3), Autosomal recessiveCerebellar hypoplasia and mental retardation with or without quadrupedal locomotion 1, 224050 (3);chr9;VLDLR, CAMRQ1;True
ENSG00000168263;Potassium channel, voltage-gated, subfamily V, member 2;NotRelevant;;Retinal cone dystrophy 3B, 610356 (3), Autosomal recessiveRetinal cone dystrophy 3B, 610356 (3);chr9;KCNV2, KV11.1, RCD3B;True
ENSG00000107249;GLIS family zinc finger protein 3;NotRelevant;;Diabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3), Autosomal recessiveDiabetes mellitus, neonatal, with congenital hypothyroidism, 610199 (3);chr9;GLIS3, ZNF515, NDH;True
ENSG00000106688;Solute carrier family 1, member 1 (high-affinity glutamate transporter;NotRelevant;ENSG00000106688;mutation identified in 1 SCZD18 family{?Schizophrenia susceptibility 18}, 615232 (3);chr9;SLC1A1, EAAC1, SCZD18, DCBXA;False
ENSG00000205808;PPAP2 domain-containing protein 2;NotRelevant;;Phospholipid phosphatase 6, 611666 (3)Phospholipid phosphatase 6, 611666 (3);chr9;PLPP6, PPAPDC2;False
ENSG00000096968;Janus kinase 2 (a protein-tyrosine kinase);NotRelevant;;{Budd-Chiari syndrome, somatic}, 600880 (3){Budd-Chiari syndrome, somatic}, 600880 (3);chr9;JAK2, THCYT3;False
ENSG00000178445;Glycine dehydrogenase (decarboxylating;NotRelevant;ENSG00000178445;Glycine encephalopathy, 605899 (3);chr9;GLDC, HYGN1, GCSP, GCE, NKH;False
ENSG00000107165;Tyrosinase-related protein 1;NotRelevant;;Albinism, oculocutaneous, type III, 203290 (3), Autosomal recessive[Skin/hair/eye pigmentation, variation in, 11 (Melanesian blond hair)], 612271 (3);chr9;TYRP1, CAS2, GP75, SHEP11;True
ENSG00000107186;Multiple PDZ domain protein;NotRelevant;;Hydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3), Autosomal recessiveHydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3);chr9;MPDZ, MUPP1, HYC2;True
ENSG00000164946;FRAS1-related extracellular matrix protein 1;NotRelevant;;Bifid nose with or without anorectal and renal anomalies, 608980 (3)Trigonocephaly 2, 614485 (3);chr9;FREM1, C9orf154, BNAR, MOTA, TRIGNO2;False
ENSG00000171855;Interferon, beta-1, fibroblast;NotRelevant;distal to IFL; ?9p23-p22;chr9;IFNB1;False
ENSG00000177047;Interferon, omega-1;NotRelevant;pseudogene IFNWP2; interspersed with IFNA;chr9;IFNW1;False
ENSG00000197919;Interferon, alpha-1;NotRelevant;very close to IFF by Fd, LD; 15-30 genesInterferon, alpha, deficiency (1);chr9;IFNA1, IFNA@;False
ENSG00000099810;Methylthioadenosine phosphorylase;NotRelevant;;Diaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3), Autosomal dominantDiaphyseal medullary stenosis with malignant fibrous histiocytoma, 112250 (3);chr9;MTAP, DMSMFH;True
ENSG00000147889;Cyclin-dependent kinase inhibitor 2A (p16, inhibits CDK4);NotRelevant;;Melanoma and neural system tumor syndrome, 155755 (3), Autosomal dominant{Melanoma, cutaneous malignant, 2}, 155601 (3);chr9;CDKN2A, MTS1, P16, MLM, CMM2;True
ENSG00000137055;Phospholipase A2-activating protein;NotRelevant;;Neurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3), Autosomal recessiveNeurodevelopmental disorder with progressive microcephaly, spasticity, and brain anomalies, 617527 (3);chr9;PLAA, PLAP, NDMSBA;True
ENSG00000096872;Intraflagellar transport 74, Chlamydomonas, homolog of;NotRelevant;mutation identified in 1 BBS20 patient;?Bardet-Biedl syndrome 20, 617119 (3), Autosomal recessive?Bardet-Biedl syndrome 20, 617119 (3);chr9;IFT74, CCDC2, CMG1, BBS20;True
ENSG00000120156;TEK tyrosine kinase, endothelial;NotRelevant;;Glaucoma 3, primary congenital, E, 617272 (3), Autosomal dominantVenous malformations, multiple cutaneous and mucosal, 600195 (3);chr9;TEK, TIE2, VMCM, GLC3E;True
ENSG00000147894;Chromosome 9 open reading frame 72;NotRelevant;;Frontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3), Autosomal dominantFrontotemporal dementia and/or amyotrophic lateral sclerosis 1, 105550 (3);chr9;C9orf72, FTDALS1, FTDALS, ALSFTD;True
ENSG00000107201;DEAD box polypeptide 58;NotRelevant;;Singleton-Merten syndrome 2, 616298 (3), Autosomal dominantSingleton-Merten syndrome 2, 616298 (3);chr9;DDX58, RIGI, SGMRT2;True
ENSG00000197579;Topoisomerase I-binding arginine/serine-rich protein;NotRelevant;;Retinitis pigmentosa 31, 609923 (3)Retinitis pigmentosa 31, 609923 (3);chr9;TOPORS, P53BP3, LUN, RP31;False
ENSG00000137074;Aprataxin;NotRelevant;;Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3), Autosomal recessiveAtaxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3);chr9;APTX, AOA, AOA1;True
ENSG00000086062;Glycoprotein-4-beta-galactosyltransferase-2 (EC 2.4.1.22);NotRelevant;;Congenital disorder of glycosylation, type IId, 607091 (3), Autosomal recessiveCongenital disorder of glycosylation, type IId, 607091 (3);chr9;B4GALT1, GGTB2, GT1, GTB, CDG2D;True
ENSG00000165269;Aquaporin-7;NotRelevant;;[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive[Glycerol quantitative trait locus], 614411 (3);chr9;AQP7, GLYCQTL;True
ENSG00000165272;Aquaporin-3;NotRelevant;incorrectly mapped to chr.7;[Blood group GIL], 607457 (3)[Blood group GIL], 607457 (3);chr9;AQP3;False
ENSG00000122735;Dynein, axonemal, intermediate chain 1;NotRelevant;;Ciliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3), Autosomal recessiveCiliary dyskinesia, primary, 1, with or without situs inversus, 244400 (3);chr9;DNAI1, CILD1, ICS, PCD;True
ENSG00000147955;Sigma nonopioid intracellular receptor 1;NotRelevant;mutation identified in 1 ALS16 family and 1 DSMA2 family;?Amyotrophic lateral sclerosis 16, juvenile, 614373 (3), Autosomal recessive?Spinal muscular atrophy, distal, autosomal recessive, 2, 605726 (3);chr9;SIGMAR1, SRBP, ALS16, DSMA2;True
ENSG00000213930;Galactose-1-phosphate uridyltransferase;NotRelevant;;Galactosemia, 230400 (3), Autosomal recessiveGalactosemia, 230400 (3);chr9;GALT;True
ENSG00000137070;Interleukin-11 receptor, alpha;NotRelevant;;Craniosynostosis and dental anomalies, 614188 (3), Autosomal recessiveCraniosynostosis and dental anomalies, 614188 (3);chr9;IL11RA, CRSDA;True
ENSG00000165280;Valosin-containing protein;NotRelevant;;Amyotrophic lateral sclerosis 14, with or without frontotemporal dementia, 613954 (3)Inclusion body myopathy with early-onset Paget disease and frontotemporal dementia 1, 167320 (3);chr9;VCP, IBMPFD1, ALS14, CMT2Y;False
ENSG00000221829;X-ray repair, complementing defective, in Chinese hamster, 9;NotRelevant;;Fanconi anemia, complementation group G, 614082 (3)Fanconi anemia, complementation group G, 614082 (3);chr9;XRCC9, FANCG;False
ENSG00000165282;Phosphatidylinositol glycan, class O;NotRelevant;;Hyperphosphatasia with mental retardation syndrome 2, 614749 (3), Autosomal recessiveHyperphosphatasia with mental retardation syndrome 2, 614749 (3);chr9;PIGO, HPMRS2;True
ENSG00000198853;RUN and SH3 domain-containing 2;NotRelevant;;Mental retardation, autosomal recessive 61, 617773 (3), Autosomal recessiveMental retardation, autosomal recessive 61, 617773 (3);chr9;RUSC2, KIAA0375, IPORIN, MRT61;True
ENSG00000269900;Mitochondrial RNA-processing endoribonuclease;NotRelevant;;Anauxetic dysplasia 1, 607095 (3), Autosomal recessiveMetaphyseal dysplasia without hypotrichosis, 250460 (3);chr9;RMRP, RMRPR, CHH;True
ENSG00000198467;Tropomyosin-2, beta;NotRelevant;;Arthrogryposis multiplex congenita, distal, type 1, 108120 (3), Autosomal dominantNemaline myopathy 4, autosomal dominant, 609285 (3);chr9;TPM2, TMSB, AMCD1, DA1, DA2B, NEM4;True
ENSG00000070610;Glucosidase, beta, acid 2;NotRelevant;;Spastic paraplegia 46, autosomal recessive, 614409 (3), Autosomal recessiveSpastic paraplegia 46, autosomal recessive, 614409 (3);chr9;GBA2, KIAA1605, SPG46;True
ENSG00000159899;Natiuretic peptide receptor 2;NotRelevant;;Acromesomelic dysplasia, Maroteaux type, 602875 (3), Autosomal recessiveShort stature with nonspecific skeletal abnormalities, 616255 (3);chr9;NPR2, ANPRB, AMDM, ECDM, SNSK;True
ENSG00000159921;UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase;NotRelevant;;Nonaka myopathy, 605820 (3), Autosomal recessiveSialuria, 269921 (3);chr9;GNE, GLCNE, IBM2, DMRV, NM;True
ENSG00000196092;Paired box homeotic gene-5 (B-cell lineage specific activator protein);NotRelevant;;{Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3){Leukemia, acute lymphoblastic, susceptibility to, 3}, 615545 (3);chr9;PAX5, BSAP, ALL3;False
ENSG00000137106;Glyoxylate reductase/hydroxypyruvate reductase;NotRelevant;;Hyperoxaluria, primary, type II, 260000 (3), Autosomal recessiveHyperoxaluria, primary, type II, 260000 (3);chr9;GRHPR, GLXR;True
ENSG00000107371;Exosome component 3;NotRelevant;;Pontocerebellar hypoplasia, type 1B, 614678 (3), Autosomal recessivePontocerebellar hypoplasia, type 1B, 614678 (3);chr9;EXOSC3, RRP40, PCH1B;True
ENSG00000165059;Protein kinase, cAMP-dependent, catalytic, gamma;NotRelevant;mutation identified in 1 BDPLT19 family;?Bleeding disorder, platelet-type, 19, 616176 (3), Autosomal recessive?Bleeding disorder, platelet-type, 19, 616176 (3);chr9;PRKACG, BDPLT19;True
ENSG00000165060;Frataxin;NotRelevant;;Friedreich ataxia, 229300 (3), Autosomal recessiveFriedreich ataxia, 229300 (3);chr9;FXN, FRDA, FARR, X25;True
ENSG00000119139;Tight junction protein 2;NotRelevant;;Cholestasis, progressive familial intrahepatic 4, 615878 (3), Autosomal recessiveHypercholanemia, familial, 607748 (3);chr9;TJP2, ZO2, PFIC4;True
ENSG00000207935;Micro RNA 204;NotRelevant;mutation identified in 1 RDICC family;?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3), Autosomal dominant?Retinal dystrophy and iris coloboma with or without cataract, 616722 (3);chr9;MIR204, MIRN204, RDICC;True
ENSG00000165091;Transmembrane channel-like protein 1;NotRelevant;;Deafness, autosomal dominant 36, 606705 (3), Autosomal dominantDeafness, autosomal recessive 7, 600974 (3);chr9;TMC1, DFNB7, DFNB11, DFNA36;True
ENSG00000119121;Transient receptor potential cation channel, subfamily M, member 6;NotRelevant;;Hypomagnesemia 1, intestinal, 602014 (3), Autosomal recessiveHypomagnesemia 1, intestinal, 602014 (3);chr9;TRPM6, CHAK2, HOMG1;True
ENSG00000197969;Vacuolar protein sorting 13A (chorein);NotRelevant;;Choreoacanthocytosis, 200150 (3), Autosomal recessiveChoreoacanthocytosis, 200150 (3);chr9;VPS13A, CHAC;True
ENSG00000156052;Guanine nucleotide-binding protein (G protein), q;NotRelevant;pseudogene on 2q;Capillary malformations, congenital, 1, somatic, mosaic, 163000 (3)Sturge-Weber syndrome, somatic, mosaic, 185300 (3);chr9;GNAQ, SWS, CMC1;False
ENSG00000148019;Centrosomal protein, 78kD;NotRelevant;;Cone-rod dystrophy and hearing loss, 617236 (3), Autosomal recessiveCone-rod dystrophy and hearing loss, 617236 (3);chr9;CEP78, CRDHL;True
ENSG00000135069;Phosphoserine aminotransferase 1;NotRelevant;mutation identified in 1 PSATD family;Neu-Laxova syndrome 2, 616038 (3), Autosomal recessiveNeu-Laxova syndrome 2, 616038 (3);chr9;PSAT1, PSAT, EPIP, PSATD, NLS2;True
ENSG00000165119;Heterogeneous nuclear ribonucleoprotein K;NotRelevant;;Au-Kline syndrome, 616580 (3), Autosomal dominantAu-Kline syndrome, 616580 (3);chr9;HNRNPK, HNRPK, AUKS;True
ENSG00000148053;Neurotrophic tyrosine kinase, receptor, type 2;NotRelevant;;Epileptic encephalopathy, early infantile, 58, 617830 (3), Autosomal dominantObesity, hyperphagia, and developmental delay, 613886 (3);chr9;NTRK2, TRKB, OBHD, EIEE58;True
ENSG00000135070;Iron-sulfur cluster assembly 1, S. cerevisiae, homolog of;NotRelevant;;Multiple mitochondrial dysfunctions syndrome 5, 617613 (3), Autosomal recessiveMultiple mitochondrial dysfunctions syndrome 5, 617613 (3);chr9;ISCA1, HBLD2, HISCA, MMDS5;True
ENSG00000187742;Selenocysteine insertion sequence-binding protein 2;NotRelevant;;Thyroid hormone metabolism, abnormal, 609698 (3)Thyroid hormone metabolism, abnormal, 609698 (3);chr9;SECISBP2, SBP2;False
ENSG00000148090;AU-specific RNA-binding protein (3-methylglutaconyl-CoA hydratase);NotRelevant;;3-methylglutaconic aciduria, type I, 250950 (3), Autosomal recessive3-methylglutaconic aciduria, type I, 250950 (3);chr9;AUH;True
ENSG00000169071;Receptor tyrosine kinase-like orphan receptor 2;NotRelevant;;Brachydactyly, type B1, 113000 (3), Autosomal dominantRobinow syndrome, autosomal recessive, 268310 (3);chr9;ROR2, BDB1, BDB, NTRKR2;True
ENSG00000090054;Serine palmitoyltransferase, long-chain base subunit 1;NotRelevant;;Neuropathy, hereditary sensory and autonomic, type IA, 162400 (3), Autosomal dominantNeuropathy, hereditary sensory and autonomic, type IA, 162400 (3);chr9;SPTLC1, LBC1, SPT1, HSN1, HSAN;True
ENSG00000196305;Isoleucine-tRNA synthetase;NotRelevant;;Growth retardation, intellectual developmental disorder, hypotonia, and hepatopathy, 617093 (3), Autosomal recessiveGrowth retardation, intellectual developmental disorder, hypotonia, and hepatopathy, 617093 (3);chr9;IARS, GRIDHH;True
ENSG00000106819;Asporin;NotRelevant;;{Lumbar disc degeneration}, 603932 (3){Osteoarthritis susceptibility 3}, 607850 (3);chr9;ASPN, PLAP1, OS3;False
ENSG00000185963;Bicaudal D, Drosophila, homolog of, 2;NotRelevant;;Spinal muscular atrophy, lower extremity-predominant, 2, AD, 615290 (3), Autosomal dominantSpinal muscular atrophy, lower extremity-predominant, 2, AD, 615290 (3);chr9;BICD2, KIAA0699, SMALED2;True
ENSG00000165140;Fructose-bisphosphatase 1;NotRelevant;;Fructose-1,6-bisphosphatase deficiency, 229700 (3), Autosomal recessiveFructose-1,6-bisphosphatase deficiency, 229700 (3);chr9;FBP1;True
ENSG00000158169;Fanconi anemia, complementation group C;NotRelevant;;Fanconi anemia, complementation group C, 227645 (3), Autosomal recessiveFanconi anemia, complementation group C, 227645 (3);chr9;FANCC, FACC;True
ENSG00000185920;Patched, Drosophila, homolog of;NotRelevant;;Basal cell carcinoma, somatic, 605462 (3)Holoprosencephaly 7, 610828 (3);chr9;PTCH1, NBCCS, BCNS, HPE7;False
ENSG00000182150;ERCC6-like 2;NotRelevant;;Bone marrow failure syndrome 2, 615715 (3), Autosomal recessiveBone marrow failure syndrome 2, 615715 (3);chr9;ERCC6L2, RAD26L, BMFS2;True
ENSG00000130948;Hydroxysteroid (17-beta) dehydrogenase 3;NotRelevant;;Pseudohermaphroditism, male, with gynecomastia, 264300 (3), Autosomal recessivePseudohermaphroditism, male, with gynecomastia, 264300 (3);chr9;HSD17B3, EDH17B3;True
ENSG00000196116;Tudor domain-containing protein 7;NotRelevant;;Cataract 36, 613887 (3), Autosomal recessiveCataract 36, 613887 (3);chr9;TDRD7, KIAA1529, TRAP, CATC4, CTRCT36;True
ENSG00000136936;XPA complementing gene;NotRelevant;;Xeroderma pigmentosum, group A, 278700 (3), Autosomal recessiveXeroderma pigmentosum, group A, 278700 (3);chr9;XPA, XPAC;True
ENSG00000178919;Forkhead box E1 (thyroid transcription factor-2);NotRelevant;;Bamforth-Lazarus syndrome, 241850 (3), Autosomal recessive{Thyroid cancer, nonmedullary, 4}, 616534 (3);chr9;FOXE1, FKHL15, TITF2, TTF2, NMTC4;True
ENSG00000095380;N-acetylneuraminic acid synthase (sialic acid synthase);NotRelevant;;Spondyloepimetaphyseal dysplasia, Camera-Genevieve type, 610442 (3), Autosomal recessiveSpondyloepimetaphyseal dysplasia, Camera-Genevieve type, 610442 (3);chr9;NANS, SAS, SEMDCG;True
ENSG00000136928;Gamma-aminobutyric acid B receptor 2;NotRelevant;;Epileptic encephalopathy, early infantile, 59, 617904 (3), Autosomal dominant{Nicotine dependence, susceptibility to}, 188890 (3);chr9;GABBR2, GPR51, EIEE59, NDPLHS;True
ENSG00000165138;Ankyrin repeat and sterile alpha motif domains-containing protein 6;NotRelevant;;Nephronophthisis 16, 615382 (3), Autosomal recessiveNephronophthisis 16, 615382 (3);chr9;ANKS6, PKDR1, NPHP16;True
ENSG00000119514;UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12;NotRelevant;;{Colorectal cancer, susceptibility to, 1}, 608812 (3){Colorectal cancer, susceptibility to, 1}, 608812 (3);chr9;GALNT12, CRCS1;False
ENSG00000106799;Transforming growth factor, beta receptor I (activin A receptor type II-like kinase, 53kD);NotRelevant;;Loeys-Dietz syndrome 1, 609192 (3), Autosomal dominant{Multiple self-healing squamous epithelioma, susceptibility to}, 132800 (3);chr9;TGFBR1, ALK5, AAT5, LDS1, MSSE;True
ENSG00000119523;Alg2, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 CDGII patient;?Congenital disorder of glycosylation, type Ii, 607906 (3), Autosomal recessiveMyasthenic syndrome, congenital, 14, with tubular aggregates, 616228 (3);chr9;ALG2, CDGII, CMSTA3, CMS14;True
ENSG00000119508;Chondrosarcoma, extraskeletal myxoid, fused to EWS in;NotRelevant;t(9;17)(q22Chondrosarcoma, extraskeletal myxoid, 612237 (3);chr9;CSMF;False
ENSG00000119509;Inversin;NotRelevant;;Nephronophthisis 2, infantile, 602088 (3), Autosomal recessiveNephronophthisis 2, infantile, 602088 (3);chr9;INVS, INV, NPHP2, NPH2;True
ENSG00000136881;Bile acid coenzyme A:amino acid N-acyltransferase (glycine N-choloyltransferase);NotRelevant;;Hypercholanemia, familial, 607748 (3), Autosomal recessiveHypercholanemia, familial, 607748 (3);chr9;BAAT;True
ENSG00000136872;Aldolase B, fructose-bisphosphatase;NotRelevant;;Fructose intolerance, hereditary, 229600 (3), Autosomal recessiveFructose intolerance, hereditary, 229600 (3);chr9;ALDOB;True
ENSG00000165029;ATP-binding cassette 1;NotRelevant;;{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3), Autosomal dominant{Coronary artery disease in familial hypercholesterolemia, protection against}, 143890 (3);chr9;ABCA1, ABC1, HDLDT1, TGD;True
ENSG00000106692;Fukutin;NotRelevant;;Cardiomyopathy, dilated, 1X, 611615 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3);chr9;FKTN, FCMD, CMD1X, LGMDR13, MDDGA4, MDDGB4, MDDGC4;True
ENSG00000186051;T-cell acute lymphocytic leukemia-2;NotRelevant;33kb from breakpoint in t(7;9)Leukemia, T-cell acute lymphocytic, somatic, 613065 (3);chr9;TAL2;False
ENSG00000095209;Transmembrane protein 38B;NotRelevant;;Osteogenesis imperfecta, type XIV, 615066 (3)Osteogenesis imperfecta, type XIV, 615066 (3);chr9;TMEM38B, TRICB, OI14;False
ENSG00000070061;Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase complex-associated protein;NotRelevant;;Dysautonomia, familial, 223900 (3), Autosomal recessiveDysautonomia, familial, 223900 (3);chr9;IKBKAP, IKAP;True
ENSG00000260230;Ferric-chelate reductase 1-like;NotRelevant;;Epileptic encephalopathy, early infantile, 37, 616981 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 37, 616981 (3);chr9;FRRS1L, C9orf4, CG6, EIEE37;True
ENSG00000030304;Receptor tyrosine kinase MuSK;NotRelevant;;Fetal akinesia deformation sequence, 208150 (3), Autosomal recessiveMyasthenic syndrome, congenital, 9, associated with acetylcholine receptor deficiency, 616325 (3);chr9;MUSK, CMS9, FADS;True
ENSG00000136875;Precursor mRNA-processing factor 4, S. cerevisiae, homolog of;NotRelevant;;Retinitis pigmentosa 70, 615922 (3), Autosomal dominantRetinitis pigmentosa 70, 615922 (3);chr9;PRPF4, PRP4, HPRP4, RP70;True
ENSG00000148218;Aminolevulinate, delta-, dehydratase;NotRelevant;linked to ABO; ORM-ALAD-AK-ABO{Lead poisoning, susceptibility to}, 612740 (3);chr9;ALAD, ALADH, PBGS;False
ENSG00000196739;Collagen, type XXVII, alpha-1;NotRelevant;;Steel syndrome, 615155 (3), Autosomal recessiveSteel syndrome, 615155 (3);chr9;COL27A1, KIAA1870, STLS;True
ENSG00000095397;Whirlin;NotRelevant;;Deafness, autosomal recessive 31, 607084 (3), Autosomal recessiveUsher syndrome, type 2D, 611383 (3);chr9;WHRN, CIP98, KIAA1526, DFNB31, USH2D;True
ENSG00000041982;Tenascin C (hexabrachion);NotRelevant;proximal to ABL;Deafness, autosomal dominant 56, 615629 (3), Autosomal dominantDeafness, autosomal dominant 56, 615629 (3);chr9;TNC, HXB, DFNA56;True
ENSG00000173077;Deleted in esophageal cancer 1;NotRelevant;;Esophageal squamous cell carcinoma, 133239 (1), Autosomal dominantEsophageal squamous cell carcinoma, 133239 (1);chr9;DEC1;True
ENSG00000119401;Tripartite-motif-containing protein 32;NotRelevant;mutation identified in 1 BBS11 family;?Bardet-Biedl syndrome 11, 615988 (3), Autosomal recessiveMuscular dystrophy, limb-girdle, autosomal recessive 8, 254110 (3);chr9;TRIM32, HT2A, LGMDR8, BBS11;True
ENSG00000136861;CDK5 regulatory subunit-associated protein 2;NotRelevant;;Microcephaly 3, primary, autosomal recessive, 604804 (3), Autosomal recessiveMicrocephaly 3, primary, autosomal recessive, 604804 (3);chr9;CDK5RAP2, KIAA1633, MCPH3;True
ENSG00000106804;Complement component-5;NotRelevant;;C5 deficiency, 609536 (3)[Eculizumab, poor response to], 615749 (3);chr9;C5, C5D, ECLZB;False
ENSG00000148180;Gelsolin;NotRelevant;40kb proximal to ABL;Amyloidosis, Finnish type, 105120 (3), Autosomal dominantAmyloidosis, Finnish type, 105120 (3);chr9;GSN;True
ENSG00000148204;Crumbs, Drosophila, homolog of;NotRelevant;;Focal segmental glomerulosclerosis 9, 616220 (3), Autosomal recessiveVentriculomegaly with cystic kidney disease, 219730 (3);chr9;CRB2, FSGS9, VMCKD;True
ENSG00000136931;Nuclear receptor subfamily 5, group A, member 1;NotRelevant;;Adrenocortical insufficiency, 612964 (3), Autosomal dominantSpermatogenic failure 8, 613957 (3);chr9;NR5A1, FTZF1, FTZ1, SF1, AD4BP, POF7, SRXY3, SPGF8, SRXX4;True
ENSG00000136944;LIM homeo box transcription factor 1, beta;NotRelevant;;Nail-patella syndrome, 161200 (3), Autosomal dominantNail-patella syndrome, 161200 (3);chr9;LMX1B, NPS1;True
ENSG00000148356;Leucine-rich repeat- and sterile alpha motif-containing 1;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2P, 614436 (3), Autosomal recessive, Autosomal dominantCharcot-Marie-Tooth disease, axonal, type 2P, 614436 (3);chr9;LRSAM1, TAL, RIFLE, CMT2P;True
ENSG00000136854;Syntaxin-binding protein 1;NotRelevant;;Epileptic encephalopathy, early infantile, 4, 612164 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 4, 612164 (3);chr9;STXBP1, UNC18, EIEE4;True
ENSG00000284547;Micro RNA 2861;NotRelevant;;[Bone mineral density QTL 15], 613418 (3), Autosomal recessive, Autosomal dominant[Bone mineral density QTL 15], 613418 (3);chr9;MIR2861, MIRN2861, BMND15;True
ENSG00000106991;Endoglin;NotRelevant;;Telangiectasia, hereditary hemorrhagic, type 1, 187300 (3), Autosomal dominantTelangiectasia, hereditary hemorrhagic, type 1, 187300 (3);chr9;ENG, END, HHT1, ORW;True
ENSG00000106992;Adenylate kinase-1;NotRelevant;proximal to Ph1 break, 9q34.1; AK1 to ORM = 17cMHemolytic anemia due to adenylate kinase deficiency, 612631 (3);chr9;AK1;False
ENSG00000136908;Dolichyl-phosphate mannosyltransferase 2, regulatory subunit;NotRelevant;;Congenital disorder of glycosylation, type Iu, 615042 (3), Autosomal recessiveCongenital disorder of glycosylation, type Iu, 615042 (3);chr9;DPM2, CDG1U;True
ENSG00000106976;Dynamin-1;NotRelevant;;Epileptic encephalopathy, early infantile, 31, 616346 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 31, 616346 (3);chr9;DNM1, EIEE31;True
ENSG00000167113;Coenzyme Q4, S. cerevisiae, homolog of;NotRelevant;;Coenzyme Q10 deficiency, primary, 7, 616276 (3), Autosomal recessiveCoenzyme Q10 deficiency, primary, 7, 616276 (3);chr9;COQ4, COQ10D7;True
ENSG00000167114;Solute carrier family 27 (fatty acid transporter), member 4;NotRelevant;;Ichthyosis prematurity syndrome, 608649 (3)Ichthyosis prematurity syndrome, 608649 (3);chr9;SLC27A4, FATP4, IPS;False
ENSG00000119392;Gle1, RNA export mediator, S. cerevisiae, homolog of;NotRelevant;;Arthrogryposis, lethal, with anterior horn cell disease, 611890 (3)Lethal congenital contracture syndrome 1, 253310 (3);chr9;GLE1, GLE1L, LCCS, LCCS1;False
ENSG00000197694;Spectrin, alpha, nonerythrocytic-1 (alpha-fodrin);NotRelevant;;Epileptic encephalopathy, early infantile, 5, 613477 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 5, 613477 (3);chr9;SPTAN1, NEAS, EIEE5;True
ENSG00000119333;WD repeat-containing protein 34;NotRelevant;;Short-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3), Autosomal recessiveShort-rib thoracic dysplasia 11 with or without polydactyly, 615633 (3);chr9;WDR34, SRTD11;True
ENSG00000119335;SET gene;NotRelevant;fused with CAIN in acute undifferentiated leukemia;Mental retardation, autosomal dominant 58, 618106 (3), Autosomal dominantMental retardation, autosomal dominant 58, 618106 (3);chr9;SET, MRD58;True
ENSG00000136802;Leucine-rich repeat-containing 8A;NotRelevant;mutation identified in 1 AGM5 patient;?Agammaglobulinemia 5, 613506 (3), Autosomal dominant?Agammaglobulinemia 5, 613506 (3);chr9;LRRC8A, KIAA1437, AGM5;True
ENSG00000175283;Dolichol kinase;NotRelevant;;Congenital disorder of glycosylation, type Im, 610768 (3), Autosomal recessiveCongenital disorder of glycosylation, type Im, 610768 (3);chr9;DOLK, TMEM15, DK1, SEC59, KIAA1094, CDG1M;True
ENSG00000095321;Carnitine acetyltransferase;NotRelevant;mutation identified in 1 NBIA8 patient;?Neurodegeneration with brain iron accumulation 8, 617917 (3), Autosomal recessive?Neurodegeneration with brain iron accumulation 8, 617917 (3);chr9;CRAT, CAT1, NBIA8;True
ENSG00000136816;Torsin 1B;NotRelevant;centromeric to TOR1A; pseudogene on chr.2;chr9;TOR1B, DQ1;False
ENSG00000136827;Torsin A;NotRelevant;;{Dystonia-1, modifier of} (3){Dystonia-1, modifier of} (3);chr9;DYT1, TOR1A;False
ENSG00000130707;Argininosuccinate synthetase 1;NotRelevant;14 pseudogenes on 11 chromosomes, including X and Y and ASSP2 on 6p23-q12;Citrullinemia, 215700 (3), Autosomal recessiveCitrullinemia, 215700 (3);chr9;ASS1, ASS;True
ENSG00000130711;PR domain-containing protein 12;NotRelevant;;Neuropathy, hereditary sensory and autonomic, type VIII, 616488 (3), Autosomal recessiveNeuropathy, hereditary sensory and autonomic, type VIII, 616488 (3);chr9;PRDM12, HSAN8;True
ENSG00000130713;Exosome component 2;NotRelevant;;Short stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3), Autosomal recessiveShort stature, hearing loss, retinitis pigmentosa, and distinctive facies, 617763 (3);chr9;EXOSC2, RRP4, SHRF;True
ENSG00000097007;Abelson murine leukemia viral (v-abl) oncogene homolog 1;NotRelevant;fusion hybrid gene with BCR1 in CML;Congenital heart defects and skeletal malformations syndrome, 617602 (3), Autosomal dominantLeukemia, Philadelphia chromosome-positive, resistant to imatinib (3);chr9;ABL1, CHDSKM;True
ENSG00000050555;Laminin, gamma-3;NotRelevant;;Cortical malformations, occipital, 614115 (3), Autosomal recessiveCortical malformations, occipital, 614115 (3);chr9;LAMC3, OCCM;True
ENSG00000126883;Nucleoporin, 214kD;NotRelevant;fused with DEK in AML; fused with ABL1 in T-ALLLeukemia, acute myeloid, somatic, 601626 (3);chr9;NUP214, D9S46E, CAN, CAIN;False
ENSG00000130714;Protein O-mannosyltransferase 1;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 1, 236670 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle), type C, 1, 609308 (3);chr9;POMT1, MDDGA1, MDDGB1, MDDGC1, LGMDR11;True
ENSG00000107290;Senataxin;NotRelevant;;Amyotrophic lateral sclerosis 4, juvenile, 602433 (3), Autosomal dominantSpinocerebellar ataxia, autosomal recessive 1, 606002 (3);chr9;SETX, SCAR1, AOA2, ALS4;True
ENSG00000165699;Hamartin (tuberous sclerosis 1 gene);NotRelevant;linked to ABO, ABL;Focal cortical dysplasia, type II, somatic, 607341 (3)Tuberous sclerosis-1, 191100 (3);chr9;TSC1, LAM;False
ENSG00000165702;Growth factor-independent 1B;NotRelevant;;Bleeding disorder, platelet-type, 17, 187900 (3), Autosomal recessive, Autosomal dominantBleeding disorder, platelet-type, 17, 187900 (3);chr9;GFI1B, BDPLT17;True
ENSG00000170835;Carboxyl-ester lipase (bile-salt stimulated lipase);NotRelevant;;Maturity-onset diabetes of the young, type VIII, 609812 (3), Autosomal dominantMaturity-onset diabetes of the young, type VIII, 609812 (3);chr9;CEL, BSSL, CELL, MODY8;True
ENSG00000175164;ABO glycosyltransferase;NotRelevant;linked to AK1;[Blood group, ABO system], 616093 (3)[Blood group, ABO system], 616093 (3);chr9;ABO;False
ENSG00000148290;Surfeit-1;NotRelevant;distal to ABL, CAN;Charcot-Marie-Tooth disease, type 4K, 616684 (3), Autosomal recessiveLeigh syndrome, due to COX IV deficiency, 256000 (3);chr9;SURF1, CMT4K;True
ENSG00000160323;A disintegrin-like and metalloprotease with thrombospondin type 1 motif, 13;NotRelevant;;Thrombotic thrombocytopenic purpura, familial, 274150 (3), Autosomal recessiveThrombotic thrombocytopenic purpura, familial, 274150 (3);chr9;ADAMTS13, VWFCP, TTP;True
ENSG00000187616;Myomaker;NotRelevant;;Carey-Fineman-Ziter syndrome, 254940 (3), Autosomal recessiveCarey-Fineman-Ziter syndrome, 254940 (3);chr9;MYMK, TMEM8C;True
ENSG00000197859;ADAMTS-like protein 2;NotRelevant;;Geleophysic dysplasia 1, 231050 (3), Autosomal recessiveGeleophysic dysplasia 1, 231050 (3);chr9;ADAMTSL2, KIAA0605, GPHYSD1;True
ENSG00000123454;Dopamine-beta-hydroxylase;NotRelevant;tightly linked to ABO;Orthostatic hypotension 1, due to DBH deficiency, 223360 (3), Autosomal recessiveOrthostatic hypotension 1, due to DBH deficiency, 223360 (3);chr9;DBH, ORTHYP1;True
ENSG00000123453;Sarcosine dehydrogenase;NotRelevant;;[Sarcosinemia], 268900 (3), Autosomal recessive[Sarcosinemia], 268900 (3);chr9;SARDH, SARD, SAR;True
ENSG00000130635;Collagen V, alpha-1 polypeptide;NotRelevant;;Ehlers-Danlos syndrome, classic type, 1, 130000 (3), Autosomal dominantEhlers-Danlos syndrome, classic type, 1, 130000 (3);chr9;COL5A1, EDSCL1;True
ENSG00000122140;Mitochondrial ribosomal protein S2;NotRelevant;;Combined oxidative phosphorylation deficiency 36, 617950 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 36, 617950 (3);chr9;MRPS2, COXPD36;True
ENSG00000165643;Spermatogenesis- and oogenesis-specific basic helix-loop-helix protein 1;NotRelevant;;Ovarian dysgenesis 5, 617690 (3), Autosomal recessiveSpermatogenic failure 32, 618115 (3);chr9;SOHLH1, NOHLH, TEB2, ODG5, SPGF32;True
ENSG00000107147;Potassium channel, subfamily T, member 1;NotRelevant;;Epilepsy, nocturnal frontal lobe, 5, 615005 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 14, 614959 (3);chr9;KCNT1, KIAA1422, EIEE14, ENFL5;True
ENSG00000107187;LIM/homeodomain protein LHX3;NotRelevant;in mouse, close to Notch1; centromeric to ABLPituitary hormone deficiency, combined, 3, 221750 (3);chr9;LHX3, CPHD3;False
ENSG00000187796;Caspase recruitment domain-containing protein 9;NotRelevant;;Candidiasis, familial, 2, autosomal recessive, 212050 (3), Autosomal recessiveCandidiasis, familial, 2, autosomal recessive, 212050 (3);chr9;CARD9, CANDF2;True
ENSG00000165688;Peptidase, mitochondrial processing, alpha;NotRelevant;;Spinocerebellar ataxia, autosomal recessive 2, 213200 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 2, 213200 (3);chr9;PMPCA, KIAA0123, SCAR2;True
ENSG00000148384;Inositol polyphosphate-5-phosphatase, 72kD;NotRelevant;;Joubert syndrome 1, 213300 (3), Autosomal recessiveMental retardation, truncal obesity, retinal dystrophy, and micropenis, 610156 (3);chr9;INPP5E, MORMS, JBTS1, CORS1;True
ENSG00000148400;Notch, Drosophila, homolog of, 1, translocation-associated;NotRelevant;;Adams-Oliver syndrome 5, 616028 (3), Autosomal dominantAortic valve disease 1, 109730 (3);chr9;NOTCH1, TAN1, AOS5, AOVD1;True
ENSG00000169692;1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase-beta);NotRelevant;;Lipodystrophy, congenital generalized, type 1, 608594 (3), Autosomal recessiveLipodystrophy, congenital generalized, type 1, 608594 (3);chr9;AGPAT2, LPAAB, BSCL, BSCL1;True
ENSG00000177239;Mannosidase, alpha, class 1B member 1;NotRelevant;;Mental retardation, autosomal recessive 15, 614202 (3), Autosomal recessiveMental retardation, autosomal recessive 15, 614202 (3);chr9;MAN1B1, MRT15;True
ENSG00000176884;Glutamate receptor, ionotropic, N-methyl D-aspartate 1;NotRelevant;;Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant, 614254 (3), Autosomal dominantNeurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive, 617820 (3);chr9;GRIN1, NMDAR1, NDHMSR, NDHMSD;True
ENSG00000176058;Taperin;NotRelevant;;Deafness, autosomal recessive 79, 613307 (3), Autosomal recessiveDeafness, autosomal recessive 79, 613307 (3);chr9;TPRN, C9orf75, DFNB79;True
ENSG00000198569;Solute carrier family 34 (sodium/phosphate cotransporter), member 3;NotRelevant;;Hypophosphatemic rickets with hypercalciuria, 241530 (3), Autosomal recessiveHypophosphatemic rickets with hypercalciuria, 241530 (3);chr9;SLC34A3, NPTIIC, HHRH;True
ENSG00000188229;Tubulin, beta-4B;NotRelevant;;Leber congenital amaurosis with early-onset deafness, 617879 (3), Autosomal dominantLeber congenital amaurosis with early-onset deafness, 617879 (3);chr9;TUBB4B, TUBB2C, LCAEOD;True
ENSG00000165802;NMDA receptor synaptonuclear signaling and neuronal migration factor;NotRelevant;;Hypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3), Autosomal dominantHypogonadotropic hypogonadism 9 with or without anosmia, 614838 (3);chr9;NSMF, NELF, HH9;True
ENSG00000181090;Euchromatic histone methyltransferase 1;NotRelevant;;Kleefstra syndrome 1, 610253 (3), Autosomal dominantKleefstra syndrome 1, 610253 (3);chr9;EHMT1, EUHMTASE1, KMT1D, DEL9q34, KLEFS1;True
ENSG00000148408;Calcium channel, voltage-dependent, L type, alpha 1B subunit;NotRelevant;mutation identified in 1 DYT23 family;?Dystonia 23, 614860 (3), Autosomal dominant?Dystonia 23, 614860 (3);chr9;CACNA1B, CACNL1A5, DYT23;True
ENSG00000261456;Tubulin, beta 8;NotRelevant;;Oocyte maturation defect 2, 616780 (3), Autosomal recessive, Autosomal dominantOocyte maturation defect 2, 616780 (3);chr10;TUBB8, OOMD2;True
ENSG00000015171;Zinc finger MYND domain-containing protein 11;NotRelevant;;Mental retardation, autosomal dominant 30, 616083 (3), Autosomal dominantMental retardation, autosomal dominant 30, 616083 (3);chr10;ZMYND11, BS69, BRAM1, MRD30;True
ENSG00000067082;Kruppel-like factor-6;NotRelevant;;Gastric cancer, somatic, 613659 (3)Prostate cancer, somatic, 176807 (3);chr10;KLF6, COPEB, BCD1, ZF9;False
ENSG00000151632;Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase, type II);NotRelevant;;46XY sex reversal 8, 614279 (3), Autosomal recessive46XY sex reversal 8, 614279 (3);chr10;AKR1C2, DDH2, DD2, HAKRD, SRXY8;True
ENSG00000198610;Aldo-keto reductase family 1, member C4 (chlordecone reductase);NotRelevant;;{46XY sex reversal 8, modifier of}, 614279 (3), Autosomal recessive{46XY sex reversal 8, modifier of}, 614279 (3);chr10;AKR1C4, CHDR, CDR, HAKRA, DD4;True
ENSG00000134460;Interleukin-2 receptor, alpha;NotRelevant;;{Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3){Diabetes, mellitus, insulin-dependent, susceptibility to, 10}, 601942 (3);chr10;IL2RA, CD25, IL2R, IDDM10, IMD41;False
ENSG00000107485;GATA-binding protein-3;NotRelevant;;Hypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3), Autosomal dominantHypoparathyroidism, sensorineural deafness, and renal dysplasia, 146255 (3);chr10;GATA3, HDR, HDRS;True
ENSG00000181192;Dehydrogenase E1 and transketolase domains-containing protein 1;NotRelevant;mutation identified in 1 CMT2Q family;2-aminoadipic 2-oxoadipic aciduria, 204750 (3), Autosomal recessive?Charcot-Marie-Tooth disease, axonal, type 2Q, 615025 (3);chr10;DHTKD1, KIAA1630, AMOXAD, CMT2Q;True
ENSG00000123240;Optineurin;NotRelevant;;Amyotrophic lateral sclerosis 12, 613435 (3){Glaucoma, normal tension, susceptibility to}, 606657 (3);chr10;OPTN, GLC1E, FIP2, HYPL, NRP, ALS12;False
ENSG00000107537;Phytanoyl-CoA hydroxylase;NotRelevant;;Refsum disease, 266500 (3), Autosomal recessiveRefsum disease, 266500 (3);chr10;PHYH, PAHX;True
ENSG00000151474;FERM domain-containing protein 4A;NotRelevant;mutation identified in 1 CCAFCA family;?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3), Autosomal recessive?Corpus callosum, agenesis of, with facial anomalies and cerebellar ataxia, 616819 (3);chr10;FRMD4A, KIAA1294, CCAFCA;True
ENSG00000152457;DNA cross-link repair protein 1C;NotRelevant;;Omenn syndrome, 603554 (3), Autosomal recessiveSevere combined immunodeficiency, Athabascan type, 602450 (3);chr10;DCLRE1C, ARTEMIS, SCIDA;True
ENSG00000077943;Integrin, alpha-8;NotRelevant;;Renal hypodysplasia/aplasia 1, 191830 (3), Autosomal recessiveRenal hypodysplasia/aplasia 1, 191830 (3);chr10;ITGA8, RHDA1;True
ENSG00000107611;Cubilin (intrinsic factor-cobalamin receptor);NotRelevant;;Megaloblastic anemia-1, Finnish type, 261100 (3), Autosomal recessiveMegaloblastic anemia-1, Finnish type, 261100 (3);chr10;CUBN, IFCR, MGA1;True
ENSG00000026025;Vimentin;NotRelevant;;Cataract 30, pulverulent, 116300 (3), Autosomal dominantCataract 30, pulverulent, 116300 (3);chr10;VIM, CTRCT30;True
ENSG00000165995;Calcium channel, voltage-dependent, beta 2 subunit;NotRelevant;;Brugada syndrome 4, 611876 (3)Brugada syndrome 4, 611876 (3);chr10;CACNB2;False
ENSG00000078403;ALL1 fused gene from chromosome 10;NotRelevant;fuses with MLL and HEAB;Leukemia, acute myeloid, 601626 (3), Autosomal dominant, Somatic mutationLeukemia, acute myeloid, 601626 (3);chr10;AF10;True
ENSG00000168267;Pancreas transcription factor 1, alpha subunit;NotRelevant;;Pancreatic agenesis 2, 615935 (3), Autosomal recessivePancreatic and cerebellar agenesis, 609069 (3);chr10;PTF1A, PACA, PAGEN2;True
ENSG00000095777;Myosin IIIA;NotRelevant;;Deafness, autosomal recessive 30, 607101 (3), Autosomal recessiveDeafness, autosomal recessive 30, 607101 (3);chr10;MYO3A, DFNB30;True
ENSG00000148459;Prenyl diphosphate synthase, subunit 1;NotRelevant;;Coenzyme Q10 deficiency, primary, 2, 614651 (3), Autosomal recessiveCoenzyme Q10 deficiency, primary, 2, 614651 (3);chr10;PDSS1, TPT, COQ1, COQ10D2;True
ENSG00000107890;Ankyrin repeat domain-containing protein 26;NotRelevant;;Thrombocytopenia 2, 188000 (3), Autosomal dominantThrombocytopenia 2, 188000 (3);chr10;ANKRD26, KIAA1074, THC2;True
ENSG00000136758;Mitochondrial escape 1-like 1;NotRelevant;mutation identified in1 OPA11 family;?Optic atrophy 11, 617302 (3), Autosomal recessive?Optic atrophy 11, 617302 (3);chr10;YME1L1, YME1L, PAMP, OPA11;True
ENSG00000099246;Ras-associated protein RAB18;NotRelevant;;Warburg micro syndrome 3, 614222 (3), Autosomal recessiveWarburg micro syndrome 3, 614222 (3);chr10;RAB18, WARBM3;True
ENSG00000169126;Armadillo repeat-containing protein 4;NotRelevant;;Ciliary dyskinesia, primary, 23, 615451 (3), Autosomal recessiveCiliary dyskinesia, primary, 23, 615451 (3);chr10;ARMC4, CILD23;True
ENSG00000095787;WW domain-containing adaptor with coiled-coil region;NotRelevant;;Desanto-Shinawi syndrome, 616708 (3), Autosomal dominantDesanto-Shinawi syndrome, 616708 (3);chr10;WAC, KIAA1844, DESSH;True
ENSG00000107951;Mitochondrial poly(A) polymerase;NotRelevant;mutation identified in 1 SPAX4 family;?Spastic ataxia 4, autosomal recessive, 613672 (3), Autosomal recessive?Spastic ataxia 4, autosomal recessive, 613672 (3);chr10;MTPAP, PAPD1, SPAX4;True
ENSG00000107968;Mitogen-activated protein kinase kinase kinase 8 (cancer Osaka thyroid oncogene);NotRelevant;;Lung cancer, somatic, 211980 (3)Lung cancer, somatic, 211980 (3);chr10;MAP3K8, COT, EST, TPL2;False
ENSG00000148516;Zinc finger E box-binding homeobox 1;NotRelevant;;Corneal dystrophy, Fuchs endothelial, 6, 613270 (3)Corneal dystrophy, posterior polymorphous, 3, 609141 (3);chr10;ZEB1, TCF8, NIL2A, PPCD3, FECD6;False
ENSG00000150093;Integrin, beta-1 (fibronectin receptor, beta polypeptide;NotRelevant;ENSG00000150093;pseudogene FNRBL on 19p;chr10;ITGB1, FNRB;False
ENSG00000165733;Bms1, ribosome assembly protein, S. cerevisiae, homolog of;NotRelevant;mutation identified in one ACC family;?Aplasia cutis congenita, nonsyndromic, 107600 (3), Autosomal dominant?Aplasia cutis congenita, nonsyndromic, 107600 (3);chr10;BMS1, BMS1L, KIAA0187, ACC;True
ENSG00000165731;RET transforming sequence;NotRelevant;ENSG00000165731;{Hirschsprung disease, susceptibility to, 1}, 142623 (3);chr10;RET, MEN2A, HSCR1;False
ENSG00000107562;Chemokine, C-X-C motif, ligand 12 (stromal cell-derived factor 1);NotRelevant;;{AIDS, resistance to}, 609423 (3){AIDS, resistance to}, 609423 (3);chr10;CXCL12, SDF1;False
ENSG00000012779;Arachidonate 5-lipoxygenase;NotRelevant;;{Asthma, diminished response to antileukotriene treatment in}, 600807 (3), Autosomal dominant{Atherosclerosis, susceptibility to} (3);chr10;ALOX5;True
ENSG00000263639;Microseminoprotein, beta;NotRelevant;;{Prostate cancer, hereditary, 13}, 611928 (3){Prostate cancer, hereditary, 13}, 611928 (3);chr10;MSMB, HPC13;False
ENSG00000263761;Growth differentiation factor 2 (bone morphogenetic protein 9);NotRelevant;;Telangiectasia, hereditary hemorrhagic, type 5, 615506 (3), Autosomal dominantTelangiectasia, hereditary hemorrhagic, type 5, 615506 (3);chr10;GDF2, BMP9, HHT5;True
ENSG00000265203;Retinol-binding protein-3, interstitial;NotRelevant;1 family identified with mutation;?Retinitis pigmentosa 66, 615233 (3), Autosomal recessive?Retinitis pigmentosa 66, 615233 (3);chr10;RBP3, RP66;True
ENSG00000225830;Excision repair cross complementing rodent repair deficiency, complementation group 6;NotRelevant;;Cerebrooculofacioskeletal syndrome 1, 214150 (3), Autosomal recessive{Macular degeneration, age-related, susceptibility to, 5}, 613761 (3);chr10;ERCC6, CKN2, COFS1, CSB, ARMD5, UVSS1, POF11;True
ENSG00000070748;Choline acetyltransferase;NotRelevant;;Myasthenic syndrome, congenital, 6, presynaptic, 254210 (3), Autosomal recessiveMyasthenic syndrome, congenital, 6, presynaptic, 254210 (3);chr10;CHAT, CMS6;True
ENSG00000187714;Solute carrier family 18 (vesicular acetylcholine), member 3;NotRelevant;;Myasthenic syndrome, congenital, 21, presynaptic, 617239 (3), Autosomal recessiveMyasthenic syndrome, congenital, 21, presynaptic, 617239 (3);chr10;SLC18A3, VACHT, CMS21;True
ENSG00000185532;Protein kinase, cGMP-dependent, regulatory, type I;NotRelevant;;Aortic aneurysm, familial thoracic 8, 615436 (3), Autosomal dominantAortic aneurysm, familial thoracic 8, 615436 (3);chr10;PRKG1, PRKG1B, PRKGR1B, AAT8;True
ENSG00000165471;Mannose-binding lectin 2, soluble (opsonic defect);NotRelevant;near MEN2A;{Chronic infections, due to MBL deficiency}, 614372 (3), Autosomal dominant{Chronic infections, due to MBL deficiency}, 614372 (3);chr10;MBL2, MBL, MBP1, MBL2D, MBPD;True
ENSG00000150275;Protocadherin 15;NotRelevant;;Deafness, autosomal recessive 23, 609533 (3), Autosomal recessiveUsher syndrome, type 1F, 602083 (3);chr10;PCDH15, DFNB23, USH1F;True
ENSG00000108064;Transcription factor A, mitochondrial;NotRelevant;mutation identified in 1 MTDPS15 family;?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type), 617156 (3), Autosomal recessive?Mitochondrial DNA depletion syndrome 15 (hepatocerebral type), 617156 (3);chr10;TFAM, TCF6L2, TCF6L1, TCF6L3, MTTF1, TCF6, MTDPS15;True
ENSG00000122870;Bicaudal C, Drosophila, homolog of, 1;NotRelevant;;{Renal dysplasia, cystic, susceptibility to}, 601331 (3), Autosomal dominant{Renal dysplasia, cystic, susceptibility to}, 601331 (3);chr10;BICC1, BICC, CYSRD;True
ENSG00000151150;Ankyrin-3, node of Ranvier;NotRelevant;mutation identified in 1 family;?Mental retardation, autosomal recessive, 37, 615493 (3), Autosomal recessive?Mental retardation, autosomal recessive, 37, 615493 (3);chr10;ANK3, MRT37;True
ENSG00000138311;Zinc finger protein 365;NotRelevant;;{Nephrolithiasis, uric acid, susceptibility to}, 605990 (3){Nephrolithiasis, uric acid, susceptibility to}, 605990 (3);chr10;ZNF365, UAN;False
ENSG00000122877;KROX-20, Drosophila, homolog of (early growth response-2);NotRelevant;;Charcot-Marie-Tooth disease, type 1D, 607678 (3), Autosomal dominantHypomyelinating neuropathy, congenital, 1, 605253 (3);chr10;EGR2, KROX20, CHN1;True
ENSG00000183230;Catenin, alpha-3;NotRelevant;;Arrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3), Autosomal dominantArrhythmogenic right ventricular dysplasia, familial, 13, 615616 (3);chr10;CTNNA3, ARVD13;True
ENSG00000108176;DNAJ/HSP40 homolog, subfamily C, member 12;NotRelevant;;Hyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3), Autosomal recessiveHyperphenylalaninemia, mild, non-BH4-deficient, 617384 (3);chr10;DNAJC12, JDP1, HPANBH4;True
ENSG00000138347;Myopalladin;NotRelevant;;Cardiomyopathy, dilated, 1KK, 615248 (3), Autosomal dominantNemaline myopathy 11, autosomal recessive, 617336 (3);chr10;MYPN, CMD1DD, CMH22, RCM4, NEM11;True
ENSG00000179774;Atonal, Drosophila, homolog of, 7;NotRelevant;;Persistent hyperplastic primary vitreous, autosomal recessive, 221900 (3), Autosomal recessivePersistent hyperplastic primary vitreous, autosomal recessive, 221900 (3);chr10;ATOH7, PHPVAR, NCRNA;True
ENSG00000138346;DNA replication helicase 2, yeast, homolog of;NotRelevant;mutation identified in 1 SCKL8 family;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3), Autosomal dominantProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3);chr10;DNA2, DNA2L, KIAA0083, PEOA6, SCKL8;True
ENSG00000165730;Storkhead box 1;NotRelevant;;Preeclampsia/eclampsia 4, 609404 (3)Preeclampsia/eclampsia 4, 609404 (3);chr10;STOX1, PEE4;False
ENSG00000198954;KIAA1279 gene;NotRelevant;;Goldberg-Shprintzen megacolon syndrome, 609460 (3), Autosomal recessiveGoldberg-Shprintzen megacolon syndrome, 609460 (3);chr10;KIAA1279;True
ENSG00000156515;Hexokinase-1;NotRelevant;10p11.2 conflicting assignment; ?2 loci on chr.10Retinitis pigmentosa 79, 617460 (3);chr10;HK1, HKD, HMSNR, RP79;False
ENSG00000122859;Neurogenin 3;NotRelevant;;Diarrhea 4, malabsorptive, congenital, 610370 (3), Autosomal recessiveDiarrhea 4, malabsorptive, congenital, 610370 (3);chr10;NEUROG3, NGN3, ATOH5;True
ENSG00000197467;Collagen XIII, alpha-1 polypeptide;NotRelevant;~550kb proximal to P4HA;Myasthenic syndrome, congenital, 19, 616720 (3), Autosomal recessiveMyasthenic syndrome, congenital, 19, 616720 (3);chr10;COL13A1, CMS19;True
ENSG00000156574;Nodal, mouse, homolog of;NotRelevant;;Heterotaxy, visceral, 5, 270100 (3), Autosomal dominantHeterotaxy, visceral, 5, 270100 (3);chr10;NODAL, HTX5;True
ENSG00000180644;Perforin;NotRelevant;mistakenly assigned to chr.17;Aplastic anemia, 609135 (3)Lymphoma, non-Hodgkin, 605027 (3);chr10;PRF1, HPLH2, FLH2;False
ENSG00000166224;Sphingosine-1-phosphate lyase 1;NotRelevant;;Nephrotic syndrome, type 14, 617575 (3), Autosomal recessiveNephrotic syndrome, type 14, 617575 (3);chr10;SGPL1, SPL, NPHS14;True
ENSG00000166228;Pterin-4a-carbinolamine dehydratase 1;NotRelevant;;Hyperphenylalaninemia, BH4-deficient, D, 264070 (3), Autosomal recessiveHyperphenylalaninemia, BH4-deficient, D, 264070 (3);chr10;PCBD1, DCOH;True
ENSG00000198246;Solute carrier family 29 (nucleoside transporter), member 3;NotRelevant;;Histiocytosis-lymphadenopathy plus syndrome, 602782 (3), Autosomal recessiveHistiocytosis-lymphadenopathy plus syndrome, 602782 (3);chr10;SLC29A3, ENT3, PHID, HCLAP;True
ENSG00000107736;Cadherin-23 (otocadherin);NotRelevant;between D10S529 and D10S573;Deafness, autosomal recessive 12, 601386 (3), Autosomal recessive{Pituitary adenoma 5, multiple types}, 617540 (3);chr10;CDH23, USH1D, DFNB12, PITA5;True
ENSG00000197746;Prosaposin (sphingolipid activator protein-1);NotRelevant;;Combined SAP deficiency, 611721 (3), Autosomal recessiveMetachromatic leukodystrophy due to SAP-b deficiency, 249900 (3);chr10;PSAP, SAP1;True
ENSG00000122863;Carbohydrate sulfotransferase 3;NotRelevant;;Spondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3), Autosomal recessiveSpondyloepiphyseal dysplasia with congenital joint dislocations, 143095 (3);chr10;CHST3, C6ST, C6ST1, HSD;True
ENSG00000138303;Activating signal cointegrator 1 complex, subunit 1;NotRelevant;mutation identified in 1 SMABF2 family;Barrett esophagus/esophageal adenocarcinoma, 614266 (3)Barrett esophagus/esophageal adenocarcinoma, 614266 (3);chr10;ASCC1, p50, SMABF2;False
ENSG00000107745;Mitochondrial calcium uptake protein 1;NotRelevant;;Myopathy with extrapyramidal signs, 615673 (3), Autosomal recessiveMyopathy with extrapyramidal signs, 615673 (3);chr10;MICU1, CBARA1, MPXPS;True
ENSG00000182180;Mitochondrial ribosomal protein S16;NotRelevant;;Combined oxidative phosphorylation deficiency 2, 610498 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 2, 610498 (3);chr10;MRPS16, COXPD2;True
ENSG00000122861;Plasminogen activator, urokinase;NotRelevant;proximal to HOX11;{Alzheimer disease, late-onset, susceptibility to}, 104300 (3), Autosomal dominant{Alzheimer disease, late-onset, susceptibility to}, 104300 (3);chr10;PLAU, URK, QPD, BDPLT5;True
ENSG00000035403;Vinculin;NotRelevant;;Cardiomyopathy, dilated, 1W, 611407 (3)Cardiomyopathy, hypertrophic, 15, 613255 (3);chr10;VCL, CMD1W, CMH15;False
ENSG00000156110;Adenosine kinase;NotRelevant;;Hypermethioninemia due to adenosine kinase deficiency, 614300 (3), Autosomal recessiveHypermethioninemia due to adenosine kinase deficiency, 614300 (3);chr10;ADK;True
ENSG00000156650;Lysine acetyltransferase 6B;NotRelevant;;Genitopatellar syndrome, 606170 (3), Autosomal dominantSBBYSS syndrome, 603736 (3);chr10;KAT6B, MYST4, MORF, GTPTS;True
ENSG00000148655;Leucine-rich melanocyte differentiation-associated protein;NotRelevant;;Albinism, oculocutaneous, type VII, 615179 (3), Autosomal recessiveAlbinism, oculocutaneous, type VII, 615179 (3);chr10;LRMDA, C10orf11, OCA7;True
ENSG00000156113;Potassium large conductance calcium-activated channel, subfamily M, alpha member 1 (slowpoke, Drosophila, homolog of);NotRelevant;mutation identified in 1 CADEDS family;?Cerebellar atrophy, developmental delay, and seizures, 617643 (3), Autosomal recessiveParoxysmal nonkinesigenic dyskinesia, 3, with or without generalized epilepsy, 609446 (3);chr10;KCNMA1, SLO, PNKD3, CADEDS;True
ENSG00000148606;Polymerase III, RNA, subunit A;NotRelevant;;Leukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 7, with or without oligodontia and/or hypogonadotropic hypogonadism, 607694 (3);chr10;POLR3A, RPC1, RPC155, ADDH, HLD7;True
ENSG00000138326;Ribosomal protein S24;NotRelevant;;Diamond-blackfan anemia 3, 610629 (3), Autosomal dominantDiamond-blackfan anemia 3, 610629 (3);chr10;RPS24, DBA3;True
ENSG00000185303;Surfactant, pulmonary-associated protein A2;NotRelevant;contiguous with SFTPA1;Pulmonary fibrosis, idiopathic, 178500 (3), Autosomal dominantPulmonary fibrosis, idiopathic, 178500 (3);chr10;SFTPA2, SPA2, COLEC5;True
ENSG00000122359;Annexin A11 (annexin XI);NotRelevant;;Amytrophic lateral sclerosis 23, 617839 (3), Autosomal dominantAmytrophic lateral sclerosis 23, 617839 (3);chr10;ANXA11, ANX11, ALS23;True
ENSG00000151224;Methionine adenosyltransferase I, alpha;NotRelevant;;Hypermethioninemia, persistent, autosomal dominant, due to methionine adenosyltransferase I/III deficiency, 250850 (3), Autosomal recessive, Autosomal dominantMethionine adenosyltransferase deficiency, autosomal recessive, 250850 (3);chr10;MAT1A, MATA1, SAMS1;True
ENSG00000148600;Cadherin-related family, member 1;NotRelevant;;Cone-rod dystrophy 15, 613660 (3), Autosomal recessiveRetinitis pigmentosa 65, 613660 (3);chr10;CDHR1, PCDH21, PRCAD, CORD15, RP65;True
ENSG00000148604;Retinal G protein coupled receptor;NotRelevant;;Retinitis pigmentosa 44, 613769 (3)Retinitis pigmentosa 44, 613769 (3);chr10;RGR, RP44;False
ENSG00000122367;LIM domain binding 3;NotRelevant;;Cardiomyopathy, dilated, 1C, with or without LVNC, 601493 (3), Autosomal dominantMyopathy, myofibrillar, 4, 609452 (3);chr10;LDB3, ZASP, CYPHER, KIAA01613, MFM4, CMD1C, CMH24, LVNC3;True
ENSG00000107779;Bone morphogenetic protein receptor, type IA;NotRelevant;;Juvenile polyposis syndrome, infantile form, 174900 (3), Autosomal dominantPolyposis, juvenile intestinal, 174900 (3);chr10;BMPR1A, ACVRLK3, ALK3;True
ENSG00000148672;Glutamate dehydrogenase-1;NotRelevant;pseudogene on Xq26-q28;Hyperinsulinism-hyperammonemia syndrome, 606762 (3), Autosomal dominantHyperinsulinism-hyperammonemia syndrome, 606762 (3);chr10;GLUD1;True
ENSG00000107789;Multiple inositol polyphosphate phosphatase 1;NotRelevant;;Thyroid carcinoma, follicular, 188470 (3), Autosomal dominantThyroid carcinoma, follicular, 188470 (3);chr10;MINPP1, HIPER1;True
ENSG00000198682;3'-phosphoadenosine 5'-phosphosulfate synthase 2;NotRelevant;;Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3), Autosomal recessiveBrachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3);chr10;PAPSS2, ATPSK2, BCYM4;True
ENSG00000138138;ATPase family, AAA domain-containing, member 1;NotRelevant;;Hyperekplexia 4, 618011 (3), Autosomal recessiveHyperekplexia 4, 618011 (3);chr10;ATAD1, THORASE, HKPX4;True
ENSG00000227268;Killin;NotRelevant;;Cowden syndrome 4, 615107 (3)Cowden syndrome 4, 615107 (3);chr10;KLLN, CWS4;False
ENSG00000171862;Phosphatase and tensin homolog (mutated in multiple advanced cancers 1);NotRelevant;;Cowden syndrome 1, 158350 (3), Autosomal dominant{Prostate cancer, somatic}, 176807 (3);chr10;PTEN, MMAC1, GLM2, CWS1;True
ENSG00000204020;Lipase family, member N;NotRelevant;;Ichthyosis, congenital, autosomal recessive 8, 613943 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 8, 613943 (3);chr10;LIPN, LIPL4, ARCI8, LI4;True
ENSG00000107796;Actin, alpha-2, smooth muscle, aorta;NotRelevant;;Aortic aneurysm, familial thoracic 6, 611788 (3), Autosomal dominantMultisystemic smooth muscle dysfunction syndrome, 613834 (3);chr10;ACTA2, ACTSA, AAT6, MYMY5;True
ENSG00000026103;Fas cell surface death receptor;NotRelevant;;Autoimmune lymphoproliferative syndrome, type IA, 601859 (3), Autosomal dominant{Autoimmune lymphoproliferative syndrome}, 601859 (3);chr10;FAS, TNFRSF6, APT1, CD95, ALPS1A;True
ENSG00000107798;Lipase A, lysosomal acid, cholesterol esterase;NotRelevant;?close to GOT;Cholesteryl ester storage disease, 278000 (3), Autosomal recessiveWolman disease, 278000 (3);chr10;LIPA, CESD;True
ENSG00000152779;Solute carrier family 16 (monocarboxylic acid transporter), member 12;NotRelevant;mutation identified in 1 CTRCT47 family;Cataract 47, juvenile, with microcornea, 612018 (3), Autosomal dominantCataract 47, juvenile, with microcornea, 612018 (3);chr10;SLC16A12, MCT12, CTRCT47;True
ENSG00000138160;Kinesin family member 11;NotRelevant;;Microcephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3), Autosomal dominantMicrocephaly with or without chorioretinopathy, lymphedema, or mental retardation, 152950 (3);chr10;KIF11, KNSL1, MCLMR;True
ENSG00000187553;Cytochrome P450, subfamily XXVIC, polypeptide 1;NotRelevant;;Focal facial dermal dysplasia 4, 614974 (3), Autosomal recessiveFocal facial dermal dysplasia 4, 614974 (3);chr10;CYP26C1, FFDD4;True
ENSG00000138180;Centrosomal protein, 55kD;NotRelevant;;Multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3), Autosomal recessiveMultinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly, 236500 (3);chr10;CEP55, MARCH;True
ENSG00000186188;Free fatty acid receptor 4;NotRelevant;;{Obesity, susceptibility to}, 607514 (3){Obesity, susceptibility to}, 607514 (3);chr10;FFAR4, O3FAR1, GPR120, PGR4, BMIQ10;False
ENSG00000138207;Retinol-binding protein-4, interstitial;NotRelevant;just centromeric of CYP2C cluster;Microphthalmia, isolated, with coloboma 10, 616428 (3), Autosomal dominantRetinal dystrophy, iris coloboma, and comedogenic acne syndrome, 615147 (3);chr10;RBP4, RDCCAS, MCOPCB10;True
ENSG00000095464;Phosphodiesterase-6C, cGMP-specific, cone, alpha prime;NotRelevant;;Cone dystrophy 4, 613093 (3), Autosomal recessiveCone dystrophy 4, 613093 (3);chr10;PDE6C, PDEA2, COD4;True
ENSG00000108231;Leucine-rich gene, glioma-inactivated, 1;NotRelevant;;Epilepsy, familial temporal lobe, 1, 600512 (3), Autosomal dominantEpilepsy, familial temporal lobe, 1, 600512 (3);chr10;LGI1, EPT, ETL1, ADLTE, ADPEAF;True
ENSG00000138193;Phospholipase C, epsilon-1;NotRelevant;;Nephrotic syndrome, type 3, 610725 (3), Autosomal recessiveNephrotic syndrome, type 3, 610725 (3);chr10;PLCE1, KIAA1516, NPHS3;True
ENSG00000119969;Helicase, lymphoid-specific;NotRelevant;;Immunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3), Autosomal recessiveImmunodeficiency-centromeric instability-facial anomalies syndrome 4, 616911 (3);chr10;HELLS, LSH, ICF4;True
ENSG00000165841;Cytochrome P450, subfamily IIC (mephenytoin 4'-hydroxylase);NotRelevant;4 genes in order: cen-C18-C19-C9-C8-tel;Clopidogrel, impaired responsiveness to, 609535 (3), Autosomal recessiveProguanil poor metabolizer, 609535 (3);chr10;CYP2C, CYP2C19;True
ENSG00000138109;Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase), polypeptide 9;NotRelevant;;Tolbutamide poor metabolizer (3)Warfarin sensitivity, 122700 (3);chr10;CYP2C9;False
ENSG00000138115;Cytochrome P450, subfamily IIc, polypeptide 8;NotRelevant;;{Drug metabolism, altered, CYP2C8-related}, 618018 (3){Drug metabolism, altered, CYP2C8-related}, 618018 (3);chr10;CYP2C8, CYP2C8DM;False
ENSG00000059573;Aldehyde dehydrogenase 18 family, member A1 (1-pyrroline-5-carboxylate synthetase);NotRelevant;GOT1 and GSAS in same pathway;Cutis laxa, autosomal dominant 3, 616603 (3), Autosomal dominantSpastic paraplegia 9B, autosomal recessive, 616586 (3);chr10;ALDH18A1, PYCS, GSAS, ARCL3A, SPG9A, SPG9B, ADCL3;True
ENSG00000119977;Tectonic family, member 3;NotRelevant;;Joubert syndrome 18, 614815 (3), Autosomal recessiveOrofaciodigital syndrome IV, 258860 (3);chr10;TCTN3, TECT3, C10orf61, OFD4, JBTS18;True
ENSG00000138185;Ectonucleoside triphosphate diphosphohydrolase 1 (CD39 antigen);NotRelevant;;Spastic paraplegia 64, autosomal recessive, 615683 (3), Autosomal recessiveSpastic paraplegia 64, autosomal recessive, 615683 (3);chr10;ENTPD1, CD39, SPG64;True
ENSG00000095585;B-cell linker protein (SH2 domain-containing leukocyte protein, 65kD);NotRelevant;mutation identified in 1 AGM4 family;?Agammaglobulinemia 4, 613502 (3), Autosomal recessive?Agammaglobulinemia 4, 613502 (3);chr10;BLNK, SLP65, AGM4;True
ENSG00000241935;4-hydroxy-2-oxoglutarate aldolase 1;NotRelevant;;Hyperoxaluria, primary, type III, 613616 (3)Hyperoxaluria, primary, type III, 613616 (3);chr10;HOGA1, DHDPSL, HP3;False
ENSG00000155256;Zinc finger FYVE domain-containing protein 27;NotRelevant;;Spastic paraplegia 33, autosomal dominant, 610244 (3), Autosomal dominantSpastic paraplegia 33, autosomal dominant, 610244 (3);chr10;ZFYVE27, SPG33;True
ENSG00000107521;HPS gene 1;NotRelevant;;Hermansky-Pudlak syndrome 1, 203300 (3), Autosomal recessiveHermansky-Pudlak syndrome 1, 203300 (3);chr10;HPS1;True
ENSG00000172987;Heparanase 2;NotRelevant;;Urofacial syndrome 1, 236730 (3), Autosomal recessiveUrofacial syndrome 1, 236730 (3);chr10;HPSE2, HPA2, UFS1;True
ENSG00000120053;Glutamic-oxaloacetic transaminase-1, soluble (EC 2.6.1.1);NotRelevant;10q26.1 = conflicting localization;Aspartate aminotransferase, serum level of, QTL1, 614419 (3)Aspartate aminotransferase, serum level of, QTL1, 614419 (3);chr10;GOT1, ASTQTL1;False
ENSG00000014919;Cytochrome c oxidase, subunit 15;NotRelevant;;Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 2, 615119 (3), Autosomal recessiveLeigh syndrome due to cytochrome c oxidase deficiency, 256000 (3);chr10;COX15, CEMCOX2;True
ENSG00000023839;ATP-binding cassette, subfamily C, member 2 (canalicular multispecific organic anion transporter);NotRelevant;;Dubin-Johnson syndrome, 237500 (3), Autosomal recessiveDubin-Johnson syndrome, 237500 (3);chr10;ABCC2, CMOAT;True
ENSG00000120054;Carboxypeptidase N, polypeptide 1, 50-kD;NotRelevant;;Carboxypeptidase N deficiency, 212070 (3), Autosomal recessiveCarboxypeptidase N deficiency, 212070 (3);chr10;CPN1, SCPN, CPN;True
ENSG00000107566;Endoplasmic reticulum lipid raft-associated protein 1;NotRelevant;;Spastic paraplegia 62, 615681 (3), Autosomal recessiveSpastic paraplegia 62, 615681 (3);chr10;ERLIN1, SPG62;True
ENSG00000213341;Conserved helix-loop-helix ubiquitous kinase;NotRelevant;;Cocoon syndrome, 613630 (3)Cocoon syndrome, 613630 (3);chr10;CHUK, IKBKA, NFKBIKA, IKKA, IKK1;False
ENSG00000095485;CWF19-like protein 1;NotRelevant;;Spinocerebellar ataxia, autosomal recessive 17, 616127 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 17, 616127 (3);chr10;CWF19L1, C19L1, SCAR17;True
ENSG00000166136;NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2 (8kD, AGGG);NotRelevant;previously assigned to 12q21;Mitochondrial complex I deficiency, nuclear type 32, 618252 (3)Mitochondrial complex I deficiency, nuclear type 32, 618252 (3);chr10;NDUFB8, MC1DN32;False
ENSG00000075891;Paired box homeotic gene-2;NotRelevant;;Glomerulosclerosis, focal segmental, 7, 616002 (3), Autosomal dominantPapillorenal syndrome, 120330 (3);chr10;PAX2, PAPRS, FSGS7;True
ENSG00000107815;Twinkle mtDNA helicase;NotRelevant;PEO digenic with POLG;Mitochondrial DNA depletion syndrome 7 (hepatocerebral type), 271245 (3), Autosomal recessiveProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 3, 609286 (3);chr10;TWNK, C10orf2, TWINKLE, PEOA3, IOSCA, MTDPS7, PRLTS5;True
ENSG00000186862;PDZ domain-containing 7;NotRelevant;;Deafness, autosomal recessive 57, 618003 (3), Autosomal recessive{Retinal disease in Usher syndrome type IIA, modifier of}, 276901 (3);chr10;PDZD7, DFNB57;True
ENSG00000107807;T-cell leukemia, homeobox 1;NotRelevant;t(7;10) or t(10;chr10;TLX1, HOX11, TCL3;False
ENSG00000107831;Fibroblast growth factor-8;NotRelevant;;Hypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3), Autosomal dominantHypogonadotropic hypogonadism 6 with or without anosmia, 612702 (3);chr10;FGF8, HH6;True
ENSG00000166189;HPS gene 6;NotRelevant;;Hermansky-Pudlak syndrome 6, 614075 (3), Autosomal recessiveHermansky-Pudlak syndrome 6, 614075 (3);chr10;HPS6, RU;True
ENSG00000107859;Paired-like homeodomain transcription factor-3;NotRelevant;;Anterior segment dysgenesis 1, multiple subtypes, 107250 (3), Autosomal dominantCataract 11, syndromic, autosomal recessive, 610623 (3);chr10;PITX3, CTPP4, CTRCT11, ASGD1;True
ENSG00000077150;Nuclear factor of kappa light chain gene enhancer in B-cells 2 (p49/p100);NotRelevant;ENSG00000077150;Immunodeficiency, common variable, 10, 615577 (3);chr10;NFKB2, LYT10, CVID10;False
ENSG00000107882;Suppressor of fused;NotRelevant;;Basal cell nevus syndrome, 109400 (3), Autosomal dominant{Meningioma, familial, susceptibility to}, 607174 (3);chr10;SUFU, SUFUXL, SUFUH, JBTS32;True
ENSG00000138175;ADP-ribosylation factor-like 3;NotRelevant;mutation identified in 1 RP83 family;Joubert syndrome 35, 618161 (3), Autosomal recessiveJoubert syndrome 35, 618161 (3);chr10;ARL3, ARFL3, JBTS35, RP83;True
ENSG00000148795;Cytochrome P450, family 17, subfamily A, polypeptide 1 (steroid 17-alpha-hydroxylase);NotRelevant;at least 2 genes; distal to GOT117-alpha-hydroxylase/17,20-lyase deficiency, 202110 (3);chr10;CYP17A1, CYP17, P450C17;False
ENSG00000148842;Cyclin M2;NotRelevant;;Hypomagnesemia 6, renal, 613882 (3), Autosomal dominantHypomagnesemia, seizures, and mental retardation, 616418 (3);chr10;CNNM2, ACDP2, HOMG6, HOMGSMR;True
ENSG00000076685;5' nucleotidase, cytosolic II;NotRelevant;;Spastic paraplegia 45, autosomal recessive, 613162 (3), Autosomal recessiveSpastic paraplegia 45, autosomal recessive, 613162 (3);chr10;NT5C2, NT5B, PNT5, SPG45;True
ENSG00000107960;STN1, CST complex subunit;NotRelevant;;Cerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3), Autosomal recessiveCerebroretinal microangiopathy with calcifications and cysts 2, 617341 (3);chr10;STN1, OBFC1, AAF44;True
ENSG00000065618;Collagen XVII, alpha-1 polypeptide;NotRelevant;;Epidermolysis bullosa, junctional, localisata variant, 226650 (3), Autosomal recessiveEpithelial recurrent erosion dystrophy, 122400 (3);chr10;COL17A1, BPAG2, ERED;True
ENSG00000197748;Cilia- and flagella-associated protein 43;NotRelevant;;Spermatogenic failure 19, 617592 (3), Autosomal recessiveSpermatogenic failure 19, 617592 (3);chr10;CFAP43, WDR96, C10orf79, SPGF19;True
ENSG00000148700;Adducin-3, gamma;NotRelevant;fusion with NUP98 in T-ALL;Cerebral palsy, spastic quadriplegic, 3, 617008 (3), Autosomal recessiveCerebral palsy, spastic quadriplegic, 3, 617008 (3);chr10;ADD3, ADDL, CPSQ3;True
ENSG00000119950;MAX-interacting protein 1;NotRelevant;;Neurofibrosarcoma, somatic (3){Prostate cancer, susceptibility to, somatic}, 176807 (3);chr10;MXI1;False
ENSG00000108055;Structural maintenance of chromosomes 3;NotRelevant;;Cornelia de Lange syndrome 3, 610759 (3), Autosomal dominantCornelia de Lange syndrome 3, 610759 (3);chr10;SMC3, CSPG6, HCAP, BAM, CDLS3;True
ENSG00000203867;RNA-binding motif protein 20;NotRelevant;;Cardiomyopathy, dilated, 1DD, 613172 (3), Autosomal dominantCardiomyopathy, dilated, 1DD, 613172 (3);chr10;RBM20;True
ENSG00000214413;BBSome interacting protein 1;NotRelevant;mutation identified in 1 BBS18 family;?Bardet-Biedl syndrome 18, 615995 (3), Autosomal recessive?Bardet-Biedl syndrome 18, 615995 (3);chr10;BBIP1, NCRNA00081, BBIP10, BBS18;True
ENSG00000108061;Suppressor of clear, C. elegans, homolog of;NotRelevant;;Noonan-like syndrome with loose anagen hair, 607721 (3), Autosomal dominantNoonan-like syndrome with loose anagen hair, 607721 (3);chr10;SHOC2, SIAA0862, SOC2, SUR8;True
ENSG00000148737;Transcription factor 7-like 2;NotRelevant;;{Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant{Diabetes mellitus, type 2, susceptibility to}, 125853 (3);chr10;TCF7L2, TCF4;True
ENSG00000148702;Hyaluronan-binding protein 2;NotRelevant;mutation identified in 1 NMTC5 family;{?Thyroid cancer, nonmedullary, 5}, 616535 (3), Autosomal dominant{Venous thromboembolism, susceptibility to}, 188050 (3);chr10;HABP2, PHBP, HGFAL, FSAP, NMTC5;True
ENSG00000043591;Adrenergic, beta-1-, receptor;NotRelevant;close linkage to ADRA2R;{Congestive heart failure and beta-blocker response, modifier of} (3){Congestive heart failure and beta-blocker response, modifier of} (3);chr10;ADRB1, ADRB1R, RHR;False
ENSG00000175535;Pancreatic lipase;NotRelevant;mutation identified in 1 family;?Pancreatic lipase deficiency, 614338 (3), Autosomal recessive?Pancreatic lipase deficiency, 614338 (3);chr10;PNLIP, PNLIPD;True
ENSG00000148704;Ventral anterior homeo box 1;NotRelevant;mutation identified in one MCOPS11 family;?Microphthalmia, syndromic 11, 614402 (3), Autosomal recessive?Microphthalmia, syndromic 11, 614402 (3);chr10;VAX1, MCOPS11;True
ENSG00000186795;Potassium channel, subfamily K, member 18;NotRelevant;;{Migraine, with or without aura, susceptibility to, 13}, 613656 (3){Migraine, with or without aura, susceptibility to, 13}, 613656 (3);chr10;KCNK18, TRESK, TRIK, MGR13;False
ENSG00000165646;Solute carrier family 18 (vesicular monoamine), member 2;NotRelevant;mutation identified in 1 PKDYS2 family;?Parkinsonism-dystonia, infantile, 2, 618049 (3), Autosomal recessive?Parkinsonism-dystonia, infantile, 2, 618049 (3);chr10;SLC18A2, VAT2, SVMT, PKDYS2;True
ENSG00000170370;Empty spiracles, Drosophila, homolog of, 2;NotRelevant;close to VAX1;Schizencephaly, 269160 (3)Schizencephaly, 269160 (3);chr10;EMX2;False
ENSG00000188613;NANOS, Drosophila, homolog of, 1;NotRelevant;;Spermatogenic failure 12, 615413 (3), Autosomal dominantSpermatogenic failure 12, 615413 (3);chr10;NANOS1, NOS1, SPGF12;True
ENSG00000183605;Sideroflexin 4;NotRelevant;;Combined oxidative phosphorylation deficiency 18, 615578 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 18, 615578 (3);chr10;SFXN4, COXPD18;True
ENSG00000151929;BCL2-associated athanogene 3;NotRelevant;;Cardiomyopathy, dilated, 1HH, 613881 (3), Autosomal dominantMyopathy, myofibrillar, 6, 612954 (3);chr10;BAG3, MFM6;True
ENSG00000120008;WD repeat-containing protein 11;NotRelevant;;Hypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3), Autosomal dominantHypogonadotropic hypogonadism 14 with or without anosmia, 614858 (3);chr10;WDR11, DR11, KIAA1351, BRWD2, HH14;True
ENSG00000066468;Fibroblast growth factor receptor-2 (bacteria-expressed kinase);NotRelevant;;Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3), Autosomal dominantScaphocephaly, maxillary retrusion, and mental retardation, 609579 (3);chr10;FGFR2, BEK, CFD1, JWS, TK14, BBDS;True
ENSG00000254636;LOC387715 gene;NotRelevant;;{Macular degeneration, age-related, 8}, 613778 (3){Macular degeneration, age-related, 8}, 613778 (3);chr10;LOC387715, ARMD8;False
ENSG00000166033;HTRA serine peptidase 1;NotRelevant;;CARASIL syndrome, 600142 (3), Autosomal recessive{Macular degeneration, age-related, neovascular type}, 610149 (3);chr10;HTRA1, PRSS11, ARMD7, CARASIL, CADASIL2;True
ENSG00000196177;Acyl-Coenzyme A dehydrogenase, short/branched chain;NotRelevant;;2-methylbutyrylglycinuria, 610006 (3), Autosomal recessive2-methylbutyrylglycinuria, 610006 (3);chr10;ACADSB, SBCAD;True
ENSG00000065154;Ornithine aminotransferase;NotRelevant;pseudogene at Xp11.2;Gyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3), Autosomal recessiveGyrate atrophy of choroid and retina with or without ornithinemia, 258870 (3);chr10;OAT, GACR;True
ENSG00000154485;Matrix metalloproteinase 21;NotRelevant;;Heterotaxy, visceral, 7, autosomal, 616749 (3), Autosomal recessiveHeterotaxy, visceral, 7, autosomal, 616749 (3);chr10;MMP21, HTX7;True
ENSG00000188690;Uroporphyrinogen III synthase;NotRelevant;;Porphyria, congenital erythropoietic, 263700 (3), Autosomal recessivePorphyria, congenital erythropoietic, 263700 (3);chr10;UROS;True
ENSG00000108001;Early B-cell factor 3;NotRelevant;;Hypotonia, ataxia, and delayed development syndrome, 617330 (3), Autosomal dominantHypotonia, ataxia, and delayed development syndrome, 617330 (3);chr10;EBF3, COE3, HADDS;True
ENSG00000148826;NK6 transcription factor related, locus 2 (Drosophila);NotRelevant;;Spastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3), Autosomal recessiveSpastic ataxia 8, autosomal recessive, with hypomyelinating leukodystrophy, 617560 (3);chr10;NKX6-2, NKX6B, NKX6.2, SPAX8;True
ENSG00000127884;Enoyl-CoA hydratase, short-chain, 1, mitochondrial;NotRelevant;;Mitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3), Autosomal recessiveMitochondrial short-chain enoyl-CoA hydratase 1 deficiency, 616277 (3);chr10;ECHS1, SCEH, ECHS1D;True
ENSG00000171772;Synaptonemal complex central element protein 1;NotRelevant;mutation identified in 1 POF12 and 1 SPGF15 family;?Premature ovarian failure 12, 616947 (3), Autosomal recessive?Spermatogenic failure 15, 616950 (3);chr10;SYCE1, POF12, SPGF15;True
ENSG00000206013;Interferon-induced transmembrane protein 5;NotRelevant;;Osteogenesis imperfecta, type V, 610967 (3), Autosomal dominantOsteogenesis imperfecta, type V, 610967 (3);chr11;IFITM5, OI5;True
ENSG00000142089;Interferon-induced transmembrane protein 3;NotRelevant;;{Influenza, severe, susceptibility to}, 614680 (3){Influenza, severe, susceptibility to}, 614680 (3);chr11;IFITM3;False
ENSG00000161328;Leucine-rich repeat-containing protein 56;NotRelevant;;Ciliary dyskinesia, primary, 39, 618254 (3), Autosomal recessiveCiliary dyskinesia, primary, 39, 618254 (3);chr11;LRRC56, CILD39;True
ENSG00000174775;Harvey rat sarcoma viral (v-Ha-ras) oncogene homolog;NotRelevant;pseudogene HRASP on X;{Bladder cancer, somatic}, 109800 (3){Thyroid carcinoma, follicular, somatic}, 188470 (3);chr11;HRAS;False
ENSG00000099849;RAS association domain family, member 7;NotRelevant;29kb 5' to HRAS1; divergently transcribed;chr11;RASSF7, C11orf13, HRC1;False
ENSG00000185507;Interferon regulatory factor 7;NotRelevant;mutation identified in 1 family;?Immunodeficiency 39, 616345 (3), Autosomal recessive?Immunodeficiency 39, 616345 (3);chr11;IRF7, IRF7A, IRF7B, IRF7C, IRF7H, IMD39;True
ENSG00000069696;Dopamine receptor D4;NotRelevant;proximal to HRAS;{Attention deficit-hyperactivity disorder}, 143465 (3), Autosomal dominant{Attention deficit-hyperactivity disorder}, 143465 (3);chr11;DRD4;True
ENSG00000177030;Deaf1, Drosophila, homolog of;NotRelevant;mutation identified in 1 DYSEIDD family;?Dyskinesia, seizures, and intellectual developmental disorder, 617171 (3), Autosomal recessiveMental retardation, autosomal dominant 24, 615828 (3);chr11;DEAF1, SPN, ZMYND5, MRD24;True
ENSG00000177106;EPS8-like protein 2;NotRelevant;;Deafness autosomal recessive 106, 617637 (3), Autosomal recessiveDeafness autosomal recessive 106, 617637 (3);chr11;EPS8L2, EPS8R2, DFNB106;True
ENSG00000177156;Transaldolase-1;NotRelevant;pseudogene on chr.1;Transaldolase deficiency, 606003 (3), Autosomal recessiveTransaldolase deficiency, 606003 (3);chr11;TALDO1;True
ENSG00000177542;Solute carrier family 25 (mitochondrial carrier, glutamate), member 22;NotRelevant;;Epileptic encephalopathy, early infantile, 3, 609304 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 3, 609304 (3);chr11;SLC25A22, GC1, EIEE3;True
ENSG00000177666;Patatin-like phospholipase domain-containing protein 2;NotRelevant;;Neutral lipid storage disease with myopathy, 610717 (3), Autosomal recessiveNeutral lipid storage disease with myopathy, 610717 (3);chr11;PNPLA2, TTS2, ATGL;True
ENSG00000177697;CD151 antigen;NotRelevant;;[Blood group, Raph], 179620 (3)[Blood group, Raph], 179620 (3);chr11;CD151, PETA3, SFA1, MER2;False
ENSG00000117983;Mucin 5, subtype B, tracheobronchial;NotRelevant;;{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3);chr11;MUC5B;True
ENSG00000117984;Cathepsin D (lysosomal aspartyl protease);NotRelevant;;Ceroid lipofuscinosis, neuronal, 10, 610127 (3), Autosomal recessiveCeroid lipofuscinosis, neuronal, 10, 610127 (3);chr11;CTSD, CPSD, CLN10;True
ENSG00000130598;Troponin I, fast-twitch skeletal muscle isoform;NotRelevant;;Arthrogryposis multiplex congenita, distal, type 2B, 601680 (3), Autosomal dominantArthrogryposis multiplex congenita, distal, type 2B, 601680 (3);chr11;TNNI2, AMCD2B, DA2B, FSSV;True
ENSG00000130595;Troponin-T3, skeletal, fast;NotRelevant;;Arthrogryposis, distal, type 2B, 601680 (3), Autosomal dominantArthrogryposis, distal, type 2B, 601680 (3);chr11;TNNT3, AMCD2B, DA2B, FSSV;True
ENSG00000130600;H19 gene;NotRelevant;same 200kb fragment as IGF2;Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominantWilms tumor 2, 194071 (3);chr11;H19, D11S813E, ASM1, BWS, WT2;True
ENSG00000167244;Insulin-like growth factor-2, or somatomedin A;NotRelevant;mutation identified in 1 GRDF family;?Growth restriction, severe, with distinctive facies, 616489 (3), Autosomal dominant?Growth restriction, severe, with distinctive facies, 616489 (3);chr11;IGF2, GRDF;True
ENSG00000254647;Insulin;NotRelevant;5'--INS-12.6kb-IGF2--3'; cen-HBBC-10cM-INS-2cM-HRAS1-3cM-THMaturity-onset diabetes of the young, type 10, 613370 (3);chr11;INS, MODY10, IDDM2;False
ENSG00000180176;Tyrosine hydroxylase;NotRelevant;distal to HRAS1;Segawa syndrome, recessive, 605407 (3), Autosomal recessiveSegawa syndrome, recessive, 605407 (3);chr11;TH, TYH;True
ENSG00000110651;CD81 antigen (target of antiproliferative antibody-1);NotRelevant;;Immunodeficiency, common variable, 6, 613496 (3), Autosomal recessiveImmunodeficiency, common variable, 6, 613496 (3);chr11;CD81, TAPA1, CVID6;True
ENSG00000053918;Potassium voltage-gated channel, KQT-like subfamily, member 1;NotRelevant;;Atrial fibrillation, familial, 3, 607554 (3), Autosomal dominant{Long QT syndrome 1, acquired, susceptibility to}, 192500 (3);chr11;KCNQ1, KCNA9, LQT1, KVLQT1, ATFB3, SQT2;True
ENSG00000269821;KCNQ1-overlapping transcript 1;NotRelevant;;Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominantBeckwith-Wiedemann syndrome, 130650 (3);chr11;KCNQ1OT1, LIT1;True
ENSG00000129757;Cyclin-dependent kinase inhibitor 1C (p57, Kip2);NotRelevant;rare cause of BWS;Beckwith-Wiedemann syndrome, 130650 (3), Autosomal dominantIMAGE syndrome, 614732 (3);chr11;CDKN1C, KIP2, BWS, IMAGE;True
ENSG00000110628;Solute carrier family 22, member 1-like (Beckwith-Wiedemann region 1A;NotRelevant;ENSG00000110628;Rhabdomyosarcoma, somatic, 268210 (3);chr11;SLC22A1L, BWSCR1A, IMPT1;False
ENSG00000148985;Post-GPI attachment to proteins 2;NotRelevant;;Hyperphosphatasia with mental retardation syndrome 3, 614207 (3), Autosomal recessiveHyperphosphatasia with mental retardation syndrome 3, 614207 (3);chr11;PGAP2, FRAG1, HPMRS3, MRT17, MRT21;True
ENSG00000167323;Stromal interaction molecule 1;NotRelevant;;Immunodeficiency 10, 612783 (3), Autosomal recessiveStormorken syndrome, 185070 (3);chr11;STIM1, TAM1, IMD10, STRMK;True
ENSG00000244734;Hemoglobin beta;NotRelevant;pseudogene HBBP1 between HBG and HBD loci;Delta-beta thalassemia, 141749 (3), Autosomal dominant{Malaria, resistance to}, 611162 (3);chr11;HBB, ECYT6;True
ENSG00000223609;Hemoglobin delta;NotRelevant;;Thalassemia due to Hb Lepore (3)Thalassemia, delta- (3);chr11;HBD;False
ENSG00000213934;Hemoglobin, gamma A;NotRelevant;;Fetal hemoglobin quantitative trait locus 1, 141749 (3), Autosomal dominantFetal hemoglobin quantitative trait locus 1, 141749 (3);chr11;HBG1;True
ENSG00000196565;Hemoglobin, gamma G;NotRelevant;;Cyanosis, transient neonatal, 613977 (3), Autosomal dominantFetal hemoglobin quantitative trait locus 1, 141749 (3);chr11;HBG2, TNCY;True
ENSG00000166311;Sphingomyelin phosphodiesterase-1, acid lysosomal;NotRelevant;;Niemann-Pick disease, type A, 257200 (3), Autosomal recessiveNiemann-Pick disease, type B, 607616 (3);chr11;SMPD1, NPD;True
ENSG00000166340;Tripeptidyl peptidase 1;NotRelevant;;Ceroid lipofuscinosis, neuronal, 2, 204500 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 7, 609270 (3);chr11;TPP1, CLN2, SCAR7;True
ENSG00000166341;Dachsous, Drosophila, homolog of, 1;NotRelevant;;Mitral valve prolapse 2, 607829 (3), Autosomal dominantVan Maldergem syndrome 1, 601390 (3);chr11;DCHS1, PCDH16, FIB1, CDH19, VMLDS1, MVP2;True
ENSG00000166402;Tubby, mouse, homolog of;NotRelevant;mutation identified in 1 RDOB family;?Retinal dystrophy and obesity, 616188 (3), Autosomal recessive?Retinal dystrophy and obesity, 616188 (3);chr11;TUB, RDOB;True
ENSG00000166407;LIM domain only 1 (rhombotin 1);NotRelevant;;Leukemia, T-cell acute lymphoblastic, 186921 (2)Leukemia, T-cell acute lymphoblastic (2);chr11;LMO1, RBTN1, RHOM1;False
ENSG00000184014;DENN domain-containing protein 5A;NotRelevant;;Epileptic encephalopathy, early infantile, 49, 617281 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 49, 617281 (3);chr11;DENND5A, RAB6IP1, KIAA1091, EIEE49;True
ENSG00000133812;SET binding factor 2 (myotubularin-related 13);NotRelevant;;Charcot-Marie-Tooth disease, type 4B2, 604563 (3), Autosomal recessiveCharcot-Marie-Tooth disease, type 4B2, 604563 (3);chr11;SBF2, MTMR13, CMT4B2;True
ENSG00000133805;Adenosine monophosphate deaminase-3, isoform E;NotRelevant;;[AMP deaminase deficiency, erythrocytic], 612874 (3), Autosomal recessive[AMP deaminase deficiency, erythrocytic], 612874 (3);chr11;AMPD3;True
ENSG00000187079;TEA domain family member 1;NotRelevant;;Sveinsson chorioretinal atrophy, 108985 (3), Autosomal dominantSveinsson chorioretinal atrophy, 108985 (3);chr11;TEAD1, TCF13, REF1;True
ENSG00000152266;Parathyroid hormone;NotRelevant;~9cM distal to CALC1; distal to MYODHypoparathyroidism, autosomal recessive, 146200 (3);chr11;PTH;True
ENSG00000197601;Fatty acyl CoA reductase 1;NotRelevant;;Peroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3), Autosomal recessivePeroxisomal fatty acyl-CoA reductase 1 disorder, 616154 (3);chr11;FAR1, MLSTD2, PFCRD;True
ENSG00000133818;Related Ras viral oncogene homolog 2;NotRelevant;;Ovarian carcinoma (3)Ovarian carcinoma (3);chr11;RRAS2, TC21;False
ENSG00000186104;Cytochrome P450, subfamily IIR, polypeptide 1 (vitamin D 25-hydroxylase);NotRelevant;;Rickets due to defect in vitamin D 25-hydroxylation, 600081 (3), Autosomal recessiveRickets due to defect in vitamin D 25-hydroxylation, 600081 (3);chr11;CYP2R1;True
ENSG00000187486;Potassium inwardly-rectifying channel, subfamily J, member 11;NotRelevant;4.5kb 3' of SUR;Diabetes mellitus, transient neonatal, 3, 610582 (3), Autosomal dominant{Diabetes mellitus, type 2, susceptibility to}, 125853 (3);chr11;KCNJ11, BIR, PHHI, HHF2, TNDM3, MODY13;True
ENSG00000006071;ATP-binding cassette, subfamily C, member 8 (sulfonylurea receptor);NotRelevant;;Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominantHypoglycemia of infancy, leucine-sensitive, 240800 (3);chr11;ABCC8, SUR, PHHI, SUR1, HHF1, TNDM2;True
ENSG00000006611;Harmonin (Usher syndrome 1C gene);NotRelevant;Acadian and Samaritan variety;Deafness, autosomal recessive 18A, 602092 (3), Autosomal recessiveUsher syndrome, type 1C, 276904 (3);chr11;USH1C, DFNB18A;True
ENSG00000188162;Otogelin;NotRelevant;;Deafness, autosomal recessive 18B, 614945 (3), Autosomal recessiveDeafness, autosomal recessive 18B, 614945 (3);chr11;OTOG, OTGN, DFNB18B;True
ENSG00000129152;Myogenic factor-3;NotRelevant;proximal to CALCA, HBB, BWS, PTH; ?11p14.3;chr11;MYOD1, MYF3;False
ENSG00000129159;Potassium voltage-gated channel, Shaw-related subfamily, member 1;NotRelevant;;Epilepsy, progressive myoclonic 7, 616187 (3), Autosomal dominantEpilepsy, progressive myoclonic 7, 616187 (3);chr11;KCNC1, EPM7;True
ENSG00000110756;HPS gene 5 (ruby-eye 2, mouse, homolog of);NotRelevant;;Hermansky-Pudlak syndrome 5, 614074 (3), Autosomal recessiveHermansky-Pudlak syndrome 5, 614074 (3);chr11;HPS5, RU2, KIAA1017;True
ENSG00000134333;Lactate dehydrogenase A;NotRelevant;;Glycogen storage disease XI, 612933 (3), Autosomal recessiveGlycogen storage disease XI, 612933 (3);chr11;LDHA, LDH1, GSD11;True
ENSG00000166796;Lactate dehydrogenase C;NotRelevant;closely linked to LDHB in other species; in man syntenic with LDHA;chr11;LDHC, LDH3;False
ENSG00000129170;Cysteine- and glycine-rich protein 3;NotRelevant;mutation identified in 1 CMD1M family;?Cardiomyopathy, dilated, 1M, 607482 (3)Cardiomyopathy, hypertrophic, 12, 612124 (3);chr11;CSRP3, CRP3, CLP, CMD1M, CMH12;False
ENSG00000165970;Solute carrier family 6 (neurotransmitter transporter, glycine), member 5;NotRelevant;;Hyperekplexia 3, 614618 (3), Autosomal recessive, Autosomal dominantHyperekplexia 3, 614618 (3);chr11;SLC6A5, GLYT2, HKPX3;True
ENSG00000171714;Anoctamin 5;NotRelevant;;Gnathodiaphyseal dysplasia, 166260 (3), Autosomal dominantMuscular dystrophy, limb-girdle, autosomal recessive 12, 611307 (3);chr11;ANO5, TMEM16E, GDD1, LGMDR12;True
ENSG00000183161;Fanconi anemia, complementation group F;NotRelevant;;Fanconi anemia, complementation group F, 603467 (3)Fanconi anemia, complementation group F, 603467 (3);chr11;FANCF;False
ENSG00000134343;Anoctamin 3;NotRelevant;;Dystonia 24, 615034 (3), Autosomal dominantDystonia 24, 615034 (3);chr11;ANO3, TMEM16C, C11orf25, DYT24;True
ENSG00000205213;Leucine-rich repeat-containing G protein-coupled receptor 4;NotRelevant;previously mapped to 5q34-q35.1;{Bone mineral density, low, susceptibility to}, 615311 (3){Bone mineral density, low, susceptibility to}, 615311 (3);chr11;LGR4, GPR48, BNMD17;False
ENSG00000176697;Brain-derived neurotrophic factor;NotRelevant;homeology with NRF3 on 12p; at p14 boundary;chr11;BDNF;False
ENSG00000131808;Follicle-stimulating hormone, beta polypeptide;NotRelevant;distal to AN2;Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3), Autosomal recessiveHypogonadotropic hypogonadism 24 without anosmia, 229070 (3);chr11;FSHB, HH24;True
ENSG00000109911;Elongation protein 4, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 AN2 patient;?Aniridia 2, 617141 (3), Autosomal dominant?Aniridia 2, 617141 (3);chr11;ELP4, PAX6NEB, AN2;True
ENSG00000007372;Paired box homeotic gene-6;NotRelevant;mutation identified in 1 patient each with MDGA, COLBN, or COLB;Aniridia, 106210 (3), Autosomal dominantOptic nerve hypoplasia, 165550 (3);chr11;PAX6, AN2, MGDA, FVH1, ASGD5;True
ENSG00000184937;Wilms tumor-1;NotRelevant;clumped: pter-FSHB-AN2-WT1-CAT;Denys-Drash syndrome, 194080 (3), Autosomal dominant, Somatic mutationWilms tumor, type 1, 194070 (3);chr11;WT1, NPHS4;True
ENSG00000085063;CD59 antigen (p18-20);NotRelevant;in mouse Ly-6 = multigene complex;Hemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3), Autosomal recessiveHemolytic anemia, CD59-mediated, with or without immune-mediated polyneuropathy, 612300 (3);chr11;CD59, MIC11;True
ENSG00000135363;LIM domain only 2 (rhombotin-like 1);NotRelevant;3rd rhombotin gene not on 11;Leukemia, acute T-cell, 180385 (2)Leukemia, acute T-cell (2);chr11;LMO2, RBTNL1, RHOM2, TTG2;False
ENSG00000121691;Catalase;NotRelevant;cen-CAT-WT1-AN2-pter;Acatalasemia, 614097 (3)Acatalasemia, 614097 (3);chr11;CAT;False
ENSG00000110435;Pyruvate dehydrogenase complex, lipoyl-containing component X;NotRelevant;;Lacticacidemia due to PDX1 deficiency, 245349 (3), Autosomal recessiveLacticacidemia due to PDX1 deficiency, 245349 (3);chr11;PDHX, PDX1, E3BP, PDHXD;True
ENSG00000026508;CD44 antigen (homing function);NotRelevant;;[Blood group, Indian system], 609027 (3)[Blood group, Indian system], 609027 (3);chr11;CD44, MDU2, MDU3, MIC4, IN;False
ENSG00000110436;Solute carrier family 1 (glial high affinity glutamate transporter), member 2;NotRelevant;;Epileptic encephalopathy, early infantile, 41, 617105 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 41, 617105 (3);chr11;SLC1A2, EAAT2, EIEE41;True
ENSG00000166326;Tripartite motif-containing protein 44;NotRelevant;mutation identified in 1 AN3 family;?Aniridia 3, 617142 (3), Autosomal dominant?Aniridia 3, 617142 (3);chr11;TRIM44, AN3;True
ENSG00000166349;Recombination activating gene-1;NotRelevant;assignment to 14 in error;Alpha/beta T-cell lymphopenia with gamma/delta T-cell expansion, severe cytomegalovirus infection, and autoimmunity, 609889 (3)Severe combined immunodeficiency, B cell-negative, 601457 (3);chr11;RAG1;False
ENSG00000175097;Recombination activating gene-2;NotRelevant;assignment to 14 in error;Combined cellular and humoral immune defects with granulomas, 233650 (3), Autosomal recessiveSevere combined immunodeficiency, B cell-negative, 601457 (3);chr11;RAG2;True
ENSG00000151348;Exostosin 2;NotRelevant;mutation identified in 1 SSMS family;Exostoses, multiple, type 2, 133701 (3), Autosomal dominantExostoses, multiple, type 2, 133701 (3);chr11;EXT2, SSMS;True
ENSG00000052850;Aristaless-like 4, mouse, homolog of;NotRelevant;;{Craniosynostosis 5, susceptibility to}, 615529 (3), Autosomal dominant{Craniosynostosis 5, susceptibility to}, 615529 (3);chr11;ALX4, PFM2, FPP, FND2, CRS5;True
ENSG00000085117;CD82 antigen;NotRelevant;;{Prostate cancer, susceptibility to}, 176807 (2), Autosomal dominant{Prostate cancer, susceptibility to}, 176807 (2);chr11;CD82, SAR2, KAI1, ST6;True
ENSG00000181830;Solute carrier family 35, member C1 (GDP-Fucose transporter 1);NotRelevant;;Congenital disorder of glycosylation, type IIc, 266265 (3), Autosomal recessiveCongenital disorder of glycosylation, type IIc, 266265 (3);chr11;SLC35C1, FUCT1, CDG2C;True
ENSG00000121653;Mitogen-activated protein kinase 8-interacting protein 1;NotRelevant;;{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent}, 125853 (3);chr11;MAPK8IP1, IB1;True
ENSG00000121680;Peroxisome biogenesis factor 16;NotRelevant;;Peroxisome biogenesis disorder 8A (Zellweger), 614876 (3), Autosomal recessivePeroxisome biogenesis disorder 8B, 614877 (3);chr11;PEX16, PBD8A, PBD8B;True
ENSG00000157613;cAMP response element-binding protein 3-like 1;NotRelevant;;Osteogenesis imperfecta, type XVI, 616229 (3), Autosomal recessiveOsteogenesis imperfecta, type XVI, 616229 (3);chr11;CREB3L1, OASIS, OI16;True
ENSG00000175213;Zinc finger protein 408;NotRelevant;mutation identified in 1 EVR6 family;?Exudative vitreoretinopathy 6, 616468 (3), Autosomal dominantRetinitis pigmentosa 72, 616469 (3);chr11;ZNF408, EVR6, RP72;True
ENSG00000180210;Coagulation factor II (thrombin);NotRelevant;;Dysprothrombinemia, 613679 (3), Autosomal recessive{Stroke, ischemic, susceptibility to}, 601367 (3);chr11;F2, THPH1, RPRGL2;True
ENSG00000134569;Low density lipoprotein receptor-related protein 4;NotRelevant;mutation identified in 1 CMS17 family;Cenani-Lenz syndactyly syndrome, 212780 (3), Autosomal recessiveSclerosteosis 2, 614305 (3);chr11;LRP4, MEGF7, CLSS, SOST2, CMS17;True
ENSG00000134574;Damage-specific DNA binding protein 2, 48kD;NotRelevant;;Xeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3), Autosomal recessiveXeroderma pigmentosum, group E, DDB-negative subtype, 278740 (3);chr11;DDB2;True
ENSG00000134575;Acid phosphatase 2, lysosomal;NotRelevant;;?Lysosomal acid phosphatase deficiency, 200950 (1), Autosomal recessive?Lysosomal acid phosphatase deficiency, 200950 (1);chr11;ACP2;True
ENSG00000134571;Myosin-binding protein C, cardiac;NotRelevant;;Cardiomyopathy, dilated, 1MM, 615396 (3), Autosomal dominantLeft ventricular noncompaction 10, 615396 (3);chr11;MYBPC3, CMH4, CMD1MM, LVNC10;True
ENSG00000165915;Solute carrier family 39 (zinc transporter), member 13;NotRelevant;;Ehlers-Danlos syndrome, spondylodysplastic type, 3, 612350 (3), Autosomal recessiveEhlers-Danlos syndrome, spondylodysplastic type, 3, 612350 (3);chr11;SLC39A13, ZIP13, EDSSPD3;True
ENSG00000165917;Receptor-associated protein of the synapse, 43kD;NotRelevant;;Fetal akinesia deformation sequence, 208150 (3), Autosomal recessiveMyasthenic syndrome, congenital, 11, associated with acetylcholine receptor deficiency, 616326 (3);chr11;RAPSN, CMS1D, CMS11, FADS;True
ENSG00000213619;NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kD;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 8, 618230 (3)Mitochondrial complex I deficiency, nuclear type 8, 618230 (3);chr11;NDUFS3, MC1DN8;False
ENSG00000030066;Nucleoporin, 160kD;NotRelevant;mutation identified in 1 NPHS19 family;?Nephrotic syndrome, type 19, 618178 (3), Autosomal recessive?Nephrotic syndrome, type 19, 618178 (3);chr11;NUP160, KIAA0197, NPHS19;True
ENSG00000149177;Protein tyrosine phosphatase, receptor type, J polypeptide;NotRelevant;;Colon cancer, somatic, 114500 (3)Colon cancer, somatic, 114500 (3);chr11;PTPRJ, DEP1;False
ENSG00000149131;Complement component-1 inhibitor;NotRelevant;;Angioedema, hereditary, types I and II, 106100 (3), Autosomal recessive, Autosomal dominantComplement component 4, partial deficiency of, 120790 (3);chr11;C1NH, HAE1, HAE2, SERPING1;True
ENSG00000172409;Cleavage and polyadenylation factor I subunit 1, yeast, homolog of;NotRelevant;;Pontocerebellar hypoplasia, type 10, 615803 (3), Autosomal recessivePontocerebellar hypoplasia, type 10, 615803 (3);chr11;CLP1, HEAB, PCH10;True
ENSG00000198561;Catenin (cadherin-associated protein), delta 1;NotRelevant;;Blepharocheilodontic syndrome 2, 617681 (3), Autosomal dominantBlepharocheilodontic syndrome 2, 617681 (3);chr11;CTNND1, CTNND, BCDS2;True
ENSG00000189057;Family with sequence similarity 111, member B;NotRelevant;;Poikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3), Autosomal dominantPoikiloderma, hereditary fibrosing, with tendon contractures, myopathy, and pulmonary fibrosis, 615704 (3);chr11;FAM111B, POIKTMP;True
ENSG00000166801;Family with sequence similarity 111, member A;NotRelevant;;Gracile bone dysplasia, 602361 (3), Autosomal dominantKenny-Caffey syndrome, type 2, 127000 (3);chr11;FAM111A, KIAA1895, KCS2, GCLEB;True
ENSG00000134812;Gastric intrinsic factor;NotRelevant;;Intrinsic factor deficiency, 261000 (3), Autosomal recessiveIntrinsic factor deficiency, 261000 (3);chr11;GIF, IF;True
ENSG00000149534;Membrane-spanning 4-domains, subfamily A, member 2 (Fc fragment of IgE, high affinity I, receptor for, beta polypeptide);NotRelevant;;{Atopy, susceptibility to}, 147050 (3), Autosomal dominant{Atopy, susceptibility to}, 147050 (3);chr11;MS4A2, FCER1B;True
ENSG00000156738;Membrane-spanning 4-domains, subfamily A, member 1;NotRelevant;;Immunodeficiency, common variable, 5, 613495 (3), Autosomal recessiveImmunodeficiency, common variable, 5, 613495 (3);chr11;MS4A1, CD20, CVID5;True
ENSG00000149506;Zona pellucida glycoprotein 1;NotRelevant;;Oocyte maturation defect 1, 615774 (3), Autosomal recessiveOocyte maturation defect 1, 615774 (3);chr11;ZP1, OOMD1;True
ENSG00000149483;Transmembrane protein 138;NotRelevant;;Joubert syndrome 16, 614465 (3), Autosomal recessiveJoubert syndrome 16, 614465 (3);chr11;TMEM138, JBTS16;True
ENSG00000187049;Transmembrane protein 216;NotRelevant;;Joubert syndrome 2, 608091 (3), Autosomal recessiveMeckel syndrome 2, 603194 (3);chr11;TMEM216, JBTS2, CORS2, MKS2;True
ENSG00000167985;Succinate dehydrogenase complex assembly factor 2;NotRelevant;;Paragangliomas 2, 601650 (3), Autosomal dominantParagangliomas 2, 601650 (3);chr11;SDHAF2, SDH5, PGL2;True
ENSG00000124920;Myelin regulatory factor;NotRelevant;;Encephalitis/encephalopathy, mild, with reversible myelin vacuolization, 618113 (3), Autosomal dominantEncephalitis/encephalopathy, mild, with reversible myelin vacuolization, 618113 (3);chr11;MYRF, 11orf9, KIAA0954, MMERV;True
ENSG00000167995;Bestrophin 1;NotRelevant;;Bestrophinopathy, autosomal recessive, 611809 (3)Vitreoretinochoroidopathy, 193220 (3);chr11;BEST1, VMD2, ARB, RP50;True
ENSG00000167996;Ferritin, heavy polypeptide 1;NotRelevant;mutation identified in 1 family;?Hemochromatosis, type 5, 615517 (3), Autosomal dominant?Hemochromatosis, type 5, 615517 (3);chr11;FTH1, FTHL6, HFE5;True
ENSG00000149489;Rod outer segment membrane protein-1;NotRelevant;digenic RP with RDS;Retinitis pigmentosa 7, digenic form, 608133 (3), Autosomal recessive, Autosomal dominantRetinitis pigmentosa 7, digenic form, 608133 (3);chr11;ROM1, ROSP1, RP7;True
ENSG00000149541;Beta-1,3-glucuronyltransferase 3;NotRelevant;pseudogene on chr.3;Multiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3), Autosomal recessiveMultiple joint dislocations, short stature, craniofacial dysmorphism, with or without congenital heart defects, 245600 (3);chr11;B3GAT3, GLCATI, JDSCD;True
ENSG00000089597;Neutral alpha-glucosidase AB;NotRelevant;;Polycystic kidney disease 3, 600666 (3), Autosomal dominantPolycystic kidney disease 3, 600666 (3);chr11;GANAB, PKD3;True
ENSG00000204922;Ubiquinol-cytochrome C reductase complex assembly factor 3;NotRelevant;mutation identified in 1 MC3DN9 patient;?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3), Autosomal recessive?Mitochondrial complex III deficiency, nuclear type 9, 616111 (3);chr11;UQCC3, C11orf83, MC3DN9;True
ENSG00000168000;Seipin;NotRelevant;;Encephalopathy, progressive, with or without lipodystrophy, 615924 (3), Autosomal recessiveSilver spastic paraplegia syndrome, 270685 (3);chr11;BSCL2, SPG17, HMN5, PELD;True
ENSG00000184743;Atlastin 3;NotRelevant;;Neuropathy, hereditary sensory, type IF, 615632 (3), Autosomal dominantNeuropathy, hereditary sensory, type IF, 615632 (3);chr11;ATL3, HSN1F;True
ENSG00000176340;Cytochrome c oxidase, subunit VIIIA;NotRelevant;mutation identified in 1 COX4D patient;?Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial?Mitochondrial complex IV deficiency, 220110 (3);chr11;COX8A;True
ENSG00000149781;Fermitin family, member 3;NotRelevant;;Leukocyte adhesion deficiency, type III, 612840 (3), Autosomal recessiveLeukocyte adhesion deficiency, type III, 612840 (3);chr11;FERMT3, KIND3, URP2, MIG2B;True
ENSG00000197891;Solute carrier family 22 (urate transporter), member 12;NotRelevant;;Hypouricemia, renal, 220150 (3), Autosomal recessiveHypouricemia, renal, 220150 (3);chr11;SLC22A12, OAT4L, URAT1;True
ENSG00000068831;Ras guanyl nucleotide-releasing protein 2;NotRelevant;mutation identified in 1 BDPLT18 family;?Bleeding disorder, platelet-type, 18, 615888 (3), Autosomal recessive?Bleeding disorder, platelet-type, 18, 615888 (3);chr11;RASGRP2, CDC25L;True
ENSG00000068976;Phosphorylase, glycogen, muscle;NotRelevant;;McArdle disease, 232600 (3), Autosomal recessiveMcArdle disease, 232600 (3);chr11;PYGM;True
ENSG00000133895;Menin;NotRelevant;linked distal to PYGM;Adrenal adenoma, somatic (3)Parathyroid adenoma, somatic (3);chr11;MEN1;False
ENSG00000014216;Calpain, large polypeptide L1;NotRelevant;;Spastic paraplegia 76, autosomal recessive, 616907 (3), Autosomal recessiveSpastic paraplegia 76, autosomal recessive, 616907 (3);chr11;CAPN1, SPG76;True
ENSG00000133884;D4, zinc, and double PHD fingers family, member 2;NotRelevant;;Coffin-Siris syndrome 7, 618027 (3), Autosomal dominantCoffin-Siris syndrome 7, 618027 (3);chr11;DPF2, REQ, UBID4, CSS7;True
ENSG00000142186;SCY1-like 1;NotRelevant;;Spinocerebellar ataxia, autosomal recessive 21, 616719 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 21, 616719 (3);chr11;SCYL1, NTKL, SCAR21;True
ENSG00000168056;Latent transforming growth factor beta binding protein-3;NotRelevant;;Dental anomalies and short stature, 601216 (3), Autosomal recessiveGeleophysic dysplasia 3, 617809 (3);chr11;LTBP3, LTBP2, DASS, GPHYSD3;True
ENSG00000172922;Ribonuclease H2, subunit C;NotRelevant;;Aicardi-Goutieres syndrome 3, 610329 (3), Autosomal recessiveAicardi-Goutieres syndrome 3, 610329 (3);chr11;RNASEH2C, AYP1, FLJ20974, AGS3;True
ENSG00000172638;EGF-containing fibulin-like extracellular matrix protein 2 (fibulin 4);NotRelevant;;Cutis laxa, autosomal recessive, type IB, 614437 (3), Autosomal recessiveCutis laxa, autosomal recessive, type IB, 614437 (3);chr11;EFEMP2, FBLN4, UPH1, ARCL1B;True
ENSG00000172500;Fibroblast growth factor, acidic, intracellular binding protein;NotRelevant;;Thauvin-Robinet-Faivre syndrome, 617107 (3), Autosomal recessiveThauvin-Robinet-Faivre syndrome, 617107 (3);chr11;FIBP, TROFAS;True
ENSG00000175334;Barrier to autointegration factor 1;NotRelevant;;Nestor-Guillermo progeria syndrome, 614008 (3), Autosomal recessiveNestor-Guillermo progeria syndrome, 614008 (3);chr11;BANF1, BAF, NGPS;True
ENSG00000175294;Cation channel, sperm-associated, 1;NotRelevant;;Spermatogenic failure 7, 612997 (3), Autosomal recessiveSpermatogenic failure 7, 612997 (3);chr11;CATSPER1, CATSPER, SPGF7;True
ENSG00000175115;Phosphofurin acidic cluster sorting protein 1;NotRelevant;;Schuurs-Hoeijmakers syndrome, 615009 (3), Autosomal dominantSchuurs-Hoeijmakers syndrome, 615009 (3);chr11;PACS1, SHMS, MRD17;True
ENSG00000174996;Kinesin, light chain 2;NotRelevant;;Spastic paraplegia, optic atrophy, and neuropathy, 609541 (3), Autosomal recessiveSpastic paraplegia, optic atrophy, and neuropathy, 609541 (3);chr11;KLC2, SPOAN;True
ENSG00000174684;Beta-1,4glucuronyltransferase 1;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 13, 615287 (3);chr11;B4GAT1, B3GNT1, IGNT, IGAT, MDDGA13;True
ENSG00000174483;BBS1 gene;NotRelevant;;Bardet-Biedl syndrome 1, 209900 (3), Autosomal recessive, Digenic recessiveBardet-Biedl syndrome 1, 209900 (3);chr11;BBS1;True
ENSG00000248746;Actinin, alpha-3;NotRelevant;;[Alpha-actinin-3 deficiency], 617749 (3)[Sprinting performance], 617749 (3);chr11;ACTN3, ACTN3D;False
ENSG00000174080;Cathepsin F;NotRelevant;;Ceroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3), Autosomal recessiveCeroid lipofuscinosis, neuronal, 13, Kufs type, 615362 (3);chr11;CTSF, CLN13;True
ENSG00000173898;Spectrin, beta, nonerythrocytic, 2;NotRelevant;;Spinocerebellar ataxia 5, 600224 (3), Autosomal dominantSpinocerebellar ataxia, autosomal recessive 14, 615386 (3);chr11;SPTBN2, SCA5, SCAR14;True
ENSG00000173599;Pyruvate carboxylase;NotRelevant;;Pyruvate carboxylase deficiency, 266150 (3), Autosomal recessivePyruvate carboxylase deficiency, 266150 (3);chr11;PC;True
ENSG00000175505;Cardiotrophin-like cytokine;NotRelevant;;Cold-induced sweating syndrome 2, 610313 (3), Autosomal recessiveCold-induced sweating syndrome 2, 610313 (3);chr11;CLCF1, BSF3, CLC, CISS2;True
ENSG00000175544;Calcium-binding protein 4;NotRelevant;;Cone-rod synaptic disorder, congenital nonprogressive, 610427 (3), Autosomal recessiveCone-rod synaptic disorder, congenital nonprogressive, 610427 (3);chr11;CABP4, CRSD, CSNB2B;True
ENSG00000110711;Aryl hydrocarbon receptor-interacting protein;NotRelevant;;Pituitary adenoma 1, multiple types, 102200 (3), Autosomal dominant, Somatic mutationPituitary adenoma predisposition, 102000 (3);chr11;AIP, XAP2, ARA9, PITA1;True
ENSG00000167791;Calcium-binding protein 2;NotRelevant;;Deafness, autosomal recessive 93, 614899 (3), Autosomal recessiveDeafness, autosomal recessive 93, 614899 (3);chr11;CABP2, DFNB93;True
ENSG00000167792;NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kD;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 4, 618225 (3)Mitochondrial complex I deficiency, nuclear type 4, 618225 (3);chr11;NDUFV1, UQOR1, MC1DN4;False
ENSG00000110057;UNC93, C. elegans, homolog of, B1;NotRelevant;;{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, 610551 (3){Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 1}, 610551 (3);chr11;UNC93B1, IIAE1;False
ENSG00000110717;NADH dehydrogenase (ubiquinone) Fe-S protein 8, 23kD (NADH-coenzyme Q reductase);NotRelevant;previously assigned to 3q28;Mitochondrial complex I deficiency, nuclear type 2, 618222 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 2, 618222 (3);chr11;NDUFS8, MC1DN2;True
ENSG00000110719;T-cell immune regulator 1;NotRelevant;;Osteopetrosis, autosomal recessive 1, 259700 (3), Autosomal recessiveOsteopetrosis, autosomal recessive 1, 259700 (3);chr11;TCIRG1, TIRC7, OC116, OPTB1;True
ENSG00000110066;Lysine methyltransferase 5B;NotRelevant;;Mental retardation, autosomal dominant 51, 617788 (3), Autosomal dominantMental retardation, autosomal dominant 51, 617788 (3);chr11;KMT5B, SUV420H1, CGI85, MRD51;True
ENSG00000162337;Low density lipoprotein receptor-related protein-5;NotRelevant;;[Bone mineral density variability 1], 601884 (3), Autosomal dominant{Osteoporosis}, 166710 (3);chr11;LRP5, BMND1, LRP7, LR3, OPPG, VBCH2, OPTA1, EVR4, PCLD4;True
ENSG00000069482;Galanin;NotRelevant;mutation identified in 1 ETL8 family;?Epilepsy, familial temporal lobe, 8, 616461 (3), Autosomal dominant?Epilepsy, familial temporal lobe, 8, 616461 (3);chr11;GAL, GALN, GLNN, ETL8;True
ENSG00000110090;Carnitine palmitoyltransferase I, liver;NotRelevant;;CPT deficiency, hepatic, type IA, 255120 (3), Autosomal recessiveCPT deficiency, hepatic, type IA, 255120 (3);chr11;CPT1A;True
ENSG00000132740;Immunoglobulin mu binding protein 2;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2S, 616155 (3), Autosomal recessiveNeuronopathy, distal hereditary motor, type VI, 604320 (3);chr11;IGHMBP2, SMUBP2, CATF1, SMARD1, HMN6, CMT2S;True
ENSG00000162341;Two-pore segment channel 2;NotRelevant;;[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3)[Skin/hair/eye pigmentation 10, blond/brown hair], 612267 (3);chr11;TPCN2, TPC2, SHEP10;False
ENSG00000110092;Cyclin D1;NotRelevant;pseudogene on 11q13;{Colorectal cancer, susceptibility to}, 114500 (3), Autosomal dominant{von Hippel-Lindau syndrome, modifier of}, 193300 (3);chr11;CCND1, PRAD1, BCL1;True
ENSG00000075388;Fibroblast growth factor-4 (heparin secretory transforming protein-1;NotRelevant;ENSG00000075388;coamplified with FGF3 in melanoma;chr11;FGF4, HSTF1;False
ENSG00000186895;Fibroblast growth factor-3 (oncogene INT2);NotRelevant;35kb 5' to HST1;Deafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3), Autosomal recessiveDeafness, congenital with inner ear agenesis, microtia, and microdontia, 610706 (3);chr11;FGF3, INT2;True
ENSG00000168040;FAS-associating protein with death domain;NotRelevant;;Infections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations, 613759 (3), Autosomal recessiveInfections, recurrent, with encephalopathy, hepatic dysfunction, and cardiovascular malformations, 613759 (3);chr11;FADD;True
ENSG00000162105;SH3 and multiple ankyrin repeat domains 2;NotRelevant;;{Autism susceptibility 17}, 613436 (3){Autism susceptibility 17}, 613436 (3);chr11;SHANK2, CORTBP1, AUTS17;False
ENSG00000172893;Delta-7-dehydrocholesterol reductase;NotRelevant;;Smith-Lemli-Opitz syndrome, 270400 (3), Autosomal recessiveSmith-Lemli-Opitz syndrome, 270400 (3);chr11;DHCR7, SLOS;True
ENSG00000137497;Nuclear mitotic apparatus protein-1;NotRelevant;fused with RARA in APL;Leukemia, acute promyelocytic, somatic, 612376 (3)Leukemia, acute promyelocytic, somatic, 612376 (3);chr11;NUMA1;False
ENSG00000184154;Leucine-rich transmembrane O-methyltransferase;NotRelevant;;Deafness, autosomal recessive 63, 611451 (3), Autosomal recessiveDeafness, autosomal recessive 63, 611451 (3);chr11;LRTOMT, LRTOMT1, LRTOMT2, DFNB63;True
ENSG00000110195;Folate receptor-1, adult;NotRelevant;telomeric of FGF3;Neurodegeneration due to cerebral folate transport deficiency, 613068 (3), Autosomal recessiveNeurodegeneration due to cerebral folate transport deficiency, 613068 (3);chr11;FOLR1;True
ENSG00000165458;Inositol polyphosphate phosphatase-like 1;NotRelevant;;Opsismodysplasia, 258480 (3), Autosomal recessiveOpsismodysplasia, 258480 (3);chr11;INPPL1, OPSMD;True
ENSG00000165462;Paired-like (astraless) homeobox 2a;NotRelevant;;Fibrosis of extraocular muscles, congenital, 2, 602078 (3), Autosomal recessiveFibrosis of extraocular muscles, congenital, 2, 602078 (3);chr11;PHOX2A, ARIX, CFEOM2;True
ENSG00000162129;Caseinolytic peptidase B;NotRelevant;;3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3), Autosomal recessive3-methylglutaconic aciduria, type VII, with cataracts, neurologic involvement and neutropenia, 616271 (3);chr11;CLPB, SKD3, MEGCANN, MGCA7;True
ENSG00000187726;DNAJ/HSP40 homolog, subfamily B, member 13;NotRelevant;;Ciliary dyskinesia, primary, 34, 617091 (3), Autosomal recessiveCiliary dyskinesia, primary, 34, 617091 (3);chr11;DNAJB13, TSARG6, CILD34;True
ENSG00000175567;Uncoupling protein-2;NotRelevant;;{Obesity, susceptibility to, BMIQ4}, 607447 (3){Obesity, susceptibility to, BMIQ4}, 607447 (3);chr11;UCP2, BMIQ4;False
ENSG00000175564;Uncoupling protein-3;NotRelevant;;{Obesity, severe, and type II diabetes}, 601665 (3), Autosomal recessive, Autosomal dominant, Multifactorial{Obesity, severe, and type II diabetes}, 601665 (3);chr11;UCP3;True
ENSG00000168014;C2 calcium-dependent domain-containing protein 3;NotRelevant;mutation identified in 1 OFD14 patient and 1 OFD14 fetus;?Orofaciodigital syndrome XIV, 615948 (3), Autosomal recessive?Orofaciodigital syndrome XIV, 615948 (3);chr11;C2CD3, OFD14;True
ENSG00000175538;Potassium voltage-gated channel, ISK-related subfamily, member 3;NotRelevant;mutation identified in 1 BRGDA6 family;?Brugada syndrome 6, 613119 (3)?Brugada syndrome 6, 613119 (3);chr11;KCNE3, HOKPP, HYPP;False
ENSG00000175536;Lipoyl(octanoyl) transferase 2;NotRelevant;;Encephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3), Autosomal recessiveEncephalopathy, neonatal severe, with lactic acidosis and brain abnormalities, 617668 (3);chr11;LIPT2;True
ENSG00000149257;Serpin peptidase inhibitor, clade H, member 1;NotRelevant;;Osteogenesis imperfecta, type X, 613848 (3), Autosomal recessive{Preterm premature rupture of the membranes, susceptibility to}, 610504 (3);chr11;SERPINH1, SERPINH2, PPROM, CBP2, CBP1, OI10;True
ENSG00000078124;Alkaline ceramidase 3;NotRelevant;mutation identified in 1 PLDECO family;?Leukodystrophy, progressive, early childhood-onset, 617762 (3), Autosomal recessive?Leukodystrophy, progressive, early childhood-onset, 617762 (3);chr11;ACER3, APHC, PHCA, PLDECO;True
ENSG00000149260;Calpain 5;NotRelevant;;Vitreoretinopathy, neovascular inflammatory, 193235 (3), Autosomal dominantVitreoretinopathy, neovascular inflammatory, 193235 (3);chr11;CAPN5, HTRA3, VRNI;True
ENSG00000137474;Myosin VIIA;NotRelevant;;Deafness, autosomal dominant 11, 601317 (3), Autosomal dominantUsher syndrome, type 1B, 276900 (3);chr11;MYO7A, USH1B, DFNB2, DFNA11;True
ENSG00000149269;p21/CDC42/RAC1-activated kinase 1;NotRelevant;;Intellectual developmental disorder with macrocephaly, seizures, and speech delay, 618158 (3), Autosomal dominantIntellectual developmental disorder with macrocephaly, seizures, and speech delay, 618158 (3);chr11;PAK1, IDDMSSD;True
ENSG00000159063;Alg8, S. cerevisiae, homolog of;NotRelevant;;Congenital disorder of glycosylation, type Ih, 608104 (3), Autosomal recessivePolycystic liver disease 3 with or without kidney cysts, 617874 (3);chr11;ALG8, CDG1H, PCLD3;True
ENSG00000137513;Asparaginyl-tRNA synthetase 2;NotRelevant;;Combined oxidative phosphorylation deficiency 24, 616239 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 24, 616239 (3);chr11;NARS2, COXPD24;True
ENSG00000149256;Teneurin transmembrane protein 4;NotRelevant;;Essential tremor, hereditary, 5, 616736 (3), Autosomal dominantEssential tremor, hereditary, 5, 616736 (3);chr11;TENM4, ODZ4, TNM4, DOC4, KIAA1302, ETM5;True
ENSG00000171204;Transmembrane protein 126B;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 29, 618250 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 29, 618250 (3);chr11;TMEM126B, MC1DN29;True
ENSG00000171202;Transmembrane protein 126A;NotRelevant;;Optic atrophy 7, 612989 (3), Autosomal recessiveOptic atrophy 7, 612989 (3);chr11;TMEM126A, OPA7;True
ENSG00000073921;Phosphatidylinositol-binding clathrin assembly protein;NotRelevant;fuses with AF10 in t(10;11)Leukemia, acute myeloid, somatic, 601626 (3);chr11;PICALM, CALM, CLTH, LAP;False
ENSG00000074266;Embryonic ectoderm development protein, mouse, homolog of;NotRelevant;;Cohen-Gibson syndrome, 617561 (3), Autosomal dominantCohen-Gibson syndrome, 617561 (3);chr11;EED, WAIT1, COGIS;True
ENSG00000149196;Hikeshi;NotRelevant;;Leukodystrophy, hypomyelinating, 13, 616881 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 13, 616881 (3);chr11;HIKESHI, C11orf73, HLD13;True
ENSG00000174804;Frizzled, Drosophila, homolog of, 4;NotRelevant;;Exudative vitreoretinopathy 1, 133780 (3), Autosomal dominantRetinopathy of prematurity, 133780 (3);chr11;FZD4, EVR1;True
ENSG00000109861;Cathepsin C;NotRelevant;;Haim-Munk syndrome, 245010 (3), Autosomal recessivePeriodontitis 1, juvenile, 170650 (3);chr11;CTSC, CPPI, PALS, PLS, HMS, PDON1, JPD;True
ENSG00000077498;Tyrosinase;NotRelevant;;Albinism, oculocutaneous, type IA, 203100 (3), Autosomal recessive{Melanoma, cutaneous malignant, susceptibility to, 8}, 601800 (3);chr11;TYR, SHEP3, CMM8, OCA1A, ATN;True
ENSG00000134640;Melatonin receptor 1B;NotRelevant;;{Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant{Diabetes mellitus, type 2, susceptibility to}, 125853 (3);chr11;MTNR1B;True
ENSG00000042429;Mediator complex subunit 17;NotRelevant;;Microcephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3), Autosomal recessiveMicrocephaly, postnatal progressive, with seizures and brain atrophy, 613668 (3);chr11;MED17, CRSP6, CRSP77, TRAP80, DRIP80;True
ENSG00000020922;Meiotic recombination 11, S. cerevisiae, homolog A of;NotRelevant;;Ataxia-telangiectasia-like disorder 1, 604391 (3), Autosomal recessiveAtaxia-telangiectasia-like disorder 1, 604391 (3);chr11;MRE11A, MRE11, ATLD;True
ENSG00000166037;Centrosomal protein 57kD;NotRelevant;;Mosaic variegated aneuploidy syndrome 2, 614114 (3), Autosomal recessiveMosaic variegated aneuploidy syndrome 2, 614114 (3);chr11;CEP57, PIG8, TSP57, KIAA0092, MVA2;True
ENSG00000087053;Myotubularin-related protein 2;NotRelevant;;Charcot-Marie-Tooth disease, type 4B1, 601382 (3), Autosomal recessiveCharcot-Marie-Tooth disease, type 4B1, 601382 (3);chr11;MTMR2, CMT4B1;True
ENSG00000184384;Mastermind-like 2;NotRelevant;t(11;19)Mucoepidermoid salivary gland carcinoma (3);chr11;MAML2, MAM3;False
ENSG00000082175;Progesterone receptor;NotRelevant;11q13 = earlier regionalization;?Progesterone resistance, 264080 (2), Autosomal recessive?Progesterone resistance, 264080 (2);chr11;PGR;True
ENSG00000137672;Transient receptor potential channel-6;NotRelevant;;Glomerulosclerosis, focal segmental, 2, 603965 (3), Autosomal dominantGlomerulosclerosis, focal segmental, 2, 603965 (3);chr11;TRPC6, TRP6, FSGS2;True
ENSG00000137691;Cilia- and flagella-associated protein 300;NotRelevant;;Ciliary dyskinesia, primary, 38, 618063 (3), Autosomal recessiveCiliary dyskinesia, primary, 38, 618063 (3);chr11;CFAP300, C11orf70, CILD38;True
ENSG00000137693;Yes-associated protein 1, 65kD;NotRelevant;;Coloboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3), Autosomal dominantColoboma, ocular, with or without hearing impairment, cleft lip/palate, and/or mental retardation, 120433 (3);chr11;YAP1, COB1;True
ENSG00000137674;Matrix metalloproteinase-20 (enamelysin);NotRelevant;;Amelogenesis imperfecta, type IIA2, 612529 (3), Autosomal recessiveAmelogenesis imperfecta, type IIA2, 612529 (3);chr11;MMP20, AI2A2;True
ENSG00000196611;Matrix metalloproteinase 1 (interstitial collagenase);NotRelevant;;COPD, rate of decline of lung function in, 606963 (3){Epidermolysis bullosa dystrophica, autosomal recessive, modifier of}, 226600 (3);chr11;MMP1, CLG;True
ENSG00000149968;Matrix metalloproteinase 3 (stromelysin 1, progelatinase);NotRelevant;;{Coronary heart disease, susceptibility to, 6}, 614466 (3){Coronary heart disease, susceptibility to, 6}, 614466 (3);chr11;MMP3, STMY1, CHDS6;False
ENSG00000137745;Matrix metalloproteinase 13 (collagenase 3);NotRelevant;;Metaphyseal anadysplasia 1, 602111 (3), Autosomal dominantSpondyloepimetaphyseal dysplasia, Missouri type, 602111 (3);chr11;MMP13, CLG3, MANDP1, MDST;True
ENSG00000187240;Dynein, cytoplasmic-2, heavy chain-1;NotRelevant;1 patient showed heterozygous NEK2 and DYNC2H1 mutations;Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3), Autosomal recessive, Digenic recessiveShort-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3);chr11;DYNC2H1, DNCH2, DHC2, ATD3, SRPS2B, SRTD3;True
ENSG00000204403;Caspase 12, apoptosis-related cysteine protease;NotRelevant;;{Sepsis, susceptibility to} (3){Sepsis, susceptibility to} (3);chr11;CASP12, CASP12P1;False
ENSG00000152578;Glutamate receptor, ionotropic, AMPA 4;NotRelevant;;Neurodevelopmental disorder with or without seizures and gait abnormalities, 617864 (3), Autosomal dominantNeurodevelopmental disorder with or without seizures and gait abnormalities, 617864 (3);chr11;GRIA4, GLUR4, NEDSGA;True
ENSG00000075239;Acetyl-Coenzyme A acetyltransferase-1 (acetoacetyl Coenzyme A thiolase);NotRelevant;cluster: cen-STMY2-CLG-STMY1-ter;Alpha-methylacetoacetic aciduria, 203750 (3), Autosomal recessiveAlpha-methylacetoacetic aciduria, 203750 (3);chr11;ACAT1;True
ENSG00000149311;Ataxia-telangiectasia mutated (includes complementation groups A, C, D, and E);NotRelevant;;Ataxia-telangiectasia, 208900 (3), Autosomal recessive{Breast cancer, susceptibility to}, 114480 (3);chr11;ATM, ATA, AT1;True
ENSG00000110723;Exophilin 5;NotRelevant;;Epidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3), Autosomal recessiveEpidermolysis bullosa, nonspecific, autosomal recessive, 615028 (3);chr11;EXPH5, SLAC2B, KIAA0624;True
ENSG00000178105;DEAD/H box-10 (RNA helicase);NotRelevant;400kb telomeric to ATM; pseudogene on 9q21-q22;chr11;DDX10;False
ENSG00000137710;Radixin;NotRelevant;;Deafness, autosomal recessive 24, 611022 (3), Autosomal recessiveDeafness, autosomal recessive 24, 611022 (3);chr11;RDX, DFNB24;True
ENSG00000137713;Protein phosphatase 2, structural/regulatory subunit A, beta;NotRelevant;;Lung cancer, 211980 (3), Autosomal recessiveLung cancer, 211980 (3);chr11;PPP2R1B;True
ENSG00000086848;Alg9, yeast, homolog of;NotRelevant;;Congenital disorder of glycosylation, type Il, 608776 (3), Autosomal recessiveGillessen-Kaesbach-Nishimura syndrome, 263210 (3);chr11;ALG9, DIBD1, CDG1L, GIKANIS;True
ENSG00000109846;Crystallin, alpha B;NotRelevant;;Cardiomyopathy, dilated, 1II, 615184 (3), Autosomal dominantMyopathy, myofibrillar, fatal infantile hypertonic, alpha-B crystallin-related, 613869 (3);chr11;CRYAB, CRYA2, CTPP2, CMD1II, CTRCT16, MFM2;True
ENSG00000150768;Dihydrolipoamide S-acetyltransferase;NotRelevant;;Pyruvate dehydrogenase E2 deficiency, 245348 (3), Autosomal recessivePyruvate dehydrogenase E2 deficiency, 245348 (3);chr11;DLAT, PDCE2;True
ENSG00000204370;Succinate dehydrogenase complex, subunit D, integral membrane protein;NotRelevant;;Mitochondrial complex II deficiency, 252011 (3), Autosomal recessivePheochromocytoma, 171300 (3);chr11;SDHD, PGL1;True
ENSG00000150787;6-pyruvoyltetrahydropterin synthase;NotRelevant;;Hyperphenylalaninemia, BH4-deficient, A, 261640 (3), Autosomal recessiveHyperphenylalaninemia, BH4-deficient, A, 261640 (3);chr11;PTS;True
ENSG00000149295;Dopamine receptor D2;NotRelevant;11q22-q23 junction; 150kb 5' to NCAM;chr11;DRD2;False
ENSG00000109906;Zinc finger- and BTB domain-containing protein 16 (promyelocytic leukemia zinc finger);NotRelevant;fused with RARA in APL of t(11;17) typeSkeletal defects, genital hypoplasia, and mental retardation, 612447 (3);chr11;ZBTB16, ZNF145, PLZF;False
ENSG00000166741;Nicotinamide N-methyltransferase;NotRelevant;;Homocysteine plasma level, 600008 (2)Homocysteine plasma level (2);chr11;NNMT;False
ENSG00000110243;Apolipoprotein A-V;NotRelevant;proximal to APOA1, APOC3, APOA4;Hyperchylomicronemia, late-onset, 144650 (3), Autosomal dominant{Hypertriglyceridemia, susceptibility to}, 145750 (3);chr11;APOA5;True
ENSG00000110245;Apolipoprotein C-III;NotRelevant;2.6kb 3' to APOA1;Apolipoprotein C-III deficiency, 614028 (3)Apolipoprotein C-III deficiency, 614028 (3);chr11;APOC3, HALP2;False
ENSG00000118137;Apolipoprotein A-I;NotRelevant;;Amyloidosis, 3 or more types, 105200 (3), Autosomal dominantHypoalphalipoproteinemia, 604091 (3);chr11;APOA1;True
ENSG00000160584;Salt-inducible kinase 3;NotRelevant;mutation identified in 1 SEMDK family;?Spondyloepimetaphyseal dysplasia, Krakow type, 618162 (3), Autosomal recessive?Spondyloepimetaphyseal dysplasia, Krakow type, 618162 (3);chr11;SIK3, KIAA0999, SEMDK;True
ENSG00000110274;Centrosomal protein, 164kD;NotRelevant;;Nephronophthisis 15, 614845 (3), Autosomal recessiveNephronophthisis 15, 614845 (3);chr11;CEP164, KIAA1052;True
ENSG00000137731;FXYD domain-containing ion transport regulator 2 (sodium-potassium-ATPase, gamma polypeptide);NotRelevant;;Hypomagnesemia 2, renal, 154020 (3), Autosomal dominantHypomagnesemia 2, renal, 154020 (3);chr11;FXYD2, ATP1G1, HOMG2;True
ENSG00000110324;Interleukin-10 receptor, alpha;NotRelevant;;Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3), Autosomal recessiveInflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3);chr11;IL10RA, IL10R, IBD28;True
ENSG00000177098;Sodium channel, voltage-gated, type IV, beta subunit;NotRelevant;;Atrial fibrillation, familial, 17, 611819 (3), Autosomal dominantLong QT syndrome-10, 611819 (3);chr11;SCN4B, LQT10, ATFB17;True
ENSG00000149575;Sodium channel, voltage-gated, type II, beta polypeptide;NotRelevant;;Atrial fibrillation, familial, 14, 615378 (3), Autosomal dominantAtrial fibrillation, familial, 14, 615378 (3);chr11;SCN2B, ATFB14;True
ENSG00000149573;Myelin protein zero-like 2;NotRelevant;;Deafness, autosomal recessive 111, 618145 (3), Autosomal recessiveDeafness, autosomal recessive 111, 618145 (3);chr11;MPZL2, EVA1, EVA, DFNB111;True
ENSG00000198851;CD3E antigen, epsilon polypeptide (TiT3 complex);NotRelevant;;Immunodeficiency 18, 615615 (3), Autosomal recessiveImmunodeficiency 18, SCID variant, 615615 (3);chr11;CD3E, IMD18;True
ENSG00000167286;CD3D antigen, delta polypeptide (TiT3 complex);NotRelevant;3 CD3 genes in 50kb;Immunodeficiency 19, 615617 (3), Autosomal recessiveImmunodeficiency 19, 615617 (3);chr11;CD3D, T3D, IMD19;True
ENSG00000160654;CD3G antigen, gamma polypeptide (TiT3 complex);NotRelevant;;Immunodeficiency 17, CD3 gamma deficient, 615607 (3), Autosomal recessiveImmunodeficiency 17, CD3 gamma deficient, 615607 (3);chr11;CD3G, IMD17;True
ENSG00000118058;Lysine (K)-specific methyltransferase 2E;NotRelevant;fuses with ENL, AF4, AF9, GMPS;Leukemia, myeloid/lymphoid or mixed-lineage, 159555 (2), Autosomal dominantWiedemann-Steiner syndrome, 605130 (3);chr11;KMT2A, MLL, HRX, HTRX1, WDSTS;True
ENSG00000095139;Archain 1;NotRelevant;60kb telomeric to MLL;Short stature, rhizomelic, with microcephaly, micrognathia, and developmental delay, 617164 (3), Autosomal dominantShort stature, rhizomelic, with microcephaly, micrognathia, and developmental delay, 617164 (3);chr11;ARCN1, SRMMD;True
ENSG00000118094;Trehalase;NotRelevant;;Trehalase deficiency, 612119 (3), Autosomal recessiveTrehalase deficiency, 612119 (3);chr11;TREH, TREHD;True
ENSG00000137700;Solute carrier family 37 (glucose-6-phosphate transporter), member 4;NotRelevant;;Glycogen storage disease Ib, 232220 (3), Autosomal recessiveGlycogen storage disease Ic, 232240 (3);chr11;SLC37A4, G6PT1;True
ENSG00000149428;Hypoxia-upregulated 1;NotRelevant;mutation identified in 1 IMD59 patient;?Immunodeficiency 59 and hypoglycemia, 233600 (3), Autosomal recessive?Immunodeficiency 59 and hypoglycemia, 233600 (3);chr11;HYOU1, IMD59;True
ENSG00000160695;Vacuolar protein sorting 11, yeast, homolog of;NotRelevant;;Leukodystrophy, hypomyelinating, 12, 616683 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 12, 616683 (3);chr11;VPS11, HLD12;True
ENSG00000256269;Hydroxymethylbilane synthase;NotRelevant;;Porphyria, acute intermittent, 176000 (3), Autosomal dominantPorphyria, acute intermittent, nonerythroid variant, 176000 (3);chr11;HMBS, PBGD, UPS;True
ENSG00000172269;Dolichyl-phosphate N-acetylglucosamine phosphotransferase;NotRelevant;;Congenital disorder of glycosylation, type Ij, 608093 (3), Autosomal recessiveMyasthenic syndrome, congenital, 13, with tubular aggregates, 614750 (3);chr11;DPAGT1, DPAGT2, DGPT, CDG1J, CMSTA2, CMS13;True
ENSG00000110395;Cas-Br-M ecotropic retroviral transforming sequence (Oncogene CBL2);NotRelevant;mutation identified in 1 JMML family;?Juvenile myelomonocytic leukemia, 607785 (3), Autosomal dominant, Somatic mutationNoonan syndrome-like disorder with or without juvenile myelomonocytic leukemia, 613563 (3);chr11;CBL, CBL2, NSLL;True
ENSG00000223953;C1q- and tumor necrosis factor-related protein 5;NotRelevant;;Retinal degeneration, late-onset, autosomal dominant, 605670 (3), Autosomal dominantRetinal degeneration, late-onset, autosomal dominant, 605670 (3);chr11;C1QTNF5, CTRP5, LORD;True
ENSG00000235718;Membrane-type frizzled-related protein;NotRelevant;;Microphthalmia, isolated 5, 611040 (3), Autosomal recessiveNanophthalmos 2, 609549 (3);chr11;MFRP, MCOP5, NNO2;True
ENSG00000110400;Nectin 1;NotRelevant;;Cleft lip/palate-ectodermal dysplasia syndrome, 225060 (3), Autosomal recessiveOrofacial cleft 7, 225060 (3);chr11;NECTIN1, PVRL1, HVEC, PVRR1, PRR1, ED4, OFC7, CLPED1;True
ENSG00000109927;Tectorin, alpha;NotRelevant;;Deafness, autosomal dominant 8/12, 601543 (3), Autosomal dominantDeafness, autosomal recessive 21, 603629 (3);chr11;TECTA, DFNA8, DFNA12, DFNB21;True
ENSG00000109929;Sterol C5-desaturase-like;NotRelevant;;Lathosterolosis, 607330 (3), Autosomal recessiveLathosterolosis, 607330 (3);chr11;SC5DL, ERG3;True
ENSG00000166250;Coxsackievirus- and adenovirus receptor-like membrane protein;NotRelevant;;Congenital short bowel syndrome, 615237 (3), Autosomal recessiveCongenital short bowel syndrome, 615237 (3);chr11;CLMP, ASAM, ACAM, CSBS;True
ENSG00000166257;Sodium channel, voltage-gated, type III, beta subunit;NotRelevant;;Atrial fibrillation, familial, 16, 613120 (3), Autosomal dominantBrugada syndrome 7, 613120 (3);chr11;SCN3B, SCNB3, BRGDA7, ATFB16;True
ENSG00000110013;Sialic acid acetylesterase;NotRelevant;;{Autoimmune disease, susceptibility to, 6}, 613551 (3){Autoimmune disease, susceptibility to, 6}, 613551 (3);chr11;SIAE, AIS6;False
ENSG00000154134;Roundabout, Drosophila, homolog of, 3;NotRelevant;;Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3), Autosomal recessiveGaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3);chr11;ROBO3, RBIG1, RIG1, HGPPS1;True
ENSG00000165478;Hepatocyte cell adhesion molecule;NotRelevant;;Megalencephalic leukoencephalopathy with subcortical cysts 2A, 613925 (3), Autosomal recessiveMegalencephalic leukoencephalopathy with subcortical cysts 2B, remitting, with or without mental retardation, 613926 (3);chr11;HEPACAM, MLC2A, MLC2B;True
ENSG00000134910;STT3A, subunit of the oligosaccharyltransferase complex (catalytic);NotRelevant;mutation identified in 1 family;?Congenital disorder of glycosylation, type Iw, 615596 (3), Autosomal recessive?Congenital disorder of glycosylation, type Iw, 615596 (3);chr11;STT3A, ITM1, TMC;True
ENSG00000198331;HYLS1 gene;NotRelevant;;Hydrolethalus syndrome, 236680 (3), Autosomal recessiveHydrolethalus syndrome, 236680 (3);chr11;HYLS1, FLJ32915;True
ENSG00000110060;Pseudouridylate synthase 3;NotRelevant;mutation identified in 1 MRT55 family;?Mental retardation, autosomal recessive 55, 617051 (3), Autosomal recessive?Mental retardation, autosomal recessive 55, 617051 (3);chr11;PUS3, MRT55;True
ENSG00000064309;Cell adhesion molecule-related/downregulated by oncogenes;NotRelevant;;Holoprosencephaly 11, 614226 (3), Autosomal dominant, Isolated casesHoloprosencephaly 11, 614226 (3);chr11;CDON, CDO, HPE11;True
ENSG00000110074;FAD-dependent oxidoreductase domain-containing protein 1;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 19, 618241 (3)Mitochondrial complex I deficiency, nuclear type 19, 618241 (3);chr11;FOXRED1, MC1DN19;False
ENSG00000150455;TIR domain-containing adaptor protein;NotRelevant;;{Bacteremia, protection against}, 614382 (3){Tuberculosis, protection against}, 607948 (3);chr11;TIRAP, BACTS1;False
ENSG00000110063;Decapping enzyme, scavenger;NotRelevant;;Al-Raqad syndrome, 616459 (3), Autosomal recessiveAl-Raqad syndrome, 616459 (3);chr11;DCPS, HINT5, DCS1, ARS;True
ENSG00000134954;Avian erythroblastosis virus E26 (v-ets) oncogene homolog-1;NotRelevant;shown by HSR; 19cM distal to THY1;chr11;ETS1;False
ENSG00000151702;Friend leukemia virus integration 1;NotRelevant;fused with EWS in Ewing sarcoma;Bleeding disorder, platelet-type, 21, 617443 (3), Autosomal recessive, Autosomal dominantBleeding disorder, platelet-type, 21, 617443 (3);chr11;FLI1, BDPLT21;True
ENSG00000151704;Potassium inwardly-rectifying channel, subfamily J, member 1;NotRelevant;;Bartter syndrome, type 2, 241200 (3), Autosomal recessiveBartter syndrome, type 2, 241200 (3);chr11;KCNJ1, ROMK1;True
ENSG00000120457;Potassium inwardly-rectifying channel, subfamily J, member 5;NotRelevant;;Hyperaldosteronism, familial, type III, 613677 (3), Autosomal dominantLong QT syndrome 13, 613485 (3);chr11;KCNJ5, GIRK4, KATP1, LQT13;True
ENSG00000149418;Suppression of tumorigenicity 14;NotRelevant;;Ichthyosis, congenital, autosomal recessive 11, 602400 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 11, 602400 (3);chr11;ST14, MTSP1, ARCI11;True
ENSG00000183715;Opioid-binding protein/cell adhesion molecule-like;NotRelevant;;{Ovarian cancer, somatic}, 167000 (3){Ovarian cancer, somatic}, 167000 (3);chr11;OPCML;False
ENSG00000166086;Junctional adhesion molecule 3;NotRelevant;;Hemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3), Autosomal recessiveHemorrhagic destruction of the brain, subependymal calcification, and cataracts, 613730 (3);chr11;JAM3;True
ENSG00000151503;Non-SMC condensin II complex subunit D3;NotRelevant;;Microcephaly 22, primary, autosomal recessive, 617984 (3), Autosomal recessiveMicrocephaly 22, primary, autosomal recessive, 617984 (3);chr11;NCAPD3, CAPD3, KIAA0056, MCPH22;True
ENSG00000151498;Acyl-CoA dehydrogenase family, member 8;NotRelevant;;Isobutyryl-CoA dehydrogenase deficiency, 611283 (3)Isobutyryl-CoA dehydrogenase deficiency, 611283 (3);chr11;ACAD8;False
ENSG00000060237;WNK lysine deficient protein kinase 1;NotRelevant;;Neuropathy, hereditary sensory and autonomic, type II, 201300 (3), Autosomal recessivePseudohypoaldosteronism, type IIC, 614492 (3);chr12;WNK1, PRKWNK1, KDP, PHA2C, HSAN2, HSN2;True
ENSG00000151062;Calcium channel, voltage-dependent, alpha-2/delta subunit 4;NotRelevant;;Retinal cone dystrophy 4, 610478 (3), Autosomal recessiveRetinal cone dystrophy 4, 610478 (3);chr12;CACNA2D4, RCD4;True
ENSG00000151067;Calcium channel, voltage-dependent, L type, alpha 1C subunit;NotRelevant;;Brugada syndrome 3, 611875 (3)Timothy syndrome, 601005 (3);chr12;CACNA1C, CACNL1A1, CCHL1A1, TS;False
ENSG00000118971;Cyclin D2;NotRelevant;;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3), Autosomal dominantMegalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 3, 615938 (3);chr12;CCND2, MPPH3;True
ENSG00000118972;Fibroblast growth factor 23;NotRelevant;;Hypophosphatemic rickets, autosomal dominant, 193100 (3), Autosomal dominantTumoral calcinosis, hyperphosphatemic, familial, 2, 617993 (3);chr12;FGF23, ADHR, HPDR2, PHPTC, HFTC2;True
ENSG00000047621;Chromosome 12 open reading frame 4;NotRelevant;;Mental retardation, autosomal recessive 66, 618221 (3), Autosomal recessiveMental retardation, autosomal recessive 66, 618221 (3);chr12;C12orf4;True
ENSG00000139180;NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 9;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 26, 618247 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 26, 618247 (3);chr12;NDUFA9, MC1DN26;True
ENSG00000111262;Potassium voltage-gated channel, shaker-related subfamily, member 1;NotRelevant;close to VWF;Episodic ataxia/myokymia syndrome, 160120 (3), Autosomal dominantEpisodic ataxia/myokymia syndrome, 160120 (3);chr12;KCNA1, AEMK, EA1;True
ENSG00000130037;Potassium voltage-gated channel, shaker-related subfamily, member 5;NotRelevant;;Atrial fibrillation, familial, 7, 612240 (3), Autosomal dominantAtrial fibrillation, familial, 7, 612240 (3);chr12;KCNA5, ATFB7;True
ENSG00000110799;Coagulation factor VIII VWF (von Willebrand factor);NotRelevant;pseudogene on chr. 22;von Willebrand disease, type 1, 193400 (3), Autosomal dominantvon Willibrand disease, type 3, 277480 (3);chr12;VWF, F8VWF;True
ENSG00000067182;Tumor necrosis factor receptor superfamily, member 1A;NotRelevant;;{Multiple sclerosis, susceptibility to, 5}, 614810 (3){Multiple sclerosis, susceptibility to, 5}, 614810 (3);chr12;TNFRSF1A, TNFR1, TNFAR, FPF, MS5;False
ENSG00000111319;Sodium channel, nonvoltage-gated 1, alpha;NotRelevant;mutation identified in 1 LIDLS3 patient;Bronchiectasis with or without elevated sweat chloride 2, 613021 (3), Autosomal dominantPseudohypoaldosteronism, type I, 264350 (3);chr12;SCNN1A, BESC2, LIDLS3;True
ENSG00000139193;CD27 antigen;NotRelevant;;Lymphoproliferative syndrome 2, 615122 (3), Autosomal recessiveLymphoproliferative syndrome 2, 615122 (3);chr12;CD27, TNFRSF7, S152. LPFS2;True
ENSG00000139190;Vesicle-associated membrane protein-1 (synaptobrevin-1);NotRelevant;;Spastic ataxia 1, autosomal dominant, 108600 (3), Autosomal dominantSpastic ataxia 1, autosomal dominant, 108600 (3);chr12;VAMP1, SYB1, SPAX1;True
ENSG00000010292;Non-SMC condensin I complex subunit D2;NotRelevant;mutation identified in 1 MCPH21 patient;?Microcephaly 21, primary, autosomal recessive, 617983 (3), Autosomal recessive?Microcephaly 21, primary, autosomal recessive, 617983 (3);chr12;NCAPD2, CNAP1, KIAA0159, MCPH21;True
ENSG00000111642;Chromodomain helicase DNA-binding protein-4;NotRelevant;;Sifrim-Hitz-Weiss syndrome, 617159 (3), Autosomal dominantSifrim-Hitz-Weiss syndrome, 617159 (3);chr12;CHD4, SIHIWES;True
ENSG00000010610;CD4 antigen (p55);NotRelevant;CD = \'cluster of differentiation\' = nomenclature of leukocyte differentiation antigens;OKT4 epitope deficiency, 613949 (3)OKT4 epitope deficiency, 613949 (3);chr12;CD4;False
ENSG00000111664;Guanine nucleotide-binding protein, beta polypeptide-3;NotRelevant;;{Hypertension, essential, susceptibility to}, 145500 (3), Multifactorial{Hypertension, essential, susceptibility to}, 145500 (3);chr12;GNB3, CSNB1H;False
ENSG00000111669;Triosephosphate isomerase-1;NotRelevant;;Hemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3), Autosomal recessiveHemolytic anemia due to triosephosphate isomerase deficiency, 615512 (3);chr12;TPI1, TPID;True
ENSG00000111676;Atrophin 1;NotRelevant;;Dentatorubro-pallidoluysian atrophy, 125370 (3), Autosomal dominantDentatorubro-pallidoluysian atrophy, 125370 (3);chr12;ATN1, DRPLA, HRS, NOD;True
ENSG00000111678;Chromosome 12 open reading frame 57;NotRelevant;;Temtamy syndrome, 218340 (3), Autosomal recessiveTemtamy syndrome, 218340 (3);chr12;C12orf57, C10, TEMTYS;True
ENSG00000126749;Essential for mitotic growth 1, S. cerevisiae, homolog of;NotRelevant;;Bowen-Conradi syndrome, 211180 (3), Autosomal recessiveBowen-Conradi syndrome, 211180 (3);chr12;EMG1, NEP1, C2F, BWCNS;True
ENSG00000182326;Complement component-1, s subcomponent;NotRelevant;;C1s deficiency, 613783 (3)Ehlers-Danlos syndrome, periodontal type, 2, 617174 (3);chr12;C1S, EDSPD2;False
ENSG00000159403;Complement component-1, r subcomponent;NotRelevant;;Ehlers-Danlos syndrome, periodontal type, 1, 130080 (3), Autosomal dominantEhlers-Danlos syndrome, periodontal type, 1, 130080 (3);chr12;C1R, EDSPD1;True
ENSG00000139197;Peroxisome biogenesis factor 5;NotRelevant;;Peroxisome biogenesis disorder 2A (Zellweger), 214110 (3), Autosomal recessiveRhizomelic chondrodysplasia punctata, type 5, 616716 (3);chr12;PEX5, PXR1, PTS1R, PBD2A, PBD2B, RCDP5;True
ENSG00000184344;Growth differentiation factor 3;NotRelevant;;Klippel-Feil syndrome 3, autosomal dominant, 613702 (3)Microphthalmia, isolated 7, 613704 (3);chr12;GDF3, KFS3, MCOPCB6, MCOP7;True
ENSG00000089818;NECAP endocytosis-associated protein 1;NotRelevant;mutation identified in 1 EIEE21 family;?Epileptic encephalopathy, early infantile, 21, 615833 (3), Autosomal recessive?Epileptic encephalopathy, early infantile, 21, 615833 (3);chr12;NECAP1, EIEE21;True
ENSG00000111732;Activation-induced cytidine deaminase;NotRelevant;;Immunodeficiency with hyper-IgM, type 2, 605258 (3), Autosomal recessiveImmunodeficiency with hyper-IgM, type 2, 605258 (3);chr12;AICDA, AID, HIGM2;True
ENSG00000197614;Microfibril-associated protein 5;NotRelevant;;Aortic aneurysm, familial thoracic 9, 616166 (3), Autosomal dominantAortic aneurysm, familial thoracic 9, 616166 (3);chr12;MFAP5, MAGP2, AAT9;True
ENSG00000166535;Alpha-2-macroglobulin-like 1;NotRelevant;;{Otitis media, susceptibility to}, 166760 (3), Autosomal dominant{Otitis media, susceptibility to}, 166760 (3);chr12;A2ML1, OMS;True
ENSG00000111752;Polyhomeotic-like 1;NotRelevant;mutations identified in 1 family;?Microcephaly 11, primary, autosomal recessive, 615414 (3), Autosomal recessive?Microcephaly 11, primary, autosomal recessive, 615414 (3);chr12;PHC1, EDR1, HPH1, RAE28, MCPH11;True
ENSG00000175899;Alpha-2-macroglobulin;NotRelevant;cluster of genes;Alpha-2-macroglobulin deficiency, 614036 (1), Autosomal dominant{Alzheimer disease, susceptibility to}, 104300 (3);chr12;A2M , A2MD;True
ENSG00000150048;C-type lectin domain family 1, member A;NotRelevant;;{Aspergillosis, susceptibility to}, 614079 (3){Aspergillosis, susceptibility to}, 614079 (3);chr12;CLEC1A, CLEC1;False
ENSG00000172243;C-type lectin domain family 7, member A;NotRelevant;in natural killer gene complex;{Aspergillosis, susceptibility to}, 614079 (3){Aspergillosis, susceptibility to}, 614079 (3);chr12;CLEC7A, CLECSF12, DECTIN1, CANDF4;False
ENSG00000173391;Low density lipoprotein, oxidized, receptor 1;NotRelevant;;{Myocardial infarction, susceptibility to}, 608446 (3){Myocardial infarction, susceptibility to}, 608446 (3);chr12;OLR1, LOX1;False
ENSG00000139083;ETS variant gene-6 (TEL oncogene);NotRelevant;fused to PDGFRB or AML1 in leukemia;Leukemia, acute myeloid, somatic, 601626 (3)Thrombocytopenia 5, 616216 (3);chr12;ETV6, TEL, THC5;False
ENSG00000070018;Low density lipoprotein receptor-related protein 6;NotRelevant;;{Coronary artery disease, autosomal dominant, 2}, 610947 (3), Autosomal dominant{Coronary artery disease, autosomal dominant, 2}, 610947 (3);chr12;LRP6, ADCAD2, STHAG7;True
ENSG00000111276;Cyclin-dependent kinase inhibitor 1B (p27, Kip1);NotRelevant;;Multiple endocrine neoplasia, type IV, 610755 (3), Autosomal dominantMultiple endocrine neoplasia, type IV, 610755 (3);chr12;CDKN1B, KIP1, CDKN4, MEN4;True
ENSG00000273079;Glutamate receptor, ionotropic, N-methyl D-aspartate 2B;NotRelevant;;Epileptic encephalopathy, early infantile, 27, 616139 (3), Autosomal dominantMental retardation, autosomal dominant 6, 613970 (3);chr12;GRIN2B, NMDAR2B, MRD6, EIEE27;True
ENSG00000070019;Guanylate cyclase 2C (heat stable enterotoxin receptor);NotRelevant;;Diarrhea 6, 614616 (3), Autosomal dominantMeconium ileus, 614665 (3);chr12;GUCY2C, GUC2C, DIAR6, MECIL;True
ENSG00000111339;ADP-ribosyltransferase-4 (Dombrock blood group);NotRelevant;;[Blood group, Dombrock], 616060 (3)[Blood group, Dombrock], 616060 (3);chr12;ART4, DO, DOK1;False
ENSG00000111341;Matrix Gla protein;NotRelevant;;Keutel syndrome, 245150 (3), Autosomal recessiveKeutel syndrome, 245150 (3);chr12;MGP;True
ENSG00000139053;Phosphodiesterase 6H, cGMP-specific, cone, gamma;NotRelevant;;Achromatopsia 6, 610024 (3), Autosomal recessive, Autosomal dominantRetinal cone dystrophy 3, 610024 (3);chr12;PDE6H, RCD3, ACHM6;True
ENSG00000151490;Protein tyrosine phosphatase, receptor type, O;NotRelevant;;Nephrotic syndrome, type 6, 614196 (3), Autosomal recessiveNephrotic syndrome, type 6, 614196 (3);chr12;PTPRO, GLEPP1, NPHS6;True
ENSG00000151491;Epidermal growth factor receptor pathway substrate-8;NotRelevant;mutation identified in 1 DFNB102 family;?Deafness, autosomal recessive 102, 615974 (3), Autosomal recessive?Deafness, autosomal recessive 102, 615974 (3);chr12;EPS8, DFNB102;True
ENSG00000139151;Phospholipase C, zeta-1;NotRelevant;mutation identified in 1 SPGF17 family;?Spermatogenic failure 17, 617214 (3), Autosomal recessive?Spermatogenic failure 17, 617214 (3);chr12;PLCZ1, SPGF17;True
ENSG00000172572;Phosphodiesterase 3A, cGMP-inhibited;NotRelevant;;Hypertension and brachydactyly syndrome, 112410 (3), Autosomal dominantHypertension and brachydactyly syndrome, 112410 (3);chr12;PDE3A, HTNB;True
ENSG00000111700;Solute carrier organic anion transporter family, member 1B3;NotRelevant;HBLRR digenic with SLCO1B1;Hyperbilirubinemia, Rotor type, digenic, 237450 (3), Digenic recessiveHyperbilirubinemia, Rotor type, digenic, 237450 (3);chr12;SLCO1B3, OATP8, OATP1B3, SLC21A8, HBLRR;True
ENSG00000134538;Solute carrier organic anion transporter family, member 1B1;NotRelevant;HBLRR digenic with SLCO1B3;Hyperbilirubinemia, Rotor type, digenic, 237450 (3), Digenic recessiveHyperbilirubinemia, Rotor type, digenic, 237450 (3);chr12;SLCO1B1, LST1, OATP2, OATPC, OATP1B1, HBLRR;True
ENSG00000121350;Pyridine nucleotide-disulfide oxidoreductase domain-containing protein 1;NotRelevant;;Myopathy, myofibrillar, 8, 617258 (3), Autosomal recessiveMyopathy, myofibrillar, 8, 617258 (3);chr12;PYROXD1, MFM8;True
ENSG00000111713;Glycogen synthase-2, liver;NotRelevant;;Glycogen storage disease 0, liver, 240600 (3), Autosomal recessiveGlycogen storage disease 0, liver, 240600 (3);chr12;GYS2;True
ENSG00000111716;Lactate dehydrogenase B;NotRelevant;;[Lactate dehydrogenase-B deficiency], 614128 (3)[Lactate dehydrogenase-B deficiency], 614128 (3);chr12;LDHB, LDHBD;False
ENSG00000069431;ATP-binding cassette, subfamily C, member 9 (sulfonylurea receptor 2);NotRelevant;;Atrial fibrillation, familial, 12, 614050 (3), Autosomal dominantHypertrichotic osteochondrodysplasia, 239850 (3);chr12;ABCC9, SUR2, CMD1O, ATFB12, CANTU;True
ENSG00000134532;SRY-box 5;NotRelevant;some LAMSHF patients have 12p12 deletions;Lamb-Shaffer syndrome, 616803 (3), Autosomal dominantLamb-Shaffer syndrome, 616803 (3);chr12;SOX5, LAMSHF;True
ENSG00000060982;Branched chain aminotransferase-1, cytosolic;NotRelevant;;?Hyperleucinemia-isoleucinemia or hypervalinemia (1)?Hyperleucinemia-isoleucinemia or hypervalinemia (1);chr12;BCAT1, BCT1;False
ENSG00000133703;Kirsten rat sarcoma-2 viral (v-Ki-ras2) oncogene homolog;NotRelevant;pseudogene KRAS1P on 6p12-p11;Arteriovenous malformation of the brain, somatic, 108010 (3)Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3);chr12;KRAS, KRAS2, RASK2, NS, CFC2, RALD;False
ENSG00000123095;Basic helix-loop-helix domain-containing protein, member E41;NotRelevant;;[Short sleeper], 612975 (3), Autosomal dominant[Short sleeper], 612975 (3);chr12;BHLHE41, BHLHB3, DEC2, SHARP1;True
ENSG00000123104;Inositol 1,4,5-triphosphate receptor, type 2;NotRelevant;mutation has been identified in 1 ANHD family;?Anhidrosis, isolated, with normal sweat glands, 106190 (3), Autosomal recessive?Anhidrosis, isolated, with normal sweat glands, 106190 (3);chr12;ITPR2, ANHD;True
ENSG00000087494;Parathyroid hormone-like hormone;NotRelevant;;Brachydactyly, type E2, 613382 (3), Autosomal dominantBrachydactyly, type E2, 613382 (3);chr12;PTHLH, BDE2;True
ENSG00000013573;DEAD/H box-11 (CHL1-related helicase gene-1);NotRelevant;;Warsaw breakage syndrome, 613398 (3), Autosomal recessiveWarsaw breakage syndrome, 613398 (3);chr12;DDX11, CHLR1, KRG2;True
ENSG00000139132;FYVE, RhoGEF, and PH domain-containing protein 4;NotRelevant;;Charcot-Marie-Tooth disease, type 4H, 609311 (3), Autosomal recessiveCharcot-Marie-Tooth disease, type 4H, 609311 (3);chr12;FGD4, FRABIN, CMT4H;True
ENSG00000087470;Dynamin 1-like;NotRelevant;;Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3), Autosomal recessive, Autosomal dominantOptic atrophy 5, 610708 (3);chr12;DNM1L, DRP1, DVLP, DYMPLE, EMPF1, OPA5;True
ENSG00000139131;Tyrosyl-tRNA synthetase 2;NotRelevant;;Myopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3), Autosomal recessiveMyopathy, lactic acidosis, and sideroblastic anemia 2, 613561 (3);chr12;YARS2, TYRRS, MLASA2;True
ENSG00000057294;Plakophilin-2;NotRelevant;pseudogene on 12p13;Arrhythmogenic right ventricular dysplasia 9, 609040 (3), Autosomal dominantArrhythmogenic right ventricular dysplasia 9, 609040 (3);chr12;PKP2, ARVD9;True
ENSG00000139133;Alg10, S. cerevisiae, homolog of;NotRelevant;;{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3), Autosomal dominant{Long QT syndrome, acquired, reduced susceptibility to}, 613688 (3);chr12;ALG10, KCR1;True
ENSG00000139116;Kinesin family member 21A;NotRelevant;;Fibrosis of extraocular muscles, congenital, 1, 135700 (3), Autosomal dominantFibrosis of extraocular muscles, congenital, 3B, 135700 (3);chr12;KIF21A, KIAA1708, FEOM1, CFEOM1, CFEOM3B;True
ENSG00000188906;Leucine-rich repeat kinase 2 (dardarin);NotRelevant;;{Parkinson disease 8}, 607060 (3), Autosomal dominant{Parkinson disease 8}, 607060 (3);chr12;LRRK2, PARK8;True
ENSG00000018236;Contactin 1;NotRelevant;mutation identified in 1 MYPCN family;?Myopathy, congenital, Compton-North, 612540 (3), Autosomal recessive?Myopathy, congenital, Compton-North, 612540 (3);chr12;CNTN1, MYPCN;True
ENSG00000139174;Prickle-like 1;NotRelevant;;Epilepsy, progressive myoclonic 1B, 612437 (3), Autosomal recessiveEpilepsy, progressive myoclonic 1B, 612437 (3);chr12;PRICKLE1, RILP, EPM1B;True
ENSG00000198001;Interleukin 1 receptor-associated kinase 4;NotRelevant;;IRAK4 deficiency, 607676 (3)Invasive pneumococcal disease, recurrent isolated, 1, 610799 (3);chr12;IRAK4, REN64, IPD1;False
ENSG00000177119;Anoctamin 6;NotRelevant;;Scott syndrome, 262890 (3), Autosomal recessiveScott syndrome, 262890 (3);chr12;ANO6, TMEM16F, SCTS, BDPLT7;True
ENSG00000189079;AT-rich interaction domain-containing protein 2;NotRelevant;;Coffin-Siris syndrome 6, 617808 (3), Autosomal dominantCoffin-Siris syndrome 6, 617808 (3);chr12;ARID2, BAF200, KIAA1557, CSS6;True
ENSG00000111424;Vitamin D (1,25-dihydroxyvitamin D3) receptor;NotRelevant;;?Osteoporosis, involutional, 166710 (1), Autosomal dominantRickets, vitamin D-resistant, type IIA, 277440 (3);chr12;VDR;True
ENSG00000139219;Collagen II, alpha-1 polypeptide;NotRelevant;;Achondrogenesis, type II or hypochondrogenesis, 200610 (3), Autosomal dominantVitreoretinopathy with phalangeal epiphyseal dysplasia (3);chr12;COL2A1;True
ENSG00000152556;Phosphofructokinase, muscle type;NotRelevant;incorrectly assigned to chr.1;Glycogen storage disease VII, 232800 (3), Autosomal recessiveGlycogen storage disease VII, 232800 (3);chr12;PFKM, GSD7;True
ENSG00000174233;Adenylate cyclase-6;NotRelevant;mutation identified in 1 LCCS8 family;?Lethal congenital contracture syndrome 8, 616287 (3), Autosomal recessive?Lethal congenital contracture syndrome 8, 616287 (3);chr12;ADCY6, LCCS8;True
ENSG00000139537;Coiled-coil domain-containing protein 65;NotRelevant;;Ciliary dyskinesia, primary, 27, 615504 (3), Autosomal recessiveCiliary dyskinesia, primary, 27, 615504 (3);chr12;CCDC65, CILD27;True
ENSG00000169884;Wingless-type MMTV integration site family, member 10B;NotRelevant;;Split-hand/foot malformation 6, 225300 (3), Autosomal recessiveTooth agenesis, selective, 8, 617073 (3);chr12;WNT10B, SHFM6, STHAG8;True
ENSG00000125084;Wingless-type MMTV integration site family, member 1 (oncogene INT1);NotRelevant;;Osteogenesis imperfecta, type XV, 615220 (3), Autosomal recessive{Osteoporosis, early-onset, susceptibility to, autosomal dominant}, 615221 (3);chr12;WNT1, INT1, OI15, BMND16;True
ENSG00000167548;Lysine (K)-specific methyltransferase 2D;NotRelevant;;Kabuki syndrome 1, 147920 (3), Autosomal dominantKabuki syndrome 1, 147920 (3);chr12;KMT2D, MLL2, ALR, KABUK1;True
ENSG00000139549;Desert hedgehog;NotRelevant;;46XY partial gonadal dysgenesis, with minifascicular neuropathy, 607080 (3)46XY sex reversal 7, 233420 (3);chr12;DHH, SRXY7, GDXYM;False
ENSG00000167552;Tubulin, alpha-1A;NotRelevant;;Lissencephaly 3, 611603 (3), Autosomal dominantLissencephaly 3, 611603 (3);chr12;TUBA1A, TUBA3, LIS3;True
ENSG00000135406;Peripherin;NotRelevant;;{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominant{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3);chr12;PRPH;True
ENSG00000167580;Aquaporin-2 (collecting duct);NotRelevant;;Diabetes insipidus, nephrogenic, 125800 (3), Autosomal recessive, Autosomal dominantDiabetes insipidus, nephrogenic, 125800 (3);chr12;AQP2;True
ENSG00000161798;Aquaporin-5;NotRelevant;;Palmoplantar keratoderma, Bothnian type, 600231 (3), Autosomal dominantPalmoplantar keratoderma, Bothnian type, 600231 (3);chr12;AQP5, PPKB;True
ENSG00000167588;Glycerol-3-phosphate dehydrogenase, soluble;NotRelevant;;Hypertriglyceridemia, transient infantile, 614480 (3), Autosomal recessiveHypertriglyceridemia, transient infantile, 614480 (3);chr12;GPD1, HTGTI;True
ENSG00000178449;Cytochrome c oxidase assembly protein COX14;NotRelevant;mutation identified in 1 Cox4 deficient family;?Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, Mitochondrial?Mitochondrial complex IV deficiency, 220110 (3);chr12;COX14, C12orf62;True
ENSG00000050405;LIM domain and actin-binding protein 1;NotRelevant;;[Low density lipoprotein cholesterol level QTL 8], 618079 (3)[Low density lipoprotein cholesterol level QTL 8], 618079 (3);chr12;LIMA1, EPLIN, SREBP3, LDLCQ8;False
ENSG00000066084;Disco-interacting protein 2, Drosophila, homolog of, B;NotRelevant;;Mental retardation, FRA12A type, 136630 (3), Autosomal dominantMental retardation, FRA12A type, 136630 (3);chr12;DIP2B, KIAA1463;True
ENSG00000110911;Solute carrier family 11 (proton-coupled divalent metal ion transporter) member 2;NotRelevant;;Anemia, hypochromic microcytic, with iron overload 1, 206100 (3), Autosomal recessiveAnemia, hypochromic microcytic, with iron overload 1, 206100 (3);chr12;SLC11A2, NRAMP2, DCT1, DMT1, AHMIO1;True
ENSG00000196876;Sodium channel, voltage gated, type VIII, alpha polypeptide;NotRelevant;mutation identified in 1 CIAT family;?Cognitive impairment with or without cerebellar ataxia, 614306 (3), Autosomal dominantSeizures, benign familial infantile, 5, 617080 (3);chr12;SCN8A, CIAT, EIEE13, BFIS5;True
ENSG00000139567;Activin A receptor, type II-like kinase 1;NotRelevant;;Telangiectasia, hereditary hemorrhagic, type 2, 600376 (3), Autosomal dominantTelangiectasia, hereditary hemorrhagic, type 2, 600376 (3);chr12;ACVRL1, ACVRLK1, ALK1, HHT2;True
ENSG00000135503;Activin A receptor, type IB;NotRelevant;;Pancreatic cancer, somatic (3)Pancreatic cancer, somatic (3);chr12;ACVR1B, ACVRLK4, ALK4;False
ENSG00000170442;Keratin 86;NotRelevant;;Monilethrix, 158000 (3), Autosomal dominantMonilethrix, 158000 (3);chr12;KRT86, KRTHB6, HB6;True
ENSG00000205426;Keratin 81;NotRelevant;;Monilethrix, 158000 (3), Autosomal dominantMonilethrix, 158000 (3);chr12;KRT81, KRTHB1, HB1;True
ENSG00000170523;Keratin 83;NotRelevant;;Erythrokeratodermia variabilis et progressiva 5, 617756 (3), Autosomal recessiveMonilethrix, 158000 (3);chr12;KRT83, KRTHB3, HB3, MNLIX, EKVP5;True
ENSG00000135443;Keratin 85;NotRelevant;;Ectodermal dysplasia 4, hair/nail type, 602032 (3), Autosomal recessiveEctodermal dysplasia 4, hair/nail type, 602032 (3);chr12;KRT85, KRTHB5, HB5, ECTD4;True
ENSG00000170454;Keratin 75;NotRelevant;;{Pseudofolliculitis barbae, susceptibility to}, 612318 (3){Pseudofolliculitis barbae, susceptibility to}, 612318 (3);chr12;KRT75, K6HF, PFB;False
ENSG00000185479;Keratin 6B;NotRelevant;;Pachyonychia congenita 4, 615728 (3)Pachyonychia congenita 4, 615728 (3);chr12;KRT6B, PC4;False
ENSG00000170465;Keratin 6C;NotRelevant;;Palmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3), Autosomal dominantPalmoplantar keratoderma, nonepidermolytic, focal or diffuse, 615735 (3);chr12;KRT6C, PPKNEFD;True
ENSG00000205420;Keratin 6A;NotRelevant;;Pachyonychia congenita 3, 615726 (3)Pachyonychia congenita 3, 615726 (3);chr12;KRT6A, PC3;False
ENSG00000186081;Keratin 5;NotRelevant;;Dowling-Degos disease 1, 179850 (3), Autosomal dominantEpidermolysis bullosa simplex-MP, 131960 (3);chr12;KRT5, DDD1;True
ENSG00000139648;Keratin 71;NotRelevant;mutation identified in 1 HYPT13 family;?Hypotrichosis 13, 615896 (3), Autosomal dominant?Hypotrichosis 13, 615896 (3);chr12;KRT71, K6IRS1, KRT6IRS1, HYPT13;True
ENSG00000170484;Keratin 74;NotRelevant;mutation identified in 1 HYPT3 family and ECTD7 family;?Ectodermal dysplasia 7, hair/nail type, 614929 (3), Autosomal recessiveWoolly hair, autosomal dominant, 194300 (3);chr12;KRT74, K6IRS4, KRT6IRS4, HTSS2, HYPT3, ADWH;True
ENSG00000172867;Keratin 2;NotRelevant;;Ichthyosis bullosa of Siemens, 146800 (3), Autosomal dominantIchthyosis bullosa of Siemens, 146800 (3);chr12;KRT2, KRT2A, KRT2E;True
ENSG00000167768;Keratin 1;NotRelevant;close to Hox-3 in mouse; class II keratinPalmoplantar keratoderma, nonepidermolytic, 600962 (3);chr12;KRT1, EPPK, NEPPK, EHK;False
ENSG00000186442;Keratin 3;NotRelevant;;Meesmann corneal dystrophy, 122100 (3), Autosomal dominantMeesmann corneal dystrophy, 122100 (3);chr12;KRT3;True
ENSG00000170477;Keratin 4;NotRelevant;class II keratin;White sponge nevus 1, 193900 (3), Autosomal dominantWhite sponge nevus 1, 193900 (3);chr12;KRT4, CYK4, WSN1;True
ENSG00000170421;Keratin 8;NotRelevant;;Cirrhosis, cryptogenic, 215600 (3), Autosomal recessive{Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3);chr12;KRT8;True
ENSG00000111057;Keratin 18;NotRelevant;contiguous to KRT8, type II heteromer partner;Cirrhosis, cryptogenic, 215600 (3), Autosomal recessive{Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3);chr12;KRT18;True
ENSG00000094914;Aladin;NotRelevant;;Achalasia-addisonianism-alacrimia syndrome, 231550 (3), Autosomal recessiveAchalasia-addisonianism-alacrimia syndrome, 231550 (3);chr12;AAAS, AAA;True
ENSG00000170374;Transcription factor Sp7;NotRelevant;;Osteogenesis imperfecta, type XII, 613849 (3), Autosomal recessiveOsteogenesis imperfecta, type XII, 613849 (3);chr12;SP7, OSX, OI12;True
ENSG00000135409;Anti-Mullerian hormone receptor, type II;NotRelevant;;Persistent Mullerian duct syndrome, type II, 261550 (3), Autosomal recessivePersistent Mullerian duct syndrome, type II, 261550 (3);chr12;AMHR2, AMHR;True
ENSG00000123364;Homeo box-C13;NotRelevant;fused with NUP98 in AML;Ectodermal dysplasia 9, hair/nail type, 614931 (3), Autosomal recessiveEctodermal dysplasia 9, hair/nail type, 614931 (3);chr12;HOXC13, HOX3G, ECTD9;True
ENSG00000135486;Heterogeneous nuclear ribonucleoprotein A1;NotRelevant;mutation identified in 1 family with IBMPFD3;Amyotrophic lateral sclerosis 20, 615426 (3), Autosomal dominantAmyotrophic lateral sclerosis 20, 615426 (3);chr12;HNRNPA1, IBMPFD3, ALS20;True
ENSG00000135424;Integrin, alpha-7;NotRelevant;;Muscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3), Autosomal recessiveMuscular dystrophy, congenital, due to ITGA7 deficiency, 613204 (3);chr12;ITGA7;True
ENSG00000135437;Retinol dehydrogenase-5;NotRelevant;;Fundus albipunctatus, 136880 (3), Autosomal recessive, Autosomal dominantFundus albipunctatus, 136880 (3);chr12;RDH5;True
ENSG00000123342;Matrix metalloproteinase-19;NotRelevant;triplication in upstream regulatory region;Cavitary optic disc anomalies, 611543 (3), Autosomal dominantCavitary optic disc anomalies, 611543 (3);chr12;MMP19, MMP18, CODA;True
ENSG00000139531;Sulfite oxidase;NotRelevant;;Sulfite oxidase deficiency, 272300 (3), Autosomal recessiveSulfite oxidase deficiency, 272300 (3);chr12;SUOX;True
ENSG00000197728;Ribosomal protein S26;NotRelevant;;Diamond-Blackfan anemia 10, 613309 (3), Autosomal dominantDiamond-Blackfan anemia 10, 613309 (3);chr12;RPS26, DBA10;True
ENSG00000065361;Transformation gene ERBB-3;NotRelevant;mutations identified in 1 LCCS2 family and 1 FERLK family;{?Erythroleukemia, familial, susceptibility to}, 133180 (3), Autosomal dominant{?Erythroleukemia, familial, susceptibility to}, 133180 (3);chr12;ERBB3, LCCS2, FERLK;True
ENSG00000139540;Solute carrier family 39 (zinc transporter), member 5;NotRelevant;;Myopia 24, autosomal dominant, 615946 (3), Autosomal dominantMyopia 24, autosomal dominant, 615946 (3);chr12;SLC39A5, MYP24;True
ENSG00000170581;Signal transducer and activator of transcription 2;NotRelevant;;Immunodeficiency 44, 616636 (3), Autosomal recessiveImmunodeficiency 44, 616636 (3);chr12;STAT2, IMD44;True
ENSG00000135517;Major intrinsic protein of lens fiber;NotRelevant;slightly distal to AQP2;Cataract 15, multiple types, 615274 (3), Autosomal dominantCataract 15, multiple types, 615274 (3);chr12;MIP, AQP0, CTRCT15;True
ENSG00000170426;Short chain dehydrogenase/reductase family 9C member 7;NotRelevant;;Ichthyosis, congenital, autosomal recessive 13, 617574 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 13, 617574 (3);chr12;SDR9C7, SDRO, ARCI13;True
ENSG00000166863;Tachykinin 3 (neuromedin K, neurokinin B);NotRelevant;;Hypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3), Autosomal recessiveHypogonadotropic hypogonadism 10 with or without anosmia, 614839 (3);chr12;TAC3, NKNB, HH10;True
ENSG00000123384;Low density lipoprotein-related protein-1 (alpha-2-macroglobulin receptor);NotRelevant;mutation identified in 1 KPA family;?Keratosis pilaris atrophicans, 604093 (3), Autosomal recessive?Keratosis pilaris atrophicans, 604093 (3);chr12;LRP1, A2MR, KPA;True
ENSG00000185482;SH3 and cystein-rich domains 3;NotRelevant;;Myopathy, congenital, Baily-Bloch, 255995 (3), Autosomal recessiveMyopathy, congenital, Baily-Bloch, 255995 (3);chr12;STAC3, NAM, MYPBB;True
ENSG00000111087;GLI family zinc finger 1;NotRelevant;;Polydactyly, postaxial, type A8, 618123 (3), Autosomal recessivePolydactyly, postaxial, type A8, 618123 (3);chr12;GLI1, PAPA8;True
ENSG00000166986;Methioninyl-tRNA synthetase;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2U, 616280 (3), Autosomal dominantInterstitial lung and liver disease, 615486 (3);chr12;MARS, MTRNS, METRS, ILLD, CMT2U;True
ENSG00000175197;DNA-damage-inducible transcript-3;NotRelevant;fused with FUS in myxoid liposarcoma;Myxoid liposarcoma, 613488 (1)Myxoid liposarcoma, 613488 (1);chr12;DDIT3, GADD153, CHOP10;False
ENSG00000155980;Kinesin family member 5A;NotRelevant;;{Amyotrophic lateral sclerosis, susceptibility to, 25}, 617921 (3), Autosomal dominant{Amyotrophic lateral sclerosis, susceptibility to, 25}, 617921 (3);chr12;KIF5A, NKHC, SPG10, NEIMY, ALS25;True
ENSG00000135454;Beta-1,4-N-acetylgalactosaminyltransferase 1;NotRelevant;;Spastic paraplegia 26, autosomal recessive, 609195 (3), Autosomal recessiveSpastic paraplegia 26, autosomal recessive, 609195 (3);chr12;B4GALNT1, GALGT, GALNACT, SPG26;True
ENSG00000135446;Cyclin-dependent kinase 4;NotRelevant;;{Melanoma, cutaneous malignant, 3}, 609048 (3), Autosomal dominant{Melanoma, cutaneous malignant, 3}, 609048 (3);chr12;CDK4, CMM3;True
ENSG00000111012;Cytochrome P450, subfamily XXVIIB, polypeptide 1;NotRelevant;;Vitamin D-dependent rickets, type I, 264700 (3), Autosomal recessiveVitamin D-dependent rickets, type I, 264700 (3);chr12;CYP27B1, VDD1, PDDR;True
ENSG00000123297;Ts translation elongation factor, mitochondrial;NotRelevant;;Combined oxidative phosphorylation deficiency 3, 610505 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 3, 610505 (3);chr12;TSFM, COXPD3;True
ENSG00000177990;DPY19-like 2;NotRelevant;pseudogene on 7p14.3;Spermatogenic failure 9, 613958 (3), Autosomal recessiveSpermatogenic failure 9, 613958 (3);chr12;DPY19L2, SPGF9;True
ENSG00000118600;Ribitol xylosyltransferase 1;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 10, 615041 (3);chr12;RXYLT1, TMEM5, MDDGA10;True
ENSG00000196935;Slit-robo GTPase-activating protein, rho, 1;NotRelevant;;{Thyroid cancer, nonmedullary, 2}, 188470 (3), Autosomal dominant{Thyroid cancer, nonmedullary, 2}, 188470 (3);chr12;SRGAP1, KIAA1304, NMTC2;True
ENSG00000183735;TANK-binding kinase 1;NotRelevant;;{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}, 617900 (3), Autosomal dominant{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8}, 617900 (3);chr12;TBK1, NAK, FTDALS4, IIAE8;True
ENSG00000135677;N-acetylglucosamine-6-sulfatase;NotRelevant;;Mucopolysaccharidosis type IIID, 252940 (3), Autosomal recessiveMucopolysaccharidosis type IIID, 252940 (3);chr12;GNS, G6S;True
ENSG00000174106;LEM domain-containing 3;NotRelevant;;Buschke-Ollendorff syndrome, 166700 (3), Autosomal dominantOsteopoikilosis with or without melorheostosis, 166700 (3);chr12;LEMD3, MAN1;True
ENSG00000174099;Methionine sulfoxide reductase B3;NotRelevant;;Deafness, autosomal recessive 74, 613718 (3), Autosomal recessiveDeafness, autosomal recessive 74, 613718 (3);chr12;MSRB3, DFNB74;True
ENSG00000149948;High-mobility group AT-hook 2;NotRelevant;fusion partners with RAD51B, ALDH2, COX6C, HEI10 in uterine leiomyomas;Leiomyoma, uterine, somatic, 150699 (1)Leiomyoma, uterine, somatic, 150699 (1);chr12;HMGA2, HMGIC, BABL;False
ENSG00000090376;Interleukin 1 receptor-associated kinase 3;NotRelevant;;{Asthma susceptibility 5}, 611064 (3){Asthma susceptibility 5}, 611064 (3);chr12;IRAK3, IRAKM, ASRT5;False
ENSG00000155974;Glutamate receptor-interacting protein 1;NotRelevant;;Fraser syndrome 3, 617667 (3), Autosomal recessiveFraser syndrome 3, 617667 (3);chr12;GRIP1, FRASRS3;True
ENSG00000111537;Interferon, gamma;NotRelevant;3 introns; none in IFF, IFL{Tuberculosis, protection against}, 607948 (3);chr12;IFNG, IFG, IFI;False
ENSG00000111581;Nucleoporin, 107kD;NotRelevant;mutation identified in 1 ODG6 family;Nephrotic syndrome, type 11, 616730 (3), Autosomal recessiveNephrotic syndrome, type 11, 616730 (3);chr12;NUP107, NUP84, NPHS11, ODG6;True
ENSG00000135679;Mouse double minute 2, homolog of (p53-binding protein);NotRelevant;;{Accelerated tumor formation, susceptibility to}, 614401 (3){Accelerated tumor formation, susceptibility to}, 614401 (3);chr12;MDM2, ACTFS;False
ENSG00000090382;Lysozyme;NotRelevant;;Amyloidosis, renal, 105200 (3), Autosomal dominantAmyloidosis, renal, 105200 (3);chr12;LYZ;True
ENSG00000139287;Tryptophan hydroxylase 2;NotRelevant;;{Attention deficit-hyperactivity disorder, susceptibility to, 7}, 613003 (3){Unipolar depression, susceptibility to}, 608516 (3);chr12;TPH2, NTPH, ADHD7;False
ENSG00000179941;BBS10 gene;NotRelevant;;Bardet-Biedl syndrome 10, 615987 (3), Autosomal recessiveBardet-Biedl syndrome 10, 615987 (3);chr12;BBS10, C12orf58, FLJ23560;True
ENSG00000067715;Synaptotagmin-1;NotRelevant;;Baker-Gordon syndrome, 618218 (3), Autosomal dominantBaker-Gordon syndrome, 618218 (3);chr12;SYT1, BAGOS;True
ENSG00000165899;Otogelin-like protein;NotRelevant;;Deafness, autosomal recessive 84B, 614944 (3), Autosomal recessiveDeafness, autosomal recessive 84B, 614944 (3);chr12;OTOGL, C12orf64, DFNB84B;True
ENSG00000139304;Protein-tyrosine phosphatase, receptor-type, Q;NotRelevant;mutation identified in 1 DFNA73 family;Deafness, autosomal dominant 73, 617663 (3), Autosomal dominantDeafness, autosomal recessive 84A, 613391 (3);chr12;PTPRQ, PTPGMC1, DFNB84A, DFNA73;True
ENSG00000111046;Myogenic factor-6;NotRelevant;6.5kb upstream from MYF5; both prob. 12q15, by HCentronuclear myopathy 3, 614408 (3);chr12;MYF6, CNM3;False
ENSG00000111049;Myogenic factor-5;NotRelevant;;Ophthalmoplegia, external, with rib and vertebral anomalies, 618155 (3), Autosomal recessiveOphthalmoplegia, external, with rib and vertebral anomalies, 618155 (3);chr12;MYF5, EORVA;True
ENSG00000180318;Aristaless-like homeobox 1 (cartilage homeoprotein 1);NotRelevant;mutation identified in 1 FND3 patient;?Frontonasal dysplasia 3, 613456 (3)?Frontonasal dysplasia 3, 613456 (3);chr12;ALX1, CART1, FND3;False
ENSG00000198707;Centrosomal protein, 290kD;NotRelevant;mutation identified in 1 BBS14 family;?Bardet-Biedl syndrome 14, 615991 (3), Autosomal recessiveSenior-Loken syndrome 6, 610189 (3);chr12;CEP290, KIAA0373, 3H11AG, JBTS5, SLSN6, LCA10, BBS14;True
ENSG00000139324;Transmembrane and tetratricopeptide repeat domains-containing protein 3;NotRelevant;;Lissencephaly 8, 617255 (3), Autosomal recessiveLissencephaly 8, 617255 (3);chr12;TMTC3, SMILE, LIS8;True
ENSG00000049130;KIT ligand (mast cell growth factor;NotRelevant;ENSG00000049130;associated with dbSNP rs12821256[Skin/hair/eye pigmentation 7, blond/brown hair], 611664 (3);chr12;KITLG, MGF, SF, SCF, SHEP7, FPHH, DCUA, DFNA69;False
ENSG00000139318;Dual-specificity phosphatase-6;NotRelevant;;Hypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3), Autosomal dominantHypogonadotropic hypogonadism 19 with or without anosmia, 615269 (3);chr12;DUSP6, MKP3, PYST1, HH19;True
ENSG00000139323;POC1 centriolar protein, Chlamydomonas, homolog of, B;NotRelevant;;Cone-rod dystrophy 20, 615973 (3), Autosomal recessiveCone-rod dystrophy 20, 615973 (3);chr12;POC1B, PIX1, CORD20;True
ENSG00000139330;Keratocan;NotRelevant;;Cornea plana 2, autosomal recessive, 217300 (3), Autosomal recessiveCornea plana 2, autosomal recessive, 217300 (3);chr12;KERA, CNA2;True
ENSG00000011465;Decorin;NotRelevant;conflicting assignments to 12q23 and 12q13.2;Corneal dystrophy, congenital stromal, 610048 (3), Autosomal dominantCorneal dystrophy, congenital stromal, 610048 (3);chr12;DCN, CSCD;True
ENSG00000169372;Caspase and RIP adaptor with death domain;NotRelevant;;Mental retardation, autosomal recessive 34, with variant lissencephaly, 614499 (3), Autosomal recessiveMental retardation, autosomal recessive 34, with variant lissencephaly, 614499 (3);chr12;CRADD, RAIDD, MRT34;True
ENSG00000173588;Centrosomal protein, 83kD;NotRelevant;;Nephronophthisis 18, 615862 (3), Autosomal recessiveNephronophthisis 18, 615862 (3);chr12;CEP83, CCDC41, NPHP18;True
ENSG00000184752;NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 12;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 23, 618244 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 23, 618244 (3);chr12;NDUFA12, MC1DN23;True
ENSG00000084110;Histidine ammonia-lyase (histidase);NotRelevant;;[Histidinemia], 235800 (3), Autosomal recessive, Autosomal dominant[Histidinemia], 235800 (3);chr12;HAL, HSTD;True
ENSG00000075415;Solute carrier family 25 (mitochondrial carrier), member 3;NotRelevant;;Mitochondrial phosphate carrier deficiency, 610773 (3)Mitochondrial phosphate carrier deficiency, 610773 (3);chr12;SLC25A3, PHC;False
ENSG00000179520;Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 (vesicular glutamate transporter 3);NotRelevant;;Deafness, autosomal dominant 25, 605583 (3), Autosomal dominantDeafness, autosomal dominant 25, 605583 (3);chr12;SLC17A8, VGLUT3, DFNA25;True
ENSG00000012504;Nuclear receptor subfamily 1 group H member 4;NotRelevant;;Cholestasis, progressive familial intrahepatic, 5, 617049 (3), Autosomal recessiveCholestasis, progressive familial intrahepatic, 5, 617049 (3);chr12;NR1H4, FXR, RIP14, PFIC5;True
ENSG00000196091;Myosin-binding protein C, slow type;NotRelevant;;Arthrogryposis, distal, type 1B, 614335 (3), Autosomal dominantLethal congenital contracture syndrome 4, 614915 (3);chr12;MYBPC1, LCCS4;True
ENSG00000139351;Synaptonemal complex protein 3;NotRelevant;;Pregnancy loss, recurrent, 4, 270960 (3), Autosomal dominantSpermatogenic failure 4, 270960 (3);chr12;SYCP3, SCP3, COR1, SPGF4, RPRGL4;True
ENSG00000111670;N-acetylglucosamine-1-phosphate transferase, alpha/beta subunits;NotRelevant;conflicting assignment to 4q;Mucolipidosis II alpha/beta, 252500 (3), Autosomal recessiveMucolipidosis III alpha/beta, 252600 (3);chr12;GNPTAB, GNPTA;True
ENSG00000075188;Nucleoporin, 37kD;NotRelevant;mutation identified in 1 MCPH24 family;?Microcephaly 24, primary, autosomal recessive, 618179 (3), Autosomal recessive?Microcephaly 24, primary, autosomal recessive, 618179 (3);chr12;NUP37, p37, MCPH24;True
ENSG00000017427;Insulin-like growth factor-1, or somatomedin C;NotRelevant;;Growth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3), Autosomal recessiveGrowth retardation with deafness and mental retardation due to IGF1 deficiency, 608747 (3);chr12;IGF1;True
ENSG00000171759;Phenylalanine hydroxylase;NotRelevant;close to IGF1;[Hyperphenylalaninemia, non-PKU mild], 261600 (3), Autosomal recessive[Hyperphenylalaninemia, non-PKU mild], 261600 (3);chr12;PAH, PKU1;True
ENSG00000139352;Achaete-scute complex, Drosophila, homolog-like 1;NotRelevant;distal to PAH and proximal to TRA1;Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominantHaddad syndrome, 209880 (3);chr12;ASCL1, ASH1;True
ENSG00000171310;Carbohydrate sulfotransferase 11;NotRelevant;mutation identified in 1 OCBMD family;?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits, 618167 (3), Autosomal recessive?Osteochondrodysplasia, brachydactyly, and overlapping malformed digits, 618167 (3);chr12;CHST11, C4ST1, OCBMD;True
ENSG00000136051;WASH complex, subunit 4;NotRelevant;mutation identified in 1 MRT43 family;?Mental retardation, autosomal recessive 43, 615817 (3), Autosomal recessive?Mental retardation, autosomal recessive 43, 615817 (3);chr12;WASHC4, KIAA1033, SWIP, MRT43;True
ENSG00000013503;Polymerase III, RNA, subunit B;NotRelevant;;Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3);chr12;POLR3B, RPC2, C128, HLD8;True
ENSG00000008405;Cryptochrome 1 (photolyase-like);NotRelevant;;{Delayed sleep phase disorder, susceptibility to}, 614163 (3), Autosomal dominant{Delayed sleep phase disorder, susceptibility to}, 614163 (3);chr12;CRY1, PHLL1, DSPD;True
ENSG00000136003;Iron-sulfur cluster scaffold, E. coli, homolog of;NotRelevant;;Myopathy with lactic acidosis, hereditary, 255125 (3), Autosomal recessiveMyopathy with lactic acidosis, hereditary, 255125 (3);chr12;ISCU, HML;True
ENSG00000076248;Uracil-DNA glycosylase;NotRelevant;;Immunodeficiency with hyper IgM, type 5, 608106 (3), Autosomal recessiveImmunodeficiency with hyper IgM, type 5, 608106 (3);chr12;UNG, DGU, HIGM5;True
ENSG00000151148;Ubiquitin-protein ligase E3B;NotRelevant;;Kaufman oculocerebrofacial syndrome, 244450 (3), Autosomal recessiveKaufman oculocerebrofacial syndrome, 244450 (3);chr12;UBE3B, BPIDS, KOS;True
ENSG00000139428;MMAB gene;NotRelevant;;Methylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3), Autosomal recessiveMethylmalonic aciduria, vitamin B12-responsive, due to defect in synthesis of adenosylcobalamin, cblB complementation type, 251110 (3);chr12;MMAB;True
ENSG00000110921;Mevalonate kinase;NotRelevant;;Hyper-IgD syndrome, 260920 (3), Autosomal recessivePorokeratosis 3, multiple types, 175900 (3);chr12;MVK, MVLK, POROK3;True
ENSG00000111199;Transient receptor potential cation channel, subfamily V, member 4 (vanilloid receptor-related osmotically activated channel);NotRelevant;mutation identified in 1 ANFH2 family;?Avascular necrosis of femoral head, primary, 2, 617383 (3), Autosomal dominant[Sodium serum level QTL 1], 613508 (3);chr12;TRPV4, VROAC, HMSN2C, CMT2C, SPSMA, SSQTL1, SMAL, BCYM3;True
ENSG00000122970;Intraflagellar transport 81, Chlamydomonas, homolog of;NotRelevant;;Short-rib thoracic dysplasia 19 with or without polydactyly, 617895 (3), Autosomal recessiveShort-rib thoracic dysplasia 19 with or without polydactyly, 617895 (3);chr12;IFT81, DV1, CDV1R, SRTD19;True
ENSG00000174437;ATPase, Ca++ transporting, slow-twitch, cardiac muscle-2;NotRelevant;;Acrokeratosis verruciformis, 101900 (3), Autosomal dominantDarier disease, 124200 (3);chr12;ATP2A2, ATP2B, DAR;True
ENSG00000204852;Tectonic family, member 1;NotRelevant;;Joubert syndrome 13, 614173 (3), Autosomal recessiveJoubert syndrome 13, 614173 (3);chr12;TECT1, JBTS13;True
ENSG00000111245;Myosin, light polypeptide-2, regulatory, cardiac, slow;NotRelevant;;Cardiomyopathy, hypertrophic, 10, 608758 (3), Autosomal dominantCardiomyopathy, hypertrophic, 10, 608758 (3);chr12;MYL2, CMH10;True
ENSG00000111249;Cut-like homeobox 2;NotRelevant;;Epileptic encephalopathy, early infantile, 67, 618141 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 67, 618141 (3);chr12;CUX2, CDP2, CUTL2, EIEE67;True
ENSG00000111252;SH2B adaptor protein 3;NotRelevant;;Erythrocytosis, somatic, 133100 (3)Thrombocythemia, somatic, 187950 (3);chr12;SH2B3, LNK;False
ENSG00000204842;Ataxin-2;NotRelevant;;{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3), Autosomal dominant{Parkinson disease, late-onset, susceptibility to}, 168600 (3);chr12;ATXN2, ATX2, SCA2, ASL13;True
ENSG00000111275;Aldehyde dehydrogenase 2 family, mitochondrial;NotRelevant;;Alcohol sensitivity, acute, 610251 (3), Autosomal dominant{Sublingual nitroglycerin, susceptibility to poor response to} (3);chr12;ALDH2;True
ENSG00000179295;Protein tyrosine phosphatase, nonreceptor-type, 11;NotRelevant;;LEOPARD syndrome 1, 151100 (3), Autosomal dominantNoonan syndrome 1, 163950 (3);chr12;PTPN11, PTP2C, SHP2, NS1, JMML, METCDS;True
ENSG00000089225;T-box 5;NotRelevant;;Holt-Oram syndrome, 142900 (3), Autosomal dominantHolt-Oram syndrome, 142900 (3);chr12;TBX5;True
ENSG00000135111;T-box 3;NotRelevant;;Ulnar-mammary syndrome, 181450 (3), Autosomal dominantUlnar-mammary syndrome, 181450 (3);chr12;TBX3;True
ENSG00000123066;Mediator complex subunit 13-like;NotRelevant;;Mental retardation and distinctive facial features with or without cardiac defects, 616789 (3), Autosomal dominantTransposition of the great arteries, dextro-looped 1, 608808 (3);chr12;MED13L, THRAP2, PROSIT240, TRAP240L, KIAA1025, MRFACD;True
ENSG00000152137;Heat-shock 22-kD protein 8;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2L, 608673 (3), Autosomal dominantNeuropathy, distal hereditary motor, type IIA, 158590 (3);chr12;HSPB8, H11, E2IG1, DHMN2, CMT2L, HMN2A;True
ENSG00000122966;Citron rho-interacting serine/threonine kinase;NotRelevant;;Microcephaly 17, primary, autosomal recessive, 617090 (3), Autosomal recessiveMicrocephaly 17, primary, autosomal recessive, 617090 (3);chr12;CIT, STK21, CRIK, MCPH17;True
ENSG00000111775;Cytochrome c oxidase, subunit VIa, polypeptide-1;NotRelevant;pseudogenes on chr.7 and chr.6;Charcot-Marie-Tooth disease, recessive intermediate D, 616039 (3), Autosomal recessiveCharcot-Marie-Tooth disease, recessive intermediate D, 616039 (3);chr12;COX6A1, CMTRID;True
ENSG00000122971;Acyl-Coenzyme A dehydrogenase, C-2 to C-3 short chain;NotRelevant;;Acyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3), Autosomal recessiveAcyl-CoA dehydrogenase, short-chain, deficiency of, 201470 (3);chr12;ACADS, SCAD;True
ENSG00000135100;HNF1 homeobox B;NotRelevant;;Diabetes mellitus, insulin-dependent, 20, 612520 (3){Diabetes mellitus, noninsulin-dependent, 2}, 125853 (3);chr12;HNF1A, TCF1, MODY3, IDDM20;False
ENSG00000158104;4-hydroxyphenylpyruvate dioxygenase;NotRelevant;;Hawkinsinuria, 140350 (3), Autosomal dominantTyrosinemia, type III, 276710 (3);chr12;HPD;True
ENSG00000158023;WD repeat-containing protein 66;NotRelevant;;Spermatogenic failure 33, 618152 (3), Autosomal recessiveSpermatogenic failure 33, 618152 (3);chr12;WDR66, CFAP251, SPGF33;True
ENSG00000110987;B-cell CLL/lymphoma-7A;NotRelevant;;B-cell non-Hodgkin lymphoma, high-grade (3)B-cell non-Hodgkin lymphoma, high-grade (3);chr12;BCL7A, BCL7;False
ENSG00000184047;Second mitochondria-derived activator of caspase;NotRelevant;;Deafness, autosomal dominant 64, 614152 (3), Autosomal dominantDeafness, autosomal dominant 64, 614152 (3);chr12;SMAC, DIABLO, DFNA64;True
ENSG00000139719;Vacuolar protein sorting 33, yeast, homolog of, A;NotRelevant;;Mucopolysaccharidosis-plus syndrome, 617303 (3), Autosomal recessiveMucopolysaccharidosis-plus syndrome, 617303 (3);chr12;VPS33A, MPSPS;True
ENSG00000130921;Chromosome 12 open reading frame 65;NotRelevant;;Combined oxidative phosphorylation deficiency 7, 613559 (3), Autosomal recessiveSpastic paraplegia 55, autosomal recessive, 615035 (3);chr12;C12orf65, COXPD7, SPG55;True
ENSG00000111361;Eukaryotic translation initiation factor 2B, subunit 1;NotRelevant;;Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessiveLeukoencephalopathy with vanishing white matter, 603896 (3);chr12;EIF2B1, EIF2BA;True
ENSG00000168778;Tectonic family, member 2;NotRelevant;mutation identified in 1 MKS8 family;Joubert syndrome 24, 616654 (3), Autosomal recessiveJoubert syndrome 24, 616654 (3);chr12;TCTN2, TECT2, MKS8, JBTS24;True
ENSG00000185344;ATPase, H+ transporting, V0 subunit A2;NotRelevant;;Cutis laxa, autosomal recessive, type IIA, 219200 (3), Autosomal recessiveWrinkly skin syndrome, 278250 (3);chr12;ATP6V0A2, WSS, ARCL2A;True
ENSG00000073060;Scavenger receptor class B, member 1 (CD36 antigen-like 1);NotRelevant;;[High density lipoprotein cholesterol level QTL6], 610762 (3)[High density lipoprotein cholesterol level QTL6], 610762 (3);chr12;SCARB1, CD36L1, CLA1, HDLQTL6;False
ENSG00000177192;Pseudourine synthase 1;NotRelevant;;Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3), Autosomal recessiveMyopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3);chr12;PUS1, MLASA1;True
ENSG00000187848;Purinergic receptor P2X, ligand-gated ion channel, 2;NotRelevant;;Deafness, autosomal dominant 41, 608224 (3), Autosomal dominantDeafness, autosomal dominant 41, 608224 (3);chr12;P2RX2, P2X2, DFNA41;True
ENSG00000177084;Polymerase (DNA directed), epsilon-1;NotRelevant;;{Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant{Colorectal cancer, susceptibility to, 12}, 615083 (3);chr12;POLE1, CRCS12, FILS;True
ENSG00000176915;Ankyrin repeat- and LEM domain-containing protein 2;NotRelevant;mutation identified in 1 MCPH16 family;?Microcephaly 16, primary, autosomal recessive, 616681 (3), Autosomal recessive?Microcephaly 16, primary, autosomal recessive, 616681 (3);chr12;ANKLE2, LEM4, KIAA0692, MCPH16;True
ENSG00000121743;Gap junction protein, alpha-3, 46kD (connexin 46);NotRelevant;;Cataract 14, multiple types, 601885 (3), Autosomal dominantCataract 14, multiple types, 601885 (3);chr13;GJA3, CX46, CZP3, CAE3, CTRCT14;True
ENSG00000165474;Gap junction protein, beta-2, 26kD (connexin 26);NotRelevant;;Bart-Pumphrey syndrome, 149200 (3), Autosomal dominantVohwinkel syndrome, 124500 (3);chr13;GJB2, CX26, DFNB1A, PPK, DFNA3A, KID, HID;True
ENSG00000121742;Gap junction protein, beta-6 (connexin-30);NotRelevant;;Deafness, autosomal dominant 3B, 612643 (3), Autosomal dominantEctodermal dysplasia 2, Clouston type, 129500 (3);chr13;GJB6, CX30, DFNA3B, DFNB1B, ECTD2, HED2;True
ENSG00000102678;Fibroblast growth factor-9 (glia-activating factor);NotRelevant;;Multiple synostoses syndrome 3, 612961 (3), Autosomal dominantMultiple synostoses syndrome 3, 612961 (3);chr13;FGF9, SYNS3;True
ENSG00000102683;Sarcoglycan, gamma (35kD dystrophin-associated glycoprotein);NotRelevant;;Muscular dystrophy, limb-girdle, autosomal recessive 5, 253700 (3), Autosomal recessiveMuscular dystrophy, limb-girdle, autosomal recessive 5, 253700 (3);chr13;SGCG, LGMDR5, DMDA1, SCG3;True
ENSG00000151835;Sacsin;NotRelevant;;Spastic ataxia, Charlevoix-Saguenay type, 270550 (3), Autosomal recessiveSpastic ataxia, Charlevoix-Saguenay type, 270550 (3);chr13;SACS, ARSACS;True
ENSG00000027001;Mitochondrial intermediate peptidase;NotRelevant;;Combined oxidative phosphorylation deficiency 31, 617228 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 31, 617228 (3);chr13;MIPEP, COXPD31;True
ENSG00000151849;Centromeric protein J;NotRelevant;mutation identified in 1 SCKL4 family;Microcephaly 6, primary, autosomal recessive, 608393 (3), Autosomal recessiveMicrocephaly 6, primary, autosomal recessive, 608393 (3);chr13;CENPJ, CPAP, MCPH6, SCKL4;True
ENSG00000132932;ATPase, class I, type 8A, member 2;NotRelevant;;?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3), Autosomal recessive?Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 4, 615268 (3);chr13;ATP8A2, ATPIB, CAMRQ4;True
ENSG00000127870;RING finger protein-6;NotRelevant;;Esophageal carcinoma, somatic, 133239 (3)Esophageal carcinoma, somatic, 133239 (3);chr13;RNF6;False
ENSG00000122026;Ribosomal protein L21;NotRelevant;;Hypotrichosis 12, 615885 (3), Autosomal dominantHypotrichosis 12, 615885 (3);chr13;RPL21, HYPT12;True
ENSG00000186184;Polymerase I, RNA, subunit D;NotRelevant;;Treacher Collins syndrome 2, 613717 (3), Autosomal recessive, Autosomal dominantTreacher Collins syndrome 2, 613717 (3);chr13;POLR1D, RPA16, RPAC2, TCS2;True
ENSG00000139515;Pancreas/duodenum homeobox protein 1;NotRelevant;;{Diabetes mellitus, type II, susceptibility to}, 125853 (3), Autosomal dominant{Diabetes mellitus, type II, susceptibility to}, 125853 (3);chr13;PDX1, IPF1, MODY4, PAGEN1;True
ENSG00000122025;fms-related tyrosine kinase-3;NotRelevant;;Leukemia, acute lymphoblastic, somatic, 613065 (3)Leukemia, acute myeloid, somatic, 601626 (3);chr13;FLT3;False
ENSG00000132963;Proteasome maturation protein;NotRelevant;;Keratosis linearis with ichthyosis congenita and sclerosing keratoderma, 601952 (3), Autosomal recessiveProteasome-associated autoinflammatory syndrome 2, 618048 (3);chr13;POMP, UMP1, PRAAS2;True
ENSG00000132965;Arachidonate 5-lipoxygenase-activating protein;NotRelevant;;{Stroke, susceptibility to}, 601367 (3), Multifactorial{Stroke, susceptibility to}, 601367 (3);chr13;ALOX5AP, FLAP;False
ENSG00000187676;Beta 3-glucosyltransferase;NotRelevant;;Peters-plus syndrome, 261540 (3), Autosomal recessivePeters-plus syndrome, 261540 (3);chr13;B3GLCT, B3GALTL, B3GTL;True
ENSG00000139618;BRCA2 gene;NotRelevant;;{Breast cancer, male, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation{Prostate cancer}, 176807 (3);chr13;BRCA2, FANCD1, BROVCA2, GLM3, PNCA2;True
ENSG00000133116;Klotho;NotRelevant;mutation identified in 1 HFTC3 patient;?Tumoral calcinosis, hyperphosphatemic, familial, 3, 617994 (3)?Tumoral calcinosis, hyperphosphatemic, familial, 3, 617994 (3);chr13;KL, KLOTHO, HFTC3;False
ENSG00000133104;Spartin;NotRelevant;;Troyer syndrome, 275900 (3), Autosomal recessiveTroyer syndrome, 275900 (3);chr13;SPG20;True
ENSG00000133111;Regulatory factor X-associated protein;NotRelevant;;Bare lymphocyte syndrome, type II, complementation group D, 209920 (3), Autosomal recessiveBare lymphocyte syndrome, type II, complementation group D, 209920 (3);chr13;RFXAP;True
ENSG00000120693;Mothers against decapentaplegic, Drosophila, homolog of, 9;NotRelevant;;Pulmonary hypertension, primary, 2, 615342 (3), Autosomal dominantPulmonary hypertension, primary, 2, 615342 (3);chr13;MADH9, SMAD9, MADH6, PPH2;True
ENSG00000120699;Exosome component 8;NotRelevant;;Pontocerebellar hypoplasia, type 1C, 616081 (3), Autosomal recessivePontocerebellar hypoplasia, type 1C, 616081 (3);chr13;EXOSC8, OIP2, RRP43, PCH1C;True
ENSG00000120686;Ubiquitin-fold modifier 1;NotRelevant;;Leukodystrophy, hypomyelinating, 14, 617899 (3), Autosomal recessiveLeukodystrophy, hypomyelinating, 14, 617899 (3);chr13;UFM1, HLD14;True
ENSG00000150893;FRAS1-related extracellular matrix protein 2;NotRelevant;;Fraser syndrome 2, 617666 (3), Autosomal recessiveFraser syndrome 2, 617666 (3);chr13;FREM2, FRASRS2;True
ENSG00000133103;Component of oligomeric golgi complex 6;NotRelevant;;Congenital disorder of glycosylation, type IIl, 614576 (3), Autosomal recessiveShaheen syndrome, 615328 (3);chr13;COG6, COD2, KIAA1134, CDG2L, SHNS;True
ENSG00000150907;Forkhead box O1A (forkhead in rhabdomyosarcoma);NotRelevant;chimeric with PAX3 in t(2;13)Rhabdomyosarcoma, alveolar, 268220 (3);chr13;FOXO1A, FKHR;False
ENSG00000102743;Solute carrier family 25 (mitochondrial carrier), member 15 (ornithine transporter 1);NotRelevant;with deficiency of factors VII and X in 3 unrelated cases;Hyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3), Autosomal recessiveHyperornithinemia-hyperammonemia-homocitrullinemia syndrome, 238970 (3);chr13;SLC25A15, ORNT1, HHH;True
ENSG00000120659;Tumor necrosis factor ligand superfamily, member 11 (osteoprotegerin ligand);NotRelevant;;Osteopetrosis, autosomal recessive 2, 259710 (3), Autosomal recessiveOsteopetrosis, autosomal recessive 2, 259710 (3);chr13;TNFSF11, OPGL, TRANCE, OPTB2;True
ENSG00000139684;Esterase D;NotRelevant;ENSG00000139684;proximal to RB1, WND;chr13;ESD;False
ENSG00000102468;5-hydroxytryptamine (serotonin) receptor-2A;NotRelevant;;{Alcohol dependence, susceptibility to}, 103780 (3), Multifactorial{Seasonal affective disorder, susceptibility to}, 608516 (3);chr13;HTR2A;False
ENSG00000136143;Succinate-CoA ligase, ADP-forming, beta subunit;NotRelevant;;Mitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3), Autosomal recessiveMitochondrial DNA depletion syndrome 5 (encephalomyopathic with or without methylmalonic aciduria), 612073 (3);chr13;SUCLA2, MTDPS5;True
ENSG00000136159;Nucleoside diphosphate-linked moiety X motif 15;NotRelevant;;{Thiopurines, poor metabolism of, 2}, 616903 (3), Autosomal dominant{Thiopurines, poor metabolism of, 2}, 616903 (3);chr13;NUDT15, MTH2, NUDT15D;True
ENSG00000136156;Integral membrane protein 2B (BRI gene);NotRelevant;mutation identified in 1 RDGCA family;Dementia, familial British, 176500 (3), Autosomal dominantDementia, familial Danish, 117300 (3);chr13;ITM2B, BRI, ABRI, FBD, RDGCA;True
ENSG00000139687;Retinoblastoma-1;NotRelevant;;Bladder cancer, somatic, 109800 (3)Small cell cancer of the lung, somatic, 182280 (3);chr13;RB1;False
ENSG00000139679;Lysophosphatidic acid receptor 6;NotRelevant;in intron 17 of RB gene;Hypotrichosis 8, 278150 (3), Autosomal recessiveWoolly hair, autosomal recessive 1, with or without hypotrichosis, 278150 (3);chr13;LPAR6, P2RY5, P2Y5, LAH3, ARWH1, HYPT8;True
ENSG00000136144;RCC1 domain- and BTB domain-containing protein 1;NotRelevant;;Retinal dystrophy with or without extraocular anomalies, 617175 (3), Autosomal recessiveRetinal dystrophy with or without extraocular anomalies, 617175 (3);chr13;RCBTB1, CLLD7, GLP, RDEOA;True
ENSG00000136104;Ribonuclease H2, subunit B;NotRelevant;;Aicardi-Goutieres syndrome 2, 610181 (3), Autosomal recessiveAicardi-Goutieres syndrome 2, 610181 (3);chr13;RNASEH2B, DLEU8, FLJ11712, AGS2;True
ENSG00000123191;ATPase, Cu++ transporting, beta polypeptide;NotRelevant;;Wilson disease, 277900 (3), Autosomal recessiveWilson disease, 277900 (3);chr13;ATP7B, WND;True
ENSG00000253710;Alg11, S. cerevisiae, homolog of;NotRelevant;;Congenital disorder of glycosylation, type Ip, 613661 (3), Autosomal recessiveCongenital disorder of glycosylation, type Ip, 613661 (3);chr13;ALG11, KIAA1266, CDG1P;True
ENSG00000139734;Diaphanous, Drosophila, homolog of, 3;NotRelevant;;Auditory neuropathy, autosomal dominant, 1, 609129 (3), Autosomal dominantAuditory neuropathy, autosomal dominant, 1, 609129 (3);chr13;DIAPH3, DIA2, DRF3, AUNA1, NSDAN;True
ENSG00000083535;Progesterone-induced blocking factor 1;NotRelevant;;Joubert syndrome 33, 617767 (3), Autosomal recessiveJoubert syndrome 33, 617767 (3);chr13;PIBF1, JBTS33;True
ENSG00000136111;TPC1 domain family, member 4;NotRelevant;;{Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3){Diabetes mellitus, noninsulin-dependent, 5}, 616087 (3);chr13;TBC1D4, AS160, KIAA0603, NIDDM5;False
ENSG00000102805;CLN5 gene;NotRelevant;;Ceroid lipofuscinosis, neuronal, 5, 256731 (3), Autosomal recessiveCeroid lipofuscinosis, neuronal, 5, 256731 (3);chr13;CLN5;True
ENSG00000136160;Endothelin receptor type B;NotRelevant;?piebald lethal in mouse;ABCD syndrome, 600501 (3), Autosomal recessive{Hirschsprung disease, susceptibility to, 2}, 600155 (3);chr13;EDNRB, HSCR2, ABCDS, WS4A;True
ENSG00000136158;Sprouty, Drosophila, homolog of, 2;NotRelevant;mutation identified in 1 IGAN3 family;{?IgA nephropathy, susceptibility to, 3}, 616818 (3), Autosomal dominant{?IgA nephropathy, susceptibility to, 3}, 616818 (3);chr13;SPRY2, IGAN3;True
ENSG00000178235;SLIT- and NTRK-like family, member 1;NotRelevant;mutation identified in 1 TTM patient;Tourette syndrome, 137580 (3), Autosomal dominantTourette syndrome, 137580 (3);chr13;SLITRK1, KIAA1910, TTM;True
ENSG00000184564;SLIT- and NTRK-like family, member 6;NotRelevant;;Deafness and myopia, 221200 (3), Autosomal recessiveDeafness and myopia, 221200 (3);chr13;SLITRK6, DFNMYP;True
ENSG00000215417;Micro RNA 17 host gene;NotRelevant;;Feingold syndrome 2, 614326 (3), Autosomal dominantFeingold syndrome 2, 614326 (3);chr13;MIR17HG, MIRH1, MIHG1, MIRHG1, C13orf25, FGLDS2;True
ENSG00000284536;Micro RNA 17;NotRelevant;within C13orf25; sequence encodes 2 micro RNAs;chr13;MIR17, MIR91, MIRN17;False
ENSG00000183098;Glypican 6;NotRelevant;;Omodysplasia 1, 258315 (3), Autosomal recessiveOmodysplasia 1, 258315 (3);chr13;GPC6, OMIMD1;True
ENSG00000088451;TDP-glucose 4,6-dehydratase;NotRelevant;;Catel-Manzke syndrome, 616145 (3), Autosomal recessiveCatel-Manzke syndrome, 616145 (3);chr13;TGDS, SDR2E1, CATMANS;True
ENSG00000134873;Claudin 10;NotRelevant;;HELIX syndrome, 617671 (3), Autosomal recessiveHELIX syndrome, 617671 (3);chr13;CLDN10, OSPL, CPETRL3, HELIX;True
ENSG00000102580;DnaJ, E. coli, homolog of, subfamily C, member 3 (protein kinase inhibitor p58);NotRelevant;mutation identified in 1 ACPHD family;?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3), Autosomal recessive?Ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus, 616192 (3);chr13;DNAJC3, PRKRI, P58, ACPHD;True
ENSG00000043355;ZIC family, member 2;NotRelevant;;Holoprosencephaly 5, 609637 (3), Autosomal dominantHoloprosencephaly 5, 609637 (3);chr13;ZIC2, HPE5;True
ENSG00000175198;Propionyl Coenzyme A carboxylase, alpha polypeptide;NotRelevant;;Propionicacidemia, 606054 (3), Autosomal recessivePropionicacidemia, 606054 (3);chr13;PCCA;True
ENSG00000102452;Sodium leak channel, nonselective;NotRelevant;;Congenital contractures of the limbs and face, hypotonia, and developmental delay, 616266 (3), Autosomal dominantHypotonia, infantile, with psychomotor retardation and characteristic facies 1, 615419 (3);chr13;NALCN, IHPRF1, CLIFAHDD;True
ENSG00000102466;Fibroblast growth factor-14;NotRelevant;;Spinocerebellar ataxia 27, 609307 (3), Autosomal dominantSpinocerebellar ataxia 27, 609307 (3);chr13;FGF14, FHF4, SCA27;True
ENSG00000134899;Excision-repair, complementing defective, in Chinese hamster, number 5;NotRelevant;;Cerebrooculofacioskeletal syndrome 3, 616570 (3), Autosomal recessiveXeroderma pigmentosum, group G/Cockayne syndrome, 278780 (3);chr13;ERCC5, XPG, COFS3;True
ENSG00000125255;Solute carrier family 10 (sodium/bile acid cotransporter family), member 2;NotRelevant;;Bile acid malabsorption, primary, 613291 (3), Autosomal recessiveBile acid malabsorption, primary, 613291 (3);chr13;SLC10A2, NTCP2, PBAM;True
ENSG00000182346;D-amino acid oxidase activator;NotRelevant;;{Schizophrenia}, 181500 (2), Autosomal dominant{Schizophrenia}, 181500 (2);chr13;DAOA, G72;True
ENSG00000174405;Ligase IV, DNA, ATP-dependent;NotRelevant;;LIG4 syndrome, 606593 (3), Autosomal recessive{Multiple myeloma, resistance to}, 254500 (3);chr13;LIG4, LIG4S;True
ENSG00000185950;Insulin receptor substrate 2;NotRelevant;;{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent}, 125853 (3);chr13;IRS2;True
ENSG00000187498;Collagen IV, alpha-1 polypeptide;NotRelevant;mutation identified in 1 RATOR family;Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps, 611773 (3), Autosomal dominant{Hemorrhage, intracerebral, susceptibility to}, 614519 (3);chr13;COL4A1, POREN1, HANAC, ICH, BSVD, RATOR;True
ENSG00000134871;Collagen IV, alpha-2 polypeptide;NotRelevant;;{Hemorrhage, intracerebral, susceptibility to}, 614519 (3){Hemorrhage, intracerebral, susceptibility to}, 614519 (3);chr13;COL4A2, POREN2, ICH;False
ENSG00000134905;Cysteinyl-tRNA synthetase 2;NotRelevant;;Combined oxidative phosphorylation deficiency 27, 616672 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 27, 616672 (3);chr13;CARS2, COXPD27;True
ENSG00000153487;Inhibitor of growth 1;NotRelevant;;Squamous cell carcinoma, head and neck, somatic, 275355 (3)Squamous cell carcinoma, head and neck, somatic, 275355 (3);chr13;ING1;False
ENSG00000057593;Coagulation factor VII;NotRelevant;;Factor VII deficiency, 227500 (3), Autosomal recessive{Myocardial infarction, decreased susceptibility to}, 608446 (3);chr13;F7;True
ENSG00000126218;Coagulation factor X;NotRelevant;;Factor X deficiency, 227600 (3), Autosomal recessiveFactor X deficiency, 227600 (3);chr13;F10;True
ENSG00000126231;Protein Z;NotRelevant;;[Protein Z deficiency], 614024 (3)[Protein Z deficiency], 614024 (3);chr13;PROZ, PZ;False
ENSG00000185974;G protein-dependent receptor kinase 1 (rhodopsin kinase);NotRelevant;;Oguchi disease-2, 613411 (3)Oguchi disease-2, 613411 (3);chr13;GRK1, RHOK, RK;False
ENSG00000198824;Chromosome alignment-maintaining phosphoprotein 1;NotRelevant;;Mental retardation, autosomal dominant 40, 616579 (3), Autosomal dominantMental retardation, autosomal dominant 40, 616579 (3);chr13;CHAMP1, ZNF828, C13orf8, KIAA1802, MRD40;True
ENSG00000092094;O-sialoglycoprotein endopeptidase;NotRelevant;;Galloway-Mowat syndrome 3, 617729 (3), Autosomal recessiveGalloway-Mowat syndrome 3, 617729 (3);chr14;OSGEP, FLJ20411, GAMOS3;True
ENSG00000198805;Purine nucleoside phosphorylase;NotRelevant;centromeric to TCRA;Immunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3), Autosomal recessiveImmunodeficiency due to purine nucleoside phosphorylase deficiency, 613179 (3);chr14;PNP, NP;True
ENSG00000214274;Angiogenin;NotRelevant;proximal to TCRA/TCRD;Amyotrophic lateral sclerosis 9, 611895 (3)Amyotrophic lateral sclerosis 9, 611895 (3);chr14;ANG, RNASE5, ALS9;False
ENSG00000092200;Retinitis pigmentosa GTPase regulator-interacting protein;NotRelevant;;Cone-rod dystrophy 13, 608194 (3)Leber congenital amaurosis 6, 613826 (3);chr14;RPGRIP1, LCA6, CORD13;False
ENSG00000100888;Chromodomain helicase DNA-binding protein 8;NotRelevant;;{Autism, susceptibility to, 18}, 615032 (3), Autosomal dominant{Autism, susceptibility to, 18}, 615032 (3);chr14;CHD8, DUPLIN, KIAA1564, AUTS18;True
ENSG00000165821;Sal-like 2;NotRelevant;mutation identified in 1 COLB family;?Coloboma, ocular, autosomal recessive, 216820 (3), Autosomal recessive?Coloboma, ocular, autosomal recessive, 216820 (3);chr14;SALL2, HSAL2, COLB;True
ENSG00000155465;Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7;NotRelevant;;Lysinuric protein intolerance, 222700 (3), Autosomal recessiveLysinuric protein intolerance, 222700 (3);chr14;SLC7A7, LPI;True
ENSG00000157227;Matrix metalloproteinase 14 (membrane-inserted);NotRelevant;mutation identified in 1 family;?Winchester syndrome, 277950 (3)?Winchester syndrome, 277950 (3);chr14;MMP14, WNCHRS;False
ENSG00000092067;CCAAT/enhancer-binding protein (C/EBP), epsilon;NotRelevant;;Specific granule deficiency, 245480 (3), Autosomal recessiveSpecific granule deficiency, 245480 (3);chr14;CEBPE, CRP1;True
ENSG00000100836;Poly(A)-binding protein, nuclear 1;NotRelevant;;Oculopharyngeal muscular dystrophy, 164300 (3), Autosomal dominantOculopharyngeal muscular dystrophy, 164300 (3);chr14;PABPN1, PABP2, PAB2;True
ENSG00000197616;Myosin, heavy polypeptide-6, cardiac muscle, alpha;NotRelevant;;Atrial septal defect 3, 614089 (3){Sick sinus syndrome 3}, 614090 (3);chr14;MYH6, ASD3, MYHCA, CMD1EE, CMH14, SSS3;False
ENSG00000092054;Myosin, heavy polypeptide-7, cardiac muscle, beta;NotRelevant;5'-B-4.5kb-A-3';Cardiomyopathy, dilated, 1S, 613426 (3), Autosomal dominantScapuloperoneal syndrome, myopathic type, 181430 (3);chr14;MYH7, CMH1, MPD1, CMD1S, SPMM, SPMD;True
ENSG00000136367;Zinc finger homeobox 2;NotRelevant;mutation identified in 1 MARSIS family;?Marsili syndrome, 147430 (3), Autosomal dominant?Marsili syndrome, 147430 (3);chr14;ZFHX2, ZFH5, ZNF409, KIAA1056, KIAA1762, MARSIS;True
ENSG00000129535;Neural retina leucine zipper;NotRelevant;;Retinal degeneration, autosomal recessive, clumped pigment type (3)Retinitis pigmentosa 27, 613750 (3);chr14;NRL, D14S46E, RP27;True
ENSG00000100889;Phosphoenolpyruvate carboxykinase 2, mitochondrial;NotRelevant;;PEPCK deficiency, mitochondrial, 261650 (1), Autosomal recessivePEPCK deficiency, mitochondrial, 261650 (1);chr14;PCK2, PEPCK2;True
ENSG00000092330;TRF1-interacting nuclear factor 2;NotRelevant;;Dyskeratosis congenita, autosomal dominant 3, 613990 (3), Autosomal dominantRevesz syndrome, 268130 (3);chr14;TINF2, TIN2, DKCA3;True
ENSG00000092295;Transglutaminase-1 (K polypeptide epidermal type I, protein-glutamine gamma-glutamyltransferase);NotRelevant;;Ichthyosis, congenital, autosomal recessive 1, 242300 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 1, 242300 (3);chr14;TGM1, ICR2, ARCI1;True
ENSG00000176165;Forkhead box G1B;NotRelevant;;Rett syndrome, congenital variant, 613454 (3), Autosomal dominantRett syndrome, congenital variant, 613454 (3);chr14;FOXG1, FOXG1B, FKHL1, FKH2, QIN, BF1;True
ENSG00000184304;Protein kinase D1;NotRelevant;;Congenital heart defects and ectodermal dysplasia, 617364 (3), Autosomal dominantCongenital heart defects and ectodermal dysplasia, 617364 (3);chr14;PRKD1, PRKCM, PKD, CHDED;True
ENSG00000100473;Cochlin;NotRelevant;mutation identified in 1 DFNB110 family;Deafness, autosomal dominant 9, 601369 (3), Autosomal dominantDeafness, autosomal dominant 9, 601369 (3);chr14;COCH, DFNA9, DFNB110;True
ENSG00000100478;Adaptor-related protein complex 4, sigma-1 subunit;NotRelevant;;Spastic paraplegia 52, autosomal recessive, 614067 (3), Autosomal recessiveSpastic paraplegia 52, autosomal recessive, 614067 (3);chr14;AP4S1, CPSQ6, SPG52;True
ENSG00000151413;Nucleotide-binding protein-like protein;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 21, 618242 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 21, 618242 (3);chr14;NUBPL, IND1, MC1DN21;True
ENSG00000165410;Cofilin 2, muscle;NotRelevant;;Nemaline myopathy 7, autosomal recessive, 610687 (3), Autosomal recessiveNemaline myopathy 7, autosomal recessive, 610687 (3);chr14;CFL2, NEM7;True
ENSG00000100902;Proteasome subunit, alpha-type, 6;NotRelevant;;{Myocardial infarction, susceptibility to}, 608446 (3){Myocardial infarction, susceptibility to}, 608446 (3);chr14;PSMA6, PROS27, P27K;False
ENSG00000100906;Nuclear factor of kappa light chain gene enhancer in B-cells inhibitor, alpha;NotRelevant;;Ectodermal dysplasia and immunodeficiency, 612132 (3), Autosomal dominantEctodermal dysplasia and immunodeficiency, 612132 (3);chr14;NFKBIA, IKBA, EDAID2;True
ENSG00000136352;NK2 homeobox 1;NotRelevant;;Chorea, hereditary benign, 118700 (3), Autosomal dominant{Thyroid cancer, nonmedullary, 1}, 188550 (3);chr14;NKX2-1, TITF1, NKX2A, TTF1, NMTC1;True
ENSG00000198807;Paired box gene 9;NotRelevant;;Tooth agenesis, selective, 3, 604625 (3), Autosomal dominantTooth agenesis, selective, 3, 604625 (3);chr14;PAX9, STHAG3;True
ENSG00000100934;Sec23, S. cerevisiae, homolog of, A;NotRelevant;;Craniolenticulosutural dysplasia, 607812 (3), Autosomal recessiveCraniolenticulosutural dysplasia, 607812 (3);chr14;SEC23A, CLSD;True
ENSG00000182400;Trafficking protein particle complex, subunit 6B;NotRelevant;;Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, 617862 (3)Neurodevelopmental disorder with microcephaly, epilepsy, and brain atrophy, 617862 (3);chr14;TRAPPC6B, TPC6, NEDMEBA;False
ENSG00000187790;FANCM gene;NotRelevant;mutation identified in 1 POF15 family;?Premature ovarian failure 15, 618096 (3), Autosomal recessiveSpermatogenic failure 28, 618086 (3);chr14;FANCM, KIAA1596, SPGF28, POF15;True
ENSG00000213741;Ribosomal protein S29;NotRelevant;;Diamond-Blackfan anemia 13, 615909 (3), Autosomal dominantDiamond-Blackfan anemia 13, 615909 (3);chr14;RPS29, DBA13;True
ENSG00000168282;Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyl- transferase;NotRelevant;;Congenital disorder of glycosylation, type IIa, 212066 (3), Autosomal recessiveCongenital disorder of glycosylation, type IIa, 212066 (3);chr14;MGAT2, CDGS2, CDG2A;True
ENSG00000165506;Kintoun, Medaka, homolog of;NotRelevant;;Ciliary dyskinesia, primary, 10, 612518 (3)Ciliary dyskinesia, primary, 10, 612518 (3);chr14;KTU, C14orf104, CILD10;False
ENSG00000100485;Son of sevenless, Drosophila, homolog of, 2;NotRelevant;;Noonan syndrome 9, 616559 (3), Autosomal dominantNoonan syndrome 9, 616559 (3);chr14;SOS2, NS9;True
ENSG00000087299;L-2-hydroxyglutarate dehydrogenase;NotRelevant;;L-2-hydroxyglutaric aciduria, 236792 (3), Autosomal recessiveL-2-hydroxyglutaric aciduria, 236792 (3);chr14;L2HGDH, C14orf160, L2HGA;True
ENSG00000198513;Atlastin GTPase 1;NotRelevant;;Neuropathy, hereditary sensory, type ID, 613708 (3), Autosomal dominantSpastic paraplegia 3A, autosomal dominant, 182600 (3);chr14;ATL1, SPG3A, HSN1D;True
ENSG00000100503;Ninein;NotRelevant;mutation identified in 1 SCKL7 family;?Seckel syndrome 7, 614851 (3), Autosomal recessive?Seckel syndrome 7, 614851 (3);chr14;NIN, KIAA1565, SCKL7;True
ENSG00000100504;Phosphorylase, glycogen, liver;NotRelevant;;Glycogen storage disease VI, 232700 (3), Autosomal recessiveGlycogen storage disease VI, 232700 (3);chr14;PYGL;True
ENSG00000168229;Prostaglandin D2 receptor;NotRelevant;;{Asthma, susceptibility to, 1}, 607277 (3){Asthma, susceptibility to, 1}, 607277 (3);chr14;PTGDR, AS1, ASRT1;False
ENSG00000125384;Prostaglandin E receptor 2, EP2 subtype, 53kD;NotRelevant;;{Asthma, aspirin-induced, susceptibility to}, 208550 (3), Autosomal recessive{Asthma, aspirin-induced, susceptibility to}, 208550 (3);chr14;PTGER2;True
ENSG00000100523;DDHD domain-containing protein 1;NotRelevant;;Spastic paraplegia 28, autosomal recessive, 609340 (3), Autosomal recessiveSpastic paraplegia 28, autosomal recessive, 609340 (3);chr14;DDHD1, PAPLA1, KIAA1705, SPG28;True
ENSG00000125378;Bone morphogenetic protein-4;NotRelevant;;Microphthalmia, syndromic 6, 607932 (3), Autosomal dominantOrofacial cleft 11, 600625 (3);chr14;BMP4, BMP2B1, BMP2B, MCOPS6, OFC11;True
ENSG00000131979;GTP cyclohydrolase 1;NotRelevant;;Dystonia, DOPA-responsive, with or without hyperphenylalaninemia, 128230 (3), Autosomal recessive, Autosomal dominantHyperphenylalaninemia, BH4-deficient, B, 233910 (3);chr14;GCH1, DYT5, HPABH4B;True
ENSG00000070269;Transmembrane protein 260;NotRelevant;;Structural heart defects and renal anomalies syndrome, 617478 (3), Autosomal recessiveStructural heart defects and renal anomalies syndrome, 617478 (3);chr14;TMEM260, C14orf101, SHDRA;True
ENSG00000165588;Orthodenticle, Drosophila, homolog of, 2;NotRelevant;;Microphthalmia, syndromic 5, 610125 (3), Autosomal dominantRetinal dystrophy, early-onset, with or without pituitary dysfunction, 610125 (3);chr14;OTX2, MCOPS5, CPHD6;True
ENSG00000100578;KIAA0586 gene;NotRelevant;;Joubert syndrome 23, 616490 (3), Autosomal recessiveShort-rib thoracic dysplasia 14 with polydactyly, 616546 (3);chr14;KIAA0586, TALPID3, JBTS23, SRTD14;True
ENSG00000165617;Dapper, antagonist of beta-catenin, 1;NotRelevant;mutation identified in 1 TBS2 family;?Townes-Brocks syndrome 2, 617466 (3), Autosomal dominant?Townes-Brocks syndrome 2, 617466 (3);chr14;DACT1, DPR1, DAPPER1, FRODO, TBS2;True
ENSG00000184302;Sine oculis homeo box, Drosophila, homolog of, 6;NotRelevant;;Optic disc anomalies with retinal and/or macular dystrophy, 212550 (3), Autosomal recessiveOptic disc anomalies with retinal and/or macular dystrophy, 212550 (3);chr14;SIX6, ODRMD;True
ENSG00000126778;Sine oculis homeo box, Drosophila, homolog of, 1;NotRelevant;;Branchiootic syndrome 3, 608389 (3), Autosomal dominantDeafness, autosomal dominant 23, 605192 (3);chr14;SIX1, BOS3, DFNA23;True
ENSG00000126814;tRNA methyltransferase 5, S. cerevisiae, homolog of;NotRelevant;;Combined oxidative phosphorylation deficiency 26, 616539 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 26, 616539 (3);chr14;TRMT5, TRM5, KIAA1393, COXPD26;True
ENSG00000027075;Protein kinase C, eta;NotRelevant;;{Cerebral infarction, susceptibility to}, 601367 (3), Multifactorial{Cerebral infarction, susceptibility to}, 601367 (3);chr14;PRKCH, PKCL, PRKCL;False
ENSG00000054654;Spectrin repeat-containing nuclear envelope protein 2 (nesprin 2);NotRelevant;;Emery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3), Autosomal dominantEmery-Dreifuss muscular dystrophy 5, autosomal dominant, 612999 (3);chr14;SYNE2, NUANCE, KIAA1011, EDMD5;True
ENSG00000140009;Estrogen receptor-2 (ER beta);NotRelevant;mutation identified in 1 ODG8 patient;?Ovarian dysgenesis 8, 618187 (3), Autosomal dominant?Ovarian dysgenesis 8, 618187 (3);chr14;ESR2, ODG8;True
ENSG00000100714;Methylenetetrahydrofolate dehydrogenase 1;NotRelevant;trifunctional protein;Combined immunodeficiency and megaloblastic anemia with or without hyperhomocysteinemia, 617780 (3), Autosomal recessive{Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3);chr14;MTHFD1, MTHFC, CIMAH;True
ENSG00000070182;Spectrin, beta, erythrocytic;NotRelevant;;Anemia, neonatal hemolytic, fatal or near-fatal, 617948 (3)Spherocytosis, type 2, 616649 (3);chr14;SPTB, SPH2, EL3, HS2;False
ENSG00000125952;MAX protein;NotRelevant;interacts with MYC;{Pheochromocytoma, susceptibility to}, 171300 (3), Autosomal dominant{Pheochromocytoma, susceptibility to}, 171300 (3);chr14;MAX;True
ENSG00000033170;Fucosyltransferase 8;NotRelevant;;Congenital disorder of glycosylation with defective fucosylation, 618005 (3), Autosomal recessiveCongenital disorder of glycosylation with defective fucosylation, 618005 (3);chr14;FUT8, CDGF;True
ENSG00000171723;Gephyrin;NotRelevant;;Molybdenum cofactor deficiency C, 615501 (3), Autosomal recessiveMolybdenum cofactor deficiency C, 615501 (3);chr14;GPHN, GPH, KIAA1385, GEPH, MOCODC;True
ENSG00000100564;Phosphatidylinositol glycan, class H;NotRelevant;;Glycosylphosphatidylinositol biosynthesis defect 17, 618010 (3), Autosomal recessiveGlycosylphosphatidylinositol biosynthesis defect 17, 618010 (3);chr14;PIGH;True
ENSG00000072042;Retinol dehydrogenase 11;NotRelevant;mutation identified in 1 RDJCSS family;?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3), Autosomal recessive?Retinal dystrophy, juvenile cataracts, and short stature syndrome, 616108 (3);chr14;RDH11, PSDR1, RALR1, RDJCSS;True
ENSG00000139988;Retinol dehydrogenase 12;NotRelevant;near RDH11;Leber congenital amaurosis 13, 612712 (3), Autosomal recessive, Autosomal dominantLeber congenital amaurosis 13, 612712 (3);chr14;RDH12, LCA13;True
ENSG00000072121;Zinc finger FYVE domain-containing protein 26;NotRelevant;;Spastic paraplegia 15, autosomal recessive, 270700 (3), Autosomal recessiveSpastic paraplegia 15, autosomal recessive, 270700 (3);chr14;ZFYVE26, KIAA0321, SPG15;True
ENSG00000072110;Actinin, alpha-1;NotRelevant;;Bleeding disorder, platelet-type, 15, 615193 (3), Autosomal dominantBleeding disorder, platelet-type, 15, 615193 (3);chr14;ACTN1, BDPLT15;True
ENSG00000198732;SPARC-related modular calcium-binding 1;NotRelevant;;Microphthalmia with limb anomalies, 206920 (3), Autosomal recessiveMicrophthalmia with limb anomalies, 206920 (3);chr14;SMOC1, OAS;True
ENSG00000080815;Presenilin 1;NotRelevant;mutation identified in 1 ACNINV3 family;?Acne inversa, familial, 3, 613737 (3), Autosomal dominantPick disease, 172700 (3);chr14;PSEN1, AD3, ACNINV3;True
ENSG00000119661;Dynein, axonemal, light chain 1;NotRelevant;;Ciliary dyskinesia, primary, 16, 614017 (3), Autosomal recessiveCiliary dyskinesia, primary, 16, 614017 (3);chr14;DNAL1, C14orf168, CILD16;True
ENSG00000119723;Coq6, S. cerevisiae, homolog of;NotRelevant;;Coenzyme Q10 deficiency, primary, 6, 614650 (3), Autosomal recessiveCoenzyme Q10 deficiency, primary, 6, 614650 (3);chr14;COQ6, CGI10, COQ10D6;True
ENSG00000119711;Aldehyde dehydrogenase 6 family, member A1 (methylmalonate semialdehyde dehydrogenase);NotRelevant;;Methylmalonate semialdehyde dehydrogenase deficiency, 614105 (3), Autosomal recessiveMethylmalonate semialdehyde dehydrogenase deficiency, 614105 (3);chr14;ALDH6A1, MMSDH;True
ENSG00000119614;C. elegans ceh-10 homeo domain-containing homolog;NotRelevant;;Microphthalmia with coloboma 3, 610092 (3)Microphthalmia, isolated 2, 610093 (3);chr14;CHX10, HOX10, MCOP2, MCOPCB3;False
ENSG00000119688;ATP-binding cassette, subfamily D, member 4 (peroxisomal membrane protein 1-like);NotRelevant;;Methylmalonic aciduria and homocystinuria, cblJ type, 614857 (3), Autosomal recessiveMethylmalonic aciduria and homocystinuria, cblJ type, 614857 (3);chr14;ABCD4, PXMP1L, P79R, PMP69, MAHCJ;True
ENSG00000119655;Epididymal secretory protein HE1;NotRelevant;;Niemann-pick disease, type C2, 607625 (3), Autosomal recessiveNiemann-pick disease, type C2, 607625 (3);chr14;NPC2, HE1;True
ENSG00000165898;Iron-sulfur cluster assembly 2, S. cerevisiae, homolog of;NotRelevant;;Multiple mitochondrial dysfunctions syndrome 4, 616370 (3), Autosomal recessiveMultiple mitochondrial dysfunctions syndrome 4, 616370 (3);chr14;ISCA2, MMDS4;True
ENSG00000119681;Latent transforming growth factor beta binding protein-2;NotRelevant;mutation identified in 1 WMS3 family;Glaucoma 3, primary congenital, D, 613086 (3)Microspherophakia and/or megalocornea, with ectopia lentis and with or without secondary glaucoma, 251750 (3);chr14;LTBP2, LTBP3, GLC3D, MSPKA, WMS3;False
ENSG00000119718;Eukaryotic translation initiation factor 2B, subunit 2;NotRelevant;;Leukoencephalopathy with vanishing white matter, 603896 (3), Autosomal recessiveOvarioleukodystrophy, 603896 (3);chr14;EIF2B2;True
ENSG00000119684;Mismatch repair gene MLH3;NotRelevant;;Colorectal cancer, hereditary nonpolyposis, type 7, 614385 (3){Endometrial cancer, susceptibility to}, 608089 (3);chr14;MLH3, HNPCC7;False
ENSG00000119638;Never in mitosis gene A-related kinase 9;NotRelevant;mutation identified in 1 APUG family;?Arthrogryposis, Perthes disease, and upward gaze palsy, 614262 (3), Autosomal recessiveNevus comedonicus, somatic, 617025 (3);chr14;NEK9, NERCC1, LCCS10, APUG, NC;True
ENSG00000119686;Feline leukemia virus subgroup C receptor 2;NotRelevant;;Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3), Autosomal recessiveProliferative vasculopathy and hydranencephaly-hydrocephaly syndrome, 225790 (3);chr14;FLVCR2, C14orf58, CCT, PVHH, EPV;True
ENSG00000119685;Tubulin tyrosine ligase-like family, member 5;NotRelevant;;Cone-rod dystrophy 19, 615860 (3), Autosomal recessiveCone-rod dystrophy 19, 615860 (3);chr14;TTLL5, STAMP, KIAA0998, CORD19;True
ENSG00000119699;Transforming growth factor, beta-3;NotRelevant;;Arrhythmogenic right ventricular dysplasia 1, 107970 (3), Autosomal dominantLoeys-Dietz syndrome 5, 615582 (3);chr14;TGFB3, ARVD1, RNHF, LDS5;True
ENSG00000119650;Intraflagellar transport 43, Chlamydomonas, homolog of;NotRelevant;mutation identified in 1 CED3 family and 1 RP81 family;?Cranioectodermal dysplasia 3, 614099 (3), Autosomal recessiveShort-rib thoracic dysplasia 18 with polydactyly, 617866 (3);chr14;IFT43, C14orf179, CED3, SRTD18, RP81;True
ENSG00000119715;Estrogen-related receptor beta;NotRelevant;;Deafness, autosomal recessive 35, 608565 (3), Autosomal recessiveDeafness, autosomal recessive 35, 608565 (3);chr14;ESRRB, ESRL2, DFNB35;True
ENSG00000119669;Interferon regulatory factor 2-binding protein like;NotRelevant;;Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3), Autosomal dominantNeurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3);chr14;IRF2BPL, C14orf4, EAP1, NEDAMSS;True
ENSG00000009830;Putative protein O-mannosyltransferase 2;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 2, 613150 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle), type C, 2, 613158 (3);chr14;POMT2, MDDGA2, MDDGB2, MDDGC2, LGMDR14;True
ENSG00000100577;Glutathione S-transferase, zeta-1 (maleylacetoacetate isomerase);NotRelevant;;[Maleylacetoacetate isomerase deficiency], 617596 (3), Autosomal recessive[Maleylacetoacetate isomerase deficiency], 617596 (3);chr14;GSTZ1, MAAI, MAAID;True
ENSG00000151445;VPS33B-interacting protein, apical-basolateral polarity regulator, spe-39 homolog;NotRelevant;;Arthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3), Autosomal recessiveArthrogryposis, renal dysfunction, and cholestasis 2, 613404 (3);chr14;VIPAS39, VIPAR, SPE39, C14orf133;True
ENSG00000100596;Serine palmitoyltransferase, long-chain base subunit 2;NotRelevant;;Neuropathy, hereditary sensory and autonomic, type IC, 613640 (3), Autosomal dominantNeuropathy, hereditary sensory and autonomic, type IC, 613640 (3);chr14;SPTLC2, KIAA0526, SPT2, LCB2, HSN1C, NSAN1C;True
ENSG00000165409;Thyroid-stimulating hormone receptor;NotRelevant;;Hyperthyroidism, familial gestational, 603373 (3)Thyroid carcinoma with thyrotoxicosis (3);chr14;TSHR, CHNG1;False
ENSG00000054983;Galactosylceramidase;NotRelevant;;Krabbe disease, 245200 (3), Autosomal recessiveKrabbe disease, 245200 (3);chr14;GALC;True
ENSG00000042317;Spermatogenesis-associated protein 7;NotRelevant;;Leber congenital amaurosis 3, 604232 (3)Retinitis pigmentosa, juvenile, autosomal recessive, 604232 (3);chr14;SPATA7, HSD3, LCA3;True
ENSG00000100722;Zinc finger CCCH domain-containing protein 14;NotRelevant;;Mental retardation, autosomal recessive 56, 617125 (3), Autosomal recessiveMental retardation, autosomal recessive 56, 617125 (3);chr14;ZC3H14, SUT2, MRT56;True
ENSG00000165533;Tetratricopeptide repeat domain 8;NotRelevant;mutation identified in 1 RP51 family;Bardet-Biedl syndrome 8, 615985 (3), Autosomal recessiveBardet-Biedl syndrome 8, 615985 (3);chr14;TTC8, BBS8, RP51;True
ENSG00000042088;Tyrosyl-DNA phosphodiesterase 1;NotRelevant;;Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3)Spinocerebellar ataxia, autosomal recessive with axonal neuropathy, 607250 (3);chr14;TDP1;True
ENSG00000198668;Calmodulin-1 (phosphorylase kinase, delta);NotRelevant;;Long QT syndrome 14, 616247 (3), Autosomal dominantVentricular tachycardia, catecholaminergic polymorphic, 4, 614916 (3);chr14;CALM1, PHKD, CPVT4, LQT14;True
ENSG00000119714;G protein-coupled receptor 68;NotRelevant;;Amelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3), Autosomal recessiveAmelogenesis imperfecta, hypomaturation type, IIA6, 617217 (3);chr14;GPR68, OGR1, AI2A6;True
ENSG00000015133;Coiled-coil domain-containing protein 88C;NotRelevant;mutation identified in 1 SCA40 family;Hydrocephalus, congenital, 1, 236600 (3), Autosomal recessiveHydrocephalus, congenital, 1, 236600 (3);chr14;CCDC88C, HKRP2, DAPLE, KIAA1509, HYC1, SCA40;True
ENSG00000140092;Fibulin 5;NotRelevant;;Cutis laxa, autosomal dominant 2, 614434 (3)Neuropathy, hereditary, with or without age-related macular degeneration, 608895 (3);chr14;FBLN5, ARMD3, ADCL2, ARCL1A, HNARMD;True
ENSG00000100815;Thyroid hormone receptor interactor 11;NotRelevant;;Achondrogenesis, type IA, 200600 (3), Autosomal recessiveAchondrogenesis, type IA, 200600 (3);chr14;TRIP11, TRIP230, CEV14, ACG1A;True
ENSG00000066427;Ataxin-3 (josephin);NotRelevant;;Machado-Joseph disease, 109150 (3), Autosomal dominantMachado-Joseph disease, 109150 (3);chr14;ATXN3, MJD, SCA3;True
ENSG00000140090;Solute carrier family 24 (sodium/potassium/calcium exchanger), member 4;NotRelevant;;Amelogenesis imperfecta, type IIA5, 615887 (3), Autosomal recessive[Skin/hair/eye pigmentation 6, blue/green eyes], 210750 (3);chr14;SLC24A4, NCKX4, SHEP6, AI2A5;True
ENSG00000170099;Corticosteroid-binding globulin;NotRelevant;;Corticosteroid-binding globulin deficiency, 611489 (3), Autosomal recessive, Autosomal dominantCorticosteroid-binding globulin deficiency, 611489 (3);chr14;CBG, SERPINA6;True
ENSG00000197249;Alpha-1-antitrypsin (serpin peptidase inhibitor, clade A, member 1);NotRelevant;;Emphysema due to AAT deficiency, 613490 (3), Autosomal recessive{Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (1);chr14;SERPINA1, PI, AAT;True
ENSG00000196136;Alpha-1-antichymotrypsin;NotRelevant;220kb from PI;Alpha-1-antichymotrypsin deficiency (3)Cerebrovascular disease, occlusive (3);chr14;SERPINA3, AACT, ACT;False
ENSG00000133937;Goosecoid;NotRelevant;;Short stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3), Autosomal recessiveShort stature, auditory canal atresia, mandibular hypoplasia, skeletal abnormalities, 602471 (3);chr14;GSC, SAMS;True
ENSG00000100697;Dicer, Drosophila, homolog of, 1;NotRelevant;;GLOW syndrome, somatic mosaic, 618272 (3)Rhabdomyosarcoma, embryonal, 2, 180295 (3);chr14;DICER1, HERNA, KIAA0928, MNG1, RMSE2, GLOW;False
ENSG00000182512;Glutaredoxin 5;NotRelevant;;Anemia, sideroblastic, 3, pyridoxine-refractory, 616860 (3), Autosomal recessiveSpasticity, childhood-onset, with hyperglycinemia, 616859 (3);chr14;GLRX5, C14orf87, PRO1238, FLB4739, PRSA, SIDBA3, SPAHGC;True
ENSG00000213231;T-cell lymphoma/leukemia 1B;NotRelevant;;Leukemia/lymphoma, T-cell, 603769 (2)Leukemia/lymphoma, T-cell (2);chr14;TCL1B, TML1;False
ENSG00000100721;T-cell lymphoma/leukemia 1A;NotRelevant;;Leukemia/lymphoma, T-cell, 186960 (2)Leukemia/lymphoma, T-cell (2);chr14;TCL1A, TCL1;False
ENSG00000140057;Adenylate kinase 7;NotRelevant;mutation identified in 1 SPGF27 family;?Spermatogenic failure 27, 617965 (3), Autosomal recessive?Spermatogenic failure 27, 617965 (3);chr14;AK7, SPGF27;True
ENSG00000100749;Vaccinia-related kinase-1;NotRelevant;;Pontocerebellar hypoplasia type 1A, 607596 (3), Autosomal recessivePontocerebellar hypoplasia type 1A, 607596 (3);chr14;VRK1, PCH1A;True
ENSG00000127152;C-cell CLL/lymphoma 11B;NotRelevant;;Immunodeficiency 49, 617237 (3), Autosomal dominantIntellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities, 618092 (3);chr14;BCL11B, CTIP2, IMD49, IDDFSTA;True
ENSG00000090061;Cyclin K;NotRelevant;mutation identified in 1 IDDHDF patient;?Intellectual developmental disorder with hypertelorism and distinctive facies, 618147 (3), Autosomal dominant?Intellectual developmental disorder with hypertelorism and distinctive facies, 618147 (3);chr14;CCNK, IDDHDF;True
ENSG00000066629;Echinoderm microtubule associated protein like 1;NotRelevant;;Band heterotopia, 600348 (3), Autosomal recessiveBand heterotopia, 600348 (3);chr14;EML1, EMAPL, EMAP, BH;True
ENSG00000100811;YY1 transcription factor;NotRelevant;;Gabriele-de Vries syndrome, 617557 (3), Autosomal dominantGabriele-de Vries syndrome, 617557 (3);chr14;YY1, GADEVS;True
ENSG00000140105;Tryptophanyl-tRNA synthetase;NotRelevant;;Neuronopathy, distal hereditary motor, type IX, 617721 (3)Neuronopathy, distal hereditary motor, type IX, 617721 (3);chr14;WARS, HMN9;False
ENSG00000197102;Dynein, cytoplasmic-1, heavy chain-1;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 20, 614228 (3), Autosomal dominantSpinal muscular atrophy, lower extremity-predominant 1, AD, 158600 (3);chr14;DYNC1H1, DNCL, DNECL, CMT20, MRD13, SMALED1;True
ENSG00000196663;Tectonin beta-propeller repeat-containing protein 2;NotRelevant;;Spastic paraplegia 49, autosomal recessive, 615031 (3), Autosomal recessiveSpastic paraplegia 49, autosomal recessive, 615031 (3);chr14;TECPR2, KIAA0329, SPG49;True
ENSG00000131323;TNF receptor-associated factor 3;NotRelevant;mutation identified in 1 IIAE5 patient;{?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, 614849 (3){?Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 5}, 614849 (3);chr14;TRAF3, CD40BP, LAP1, CAP1, CRAF1, IIAE5;False
ENSG00000166126;Amnionless, mouse, homolog of;NotRelevant;;Megaloblastic anemia-1, Norwegian type, 261100 (3), Autosomal recessiveMegaloblastic anemia-1, Norwegian type, 261100 (3);chr14;AMN;True
ENSG00000166165;Creatine kinase, brain type;NotRelevant;distal to PI and AACT; closely linked to AKT1 and IGH;chr14;CKB, CKBB, BCK;False
ENSG00000256053;Apoptogenic protein 1, mitochondrial;NotRelevant;;Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, MitochondrialMitochondrial complex IV deficiency, 220110 (3);chr14;APOPT1, APOP;True
ENSG00000126215;X-ray-repair, complementing defective, repair in Chinese hamster cells-3;NotRelevant;;{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation{Melanoma, cutaneous malignant, 6}, 613972 (3);chr14;XRCC3, CMM6;True
ENSG00000156414;TUDOR domain-containing protein 9;NotRelevant;mutation identified in one SPGF30 family;?Spermatogenic failure 30, 618110 (3), Autosomal recessive?Spermatogenic failure 30, 618110 (3);chr14;TDRD9, C14orf75, HLS, SPNE, SPGF30;True
ENSG00000203485;Inverted formin 2;NotRelevant;;Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3), Autosomal dominantGlomerulosclerosis, focal segmental, 5, 613237 (3);chr14;INF2, FSGS5, C14orf173, CMTDIE;True
ENSG00000185100;Adenylosuccinate synthase-like 1;NotRelevant;;Myopathy, distal, 5, 617030 (3), Autosomal recessiveMyopathy, distal, 5, 617030 (3);chr14;ADSSL1, MPD5;True
ENSG00000142208;Murine thymoma viral (v-akt) oncogene homolog-1;NotRelevant;proximal to IGH;Breast cancer, somatic, 114480 (3){Schizophrenia, susceptibility to}, 181500 (2);chr14;AKT1, CWS6;False
ENSG00000179627;Zinc finger- and BTB domain-containing protein 42;NotRelevant;mutation identified in 1 LCCS6 family;?Lethal congenital contracture syndrome 6, 616248 (3), Autosomal recessive?Lethal congenital contracture syndrome 6, 616248 (3);chr14;ZBTB42, ZNF925, LCCS6;True
ENSG00000185024;BRF1, S. cerevisiae, homolog of (TATA box-binding protein-associated factor 3C);NotRelevant;;Cerebellofaciodental syndrome, 616202 (3), Autosomal recessiveCerebellofaciodental syndrome, 616202 (3);chr14;BRF1, TAF3C, GTF3B, TF3B90, CFDS;True
ENSG00000179364;Phosphofurin acidic cluster sorting protein 2;NotRelevant;;Epileptic encephalopathy, early infantile, 66, 618067 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 66, 618067 (3);chr14;PACS2, KIAA0602, EIEE66;True
ENSG00000170113;Nonimprinted gene in Prader-Willi syndrome/Angelman syndrome chromosome region 1;NotRelevant;;Spastic paraplegia 6, autosomal dominant, 600363 (3), Autosomal dominantSpastic paraplegia 6, autosomal dominant, 600363 (3);chr15;NIPA1, SPG6;True
ENSG00000179455;Makorin 3;NotRelevant;expressed only from paternal allele;Precocious puberty, central, 2, 615346 (3), Autosomal dominantPrecocious puberty, central, 2, 615346 (3);chr15;MKRN3, ZFP127, ZNF127, CPPB2;True
ENSG00000254585;MAGE-like 2;NotRelevant;;Schaaf-Yang syndrome, 615547 (3), Autosomal dominantSchaaf-Yang syndrome, 615547 (3);chr15;MAGEL2, NDNL1, SHFYNG;True
ENSG00000182636;Necdin;NotRelevant;;Prader-Willi syndrome, 176270 (3), Isolated casesPrader-Willi syndrome, 176270 (3);chr15;NDN;False
ENSG00000128739;Small nuclear ribonucleoprotein polypeptide N;NotRelevant;;Prader-Willi syndrome, 176270 (3), Isolated casesPrader-Willi syndrome, 176270 (3);chr15;SNRPN;False
ENSG00000114062;Ubiquitin protein ligase E3A;NotRelevant;same location as PWS;Angelman syndrome, 105830 (3), Isolated casesAngelman syndrome, 105830 (3);chr15;UBE3A, ANCR;False
ENSG00000166206;Gamma-aminobutyric acid (GABA) A receptor, beta-3;NotRelevant;;{Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3){Epilepsy, childhood absence, susceptibility to, 5}, 612269 (3);chr15;GABRB3, ECA5, EIEE43;False
ENSG00000104044;Pink-eye dilution, murine, homolog of (oculocutaneous albinism II);NotRelevant;?hypopigmentation in PWS and AS;Albinism, brown oculocutaneous, 203200 (3), Autosomal recessive[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3);chr15;OCA2, P, PED, D15S12, BOCA, EYCL3, HCL3, SHEP1;True
ENSG00000128731;HECT domain and RCC1-like domain 2;NotRelevant;mutations in intron 4;Mental retardation, autosomal recessive 38, 615516 (3), Autosomal recessive[Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3);chr15;HERC2, SHEP1, MRT38;True
ENSG00000185115;NSE3 homolog, SMC5-SMC6 complex component;NotRelevant;;Lung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3), Autosomal recessiveLung disease, immunodeficiency, and chromosome breakage syndrome, 617241 (3);chr15;NSMCE3, NDNL2, MAGEG1, LICS;True
ENSG00000198690;FANCD2/FANCI-associated nuclease 1;NotRelevant;;Interstitial nephritis, karyomegalic, 614817 (3), Autosomal recessiveInterstitial nephritis, karyomegalic, 614817 (3);chr15;FAN1, MTMR15, KIAA1018, KMIN;True
ENSG00000134160;Transient receptor potential cation channel, subfamily M, member 1 (melastatin);NotRelevant;;Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3)Night blindness, congenital stationary (complete), 1C, autosomal recessive, 613216 (3);chr15;TRPM1, MLSN1, CSNB1C;True
ENSG00000140199;Solute carrier family 12 (potassium/chloride transporters), member 6;NotRelevant;;Agenesis of the corpus callosum with peripheral neuropathy, 218000 (3), Autosomal recessiveAgenesis of the corpus callosum with peripheral neuropathy, 218000 (3);chr15;SLC12A6, KCC3A, KCC3B, KCC3, ACCPN;True
ENSG00000182117;Nucleolar protein family A, member 3;NotRelevant;;Dyskeratosis congenita, autosomal recessive 1, 224230 (3), Autosomal recessiveDyskeratosis congenita, autosomal recessive 1, 224230 (3);chr15;NOLA3, NOP10, DKCB1;True
ENSG00000159251;Actin, alpha, cardiac muscle;NotRelevant;;Atrial septal defect 5, 612794 (3), Autosomal dominantLeft ventricular noncompaction 4, 613424 (3);chr15;ACTC1, CMD1R, CMH11, ASD5, LVNC4;True
ENSG00000186073;Chromosome 15 open reading fram 41;NotRelevant;;Dyserythropoietic anemia, congenital, type Ib, 615631 (3), Autosomal recessiveDyserythropoietic anemia, congenital, type Ib, 615631 (3);chr15;C15orf41;True
ENSG00000134138;Meis1, mouse, homolog of, 2;NotRelevant;;Cleft palate, cardiac defects, and mental retardation, 600987 (3), Autosomal dominantCleft palate, cardiac defects, and mental retardation, 600987 (3);chr15;MEIS2, MRG1, CPCMR;True
ENSG00000166068;Sprouty-related EVH1 domain-containing protein 1;NotRelevant;;Legius syndrome, 611431 (3), Autosomal dominantLegius syndrome, 611431 (3);chr15;SPRED1, NFLS;True
ENSG00000128829;Eukaryotic translation initiation factor 2-alpha kinase 4;NotRelevant;;Pulmonary venoocclusive disease 2, 234810 (3), Autosomal recessivePulmonary venoocclusive disease 2, 234810 (3);chr15;EIF2AK4, GCN2, KIAA1338, PVOD2;True
ENSG00000156970;Budding uninhibited by benzimidazoles 1, S. cerevisiae, homolog of, beta;NotRelevant;;Colorectal cancer, somatic, 114500 (3)[Premature chromatid separation trait], 176430 (3);chr15;BUB1B, BUBR1, MVA1;False
ENSG00000137841;Phospholipase C, beta-2;NotRelevant;;Platelet PLC beta-2 deficiency (1)Platelet PLC beta-2 deficiency (1);chr15;PLCB2;False
ENSG00000128928;Isovaleryl Coenzyme A dehydrogenase;NotRelevant;;Isovaleric acidemia, 243500 (3), Autosomal recessiveIsovaleric acidemia, 243500 (3);chr15;IVD;True
ENSG00000169105;Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14;NotRelevant;;Ehlers-Danlos syndrome, musculocontractural type 1, 601776 (3), Autosomal recessiveEhlers-Danlos syndrome, musculocontractural type 1, 601776 (3);chr15;CHST14, D4ST1, ATCS, EDSMC1;True
ENSG00000137812;Kinetochore scaffold 1;NotRelevant;;Microcephaly 4, primary, autosomal recessive, 604321 (3), Autosomal recessiveMicrocephaly 4, primary, autosomal recessive, 604321 (3);chr15;KNL1, CASC5, AF15Q14, KIAA1570, D40, MCPH4;True
ENSG00000051180;RAD51, S. cerevisiae, homolog of, A (E. coli RecA homolog);NotRelevant;mutation identified in 1 FANCR patient;{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation{Breast cancer, susceptibility to}, 114480 (3);chr15;RAD51A, RECA, MRMV2, FANCR;True
ENSG00000128917;Delta-like 4;NotRelevant;;Adams-Oliver syndrome 6, 616589 (3), Autosomal dominantAdams-Oliver syndrome 6, 616589 (3);chr15;DLL4, AOS6;True
ENSG00000137806;NADH-ubiquinone oxidoreductase 1 alpha subcomplex, assembly factor 1;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 11, 618234 (3)Mitochondrial complex I deficiency, nuclear type 11, 618234 (3);chr15;NDUFAF1, CIA30, CGI65, MC1DN11;False
ENSG00000137802;Mitogen-activated protein kinase-binding protein 1;NotRelevant;;Nephronophthisis 20, 617271 (3), Autosomal recessiveNephronophthisis 20, 617271 (3);chr15;MAPKBP1, JNKBP1, NPHP20;True
ENSG00000092529;Calpain, large polypeptide L3;NotRelevant;;Muscular dystrophy, limb-girdle, autosomal dominant 4, 618129 (3), Autosomal dominantMuscular dystrophy, limb-girdle, autosomal recessive 1, 253600 (3);chr15;CAPN3, CANP3, LGMDR1, LGMDD4;True
ENSG00000140326;Codanin 1;NotRelevant;;Dyserythropoietic anemia, congenital, type Ia, 224120 (3), Autosomal recessiveDyserythropoietic anemia, congenital, type Ia, 224120 (3);chr15;CDAN1, CDA1, CDAN1A;True
ENSG00000128881;Tau tubulin kinase 2;NotRelevant;;Spinocerebellar ataxia 11, 604432 (3), Autosomal dominantSpinocerebellar ataxia 11, 604432 (3);chr15;TTBK2, SCA11;True
ENSG00000159459;Ubiquitin-protein ligase E3-alpha;NotRelevant;;Johanson-Blizzard syndrome, 243800 (3), Autosomal recessiveJohanson-Blizzard syndrome, 243800 (3);chr15;UBR1, JBS;True
ENSG00000166947;Erythrocyte surface protein band 4.2;NotRelevant;;Spherocytosis, type 5, 612690 (3)Spherocytosis, type 5, 612690 (3);chr15;EPB42, SPH5;False
ENSG00000104055;Transglutaminase 5;NotRelevant;;Peeling skin syndrome 2, 609796 (3), Autosomal recessivePeeling skin syndrome 2, 609796 (3);chr15;TGM5, TGX, PSS2;True
ENSG00000137822;Tubulin-gamma complex-associated protein 4;NotRelevant;;Microcephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3), Autosomal recessiveMicrocephaly and chorioretinopathy, autosomal recessive, 3, 616335 (3);chr15;TUBGCP4, GCP4, MCCRP3;True
ENSG00000242866;Stereocilin;NotRelevant;;Deafness, autosomal recessive 16, 603720 (3), Autosomal recessiveDeafness, autosomal recessive 16, 603720 (3);chr15;STRC, DFNB16;True
ENSG00000104133;Spastascin;NotRelevant;;Amyotrophic lateral sclerosis 5, juvenile, 602099 (3), Autosomal recessiveSpastic paraplegia 11, autosomal recessive, 604360 (3);chr15;SPG11, KIAA1840, FLJ21439, ALS5, CMT2X;True
ENSG00000229474;Protein associated with topoisomerase II, S. Cerevisiae, homolog of;NotRelevant;;Oocyte maturation defect 4, 617743 (3), Autosomal recessiveOocyte maturation defect 4, 617743 (3);chr15;PATL2, PAT1A, OOMD4;True
ENSG00000166710;Beta-2-microglobulin;NotRelevant;mutation identified in 1 FVA family;?Amyloidosis, familial visceral, 105200 (3), Autosomal dominantImmunodeficiency 43, 241600 (3);chr15;B2M, IMD43;True
ENSG00000140263;Sorbitol dehydrogenase;NotRelevant;;?Cataract, congenital, 182500 (2)?Cataract, congenital (2);chr15;SORD, SORD1;False
ENSG00000140279;Dual oxidase 2 (thyroid oxidase 2);NotRelevant;;Thyroid dyshormonogenesis 6, 607200 (3), Autosomal recessiveThyroid dyshormonogenesis 6, 607200 (3);chr15;DUOX2, THOX2, TDH6;True
ENSG00000140274;Dual oxidase maturation factor 2;NotRelevant;head-to-head with DUOX2;Thyroid dyshormonogenesis 5, 274900 (3), Autosomal recessiveThyroid dyshormonogenesis 5, 274900 (3);chr15;DUOXA2, TDH5;True
ENSG00000171766;L-arginine:glycine amidinotransferase;NotRelevant;;Cerebral creatine deficiency syndrome 3, 612718 (3), Autosomal recessiveCerebral creatine deficiency syndrome 3, 612718 (3);chr15;GATM, AGAT, CCDS3;True
ENSG00000104164;Biogenesis of lysosome-related organelles complex 1, subunit 6;NotRelevant;mutation identified in 1 HPS9 patient;?Hermansky-pudlak syndrome 9, 614171 (3), Autosomal recessive?Hermansky-pudlak syndrome 9, 614171 (3);chr15;BLOC1S6, BLOS6, PLDN, PA, HPS9;True
ENSG00000188467;Solute carrier family 24 (sodium/potassium/calcium exchanger), member 5;NotRelevant;;Albinism, oculocutaneous, type VI, 113750 (3), Autosomal recessive[Skin/hair/eye pigmentation 4, fair/dark skin], 113750 (3);chr15;SLC24A5, NCKX5, SHEP4, OCA6;True
ENSG00000074803;Solute carrier family 12 (sodium/potassium/chloride transporters), member 1;NotRelevant;;Bartter syndrome, type 1, 601678 (3), Autosomal recessiveBartter syndrome, type 1, 601678 (3);chr15;SLC12A1, NKCC2;True
ENSG00000166147;Fibrillin-1;NotRelevant;;Acromicric dysplasia, 102370 (3), Autosomal dominantWeill-Marchesani syndrome 2, dominant, 608328 (3);chr15;FBN1, MFS1, WMS2, SSKS, GPHYSD2, ACMICD, ECTOL1, MFLS;True
ENSG00000103995;Centrosomal protein, 152kD;NotRelevant;;Microcephaly 9, primary, autosomal recessive, 614852 (3), Autosomal recessiveSeckel syndrome 5, 613823 (3);chr15;CEP152, KIAA0912, MCPH9, SCKL5;True
ENSG00000140287;Histidine decarboxylase;NotRelevant;;{Gilles de la Tourette syndrome, susceptibility to}, 137580 (3), Autosomal dominant{Gilles de la Tourette syndrome, susceptibility to}, 137580 (3);chr15;HDC;True
ENSG00000138592;Ubiquitin-specific protease 8;NotRelevant;;Pituitary adenoma 4, ACTH-secreting, somatic, 219090 (3)Pituitary adenoma 4, ACTH-secreting, somatic, 219090 (3);chr15;USP8, HUMORF8, PITA4;False
ENSG00000092439;Transient receptor potential cation channel, subfamily M, member 7;NotRelevant;;{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3), Autosomal dominant{Amyotrophic lateral sclerosis-parkinsonism/dementia complex, susceptibility to}, 105500 (3);chr15;TRPM7, LTRPC7, CHAK, ALSPDC;True
ENSG00000081014;Adaptor-related protein complex 4, epsilon-1 subunit;NotRelevant;;Spastic paraplegia 51, autosomal recessive, 613744 (3), Autosomal recessiveStuttering, familial persistent, 1, 184450 (3);chr15;AP4E1, SPG51, CPSQ4, STUT1;True
ENSG00000137869;Cytochrome P450, family 19, subfamily A, polypeptide 1 (aromatization of androgens);NotRelevant;close to CYP11 in mouse;Aromatase deficiency, 613546 (3)Aromatase excess syndrome, 139300 (3);chr15;CYP19A1, CYP19, ARO;False
ENSG00000186417;Gliomedin;NotRelevant;;Lethal congenital contracture syndrome 11, 617194 (3), Autosomal recessiveLethal congenital contracture syndrome 11, 617194 (3);chr15;GLDN, CRGL2, LCCS11;True
ENSG00000104093;DMX-like 2;NotRelevant;mutation identified in 1 PEPNS family and 1 DFNA71 family;?Deafness, autosomal dominant 71, 617605 (3), Autosomal dominant?Polyendocrine-polyneuropathy syndrome, 616113 (3);chr15;DMXL2, RC3, KIAA0856, PEPNS, DFNA71;True
ENSG00000069966;Guanine nucleotide-binding protein, beta-5;NotRelevant;;Intellectual developmental disorder with cardiac arrhythmia, 617173 (3), Autosomal recessiveLanguage delay and ADHD/cognitive impairment with or without cardiac arrhythmia, 617182 (3);chr15;GNB5, GB5, IDDCA, LADCI;True
ENSG00000197535;Myosin Va;NotRelevant;;Griscelli syndrome, type 1, 214450 (3), Autosomal recessiveGriscelli syndrome, type 1, 214450 (3);chr15;MYO5A, MYH12, GS1;True
ENSG00000166415;WD repeat-containing protein 72;NotRelevant;;Amelogenesis imperfecta, type IIA3, 613211 (3), Autosomal recessiveAmelogenesis imperfecta, type IIA3, 613211 (3);chr15;WDR72, AI2A3;True
ENSG00000069974;Ras-associated protein RAB27A;NotRelevant;;Griscelli syndrome, type 2, 607624 (3), Autosomal recessiveGriscelli syndrome, type 2, 607624 (3);chr15;RAB27A, RAM, GS2;True
ENSG00000256061;Dynein, axonemal, assembly factor 4;NotRelevant;not confirmed by some studies;Ciliary dyskinesia, primary, 25, 615482 (3), Autosomal recessive{Dyslexia, susceptibility to, 1}, 127700 (3);chr15;DNAAF4, DYX1C1, DYXC1, DYX1, CILD25;True
ENSG00000140262;Transcription factor-12 (HTF4, helix-loop-helix transcription factors-4);NotRelevant;;Craniosynostosis 3, 615314 (3), Autosomal dominantCraniosynostosis 3, 615314 (3);chr15;TCF12, HTF4, CRS3;True
ENSG00000166035;Lipase C, hepatic;NotRelevant;;{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent}, 125853 (3);chr15;LIPC, HL, LIPH, HDLCQ12;True
ENSG00000137845;A disintegrin and metalloprotease domain 10;NotRelevant;;{Alzheimer disease 18, susceptibility to}, 615590 (3){Alzheimer disease 18, susceptibility to}, 615590 (3);chr15;ADAM10, MADM, RAK, AD18;False
ENSG00000157483;Myosin IE;NotRelevant;;Glomerulosclerosis, focal segmental, 6, 614131 (3), Autosomal recessiveGlomerulosclerosis, focal segmental, 6, 614131 (3);chr15;MYO1E, MYO1C, FSGS6;True
ENSG00000182718;Annexin A2 (lipocortin I);NotRelevant;pseudogenes ANX2P1 on 4q21-q31; ANX2P2 on 9p13;chr15;ANXA2, ANX2L4, LPC2D, LIP2;False
ENSG00000069667;RAR-related orphan receptor A;NotRelevant;;Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, 618060 (3), Autosomal dominantIntellectual developmental disorder with or without epilepsy or cerebellar ataxia, 618060 (3);chr15;RORA, IDDECA;True
ENSG00000129003;Vacuolar protein sorting 13, yeast, homolog of, C;NotRelevant;;Parkinson disease 23, autosomal recessive, early onset, 616840 (3), Autosomal recessiveParkinson disease 23, autosomal recessive, early onset, 616840 (3);chr15;VPS13C, KIAA1421, PARK23;True
ENSG00000140416;Tropomyosin 1, alpha;NotRelevant;;Cardiomyopathy, dilated, 1Y, 611878 (3), Autosomal dominantLeft ventricular noncompaction 9, 611878 (3);chr15;TPM1, CMH3, CMD1Y , LVNC9;True
ENSG00000074410;Carbonic anhydrase XII;NotRelevant;;Hyperchlorhidrosis, isolated, 143860 (3), Autosomal recessiveHyperchlorhidrosis, isolated, 143860 (3);chr15;CA12;True
ENSG00000103657;HECT domain and RCC1-like domain 1;NotRelevant;;Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3), Autosomal recessiveMacrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3);chr15;HERC1, MDFPMR;True
ENSG00000166794;Peptidyl-prolyl isomerase B;NotRelevant;;Osteogenesis imperfecta, type IX, 259440 (3), Autosomal recessiveOsteogenesis imperfecta, type IX, 259440 (3);chr15;PPIB, CYPB, OI9;True
ENSG00000103671;Thyroid hormone receptor interactor 4;NotRelevant;mutation identified in 1 MDCDC family;?Muscular dystrophy, congenital, Davignon-Chauveau type, 617066 (3), Autosomal recessiveSpinal muscular atrophy with congenital bone fractures 1, 616866 (3);chr15;TRIP4, ASC1, SMABF1, MDCDC;True
ENSG00000090487;Acidic cluster protein, 33kD, (maspardin);NotRelevant;;Mast syndrome, 248900 (3), Autosomal recessiveMast syndrome, 248900 (3);chr15;ACP33, MAST, SPG21;True
ENSG00000103707;Mitochondrial methionyl-tRNA formyltransferase;NotRelevant;;Combined oxidative phosphorylation deficiency 15, 614947 (3), Autosomal recessiveMitochondrial complex I deficiency, nuclear type 27, 618248 (3);chr15;MTFMT, COXPD15, MC1DN27;True
ENSG00000234438;Kelch repeat and BTB/POZ domains-containing protein 13;NotRelevant;;Nemaline myopathy 6, autosomal dominant, 609273 (3), Autosomal dominantNemaline myopathy 6, autosomal dominant, 609273 (3);chr15;KBTBD13, NEM6;True
ENSG00000166855;Caseinolytic mitochondrial matrix peptidase chaperone subunit;NotRelevant;mutation identified in 1 EPP2 family;?Protoporphyria, erythropoietic, 2, 618015 (3), Autosomal dominant?Protoporphyria, erythropoietic, 2, 618015 (3);chr15;CLPX, EPP2;True
ENSG00000138615;Cartilage intermediate layer protein;NotRelevant;;{Lumbar disc disease, susceptibility to}, 603932 (3){Lumbar disc disease, susceptibility to}, 603932 (3);chr15;CILP;False
ENSG00000074621;Solute carrier family 24 (sodium/potassium/calcium exchanger), member 1;NotRelevant;;Night blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3), Autosomal recessiveNight blindness, congenital stationary (complete), 1D, autosomal recessive, 613830 (3);chr15;SLC24A1, NCKX1, CSNB1D;True
ENSG00000169032;Mitogen-activated protein kinase kinase 1;NotRelevant;pseudogene on 8p21;Cardiofaciocutaneous syndrome 3, 615279 (3)Cardiofaciocutaneous syndrome 3, 615279 (3);chr15;MAP2K1, PRKMK1, MKK1, MEK1, CFC3;False
ENSG00000137834;Mothers against decapentaplegic, Drosophila, homolog of, 6;NotRelevant;;Aortic valve disease 2, 614823 (3), Autosomal dominant{Craniosynostosis 7, susceptibility to}, 617439 (3);chr15;SMAD6, MADH6, AOVD2;True
ENSG00000166949;Mothers against decapentaplegic, Drosophila, homolog of, 3;NotRelevant;;Loeys-Dietz syndrome 3, 613795 (3), Autosomal dominantLoeys-Dietz syndrome 3, 613795 (3);chr15;SMAD3, MADH3, LDS3;True
ENSG00000103591;Alpha- and gamma-adaptin-binding protein;NotRelevant;;Keratoderma, palmoplantar, punctate type IA, 148600 (3), Autosomal dominantKeratoderma, palmoplantar, punctate type IA, 148600 (3);chr15;AAGAB, p34, PPKP1A, PPKP1, KPPP1;True
ENSG00000128973;CLN6 gene;NotRelevant;;Ceroid lipofuscinosis, neuronal, 6, 601780 (3), Autosomal recessiveCeroid lipofuscinosis, neuronal, Kufs type, adult onset, 204300 (3);chr15;CLN6, CLN4A;True
ENSG00000278570;Nuclear receptor subfamily 2, group E, member 3;NotRelevant;near BBS4;Enhanced S-cone syndrome, 268100 (3), Autosomal recessiveRetinitis pigmentosa 37, 611131 (3);chr15;NR2E3, PNR, ESCS, RP37;True
ENSG00000066933;Myosin IXa;NotRelevant;;Myasthenic syndrome, congenital, 24, presynaptic, 618198 (3), Autosomal recessiveMyasthenic syndrome, congenital, 24, presynaptic, 618198 (3);chr15;MYO9A, CMS24;True
ENSG00000213614;Hexosaminidase A, alpha polypeptide;NotRelevant;on 15q+ in APL;GM2-gangliosidosis, several forms, 272800 (3), Autosomal recessive[Hex A pseudodeficiency], 272800 (3);chr15;HEXA, TSD;True
ENSG00000140463;BBS4 gene;NotRelevant;;Bardet-Biedl syndrome 4, 615982 (3), Autosomal recessiveBardet-Biedl syndrome 4, 615982 (3);chr15;BBS4;True
ENSG00000138622;Hyperpolarization-activated cyclic nucleotide-gated potassium channel 4;NotRelevant;;Brugada syndrome 8, 613123 (3)Sick sinus syndrome 2, 163800 (3);chr15;HCN4, SSS2;False
ENSG00000129038;Lysyl oxidase-like 1;NotRelevant;;{Exfoliation syndrome, susceptibility to}, 177650 (3), Autosomal dominant{Exfoliation syndrome, susceptibility to}, 177650 (3);chr15;LOXL1, LOXL;True
ENSG00000140464;Promyelocytic leukemia, inducer of;NotRelevant;fused with RARA in APL;Leukemia, acute promyelocytic, PML/RARA type (3)Leukemia, acute promyelocytic, PML/RARA type (3);chr15;PML, MYL;False
ENSG00000137868;Stimulated by retinoic acid 6, mouse, homolog of;NotRelevant;;Microphthalmia, isolated, with coloboma 8, 601186 (3), Autosomal recessiveMicrophthalmia, syndromic 9, 601186 (3);chr15;STRA6, MCOPS9, MCOPCB8;True
ENSG00000140459;Cytochrome P450, subfamily XIA, polypeptide 1 (cholesterol side chain cleavage enzyme);NotRelevant;;Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3)Adrenal insufficiency, congenital, with 46XY sex reversal, partial or complete, 613743 (3);chr15;CYP11A1, P450SCC;False
ENSG00000138623;Semaphorin 7A;NotRelevant;;[Blood group, John-Milton-Hagen system], 614745 (3)[Blood group, John-Milton-Hagen system], 614745 (3);chr15;SEMA7A, SEMAL, SEMAK1, CDW108, JMH;False
ENSG00000179151;Enhancer of mRNA decapping 3, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 MRT50 family;?Mental retardation, autosomal recessive 50, 616460 (3), Autosomal recessive?Mental retardation, autosomal recessive 50, 616460 (3);chr15;EDC3, YJDC, MRT50;True
ENSG00000178802;Mannosephosphate isomerase (phosphomannose isomerase 1);NotRelevant;;Congenital disorder of glycosylation, type Ib, 602579 (3), Autosomal recessiveCongenital disorder of glycosylation, type Ib, 602579 (3);chr15;MPI, PMI1, CDG1B;True
ENSG00000169375;Sin3, yeast, homolog of, A;NotRelevant;;Witteveen-Kolk syndrome, 613406 (3), Autosomal dominantWitteveen-Kolk syndrome, 613406 (3);chr15;SIN3A, WITKOS;True
ENSG00000140374;Electron transfer flavoprotein, alpha polypeptide;NotRelevant;;Glutaric acidemia IIA, 231680 (3), Autosomal recessiveGlutaric acidemia IIA, 231680 (3);chr15;ETFA, GA2, MADD;True
ENSG00000140386;S-phase cyclin A-associated protein in the endoplasmic reticulum;NotRelevant;;Intellectual developmental disorder and retinitis pigmentosa, 618195 (3), Autosomal recessiveIntellectual developmental disorder and retinitis pigmentosa, 618195 (3);chr15;SCAPER, KIAA1454, IDDRP;True
ENSG00000140368;Proline-serine-threonine phosphatase-interacting protein 1;NotRelevant;;Pyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3), Autosomal dominantPyogenic sterile arthritis, pyoderma gangrenosum, and acne, 604416 (3);chr15;PSTPIP1, PSTPIP, CD2BP1, PAPAS;True
ENSG00000169783;Leucine-rich repeat- and Ig domain-containing NOGO receptor-interacting protein 1;NotRelevant;;Mental retardation, autosomal recessive 64, 618103 (3), Autosomal recessiveMental retardation, autosomal recessive 64, 618103 (3);chr15;LINGO1, LRRN6A, LERN1, MRT64;True
ENSG00000136425;Calcium- and integrin-binding protein 2;NotRelevant;;Deafness, autosomal recessive 48, 609439 (3), Autosomal recessiveUsher syndrome, type IJ, 614869 (3);chr15;CIB2, KIP2;True
ENSG00000169684;Cholinergic receptor, neuronal nicotinic, alpha polypeptide-5;NotRelevant;;{Lung cancer susceptibility 2}, 612052 (3){Nicotine dependence, susceptibility to}, 612052 (3);chr15;CHRNA5, LNCR2;False
ENSG00000080644;Cholinergic receptor, neuronal nicotinic, alpha polypeptide-3;NotRelevant;;{Lung cancer susceptibility 2}, 612052 (3){Lung cancer susceptibility 2}, 612052 (3);chr15;CHRNA3, LNCR2, PAOD2;False
ENSG00000207695;Micro RNA 184;NotRelevant;;EDICT syndrome, 614303 (3), Autosomal dominantEDICT syndrome, 614303 (3);chr15;MIR184, MIRN184, KTCNCT, EDICT;True
ENSG00000103876;Fumarylacetoacetase;NotRelevant;;Tyrosinemia, type I, 276700 (3), Autosomal recessiveTyrosinemia, type I, 276700 (3);chr15;FAH;True
ENSG00000172379;Aryl hydrocarbon receptor nuclear translocator 2;NotRelevant;mutation identified in 1 WEDAS family;?Webb-Dattani syndrome, 615926 (3), Autosomal recessive?Webb-Dattani syndrome, 615926 (3);chr15;ARNT2, WEDAS;True
ENSG00000140598;Elongation factor-like GTPase 1;NotRelevant;;Shwachman-Diamond syndrome 2, 617941 (3), Autosomal recessiveShwachman-Diamond syndrome 2, 617941 (3);chr15;EFL1, RIA1, EFTUD1, FAM42A, SDS2;True
ENSG00000182774;Ribosomal protein S17;NotRelevant;previously on chr.11; pseudogenes on 5q33-qter and 17qDiamond-Blackfan anemia 4, 612527 (3);chr15;RPS17, RPS17L1, RPS17L2, DBA4;False
ENSG00000103723;Adaptor-related protein complex 3, beta 2 subunit;NotRelevant;;Epileptic encephalopathy, early infantile, 48, 617276 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 48, 617276 (3);chr15;AP3B2, NAPTB, EIEE48;True
ENSG00000103942;Homer, homolog 2 (Drosophila);NotRelevant;mutation identified in 1 DFNA68 family;?Deafness, autosomal dominant 68, 616707 (3), Autosomal dominant?Deafness, autosomal dominant 68, 616707 (3);chr15;HOMER2, HOMER2B, HOMER2A, DFNA68;True
ENSG00000177082;WD repeat-containing protein 73;NotRelevant;;Galloway-Mowat syndrome 1, 251300 (3), Autosomal recessiveGalloway-Mowat syndrome 1, 251300 (3);chr15;WDR73, HSPC264, GAMOS1;True
ENSG00000136383;Alpha kinase 3;NotRelevant;;Cardiomyopathy, familial hypertrophic 27, 618052 (3), Autosomal recessiveCardiomyopathy, familial hypertrophic 27, 618052 (3);chr15;ALPK3, MIDORI, KIAA1330, CMH27;True
ENSG00000273540;ATP/GTP-binding protein-like 1;NotRelevant;;Corneal dystrophy, Fuchs endothelial, 8, 615523 (3), Autosomal dominantCorneal dystrophy, Fuchs endothelial, 8, 615523 (3);chr15;AGBL1, CCP4, FECD8;True
ENSG00000157766;Aggrecan (chondroitin sulfate proteoglycan-1, large aggregating proteoglycan, antigen identifies by monoclonal antibody A0122);NotRelevant;mutation identified in 1 SEDK family and 1 SEMDAG family;Short stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3), Autosomal dominantShort stature and advanced bone age, with or without early-onset osteoarthritis and/or osteochondritis dissecans, 165800 (3);chr15;ACAN, AGC1, CSPG1, MSK16, SEDK, SSOAOD;True
ENSG00000140522;Retinaldehyde-binding protein-1, cellular;NotRelevant;;Bothnia retinal dystrophy, 607475 (3), Autosomal recessiveRetinitis punctata albescens, 136880 (3);chr15;RLBP1;True
ENSG00000140525;FANCI gene;NotRelevant;;Fanconi anemia, complementation group I, 609053 (3), Autosomal recessiveFanconi anemia, complementation group I, 609053 (3);chr15;FANCI, KIAA1794;True
ENSG00000140521;Polymerase (DNA directed), gamma;NotRelevant;PEO also digenic with C10orf2;Mitochondrial DNA depletion syndrome 4A (Alpers type), 203700 (3), Autosomal recessiveProgressive external ophthalmoplegia, autosomal recessive 1, 258450 (3);chr15;POLG, POLG1, POLGA, PEO, SANDO, SCAE, MTDPS4A, MTDPS4B, MIRAS;True
ENSG00000166813;Kinesin family member 7;NotRelevant;mutation identified in 1 HLS2 family and 1 AGBK family;Acrocallosal syndrome, 200990 (3), Autosomal recessiveJoubert syndrome 12, 200990 (3);chr15;KIF7, HLS2, ACLS, JBTS12, AGBK;True
ENSG00000166819;Perilipin 1;NotRelevant;;Lipodystrophy, familial partial, type 4, 613877 (3), Autosomal dominantLipodystrophy, familial partial, type 4, 613877 (3);chr15;PLIN1, PLIN, FPLD4;True
ENSG00000188095;Mesoderm posterior bHLH transcription factor 2;NotRelevant;;Spondylocostal dysostosis 2, autosomal recessive, 608681 (3)Spondylocostal dysostosis 2, autosomal recessive, 608681 (3);chr15;MESP2, SCDO2;True
ENSG00000182054;Isocitrate dehydrogenase, mitochondrial;NotRelevant;;D-2-hydroxyglutaric aciduria 2, 613657 (3)D-2-hydroxyglutaric aciduria 2, 613657 (3);chr15;IDH2, IDPM, D2HGA2;False
ENSG00000185043;Calcium- and integrin-binding protein 1;NotRelevant;;Epidermodysplasia verruciformis 3, 618267 (3), Autosomal recessiveEpidermodysplasia verruciformis 3, 618267 (3);chr15;CIB1, KIP;True
ENSG00000197299;DNA helicase, RecQ-like 3;NotRelevant;;Bloom syndrome, 210900 (3), Autosomal recessiveBloom syndrome, 210900 (3);chr15;RECQL3, RECQ2, BLM, BS, MGRISCE1;True
ENSG00000184056;Vacuolar protein sorting 33, yeast, homolog of, B;NotRelevant;;Arthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3), Autosomal recessiveArthrogryposis, renal dysfunction, and cholestasis 1, 208085 (3);chr15;VPS33B;True
ENSG00000173575;Chromodomain helicase DNA binding protein-2;NotRelevant;;Epileptic encephalopathy, childhood-onset, 615369 (3), Autosomal dominantEpileptic encephalopathy, childhood-onset, 615369 (3);chr15;CHD2, EEOC;True
ENSG00000185551;Nuclear receptor subfamily 2, group F, member 2 (transcription factor COUP 2);NotRelevant;;Congenital heart defects, multiple types, 4, 615779 (3), Autosomal dominantCongenital heart defects, multiple types, 4, 615779 (3);chr15;NR2F2, TFCOUP2, ARP1, CHTD4;True
ENSG00000140443;Insulin-like growth factor-1 receptor;NotRelevant;;Insulin-like growth factor I, resistance to, 270450 (3), Autosomal recessive, Autosomal dominantInsulin-like growth factor I, resistance to, 270450 (3);chr15;IGF1R;True
ENSG00000068305;MADS box transcription enhancer factor 2, polypeptide A (myocyte enhancer factor 2A);NotRelevant;;{Coronary artery disease, autosomal dominant, 1}, 608320 (3), Autosomal dominant{Coronary artery disease, autosomal dominant, 1}, 608320 (3);chr15;MEF2A, ADCAD1;True
ENSG00000140470;A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 17;NotRelevant;;Weill-Marchesani 4 syndrome, recessive, 613195 (3), Autosomal recessiveWeill-Marchesani 4 syndrome, recessive, 613195 (3);chr15;ADAMTS17, WMS4;True
ENSG00000154227;Ceramide synthase 3;NotRelevant;;Ichthyosis, congenital, autosomal recessive 9, 615023 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 9, 615023 (3);chr15;CERS3, LASS3, ARCI9;True
ENSG00000140471;Lines, Drosophila, homolog of, 1;NotRelevant;;Mental retardation, autosomal recessive 27, 614340 (3), Autosomal recessiveMental retardation, autosomal recessive 27, 614340 (3);chr15;LINS1, WINS1, FLJ10583, MRT27;True
ENSG00000184254;Aldehyde dehydrogenase 1 family, member A3;NotRelevant;;Microphthalmia, isolated 8, 615113 (3), Autosomal recessiveMicrophthalmia, isolated 8, 615113 (3);chr15;ALDH1A3, ALDH6, MCOP8;True
ENSG00000131873;Carbohydrate synthase 1;NotRelevant;;Temtamy preaxial brachydactyly syndrome, 605282 (3), Autosomal recessiveTemtamy preaxial brachydactyly syndrome, 605282 (3);chr15;CHSY1, KIAA0990, TPBS;True
ENSG00000103148;Nitrogen permease regulator-like 3;NotRelevant;;Epilepsy, familial focal, with variable foci 3, 617118 (3), Autosomal dominantEpilepsy, familial focal, with variable foci 3, 617118 (3);chr16;NPRL3, CGTHBA, FFEVF3;True
ENSG00000188536;Hemoglobin alpha-2;NotRelevant;;Erythrocytosis 7, 617981 (3)Thalassemia, alpha-, 604131 (3);chr16;HBA2, HBH, ECYT7;False
ENSG00000206172;Hemoglobin alpha-1;NotRelevant;1, 2, or 3 loci; 5'-zeta-pseudozeta-pseudoalpha-alpha-2-alpha-1-3'Thalassemias, alpha-, 604131 (3);chr16;HBA1, HBH, METHBA, ECYT7;False
ENSG00000103126;Axis inhibitor 1;NotRelevant;hypermethylation of AXIN1 promoter seen in 1 CDUP patient;?Caudal duplication anomaly, 607864 (3)Hepatocellular carcinoma, somatic, 114550 (3);chr16;AXIN1, AXIN;False
ENSG00000103266;STIP1 homologous and U box-containing protein 1;NotRelevant;mutation identified in 1 SCA48 family;?Spinocerebellar ataxia 48, 618093 (3), Autosomal dominantSpinocerebellar ataxia, autosomal recessive 16, 615768 (3);chr16;STUB1, CHIP, SCAR16, SCA48;True
ENSG00000162004;Coiled-coil domain-containing protein 78;NotRelevant;mutation identified in 1 CNM4 family;?Centronuclear myopathy 4, 614807 (3), Autosomal dominant?Centronuclear myopathy 4, 614807 (3);chr16;CCDC78, C16orf25, CNM4;True
ENSG00000103227;Lipase maturation factor 1;NotRelevant;;Lipase deficiency, combined, 246650 (3), Autosomal recessiveLipase deficiency, combined, 246650 (3);chr16;LMF1, TMEM112;True
ENSG00000162009;Somatostatin receptor-5;NotRelevant;;Somatostatin analog, resistance to (3)Somatostatin analog, resistance to (3);chr16;SSTR5;False
ENSG00000196557;Calcium channel, voltage-dependent, T type, alpha-1H subunit;NotRelevant;;{Epilepsy, childhood absence, susceptibility to, 6}, 611942 (3){Epilepsy, idiopathic generalized, susceptibility to, 6}, 611942 (3);chr16;CACNA1H, EIG6, ECA6, HALD4;False
ENSG00000090581;N-acetylglucosamine-1-phosphotransferase, gamma subunit;NotRelevant;;Mucolipidosis III gamma, 252605 (3), Autosomal recessiveMucolipidosis III gamma, 252605 (3);chr16;GNPTAG;True
ENSG00000103249;Chloride channel-7;NotRelevant;;Osteopetrosis, autosomal dominant 2, 166600 (3), Autosomal dominantOsteopetrosis, autosomal recessive 4, 611490 (3);chr16;CLCN7, CLC7, OPTA2, OPTB4;True
ENSG00000100726;Telomere maintenance 2, S. cerevisiae, homolog of;NotRelevant;;You-Hoover-Fong syndrome, 616954 (3), Autosomal recessiveYou-Hoover-Fong syndrome, 616954 (3);chr16;TELO2, TEL2, CLK2, KIAA0683, HCLK2, YHFS;True
ENSG00000187535;Intraflagellar transport 140, Chlamydomonas, homolog of;NotRelevant;;Retinitis pigmentosa 80, 617781 (3), Autosomal recessiveShort-rib thoracic dysplasia 9 with or without polydactyly, 266920 (3);chr16;IFT140, KIAA0590, SRTD9, MZSDS, RP80;True
ENSG00000074071;Mitochondrial ribosomal protein S34;NotRelevant;;Combined oxidative phosphorylation deficiency 32, 617664 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 32, 617664 (3);chr16;MRPS34, MRPS12, COXPD32;True
ENSG00000099769;Insulin-like growth factor-binding protein, acid-labile subunit;NotRelevant;;Acid-labile subunit, deficiency of, 615961 (3)Acid-labile subunit, deficiency of, 615961 (3);chr16;IGFALS, ALS, ACLSD;False
ENSG00000063854;Hydroxyacyl glutathione hydrolase;NotRelevant;ENSG00000063854;[Glyoxalase II deficiency], 614033 (1);chr16;HAGH, GLO2;False
ENSG00000162039;Meiosis-specific protein with OB domains;NotRelevant;mutation identified in one SPGF22 family;?Spermatogenic failure 22, 617706 (3), Autosomal recessive?Spermatogenic failure 22, 617706 (3);chr16;MEIOB, SPGF22;True
ENSG00000127554;Growth factor, erv1, S. cerevisiae, homolog of (augmenter of liver regeneration);NotRelevant;;Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3)Myopathy, mitochondrial progressive, with congenital cataract, hearing loss, and developmental delay, 613076 (3);chr16;GFER, ERV1, ALR;False
ENSG00000065057;Endonuclease III, E. coli, homolog of;NotRelevant;;Familial adenomatous polyposis 3, 616415 (3), Autosomal recessiveFamilial adenomatous polyposis 3, 616415 (3);chr16;NTHL1, OCTS3, FAP3;True
ENSG00000103197;Tuberin (tuberous sclerosis 2 gene);NotRelevant;somatic mutation identified in 1 FCORD2 patient;?Focal cortical dysplasia, type II, somatic, 607341 (3)Tuberous sclerosis-2, 613254 (3);chr16;TSC2, LAM;False
ENSG00000008710;Polycystin-1;NotRelevant;;Polycystic kidney disease 1, 173900 (3), Autosomal dominantPolycystic kidney disease 1, 173900 (3);chr16;PKD1;True
ENSG00000131653;TNF receptor-associated factor 7;NotRelevant;;Cardiac, facial, and digital anomalies with developmental delay, 618164 (3), Autosomal dominantCardiac, facial, and digital anomalies with developmental delay, 618164 (3);chr16;TRAF7, RFWD1, CAFDADD;True
ENSG00000167972;ATP-binding cassette-3;NotRelevant;;Surfactant metabolism dysfunction, pulmonary, 3, 610921 (3), Autosomal recessiveSurfactant metabolism dysfunction, pulmonary, 3, 610921 (3);chr16;ABCA3, ABC3, SMDP3;True
ENSG00000162065;TBC1 domain family, member 24;NotRelevant;;DOORS syndrome, 220500 (3), Autosomal recessiveMyoclonic epilepsy, infantile, familial, 605021 (3);chr16;TBC1D24, KIAA1171, FIME, EIEE16, DOORS, DFNB86, DFNA65;True
ENSG00000131652;THO complex subunit 6;NotRelevant;;Beaulieu-Boycott-Innes syndrome, 613680 (3), Autosomal recessiveBeaulieu-Boycott-Innes syndrome, 613680 (3);chr16;THOC6, FSAP35, BBIS;True
ENSG00000103313;Pyrin (marenostrin);NotRelevant;between D16S80 and D16S283;Familial Mediterranean fever, AD, 134610 (3), Autosomal dominantFamilial Mediterranean fever, AR, 249100 (3);chr16;MEFV, MEF, FMF;True
ENSG00000188827;Slx4, S. cerevisiae, homolog of;NotRelevant;;Fanconi anemia, complementation group P, 613951 (3), Autosomal recessiveFanconi anemia, complementation group P, 613951 (3);chr16;SLX4, BTBD12, MUS312, KIAA1784, KIAA1987, FANCP;True
ENSG00000213918;Deoxyribonuclease I;NotRelevant;;{Systemic lupus erythematosus, susceptibility to}, 152700 (3), Autosomal dominant{Systemic lupus erythematosus, susceptibility to}, 152700 (3);chr16;DNASE1, DNL1;True
ENSG00000005339;CREB binding protein;NotRelevant;fusion partner with MORF in AML; fusion partner with MLL in therapy-related acute leukemiaRubinstein-Taybi syndrome 1, 180849 (3);chr16;CREBBP, CBP, RSTS1;False
ENSG00000126603;GLIS family zinc finger protein 2;NotRelevant;;Nephronophthisis 7, 611498 (3)Nephronophthisis 7, 611498 (3);chr16;GLIS2, NPHP7;False
ENSG00000217930;Presequence translocase-associated motor 16, S. cerevisiae, homolog of;NotRelevant;;Spondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3), Autosomal recessiveSpondylometaphyseal dysplasia, Megarbane-Dagher-Melike type, 613320 (3);chr16;PAM16, MAGMAS, SMDMDM;True
ENSG00000140623;Septin 12;NotRelevant;;Spermatogenic failure 10, 614822 (3), Autosomal dominantSpermatogenic failure 10, 614822 (3);chr16;SEPT12, SPGF10;True
ENSG00000067836;Rogdi, Drosophila, homolog of;NotRelevant;;Kohlschutter-Tonz syndrome, 226750 (3), Autosomal recessiveKohlschutter-Tonz syndrome, 226750 (3);chr16;ROGDI, KTZS;True
ENSG00000033011;Alg1, yeast, homolog of (beta-1,4 mannosyltransferase);NotRelevant;;Congenital disorder of glycosylation, type Ik, 608540 (3), Autosomal recessiveCongenital disorder of glycosylation, type Ik, 608540 (3);chr16;ALG1, HMAT1, HMT1, CDG1K;True
ENSG00000183044;4-aminobutyrate aminotransferase;NotRelevant;;GABA-transaminase deficiency, 613163 (3), Autosomal recessiveGABA-transaminase deficiency, 613163 (3);chr16;ABAT, GABAT;True
ENSG00000140650;Phosphomannomutase 2;NotRelevant;;Congenital disorder of glycosylation, type Ia, 212065 (3), Autosomal recessiveCongenital disorder of glycosylation, type Ia, 212065 (3);chr16;PMM2, CDG1A;True
ENSG00000183454;Glutamate receptor, ionotropic, N-methyl D-aspartate 2A;NotRelevant;;Epilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3), Autosomal dominantEpilepsy, focal, with speech disorder and with or without mental retardation, 245570 (3);chr16;GRIN2A, NMDAR2A, FESD, LKS;True
ENSG00000213853;Epithelial membrane protein 2;NotRelevant;;Nephrotic syndrome, type 10, 615861 (3), Autosomal recessiveNephrotic syndrome, type 10, 615861 (3);chr16;EMP2, NPHS10;True
ENSG00000179583;Class II major histocompatibility complex transactivator;NotRelevant;;Bare lymphocyte syndrome, type II, complementation group A, 209920 (3), Autosomal recessive{Rheumatoid arthritis, susceptibility to}, 180300 (3);chr16;CIITA, MHC2TA, C2TA;True
ENSG00000189067;LPS-induced TNFA factor;NotRelevant;;Charcot-Marie-Tooth disease, type 1C, 601098 (3), Autosomal dominantCharcot-Marie-Tooth disease, type 1C, 601098 (3);chr16;LITAF, CMT1C;True
ENSG00000175595;Excision-repair, complementing defective, in Chinese hamster, number 4;NotRelevant;mutation identified in 1 XFEPS patient;Fanconi anemia, complementation group Q, 615272 (3), Autosomal recessiveXeroderma pigmentosum, type F/Cockayne syndrome, 278760 (3);chr16;ERCC4, XPF, FANCQ, XFEPS;True
ENSG00000140694;Polyadenylate-specific ribonuclease;NotRelevant;;Dyskeratosis congenita, autosomal recessive 6, 616353 (3), Autosomal recessivePulmonary fibrosis and/or bone marrow failure, telomere-related, 4, 616371 (3);chr16;PARN, DAN, DKCB6, PFBMFT4;True
ENSG00000072864;nudE neurodevelopment protein 1;NotRelevant;mutation identified in 1 MHAC family;Lissencephaly 4 (with microcephaly), 614019 (3), Autosomal recessiveLissencephaly 4 (with microcephaly), 614019 (3);chr16;NDE1, NUDE, LIS4, MHAC;True
ENSG00000133392;Myosin, heavy polypeptide-11, smooth muscle;NotRelevant;fused with CBFB by inversion in acute myelomonocytic leukemia;Aortic aneurysm, familial thoracic 4, 132900 (3), Autosomal dominantAortic aneurysm, familial thoracic 4, 132900 (3);chr16;MYH11, AAT4, FAA4;True
ENSG00000091262;ATP-binding cassette, subfamily C, member 6;NotRelevant;;Arterial calcification, generalized, of infancy, 2, 614473 (3), Autosomal recessivePseudoxanthoma elasticum, forme fruste, 177850 (3);chr16;ABCC6, ARA, ABC34, MLP1, PXE, GACI2;True
ENSG00000103489;Xylosyltransferase 1;NotRelevant;;Desbuquois dysplasia 2, 615777 (3), Autosomal recessive{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3);chr16;XYLT1, XT1, DBQD2;True
ENSG00000170540;ADP-ribosylation factor-like 6 interacting protein 1;NotRelevant;mutation identified in 1 family;?Spastic paraplegia 61, autosomal recessive, 615685 (3), Autosomal recessive?Spastic paraplegia 61, autosomal recessive, 615685 (3);chr16;ARL6IP1, KIAA0069, SPG61;True
ENSG00000167186;COQ7, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 COQ10D8 patient;?Coenzyme Q10 deficiency, primary, 8, 616733 (3), Autosomal recessive?Coenzyme Q10 deficiency, primary, 8, 616733 (3);chr16;COQ7, CLK1, COQ10D8;True
ENSG00000169344;Uromodulin (uromucoid, Tamm-Horsfall glycoprotein);NotRelevant;;Glomerulocystic kidney disease with hyperuricemia and isosthenuria, 609886 (3)Medullary cystic kidney disease 2, 603860 (3);chr16;UMOD, HNFJ1, FJHN, MCKD2, ADMCKD2;False
ENSG00000005187;Acyl-CoA synthetase medium-chain family member 3;NotRelevant;;{?Hypertension, essential} (1){?Hypertension, essential} (1);chr16;ACSM3, SAH;False
ENSG00000103316;Crystallin, mu;NotRelevant;;Deafness, autosomal dominant 40, 616357 (3), Autosomal dominantDeafness, autosomal dominant 40, 616357 (3);chr16;CRYM, DFNA40;True
ENSG00000155719;Otoancorin;NotRelevant;;Deafness, autosomal recessive 22, 607039 (3), Autosomal recessiveDeafness, autosomal recessive 22, 607039 (3);chr16;OTOA, DFNB22;True
ENSG00000140740;Ubiquinol-cytochrome c reductase core protein II;NotRelevant;;Mitochondrial complex III deficiency, nuclear type 5, 615160 (3), Autosomal recessiveMitochondrial complex III deficiency, nuclear type 5, 615160 (3);chr16;UQCRC2, MC3DN5;True
ENSG00000166828;Sodium channel, nonvoltage-gated 1, gamma;NotRelevant;same 400kb fragment as SCNN1B;Bronchiectasis with or without elevated sweat chloride 3, 613071 (3), Autosomal dominantPseudohypoaldosteronism, type I, 264350 (3);chr16;SCNN1G, PHA1, BESC3, LDLS2;True
ENSG00000168447;Sodium channel, nonvoltage-gated 1, beta;NotRelevant;;Bronchiectasis with or without elevated sweat chloride 1, 211400 (3), Autosomal dominantPseudohypoaldosteronism, type I, 264350 (3);chr16;SCNN1B, BESC1, LIDLS1;True
ENSG00000168434;Component of oligomeric golgi complex 7;NotRelevant;;Congenital disorder of glycosylation, type IIe, 608779 (3)Congenital disorder of glycosylation, type IIe, 608779 (3);chr16;COG7, CDG2E;False
ENSG00000103356;Glutamyl-tRNA synthetase 2;NotRelevant;;Combined oxidative phosphorylation deficiency 12, 614924 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 12, 614924 (3);chr16;EARS2, KIAA1970, COXPD12;True
ENSG00000083093;Partner and localizer of BRCA2;NotRelevant;;{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation{Pancreatic cancer, susceptibility to, 3}, 613348 (3);chr16;PALB2, FANCN, PNCA3;True
ENSG00000090905;Trinucleotide repeat-containing gene 6A;NotRelevant;mutation identified in 1 FAME6 family;?Epilepsy, familial adult myoclonic, 6, 618074 (3)?Epilepsy, familial adult myoclonic, 6, 618074 (3);chr16;TNRC6A, GW182, KIAA1460, FAME6;False
ENSG00000077238;Interleukin-4 receptor;NotRelevant;;{AIDS, slow progression to}, 609423 (3){Atopy, susceptibility to}, 147050 (3);chr16;IL4R, IL4RA;False
ENSG00000103522;Interleukin 21 receptor;NotRelevant;fusion partner with BCL6;[IgE, elevated level of], 147050 (3), Autosomal dominant[IgE, elevated level of], 147050 (3);chr16;IL21R, IMD56;True
ENSG00000047578;Katanin-interacting protein;NotRelevant;;Joubert syndrome 26, 616784 (3), Autosomal recessiveJoubert syndrome 26, 616784 (3);chr16;KATNIP, KIAA0556;True
ENSG00000188603;Battenin;NotRelevant;;Ceroid lipofuscinosis, neuronal, 3, 204200 (3), Autosomal recessiveCeroid lipofuscinosis, neuronal, 3, 204200 (3);chr16;CLN3, BTS;True
ENSG00000178952;Tu translation elongation factor, mitochondrial;NotRelevant;pseudogene on chr.17;Combined oxidative phosphorylation deficiency 4, 610678 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 4, 610678 (3);chr16;TUFM, EFTU, COXPD4;True
ENSG00000196296;ATPase, Ca++ transporting, fast-twitch, 1;NotRelevant;;Brody myopathy, 601003 (3), Autosomal recessiveBrody myopathy, 601003 (3);chr16;ATP2A1, SERCA1;True
ENSG00000177455;CD19 antigen;NotRelevant;;Immunodeficiency, common variable, 3, 613493 (3), Autosomal recessiveImmunodeficiency, common variable, 3, 613493 (3);chr16;CD19, CVID3;True
ENSG00000213658;Linker for activation of T cells;NotRelevant;;Immunodeficiency 52, 617514 (3), Autosomal recessiveImmunodeficiency 52, 617514 (3);chr16;LAT, IMD52;True
ENSG00000079616;Kinesin family member 22;NotRelevant;;Spondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3), Autosomal dominantSpondyloepimetaphyseal dysplasia with joint laxity, type 2, 603546 (3);chr16;KIF22, KNSL4, KID, OBP, SEMDJL2;True
ENSG00000167371;Proline-rich transmembrane protein 2;NotRelevant;;Convulsions, familial infantile, with paroxysmal choreoathetosis, 602066 (3), Autosomal dominantSeizures, benign familial infantile, 2, 605751 (3);chr16;PRRT2, PKC, DYT10, EKD1, BFIS2, BFIC2, ICCA;True
ENSG00000149925;Aldolase A, fructose-bisphosphatase;NotRelevant;pseudogenes on 3 and 10;Glycogen storage disease XII, 611881 (3), Autosomal recessiveGlycogen storage disease XII, 611881 (3);chr16;ALDOA, GSD12;True
ENSG00000149922;T-box 6;NotRelevant;;Spondylocostal dysostosis 5, 122600 (3), Autosomal recessive, Autosomal dominantSpondylocostal dysostosis 5, 122600 (3);chr16;TBX6, SCDO5;True
ENSG00000102879;Coronin 1A;NotRelevant;;Immunodeficiency 8, 615401 (3), Autosomal recessiveImmunodeficiency 8, 615401 (3);chr16;CORO1A, TACO, CLIPINA, IMD8;True
ENSG00000080603;SNF2-related CBP activator protein;NotRelevant;;Floating-Harbor syndrome, 136140 (3), Autosomal dominantFloating-Harbor syndrome, 136140 (3);chr16;SRCAP, SWR1, KIAA0309, FLHS;True
ENSG00000156873;Phosphorylase kinase, gamma 2 (testis/liver);NotRelevant;;Cirrhosis due to liver phosphorylase kinase deficiency (3)Glycogen storage disease IXc, 613027 (3);chr16;PHKG2, GSD9C;False
ENSG00000099377;3-beta-hydroxy-delta-5-C27-steroid oxidoreductase;NotRelevant;;Bile acid synthesis defect, congenital, 1, 607765 (3), Autosomal recessiveBile acid synthesis defect, congenital, 1, 607765 (3);chr16;HSD3B7, CBAS1;True
ENSG00000099365;Syntaxin 1B;NotRelevant;;Generalized epilepsy with febrile seizures plus, type 9, 616172 (3), Autosomal dominantGeneralized epilepsy with febrile seizures plus, type 9, 616172 (3);chr16;STX1B, GEFSP9;True
ENSG00000167397;Vitamin K epoxide reductase complex, subunit 1;NotRelevant;;Vitamin K-dependent clotting factors, combined deficiency of, 2, 607473 (3)Warfarin resistance, 122700 (3);chr16;VKORC1, VKOR, VKCFD2, FLJ00289;False
ENSG00000103507;Branched-chain alpha-keto acid dehydrogenase kinase;NotRelevant;;Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3)Branched-chain ketoacid dehydrogenase kinase deficiency, 614923 (3);chr16;BCKDK, BDK, BCKDKD;False
ENSG00000089280;Fusion, derived from 12-16 translocation, malignant liposarcoma;NotRelevant;fused with DDIT3 in myxoid liposarcoma, with ERG in leukemia, and ATF1 in angiomatoid fibrous histiocytoma;Amyotrophic lateral sclerosis 6, with or without frontotemporal dementia, 608030 (3)Essential tremor, hereditary, 4, 614782 (3);chr16;FUS, TLS, ALS6, ETM4;False
ENSG00000169896;Integrin, alpha-M (complement component receptor-3, alpha;NotRelevant;3684;ENSG00000169896{Systemic lupus erythematous, association with susceptibility to, 6}, 609939 (3);chr16;ITGAM, CR3A, CD11B, MAC1A, SLEB6;False
ENSG00000140691;Armadillo repeat-containing protein 5;NotRelevant;;ACTH-independent macronodular adrenal hyperplasia 2, 615954 (3), Autosomal dominant, Somatic mutationACTH-independent macronodular adrenal hyperplasia 2, 615954 (3);chr16;ARMC5, AIMAH2;True
ENSG00000140675;Solute carrier family 5 (sodium/glucose cotransporter), member 2;NotRelevant;;Renal glucosuria, 233100 (3), Autosomal recessive, Autosomal dominantRenal glucosuria, 233100 (3);chr16;SLC5A2, SGLT2;True
ENSG00000069329;Vacuolar protein sorting 35, yeast, homolog of;NotRelevant;;{Parkinson disease 17}, 614203 (3), Autosomal dominant{Parkinson disease 17}, 614203 (3);chr16;VPS35, MEM3, PARK17;True
ENSG00000091651;Origin recognition complex, subunit 6, S. cerevisiae, homolog of;NotRelevant;;Meier-Gorlin syndrome 3, 613803 (3), Autosomal recessiveMeier-Gorlin syndrome 3, 613803 (3);chr16;ORC6, ORC6L;True
ENSG00000166123;Glutamate pyruvate transaminase 2;NotRelevant;;Mental retardation, autosomal recessive 49, 616281 (3), Autosomal recessiveMental retardation, autosomal recessive 49, 616281 (3);chr16;GPT2, ALT2, MRT49;True
ENSG00000102893;Phosphorylase kinase, beta polypeptide;NotRelevant;;Phosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3), Autosomal recessivePhosphorylase kinase deficiency of liver and muscle, autosomal recessive, 261750 (3);chr16;PHKB;True
ENSG00000121270;ATP-binding cassette, subfamily C, member 11;NotRelevant;;[Axillary odor, variation in], 117800 (3), Autosomal dominant[Earwax, wet/dry], 117800 (3);chr16;ABCC11, MRP8, EWWD, WW;True
ENSG00000102935;Zinc finger protein 423;NotRelevant;;Joubert syndrome 19, 614844 (3), Autosomal recessive, Autosomal dominantNephronophthisis 14, 614844 (3);chr16;ZNF423, ZFP423, OAZ, KIAA0760, NPHP14, JBTS19;True
ENSG00000167207;Nucleotide-binding oligomerization domain protein 2;NotRelevant;;Blau syndrome, 186580 (3), Autosomal dominant{Yao syndrome}, 617321 (3);chr16;NOD2, CARD15, IBD1, CD, YAOS, BLAUS;True
ENSG00000083799;CYLD gene;NotRelevant;behaves as tumor suppressor;Brooke-Spiegler syndrome, 605041 (3), Autosomal dominantTrichoepithelioma, multiple familial, 1, 601606 (3);chr16;CYLD, CDMT, EAC, MFT1, KIAA0849, BRSS;True
ENSG00000103449;Sal-like 1;NotRelevant;;Townes-Brocks branchiootorenal-like syndrome, 107480 (3), Autosomal dominantTownes-Brocks syndrome 1, 107480 (3);chr16;SALL1, HSAL1, TBS;True
ENSG00000103494;RPGRIP1-like;NotRelevant;;COACH syndrome, 216360 (3), Autosomal recessiveMeckel syndrome 5, 611561 (3);chr16;RPGRIP1L, KIAA1005, JBTS7, MKS5;True
ENSG00000140718;Fat mass- and obesity-associated gene;NotRelevant;;Growth retardation, developmental delay, facial dysmorphism, 612938 (3), Autosomal recessive{Obesity, susceptibility to, BMIQ14}, 612460 (3);chr16;FTO, GDFD, BMIQ14;True
ENSG00000176842;Iroquois homeo box protein 5;NotRelevant;;Hamamy syndrome, 611174 (3), Autosomal recessiveHamamy syndrome, 611174 (3);chr16;IRX5, HMMS;True
ENSG00000087245;Matrix metalloproteinase 2 (gelatinase A, 72kD type IV collagenase);NotRelevant;near MT1,2;Multicentric osteolysis, nodulosis, and arthropathy, 259600 (3), Autosomal recessiveMulticentric osteolysis, nodulosis, and arthropathy, 259600 (3);chr16;MMP2, CLG4A, MONA;True
ENSG00000103546;Solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2, cocaine- and antidepressant-sensitive;NotRelevant;mutation identified in 1 ORSTI family;?Orthostatic intolerance, 604715 (3)?Orthostatic intolerance, 604715 (3);chr16;SLC6A2, NAT1, NET1;False
ENSG00000198848;Carboxylesterase 1 (monocyte/macrophage serine esterase 1);NotRelevant;;Drug metabolism, altered, CES1-related, 618057 (3)Drug metabolism, altered, CES1-related, 618057 (3);chr16;CES1, SES1;False
ENSG00000087258;Guanine nucleotide-binding protein (G protein), alpha-activating activity;NotRelevant;close to MT1 in mouse;Epileptic encephalopathy, early infantile, 17, 615473 (3), Autosomal dominantNeurodevelopmental disorder with involuntary movements, 617493 (3);chr16;GNAO1, EIEE17, NEDIM;True
ENSG00000125124;Bardet-Biedl syndrome 2;NotRelevant;;Bardet-Biedl syndrome 2, 615981 (3), Autosomal recessiveRetinitis pigmentosa 74, 616562 (3);chr16;BBS2, RP74;True
ENSG00000102900;Nucleoporin, 93kD;NotRelevant;;Nephrotic syndrome, type 12, 616892 (3), Autosomal recessiveNephrotic syndrome, type 12, 616892 (3);chr16;NUP93, NIC96, KIAA0095, NPHS12;True
ENSG00000070915;Solute carrier family 12 (sodium/potassium/chloride transporters), member 3;NotRelevant;;Gitelman syndrome, 263800 (3), Autosomal recessiveGitelman syndrome, 263800 (3);chr16;SLC12A3, NCCT, TSC;True
ENSG00000087237;Cholesteryl ester transfer protein, plasma;NotRelevant;;[High density lipoprotein cholesterol level QTL 10], 143470 (3), Autosomal dominant[High density lipoprotein cholesterol level QTL 10], 143470 (3);chr16;CETP, HDLCQ10;True
ENSG00000159579;RING finger- and SPRY domain-containing protein 11;NotRelevant;;Spondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3), Autosomal recessiveSpondyloepimetaphyseal dysplasia, Faden-Alkuraya type, 616723 (3);chr16;RSPRY1, KIAA1972, SEMDFA;True
ENSG00000102931;ADP ribosylation factor-like 2-binding protein;NotRelevant;;Retinitis pigmentosa with or without situs inversus, 615434 (3), Autosomal recessiveRetinitis pigmentosa with or without situs inversus, 615434 (3);chr16;ARL2BP, BART;True
ENSG00000088682;Coq9, S. cerevisiae, homolog of;NotRelevant;;Coenzyme Q10 deficiency, primary, 5, 614654 (3), Autosomal recessiveCoenzyme Q10 deficiency, primary, 5, 614654 (3);chr16;COQ9, C16orf49, COQ10D5;True
ENSG00000205336;Adhesion G protein-coupled receptor G1;NotRelevant;;Polymicrogyria, bilateral frontoparietal, 606854 (3), Autosomal recessivePolymicrogyria, bilateral perisylvian, 615752 (3);chr16;ADGRG1, GPR56, TM7XN1, BFPP, BPPR;True
ENSG00000140854;Katanin, p80 subunit, B1;NotRelevant;;Lissencephaly 6, with microcephaly, 616212 (3), Autosomal recessiveLissencephaly 6, with microcephaly, 616212 (3);chr16;KATNB1, LIS6;True
ENSG00000070729;Cyclic nucleotide gated channel, beta 1;NotRelevant;;Retinitis pigmentosa 45, 613767 (3), Autosomal recessiveRetinitis pigmentosa 45, 613767 (3);chr16;CNGB1, CNCG3L, CNCG2, RP45;True
ENSG00000103005;U6 small nuclear RNA biogenesis phosphodiesterase 1;NotRelevant;;Poikiloderma with neutropenia, 604173 (3), Autosomal recessivePoikiloderma with neutropenia, 604173 (3);chr16;USB1, C16orf57, PN;True
ENSG00000140937;Cadherin-11 (OB-cadherin, osteoblast);NotRelevant;;Elsahy-Waters syndrome, 211380 (3), Autosomal recessiveElsahy-Waters syndrome, 211380 (3);chr16;CDH11, CAD11, ESWS;True
ENSG00000166546;Brain-expressed, associated with NEDD4;NotRelevant;;Spinocerebellar ataxia 31, 117210 (3), Autosomal dominantSpinocerebellar ataxia 31, 117210 (3);chr16;BEAN, SCA31;True
ENSG00000166548;Thymidine kinase, mitochondrial;NotRelevant;mutation identified in 1 PEOB3 family;Mitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3), Autosomal recessiveMitochondrial DNA depletion syndrome 2 (myopathic type), 609560 (3);chr16;TK2, MTDPS2, PEOB3;True
ENSG00000067955;Core-binding factor, beta subunit;NotRelevant;inv(16)(p13;q22)Myeloid leukemia, acute, M4/M4Eo subtype, somatic, 601626 (1);chr16;CBFB, PEBP2B;False
ENSG00000102878;Heat-shock transcription factor 4;NotRelevant;;Cataract 5, multiple types, 116800 (3), Autosomal dominantCataract 5, multiple types, 116800 (3);chr16;HSF4, CTM, CTRCT5;True
ENSG00000140939;Nucleolar protein 3;NotRelevant;;Myoclonus, familial cortical, 614937 (3), Autosomal dominantMyoclonus, familial cortical, 614937 (3);chr16;NOL3, NOP, MYC, ARC, FCM;True
ENSG00000176387;Hydroxysteroid (11-beta) dehydrogenase 2;NotRelevant;;Apparent mineralocorticoid excess, 218030 (3), Autosomal recessiveApparent mineralocorticoid excess, 218030 (3);chr16;HSD11B2, HSD11K, AME;True
ENSG00000159723;Agouti-related transcript, mouse, homolog of;NotRelevant;;{Leanness, inherited} (3){Obesity, late-onset}, 601665 (3);chr16;AGRP, ART, AGRT;False
ENSG00000102974;CCCTC-binding factor;NotRelevant;;Mental retardation, autosomal dominant 21, 615502 (3), Autosomal dominantMental retardation, autosomal dominant 21, 615502 (3);chr16;CTCF, MRD21;True
ENSG00000159753;Capping protein regulator and myosin 1 linker 2;NotRelevant;;Immunodeficiency 58, 618131 (3), Autosomal recessiveImmunodeficiency 58, 618131 (3);chr16;CARMIL2, RLTPR, IMD58;True
ENSG00000102977;Acd, mouse, homolog of;NotRelevant;mutation has been identified in 1 DKCA7 and 1 DKCB7 family;?Dyskeratosis congenita, autosomal dominant 6, 616553 (3), Autosomal recessive, Autosomal dominant?Dyskeratosis congenita, autosomal recessive 7, 616553 (3);chr16;ACD, PTOP, PIP1, TINT1;True
ENSG00000213398;Lecithin-cholesterol acyltransferase;NotRelevant;very close to HP;Fish-eye disease, 136120 (3), Autosomal recessiveNorum disease, 245900 (3);chr16;LCAT;True
ENSG00000132600;Protein arginine N-methyltransferase 7;NotRelevant;;Short stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3), Autosomal recessiveShort stature, brachydactyly, intellectual developmental disability, and seizures, 617157 (3);chr16;PRMT7, KIAA1933, SBIDDS;True
ENSG00000062038;Cadherin-3 (P-cadherin);NotRelevant;in mouse tightly linked to ECAD;Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3), Autosomal recessiveHypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3);chr16;CDH3, CDHP, PCAD, HJMD;True
ENSG00000039068;Cadherin-1 (E-cadherin;NotRelevant;ENSG00000039068;near LCAT{Prostate cancer, susceptibility to}, 176807 (3);chr16;CDH1, UVO, LCAM, ECAD, BCDS1;False
ENSG00000213380;Component of oligomeric golgi complex 8;NotRelevant;;Congenital disorder of glycosylation, type IIh, 611182 (3)Congenital disorder of glycosylation, type IIh, 611182 (3);chr16;COG8, DOR1, CDG2H;False
ENSG00000181019;NAD(P)H dehydrogenase, quinone 1 (diaphorase-4);NotRelevant;;{Benzene toxicity, susceptibility to} (3){Leukemia, post-chemotherapy, susceptibility to} (3);chr16;NQO1, DIA4, NMOR1;False
ENSG00000090861;Alanyl-tRNA synthetase;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2N, 613287 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 29, 616339 (3);chr16;AARS, CMT2N, EIEE29;True
ENSG00000103051;Component of oligomeric golgi complex 4;NotRelevant;;Congenital disorder of glycosylation, type IIj, 613489 (3), Autosomal recessiveSaul-Wilson syndrome, 618150 (3);chr16;COG4, COD1, CDG2J, SWILS;True
ENSG00000103043;Vac14, S. cerevisiae, homolog of;NotRelevant;;Striatonigral degeneration, childhood-onset, 617054 (3), Autosomal recessiveStriatonigral degeneration, childhood-onset, 617054 (3);chr16;VAC14, TAX1BP2, TRX, SNDC;True
ENSG00000157423;Hydin, mouse, homolog of;NotRelevant;duplicated copy on 1q21.1;Ciliary dyskinesia, primary, 5, 608647 (3), Autosomal recessiveCiliary dyskinesia, primary, 5, 608647 (3);chr16;HYDIN, HYDIN1, CILD5;True
ENSG00000198650;Tyrosine aminotransferase, soluble;NotRelevant;;Tyrosinemia, type II, 276600 (3), Autosomal recessiveTyrosinemia, type II, 276600 (3);chr16;TAT;True
ENSG00000102967;Dihydroorotate dehydrogenase;NotRelevant;;Miller syndrome, 263750 (3), Autosomal recessiveMiller syndrome, 263750 (3);chr16;DHODH, URA1, POADS;True
ENSG00000257017;Haptoglobin;NotRelevant;just distal to fra16q22.1;[Anhaptoglobinemia], 614081 (3)[Hypohaptoglobinemia], 614081 (3);chr16;HP;False
ENSG00000261701;Haptoglobin-related locus;NotRelevant;2.2kb 3' to HP; multiple tandem genes in blacks;chr16;HPR;False
ENSG00000140829;DEAH (Asp-Glu-Ala-His) box polypeptide 38 (PRP6, S. cerevisiae, homolog of);NotRelevant;;Retinitis pigmentosa 84, 618220 (3), Autosomal recessiveRetinitis pigmentosa 84, 618220 (3);chr16;DHX38, DDX38, PRP16, RP84;True
ENSG00000118557;Polyamine-modulated factor 1-binding protein 1;NotRelevant;;Spermatogenic failure 31, 618112 (3), Autosomal recessiveSpermatogenic failure 31, 618112 (3);chr16;PMFBP1, STAP, SPGF31;True
ENSG00000140836;Zinc finger homeobox 3;NotRelevant;;{Prostate cancer, susceptibility to, somatic}, 176807 (3){Prostate cancer, susceptibility to, somatic}, 176807 (3);chr16;ZFHX3, ATBF1;False
ENSG00000168411;RING finger and WD repeat domains-containing protein 3;NotRelevant;mutation identified in 1 FANCW patient;?Fanconi anemia, complementation group W, 617784 (3), Autosomal recessive?Fanconi anemia, complementation group W, 617784 (3);chr16;RFWD3, FANCW;True
ENSG00000103089;Fatty acid 2-hydroxylase;NotRelevant;;Spastic paraplegia 35, autosomal recessive, 612319 (3), Autosomal recessiveSpastic paraplegia 35, autosomal recessive, 612319 (3);chr16;FA2H, FAAH, FAXDC1, FAH1, SCS7, SPG35;True
ENSG00000183196;Carbohydrate sulfotransferase-6 (GlcNAc-6-sulfotransferase, corneal);NotRelevant;;Macular corneal dystrophy, 217800 (3), Autosomal recessiveMacular corneal dystrophy, 217800 (3);chr16;CHST6, MCDC1;True
ENSG00000205084;Transmembrane protein 231;NotRelevant;;Joubert syndrome 20, 614970 (3), Autosomal recessiveMeckel syndrome 11, 615397 (3);chr16;TMEM231, JBTS20, MKS11;True
ENSG00000065427;Lysyl-tRNA synthetase;NotRelevant;mutation identified in 1 CMTRIB patient;?Charcot-Marie-Tooth disease, recessive intermediate, B, 613641 (3), Autosomal recessiveDeafness, autosomal recessive 89, 613916 (3);chr16;KARS, CMTRIB, DFNB89;True
ENSG00000140873;A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 18;NotRelevant;;Microcornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3), Autosomal recessiveMicrocornea, myopic chorioretinal atrophy, and telecanthus, 615458 (3);chr16;ADAMTS18, MMCAT;True
ENSG00000186153;WW domain-containing oxidoreductase;NotRelevant;;Epileptic encephalopathy, early infantile, 28, 616211 (3), Autosomal recessiveSpinocerebellar ataxia, autosomal recessive 12, 614322 (3);chr16;WWOX, FOR, SCAR12, EIEE28;True
ENSG00000178573;v-Maf avian musculoaponeurotic fibrosarcoma oncogene homolog;NotRelevant;;Ayme-Gripp syndrome, 601088 (3), Autosomal dominantCataract 21, multiple types, 610202 (3);chr16;MAF, CCA4, CTRCT21, AYGRP;True
ENSG00000140905;Glycine cleavage system H protein;NotRelevant;mutation identified in 1 NKH patient;?Glycine encephalopathy, 605899 (3), Autosomal recessive?Glycine encephalopathy, 605899 (3);chr16;GCSH, NKH;True
ENSG00000135697;Beta-carotene oxygenase 1;NotRelevant;mutation identified in 1 HCVAD patient;?Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3), Autosomal dominant?Hypercarotenemia and vitamin A deficiency, autosomal dominant, 115300 (3);chr16;BCO1, BCMO1, BCDO;True
ENSG00000261609;Gigaxonin;NotRelevant;;Giant axonal neuropathy-1, 256850 (3), Autosomal recessiveGiant axonal neuropathy-1, 256850 (3);chr16;GAN, GAN1;True
ENSG00000197943;Phospholipase C, gamma 2;NotRelevant;;Autoinflammation, antibody deficiency, and immune dysregulation syndrome, 614878 (3), Autosomal dominantFamilial cold autoinflammatory syndrome 3, 614468 (3);chr16;PLCG2, FCAS3, APLAID;True
ENSG00000103150;Malonyl-CoA decarboxylase;NotRelevant;;Malonyl-CoA decarboxylase deficiency, 248360 (3), Autosomal recessiveMalonyl-CoA decarboxylase deficiency, 248360 (3);chr16;MLYCD, MCD;True
ENSG00000166558;Solute carrier family 38 (amino acid transporter), member 8;NotRelevant;;Foveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3), Autosomal recessiveFoveal hypoplasia 2, with or without optic nerve misrouting and/or anterior segment dysgenesis, 609218 (3);chr16;SLC38A8, FVH2;True
ENSG00000154099;Dynein, axonemal, assembly factor 1;NotRelevant;;Ciliary dyskinesia, primary, 13, 613193 (3), Autosomal recessiveCiliary dyskinesia, primary, 13, 613193 (3);chr16;DNAAF1, LRRC50, ODA7, CILD13;True
ENSG00000140968;Interferon regulatory factor 8;NotRelevant;;Immunodeficiency 32A, mycobacteriosis, autosomal dominant, 614893 (3), Autosomal dominantImmunodeficiency 32B, monocyte and dendritic cell deficiency, autosomal recessive, 226990 (3);chr16;IRF8, ICSBP1, IMD32A, IMD32B;True
ENSG00000103241;Forkhead box F1;NotRelevant;;Alveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3), Autosomal dominantAlveolar capillary dysplasia with misalignment of pulmonary veins, 265380 (3);chr16;FOXF1, FKHL5, ACDMPV;True
ENSG00000176692;Forkhead box C2;NotRelevant;;Lymphedema-distichiasis syndrome, 153400 (3), Autosomal dominantLymphedema-distichiasis syndrome, 153400 (3);chr16;FOXC2, FKHL14, MFH1;True
ENSG00000103264;F-box only protein 31;NotRelevant;mutation identified in 1 MRT45 family;?Mental retardation, autosomal recessive 45, 615979 (3), Autosomal recessive?Mental retardation, autosomal recessive 45, 615979 (3);chr16;FBXO31, FBX31, FBXO14, FBX14, MRT45;True
ENSG00000154118;Junctophilin 3;NotRelevant;mutation identified in 1 HDL2 family;Huntington disease-like 2, 606438 (3), Autosomal dominantHuntington disease-like 2, 606438 (3);chr16;JPH3, JP3, HDL2;True
ENSG00000174990;Carbonic anhydrase VA (mitochondrial);NotRelevant;pseudogene on 16p;Hyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3), Autosomal recessiveHyperammonemia due to carbonic anhydrase VA deficiency, 615751 (3);chr16;CA5A, CA5AD;True
ENSG00000225614;Zinc finger protein 469;NotRelevant;;Brittle cornea syndrome 1, 229200 (3), Autosomal recessiveBrittle cornea syndrome 1, 229200 (3);chr16;ZNF469, KIAA1858, BCS1;True
ENSG00000051523;Cytochrome b-245, alpha polypeptide;NotRelevant;;Chronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3), Autosomal recessiveChronic granulomatous disease, autosomal, due to deficiency of CYBA, 233690 (3);chr16;CYBA;True
ENSG00000167508;Mevalonate pyrophosphate decarboxylase;NotRelevant;;Porokeratosis 7, multiple types, 614714 (3), Autosomal dominantPorokeratosis 7, multiple types, 614714 (3);chr16;MVD, MPD, POROK7;True
ENSG00000174177;Cytosolic thiouridylase, subunit 2;NotRelevant;;Microcephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, 618142 (3), Autosomal recessiveMicrocephaly, facial dysmorphism, renal agenesis, and ambiguous genitalia syndrome, 618142 (3);chr16;CTU2, C16orf84, NCS2, MFRG;True
ENSG00000103335;PIEZO1 ion channel;NotRelevant;;Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3), Autosomal dominantLymphatic malformation 6, 616843 (3);chr16;PIEZO1, FAM38A, MIB, DHS, LMPHM6;True
ENSG00000167513;Chromatin licensing and DNA replication factor 1;NotRelevant;;Meier-Gorlin syndrome 4, 613804 (3), Autosomal recessiveMeier-Gorlin syndrome 4, 613804 (3);chr16;CDT1;True
ENSG00000198931;Adenine phosphoribosyltransferase;NotRelevant;telomeric to GALNS, transcribed in same cen-tel direction;Adenine phosphoribosyltransferase deficiency, 614723 (3), Autosomal recessiveAdenine phosphoribosyltransferase deficiency, 614723 (3);chr16;APRT, APRTD;True
ENSG00000141012;Galactosamine (N-acetyl)-6-sulfate sulfatase;NotRelevant;centromeric to APRT;Mucopolysaccharidosis IVA, 253000 (3), Autosomal recessiveMucopolysaccharidosis IVA, 253000 (3);chr16;GALNS, MPS4A;True
ENSG00000176715;Acyl-CoA synthetase family member 3;NotRelevant;;Combined malonic and methylmalonic aciduria, 614265 (3)Combined malonic and methylmalonic aciduria, 614265 (3);chr16;ACSF3;False
ENSG00000129910;Cadherin-15, M-cadherin (myotubule);NotRelevant;tightly linked to Aprt in mouse;Mental retardation, autosomal dominant 3, 612580 (3)Mental retardation, autosomal dominant 3, 612580 (3);chr16;CDH15, CDH14, CDH3, MRD3;True
ENSG00000167522;Ankyrin repeat domain-containing protein 11;NotRelevant;;KBG syndrome, 148050 (3), Autosomal dominantKBG syndrome, 148050 (3);chr16;ANKRD11, ANCO1, KBGS;True
ENSG00000197912;Paraplegin;NotRelevant;;Spastic paraplegia 7, autosomal recessive, 607259 (3), Autosomal recessive, Autosomal dominantSpastic paraplegia 7, autosomal recessive, 607259 (3);chr16;PGN, SPG7, CMAR, CAR;True
ENSG00000131165;CHMP family, member 1A;NotRelevant;;Pontocerebellar hypoplasia, type 8, 614961 (3), Autosomal recessivePontocerebellar hypoplasia, type 8, 614961 (3);chr16;CHMP1A, PCOLN3, PRSM1, PCH8;True
ENSG00000185324;Cyclin-dependent kinase 10;NotRelevant;;Al Kaissi syndrome, 617694 (3), Autosomal recessiveAl Kaissi syndrome, 617694 (3);chr16;CDK10, PISSLRE, ALSAS;True
ENSG00000187741;Fanconi anemia, complementation group A;NotRelevant;linkage heterogeneity;Fanconi anemia, complementation group A, 227650 (3), Autosomal recessiveFanconi anemia, complementation group A, 227650 (3);chr16;FANCA, FACA, FA1, FA, FAA;True
ENSG00000258839;Melanocortin-1 receptor (alpha melanocyte-stimulating hormone receptor);NotRelevant;;{Albinism, oculocutaneous, type II, modifier of}, 203200 (3), Autosomal recessive{UV-induced skin damage}, 266300 (3);chr16;MC1R, SHEP2, CMM5;True
ENSG00000258947;Tubulin, beta-3;NotRelevant;;Cortical dysplasia, complex, with other brain malformations 1, 614039 (3), Autosomal dominantFibrosis of extraocular muscles, congenital, 3A, 600638 (3);chr16;TUBB3, TUBB4, CFEOM3A, CDCBM1;True
ENSG00000141013;Growth arrest-specific 8;NotRelevant;;Ciliary dyskinesia, primary, 33, 616726 (3), Autosomal recessiveCiliary dyskinesia, primary, 33, 616726 (3);chr16;GAS8, GAS11, CILD33;True
ENSG00000141252;Vacuolar protein sorting 53, S. cerevisiae, homolog of;NotRelevant;;Pontocerebellar hypoplasia, type 2E, 615851 (3), Autosomal recessivePontocerebellar hypoplasia, type 2E, 615851 (3);chr17;VPS53, HCCS1, PCH2E;True
ENSG00000179409;Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities;NotRelevant;;Neurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities, 617913 (3), Autosomal recessiveNeurodevelopmental disorder with microcephaly, cataracts, and renal abnormalities, 617913 (3);chr17;GEMIN4, NEDMCR;True
ENSG00000205899;Basic helix-loop-helix family, member A9;NotRelevant;mutation identified in 1 CCSPD family;?Camptosynpolydactyly, complex, 607539 (3), Autosomal recessiveSyndactyly, mesoaxial synostotic, with phalangeal reduction, 609432 (3);chr17;BHLHA9, BHLHF42, MSSD, CCSPD;True
ENSG00000132376;Inositol polyphosphate-5-phosphatase K;NotRelevant;;Muscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3), Autosomal recessiveMuscular dystrophy, congenital, with cataracts and intellectual disability, 617404 (3);chr17;INPP5K, SKIP, MDCCAID;True
ENSG00000174231;Precursor mRNA-processing factor 8, S. cerevisiae, homolog of;NotRelevant;;Retinitis pigmentosa 13, 600059 (3), Autosomal dominantRetinitis pigmentosa 13, 600059 (3);chr17;PRPF8, PRPC8, RP13;True
ENSG00000167716;WD repeat-containing protein 81;NotRelevant;;Cerebellar ataxia, mental retardation, and dysequilibrium syndrome 2, 610185 (3), Autosomal recessiveHydrocephalus, congenital, 3, with brain anomalies, 617967 (3);chr17;WDR81, CAMRQ2, HYC3;True
ENSG00000167711;Alpha-2-plasmin inhibitor;NotRelevant;;Alpha-2-plasmin inhibitor deficiency, 262850 (3), Autosomal recessiveAlpha-2-plasmin inhibitor deficiency, 262850 (3);chr17;PLI, SERPINF2;True
ENSG00000132386;Serpin peptidase inhibitor, clade F, member 1;NotRelevant;same region as RP13;Osteogenesis imperfecta, type VI, 613982 (3)Osteogenesis imperfecta, type VI, 613982 (3);chr17;SERPINF1, PEDF, OI6;False
ENSG00000108963;DPH1, S. cerevisiae, homolog of (ovarian cancer gene 1);NotRelevant;;Developmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3), Autosomal recessiveDevelopmental delay with short stature, dysmorphic features, and sparse hair, 616901 (3);chr17;DPH1, DPH2L1, OVCA1, DEDSSH;True
ENSG00000007168;Platelet-activating factor acetylhydrolase, isoform 1B, alpha subunit;NotRelevant;;Lissencephaly 1, 607432 (3), Isolated casesSubcortical laminar heterotopia, 607432 (3);chr17;PAFAH1B1, LIS1;False
ENSG00000108381;Aspartoacylase (aminoacylase-2);NotRelevant;;Canavan disease, 271900 (3), Autosomal recessiveCanavan disease, 271900 (3);chr17;ASPA;True
ENSG00000167723;Transient receptor potential cation channel, subfamily V, member 3;NotRelevant;mutation identified in 1 FNEPPK2 family;Olmsted syndrome, 614594 (3), Autosomal dominantOlmsted syndrome, 614594 (3);chr17;TRPV3, OLMS, FNEPPK2;True
ENSG00000197417;Sedoheptulokinase;NotRelevant;;[Sedoheptulokinase deficiency], 617213 (3), Autosomal recessive[Sedoheptulokinase deficiency], 617213 (3);chr17;SHPK, CARKL;True
ENSG00000040531;Cystinosin;NotRelevant;?3 allelic forms;Cystinosis, atypical nephropathic, 219800 (3), Autosomal recessiveCystinosis, ocular nonnephropathic, 219750 (3);chr17;CTNS;True
ENSG00000141497;Zinc finger MYND-containing protein 15;NotRelevant;mutation identified in 1 SPGF14 family;?Spermatogenic failure 14, 615842 (3), Autosomal recessive?Spermatogenic failure 14, 615842 (3);chr17;ZMYND15, SPGF14;True
ENSG00000108556;Cholinergic receptor, nicotinic, epsilon polypeptide;NotRelevant;;Myasthenic syndrome, congenital, 4A, slow-channel, 605809 (3), Autosomal recessive, Autosomal dominantMyasthenic syndrome, congenital, 4C, associated with acetylcholine receptor deficiency, 608931 (3);chr17;CHRNE, SCCMS, CMS4A, CMS4B, CMS4C;True
ENSG00000185245;Glycoprotein Ib, platelet, alpha polypeptide;NotRelevant;;Bernard-Soulier syndrome, type A1 (recessive), 231200 (3), Autosomal recessive{Nonarteritic anterior ischemic optic neuropathy, susceptibility to}, 258660 (3);chr17;GP1BA, BSS, BDPLT1, VWDP, BDPLT3;True
ENSG00000108518;Profilin-1;NotRelevant;;Amyotrophic lateral sclerosis 18, 614808 (3)Amyotrophic lateral sclerosis 18, 614808 (3);chr17;PFN1, ALS18;False
ENSG00000108515;Enolase-3, beta, muscle;NotRelevant;mutation identified in 1 GSD13 patient;?Glycogen storage disease XIII, 612932 (3), Autosomal recessive?Glycogen storage disease XIII, 612932 (3);chr17;ENO3, GSD13;True
ENSG00000129250;Kinesin family member 1C;NotRelevant;;Spastic ataxia 2, autosomal recessive, 611302 (3), Autosomal recessiveSpastic ataxia 2, autosomal recessive, 611302 (3);chr17;KIF1C, LTXS1, KIAA0706, SPAX2;True
ENSG00000132517;Solute carrier family 52, riboflavin transporter, member 1;NotRelevant;;Riboflavin deficiency, 615026 (3), Autosomal dominantRiboflavin deficiency, 615026 (3);chr17;SLC52A1, GPR172B, GPCR42, PAR2, FLJ10060, RBFVD;True
ENSG00000108561;Complement component C1q binding protein (hyaluronic acid-binding protein 1);NotRelevant;;Combined oxidative phosphorylation deficiency 33, 617713 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 33, 617713 (3);chr17;C1QBP, HABP1, COXPD33;True
ENSG00000091592;NLR family, pyrin domain containing 1;NotRelevant;;Autoinflammation with arthritis and dyskeratosis, 617388 (3), Autosomal recessive, Autosomal dominant{Vitiligo-associated multiple autoimmune disease susceptibility 1}, 606579 (3);chr17;NLRP1, NALP1, KIAA0926, DEFCAP, CARD7, SLEV1, VAMAS1, MSPC, AIADK;True
ENSG00000129221;Arylhydrocarbon-interacting receptor protein-like 1;NotRelevant;LCA1 due to GUCY2D mutation also on 17p13.1;Cone-rod dystrophy, 604393 (3), Autosomal recessiveRetinitis pigmentosa, juvenile, 604393 (3);chr17;AIPL1, LCA4;True
ENSG00000091622;Phosphatidylinositol transfer protein, membrane-associated, 3;NotRelevant;;Cone-rod dystrophy 5, 600977 (3), Autosomal dominantCone-rod dystrophy 5, 600977 (3);chr17;PITPNM3, NIR1, CORD5;True
ENSG00000198920;KIAA0753 gene;NotRelevant;mutation identified in 1 OFD15 patient;?Orofaciodigital syndrome XV, 617127 (3), Autosomal recessive?Orofaciodigital syndrome XV, 617127 (3);chr17;KIAA0753, OFIP, OFD15;True
ENSG00000141485;Solute carrier family 13 (sodium-dependent citrate transporter), member 5;NotRelevant;;Epileptic encephalopathy, early infantile, 25, 615905 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 25, 615905 (3);chr17;SLC13A5, NACT, EIEE25;True
ENSG00000072778;Acyl-Coenzyme A dehydrogenase, very long chain;NotRelevant;;VLCAD deficiency, 201475 (3), Autosomal recessiveVLCAD deficiency, 201475 (3);chr17;ACADVL, VLCAD;True
ENSG00000170175;Cholinergic receptor, nicotinic, beta polypeptide-1, muscle;NotRelevant;mutation identified in 1 CMS2C family;Myasthenic syndrome, congenital, 2A, slow-channel, 616313 (3), Autosomal dominantMyasthenic syndrome, congenital, 2A, slow-channel, 616313 (3);chr17;CHRNB1, ACHRB, SCCMS, CMS2A, CMS2C;True
ENSG00000129255;Mannose-P-dolichol utilization defect 1;NotRelevant;;Congenital disorder of glycosylation, type If, 609180 (3), Autosomal recessiveCongenital disorder of glycosylation, type If, 609180 (3);chr17;MPDU1, SL15, CDGIF;True
ENSG00000141510;Tumor protein p53;NotRelevant;;Adrenocortical carcinoma, pediatric, 202300 (3), Autosomal dominant{Glioma susceptibility 1}, 137800 (3);chr17;TP53, P53, LFS1 , BCC7, BMFS5;True
ENSG00000141499;WD repeat-containing protein antisense to TP53;NotRelevant;;Dyskeratosis congenita, autosomal recessive 3, 613988 (3), Autosomal recessiveDyskeratosis congenita, autosomal recessive 3, 613988 (3);chr17;WRAP53, TCAB1, WDR79, DKCB3;True
ENSG00000170004;Chromodomain helicase DNA binding protein-3;NotRelevant;;Snijders Blok-Campeau syndrome, 618205 (3), Autosomal dominantSnijders Blok-Campeau syndrome, 618205 (3);chr17;CHD3, SNIBCPS;True
ENSG00000132518;Guanylate cyclase 2D, membrane, retina-specific;NotRelevant;mutation identified in 1 CACD1 family;?Choroidal dystrophy, central areolar 1, 215500 (3), Autosomal recessiveLeber congenital amaurosis 1, 204000 (3);chr17;GUCY2D, GUC2D, LCA1, CORD6, RCD2, CACD1;True
ENSG00000179477;Archidonate 12-lipoxygenase, R type;NotRelevant;;Ichthyosis, congenital, autosomal recessive 2, 242100 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 2, 242100 (3);chr17;ALOX12B, ARCI2;True
ENSG00000179148;Arachidonate lipoxygenase 3;NotRelevant;;Ichthyosis, congenital, autosomal recessive 3, 606545 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 3, 606545 (3);chr17;ALOXE3, ARCI3;True
ENSG00000179111;Hairy/enhancer of split, Drosophila, homolog of, 7;NotRelevant;;Spondylocostal dysostosis 4, autosomal recessive, 613686 (3), Autosomal recessiveSpondylocostal dysostosis 4, autosomal recessive, 613686 (3);chr17;HES7, SCDO4;True
ENSG00000179029;Transmembrane protein 107;NotRelevant;mutation identified in 1 JBTS29;?Joubert syndrome 29, 617562 (3), Autosomal recessiveOrofaciodigital syndrome XVI, 617563 (3);chr17;TMEM107, MKS13, JBTS29;True
ENSG00000200463;Small nucleolar RNA,  C/D box, 118;NotRelevant;;Leukoencephalopathy, brain calcifications, and cysts, 614561 (3), Autosomal recessiveLeukoencephalopathy, brain calcifications, and cysts, 614561 (3);chr17;SNORD118, LCC;True
ENSG00000178971;Conserved telomere maintenance component 1;NotRelevant;;Cerebroretinal microangiopathy with calcifications and cysts, 612199 (3), Autosomal recessiveCerebroretinal microangiopathy with calcifications and cysts, 612199 (3);chr17;CTC1, CRMCC, C17orf68, AAF132;True
ENSG00000161970;Ribosomal protein L26;NotRelevant;mutation identified in 1 family;?Diamond-Blackfan anemia 11, 614900 (3), Autosomal dominant?Diamond-Blackfan anemia 11, 614900 (3);chr17;RPL26, DBA11;True
ENSG00000141506;Phosphatidylinositol 3-kinase, regulatory subunit 5;NotRelevant;;Ataxia-oculomotor apraxia 3, 615217 (3), Autosomal recessiveAtaxia-oculomotor apraxia 3, 615217 (3);chr17;PIK3R5, p101;True
ENSG00000133020;Myosin, heavy polypeptide-8, skeletal muscle, perinatal;NotRelevant;;Carney complex variant, 608837 (3)Trismus-pseudocamptodactyly syndrome, 158300 (3);chr17;MYH8, DA7;False
ENSG00000125414;Myosin, heavy polypeptide-2, skeletal muscle, adult;NotRelevant;;Proximal myopathy and ophthalmoplegia, 605637 (3), Autosomal recessive, Autosomal dominantProximal myopathy and ophthalmoplegia, 605637 (3);chr17;MYH2, MYPOP;True
ENSG00000109063;Myosin, heavy polypeptide-3, skeletal muscle, embryonic;NotRelevant;;Arthrogryposis, distal, type 2A, 193700 (3), Autosomal dominantArthrogryposis, distal, type 8, 178110 (3);chr17;MYH3, DA2A, DA2B, DA8;True
ENSG00000133028;SCO1 cytochrome c oxidase assembly protein;NotRelevant;;Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, MitochondrialMitochondrial complex IV deficiency, 220110 (3);chr17;SCO1, SCOD1;True
ENSG00000006744;elaC, E. coli, homolog 2;NotRelevant;at ~365cR;Combined oxidative phosphorylation deficiency 17, 615440 (3), Autosomal recessive{Prostate cancer, hereditary, 2, susceptibility to}, 614731 (3);chr17;ELAC2, HPC2, COXPD17;True
ENSG00000006695;Cytochrome c oxidase, subunit X;NotRelevant;;Leigh syndrome due to mitochondrial COX4 deficiency, 256000 (3), Autosomal recessive, MitochondrialMitochondrial complex IV deficiency, 220110 (3);chr17;COX10;True
ENSG00000109099;Peripheral myelin protein-22;NotRelevant;mutation identified in 1 CIDP family;Charcot-Marie-Tooth disease, type 1A, 118220 (3), Autosomal dominantRoussy-Levy syndrome, 180800 (3);chr17;PMP22, CMT1A, CMT1E, DSS, CIDP;True
ENSG00000011295;Tetratricopeptide repeat domain 19;NotRelevant;;Mitochondrial complex III deficiency, nuclear type 2, 615157 (3), Autosomal recessiveMitochondrial complex III deficiency, nuclear type 2, 615157 (3);chr17;TTC19, MC3DN2;True
ENSG00000108474;Phosphatidylinositol glycan, class L;NotRelevant;;CHIME syndrome, 280000 (3), Autosomal recessiveCHIME syndrome, 280000 (3);chr17;PIGL, CHIME;True
ENSG00000240505;Tumor necrosis factor receptor superfamily, member 13B;NotRelevant;;Immunodeficiency, common variable, 2, 240500 (3), Autosomal recessive, Autosomal dominantImmunoglobulin A deficiency 2, 609529 (3);chr17;TNFRSF13B, TACI, CVID2;True
ENSG00000154803;Folliculin;NotRelevant;;Birt-Hogg-Dube syndrome, 135150 (3), Autosomal dominantRenal carcinoma, chromophobe, somatic, 144700 (3);chr17;FLCN, BHD;True
ENSG00000108557;Retinoic acid-induced gene 1;NotRelevant;;Smith-Magenis syndrome, 182290 (3), Autosomal dominant, Isolated casesSmith-Magenis syndrome, 182290 (3);chr17;RAI1, SMCR, SMS;True
ENSG00000171953;ATP synthase, mitochondrial F1 complex, assembly factor 2;NotRelevant;mutation identified in 1 MC5DN1 patient;?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3), Autosomal recessive?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 1, 604273 (3);chr17;ATPAF2, ATP12, MC5DN1;True
ENSG00000091536;Myosin XVA;NotRelevant;;Deafness, autosomal recessive 3, 600316 (3), Autosomal recessiveDeafness, autosomal recessive 3, 600316 (3);chr17;MYO15A, DFNB3;True
ENSG00000177302;Topoisomerase (DNA) III, alpha;NotRelevant;mutation identified in 1 PEOB5 patient;Microcephaly, growth restriction, and increased sister chromatid exchange 2, 618097 (3), Autosomal recessiveMicrocephaly, growth restriction, and increased sister chromatid exchange 2, 618097 (3);chr17;TOP3A, MGRISCE2, PEOB5;True
ENSG00000108641;B9 domain-containing protein 1;NotRelevant;mutation identified in 1 MKS9 patient;Joubert syndrome 27, 617120 (3), Autosomal recessiveJoubert syndrome 27, 617120 (3);chr17;B9D1, MKSR1, MKS9, JBTS27;True
ENSG00000072210;Aldehyde dehydrogenase 3 family, member A2 (fatty aldehyde dehydrogenase);NotRelevant;;Sjogren-Larsson syndrome, 270200 (3), Autosomal recessiveSjogren-Larsson syndrome, 270200 (3);chr17;ALDH3A2, ALDH10, SLS, FALDH;True
ENSG00000108599;A-kinase anchor protein 10;NotRelevant;;{Cardiac conduction defect, susceptibility to}, 115080 (3), Autosomal dominant{Cardiac conduction defect, susceptibility to}, 115080 (3);chr17;AKAP10;True
ENSG00000260458;Potassium channel, inwardly rectifying, subfamily J, member 18;NotRelevant;;{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3), Isolated cases{Thyrotoxic periodic paralysis, susceptibility to, 2}, 613239 (3);chr17;KCNJ18, KIR2.6, TTPP2;False
ENSG00000007171;Nitric oxide synthase 2A, inducible, hepatocytes;NotRelevant;?cluster of 3 NOS2 genes;{Hypertension, susceptibility to}, 145500 (2), Multifactorial{Malaria, resistance to}, 611162 (3);chr17;NOS2A, NOS2;False
ENSG00000244045;Transmembrane protein 199;NotRelevant;;Congenital disorder of glycosylation, type IIp, 616829 (3), Autosomal recessiveCongenital disorder of glycosylation, type IIp, 616829 (3);chr17;TMEM199, VMA12, VPH2, C17orf32, CDG2P;True
ENSG00000076351;Solute carrier family 46 (folate transporter), member 1;NotRelevant;;Folate malabsorption, hereditary, 229050 (3), Autosomal recessiveFolate malabsorption, hereditary, 229050 (3);chr17;SLC46A1, HCP1, PCFT;True
ENSG00000109101;Forkhead box N1 (winged helix nude);NotRelevant;;T-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3), Autosomal recessiveT-cell immunodeficiency, congenital alopecia, and nail dystrophy, 601705 (3);chr17;FOXN1, WHN;True
ENSG00000109103;Unc119, C. elegans, homolog of (human retinal gene 4);NotRelevant;mutation identified in 1 IMD13 family and CORD family;?Cone-rod dystrophy (3)?Immunodeficiency 13, 615518 (3);chr17;UNC119, HRG4, IMD13;False
ENSG00000087111;Phosphatidylinositol glycan, class S;NotRelevant;;Glycosylphosphatidylinositol biosynthesis defect 18, 618143 (3), Autosomal recessiveGlycosylphosphatidylinositol biosynthesis defect 18, 618143 (3);chr17;PIGS, GPIBD18;True
ENSG00000160602;Never in mitosis gene A-related kinase 8;NotRelevant;mutations identified in 1 family with NPHP9;?Nephronophthisis 9, 613824 (3)Renal-hepatic-pancreatic dysplasia 2, 615415 (3);chr17;NEK8, JCK, NPHP9, RHPD2;False
ENSG00000132591;ERA G-protein-like 1;NotRelevant;;Perrault syndrome 6, 617565 (3), Autosomal recessivePerrault syndrome 6, 617565 (3);chr17;ERAL1, ERAL1A, ERAL1B, PRLTS6;True
ENSG00000108255;Crystallin, beta A1;NotRelevant;centromeric to NF1;Cataract 10, multiple types, 600881 (3), Autosomal dominantCataract 10, multiple types, 600881 (3);chr17;CRYBA1, CRYB1, CTRCT10;True
ENSG00000108576;Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4;NotRelevant;;{Anxiety-related personality traits}, 607834 (3){Obsessive-compulsive disorder}, 164230 (3);chr17;SLC6A4, HTT, OCD1;False
ENSG00000181481;Ring finger protein 135;NotRelevant;;Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3)Macrocephaly, macrosomia, facial dysmorphism syndrome, 614192 (3);chr17;RNF135, MMFD;False
ENSG00000196712;Neurofibromin (neurofibromatosis, type I);NotRelevant;;Leukemia, juvenile myelomonocytic, 607785 (3), Autosomal dominant, Somatic mutationWatson syndrome, 193520 (3);chr17;NF1, VRNF, WSS, NFNS;True
ENSG00000006042;Transmembrane protein 98;NotRelevant;;Nanophthalmos 4, 615972 (3), Autosomal dominantNanophthalmos 4, 615972 (3);chr17;TMEM98, NNO4;True
ENSG00000108691;Small inducible cytokine A2 (monocyte chemotactic protein, homologous to mouse Sig-je);NotRelevant;;{Coronary artery disease, modifier of} (3){Spina bifida, susceptibility to}, 182940 (3);chr17;CCL2, SCYA2, MCP1, MCAF;False
ENSG00000172156;Chemokine, C-C motif, ligand 11;NotRelevant;;{Asthma, susceptibility to}, 600807 (3), Autosomal dominant{HIV1, resistance to}, 609423 (3);chr17;CCL11, SCYA11;True
ENSG00000185379;RAD51, S. cerevisiae, homolog of, D;NotRelevant;;{Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3){Breast-ovarian cancer, familial, susceptibility to, 4}, 614291 (3);chr17;RAD51D, RAD51L3, BROVCA4;False
ENSG00000141161;UNC45, C. elegans, homolog of, B;NotRelevant;mutation identified in 1 CTRCT43 family;?Cataract 43, 616279 (3), Autosomal dominant?Cataract 43, 616279 (3);chr17;UNC45B, SMUNC45, CTRCT43;True
ENSG00000236320;Schlafen family, member 14;NotRelevant;;Bleeding disorder, platelet-type, 20, 616913 (3), Autosomal dominantBleeding disorder, platelet-type, 20, 616913 (3);chr17;SLFN14, BDPLT20;True
ENSG00000108733;Peroxisome biogenesis factor 12;NotRelevant;;Peroxisome biogenesis disorder 3A (Zellweger), 614859 (3), Autosomal recessivePeroxisome biogenesis disorder 3B, 266510 (3);chr17;PEX12, PBD3A;True
ENSG00000270647;TAF15 RNA polymerase II, TATA box-binding protein-associated factor, 68kD;NotRelevant;fusion gene with CSMF;Chondrosarcoma, extraskeletal myxoid, 612237 (1)Chondrosarcoma, extraskeletal myxoid, 612237 (1);chr17;TAF15, TAF2N, RBP56;False
ENSG00000271503;Chemokine, C-C motif, ligand 5;NotRelevant;;{HIV-1 disease, delayed progression of} (3){HIV-1 disease, rapid progression of} (3);chr17;CCL5, SCYA5, D17S136E, TCP228;False
ENSG00000277632;Chemokine, C-C motif, ligand 3;NotRelevant;in 47kb, CCL18-CCL3-CCL4;{HIV infection, resistance to}, 609423 (2){HIV infection, resistance to}, 609423 (2);chr17;CCL3, SCYA3, MIP1A;False
ENSG00000273611;Zinc finger HIT domain-containing protein 3;NotRelevant;;PEHO syndrome, 260565 (3), Autosomal recessivePEHO syndrome, 260565 (3);chr17;ZNHIT3, TRIP3, PEHO;True
ENSG00000277161;Phosphatidylinositol glycan, class W;NotRelevant;;Glycosylphosphatidylinositol biosynthesis defect 11, 616025 (3), Autosomal recessiveGlycosylphosphatidylinositol biosynthesis defect 11, 616025 (3);chr17;PIGW, HPMRS5;True
ENSG00000278540;Acetyl-Coenzyme A carboxylase, alpha;NotRelevant;proximal to q21.33; others put at 17q12Acetyl-CoA carboxylase deficiency, 613933 (1);chr17;ACACA, ACAC, ACC1, ACACAD;False
ENSG00000275410;HNF1 homeobox B (transcription factor 2);NotRelevant;;Diabetes mellitus, noninsulin-dependent, 125853 (3), Autosomal dominant{Renal cell carcinoma}, 144700 (3);chr17;HNF1B, TCF2, HNF2, MODY5, FJHN, HPC11;True
ENSG00000277399;G protein-coupled receptor 179;NotRelevant;;Night blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3), Autosomal recessiveNight blindness, congenital stationary (complete), 1E, autosomal recessive, 614565 (3);chr17;GPR179, GPR158L, GPR158L1, CSNB1E;True
ENSG00000173991;Telethonin;NotRelevant;;Cardiomyopathy, hypertrophic, 25, 607487 (3), Autosomal dominantMuscular dystrophy, limb-girdle, autosomal recessive 7, 601954 (3);chr17;TCAP, LGMDR7, CMH25;True
ENSG00000161395;Post-GPI attachment to proteins 3;NotRelevant;;Hyperphosphatasia with mental retardation syndrome 4, 615716 (3), Autosomal recessiveHyperphosphatasia with mental retardation syndrome 4, 615716 (3);chr17;PGAP3, PERLD1, CAB2, MGC9753, HPMRS4;True
ENSG00000141736;Avian erythroblastic leukemia viral (v-erb-b2) oncogene homolog 2 (neuro/glioblastoma derived oncogene homolog);NotRelevant;;Adenocarcinoma of lung, somatic, 211980 (3)Ovarian cancer, somatic, (3);chr17;ERBB2, NGL, NEU, HER2;False
ENSG00000126351;Thyroid hormone receptor, alpha (oncogene ERBA1);NotRelevant;;Hypothyroidism, congenital, nongoitrous, 6, 614450 (3), Autosomal dominantHypothyroidism, congenital, nongoitrous, 6, 614450 (3);chr17;THRA, ERBA1, THRA1, CHNG6;True
ENSG00000094804;Cell division cycle 6, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 MGORS5 patient;?Meier-Gorlin syndrome 5, 613805 (3), Autosomal recessive?Meier-Gorlin syndrome 5, 613805 (3);chr17;CDC6, CDC18L, MGORS5;True
ENSG00000131759;Retinoic acid receptor, alpha polypeptide;NotRelevant;fused with MYL in APL;Leukemia, acute promyelocytic, 612376 (1)Leukemia, acute promyelocytic, 612376 (1);chr17;RARA;False
ENSG00000131747;Topoisomerase (DNA) II, alpha, 170kD;NotRelevant;;DNA topoisomerase II, resistance to inhibition of, by amsacrine (3)DNA topoisomerase II, resistance to inhibition of, by amsacrine (3);chr17;TOP2A, TOP2;False
ENSG00000073584;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily E, member 1;NotRelevant;;Coffin-Siris syndrome 5, 616938 (3), Autosomal dominant{Meningioma, familial, susceptibility to}, 607174 (3);chr17;SMARCE1, BAF57, CSS5;True
ENSG00000204897;Keratin 25, type I;NotRelevant;;Woolly hair, autosomal recessive 3, 616760 (3), Autosomal recessiveWoolly hair, autosomal recessive 3, 616760 (3);chr17;KRT25, K25, KRT24IRS1, ARWH3;True
ENSG00000186395;Keratin 10;NotRelevant;in cluster of class I keratins;Epidermolytic hyperkeratosis, 113800 (3), Autosomal recessive, Autosomal dominantIchthyosis, cyclic, with epidermolytic hyperkeratosis, 607602 (3);chr17;KRT10, EHK, BCIE, BIE;True
ENSG00000187242;Keratin 12;NotRelevant;;Meesmann corneal dystrophy, 122100 (3), Autosomal dominantMeesmann corneal dystrophy, 122100 (3);chr17;KRT12;True
ENSG00000171401;Keratin 13;NotRelevant;in same PFGE fragment as KRT10, KRT15;White sponge nevus 2, 615785 (3), Autosomal dominantWhite sponge nevus 2, 615785 (3);chr17;KRT13, WSN2;True
ENSG00000171403;Keratin 9;NotRelevant;;Palmoplantar keratoderma, epidermolytic, 144200 (3), Autosomal dominantPalmoplantar keratoderma, epidermolytic, 144200 (3);chr17;KRT9, EPPK;True
ENSG00000186847;Keratin 14;NotRelevant;;Dermatopathia pigmentosa reticularis, 125595 (3), Autosomal dominantNaegeli-Franceschetti-Jadassohn syndrome, 161000 (3);chr17;KRT14;True
ENSG00000186832;Keratin 16;NotRelevant;probably 17q21-q22;Pachyonychia congenita 1, 167200 (3), Autosomal dominantPalmoplantar keratoderma, nonepidermolytic, focal, 613000 (3);chr17;KRT16, FNEPPK, PC1;True
ENSG00000128422;Keratin 17;NotRelevant;~5' to KRT16; probably 17q21-q22Steatocystoma multiplex, 184500 (3);chr17;KRT17, PC2, PCHC1;False
ENSG00000173801;Junction plakoglobin;NotRelevant;incorrectly mapped to 7; close to BRCA1Naxos disease, 601214 (3);chr17;JUP, DP3, PDGB, ARVD12;False
ENSG00000141756;FK506-binding protein 10;NotRelevant;;Bruck syndrome 1, 259450 (3), Autosomal recessiveOsteogenesis imperfecta, type XI, 610968 (3);chr17;FKBP10, FKBP65, OI11, BRKS1;True
ENSG00000161594;Kelch-like 10;NotRelevant;;Spermatogenic failure 11, 615081 (3), Autosomal dominantSpermatogenic failure 11, 615081 (3);chr17;KLHL10, SPGF11;True
ENSG00000204815;Tetratricopeptide repeat domain-containing protein 25;NotRelevant;;Ciliary dyskinesia, primary, 35, 617092 (3), Autosomal recessiveCiliary dyskinesia, primary, 35, 617092 (3);chr17;TTC25, CILD35;True
ENSG00000161610;Hypocretin;NotRelevant;mutation identified in 1 NRCLP1 patient;?Narcolepsy 1, 161400 (3), Autosomal dominant?Narcolepsy 1, 161400 (3);chr17;HCRT, OX, NRCLP1;True
ENSG00000173757;Signal transducer and activator of transcription 5B;NotRelevant;fused with RARA in PML;Growth hormone insensitivity with immunodeficiency, 245590 (3)Leukemia, acute promyelocytic, somatic, 102578 (3);chr17;STAT5B;False
ENSG00000168610;Signal transducer and activator of transcription-3 (acute-phase response factor);NotRelevant;;Autoimmune disease, multisystem, infantile-onset, 1, 615952 (3), Autosomal dominantHyper-IgE recurrent infection syndrome, 147060 (3);chr17;STAT3, APRF, HIES, ADMIO1;True
ENSG00000177469;Caveolae-associated protein 1;NotRelevant;;Lipodystrophy, congenital generalized, type 4, 613327 (3), Autosomal recessiveLipodystrophy, congenital generalized, type 4, 613327 (3);chr17;CAVIN1, PTRF;True
ENSG00000108784;N-acetylglucosaminidase, alpha-;NotRelevant;mutation identified in 1 CMT2V family;?Charcot-Marie-Tooth disease, axonal, type 2V, 616491 (3), Autosomal dominantMucopolysaccharidosis type IIIB (Sanfilippo B), 252920 (3);chr17;NAGLU, MPS3B, CMT2V;True
ENSG00000068120;Coenzyme A synthase;NotRelevant;;Neurodegeneration with brain iron accumulation 6, 615643 (3), Autosomal recessiveNeurodegeneration with brain iron accumulation 6, 615643 (3);chr17;COASY, NBIA6;True
ENSG00000131470;PSMC3-interacting protein;NotRelevant;;Ovarian dysgenesis 3, 614324 (3), Autosomal recessiveOvarian dysgenesis 3, 614324 (3);chr17;PSMC3IP, TBPIP, GT198, HOP2, ODG3;True
ENSG00000131462;Tubulin, gamma 1;NotRelevant;;Cortical dysplasia, complex, with other brain malformations 4, 615412 (3), Autosomal dominantCortical dysplasia, complex, with other brain malformations 4, 615412 (3);chr17;TUBG1, CDCBM4;True
ENSG00000108797;Contactin-associated protein 1;NotRelevant;;Hypomyelinating neuropathy, congenital, 3, 618186 (3), Autosomal recessiveLethal congenital contracture syndrome 7, 616286 (3);chr17;CNTNAP1, CASPR, P190, CHN3;True
ENSG00000126562;WNK lysine deficient protein kinase 4;NotRelevant;;Pseudohypoaldosteronism, type IIB, 614491 (3), Autosomal dominantPseudohypoaldosteronism, type IIB, 614491 (3);chr17;WNK4, PRKWNK4, PHA2B;True
ENSG00000131482;Glucose-6-phosphatase, catalytic;NotRelevant;;Glycogen storage disease Ia, 232200 (3), Autosomal recessiveGlycogen storage disease Ia, 232200 (3);chr17;G6PC, G6PT;True
ENSG00000131469;Ribosomal protein L27;NotRelevant;mutation identified in 1 DBA16 patient;?Diamond-Blackfan anemia 16, 617408 (3), Autosomal dominant?Diamond-Blackfan anemia 16, 617408 (3);chr17;RPL27, DBA16;True
ENSG00000012048;Breast cancer-1 gene;NotRelevant;;{Breast-ovarian cancer, familial, 1}, 604370 (3), Autosomal dominant, Multifactorial{Pancreatic cancer, susceptibility to, 4}, 614320 (3);chr17;BRCA1, PSCP, BROVCA1, PNCA4, FANCS;True
ENSG00000005102;Mesenchyme homeo box 1 (Mox1, mouse, homolog of);NotRelevant;;Klippel-Feil syndrome 2, 214300 (3), Autosomal recessiveKlippel-Feil syndrome 2, 214300 (3);chr17;MEOX1, MOX1, KFS2;True
ENSG00000167941;Sclerostin;NotRelevant;;Craniodiaphyseal dysplasia, autosomal dominant, 122860 (3), Autosomal dominantVan Buchem disease, 239100 (3);chr17;SOST, VBCH, CDD, SOST1;True
ENSG00000161653;N-acetylglutamate synthase;NotRelevant;;N-acetylglutamate synthase deficiency, 237310 (3), Autosomal recessiveN-acetylglutamate synthase deficiency, 237310 (3);chr17;NAGS;True
ENSG00000141349;Glucose-6-phosphatase, catalytic, 3;NotRelevant;;Dursun syndrome, 612541 (3), Autosomal recessiveNeutropenia, severe congenital 4, autosomal recessive, 612541 (3);chr17;G6PC3, UGRP, SCN4;True
ENSG00000108312;Upstream binding transcription factor, RNA polymerase I;NotRelevant;;Neurodegeneration, childhood-onset, with brain atrophy, 617672 (3), Autosomal dominantNeurodegeneration, childhood-onset, with brain atrophy, 617672 (3);chr17;UBTF, UBF, CONDBA;True
ENSG00000004939;Solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group);NotRelevant;;[Blood group, Diego], 110500 (3)[Malaria, resistance to], 611162 (3);chr17;SLC4A1, AE1, EPB3, SPH4, SAO, CHC;False
ENSG00000030582;Granulin;NotRelevant;;Aphasia, primary progressive, 607485 (3), Autosomal dominantFrontotemporal lobar degeneration with ubiquitin-positive inclusions, 607485 (3);chr17;GRN, CLN11;True
ENSG00000005961;Integrin, alpha-2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41B);NotRelevant;3' to GP3A; BAK platelet antigenThrombocytopenia, neonatal alloimmune, BAK antigen related (3);chr17;ITGA2B, GP2B, CD41B, GT, BDPLT2, BDPLT16;False
ENSG00000108883;Elongation factor Tu GTP-binding domain-containing 2;NotRelevant;;Mandibulofacial dysostosis, Guion-Almeida type, 610536 (3), Autosomal dominantMandibulofacial dysostosis, Guion-Almeida type, 610536 (3);chr17;EFTUD2, KIAA0031, MFDGA;True
ENSG00000167131;Coiled-coil domain-containing protein 103;NotRelevant;;Ciliary dyskinesia, primary, 17, 614679 (3), Autosomal recessiveCiliary dyskinesia, primary, 17, 614679 (3);chr17;CCDC103, SMH, PR46B, CILD17;True
ENSG00000131095;Glial fibrillary acidic protein;NotRelevant;;Alexander disease, 203450 (3), Autosomal dominantAlexander disease, 203450 (3);chr17;GFAP, ALXDRD;True
ENSG00000225190;Pleckstrin homology domain-containing protein, family M, member 1;NotRelevant;mutation identified in 1 OPTB6 family;Osteopetrosis, autosomal dominant 3, 618107 (3), Autosomal dominantOsteopetrosis, autosomal dominant 3, 618107 (3);chr17;PLEKHM1, AP162, KIAA0356, OPTB6, OPTA3;True
ENSG00000186868;Microtubule-associated protein tau;NotRelevant;see 6p21;Dementia, frontotemporal, with or without parkinsonism, 600274 (3), Autosomal dominant{Parkinson disease, susceptibility to}, 168600 (3);chr17;MAPT, MTBT1, DDPAC, MSTD;True
ENSG00000120071;KAT8 regulatory NSL complex subunit 1;NotRelevant;;Koolen-De Vries syndrome, 610443 (3), Autosomal dominantKoolen-De Vries syndrome, 610443 (3);chr17;KANSL1, KIAA1267, MSL1V1, KDVS;True
ENSG00000108379;Wingless-type MMTV integration site family, member 3;NotRelevant;mutation identified in 1 TETAMS1 family;?Tetra-amelia syndrome 1, 273395 (3), Autosomal recessive?Tetra-amelia syndrome 1, 273395 (3);chr17;WNT3, INT4, TETAMS;True
ENSG00000108433;Golgi snap receptor complex member 2;NotRelevant;;Epilepsy, progressive myoclonic 6, 614018 (3), Autosomal recessiveEpilepsy, progressive myoclonic 6, 614018 (3);chr17;GOSR2, GS27, EPM6;True
ENSG00000198336;Myosin, light polypeptide-4, alkali, atrial, embryonic;NotRelevant;mutation identified in 1 ATFB18 family;?Atrial fibrillation, familial, 18, 617280 (3), Autosomal dominant?Atrial fibrillation, familial, 18, 617280 (3);chr17;MYL4;True
ENSG00000259207;Integrin, beta-3 (platelet glycoprotein IIIa;NotRelevant;ENSG00000259207;in same 260kb fragment as GP2B{Myocardial infarction, susceptibility to}, 608446 (3);chr17;ITGB3, GP3A, GT, BDPLT2, BDPLT16;False
ENSG00000073861;T-box 21;NotRelevant;;Asthma and nasal polyps, 208550 (3), Autosomal recessive{Asthma, aspirin-induced, susceptibility to}, 208550 (3);chr17;TBX21, TBET;True
ENSG00000108439;Pyridoxamine 5'-phosphate oxidase;NotRelevant;;Pyridoxamine 5'-phosphate oxidase deficiency, 610090 (3), Autosomal recessivePyridoxamine 5'-phosphate oxidase deficiency, 610090 (3);chr17;PNPO;True
ENSG00000120094;Homeo box-B1;NotRelevant;;Facial paresis, hereditary congenital, 3, 614744 (3), Autosomal recessiveFacial paresis, hereditary congenital, 3, 614744 (3);chr17;HOXB1, HOX2I, HCFP3;True
ENSG00000159184;Homeo box B13;NotRelevant;;{Prostate cancer, hereditary, 9}, 610997 (3){Prostate cancer, hereditary, 9}, 610997 (3);chr17;HOXB13, HPC9;False
ENSG00000167085;Prohibitin;NotRelevant;;{Breast cancer, susceptibility to}, 114480 (3), Autosomal dominant, Somatic mutation{Breast cancer, susceptibility to}, 114480 (3);chr17;PHB;True
ENSG00000064300;Nerve growth factor receptor;NotRelevant;distal to APL breakpoint, q21; < 0.5mb from HOX2;chr17;NGFR, TNFRSF16;False
ENSG00000108813;Distal-less homeo box-4;NotRelevant;mutation identified in 1 OFC15 family;?Orofacial cleft 15, 616788 (3), Autosomal dominant?Orofacial cleft 15, 616788 (3);chr17;DLX4, DLX7, DLX8, OFC15;True
ENSG00000064195;Distal-less homeo box-3;NotRelevant;;Amelogenesis imperfecta, type IV, 104510 (3), Autosomal dominantTrichodontoosseous syndrome, 190320 (3);chr17;DLX3, TDO, AI4;True
ENSG00000005884;Integrin, alpha-3;NotRelevant;;Interstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3), Autosomal recessiveInterstitial lung disease, nephrotic syndrome, and epidermolysis bullosa, congenital, 614748 (3);chr17;ITGA3, CD49C, GAPB3, ILNEB;True
ENSG00000108823;Sarcoglycan, alpha (50kD dystrophin-associated glycoprotein;NotRelevant;ENSG00000108823;Muscular dystrophy, limb-girdle, autosomal recessive 3, 608099 (3);chr17;SGCA, ADL, DAG2, LGMDR3;True
ENSG00000108821;Collagen I, alpha-1 polypeptide;NotRelevant;fused with PDGFB in DFPB;{Bone mineral density variation QTL, osteoporosis}, 166710 (3), Autosomal dominant{Bone mineral density variation QTL, osteoporosis}, 166710 (3);chr17;COL1A1, OI1, OI2, OI3, OI4, EDSARTH1;True
ENSG00000015532;Xylosyltransferase 2;NotRelevant;;{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3), Autosomal recessive{Pseudoxanthoma elasticum, modifier of severity of}, 264800 (3);chr17;XYLT2, XT2, SOS;True
ENSG00000006283;Calcium channel, voltage-dependent, T type, alpha-1G subunit;NotRelevant;;Spinocerebellar ataxia 42, 616795 (3), Autosomal dominantSpinocerebellar ataxia 42, early-onset, severe, with neurodevelopmental deficits, 618087 (3);chr17;CACNA1G, SCA42, SCA42ND;True
ENSG00000239672;Non-metastatic cells 1, protein (NM23A) expressed in;NotRelevant;;Neuroblastoma, 256700 (3), Autosomal dominant, Isolated casesNeuroblastoma, 256700 (3);chr17;NME1, NM23;True
ENSG00000183691;Noggin, mouse, homolog of;NotRelevant;;Brachydactyly, type B2, 611377 (3), Autosomal dominantTarsal-carpal coalition syndrome, 186570 (3);chr17;NOG, SYM1, SYNS1A;True
ENSG00000153933;Diacylglycerol kinase, epsilon, 64-kD;NotRelevant;;{Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3), Autosomal recessive{Hemolytic uremic syndrome, atypical, susceptibility to, 7}, 615008 (3);chr17;DGKE, NPHS7, AHUS7;True
ENSG00000121053;Eosinophil peroxidase;NotRelevant;;[Eosinophil peroxidase deficiency], 261500 (3), Autosomal recessive[Eosinophil peroxidase deficiency], 261500 (3);chr17;EPX, EPXD;True
ENSG00000011143;MKS1 gene;NotRelevant;frequent in Finland;Bardet-Biedl syndrome 13, 615990 (3), Autosomal recessiveMeckel syndrome 1, 249000 (3);chr17;MKS1, MKS, BBS13, JBTS28;True
ENSG00000005381;Myeloperoxidase;NotRelevant;translocated in t(15;17)(q22{Lung cancer, protection against, in smokers} (3);chr17;MPO;False
ENSG00000108375;Ring finger protein 43;NotRelevant;;Sessile serrated polyposis cancer syndrome, 617108 (3), Autosomal dominantSessile serrated polyposis cancer syndrome, 617108 (3);chr17;RNF43, RNF124, SSPCS;True
ENSG00000121101;Testis-expressed gene 14;NotRelevant;mutation identified in 1 SPGF23 family;?Spermatogenic failure 23, 617707 (3), Autosomal recessive?Spermatogenic failure 23, 617707 (3);chr17;TEX14, SPGF23;True
ENSG00000108384;RAD51, S. cerevisiae, homolog of, C;NotRelevant;;{Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3){Breast-ovarian cancer, familial, susceptibility to, 3}, 613399 (3);chr17;RAD51C, FANCO, BROVCA3;False
ENSG00000108395;Tripartite motif-containing 37;NotRelevant;;Mulibrey nanism, 253250 (3), Autosomal recessiveMulibrey nanism, 253250 (3);chr17;TRIM37, MUL, KIAA0898;True
ENSG00000141367;Clathrin, heavy polypeptide (Hc);NotRelevant;fusion gene with TFE3 in renal adenocarcinoma;Mental retardation, autosomal dominant 56, 617854 (3)Mental retardation, autosomal dominant 56, 617854 (3);chr17;CLTC, MRD56;True
ENSG00000141378;Peptidyl-tRNA hydrolase 2;NotRelevant;;Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3), Autosomal recessiveInfantile-onset multisystem neurologic, endocrine, and pancreatic disease, 616263 (3);chr17;PTRH2, BIT1, IMNEPD;True
ENSG00000167434;Carbonic anhydrase IV;NotRelevant;;Retinitis pigmentosa 17, 600852 (3), Autosomal dominantRetinitis pigmentosa 17, 600852 (3);chr17;CA4, RP17;True
ENSG00000170836;Protein phosphatase, magnesium-dependent, 1, delta isoform;NotRelevant;amplified in breast cancer;Breast cancer, somatic, 114480 (3)Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, 617450 (3);chr17;PPM1D, WIP1, IDDGIP;False
ENSG00000121068;T-box 2;NotRelevant;;Vertebral anomalies and variable endocrine and T-cell dysfunction, 618223 (3), Autosomal dominantVertebral anomalies and variable endocrine and T-cell dysfunction, 618223 (3);chr17;TBX2, VETD;True
ENSG00000121075;T-box 4;NotRelevant;;Ischiocoxopodopatellar syndrome, 147891 (3), Autosomal dominantIschiocoxopodopatellar syndrome, 147891 (3);chr17;TBX4, ICPPS;True
ENSG00000136492;BRCA1-associated C-terminal helicase 1;NotRelevant;?or 17q23;Breast cancer, early-onset, 114480 (3), Autosomal dominant, Somatic mutationFanconi anemia, complementation group J, 609054 (3);chr17;BRIP1, BACH1, FANCJ;True
ENSG00000146872;Tousled-like kinase 2;NotRelevant;;Mental retardation, autosomal dominant 57, 618050 (3), Autosomal dominantMental retardation, autosomal dominant 57, 618050 (3);chr17;TLK2, MRD57;True
ENSG00000008283;Cytochrome b-561;NotRelevant;;Orthostatic hypotension 2, 618182 (3), Autosomal recessiveOrthostatic hypotension 2, 618182 (3);chr17;CYB561, ORTHYP2;True
ENSG00000159640;Angiotensin I converting enzyme (dipeptidyl carboxypeptidase-1);NotRelevant;;[Angiotensin I-converting enzyme, benign serum increase] (3){Stroke, hemorrhagic}, 614519 (3);chr17;ACE, DCP1, ACE1, MVCD3, ICH;False
ENSG00000136463;Translational activator of mitochondrially encoded cytochrome c oxidase subunit I;NotRelevant;;Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, MitochondrialMitochondrial complex IV deficiency, 220110 (3);chr17;TACO1, CCDC44;True
ENSG00000266173;STE20-related kinase adaptor alpha;NotRelevant;;Polyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3), Autosomal recessivePolyhydramnios, megalencephaly, and symptomatic epilepsy, 611087 (3);chr17;STRADA, STRAD, LYK5;True
ENSG00000108588;Coiled-coil domain-containing protein 47;NotRelevant;;Trichohepatoneurodevelopmental syndrome, 618268 (3)Trichohepatoneurodevelopmental syndrome, 618268 (3);chr17;CCDC47, THNS;False
ENSG00000108604;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily d, member 2;NotRelevant;;Specific granule deficiency 2, 617475 (3), Autosomal recessiveSpecific granule deficiency 2, 617475 (3);chr17;SMARCD2, BAF60B, SGD2;True
ENSG00000136488;Chorionic somatomammotropin hormone-1;NotRelevant;;[Placental lactogen deficiency] (1)[Placental lactogen deficiency] (1);chr17;CSH1, CSA, PL;False
ENSG00000259384;Growth hormone-1;NotRelevant;5'-GH1-CSHP1-CSH1-GH2-CSH2-3';Growth hormone deficiency, isolated, type IA, 262400 (3), Autosomal recessiveKowarski syndrome, 262650 (3);chr17;GH1, GHN, IGHD1A, IGHD1B, IGHD2;True
ENSG00000007312;CD79B antigen;NotRelevant;;Agammaglobulinemia 6, 612692 (3), Autosomal recessiveAgammaglobulinemia 6, 612692 (3);chr17;CD79B, IGB, B29, AGM6;True
ENSG00000007314;Sodium channel, voltage-gated, type IV, alpha polypeptide;NotRelevant;21.5kb from GH1;Hyperkalemic periodic paralysis, type 2, 170500 (3), Autosomal dominantParamyotonia congenita, 168300 (3);chr17;SCN4A, HYPP, NAC1A, HOKPP2, CMS16;True
ENSG00000256525;Polymerase, DNA, gamma-2;NotRelevant;;Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3), Autosomal dominantProgressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 4, 610131 (3);chr17;POLG2, POLGB, PEOA4;True
ENSG00000108370;Regulator of G protein signaling 9;NotRelevant;;Bradyopsia, 608415 (3)Bradyopsia, 608415 (3);chr17;RGS9, PERRS;False
ENSG00000168646;Axis inhibitor 2 (conductin, mouse, homolog of);NotRelevant;;Colorectal cancer, somatic, 114500 (3)Oligodontia-colorectal cancer syndrome, 608615 (3);chr17;AXIN2, ODCRCS;False
ENSG00000154229;Protein kinase C, alpha polypeptide;NotRelevant;cen-COL1A1-PKCA-GH1;Pituitary tumor, invasive (3)Pituitary tumor, invasive (3);chr17;PRKCA, PKCA;False
ENSG00000197170;Proteasome 26S subunit, non-ATPase, 12;NotRelevant;;Stankiewicz-Isidor syndrome, 617516 (3), Autosomal dominantStankiewicz-Isidor syndrome, 617516 (3);chr17;PSMD12, P55, STISS;True
ENSG00000171634;Bromodomain PHD finger transcription factor;NotRelevant;;Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3), Autosomal dominantNeurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3);chr17;BPTF, FALZ, FAC1, NURF301, NEDDFL;True
ENSG00000141337;Arylsulfatase G;NotRelevant;;Usher syndrome, type IV, 618144 (3), Autosomal recessiveUsher syndrome, type IV, 618144 (3);chr17;ARSG, KIAA1001, USH4;True
ENSG00000108946;Protein kinase, cAMP-dependent, regulatory, type I, alpha;NotRelevant;fused with RET to form PTC2;Acrodysostosis 1, with or without hormone resistance, 101800 (3), Autosomal dominantPigmented nodular adrenocortical disease, primary, 1, 610489 (3);chr17;PRKAR1A, TSE1, CNC1, CAR, PPNAD1, ACRDYS1;True
ENSG00000108950;Family with sequence similarity 20, member A;NotRelevant;;Amelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3), Autosomal recessiveAmelogenesis imperfecta, type IG (enamel-renal syndrome), 204690 (3);chr17;FAM20A, AIGFS, AI1G;True
ENSG00000154265;ATP-binding cassette, subfamily A, member 5;NotRelevant;mutation identified in 1 HTC3 patient;?Hypertrichosis, congenital generalized, with gingival hyperplasia, 135400 (3), Autosomal recessive?Hypertrichosis, congenital generalized, with gingival hyperplasia, 135400 (3);chr17;ABCA5, KIAA1888, HTC3;True
ENSG00000123700;Potassium channel, inwardly rectifying, subfamily J, member 2;NotRelevant;;Andersen syndrome, 170390 (3), Autosomal dominantShort QT syndrome 3, 609622 (3);chr17;KCNJ2, HHIRK1, KIR2.1, IRK1, LQT7, SQT3, ATFB9;True
ENSG00000125398;SRY (sex-determining region Y)-box 9;NotRelevant;;Acampomelic campomelic dysplasia, 114290 (3), Autosomal dominantCampomelic dysplasia, 114290 (3);chr17;SOX9, CMD1, SRA1;True
ENSG00000166685;Component of oligomeric golgi complex 1;NotRelevant;;Congenital disorder of glycosylation, type IIg, 611209 (3)Congenital disorder of glycosylation, type IIg, 611209 (3);chr17;COG1, LDLB, KIAA1381, CDG2G;False
ENSG00000171595;Dynein, axonemal, intermediate chain 2;NotRelevant;;Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3)Ciliary dyskinesia, primary, 9, with or without situs inversus, 612444 (3);chr17;DNAI2, CILD9;False
ENSG00000109062;Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulatory factor 1;NotRelevant;;Nephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3), Autosomal dominantNephrolithiasis/osteoporosis, hypophosphatemic, 2, 612287 (3);chr17;SLC9A3R1, EBP50, NHERF1, NPHLOP2;True
ENSG00000161513;Ferredoxin reductase (adrenodoxin reductase);NotRelevant;;Auditory neuropathy and optic atrophy, 617717 (3), Autosomal recessiveAuditory neuropathy and optic atrophy, 617717 (3);chr17;FDXR, ADXR, ANOA;True
ENSG00000182040;Scaffold protein containing ankyrin repeats and SAM domain;NotRelevant;?allelic to DFNA20;Usher syndrome, type 1G, 606943 (3), Autosomal recessiveUsher syndrome, type 1G, 606943 (3);chr17;SANS, USH1G;True
ENSG00000125450;Nucleoporin 85kD;NotRelevant;;Nephrotic syndrome, type 17, 618176 (3), Autosomal recessiveNephrotic syndrome, type 17, 618176 (3);chr17;NUP85, PCNT1, PCNT, NPHS17;True
ENSG00000125445;Mitochondrial ribosomal protein S7;NotRelevant;mutation identified in 1 COXPD34 family;?Combined oxidative phosphorylation deficiency 34, 617872 (3), Autosomal recessive?Combined oxidative phosphorylation deficiency 34, 617872 (3);chr17;MRPS7, COXPD34;True
ENSG00000125454;Solute carrier family 25 (mitochondrial deoxynucleotide carrier), member 19;NotRelevant;;Microcephaly, Amish type, 607196 (3), Autosomal recessiveThiamine metabolism dysfunction syndrome 4 (progressive polyneuropathy type), 613710 (3);chr17;SLC25A19, DNC, MUP1, MCPHA, THMD3, THMD4;True
ENSG00000182173;tRNA splicing endonuclease 54, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 PCH5 patient;Pontocerebellar hypoplasia type 2A, 277470 (3), Autosomal recessivePontocerebellar hypoplasia type 4, 225753 (3);chr17;TSEN54, SEN54, PCH2A, PCH4, PCH5;True
ENSG00000132470;Integrin, beta-4;NotRelevant;;Epidermolysis bullosa of hands and feet, 131800 (3), Autosomal dominantEpidermolysis bullosa, junctional, with pyloric atresia, 226730 (3);chr17;ITGB4;True
ENSG00000108479;Galactokinase-1;NotRelevant;;Galactokinase deficiency with cataracts, 230200 (3), Autosomal recessiveGalactokinase deficiency with cataracts, 230200 (3);chr17;GALK1;True
ENSG00000092929;UNC13, C. elegans, homolog of, D;NotRelevant;;Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3)Hemophagocytic lymphohistiocytosis, familial, 3, 608898 (3);chr17;UNC13D, MUNC13-4, HPLH3, HLH3, FHL3;False
ENSG00000132471;WW domain-binding protein 2;NotRelevant;;Deafness, autosomal recessive 107, 617639 (3), Autosomal recessiveDeafness, autosomal recessive 107, 617639 (3);chr17;WBP2, DFNB107;True
ENSG00000161533;Acyl-Coenzyme A oxidase 1, palmitoyl;NotRelevant;;Peroxisomal acyl-CoA oxidase deficiency, 264470 (3), Autosomal recessivePeroxisomal acyl-CoA oxidase deficiency, 264470 (3);chr17;ACOX1, ACOX, SCOX;True
ENSG00000129667;Rhomboid 5, Drosophila, homolog of, 2;NotRelevant;;Tylosis with esophageal cancer, 148500 (3), Autosomal dominantTylosis with esophageal cancer, 148500 (3);chr17;RHBDF2, IRHOM2, TOC;True
ENSG00000214140;PRCD, Dog, homolog of;NotRelevant;;Retinitis pigmentosa 36, 610599 (3)Retinitis pigmentosa 36, 610599 (3);chr17;PRCD, RP36;False
ENSG00000181038;Methyltransferase-like 23;NotRelevant;;Mental retardation, autosomal recessive 44, 615942 (3), Autosomal recessiveMental retardation, autosomal recessive 44, 615942 (3);chr17;METTL23, C17orf95, MRT44;True
ENSG00000184640;Septin 9;NotRelevant;;Amyotrophy, hereditary neuralgic, 162100 (3), Autosomal dominantOvarian carcinoma (1);chr17;SEPT9, MSF, MSF1, NAPB;True
ENSG00000141524;Transmembrane channel-like 6;NotRelevant;;Epidermodysplasia verruciformis, 226400 (3), Autosomal recessiveEpidermodysplasia verruciformis, 226400 (3);chr17;TMC6, EVER1, EV1;True
ENSG00000167895;Transmembrane channel-like 8;NotRelevant;previously mapped to 2p24-p21;Epidermodysplasia verruciformis 2, 618231 (3)Epidermodysplasia verruciformis 2, 618231 (3);chr17;TMC8, EVER2, EV2;False
ENSG00000108639;Synaptogyrin 2;NotRelevant;pseudogene on 15q11; near EV1, EV2, TK1;chr17;SYNGR2;False
ENSG00000171302;Calcium-activated nucleotidase 1;NotRelevant;;Desbuquois dysplasia 1, 251450 (3), Autosomal recessiveEpiphyseal dysplasia, multiple, 7, 617719 (3);chr17;CANT1, SCAN1, DBQD1, EDM7;True
ENSG00000173894;Chromobox homolog 2, Drosophila polycomb class;NotRelevant;mutation identified in 1 SRXY5 patient;?46XY sex reversal 5, 613080 (3), Autosomal recessive?46XY sex reversal 5, 613080 (3);chr17;CBX2, M33, SRXY5;True
ENSG00000141519;Coiled-coil domain-containing protein 40;NotRelevant;;Ciliary dyskinesia, primary, 15, 613808 (3)Ciliary dyskinesia, primary, 15, 613808 (3);chr17;CCDC40, KIAA1640;False
ENSG00000171298;Glucosidase, acid alpha-;NotRelevant;distal to TK1;Glycogen storage disease II, 232300 (3), Autosomal recessiveGlycogen storage disease II, 232300 (3);chr17;GAA;True
ENSG00000141543;DEAD/H Box 48;NotRelevant;;Robin sequence with cleft mandible and limb anomalies, 268305 (3), Autosomal recessiveRobin sequence with cleft mandible and limb anomalies, 268305 (3);chr17;DDX48, EIF4A3, MUK34, NMP265, KIAA0111, RCPS;True
ENSG00000141527;Caspase recruitment domain-containing protein 14;NotRelevant;;Pityriasis rubra pilaris, 173200 (3), Autosomal dominantPsoriasis 2, 602723 (3);chr17;CARD14, CARMA2, BIMP2, PSORS2, PSS1, PRP;True
ENSG00000181523;N-sulfoglucosamine sulfohydrolase (sulfamidase);NotRelevant;;Mucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3), Autosomal recessiveMucopolysaccharidosis type IIIA (Sanfilippo A), 252900 (3);chr17;SGSH, MPS3A, SFMD;True
ENSG00000173821;Ring finger protein 213;NotRelevant;;{Moyamoya disease 2, susceptibility to}, 607151 (3){Moyamoya disease 2, susceptibility to}, 607151 (3);chr17;RNF213, ALO17, KIAA1618, MYMY2;False
ENSG00000184009;Actin, gamma-1;NotRelevant;;Baraitser-Winter syndrome 2, 614583 (3), Autosomal dominantDeafness, autosomal dominant 20/26, 604717 (3);chr17;ACTG1, DFNA20, DFNA26, BRWS2;True
ENSG00000186765;Fascin, sea urchin, homolog of, 2;NotRelevant;within 200kb of ACTG1;Retinitis pigmentosa 30, 607921 (3)Retinitis pigmentosa 30, 607921 (3);chr17;FSCN2, RFSN, RP30;False
ENSG00000185527;Phosphodiesterase-6G, cGMP-specific, rod, gamma;NotRelevant;;Retinitis pigmentosa 57, 613582 (3), Autosomal recessiveRetinitis pigmentosa 57, 613582 (3);chr17;PDE6G, PDEG, RP57;True
ENSG00000215644;Glucagon receptor;NotRelevant;;{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent}, 125853 (3);chr17;GCGR;True
ENSG00000185624;Procollagen-proline, 2-oxoglutarate-4-dioxygenase, beta polypeptide;NotRelevant;;Cole-Carpenter syndrome 1, 112240 (3), Autosomal dominantCole-Carpenter syndrome 1, 112240 (3);chr17;P4HB, PROHB, CLCRP1;True
ENSG00000141522;Rho GDP dissociation inhibitor (GDI) alpha;NotRelevant;;Nephrotic syndrome, type 8, 615244 (3), Autosomal recessiveNephrotic syndrome, type 8, 615244 (3);chr17;ARHGDIA, GDIA1, NPHS8;True
ENSG00000183010;Pyrroline-5-carboxylate reductase-1;NotRelevant;;Cutis laxa, autosomal recessive, type IIB, 612940 (3), Autosomal recessiveCutis laxa, autosomal recessive, type IIIB, 614438 (3);chr17;PYCR1, PRO3, ARCL2B, ARCL3B;True
ENSG00000169696;Alveolar soft-part sarcoma chromosome region, candidate 1;NotRelevant;t(X;17)(p11.2Alveolar soft-part sarcoma, 606243 (3);chr17;ASPSCR1, RCC17, ASPL, ASPS;False
ENSG00000169738;Dicarbonyl/L-xylulose reductase;NotRelevant;;[Pentosuria], 260800 (3), Autosomal recessive[Pentosuria], 260800 (3);chr17;DCXR, P34H, PNTSU;True
ENSG00000141551;Casein kinase-1, delta;NotRelevant;;Advanced sleep-phase syndrome, familial, 2, 615224 (3), Autosomal dominantAdvanced sleep-phase syndrome, familial, 2, 615224 (3);chr17;CSNK1D, ASPS, FASPS2;True
ENSG00000141580;WD repeat domain 45B;NotRelevant;;Neurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3), Autosomal recessiveNeurodevelopmental disorder with spastic quadriplegia and brain abnormalities with or without seizures, 617977 (3);chr17;WDR45B, WIPI3, WDR45L, NEDSBAS;True
ENSG00000141556;Tubulin-specific chaperone D;NotRelevant;;Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3), Autosomal recessiveEncephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3);chr17;TBCD, PEBAT;True
ENSG00000141579;Zinc finger protein 750;NotRelevant;;Seborrhea-like dermatitis with psoriasiform elements, 610227 (3)Seborrhea-like dermatitis with psoriasiform elements, 610227 (3);chr17;ZNF750, FLJ13841;False
ENSG00000101596;Structural maintenance of chromosomes flexible hinge domain-containing protein 1;NotRelevant;;Bosma arhinia microphthalmia syndrome, 603457 (3), Autosomal dominantFascioscapulohumeral muscular dystrophy 2, digenic, 158901 (3);chr18;SMCHD1, KIAA0650, BAMS;True
ENSG00000101577;Lipin 2;NotRelevant;;Majeed syndrome, 609628 (3)Majeed syndrome, 609628 (3);chr18;LPIN2;False
ENSG00000177426;TG-interacting factor 1;NotRelevant;;Holoprosencephaly 4, 142946 (3), Autosomal dominantHoloprosencephaly 4, 142946 (3);chr18;TGIF1, HPE4;True
ENSG00000101680;Laminin, alpha-1;NotRelevant;;Poretti-Boltshauser syndrome, 615960 (3), Autosomal recessivePoretti-Boltshauser syndrome, 615960 (3);chr18;LAMA1, PTBHS;True
ENSG00000178127;NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kD;NotRelevant;pseudogene on 19q13.3-qter;Mitochondrial complex I deficiency, nuclear type 7, 618229 (3)Mitochondrial complex I deficiency, nuclear type 7, 618229 (3);chr18;NDUFV2, MC1DN7;False
ENSG00000154856;Adenomatosis polyposis coli down-regulated 1;NotRelevant;;Hypotrichosis 1, 605389 (3), Autosomal dominantHypotrichosis 1, 605389 (3);chr18;APCDD1, HHS, HYPT1, HTS;True
ENSG00000154864;PIEZO-type mechanosensitive ion channel component 2;NotRelevant;mutation identified in 1 MWKS patient;Arthrogryposis, distal, type 3, 114300 (3), Autosomal dominantArthrogryposis, distal, with impaired proprioception and touch, 617146 (3);chr18;PIEZO2, FAM38B, DA5, DA3, MWKS, DAIPT;True
ENSG00000141404;Guanine nucleotide-binding protein, alpha-subunit, olfactory type;NotRelevant;;Dystonia 25, 615073 (3), Autosomal dominantDystonia 25, 615073 (3);chr18;GNAL, DYT25;True
ENSG00000176014;Tubulin, beta-6;NotRelevant;mutation identified in 1 FPVEPD family;?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction, 617732 (3), Autosomal dominant?Facial palsy, congenitla, with ptosis and velopharyngeal dysfunction, 617732 (3);chr18;TUBB6, FPVEPD;True
ENSG00000141385;ATPase family gene 3-like 2;NotRelevant;;Spastic ataxia 5, autosomal recessive, 614487 (3), Autosomal recessiveSpinocerebellar ataxia 28, 610246 (3);chr18;AFG3L2, SCA28, SPAX5;True
ENSG00000185231;Melanocortin-2 receptor (ACTH receptor);NotRelevant;;Glucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3), Autosomal recessiveGlucocorticoid deficiency, due to ACTH unresponsiveness, 202200 (3);chr18;MC2R;True
ENSG00000141449;GREB1-like protein;NotRelevant;;Renal hypodysplasia/aplasia 3, 617805 (3), Autosomal dominantRenal hypodysplasia/aplasia 3, 617805 (3);chr18;GREB1L, C18orf6, KIAA1772, RHDA3;True
ENSG00000101752;Mindbomb, Drosophila, homolog of, 1;NotRelevant;;Left ventricular noncompaction 7, 615092 (3), Autosomal dominantLeft ventricular noncompaction 7, 615092 (3);chr18;MIB1, MIB, DIP1, KIAA1323, LVNC7;True
ENSG00000141448;GATA-binding protein-6;NotRelevant;;Atrial septal defect 9, 614475 (3), Autosomal dominantTetralogy of Fallot, 187500 (3);chr18;GATA6, AVSD5, ASD9, PACHD;True
ENSG00000101773;Retinoblastoma-binding protein 8;NotRelevant;;Jawad syndrome, 251255 (3), Autosomal recessiveSeckel syndrome 2, 606744 (3);chr18;RBBP8, RIM, SCKL2, JWDS;True
ENSG00000141458;NPC1 gene;NotRelevant;some families not linked to 18; type D prob. allelicNiemann-Pick disease, type D, 257220 (3);chr18;NPC1, NPC;False
ENSG00000053747;Laminin, alpha-3 (nicein, 150kD;NotRelevant;LAMA3;3909Laryngoonychocutaneous syndrome, 245660 (3);chr18;LAMA3, LOCS;False
ENSG00000141380;Synovial sarcoma translocation, chromosome 18;NotRelevant;5' SYST/3' SSRC in t(X;18)Sarcoma, synovial (1);chr18;SS18, SSXT, SYT;False
ENSG00000141384;TAF4b RNA polymerase II, TATA box-binding protein-associated factor, 105kD;NotRelevant;mutation identified in 1 SPGF13 family;?Spermatogenic failure 13, 615841 (3), Autosomal recessive?Spermatogenic failure 13, 615841 (3);chr18;TAF4B, TAF2C2, TAFII105, SPGF13;True
ENSG00000134504;Potassium channel tetramerization domain-containing 1;NotRelevant;;Scalp-ear-nipple syndrome, 181270 (3), Autosomal dominantScalp-ear-nipple syndrome, 181270 (3);chr18;KCTD1, SENS;True
ENSG00000134762;Desmocollin-3;NotRelevant;mutation identified in 1 HYPTSV family;?Hypotrichosis and recurrent skin vesicles, 613102 (3), Autosomal recessive?Hypotrichosis and recurrent skin vesicles, 613102 (3);chr18;DSC3, DSC4;True
ENSG00000134755;Desmocollin-2;NotRelevant;;Arrhythmogenic right ventricular dysplasia 11, 610476 (3), Autosomal recessive, Autosomal dominantArrhythmogenic right ventricular dysplasia 11, 610476 (3);chr18;DSC2, DSC3, ARVD11;True
ENSG00000134760;Desmoglein-1;NotRelevant;pemphigus foliaceous antigen;Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper IgE, 615508 (3), Autosomal recessiveKeratosis palmoplantaris striata I, AD, 148700 (3);chr18;DSG1, PPKS1, SPPK1, EPKHE;True
ENSG00000175065;Desmoglein 4;NotRelevant;;Hypotrichosis 6, 607903 (3), Autosomal recessiveHypotrichosis 6, 607903 (3);chr18;DSG4, LAH, HYPT6;True
ENSG00000046604;Desmoglein-2;NotRelevant;;Arrhythmogenic right ventricular dysplasia 10, 610193 (3), Autosomal dominantCardiomyopathy, dilated, 1BB, 612877 (3);chr18;DSG2, ARVD10, ARVC10, CMD1BB;True
ENSG00000118271;Transthyretin (prealbumin);NotRelevant;;Amyloidosis, hereditary, transthyretin-related, 105210 (3), Autosomal dominant[Dystransthyretinemic hyperthyroxinemia], 145680 (3);chr18;TTR, PALB;True
ENSG00000101695;RING finger protein 125;NotRelevant;;Tenorio syndrome, 616260 (3), Autosomal dominantTenorio syndrome, 616260 (3);chr18;RNF125, TRAC1, TNORS;True
ENSG00000141431;Additional sex combs-like 3;NotRelevant;;Bainbridge-Ropers syndrome, 615485 (3), Autosomal dominantBainbridge-Ropers syndrome, 615485 (3);chr18;ASXL3, KIAA1713, BRPS;True
ENSG00000134769;Dystobrevin, alpha (dystrophin-related protein 3);NotRelevant;;Left ventricular noncompaction 1, with or without congenital heart defects, 604169 (3), Autosomal dominantLeft ventricular noncompaction 1, with or without congenital heart defects, 604169 (3);chr18;DTNA, D18S892E, DRP3, LVNC1;True
ENSG00000166974;Microtubule-associated protein, RP/EB family, member 2;NotRelevant;;Symmetric circumferential skin creases, congenital, 2, 616734 (3), Autosomal dominantSymmetric circumferential skin creases, congenital, 2, 616734 (3);chr18;MAPRE2, EB2, RP1, CSCSC2;True
ENSG00000134759;Elongator acetyltransferase complex, subunit 2;NotRelevant;;Mental retardation, autosomal recessive 58, 617270 (3), Autosomal recessiveMental retardation, autosomal recessive 58, 617270 (3);chr18;ELP2, STATIP1, MRT58;True
ENSG00000075643;Molybdenum cofactor sulfurase;NotRelevant;;Xanthinuria, type II, 603592 (3), Autosomal recessiveXanthinuria, type II, 603592 (3);chr18;MOCOS, MCS, XAN2;True
ENSG00000152217;SET-binding protein 1;NotRelevant;fused with NUP98 in ALL;Mental retardation, autosomal dominant 29, 616078 (3), Autosomal dominantSchinzel-Giedion midface retraction syndrome, 269150 (3);chr18;SETBP1, KIAA0437, SEB, MRD29;True
ENSG00000141469;Solute carrier family 14 (urea transporter), member 1 (Kidd blood group);NotRelevant;previous suggestion of chr.7 or chr.2;[Blood group, Kidd], 111000 (3)[Blood group, Kidd], 111000 (3);chr18;SLC14A1, JK, UTE, UT1;False
ENSG00000152223;Ectopic P-granules autophagy protein 5, C. elegans, homolog of;NotRelevant;;Vici syndrome, 242840 (3), Autosomal recessiveVici syndrome, 242840 (3);chr18;EPG5, KIAA1632, HEEW1, VICIS;True
ENSG00000152234;ATP synthase, H+ transporting (ATPase, mitochondrial);NotRelevant;pseudogenes on chr. 2, chr. 9, and chr.16; mutation identified in 1 MC5DN4 family and 1 COXPD22 family?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 4, 615228 (3);chr18;ATP5A1, ATPM, ATP5A, ORM, MC5DN4, COXPD22;False
ENSG00000167210;Lipoxygenase homology domains-containing 1;NotRelevant;;Deafness, autosomal recessive 77, 613079 (3), Autosomal recessiveDeafness, autosomal recessive 77, 613079 (3);chr18;LOXHD1, DFNB77;True
ENSG00000134049;Immediate-early response 3-interacting protein 1;NotRelevant;;Microcephaly, epilepsy, and diabetes syndrome, 614231 (3), Autosomal recessiveMicrocephaly, epilepsy, and diabetes syndrome, 614231 (3);chr18;IER3IP1, MEDS;True
ENSG00000101665;Mothers against decapentaplegic, Drosophila, homolog of, 7;NotRelevant;;{Colorectal cancer, susceptibility to, 3}, 612229 (3){Colorectal cancer, susceptibility to, 3}, 612229 (3);chr18;SMAD7, MADH7, CRCS3;False
ENSG00000141627;Dymeclin;NotRelevant;;Dyggve-Melchior-Clausen disease, 223800 (3), Autosomal recessiveSmith-McCort dysplasia, 607326 (3);chr18;DYM, FLJ90130, DMC, SMC;True
ENSG00000167306;Myosin VB;NotRelevant;;Microvillus inclusion disease, 251850 (3), Autosomal recessiveMicrovillus inclusion disease, 251850 (3);chr18;MYO5B, KIAA1119;True
ENSG00000172361;Coiled-coil domain-containing protein 11;NotRelevant;;Heterotaxy, visceral, 6, autosomal recessive, 614779 (3), Autosomal recessiveHeterotaxy, visceral, 6, autosomal recessive, 614779 (3);chr18;CCDC11, HTX6;True
ENSG00000082212;Malic enzyme, mitochondrial;NotRelevant;10cM distal to F13A; previously mapped to chr.6;chr18;ME2;False
ENSG00000141646;Mothers against decapentaplegic, Drosophila, homolog of, 4;NotRelevant;;Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome, 175050 (3), Autosomal dominantPolyposis, juvenile intestinal, 174900 (3);chr18;SMAD4, MADH4, DPC4, JIP, MYHRS;True
ENSG00000187323;Deleted in colorectal carcinoma;NotRelevant;;Colorectal cancer, somatic, 114500 (3)Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3);chr18;DCC, MRMV1, HGPPS2;False
ENSG00000196628;Transcription factor-4 (immunoglobulin transcription factor-2);NotRelevant;;Corneal dystrophy, Fuchs endothelial, 3, 613267 (3), Autosomal dominantPitt-Hopkins syndrome, 610954 (3);chr18;TCF4, SEF2, ITF2, PTHS, FECD3;True
ENSG00000066926;Ferrochelatase;NotRelevant;;Protoporphyria, erythropoietic, 1, 177000 (3), Autosomal recessiveProtoporphyria, erythropoietic, 1, 177000 (3);chr18;FECH, FCE, EPP1;True
ENSG00000081923;ATPase, class I, type 8B, member 1;NotRelevant;;Cholestasis, benign recurrent intrahepatic, 243300 (3), Autosomal recessiveCholestasis, progressive familial intrahepatic 1, 211600 (3);chr18;ATP8B1, FIC1, BRIC, PFIC1, ICP1;True
ENSG00000049759;Ubiquitin protein ligase NEDD4-like;NotRelevant;;Periventricular nodular heterotopia 7, 617201 (3), Autosomal dominantPeriventricular nodular heterotopia 7, 617201 (3);chr18;NEDD4L, KIAA0439, RSP5, PVNH7;True
ENSG00000172175;Mucosa-associated lymphoid tissue lymphoma translocation gene 1;NotRelevant;fused with API2 in MALT lymphoma;Immunodeficiency 12, 615468 (3), Autosomal recessiveImmunodeficiency 12, 615468 (3);chr18;MALT1, MLT, IMD12;True
ENSG00000134438;Retina and anterior neural fold homeobox gene;NotRelevant;;Microphthalmia, isolated 3, 611038 (3), Autosomal recessiveMicrophthalmia, isolated 3, 611038 (3);chr18;RAX, RX, MCOP3;True
ENSG00000074695;Lectin, mannose-binding, 1;NotRelevant;;Combined factor V and VIII deficiency, 227300 (3), Autosomal recessiveCombined factor V and VIII deficiency, 227300 (3);chr18;LMAN1, ERGIC53, F5F8D, MCFD1;True
ENSG00000183287;Collagen and calcium-binding EGF domain-containing protein 1;NotRelevant;;Hennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3), Autosomal recessiveHennekam lymphangiectasia-lymphedema syndrome 1, 235510 (3);chr18;CCBE1, KIAA1983, HKLLS1;True
ENSG00000166603;Melanocortin-4 receptor;NotRelevant;;Obesity, autosomal dominant, 601665 (3), Autosomal recessive, Autosomal dominant, MultifactorialObesity, autosomal dominant, 601665 (3);chr18;MC4R;True
ENSG00000197563;Phosphatidylinositol glycan, class N;NotRelevant;;Multiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3), Autosomal recessiveMultiple congenital anomalies-hypotonia-seizures syndrome 1, 614080 (3);chr18;PIGN, MCAHS1;True
ENSG00000141655;Tumor necrosis factor receptor superfamily, member 11A;NotRelevant;;Osteolysis, familial expansile, 174810 (3), Autosomal dominant{Paget disease of bone 2, early-onset}, 602080 (3);chr18;TNFRSF11A, RANK, ODFR, FEO, OPTB7, PDB2;True
ENSG00000171791;B-cell CLL/lymphoma-2;NotRelevant;most frequent hematologic malignancy t(14;18)(q32Leukemia/lymphoma, B-cell, 2 (3);chr18;BCL2;False
ENSG00000119537;3-ketodihydrosphingosine reductase;NotRelevant;~10kb 5' to BCL2;Erythrokeratodermia variabilis et progressiva 4, 617526 (3), Autosomal recessiveErythrokeratodermia variabilis et progressiva 4, 617526 (3);chr18;KDSR, FVT1, EKVP4;True
ENSG00000166396;Serpin peptidase inhibitor, clade B (ovalbumin), member 7;NotRelevant;;Palmoplantar keratoderma, Nagashima type, 615598 (3), Autosomal recessivePalmoplantar keratoderma, Nagashima type, 615598 (3);chr18;SERPINB7, MEGSIN, PPKN;True
ENSG00000166401;Serpin family B, member 8;NotRelevant;;Peeling skin syndrome 5, 617115 (3), Autosomal recessivePeeling skin syndrome 5, 617115 (3);chr18;SERPINB8, PI8, CAP2, PSS5;True
ENSG00000176225;Rotatin;NotRelevant;;Microcephaly, short stature, and polymicrogyria with seizures, 614833 (3), Autosomal recessiveMicrocephaly, short stature, and polymicrogyria with seizures, 614833 (3);chr18;RTTN, MSSP;True
ENSG00000166347;Cytochrome b5;NotRelevant;pseudogenes on X, 14q, 20p; mutation identified in 1 MET5 patientMethemoglobinemia and ambiguous genitalia, 250790 (3);chr18;CYB5A, MCB5, METAG;False
ENSG00000179981;Teashirt zinc finger homeobox 1;NotRelevant;;Aural atresia, congenital, 607842 (3), Autosomal dominantAural atresia, congenital, 607842 (3);chr18;TSHZ1, TSH1, CAA;True
ENSG00000060069;C-terminal domain of RNA polymerase II subunit A, phosphatase of, subunit 1;NotRelevant;;Congenital cataracts, facial dysmorphism, and neuropathy, 604168 (3), Autosomal recessiveCongenital cataracts, facial dysmorphism, and neuropathy, 604168 (3);chr18;CTDP1, FCP1, CCFDN;True
ENSG00000141759;Thioredoxin-like 4A;NotRelevant;;Burn-McKeown syndrome, 608572 (3), Autosomal recessiveBurn-McKeown syndrome, 608572 (3);chr18;TXNL4A, DIM1, BMKS;True
ENSG00000172270;Basigin (blood group OK);NotRelevant;;[Blood group, OK], 111380 (3)[Blood group, OK], 111380 (3);chr19;BSG;False
ENSG00000197561;Elastase, neutrophil-expressed;NotRelevant;;Neutropenia, cyclic, 162800 (3), Autosomal dominantNeutropenia, severe congenital 1, autosomal dominant, 202700 (3);chr19;ELANE, ELA2, SCN1;True
ENSG00000197766;Complement factor D;NotRelevant;;Complement factor D deficiency, 613912 (3), Autosomal recessiveComplement factor D deficiency, 613912 (3);chr19;CFD, ADN;True
ENSG00000116014;KISS1 receptor;NotRelevant;mutation identified in 1 CPPB1 patient;Hypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3), Autosomal recessiveHypogonadotropic hypogonadism 8 with or without anosmia, 614837 (3);chr19;KISS1R, GPR54, HH8, CPPB1;True
ENSG00000064687;ATP-binding cassette, subfamily A, member 7;NotRelevant;;{Alzheimer disease 9, susceptibility to}, 608907 (3), Autosomal dominant{Alzheimer disease 9, susceptibility to}, 608907 (3);chr19;ABCA7, ABCX, AD9;True
ENSG00000167468;Glutathione peroxidase-4 (phospholipid hydroperoxidase);NotRelevant;;Spondylometaphyseal dysplasia, Sedaghatian type, 250220 (3), Autosomal recessiveSpondylometaphyseal dysplasia, Sedaghatian type, 250220 (3);chr19;GPX4, SMDS;True
ENSG00000118046;Serine/threonine protein kinase-11;NotRelevant;;Melanoma, malignant, somatic (3)Testicular tumor, somatic, 273300 (3);chr19;STK11, PJS, LKB1;False
ENSG00000099624;ATP synthase F1 subunit delta;NotRelevant;;Mitochondrial complex V (ATP synthase) deficiency, 618120 (3), Autosomal recessiveMitochondrial complex V (ATP synthase) deficiency, 618120 (3);chr19;ATP5F1D, ATP5D, MC5DN5;True
ENSG00000115286;NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kD (NADH-coenzyme Q reductase);NotRelevant;;Mitochondrial complex I deficiency, nuclear type 3, 618224 (3)Mitochondrial complex I deficiency, nuclear type 3, 618224 (3);chr19;NDUFS7, PSST, MC1DN3;False
ENSG00000130005;Guanidinoacetate methyltransferase;NotRelevant;;Cerebral creatine deficiency syndrome 2, 612736 (3), Autosomal recessiveCerebral creatine deficiency syndrome 2, 612736 (3);chr19;GAMT, CCDS2;True
ENSG00000115266;APC2 gene;NotRelevant;mutation identified in 1 SOTOS3 family;?Sotos syndrome 3, 617169 (3), Autosomal recessive?Sotos syndrome 3, 617169 (3);chr19;APC2, APCL, SOTOS3;True
ENSG00000115255;Receptor expression-enhancing protein 6;NotRelevant;;Retinitis pigmentosa 77, 617304 (3), Autosomal recessiveRetinitis pigmentosa 77, 617304 (3);chr19;REEP6, DP1L1, TB2L1, C19orf32, RP77;True
ENSG00000071564;Transcription factor-3 (E2A immunoglobulin enhancer-binding factors E12/E47);NotRelevant;;Agammaglobulinemia 8, autosomal dominant, 616941 (3), Autosomal dominantAgammaglobulinemia 8, autosomal dominant, 616941 (3);chr19;TCF3, E2A, AGM8;True
ENSG00000213638;Adenosine deaminase, tRNA-specific, 3;NotRelevant;;Mental retardation, autosomal recessive 36, 615286 (3), Autosomal recessiveMental retardation, autosomal recessive 36, 615286 (3);chr19;ADAT3, TAD3, MRT36;True
ENSG00000065000;Adaptor-related protein complex 3, delta-1 subunit;NotRelevant;mutation identified in 1 HPS10 patient;?Hermansky-Pudlak syndrome 10, 617050 (3), Autosomal recessive?Hermansky-Pudlak syndrome 10, 617050 (3);chr19;AP3D1, HPS10;True
ENSG00000104899;Anti-Mullerian hormone;NotRelevant;;Persistent Mullerian duct syndrome, type I, 261550 (3), Autosomal recessivePersistent Mullerian duct syndrome, type I, 261550 (3);chr19;AMH, MIF;True
ENSG00000176619;Lamin B2;NotRelevant;mutation identified in 1 EPM9 family;?Epilepsy, progressive myoclonic, 9, 616540 (3), Autosomal recessive{Lipodystrophy, partial, acquired, susceptibility to}, 608709 (3);chr19;LMNB2, LMN2, EPM9;True
ENSG00000104953;Transducin-like enhancer of split 6;NotRelevant;;Preimplantation embryonic lethality, 616814 (3), Autosomal recessivePreimplantation embryonic lethality, 616814 (3);chr19;TLE6, GRG6, PREMBL;True
ENSG00000088256;Guanine nucleotide-binding protein, Gq class, GNA11;NotRelevant;;Hypocalcemia, autosomal dominant 2, 615361 (3), Autosomal dominantHypocalciuric hypercalcemia, type II, 145981 (3);chr19;GNA11, HHC2, HYPOC2;True
ENSG00000179855;GAIP C-terminus-interacting protein 3;NotRelevant;;Deafness, autosomal recessive 15, 601869 (3), Autosomal recessiveDeafness, autosomal recessive 15, 601869 (3);chr19;GIPC3, DFNB15, DFNB72, DFNB95;True
ENSG00000006638;Thromboxane A2 receptor;NotRelevant;;{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3), Autosomal dominant{Bleeding disorder, platelet-type, 13, susceptibility to}, 614009 (3);chr19;TBXA2R, BDPLT13;True
ENSG00000186111;Phosphatidylinositol-4-phosphate 5-kinase, type I, gamma;NotRelevant;;Lethal congenital contractural syndrome 3, 611369 (3), Autosomal recessiveLethal congenital contractural syndrome 3, 611369 (3);chr19;PIP5K1C, LCCS3;True
ENSG00000173976;Retina and anterior neural fold homeobox 2;NotRelevant;mutation identified in 1 ARMD6 patient;Cone-rod dystrophy 11, 610381 (3), Autosomal dominantCone-rod dystrophy 11, 610381 (3);chr19;RAX2, RAXL1, QRX, CORD11, ARMD6;True
ENSG00000167654;Caytaxin;NotRelevant;;Ataxia, cerebellar, Cayman type, 601238 (3), Autosomal recessiveAtaxia, cerebellar, Cayman type, 601238 (3);chr19;ATCAY, CLAC, KIAA1872;True
ENSG00000167658;Eukaryotic translation elongation factor-2;NotRelevant;mutation identified in 1 family;?Spinocerebellar ataxia 26, 609306 (3), Autosomal dominant?Spinocerebellar ataxia 26, 609306 (3);chr19;EEF2, EF2, SCA26;True
ENSG00000126934;Mitogen-activated protein kinase kinase 2;NotRelevant;previously assigned to 7q32;Cardiofaciocutaneous syndrome 4, 615280 (3)Cardiofaciocutaneous syndrome 4, 615280 (3);chr19;MAP2K2, PRKMK2, MEK2, MKK2, CFC4;False
ENSG00000141985;SH3 domain GRB2-like 1 (Extra 11-19 leukemia fusion gene);NotRelevant;;Leukemia, acute myeloid, 601626 (1), Autosomal dominant, Somatic mutationLeukemia, acute myeloid, 601626 (1);chr19;SH3GL1, EEN;True
ENSG00000127666;TIR domain-containing adaptor molecule 1;NotRelevant;;{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, 614850 (3), Autosomal recessive, Autosomal dominant{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, 614850 (3);chr19;TICAM1, TRIF, IIAE6;True
ENSG00000196365;lon peptidase 1, mitochondrial;NotRelevant;;CODAS syndrome, 600373 (3), Autosomal recessiveCODAS syndrome, 600373 (3);chr19;LONP1, PRSS15, LON, CODASS;True
ENSG00000156413;Fucosyltransferase 6 (alpha (1,3) fucosyltransferase);NotRelevant;in cluster with FUT3, FUT5;Fucosyltransferase 6 deficiency, 613852 (3)Fucosyltransferase 6 deficiency, 613852 (3);chr19;FUT6;False
ENSG00000171124;Fucosyltransferase 3;NotRelevant;cen-FUT5-23kb-FUT3-14kb-FUT6-ter;[Blood group, Lewis] (3)[Blood group, Lewis] (3);chr19;FUT3, LE;False
ENSG00000174886;NADH-dehydrogenase 1 alpha subcomplex, 11;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 14, 618236 (3)Mitochondrial complex I deficiency, nuclear type 14, 618236 (3);chr19;NDUFA11, MC1DN14;False
ENSG00000125656;ATP-dependent protease ClpAP, E. coli, proteolytic subunit, homolog of;NotRelevant;;Perrault syndrome 3, 614129 (3), Autosomal recessivePerrault syndrome 3, 614129 (3);chr19;CLPP, PRLTS3, DFNB81;True
ENSG00000104833;Tubulin, beta-4A;NotRelevant;;Dystonia 4, torsion, autosomal dominant, 128101 (3), Autosomal dominantLeukodystrophy, hypomyelinating, 6, 612438 (3);chr19;TUBB4A, DYT4, HLD6;True
ENSG00000125730;Complement component-3;NotRelevant;LE ~7cM in males vs. C3 RFLP;C3 deficiency, 613779 (3), Autosomal recessive{Macular degeneration, age-related, 9}, 611378 (3);chr19;C3, ARMD9, AHUS5;True
ENSG00000171105;Insulin receptor;NotRelevant;1 gene for alpha and beta subunits;Diabetes mellitus, insulin-resistant, with acanthosis nigricans, 610549 (3)Rabson-Mendenhall syndrome, 262190 (3);chr19;INSR, HHF5;False
ENSG00000104880;Rho guanine nucleotide exchange factor 18;NotRelevant;;Retinitis pigmentosa 78, 617433 (3), Autosomal recessiveRetinitis pigmentosa 78, 617433 (3);chr19;ARHGEF18, KIAA0521, RP78;True
ENSG00000090674;Mucolipin 1;NotRelevant;;Mucolipidosis IV, 252650 (3), Autosomal recessiveMucolipidosis IV, 252650 (3);chr19;MCOLN1, ML4;True
ENSG00000032444;Patatin-like phospholipase domain-containing protein 6;NotRelevant;mutation identified in 1 LMNS family;Boucher-Neuhauser syndrome, 215470 (3), Autosomal recessiveSpastic paraplegia 39, autosomal recessive, 612020 (3);chr19;PNPLA6, NTE, SPG39, NTEMND, BNHS, LNMS, OMCS;True
ENSG00000229833;PET100, S. cerevisiae, homolog of;NotRelevant;;Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, MitochondrialMitochondrial complex IV deficiency, 220110 (3);chr19;PET100, C19orf79;True
ENSG00000076944;Syntaxin binding protein 2;NotRelevant;;Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3)Hemophagocytic lymphohistiocytosis, familial, 5, 613101 (3);chr19;STXBP2, UNC18B, FHL5;False
ENSG00000104918;Resistin;NotRelevant;;{Diabetes mellitus, noninsulin-dependent, susceptibility to}, 125853 (3), Autosomal dominant{Hypertension, insulin resistance-related, susceptibility to}, 125853 (3);chr19;RETN, RSTN, FIZZ3;True
ENSG00000090659;CD209 antigen;NotRelevant;;{Dengue fever, protection against}, 614371 (3){Mycobacterium tuberculosis, susceptibility to}, 607948 (3);chr19;CD209, CDSIGN;False
ENSG00000104938;C-type lectin domain family 4, member M;NotRelevant;;SARS infection, protection against, 605872 (2)SARS infection, protection against (2);chr19;CLEC4M, CD209L, LSIGN, DCSIGNR;False
ENSG00000167775;CD320 molecule;NotRelevant;;Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3)Methylmalonic aciduria, transient, due to transcobalamin receptor defect, 613646 (3);chr19;CD320, 8D6, 8D6A, TCBLR;False
ENSG00000233927;Ribosomal protein S28;NotRelevant;;Diamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3), Autosomal dominantDiamond Blackfan anemia 15 with mandibulofacial dysostosis, 606164 (3);chr19;RPS28, DBA15;True
ENSG00000167772;Angiopoietin-like 4;NotRelevant;;Plasma triglyceride level QTL, low, 615881 (3), Autosomal dominantPlasma triglyceride level QTL, low, 615881 (3);chr19;ANGPTL4, PGAR, HFARP, FIAF, TGQTL;True
ENSG00000185236;Ras-associated protein RAB11B;NotRelevant;;Neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3), Autosomal dominantNeurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter, 617807 (3);chr19;RAB11B, NDAGSCW;True
ENSG00000142303;A disintegrin-like and metalloproteinase with thrombospondin type 1 motif, 10;NotRelevant;;Weill-Marchesani syndrome 1, recessive, 277600 (3), Autosomal recessiveWeill-Marchesani syndrome 1, recessive, 277600 (3);chr19;ADAMTS10, WMS1;True
ENSG00000130816;DNA methyltransferase 1;NotRelevant;;Cerebellar ataxia, deafness, and narcolepsy, autosomal dominant, 604121 (3), Autosomal dominantNeuropathy, hereditary sensory, type IE, 614116 (3);chr19;DNMT1, MCMT, HSN1E, ADCADN;True
ENSG00000267534;Sphingosine-1-phosphate receptor 2;NotRelevant;;Deafness, autosomal recessive 68, 610419 (3), Autosomal recessiveDeafness, autosomal recessive 68, 610419 (3);chr19;S1PR2, EDG5, DFNB68;True
ENSG00000090339;Intercellular adhesion molecule-1;NotRelevant;close to Ldlr in mouse;{Malaria, cerebral, susceptibility to}, 611162 (3){Malaria, cerebral, susceptibility to}, 611162 (3);chr19;ICAM1;False
ENSG00000105371;Intracellular adhesion molecule 4;NotRelevant;close to C3, LU;[Blood group, Landsteiner-Wiener], 111250 (3)[Blood group, Landsteiner-Wiener], 111250 (3);chr19;ICAM4, CD242, LW;False
ENSG00000105397;Tyrosine kinase 2;NotRelevant;;Immunodeficiency 35, 611521 (3), Autosomal recessiveImmunodeficiency 35, 611521 (3);chr19;TYK2, IMD35;True
ENSG00000079805;Dynamin-2;NotRelevant;1 LCCS5 family identified with mutation;Centronuclear myopathy 1, 160150 (3), Autosomal dominantLethal congenital contracture syndrome 5, 615368 (3);chr19;DNM2, CMTDIB, CMTDI1, CMT2M, LCCS5;True
ENSG00000127616;SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4;NotRelevant;;Coffin-Siris syndrome 4, 614609 (3), Autosomal dominant{Rhabdoid tumor predisposition syndrome 2}, 613325 (3);chr19;SMARCA4, BRG1, RTPS2, MRD16, CSS4;True
ENSG00000130164;Low density lipoprotein receptor;NotRelevant;~20cM distal to C3;Hypercholesterolemia, familial, 143890 (3), Autosomal dominantLDL cholesterol level QTL2, 143890 (3);chr19;LDLR, FHC, FH, LDLCQ2;True
ENSG00000197256;KN motif- and ankyrin repeat domain-containing protein 2;NotRelevant;;Nephrotic syndrome, type 16, 617783 (3), Autosomal recessivePalmoplantar keratoderma and woolly hair, 616099 (3);chr19;KANK2, ANKRD25, KIAA1518, PPKWH, NPHS16;True
ENSG00000130158;Dedicator of cytokinesis 6;NotRelevant;;Adams-Oliver syndrome 2, 614219 (3), Autosomal recessiveAdams-Oliver syndrome 2, 614219 (3);chr19;DOCK6, KIAA1395, AOS2;True
ENSG00000187266;Erythropoietin receptor;NotRelevant;;[Erythrocytosis, familial, 1], 133100 (3), Autosomal dominant[Erythrocytosis, familial, 1], 133100 (3);chr19;EPOR;True
ENSG00000198003;Coiled-coil domain-containing protein 151;NotRelevant;;Ciliary dyskinesia, primary, 30, 616037 (3), Autosomal recessiveCiliary dyskinesia, primary, 30, 616037 (3);chr19;CCDC151, CILD30;True
ENSG00000130175;Protein kinase C substrate 80K-H;NotRelevant;;Polycystic liver disease 1, 174050 (3), Autosomal dominantPolycystic liver disease 1, 174050 (3);chr19;PRKCSH, G19P1, PCLD1;True
ENSG00000102575;Acid phosphatase 5, tartrate resistant;NotRelevant;incorrectly assigned to 15 by A;Spondyloenchondrodysplasia with immune dysregulation, 607944 (3), Autosomal recessiveSpondyloenchondrodysplasia with immune dysregulation, 607944 (3);chr19;ACP5, SPENCDI;True
ENSG00000104774;Mannosidase, alpha, class 2B, member 1;NotRelevant;;Mannosidosis, alpha-, types I and II, 248500 (3), Autosomal recessiveMannosidosis, alpha-, types I and II, 248500 (3);chr19;MAN2B1, MANB;True
ENSG00000104889;Ribonuclease H2, large subunit;NotRelevant;;Aicardi-Goutieres syndrome 4, 610333 (3), Autosomal recessiveAicardi-Goutieres syndrome 4, 610333 (3);chr19;RNASEH2A, RNHIA, AGS4;True
ENSG00000105610;Kruppel-like factor 1, erythroid;NotRelevant;;Blood group--Lutheran inhibitor, 111150 (3)[Hereditary persistence of fetal hemoglobin], 613566 (3);chr19;KLF1, EKLF, INLU, HBFQTL6, CDAN4;False
ENSG00000105607;Glutaryl-Coenzyme A dehydrogenase;NotRelevant;;Glutaricaciduria, type I, 231670 (3), Autosomal recessiveGlutaricaciduria, type I, 231670 (3);chr19;GCDH;True
ENSG00000179218;Sicca syndrome antigen A (autoantigen Ro;NotRelevant;ENSG00000179218;distal to C3, near LDLRThrombocythemia, somatic, 187950 (3);chr19;CALR, SSA;False
ENSG00000008441;Nuclear factor I/X (CCAAT-binding transcription factor);NotRelevant;;Marshall-Smith syndrome, 602535 (3), Autosomal dominantSotos syndrome 2, 614753 (3);chr19;NFIX, NF1A, SOTOS2, MRSHSS;True
ENSG00000104903;Lymphoblastic leukemia derived sequence-1;NotRelevant;;Leukemia, T-cell acute lymphoblastoid, 151440 (2)Leukemia, T-cell acute lymphoblastoid (2);chr19;LYL1;False
ENSG00000160877;Nucleus accumbens-associated protein 1, BEN and BTB/POZ domains-containing;NotRelevant;;Neurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3), Autosomal dominantNeurodevelopmental disorder with epilepsy, cataracts, feeding difficulties, and delayed brain myelination, 617393 (3);chr19;NACC1, BTBD14B, NECFM;True
ENSG00000141837;Calcium channel, voltage-dependent, P/Q type, alpha 1A subunit;NotRelevant;;Epileptic encephalopathy, early infantile, 42, 617106 (3), Autosomal dominantSpinocerebellar ataxia 6, 183086 (3);chr19;CACNA1A, CACNL1A4, SCA6, EIEE42;True
ENSG00000132024;Coiled-coil and C2 domain-containing 1A;NotRelevant;;Mental retardation, autosomal recessive 3, 608443 (3), Autosomal recessiveMental retardation, autosomal recessive 3, 608443 (3);chr19;CC2D1A, MRT3;True
ENSG00000072062;Protein kinase, cAMP-dependent, catalytic, alpha;NotRelevant;;Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3)Cushing syndrome, ACTH-independent adrenal, somatic, 615830 (3);chr19;PRKACA;False
ENSG00000099797;Trans-2,3-enoyl-CoA reductase;NotRelevant;;Mental retardation, autosomal recessive 14, 614020 (3), Autosomal recessiveMental retardation, autosomal recessive 14, 614020 (3);chr19;TECR, GPSN2, TER, SC2, MRT14;True
ENSG00000127507;Adhesion G protein-coupled receptor E2;NotRelevant;;Vibratory urticaria, 125630 (3), Autosomal dominantVibratory urticaria, 125630 (3);chr19;ADGRE2, EMR2, VBU;True
ENSG00000105141;Caspase 14, apoptosis-related cysteine protease;NotRelevant;;Ichthyosis, congenital, autosomal recessive 12, 617320 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 12, 617320 (3);chr19;CASP14, ARCI12;True
ENSG00000074181;Notch, Drosophila, homolog of, 3;NotRelevant;mutation identified in 1 IMF2 family;Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy 1, 125310 (3), Autosomal dominantLateral meningocele syndrome, 130720 (3);chr19;NOTCH3, CADASIL1, CASIL, IMF2, LMNS;True
ENSG00000171954;Cytochrome P450, family 4, subfamily F, polypeptide 22;NotRelevant;;Ichthyosis, congenital, autosomal recessive 5, 604777 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 5, 604777 (3);chr19;CYP4F22, ARCI5, LI3;True
ENSG00000160111;Complement component 3- and pregnancy zone protein-like alpha-2-macroglobin domain-containing protein 8;NotRelevant;;Anterior segment dysgenesis 8, 617319 (3), Autosomal recessiveAnterior segment dysgenesis 8, 617319 (3);chr19;CPAMD8, KIAA1283, ASGD8;True
ENSG00000099331;Myosin IXB;NotRelevant;;{Celiac disease, susceptibility to, 4}, 609753 (3){Celiac disease, susceptibility to, 4}, 609753 (3);chr19;MYO9B, MYR5, CELIAC4;False
ENSG00000130299;GTP-binding protein 3;NotRelevant;;Combined oxidative phosphorylation deficiency 23, 616198 (3), Autosomal recessiveCombined oxidative phosphorylation deficiency 23, 616198 (3);chr19;GTPBP3, MSS1, COXPD23;True
ENSG00000130300;Plasmalemma vesicle-associated protein;NotRelevant;;Diarrhea 10, protein-losing enteropathy type, 618183 (3), Autosomal recessiveDiarrhea 10, protein-losing enteropathy type, 618183 (3);chr19;PLVAP, PV1, DIAR10;True
ENSG00000248099;Insulin-like 3, Leydig cell;NotRelevant;;Cryptorchidism, 219050 (3), Autosomal dominantCryptorchidism, 219050 (3);chr19;INSL3;True
ENSG00000105639;Janus kinase 3 (Janus kinase, leukocyte);NotRelevant;;SCID, autosomal recessive, T-negative/B-positive type, 600802 (3), Autosomal recessiveSCID, autosomal recessive, T-negative/B-positive type, 600802 (3);chr19;JAK3, JAKL;True
ENSG00000105641;Solute carrier family 5 (sodium iodide symporter), member-5;NotRelevant;;Thyroid dyshormonogenesis 1, 274400 (3), Autosomal recessiveThyroid dyshormonogenesis 1, 274400 (3);chr19;SLC5A5, NIS, TDH1;True
ENSG00000096996;Interleukin-12 receptor, beta-1;NotRelevant;;Immunodeficiency 30, 614891 (3), Autosomal recessiveImmunodeficiency 30, 614891 (3);chr19;IL12RB1, IMD30;True
ENSG00000105647;Phosphatidylinositol 3-kinase, regulatory subunit 2;NotRelevant;;Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3), Autosomal dominantMegalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1, 603387 (3);chr19;PIK3R2, MPPH1;True
ENSG00000006016;Cytokine-like factor 1;NotRelevant;;Cold-induced sweating syndrome 1, 272430 (3), Autosomal recessiveCold-induced sweating syndrome 1, 272430 (3);chr19;CRLF1, CISS1;True
ENSG00000105662;CREB-regulated transcription coactivator 1;NotRelevant;t(11;19)Mucoepidermoid salivary gland carcinoma (3);chr19;CRTC1, MECT1, KIAA0616, FLJ14027;False
ENSG00000105664;Cartilage oligomeric matrix protein;NotRelevant;;Epiphyseal dysplasia, multiple, 1, 132400 (3), Autosomal dominantPseudoachondroplasia, 177170 (3);chr19;COMP, EDM1, MED, PSACH;True
ENSG00000223802;Ceramide synthase 1;NotRelevant;mutation identified in 1 EPM8 family;?Epilepsy, progressive myoclonic, 8, 616230 (3), Autosomal recessive?Epilepsy, progressive myoclonic, 8, 616230 (3);chr19;CERS1, LASS1, UOG1, EPM8;True
ENSG00000223802;Growth/differentiation factor 1;NotRelevant;;Congenital heart defects, multiple types, 6, 613854 (3), Autosomal dominantRight atrial isomerism (Ivemark), 208530 (3);chr19;GDF1, DTGA3, DORV, RAI, CHTD6;True
ENSG00000064490;Regulatory factor X, ankyrin repeat-containing;NotRelevant;;MHC class II deficiency, complementation group B, 209920 (3), Autosomal recessiveMHC class II deficiency, complementation group B, 209920 (3);chr19;RFXANK;True
ENSG00000186010;NADH-ubiquinone oxidoreductase 1 alpha subcomplex, 13;NotRelevant;mutation identified in 1 MC1DN28 family;?Mitochondrial complex I deficiency, nuclear type 28, 618249 (3), Autosomal recessive{Thyroid carcinoma, Hurthle cell}, 607464 (3);chr19;NDUFA13, GRIM19, MC1DN28;True
ENSG00000131943;Chromosome 19 open reading frame 12;NotRelevant;mutation identified in 1 SPG43 family;Neurodegeneration with brain iron accumulation 4, 614298 (3), Autosomal recessiveNeurodegeneration with brain iron accumulation 4, 614298 (3);chr19;C19orf12, NBIA4, SPG43;True
ENSG00000186326;Regulator of G protein signaling 9-binding protein;NotRelevant;;Bradyopsia, 608415 (3)Bradyopsia, 608415 (3);chr19;RGS9BP, R9AP, RGS9, PERRS;False
ENSG00000021488;Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9;NotRelevant;;Cystinuria, 220100 (3), Autosomal recessive, Autosomal dominantCystinuria, 220100 (3);chr19;SLC7A9, CSNU3;True
ENSG00000245848;CCAAT/enhancer-binding protein (C/EBP), alpha;NotRelevant;germline mutation identified in 1 AML family;?Leukemia, acute myeloid, 601626 (3), Autosomal dominant, Somatic mutationLeukemia, acute myeloid, somatic, 601626 (3);chr19;CEBPA, CEBP;True
ENSG00000124299;Peptidase D (prolidase);NotRelevant;closely linked to APOC2;Prolidase deficiency, 170100 (3), Autosomal recessiveProlidase deficiency, 170100 (3);chr19;PEPD;True
ENSG00000124302;Carbohydrate sulfotransferase 8;NotRelevant;mutation has been identified in 1 PSS3 family;?Peeling skin syndrome 3, 616265 (3), Autosomal recessive?Peeling skin syndrome 3, 616265 (3);chr19;CHST8, GALNAC4ST1, PSS3;True
ENSG00000105220;Glucose phosphate isomerase;NotRelevant;ENSG00000105220;Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency, 613470 (3);chr19;GPI;False
ENSG00000105711;Sodium channel, voltage-gated, type I, beta polypeptide;NotRelevant;;Atrial fibrillation, familial, 13, 615377 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 52, 617350 (3);chr19;SCN1B, GEFSP1, BRGDA5, ATFB13, EIEE52;True
ENSG00000153902;Leucine-rich gene, glioma-inactivated, 4;NotRelevant;;Arthrogryposis multiplex congenita, neurogenic, with myelin defect, 617468 (3), Autosomal recessiveArthrogryposis multiplex congenita, neurogenic, with myelin defect, 617468 (3);chr19;LGI4, AMCNMY;True
ENSG00000105697;Hepcidin antimicrobial peptide;NotRelevant;digenic form with HAMP and HFE mutations;Hemochromatosis, type 2B, 613313 (3), Autosomal recessiveHemochromatosis, type 2B, 613313 (3);chr19;HAMP, LEAP1, HEPC, HFE2B;True
ENSG00000105695;Myelin-associated glycoprotein;NotRelevant;;Spastic paraplegia 75, autosomal recessive, 616680 (3), Autosomal recessiveSpastic paraplegia 75, autosomal recessive, 616680 (3);chr19;MAG, GMA, SPG75;True
ENSG00000126267;Cytochrome c oxidase, subunit VIb polypeptide 1 (ubiquitous);NotRelevant;;Mitochondrial complex IV deficiency, 220110 (3), Autosomal recessive, MitochondrialMitochondrial complex IV deficiency, 220110 (3);chr19;COX6B1;True
ENSG00000272333;Lysine (K)-specific methyltransferase 2B;NotRelevant;;Dystonia 28, childhood-onset, 617284 (3), Autosomal dominantDystonia 28, childhood-onset, 617284 (3);chr19;KMT2B, MLL4, KIAA0304, DYT28;True
ENSG00000205155;Presenilin enhancer 2, C. elegans, homolog of;NotRelevant;;Acne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3), Autosomal dominantAcne inversa, familial, 2, with or without Dowling-Degos disease, 613736 (3);chr19;PSENEN, PEN2, ACNINV2;True
ENSG00000161270;Nephrin;NotRelevant;;Nephrotic syndrome, type 1, 256300 (3), Autosomal recessiveNephrotic syndrome, type 1, 256300 (3);chr19;NPHS1, NPHN;True
ENSG00000011600;TYRO protein tyrosine kinase-binding protein;NotRelevant;;Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, 221770 (3), Autosomal recessivePolycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1, 221770 (3);chr19;TYROBP, DAP12, PLOSL1;True
ENSG00000205138;Succinate dehydrogenase complex assembly factor 1;NotRelevant;;Mitochondrial complex II deficiency, 252011 (3), Autosomal recessiveMitochondrial complex II deficiency, 252011 (3);chr19;SDHAF1;True
ENSG00000181392;Spectrin repeat-containing nuclear envelope protein 4;NotRelevant;;Deafness, autosomal recessive 76, 615540 (3), Autosomal recessiveDeafness, autosomal recessive 76, 615540 (3);chr19;SYNE4, NESP4, C19orf46, DFNB76;True
ENSG00000075702;WD repeat-containing protein 62;NotRelevant;;Microcephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3), Autosomal recessiveMicrocephaly 2, primary, autosomal recessive, with or without cortical malformations, 604317 (3);chr19;WDR62, C19orf14, MCPH2;True
ENSG00000105738;SIPA1-like protein 3;NotRelevant;mutation identified in 1 CTRCT45 family;?Cataract 45, 616851 (3), Autosomal recessive?Cataract 45, 616851 (3);chr19;SIPA1L3, SPAL3, SPAR3, KIAA0545, CTRCT45;True
ENSG00000167642;Serine protease inhibitor, Kunitz-type, 2 (hepatocyte growth factor activator inhibitor 2;NotRelevant;ENSG00000167642;Diarrhea 3, secretory sodium, congenital, syndromic, 270420 (3);chr19;SPINT2, HAI2, DIAR3;False
ENSG00000196218;Ryanodine receptor-1, skeletal;NotRelevant;;Central core disease, 117000 (3), Autosomal recessive, Autosomal dominant{Malignant hyperthermia susceptibility 1}, 145600 (3);chr19;RYR1, MHS, CCO;True
ENSG00000130402;Actinin, alpha-4;NotRelevant;;Glomerulosclerosis, focal segmental, 1, 603278 (3), Autosomal dominantGlomerulosclerosis, focal segmental, 1, 603278 (3);chr19;ACTN4, FSGS1, FSGS;True
ENSG00000104835;Seryl-tRNA synthetase 2;NotRelevant;;Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3), Autosomal recessiveHyperuricemia, pulmonary hypertension, renal failure, and alkalosis, 613845 (3);chr19;SARS2;True
ENSG00000197110;Interferon, lambda 3;NotRelevant;;{Hepatitis C virus infection, response to therapy of}, 609532 (3){Hepatitis C virus infection, response to therapy of}, 609532 (3);chr19;IFNL3, IL28B;False
ENSG00000090924;Pleckstrin homology domain- and RhoGEF domain-containing protein G2;NotRelevant;;Leukodystrophy and acquired microcephaly with or without dystonia, 616763 (3), Autosomal recessiveLeukodystrophy and acquired microcephaly with or without dystonia, 616763 (3);chr19;PLEKHG2, CLG, LDAMD;True
ENSG00000105197;Translocase of inner mitochondrial membrane 50, yeast, homolog of;NotRelevant;;3-methylglutaconic aciduria, type IX, 617698 (3), Autosomal recessive3-methylglutaconic aciduria, type IX, 617698 (3);chr19;TIMM50, TIM50, MGCA9;True
ENSG00000090932;Delta, Drosophila, homolog of;NotRelevant;;Spondylocostal dysostosis 1, autosomal recessive, 277300 (3), Autosomal recessiveSpondylocostal dysostosis 1, autosomal recessive, 277300 (3);chr19;DLL3, SCDO1;True
ENSG00000105204;Dual-specificity tyrosine phosphorylation-regulated kinase 1B;NotRelevant;;Abdominal obesity-metabolic syndrome 3, 615812 (3), Autosomal dominantAbdominal obesity-metabolic syndrome 3, 615812 (3);chr19;DYRK1B, MIRK, AOMS3;True
ENSG00000105221;Murine thymoma viral (v-akt) homolog-2;NotRelevant;;Diabetes mellitus, type II, 125853 (3), Autosomal dominantHypoinsulinemic hypoglycemia with hemihypertrophy, 240900 (3);chr19;AKT2, HIHGHH;True
ENSG00000105223;Phospholipase D family, member 3;NotRelevant;mutation identified in 1 SCA46 family;?Spinocerebellar ataxia 46, 617770 (3), Autosomal dominant?Spinocerebellar ataxia 46, 617770 (3);chr19;PLD3, HUK4, SCA46;True
ENSG00000105227;Periaxin;NotRelevant;;Charcot-Marie-Tooth disease, type 4F, 614895 (3), Autosomal recessiveDejerine-Sottas disease, 145900 (3);chr19;PRX, CMT4F;True
ENSG00000160460;Spectrin, beta, nonerythrocytic, 4 (quivering, mouse, homolog of);NotRelevant;;Neurodevelopmental disorder with hypotonia, neuropathy, and deafness, 617519 (3), Autosomal recessiveNeurodevelopmental disorder with hypotonia, neuropathy, and deafness, 617519 (3);chr19;SPTBN4, QV, NEDHND, CMND;True
ENSG00000090006;Latent transforming growth factor-beta-binding protein 4;NotRelevant;;Cutis laxa, autosomal recessive, type IC, 613177 (3), Autosomal recessiveCutis laxa, autosomal recessive, type IC, 613177 (3);chr19;LTBP4, LTBP4S, LTBP4L, ARCL1C;True
ENSG00000123815;Coenzyme Q8B;NotRelevant;;Nephrotic syndrome, type 9, 615573 (3), Autosomal recessiveNephrotic syndrome, type 9, 615573 (3);chr19;COQ8B, ADCK4, NPHS9;True
ENSG00000086544;Inositol 1,4,5-trisphosphate 3-kinase C;NotRelevant;;{Kawasaki disease, susceptibility to}, 611775 (3){Kawasaki disease, susceptibility to}, 611775 (3);chr19;ITPKC;False
ENSG00000255974;Cytochrome P450, subfamily IIA, phenobarbital-inducible, polypeptide 6;NotRelevant;;Coumarin resistance, 122700 (3), Autosomal dominant{Nicotine addiction, protection from}, 188890 (3);chr19;CYP2A6, CYP2A3, CYP2A, P450C2A;True
ENSG00000197408;Cytochrome P450, family 2, subfamily B, polypeptide 6;NotRelevant;same NotI fragment as CYP2A;{Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3){Efavirenz central nervous system toxicity, susceptibility to}, 614546 (3);chr19;CYP2B6, CYP2B, EFVM;False
ENSG00000105329;Transforming growth factor, beta-1;NotRelevant;;Camurati-Engelmann disease, 131300 (3), Autosomal dominant{Cystic fibrosis lung disease, modifier of}, 219700 (3);chr19;TGFB1, DPD1, CED, IBDIMDE;True
ENSG00000123810;B9 domain-containing protein 2;NotRelevant;mutation identified in 1 MKS10 family;Joubert syndrome 34, 614175 (3), Autosomal recessiveJoubert syndrome 34, 614175 (3);chr19;B9D2, MKS10, JBTS34;True
ENSG00000248098;Branched chain keto acid dehydrogenase E1, alpha polypeptide;NotRelevant;;Maple syrup urine disease, type Ia, 248600 (3), Autosomal recessiveMaple syrup urine disease, type Ia, 248600 (3);chr19;BCKDHA, MSUD1;True
ENSG00000105372;Ribosomal protein S19;NotRelevant;;Diamond-Blackfan anemia 1, 105650 (3), Autosomal dominantDiamond-Blackfan anemia 1, 105650 (3);chr19;RPS19, DBA, DBA1;True
ENSG00000105369;CD79A antigen (immunoglobulin-associated alpha);NotRelevant;;Agammaglobulinemia 3, 613501 (3), Autosomal recessiveAgammaglobulinemia 3, 613501 (3);chr19;CD79A, IGA;True
ENSG00000105409;ATPase, Na+K+ transporting, alpha-3 polypeptide;NotRelevant;;Alternating hemiplegia of childhood 2, 614820 (3), Autosomal dominantDystonia-12, 128235 (3);chr19;ATP1A3, DYT12, RDP, AHC2, CAPOS;True
ENSG00000105722;ETS2 repressor factor;NotRelevant;;Chitayat syndrome, 617180 (3), Autosomal dominantCraniosynostosis 4, 600775 (3);chr19;ERF, PE2, CRS4, CHYTS;True
ENSG00000079432;Capicua, Drosophila, homolog of;NotRelevant;;Mental retardation, autosomal dominant 45, 617600 (3), Autosomal dominantMental retardation, autosomal dominant 45, 617600 (3);chr19;CIC, KIAA0306, MRD45;True
ENSG00000105429;Multiple epidermal growth factor-like domains 8;NotRelevant;;Carpenter syndrome 2, 614976 (3), Autosomal recessiveCarpenter syndrome 2, 614976 (3);chr19;MEGF8, EGFL4, CRPT2;True
ENSG00000079435;Lipase E, hormone-sensitive;NotRelevant;;Lipodystrophy, familial partial, type 6, 615980 (3), Autosomal recessiveLipodystrophy, familial partial, type 6, 615980 (3);chr19;LIPE, LHS, FPLD6;True
ENSG00000105755;ETHE1 gene;NotRelevant;;Ethylmalonic encephalopathy, 602473 (3), Autosomal recessiveEthylmalonic encephalopathy, 602473 (3);chr19;ETHE1, HSCO, D83198;True
ENSG00000073050;X-ray-repair, complementing defective, repair in Chinese hamster cells-1;NotRelevant;mutation identified in 1 SCAR26 patient;?Spinocerebellar ataxia, autosomal recessive 26, 617633 (3), Autosomal recessive?Spinocerebellar ataxia, autosomal recessive 26, 617633 (3);chr19;XRCC1, SCAR26;True
ENSG00000105771;Chromosome 19 open reading frame 61;NotRelevant;;Heart and brain malformation syndrome, 616920 (3), Autosomal recessiveHeart and brain malformation syndrome, 616920 (3);chr19;C19orf61, SMG9, HBMS;True
ENSG00000104783;Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4;NotRelevant;;Dehydrated hereditary stomatocytosis 2, 616689 (3), Autosomal dominantDehydrated hereditary stomatocytosis 2, 616689 (3);chr19;KCNN4, KCA4, SK4, DHS2;True
ENSG00000213892;Carcinoembryonic antigen-related cell adhesion molecule 16;NotRelevant;;Deafness, autosomal dominant 4B, 614614 (3), Autosomal dominantDeafness, autosomal dominant 4B, 614614 (3);chr19;CEACAM16, CEAL2, DFNA4B;True
ENSG00000069399;B-cell CLL/lymphoma-3;NotRelevant;;Leukemia/lymphoma, B-cell, 3, 109560 (2)Leukemia/lymphoma, B-cell, 3 (2);chr19;BCL3;False
ENSG00000187244;B-cell adhesion molecule;NotRelevant;linked to SE;[Blood group, Auberger system], 111200 (3)[Blood group, Lutheran system], 111200 (3);chr19;LU, AU, BCAM;False
ENSG00000130203;Apolipoprotein E;NotRelevant;possible 2nd locus for AD2 on chr.19;Alzheimer disease-2, 104310 (3), Autosomal dominant{Coronary artery disease, severe, susceptibility to}, 617347 (3);chr19;APOE, AD2, LPG, LDLCQ5;True
ENSG00000234906;Apolipoprotein C-II;NotRelevant;;Hyperlipoproteinemia, type Ib, 207750 (3), Autosomal recessiveHyperlipoproteinemia, type Ib, 207750 (3);chr19;APOC2;True
ENSG00000104856;v-rel avian reticuloendotheliosis viral oncogene homolog B;NotRelevant;mutation identified in 1 IMD53 family;?Immunodeficiency 53, 617585 (3), Autosomal recessive?Immunodeficiency 53, 617585 (3);chr19;RELB, IREL, IMD53;True
ENSG00000189114;Biogenesis of lysosome-related organelles complex 1, subunit 3;NotRelevant;;Hermansky-Pudlak syndrome 8, 614077 (3), Autosomal recessiveHermansky-Pudlak syndrome 8, 614077 (3);chr19;BLOC1S3, BLOS3, HPS8;True
ENSG00000104884;Excision repair cross complementing rodent repair deficiency, complementation group-2;NotRelevant;< 250kb from ERCC1; mutation identified in 1 COFS2 patientXeroderma pigmentosum, group D, 278730 (3);chr19;ERCC2, EM9, XPD, COFS2, TTD1;False
ENSG00000012061;Excision repair cross complementing rodent repair deficiency, complementation group-1;NotRelevant;distal to CKM;Cerebrooculofacioskeletal syndrome 4, 610758 (3), Autosomal recessiveCerebrooculofacioskeletal syndrome 4, 610758 (3);chr19;ERCC1, UV20, COFS4;True
ENSG00000125744;Reticulon-2;NotRelevant;;Spastic paraplegia 12, autosomal dominant, 604805 (3), Autosomal dominantSpastic paraplegia 12, autosomal dominant, 604805 (3);chr19;RTN2, NSPL1, SPG12;True
ENSG00000125741;OPA3 gene;NotRelevant;;3-methylglutaconic aciduria, type III, 258501 (3), Autosomal recessiveOptic atrophy 3 with cataract, 165300 (3);chr19;OPA3, MGA3;True
ENSG00000010310;Gastric inhibitory polypeptide receptor;NotRelevant;;[Plasma glucose, 2-hour, QTL 2], 137241 (2)[Plasma glucose, 2-hour, QTL 2] (2);chr19;GIPR, PGQTL2;False
ENSG00000177045;Sine oculis homeo box, Drosophila, homolog of, 5;NotRelevant;;Branchiootorenal syndrome 2, 610896 (3)Branchiootorenal syndrome 2, 610896 (3);chr19;SIX5, DMAHP, BOR2;False
ENSG00000104936;Dystrophia myotonica-protein kinase;NotRelevant;distal to APOLP2; distal to CKMMyotonic dystrophy 1, 160900 (3);chr19;DMPK, DM, DMK;False
ENSG00000169515;Coiled-coil domain-containing protein 8;NotRelevant;;3-M syndrome 3, 614205 (3), Autosomal recessive3-M syndrome 3, 614205 (3);chr19;CCDC8, 3M3;True
ENSG00000181027;Fukutin-related protein;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 5, 613153 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (limb-girdle), type C, 5, 607155 (3);chr19;FKRP, MDC1C, LGMDR9, MDDGA5, MDDGB5, MDDGC5;True
ENSG00000042753;Adaptor-related protein complex 2, sigma 1 subunit;NotRelevant;;Hypocalciuric hypercalcemia, type III, 600740 (3), Autosomal dominantHypocalciuric hypercalcemia, type III, 600740 (3);chr19;AP2S1, CLAPS2, AP17, HHC3;True
ENSG00000118162;Kaptin;NotRelevant;;Mental retardation, autosomal recessive 41, 615637 (3), Autosomal recessiveMental retardation, autosomal recessive 41, 615637 (3);chr19;KPTN, 2E4, MRT41;True
ENSG00000105392;Cone-rod homeo box-containing gene;NotRelevant;;Cone-rod retinal dystrophy-2, 120970 (3), Autosomal dominantLeber congenital amaurosis 7, 613829 (3);chr19;CRX, CORD2, CRD, LCA7;True
ENSG00000105479;Coiled-coil domain-containing protein 114;NotRelevant;;Ciliary dyskinesia, primary, 20, 615067 (3), Autosomal recessiveCiliary dyskinesia, primary, 20, 615067 (3);chr19;CCDC114, CILD20;True
ENSG00000105464;Glutamate receptor, ionotropic, N-methyl-D-aspartate 2D;NotRelevant;;Epileptic encephalopathy, early infantile, 46, 617162 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 46, 617162 (3);chr19;GRIN2D, NMDAR2D, EIEE46;True
ENSG00000088002;Sulfotransferase family 2B, member 1;NotRelevant;;Ichthyosis, congenital, autosomal recessive 14, 617571 (3), Autosomal recessiveIchthyosis, congenital, autosomal recessive 14, 617571 (3);chr19;SULT2B1, ARCI14;True
ENSG00000176920;Fucosyltransferase-2 (secretor);NotRelevant;H, SE = alpha-L-fucosyltransferases; from common ancestral genes{Vitamin B12 plasma level QTL1}, 612542 (3);chr19;FUT2, SE, B12QTL1;False
ENSG00000174951;Fucosyltransferase-1 (Bombay phenotype);NotRelevant;SE tightly linked;[Bombay phenotype], 616754 (3), Autosomal recessive[Bombay phenotype], 616754 (3);chr19;FUT1, H, HH;True
ENSG00000105552;Branched chain aminotransferase-2, mitochondrial;NotRelevant;;?Hypervalinemia or hyperleucine-isoleucinemia (1)?Hypervalinemia or hyperleucine-isoleucinemia (1);chr19;BCAT2, BCT2;False
ENSG00000087088;BCL2-associated X protein;NotRelevant;;Colorectal cancer, somatic, 114500 (3)T-cell acute lymphoblastic leukemia, somatic, 613065 (3);chr19;BAX;False
ENSG00000087086;Ferritin, light chain;NotRelevant;;Hyperferritinemia-cataract syndrome, 600886 (3), Autosomal dominantNeurodegeneration with brain iron accumulation 3, 606159 (3);chr19;FTL, NBIA3, LFTD;True
ENSG00000104812;Glycogen synthase;NotRelevant;;Glycogen storage disease 0, muscle, 611556 (3), Autosomal recessiveGlycogen storage disease 0, muscle, 611556 (3);chr19;GYS1, GYS;True
ENSG00000104826;Luteinizing hormone, beta polypeptide;NotRelevant;beta chains of FSH, TSH on 11p, 1p, respectively;Hypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3), Autosomal recessiveHypogonadotropic hypogonadism 23 with or without anosmia, 228300 (3);chr19;LHB, HH23;True
ENSG00000225950;Neurotrophin-4 (neurotrophin-4/5);NotRelevant;3 genes, ? functional, also on 19;Glaucoma 1, open angle, 1O, 613100 (3)Glaucoma 1, open angle, 1O, 613100 (3);chr19;NTF4 , NTF5, NT5, NT4, GLC1O;False
ENSG00000130529;Transient receptor potential cation channel, subfamily M, member 4;NotRelevant;;Progressive familial heart block, type IB, 604559 (3), Autosomal dominantProgressive familial heart block, type IB, 604559 (3);chr19;TRPM4, PFHB1B;True
ENSG00000126456;Interferon regulatory factor 3;NotRelevant;;{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}, 616532 (3), Autosomal dominant{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 7}, 616532 (3);chr19;IRF3, IIAE7;True
ENSG00000169169;Carnitine palmitoyltransferase IC;NotRelevant;mutation identified in 1 SPG73 family;?Spastic paraplegia 73, autosomal dominant, 616282 (3), Autosomal dominant?Spastic paraplegia 73, autosomal dominant, 616282 (3);chr19;CPT1C, SPG73;True
ENSG00000010361;Fuzzy, Drosophila, homolog of;NotRelevant;;Neural tube defects, 182940 (3), Autosomal dominantNeural tube defects, 182940 (3);chr19;FUZ, NTD;True
ENSG00000104973;Mediator of RNA polymerase II transcription, subunit 25, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 CMT2B2 family;Basel-Vanagait-Smirin-Yosef syndrome, 616449 (3), Autosomal recessiveBasel-Vanagait-Smirin-Yosef syndrome, 616449 (3);chr19;MED25, PTOV2, ARC92, CMT2B2, BVSYS;True
ENSG00000039650;Polynucleotide kinase 3' phosphatase;NotRelevant;;Ataxia-oculomotor apraxia 4, 616267 (3), Autosomal recessiveMicrocephaly, seizures, and developmental delay, 613402 (3);chr19;PNKP, PNK, MCSZ, EIEE10, AOA4;True
ENSG00000213024;Nucleoporin, 62-kD;NotRelevant;;Striatonigral degeneration, infantile, 271930 (3), Autosomal recessiveStriatonigral degeneration, infantile, 271930 (3);chr19;NUP62, SNDI, IBSN;True
ENSG00000105357;Myosin, heavy chain 14, nonmuscle;NotRelevant;mutation identified in 1 PNMHH family;Deafness, autosomal dominant 4A, 600652 (3), Autosomal dominantDeafness, autosomal dominant 4A, 600652 (3);chr19;MYH14, KIAA2034, DFNA4A, PNMHH;True
ENSG00000131398;Potassium voltage-gated channel, Shaw-related subfamily, member 3;NotRelevant;;Spinocerebellar ataxia 13, 605259 (3), Autosomal dominantSpinocerebellar ataxia 13, 605259 (3);chr19;KCNC3, SCA13;True
ENSG00000062822;Polymerase (DNA directed), delta 1, catalytic subunit;NotRelevant;;{Colorectal cancer, susceptibility to, 10}, 612591 (3), Autosomal dominant{Colorectal cancer, susceptibility to, 10}, 612591 (3);chr19;POLD1, CRCS10, MDPL;True
ENSG00000142513;Acid phosphatase, testicular;NotRelevant;;Amelogenesis imperfecta, type IJ, 617297 (3), Autosomal recessiveAmelogenesis imperfecta, type IJ, 617297 (3);chr19;ACPT, AI1J;True
ENSG00000167748;Kallikrein 1;NotRelevant;~10cM distal to APOC2;[Kallikrein, decreased urinary activity of], 615953 (3)[Kallikrein, decreased urinary activity of], 615953 (3);chr19;KLK1, KLKR;False
ENSG00000167749;Kallikrein-related peptidase 4;NotRelevant;;Amelogenesis imperfecta, type IIA1, 204700 (3), Autosomal recessiveAmelogenesis imperfecta, type IIA1, 204700 (3);chr19;KLK4, EMSP1, PRSS17, AI2A1;True
ENSG00000105379;Electron transfer flavoprotein, beta polypeptide;NotRelevant;;Glutaric acidemia IIB, 231680 (3), Autosomal recessiveGlutaric acidemia IIB, 231680 (3);chr19;ETFB, MADD;True
ENSG00000105370;Lens intrinsic protein 2, 19kD;NotRelevant;same cosmid as ETFB;Cataract 19, multiple types, 615277 (3), Autosomal recessiveCataract 19, multiple types, 615277 (3);chr19;LIM2, MP19, CTRCT19;True
ENSG00000105568;Protein phosphatase 2, structural/regulatory subunit A, alpha;NotRelevant;;Mental retardation, autosomal dominant 36, 616362 (3), Autosomal dominantMental retardation, autosomal dominant 36, 616362 (3);chr19;PPP2R1A, MRD36;True
ENSG00000142405;NLR family, pyrin domain containing 12;NotRelevant;;Familial cold autoinflammatory syndrome 2, 611762 (3), Autosomal dominantFamilial cold autoinflammatory syndrome 2, 611762 (3);chr19;NLRP12, NALP12, PYPAF7, RNO, FCAS2;True
ENSG00000126583;Protein kinase C, gamma polypeptide;NotRelevant;;Spinocerebellar ataxia 14, 605361 (3), Autosomal dominantSpinocerebellar ataxia 14, 605361 (3);chr19;PRKCG, PKCC, PKCG, SCA14;True
ENSG00000105618;Precursor RNA-processing factor 31, S. cerevisiae, homolog of;NotRelevant;;Retinitis pigmentosa 11, 600138 (3), Autosomal dominantRetinitis pigmentosa 11, 600138 (3);chr19;PRPF31, PRP31, RP11;True
ENSG00000125505;Membrane bound O-acyltransferase domain containing 7;NotRelevant;;Mental retardation, autosomal recessive 57, 617188 (3), Autosomal recessiveMental retardation, autosomal recessive 57, 617188 (3);chr19;MBOAT7, BB1, LENG4, MRT57;True
ENSG00000170892;tRNA splicing endonuclease 34, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 PCH2C patient;?Pontocerebellar hypoplasia type 2C, 612390 (3)?Pontocerebellar hypoplasia type 2C, 612390 (3);chr19;TSEN34, PCH2C, LENG5, SEN34;False
ENSG00000167633;Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1;NotRelevant;;{AIDS, delayed/rapid progression to}, 609423 (3){AIDS, delayed/rapid progression to}, 609423 (3);chr19;KIR3DL1, NKAT3, NKB1, AMB11, KIR3DS1;False
ENSG00000167634;NACHT domain-, leucine-rich repeat-, and PYD-containing protein 7;NotRelevant;;Hydatidiform mole, recurrent, 1, 231090 (3), Autosomal recessiveHydatidiform mole, recurrent, 1, 231090 (3);chr19;NALP7, NOD12, PYPAF3, HYDM;True
ENSG00000088053;Glycoprotein VI, platelet;NotRelevant;;Bleeding disorder, platelet-type, 11, 614201 (3), Autosomal recessiveBleeding disorder, platelet-type, 11, 614201 (3);chr19;GP6, GPIV, BDPLT11;True
ENSG00000105048;Troponin-T1, skeletal, slow;NotRelevant;;Nemaline myopathy 5, Amish type, 605355 (3), Autosomal recessiveNemaline myopathy 5, Amish type, 605355 (3);chr19;TNNT1, ANM, NEM5;True
ENSG00000129991;Troponin-I, cardiac;NotRelevant;mutation identified in 1 CMD2A family;Cardiomyopathy, dilated, 1FF, 613286 (3)Cardiomyopathy, hypertrophic, 7, 613690 (3);chr19;TNNI3, CMH7, CMD2A, RCM1, CMD1FF;False
ENSG00000167646;Dynein, axonemal, assembly factor 3;NotRelevant;;Ciliary dyskinesia, primary, 2, 606763 (3), Autosomal recessiveCiliary dyskinesia, primary, 2, 606763 (3);chr19;DNAAF3, PF22, DAB1, CILD2;True
ENSG00000105146;Aurora kinase C;NotRelevant;;Spermatogenic failure 5, 243060 (3), Autosomal recessiveSpermatogenic failure 5, 243060 (3);chr19;AURKC, STK13, AIE2, SPGF5;True
ENSG00000125826;RANBP-type and C3HC4-type zinc finger-containing 1;NotRelevant;;Polyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3), Autosomal recessivePolyglucosan body myopathy 1 with or without immunodeficiency, 615895 (3);chr20;RBCK1, HOIL1, PGBM1, PBMEI;True
ENSG00000125875;TBC1 domain family, member 20;NotRelevant;;Warburg micro syndrome 4, 615663 (3), Autosomal recessiveWarburg micro syndrome 4, 615663 (3);chr20;TBC1D20, C20orf140, WARBM4;True
ENSG00000101266;Casein kinase-2, alpha-1 polypeptide;NotRelevant;pseudogene on 11p15;Okur-Chung neurodevelopmental syndrome, 617062 (3), Autosomal dominantOkur-Chung neurodevelopmental syndrome, 617062 (3);chr20;CSNK2A1, CK2A1, OCNDS;True
ENSG00000101276;Solute carrier family 52, riboflavin transporter, member 3;NotRelevant;mutation identified in 1 FZLD family;Brown-Vialetto-Van Laere syndrome 1, 211530 (3), Autosomal recessiveBrown-Vialetto-Van Laere syndrome 1, 211530 (3);chr20;SLC52A3, C20orf54, RFT2, BVVLS1;True
ENSG00000101282;R-spondin family, member 4;NotRelevant;;Anonychia congenita, 206800 (3), Autosomal recessiveAnonychia congenita, 206800 (3);chr20;RSPO4, CRISTIN4;True
ENSG00000101327;Prodynorphin;NotRelevant;;Spinocerebellar ataxia 23, 610245 (3), Autosomal dominantSpinocerebellar ataxia 23, 610245 (3);chr20;PDYN, SCA23;True
ENSG00000125780;Transglutaminase-3 (E polypeptide, protein-glutamine-gamma-glutamyl transferase);NotRelevant;mutation identified in 1 UHS2 patient;?Uncombable hair syndrome 2, 617251 (3), Autosomal recessive?Uncombable hair syndrome 2, 617251 (3);chr20;TGM3, UHS2;True
ENSG00000166948;Transglutaminase 6;NotRelevant;;Spinocerebellar ataxia 35, 613908 (3), Autosomal dominantSpinocerebellar ataxia 35, 613908 (3);chr20;TGM6, TG6, TGY, SCA35;True
ENSG00000125835;Small nuclear ribonucleoprotein polypeptides B and B1;NotRelevant;;Cerebrocostomandibular syndrome, 117650 (3), Autosomal dominantCerebrocostomandibular syndrome, 117650 (3);chr20;SNRPB, CCMS;True
ENSG00000101361;Nop56, S. cerevisiae, homolog of;NotRelevant;;Spinocerebellar ataxia 36, 614153 (3), Autosomal dominantSpinocerebellar ataxia 36, 614153 (3);chr20;NOP56, SCA36;True
ENSG00000101365;Isocitrate dehydrogenase 3, beta subunit;NotRelevant;;Retinitis pigmentosa 46, 612572 (3)Retinitis pigmentosa 46, 612572 (3);chr20;IDH3B, RP46;False
ENSG00000101200;Arginine vasopressin (neurophysin II, antidiuretic hormone);NotRelevant;distal 20p;Diabetes insipidus, neurohypophyseal, 125700 (3), Autosomal dominantDiabetes insipidus, neurohypophyseal, 125700 (3);chr20;AVP, AVRP, VP;True
ENSG00000198171;DDRGK domain-containing protein 1;NotRelevant;;Spondyloepimetaphyseal dysplasia, Shohat type, 602557 (3), Autosomal recessiveSpondyloepimetaphyseal dysplasia, Shohat type, 602557 (3);chr20;DDRGK1, UFBP1, C20orf116, SEMDSH;True
ENSG00000125877;Inosine triphosphatase-A;NotRelevant;;Epileptic encephalopathy, early infantile, 35, 616647 (3), Autosomal recessive[Inosine triphosphatase deficiency], 613850 (3);chr20;ITPA, EIEE35;True
ENSG00000088836;Solute carrier family 4 (sodium borate cotransporter), member 11;NotRelevant;;Corneal dystrophy, Fuchs endothelial, 4, 613268 (3)Corneal endothelial dystrophy, autosomal recessive, 217700 (3);chr20;SLC4A11, BTR1, NABC1, CHED, CDPD, FECD4;True
ENSG00000125779;Pantothenate kinase 2;NotRelevant;;HARP syndrome, 607236 (3), Autosomal recessiveNeurodegeneration with brain iron accumulation 1, 234200 (3);chr20;PANK2, NBIA1, PKAN, HARP;True
ENSG00000171867;Prion protein (p27-30);NotRelevant;pter-PRNP-SCG1-BMP2A-PAX1-cen;Cerebral amyloid angiopathy, PRNP-related, 137440 (3), Autosomal dominant{Kuru, susceptibility to}, 245300 (3);chr20;PRNP, PRIP, KURU, CJD;True
ENSG00000132646;Proliferating cell nuclear antigen;NotRelevant;pseudogenes on X and 6; mutation identified in one ATLD2 family?Ataxia-telangiectasia-like disorder 2, 615919 (3);chr20;PCNA, ATLD2;False
ENSG00000101292;Prokineticin receptor 2;NotRelevant;;Hypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3), Autosomal dominantHypogonadotropic hypogonadism 3 with or without anosmia, 244200 (3);chr20;PROKR2, PKR2, GPR73L1, HH3;True
ENSG00000125885;Minichromosome maintenance complement component 8;NotRelevant;mutation identified in 1 POF10 family;?Premature ovarian failure 10, 612885 (3), Autosomal recessive?Premature ovarian failure 10, 612885 (3);chr20;MCM8, POF10;True
ENSG00000101311;Fermitin family, member 1;NotRelevant;;Kindler syndrome, 173650 (3), Autosomal recessiveKindler syndrome, 173650 (3);chr20;FERMT1, KIND1, URP1, C20orf42;True
ENSG00000125845;Bone morphogenetic protein-2;NotRelevant;;Brachydactyly, type A2, 112600 (3), Autosomal dominant{HFE hemochromatosis, modifier of}, 235200 (3);chr20;BMP2, BMP2A, BDA2, SSFSC;True
ENSG00000182621;Phospholipase C, beta-1;NotRelevant;;Epileptic encephalopathy, early infantile, 12, 613722 (3), Autosomal recessiveEpileptic encephalopathy, early infantile, 12, 613722 (3);chr20;PLCB1, KIAA0581, PLCB1A, PLCB1B, EIEE12;True
ENSG00000101333;Phospholipase C, beta 4;NotRelevant;;Auriculocondylar syndrome 2, 614669 (3), Autosomal recessive, Autosomal dominantAuriculocondylar syndrome 2, 614669 (3);chr20;PLCB4, ARCND2;True
ENSG00000132639;Synaptosomal-associated protein, 25kD;NotRelevant;mutation identified in 1 CMS18 patient;?Myasthenic syndrome, congenital, 18, 616330 (3), Autosomal dominant?Myasthenic syndrome, congenital, 18, 616330 (3);chr20;SNAP25, CMS18;True
ENSG00000125863;McKusick-Kaufman syndrome gene;NotRelevant;;Bardet-Biedl syndrome 6, 605231 (3), Autosomal recessiveMcKusick-Kaufman syndrome, 236700 (3);chr20;MKKS, HMCS, KMS, MKS, BBS6;True
ENSG00000101384;Jagged 1;NotRelevant;mutation identified in 1 DCHE family;Alagille syndrome 1, 118450 (3), Autosomal dominantTetralogy of Fallot, 187500 (3);chr20;JAG1, AGS1, AHD, DCHE;True
ENSG00000101247;NADH dehydrogenase (ubiquinone) complex I, assembly factor T;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 16, 616238 (3)Mitochondrial complex I deficiency, nuclear type 16, 616238 (3);chr20;NDUFAF5, C20orf7, MC1DN16;False
ENSG00000125848;Fibronectin-like domain-containing leucine-rich transmembrane protein-3;NotRelevant;;Hypogonadotropic hypogonadism 21 with anosmia, 615271 (3), Autosomal dominantHypogonadotropic hypogonadism 21 with anosmia, 615271 (3);chr20;FLRT3, HH21;True
ENSG00000125864;Beaded filament structural protein-1 (filensin);NotRelevant;;Cataract 33, multiple types, 611391 (3), Autosomal recessive, Autosomal dominantCataract 33, multiple types, 611391 (3);chr20;BFSP1, CP115, CTRCT33;True
ENSG00000125871;Mitochondrial genome maintenance exonuclease 1;NotRelevant;;Mitochondrial DNA depletion syndrome 11, 615084 (3), Autosomal recessiveMitochondrial DNA depletion syndrome 11, 615084 (3);chr20;MGME1, C20orf72, MTDPS11;True
ENSG00000125850;ovo-like 2;NotRelevant;;Corneal dystrophy, posterior polymorphous, 1, 122000 (3), Autosomal dominantCorneal dystrophy, posterior polymorphous, 1, 122000 (3);chr20;OVOL2, ZNF339, PPCD1;True
ENSG00000101310;Sec23, S. cerevisiae, homolog of, B;NotRelevant;mutation identified in 1 CWS7 family;?Cowden syndrome 7, 616858 (3), Autosomal dominantDyserythropoietic anemia, congenital, type II, 224100 (3);chr20;SEC23B, CDAN2, HEMPAS, CWS7;True
ENSG00000132669;RAS and RAB interactor 2;NotRelevant;;Macrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3), Autosomal recessiveMacrocephaly, alopecia, cutis laxa, and scoliosis, 613075 (3);chr20;RIN2, MACS;True
ENSG00000088970;Kizuna centrosomal protein;NotRelevant;;Retinitis pigmentosa 69, 615780 (3), Autosomal recessiveRetinitis pigmentosa 69, 615780 (3);chr20;KIZ, KIZUNA, C20orf19, RP69;True
ENSG00000125813;Paired box homeotic gene-1;NotRelevant;mutation identified in 1 family;?Otofaciocervical syndrome 2, 615560 (3), Autosomal recessive?Otofaciocervical syndrome 2, 615560 (3);chr20;PAX1, OFC2;True
ENSG00000178726;Thrombomodulin;NotRelevant;;{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3), Autosomal dominant{Hemolytic uremic syndrome, atypical, susceptibility to, 6}, 612926 (3);chr20;THBD, THRM, AHUS6, THPH12;True
ENSG00000125812;GDNF-inducible zinc finger protein 1;NotRelevant;;Joint laxity, short stature, and myopia, 617662 (3), Autosomal recessiveJoint laxity, short stature, and myopia, 617662 (3);chr20;GZF1, ZNF336, JLSM;True
ENSG00000101439;Cystatin C;NotRelevant;proximal to 20p11.2;Cerebral amyloid angiopathy, 105150 (3), Autosomal dominant{Macular degeneration, age-related, 11}, 611953 (3);chr20;CST3, ARMD11;True
ENSG00000100987;Visual system homeo box gene 1, zebrafish, homolog of;NotRelevant;mutation identified in 1 CAASDS family;?Craniofacial anomalies and anterior segment dysgenesis syndrome, 614195 (3)Keratoconus 1, 148300 (3);chr20;VSX1, RINX, KTCN1, CAASDS;False
ENSG00000100997;Abhydrolase domain-containing protein 12;NotRelevant;;Polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3), Autosomal recessivePolyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract, 612674 (3);chr20;ABHD12, PHARC;True
ENSG00000101003;GINS complex subunit 1;NotRelevant;;Immunodeficiency 55, 617827 (3), Autosomal recessiveImmunodeficiency 55, 617827 (3);chr20;GINS1, PSF1, KIAA0186, IMD55;True
ENSG00000131055;Cytochrome c oxidase, subunit IV, isoform 2;NotRelevant;;Exocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3), Autosomal recessiveExocrine pancreatic insufficiency, dyserythropoietic anemia, and calvarial hyperostosis, 612714 (3);chr20;COX4I2;True
ENSG00000101306;Myosin light chain kinase 2;NotRelevant;;Cardiomyopathy, hypertrophic, 1, digenic, 192600 (3), Autosomal dominantCardiomyopathy, hypertrophic, 1, digenic, 192600 (3);chr20;MYLK2, MLCK;True
ENSG00000101346;Protein O-fucosyltransferase 1;NotRelevant;;Dowling-Degos disease 2, 615327 (3), Autosomal dominantDowling-Degos disease 2, 615327 (3);chr20;POFUT1, OFUCT1, KIAA0180, DDD2;True
ENSG00000171456;Additional sex combs-like 1;NotRelevant;;Bohring-Opitz syndrome, 605039 (3), Autosomal dominantMyelodysplastic syndrome, somatic, 614286 (3);chr20;ASXL1, KIAA0978, BOPS, MDS;True
ENSG00000088305;DNA methyltransferase 3B;NotRelevant;;Immunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3), Autosomal recessiveImmunodeficiency-centromeric instability-facial anomalies syndrome 1, 242860 (3);chr20;DNMT3B, ICF1;True
ENSG00000167098;Sad1 and Unc84 domain-containing protein 5;NotRelevant;;Spermatogenic failure 16, 617187 (3), Autosomal recessiveSpermatogenic failure 16, 617187 (3);chr20;SUN5, TSARG4, SPAG4L, SPGF16;True
ENSG00000101400;Syntrophin, alpha-1;NotRelevant;;Long QT syndrome 12, 612955 (3), Autosomal dominantLong QT syndrome 12, 612955 (3);chr20;SNTA1, SNT1, TACIP1, LQT12;True
ENSG00000101421;CHMP family, member 4B;NotRelevant;;Cataract 31, multiple types, 605387 (3), Autosomal dominantCataract 31, multiple types, 605387 (3);chr20;CHMP4B, SNF7, CTPP3, CTRCT31;True
ENSG00000101440;Agouti, mouse, signaling protein;NotRelevant;;[Skin/hair/eye pigmentation 9, brown/nonbrown eyes], 611742 (3)[Skin/hair/eye pigmentation 9, dark/light hair], 611742 (3);chr20;ASIP, AGTIL, SHEP9;False
ENSG00000101444;S-adenosylhomocysteine hydrolase;NotRelevant;~13cM from ADA;Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3), Autosomal recessiveHypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase, 613752 (3);chr20;AHCY, SAHH;True
ENSG00000078747;Itchy, mouse, homolog of;NotRelevant;;Autoimmune disease, multisystem, with facial dysmorphism, 613385 (3), Autosomal recessiveAutoimmune disease, multisystem, with facial dysmorphism, 613385 (3);chr20;ITCH, AIP4, NAPP1, ADMFD;True
ENSG00000100983;Glutathione synthetase;NotRelevant;;Glutathione synthetase deficiency, 266130 (3), Autosomal recessiveHemolytic anemia due to glutathione synthetase deficiency, 231900 (3);chr20;GSS, GSHS;True
ENSG00000125965;Growth/differentiation factor-5 (cartilage-derived morphogenetic protein-1);NotRelevant;mutation identified in 1 AMDHT family;?Acromesomelic dysplasia, Hunter-Thompson type, 201250 (3), Autosomal recessive{Osteoarthritis-5}, 612400 (3);chr20;GDF5, CDMP1, SYNS2, OS5, BDA1C, SYM1B;True
ENSG00000244462;RNA-binding motif protein 12;NotRelevant;;{Schizophrenia 19, susceptibility to}, 617629 (3), Autosomal dominant{Schizophrenia 19, susceptibility to}, 617629 (3);chr20;RBM12, KIAA0765, SCZD19;True
ENSG00000088367;Erythrocyte membrane protein band 4.1-like 1;NotRelevant;mutation identified in 1 patient;?Mental retardation, autosomal dominant 11, 614257 (3)?Mental retardation, autosomal dominant 11, 614257 (3);chr20;EPB41L1, MRD11;True
ENSG00000101347;SAM domain- and HD domain-containing protein 1;NotRelevant;mutation identified in 1 CHBL2 family;Aicardi-Goutieres syndrome 5, 612952 (3), Autosomal recessiveAicardi-Goutieres syndrome 5, 612952 (3);chr20;SAMHD1, AGS5, DCIP, CHBL2;True
ENSG00000118702;Growth hormone releasing hormone (somatocrinin);NotRelevant;;Gigantism due to GHRF hypersecretion (1)Gigantism due to GHRF hypersecretion (1);chr20;GHRH, GHRF;False
ENSG00000197122;Protooncogene SRC, Rous sarcoma;NotRelevant;mutation identified in 1 THC6 family;Colon cancer, advanced, somatic, 114500 (3)Colon cancer, advanced, somatic, 114500 (3);chr20;SRC, ASV, SRC1, THC6;False
ENSG00000204103;v-MAF musculoaponeurotic fibrosarcoma oncogene family, protein B;NotRelevant;;Duane retraction syndrome 3, 617041 (3), Autosomal dominantMulticentric carpotarsal osteolysis syndrome, 166300 (3);chr20;MAFB, KRML, MCTO, DURS3;True
ENSG00000198900;Topoisomerase (DNA) I;NotRelevant;pseudogenes on chr.1 and 22;DNA topoisomerase I, camptothecin-resistant (3)DNA topoisomerase I, camptothecin-resistant (3);chr20;TOP1;False
ENSG00000101052;Intraflagellar transport 52, Chlamydomonas, homolog of;NotRelevant;;Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3), Autosomal recessiveShort-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3);chr20;IFT52;True
ENSG00000149596;Junctophilin 2;NotRelevant;;Cardiomyopathy, hypertrophic, 17, 613873 (3), Autosomal dominantCardiomyopathy, hypertrophic, 17, 613873 (3);chr20;JPH2, JP2, CMH17;True
ENSG00000101076;Hepatocyte nuclear factor 4, alpha (transcription factor-14);NotRelevant;;{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant{Diabetes mellitus, noninsulin-dependent}, 125853 (3);chr20;HNF4A, TCF14, MODY1, FRTS4;True
ENSG00000196839;Adenosine deaminase;NotRelevant;;Adenosine deaminase deficiency, partial, 102700 (3), Autosomal recessive, Somatic mosaicismSevere combined immunodeficiency due to ADA deficiency, 102700 (3);chr20;ADA;True
ENSG00000101109;Serine/threonine protein kinase 4;NotRelevant;;T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3)T-cell immunodeficiency, recurrent infections, autoimmunity, and cardiac malformations, 614868 (3);chr20;STK4, MST1, KRS2, TIIAC;False
ENSG00000124155;Phosphatidylinositol glycan, class T;NotRelevant;mutation identified in 1 PNH2 family;Multiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3), Autosomal recessiveMultiple congenital anomalies-hypotonia-seizures syndrome 3, 615398 (3);chr20;PIGT, NDAP, PNH2, MCAHS3;True
ENSG00000064601;Cathepsin A (protective protein for beta-galactosidase);NotRelevant;;Galactosialidosis, 256540 (3), Autosomal recessiveGalactosialidosis, 256540 (3);chr20;CTSA, PPGB, GSL, NGBE, GLB2;True
ENSG00000100979;Phospholipid transfer protein;NotRelevant;;[High density lipoprotein cholesterol level QTL 9] (3)[High density lipoprotein cholesterol level QTL 9] (3);chr20;PLTP, HDLCQ9;False
ENSG00000198026;Zinc finger protein 335;NotRelevant;mutation identified in 1 MCPH10 family;?Microcephaly 10, primary, autosomal recessive, 615095 (3), Autosomal recessive?Microcephaly 10, primary, autosomal recessive, 615095 (3);chr20;ZNF335, NIF1, NIF2, MCPH10;True
ENSG00000100985;Matrix metalloproteinase 9 (gelatinase B, 92kD type IV collagenase);NotRelevant;;Metaphyseal anadysplasia 2, 613073 (3)Metaphyseal anadysplasia 2, 613073 (3);chr20;MMP9, CLG4B, MANDP2;False
ENSG00000124140;Solute carrier family 12, (potassium-chloride transporter) member 5;NotRelevant;;{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3), Autosomal dominant{Epilepsy, idiopathic generalized, susceptibility to, 14}, 616685 (3);chr20;SLC12A5, KCC2, KIAA1176, EIEE34, EIG14;True
ENSG00000101017;CD40 antigen;NotRelevant;;Immunodeficiency with hyper-IgM, type 3, 606843 (3), Autosomal recessiveImmunodeficiency with hyper-IgM, type 3, 606843 (3);chr20;CD40, TNFRSF5;True
ENSG00000062598;Engulfment and cell motility gene 2;NotRelevant;;Vascular malformation, primary intraosseous, 606893 (3), Autosomal recessiveVascular malformation, primary intraosseous, 606893 (3);chr20;ELMO2, CED12, VMPI;True
ENSG00000172315;TP53-regulating kinase;NotRelevant;;Galloway-Mowat syndrome 4, 617730 (3), Autosomal recessiveGalloway-Mowat syndrome 4, 617730 (3);chr20;TP53RK, PRPK, GAMOS4;True
ENSG00000197496;Solute carrier family 2 (facilitated glucose transporter), member 10;NotRelevant;;Arterial tortuosity syndrome, 208050 (3), Autosomal recessiveArterial tortuosity syndrome, 208050 (3);chr20;SLC2A10, GLUT10, ATS;True
ENSG00000124198;ADP-ribosylation factor guanine nucleotide-exchange factor 2, brefeldin A-inhibited;NotRelevant;;Periventricular heterotopia with microcephaly, 608097 (3), Autosomal recessivePeriventricular heterotopia with microcephaly, 608097 (3);chr20;ARFGEF2, BIG2, PVNH2;True
ENSG00000158445;Potassium voltage-gated channel, Shab-related subfamily, member 1;NotRelevant;;Epileptic encephalopathy, early infantile, 26, 616056 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 26, 616056 (3);chr20;KCNB1, EIEE26;True
ENSG00000124212;Prostaglandin I2 synthase;NotRelevant;;Hypertension, essential, 145500 (3), MultifactorialHypertension, essential, 145500 (3);chr20;PTGIS, CYP8A1, PGIS, CYP8;False
ENSG00000196396;Protein tyrosine phosphatase, nonreceptor-type, 1;NotRelevant;20pter-q12 by REa;{Insulin resistance, susceptibility to}, 125853 (3), Autosomal dominant{Insulin resistance, susceptibility to}, 125853 (3);chr20;PTPN1, PTP1B;True
ENSG00000101126;Activity-dependent neuroprotector homeobox;NotRelevant;;Helsmoortel-van der Aa syndrome, 615873 (3), Autosomal dominantHelsmoortel-van der Aa syndrome, 615873 (3);chr20;ADNP, ADNP1, KIAA0784, HVDAS, MRD28;True
ENSG00000000419;Dolichyl-phosphate mannosyltransferase 1, catalytic subunit;NotRelevant;;Congenital disorder of glycosylation, type Ie, 608799 (3), Autosomal recessiveCongenital disorder of glycosylation, type Ie, 608799 (3);chr20;DPM1, MPDS, CDGIE;True
ENSG00000101115;sal-like 4;NotRelevant;;Duane-radial ray syndrome, 607323 (3), Autosomal dominantIVIC syndrome, 147750 (3);chr20;SALL4, HSAL4;True
ENSG00000019186;Cytochrome P450, family 24, subfamily A, polypeptide 1 (vitamin D 24-hydroxylase);NotRelevant;;Hypercalcemia, infantile, 1, 143880 (3), Autosomal recessiveHypercalcemia, infantile, 1, 143880 (3);chr20;CYP24A1, CYP24, HCINF1;True
ENSG00000124089;Melanocortin-3 receptor;NotRelevant;;{Mycobacterium tuberculosis, protection against}, 607948 (3){Obesity, severe, susceptibility to, BMIQ9}, 602025 (3);chr20;MC3R, BMIQ9;False
ENSG00000087586;Aurora kinase A;NotRelevant;;{Colon cancer, susceptibility to}, 114500 (3), Autosomal dominant{Colon cancer, susceptibility to}, 114500 (3);chr20;AURKA, STK15, AURORA2, BTAK, ARK1, STK6, AIK;True
ENSG00000124253;Phosphoenolpyruvate carboxykinase-1 (soluble);NotRelevant;mutation identified in 1 PCKDC family;?Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3), Autosomal recessive?Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3);chr20;PCK1, PCKDC;True
ENSG00000124164;Vesicle-associated membrane protein-associated protein B;NotRelevant;;Amyotrophic lateral sclerosis 8, 608627 (3), Autosomal dominantSpinal muscular atrophy, late-onset, Finkel type, 182980 (3);chr20;VAPB, VAPC, ALS8;True
ENSG00000124222;Syntaxin 16;NotRelevant;;Pseudohypoparathyroidism, type IB, 603233 (3), Autosomal dominantPseudohypoparathyroidism, type IB, 603233 (3);chr20;STX16, SYN16;True
ENSG00000235590;GNAS antisense RNA 1;NotRelevant;;Pseudohypoparathyroidism, type IB, 603233 (3), Autosomal dominantPseudohypoparathyroidism, type IB, 603233 (3);chr20;GNASAS1, GNASAS, SANG, NESPAS;True
ENSG00000087460;GNAS complex locus (guanine nucleotide binding protein (G protein), alpha stimulating activity polypeptide 1);NotRelevant;;ACTH-independent macronodular adrenal hyperplasia, 219080 (3), Isolated casesPseudopseudohypoparathyroidism, 612463 (3);chr20;GNAS, GNAS1, GPSA, POH, PHP1B, PHP1A, AHO, PHP1C, PITA3;False
ENSG00000101162;Tubulin, beta-1;NotRelevant;;Macrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3), Autosomal dominantMacrothrombocytopenia, autosomal dominant, TUBB1-related, 613112 (3);chr20;TUBB1;True
ENSG00000124172;ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit;NotRelevant;pseudogene on 4q25; mutation identified in 1 MC5DN3 patient?Mitochondrial complex V (ATP synthase) deficiency, nuclear type 3, 614053 (3);chr20;ATP5E, MC5DN3;False
ENSG00000124205;Endothelin-3;NotRelevant;;Central hypoventilation syndrome, congenital, 209880 (3), Autosomal dominant{Hirschsprung disease, susceptibility to, 4}, 613712 (3);chr20;EDN3, WS4B, HSCR4;True
ENSG00000130703;Oxysterol-binding protein-like protein 2;NotRelevant;;Deafness, autosomal dominant 67, 616340 (3), Autosomal dominantDeafness, autosomal dominant 67, 616340 (3);chr20;OSBPL2, ORP2, KIAA0772, DNFA67;True
ENSG00000130700;GATA-binding protein 5;NotRelevant;;Congenital heart defects, multiple types, 5, 617912 (3), Autosomal recessive, Autosomal dominantCongenital heart defects, multiple types, 5, 617912 (3);chr20;GATA5, CHTD5;True
ENSG00000092758;Collagen IX, alpha-3 polypeptide;NotRelevant;;Epiphyseal dysplasia, multiple, 3, with or without myopathy, 600969 (3), Autosomal dominant{Intervertebral disc disease, susceptibility to}, 603932 (3);chr20;COL9A3, EDM3, IDD;True
ENSG00000101194;Solute carrier family 17, member 9;NotRelevant;;Porokeratosis 8, disseminated superficial actinic type, 616063 (3), Autosomal dominantPorokeratosis 8, disseminated superficial actinic type, 616063 (3);chr20;SLC17A9, C20orf59, POROK8;True
ENSG00000101204;Cholinergic receptor, nicotinic, alpha polypeptide-4;NotRelevant;;Epilepsy, nocturnal frontal lobe, 1, 600513 (3), Autosomal dominant{Nicotine addiction, susceptibility to}, 188890 (3);chr20;CHRNA4, ENFL1;True
ENSG00000075043;Potassium voltage-gated channel, KQT-like subfamily, member 2;NotRelevant;;Epileptic encephalopathy, early infantile, 7, 613720 (3), Autosomal dominantSeizures, benign neonatal, 1, 121200 (3);chr20;KCNQ2, EBN1, EIEE7, BFNS1;True
ENSG00000101210;Eukaryotic translation elongation factor-1, alpha-2;NotRelevant;;Epileptic encephalopathy, early infantile, 33, 616409 (3), Autosomal dominantMental retardation, autosomal dominant 38, 616393 (3);chr20;EEF1A2, EIEE33, MRD38;True
ENSG00000258366;Regulator of telomere elongation helicase 1;NotRelevant;;Dyskeratosis congenita, autosomal dominant 4, 615190 (3), Autosomal recessive, Autosomal dominantPulmonary fibrosis and/or bone marrow failure, telomere-related, 3, 616373 (3);chr20;RTEL1, C20orf41, NHL, KIAA1088, DKCB5, DKCA4, PFBMFT3;True
ENSG00000101152;DNAJ/HSP40 homolog, subfamily C, member 5;NotRelevant;;Ceroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3), Autosomal dominantCeroid lipofuscinosis, neuronal, 4, Parry type, 162350 (3);chr20;DNAJC5, DNAJC5A, CSP, CLN4B;True
ENSG00000101161;Precursor mRNA-processing factor 6, S. cerevisiae, homolog of;NotRelevant;;Retinitis pigmentosa 60, 613983 (3), Autosomal dominantRetinitis pigmentosa 60, 613983 (3);chr20;PRPF6, PRP6, ANT1, TOM, C20orf14;True
ENSG00000203883;SOX18, mouse, homolog of;NotRelevant;;Hypotrichosis-lymphedema-telangiectasia syndrome, 607823 (3), Autosomal recessiveHypotrichosis-lymphedema-telangiectasia-renal defect syndrome, 137940 (3);chr20;SOX18, HLTS, HLTRS;True
ENSG00000188992;Lipase I;NotRelevant;;{Hypertriglyceridemia, susceptibility to}, 145750 (3), Autosomal dominant{Hypertriglyceridemia, susceptibility to}, 145750 (3);chr21;LIPI, LPDL, PRED5;True
ENSG00000154646;Transmembrane protease, serine 15;NotRelevant;;Enterokinase deficiency, 226200 (3), Autosomal recessiveEnterokinase deficiency, 226200 (3);chr21;TMPRSS15, PRSS7, ENTK;True
ENSG00000142192;Amyloid beta (A4) precursor protein;NotRelevant;proximal to SOD; very distal q21 or boundary with q22Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants, 605714 (3);chr21;APP, AAA, CVAP, AD1;False
ENSG00000142168;Superoxide dismutase-1, soluble;NotRelevant;mid q22.1;Amyotrophic lateral sclerosis 1, 105400 (3), Autosomal recessive, Autosomal dominantAmyotrophic lateral sclerosis 1, 105400 (3);chr21;SOD1, ALS1;True
ENSG00000170262;Melanocortin 2 receptor accessory protein;NotRelevant;;Glucocorticoid deficiency 2, 607398 (3), Autosomal recessiveGlucocorticoid deficiency 2, 607398 (3);chr21;MRAP, FALP, C21orf61, GCCD2, FGD2;True
ENSG00000159079;Chromosome 21 open reading frame 59;NotRelevant;;Ciliary dyskinesia, primary, 26, 615500 (3), Autosomal recessiveCiliary dyskinesia, primary, 26, 615500 (3);chr21;C21orf59, CILD26;True
ENSG00000159082;Synaptojanin 1;NotRelevant;;Epileptic encephalopathy, early infantile, 53, 617389 (3), Autosomal recessiveParkinson disease 20, early-onset, 615530 (3);chr21;SYNJ1, PARK20, EIEE53;True
ENSG00000159110;Interferon, alpha, beta, and omega, receptor 2;NotRelevant;mutation identified in 1 IMD45 family;{Hepatitis B virus, susceptibility to}, 610424 (3){Hepatitis B virus, susceptibility to}, 610424 (3);chr21;IFNAR2, IMD45;False
ENSG00000243646;Cytokine receptor, family II, member 4;NotRelevant;35kb distal to IFNAR; D21S58{Hepatitis B virus, susceptibility to}, 610424 (3);chr21;CRFB4, IBD25;False
ENSG00000159128;Interferon gamma receptor-2 (interferon gamma transducer 1);NotRelevant;;Immunodeficiency 28, mycobacteriosis, 614889 (3), Autosomal recessiveImmunodeficiency 28, mycobacteriosis, 614889 (3);chr21;IFNGR2, IFNGT1, IFGR2, IMD28;True
ENSG00000159131;Phosphoribosylglycinamide formyltransferase (phosphoribosylglycinamide synthetase;NotRelevant;ENSG00000159131;multifunctional protein: Ade(-)C, Ade(-)G, GART;chr21;GART, PRGS, PGFT;False
ENSG00000159140;SON DNA-binding protein;NotRelevant;;ZTTK syndrome, 617140 (3), Autosomal dominantZTTK syndrome, 617140 (3);chr21;SON, TOKIMS;True
ENSG00000159147;Downstream neighbor of SON;NotRelevant;;Microcephaly, short stature, and limb abnormalities, 617604 (3), Autosomal recessiveMicrocephaly-micromelia syndrome, 251230 (3);chr21;DONSON, C21orf60, MISSLA, MIMIS;True
ENSG00000159197;Potassium voltage-gated channel, Isk-related family, member 2;NotRelevant;;Atrial fibrillation, familial, 4, 611493 (3)Long QT syndrome 6, 613693 (3);chr21;KCNE2, MIRP1, LQT6, ATFB4;False
ENSG00000180509;Potassium voltage-gated channel, Isk-related subfamily, member 1;NotRelevant;;Jervell and Lange-Nielsen syndrome 2, 612347 (3), Autosomal recessiveLong QT syndrome 5, 613695 (3);chr21;KCNE1, JLNS, LQT5, JLNS2;True
ENSG00000159216;Runt-related transcription factor 1 (aml1 oncogene);NotRelevant;;Leukemia, acute myeloid, 601626 (3), Autosomal dominant, Somatic mutationPlatelet disorder, familial, with associated myeloid malignancy, 601399 (3);chr21;RUNX1, CBFA2, AML1;True
ENSG00000159261;Claudin 14;NotRelevant;;Deafness, autosomal recessive 29, 614035 (3), Autosomal recessiveDeafness, autosomal recessive 29, 614035 (3);chr21;CLDN14, DFNB29;True
ENSG00000159267;Holocarboxylase synthetase;NotRelevant;;Holocarboxylase synthetase deficiency, 253270 (3), Autosomal recessiveHolocarboxylase synthetase deficiency, 253270 (3);chr21;HLCS, HCS;True
ENSG00000185808;Phosphatidylinositol glycan, class P;NotRelevant;mutation identified one EIEE55 family;?Epileptic encephalopathy, early infantile, 55, 617599 (3), Autosomal recessive?Epileptic encephalopathy, early infantile, 55, 617599 (3);chr21;PIGP, DSCR5, EIEE55;True
ENSG00000157540;Dual specificity tyrosine-(Y)-phosphorylation regulated kinase-1A (\'minibrain\', Drosophila, homolog of);NotRelevant;?triplicate state responsible for mental defect in Down syndrome;Mental retardation, autosomal dominant 7, 614104 (3), Autosomal dominantMental retardation, autosomal dominant 7, 614104 (3);chr21;DYRK1A, MNBH, MNB, MRD7;True
ENSG00000157542;Potassium inwardly-rectifying channel, subfamily J, member 6;NotRelevant;;Keppen-Lubinsky syndrome, 614098 (3), Autosomal dominantKeppen-Lubinsky syndrome, 614098 (3);chr21;KCNJ6, GIRK2, KCNJ7, KPLBS;True
ENSG00000183421;Receptor-interacting serine-threonine kinase 4;NotRelevant;;CHAND syndrome, 214350 (3), Autosomal recessivePopliteal pterygium syndrome, Bartsocas-Papas type, 263650 (3);chr21;RIPK4, NKRD3, DIK, PPS2, CHANDS;True
ENSG00000160183;Transmembrane protease, serine 3;NotRelevant;;Deafness, autosomal recessive 8/10, 601072 (3), Autosomal recessiveDeafness, autosomal recessive 8/10, 601072 (3);chr21;TMPRSS3, ECHOS1, DFNB8, DFNB10;True
ENSG00000160188;Radial spoke head 1, Chlamydomonas, homolog of;NotRelevant;;Ciliary dyskinesia, primary, 24, 615481 (3), Autosomal recessiveCiliary dyskinesia, primary, 24, 615481 (3);chr21;RSPH1, TSGA2, TSA2, CILD24;True
ENSG00000160200;Cystathionine beta-synthase;NotRelevant;subtelomeric;Homocystinuria, B6-responsive and nonresponsive types, 236200 (3), Autosomal recessiveThrombosis, hyperhomocysteinemic, 236200 (3);chr21;CBS;True
ENSG00000160202;Crystallin, alpha A;NotRelevant;;Cataract 9, multiple types, 604219 (3), Autosomal recessive, Autosomal dominantCataract 9, multiple types, 604219 (3);chr21;CRYAA, CRYA1, CTRCT9;True
ENSG00000142178;Salt-inducible kinase 1;NotRelevant;;Epileptic encephalopathy, early infantile, 30, 616341 (3), Autosomal dominantEpileptic encephalopathy, early infantile, 30, 616341 (3);chr21;SIK1, SNF1LK, MSK, EIEE30;True
ENSG00000160213;Cystatin B (stefin B);NotRelevant;;Epilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3), Autosomal recessiveEpilepsy, progressive myoclonic 1A (Unverricht and Lundborg), 254800 (3);chr21;CSTB, STFB, EPM1, PME, EPM1A, ULD;True
ENSG00000160224;Autoimmune regulator;NotRelevant;;Autoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3), Autosomal recessive, Autosomal dominantAutoimmune polyendocrinopathy syndrome , type I, with or without reversible metaphyseal dysplasia, 240300 (3);chr21;AIRE, APECED, APS1;True
ENSG00000141959;Phosphofructokinase, liver type;NotRelevant;;Hemolytic anemia due to phosphofructokinase deficiency (1)Hemolytic anemia due to phosphofructokinase deficiency (1);chr21;PFKL;False
ENSG00000160226;Cilia and flagella-associated protein 410;NotRelevant;;Retinal dystrophy with macular staphyloma, 617547 (3), Autosomal recessiveSpondylometaphyseal dysplasia, axial, 602271 (3);chr21;CFAP410, C21orf2, SMDAX, RDMS;True
ENSG00000175894;Thrombospondin-type laminin G domain and EAR repeats;NotRelevant;mutation identified in 1 DFNB98 family;?Deafness, autosomal recessive 98, 614861 (3), Autosomal recessiveEctodermal dysplasia 14, hair/tooth type with or without hypohidrosis, 618180 (3);chr21;TSPEAR, C21orf29, DFNB98, ECTD14;True
ENSG00000160255;Integrin, beta-2 (antigen CD18 (p95), lymphocyte function-associated antigen-1;NotRelevant;ENSG00000160255;common subunit for CR3, LFA1, and P150,95Leukocyte adhesion deficiency, 116920 (3);chr21;ITGB2, CD18, LCAMB, LAD;False
ENSG00000182871;Collagen XVIII, alpha-1 polypeptide;NotRelevant;;Knobloch syndrome, type 1, 267750 (3), Autosomal recessiveKnobloch syndrome, type 1, 267750 (3);chr21;COL18A1, KNO1;True
ENSG00000142156;Collagen VI, alpha-1 polypeptide;NotRelevant;;Bethlem myopathy 1, 158810 (3), Autosomal recessive, Autosomal dominantUllrich congenital muscular dystrophy 1, 254090 (3);chr21;COL6A1, BTHLM1, UCHMD1;True
ENSG00000142173;Collagen VI, alpha-2 polypeptide;NotRelevant;mutation identified in 1 MYSCL family;Bethlem myopathy 1, 158810 (3), Autosomal recessive, Autosomal dominantUllrich congenital muscular dystrophy 1, 254090 (3);chr21;COL6A2, BTHLM1, UCMD1;True
ENSG00000160282;Formiminotransferase cyclodeminase;NotRelevant;;Glutamate formiminotransferase deficiency, 229100 (3), Autosomal recessiveGlutamate formiminotransferase deficiency, 229100 (3);chr21;FTCD;True
ENSG00000160285;Lanosterol synthase;NotRelevant;;Cataract 44, 616509 (3), Autosomal recessiveCataract 44, 616509 (3);chr21;LSS, OSC, CTRCT44;True
ENSG00000160294;Minichromosome maintenance 3-associated protein, 80-kD;NotRelevant;;Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3), Autosomal recessivePeripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3);chr21;MCM3AP, MAP80, GANP, PNRIID;True
ENSG00000160299;Pericentrin;NotRelevant;;Microcephalic osteodysplastic primordial dwarfism, type II, 210720 (3), Autosomal recessiveMicrocephalic osteodysplastic primordial dwarfism, type II, 210720 (3);chr21;PCNT, PCNT2, KEN, SCKL4, MOPD2;True
ENSG00000177663;Interleukin 17 receptor A;NotRelevant;;Immunodeficiency 51, 613953 (3), Autosomal recessiveImmunodeficiency 51, 613953 (3);chr22;IL17RA, IL17R, IMD51;True
ENSG00000093072;Cat eye syndrome chromosome region, candidate 1;NotRelevant;mutation identified in 1 SNEDS family;Polyarteritis nodosa, childhood-onset, 615688 (3), Autosomal recessivePolyarteritis nodosa, childhood-onset, 615688 (3);chr22;CECR1, PAN, SNEDS;True
ENSG00000131100;ATPase, H+ transporting, V1 subunit E1;NotRelevant;;Cutis laxa, autosomal recessive, type IIC, 617402 (3), Autosomal recessiveCutis laxa, autosomal recessive, type IIC, 617402 (3);chr22;ATP6V1E1, ATP6E, ARCL2C;True
ENSG00000215193;Peroxisome biogenesis factor 26;NotRelevant;;Peroxisome biogenesis disorder 7A (Zellweger), 614872 (3), Autosomal recessivePeroxisome biogenesis disorder 7B, 614873 (3);chr22;PEX26, PBD7A, PBD7B;True
ENSG00000183785;Tubulin, alpha 8;NotRelevant;;Cortical dysplasia, complex, with other brain malformations 8, 613180 (3), Autosomal recessiveCortical dysplasia, complex, with other brain malformations 8, 613180 (3);chr22;TUBA8, TUBAL2, CDCBM8;True
ENSG00000184979;Ubiquitin-specific protease 18;NotRelevant;;Pseudo-TORCH syndrome 2, 617397 (3), Autosomal recessivePseudo-TORCH syndrome 2, 617397 (3);chr22;USP18, UBP43, ISG43, PTORCH2;True
ENSG00000100033;Proline dehydrogenase (proline oxidase);NotRelevant;;Hyperprolinemia, type I, 239500 (3), Autosomal recessive{Schizophrenia, susceptibility to, 4}, 600850 (3);chr22;PRODH, PRODH2, SCZD4;True
ENSG00000100075;Solute carrier family 25 (mitochondrial citrate transporter), member 1;NotRelevant;mutation identified in 1 CMS23 family;Combined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3), Autosomal recessiveCombined D-2- and L-2-hydroxyglutaric aciduria, 615182 (3);chr22;SLC25A1, SLC20A3, CTP, D2L2AD, CMS23;True
ENSG00000093009;Cell division cycle 45, S. Cerevisiae, homolog-like;NotRelevant;;Meier-Gorlin syndrome 7, 617063 (3), Autosomal recessiveMeier-Gorlin syndrome 7, 617063 (3);chr22;CDC45L, CDC45L2, MGORS7;True
ENSG00000203618;Glycoprotein Ib, platelet, beta polypeptide;NotRelevant;;Bernard-Soulier syndrome, type B, 231200 (3), Autosomal recessiveGiant platelet disorder, isolated, 231200 (3);chr22;GP1BB, BS, BDPLT1;True
ENSG00000184058;T-box 1;NotRelevant;;Conotruncal anomaly face syndrome, 217095 (3)Velocardiofacial syndrome, 192430 (3);chr22;TBX1, DGS, CTHM, CAFS, TGA, DORV, VCFS, DGCR;False
ENSG00000184470;Thioredoxin reductase 2;NotRelevant;mutation identified in 1 GCCD5 family;?Glucocorticoid deficiency 5, 617825 (3), Autosomal recessive?Glucocorticoid deficiency 5, 617825 (3);chr22;TXNRD2, TRXR2, SELZ, GCCD5;True
ENSG00000093010;Catechol-O-methyltransferase;NotRelevant;;{Panic disorder, susceptibility to}, 167870 (3), ?Autosomal dominant{Schizophrenia, susceptibility to}, 181500 (3);chr22;COMT;True
ENSG00000183597;Transport and golgi organization 2, Drosophila, homolog of;NotRelevant;;Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3), Autosomal recessiveMetabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3);chr22;TANGO2, C22orf25, MECRCN;True
ENSG00000040608;NOGO receptor (reticulon 4 receptor);NotRelevant;;{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant{Schizophrenia, susceptibility to}, 181500 (3);chr22;RTN4R, NOGOR;True
ENSG00000244486;Scavenger receptor class F, member 2;NotRelevant;;Van den Ende-Gupta syndrome, 600920 (3), Autosomal recessiveVan den Ende-Gupta syndrome, 600920 (3);chr22;SCARF2, SREC2, VDEGS;True
ENSG00000241973;Phosphatidylinositol 4-kinase, catalytic, alpha;NotRelevant;;Polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3), Autosomal recessivePolymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis, 616531 (3);chr22;PI4KA, PIK4CA, PMGYCHA;True
ENSG00000099937;Heparin cofactor II;NotRelevant;proximal to BCR;Thrombophilia due to heparin cofactor II deficiency, 612356 (3), Autosomal dominantThrombophilia due to heparin cofactor II deficiency, 612356 (3);chr22;HCF2, HC2, SERPIND1, THPH10;True
ENSG00000099940;Synaptosomal-associated protein, 29kD;NotRelevant;;Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3), Autosomal recessiveCerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome, 609528 (3);chr22;SNAP29, CEDNIK;True
ENSG00000099949;Leucine-zipper-like regulator-1;NotRelevant;;Noonan syndrome 10, 616564 (3), Autosomal dominant{Schwannomatosis-2, susceptibility to}, 615670 (3);chr22;LZTR1, SWNTS2, NS10, NS2;True
ENSG00000133475;Gamma-glutamyltransferase-2;NotRelevant;;[Gamma-glutamyltransferase, familial high serum], 137181 (2)[Gamma-glutamyltransferase, familial high serum] (2);chr22;GGT2;False
ENSG00000186716;Breakpoint cluster region;NotRelevant;Ph1=t(9;22) (q34.1Leukemia, chronic myeloid, somatic, 608232 (3);chr22;BCR, CML, PHL, ALL;False
ENSG00000128322;Immunoglobulin lambda-like polypeptide 1 (immunoglobulin omega peptide);NotRelevant;between BCR2 and BCR4; distal to IGLCAgammaglobulinemia 2, 613500 (3);chr22;IGLL1, IGO, IGL5, VPREB2, AGM2;False
ENSG00000250479;Coiled-coil-helix-coiled-coil-helix domain-containing protein 10;NotRelevant;mutation identified in 1 IMMD family;Frontotemporal dementia and/or amyotrophic lateral sclerosis 2, 615911 (3), Autosomal dominantSpinal muscular atrophy, Jokela type, 615048 (3);chr22;CHCHD10, FTDALS2, SMAJ, IMMD;True
ENSG00000099956;SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1;NotRelevant;;Coffin-Siris syndrome 3, 614608 (3), Autosomal dominant{Schwannomatosis-1, susceptibility to}, 162091 (3);chr22;SMARCB1, SNF5, INI1, RDT, RTPS1, MRD15, SWNTS1, CSS3;True
ENSG00000240972;Macrophage migration inhibitory factor;NotRelevant;previously assigned to chr.19;{Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3){Rheumatoid arthritis, systemic juvenile, susceptibility to}, 604302 (3);chr22;MIF;False
ENSG00000100014;Sperm antigen with calponin homology and coiled-coil domains 1-like;NotRelevant;mutation identified in 1 OBLFC1 patient;?Facial clefting, oblique, 1, 600251 (3), Autosomal dominantOpitz GBBB syndrome, type II, 145410 (3);chr22;SPECC1L, KIAA0376, OBLFC1, GBBB2, TBHS;True
ENSG00000100024;Beta-ureidopropionase;NotRelevant;;Beta-ureidopropionase deficiency, 613161 (3), Autosomal recessiveBeta-ureidopropionase deficiency, 613161 (3);chr22;UPB1, BUP1;True
ENSG00000100031;Gamma-glutamyltransferase 1;NotRelevant;mutation identified in 1 GGTD family;?Glutathioninuria, 231950 (3), Autosomal recessive?Glutathioninuria, 231950 (3);chr22;GGT1, GGT, GGTD;True
ENSG00000100053;Crystallin, beta-B3;NotRelevant;;Cataract 22, 609741 (3), Autosomal recessive, Autosomal dominantCataract 22, 609741 (3);chr22;CRYBB3, CRYB3, CATCN2, CTRCT22;True
ENSG00000244752;Crystallin, beta-B2;NotRelevant;2nd CRYB2 gene in same region;Cataract 3, multiple types, 601547 (3), Autosomal dominantCataract 3, multiple types, 601547 (3);chr22;CRYBB2, CRYB2, CTRCT3, CCA2;True
ENSG00000133454;Myosin XVIIIB;NotRelevant;;Klippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3), Autosomal recessiveKlippel-Feil syndrome 4, autosomal recessive, with myopathy and facial dysmorphism, 616549 (3);chr22;MYO18B, KFS4;True
ENSG00000100099;HPS gene 4;NotRelevant;;Hermansky-Pudlak syndrome 4, 614073 (3), Autosomal recessiveHermansky-Pudlak syndrome 4, 614073 (3);chr22;HPS4;True
ENSG00000100122;Crystallin, beta B1;NotRelevant;;Cataract 17, multiple types, 611544 (3), Autosomal recessive, Autosomal dominantCataract 17, multiple types, 611544 (3);chr22;CRYBB1, CATCN3, CTRCT17;True
ENSG00000196431;Crystallin, beta polypeptide A4;NotRelevant;;Cataract 23, 610425 (3)Cataract 23, 610425 (3);chr22;CRYBA4, CTRCT23;False
ENSG00000225783;MIAT gene;NotRelevant;;{Myocardial infarction, susceptibility to}, 608446 (3){Myocardial infarction, susceptibility to}, 608446 (3);chr22;MIAT, C22orf35;False
ENSG00000169184;Meningioma chromosome region;NotRelevant;fused with TEL in AML;Meningioma, 607174 (3), Autosomal dominantMeningioma, 607174 (3);chr22;MN1, MGCR;True
ENSG00000183765;Checkpoint kinase 2, S. pombe, homolog of (RAD53, S. cerevisiae, homolog of);NotRelevant;;{Breast and colorectal cancer, susceptibility to} (3){Prostate cancer, familial, susceptibility to}, 176807 (3);chr22;CHEK2, RAD53, CHK2, CDS1, LFS2;False
ENSG00000100219;X-box-binding protein-1;NotRelevant;pseudogene on chr.5;{Major affective disorder-7, susceptibility to}, 612371 (3){Major affective disorder-7, susceptibility to}, 612371 (3);chr22;XBP1, XBP2;False
ENSG00000183762;Kringle domain-containing transmembrane protein 1;NotRelevant;;Ectodermal dysplasia 13, hair/tooth type, 617392 (3), Autosomal recessiveEctodermal dysplasia 13, hair/tooth type, 617392 (3);chr22;KREMEN1, KRM1, ECTD13;True
ENSG00000182944;Ewing sarcoma breakpoint region-1;NotRelevant;t(11;22)(q24Neuroepithelioma, 612219 (3);chr22;EWSR1, EWS;False
ENSG00000100285;Neurofilament, heavy polypeptide;NotRelevant;mutation identified in 1 family with ALS susceptibility;?{Amyotrophic lateral sclerosis, susceptibility to}, 105400 (3), Autosomal recessive, Autosomal dominantCharcot-Marie-Tooth disease, axonal, type 2CC, 616924 (3);chr22;NEFH, CMT2CC;True
ENSG00000186575;Merlin;NotRelevant;loss of heterozygosity;Meningioma, NF2-related, somatic, 607174 (3)Schwannomatosis, somatic, 162091 (3);chr22;NF2;False
ENSG00000185339;Transcobalamin II;NotRelevant;linked to P1;Transcobalamin II deficiency, 275350 (3), Autosomal recessiveTranscobalamin II deficiency, 275350 (3);chr22;TCN2, TC2;True
ENSG00000133422;MORC family CW-type zinc finger protein 2;NotRelevant;;Charcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3), Autosomal dominantCharcot-Marie-Tooth disease, axonal, type 2Z, 616688 (3);chr22;MORC2, ZCW3, ZCWCC1, KIAA0852, CMT2Z;True
ENSG00000100150;DEP domain-containing protein 5;NotRelevant;;Epilepsy, familial focal, with variable foci 1, 604364 (3), Autosomal dominantEpilepsy, familial focal, with variable foci 1, 604364 (3);chr22;DEPDC5, KIAA0645, FFEVF1;True
ENSG00000100170;Solute carrier family 5 (sodium/glucose transporter), member 1;NotRelevant;;Glucose/galactose malabsorption, 606824 (3), Autosomal recessiveGlucose/galactose malabsorption, 606824 (3);chr22;SLC5A1, SGLT1;True
ENSG00000100225;F-box only protein 7;NotRelevant;;Parkinson disease 15, autosomal recessive, 260300 (3), Autosomal recessiveParkinson disease 15, autosomal recessive, 260300 (3);chr22;FBXO7, FBX7, FBX, PKPS, PARK15;True
ENSG00000100234;Tissue inhibitor of metalloproteinase-3;NotRelevant;;Sorsby fundus dystrophy, 136900 (3), Autosomal dominantSorsby fundus dystrophy, 136900 (3);chr22;TIMP3, SFD;True
ENSG00000133424;Acetylglucosaminyltransferase-like protein;NotRelevant;;Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6, 613154 (3), Autosomal recessiveMuscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B, 6, 608840 (3);chr22;LARGE, KIAA0609, MDC1D, MDDGA6, MDDGB6;True
ENSG00000100292;Heme oxygenase 1;NotRelevant;;Heme oxygenase-1 deficiency, 614034 (3){Pulmonary disease, chronic obstructive, susceptibility to}, 606963 (3);chr22;HMOX1, HMOX1D;False
ENSG00000100297;Minichromosome maintenance, S. cerevisiae, homolog of, 5;NotRelevant;mutation identified in 1 MGORS8 patient;?Meier-Gorlin syndrome 8, 617564 (3), Autosomal recessive?Meier-Gorlin syndrome 8, 617564 (3);chr22;MCM5, CDC46, MGORS8;True
ENSG00000100336;Apolipoprotein L4;NotRelevant;;{Schizophrenia}, 181500 (1), Autosomal dominant{Schizophrenia}, 181500 (1);chr22;APOL4;True
ENSG00000128335;Apolipoprotein L2;NotRelevant;;{Schizophrenia}, 181500 (1), Autosomal dominant{Schizophrenia}, 181500 (1);chr22;APOL2;True
ENSG00000100342;Apolipoprotein L1;NotRelevant;;{End-stage renal disease, nondiabetic, susceptibility to}, 612551 (3){Glomerulosclerosis, focal segmental, 4, susceptibility to}, 612551 (3);chr22;APOL1, FSGS4;False
ENSG00000100345;Myosin, heavy polypeptide-9, nonmuscle;NotRelevant;;Deafness, autosomal dominant 17, 603622 (3), Autosomal dominantMacrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss, 155100 (3);chr22;MYH9, MHA, FTNS, DFNA17, BDPLT6, MATINS;True
ENSG00000100348;Thioredoxin 2;NotRelevant;mutation identified in 1 COXPD29 patient;?Combined oxidative phosphorylation deficiency 29, 616811 (3), Autosomal recessive?Combined oxidative phosphorylation deficiency 29, 616811 (3);chr22;TXN2, TRX2, MTRX, COXPD29;True
ENSG00000166862;Calcium channel, voltage-dependent, gamma-2 subunit (stargazin);NotRelevant;mutation identified one MRD10 patient;?Mental retardation, autosomal dominant 10, 614256 (3)?Mental retardation, autosomal dominant 10, 614256 (3);chr22;CACNG2, MRD10;True
ENSG00000100360;Intraflagellar transport 27, Chlamydomonas, homolog of;NotRelevant;mutation identified in 1 BBS19 family;?Bardet-Biedl syndrome 19, 615996 (3), Autosomal recessive?Bardet-Biedl syndrome 19, 615996 (3);chr22;IFT27, RABL4, BBS19;True
ENSG00000100365;Neutrophil cytosolic factor-4;NotRelevant;mutation identified in 1 CGD3 patient;?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3), Autosomal recessive?Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type III, 613960 (3);chr22;NCF4, P40PHOX, CGD3;True
ENSG00000100368;Colony-stimulating factor-2 receptor, beta, low-affinity;NotRelevant;;Surfactant metabolism dysfunction, pulmonary, 5, 614370 (3), Autosomal recessiveSurfactant metabolism dysfunction, pulmonary, 5, 614370 (3);chr22;CSF2RB, SMDP5;True
ENSG00000100379;Potassium channel tetramerization domain-containing protein 17;NotRelevant;;Dystonia 26, myoclonic, 616398 (3), Autosomal dominantDystonia 26, myoclonic, 616398 (3);chr22;KCTD17;True
ENSG00000187045;Transmembrane protease, serine 6 (matriptase 2);NotRelevant;;Iron-refractory iron deficiency anemia, 206200 (3), Autosomal recessiveIron-refractory iron deficiency anemia, 206200 (3);chr22;TMPRSS6, IRIDA;True
ENSG00000128340;Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP-binding protein Rac2);NotRelevant;;Neutrophil immunodeficiency syndrome, 608203 (3)Neutrophil immunodeficiency syndrome, 608203 (3);chr22;RAC2;False
ENSG00000100079;Lectin, galactoside-binding, soluble, 2;NotRelevant;;{Myocardial infarction, susceptibility to}, 608446 (3){Myocardial infarction, susceptibility to}, 608446 (3);chr22;LGALS2;False
ENSG00000100106;Trio- and F-actin-binding protein;NotRelevant;;Deafness, autosomal recessive 28, 609823 (3), Autosomal recessiveDeafness, autosomal recessive 28, 609823 (3);chr22;TRIOBP, KIAA1662;True
ENSG00000100146;SRY (sex-determining region Y)-box-10;NotRelevant;megacolon and spotting in mice;PCWH syndrome, 609136 (3), Autosomal dominantWaardenburg syndrome, type 4C, 613266 (3);chr22;SOX10, WS4, WS4C, PCWH;True
ENSG00000184381;Phospholipase A2, group VI;NotRelevant;;Infantile neuroaxonal dystrophy 1, 256600 (3), Autosomal recessiveParkinson disease 14, autosomal recessive, 612953 (3);chr22;PLA2G6, IPLA2, INAD1, NBIA2B, NBIA2A, PARK14;True
ENSG00000100246;Dynein, axonemal, light chain 4;NotRelevant;mutation identified in 1 MRMV3 family;?Mirror movements 3, 616059 (3), Autosomal recessive?Mirror movements 3, 616059 (3);chr22;DNAL4, MRMV3;True
ENSG00000100311;Platelet-derived growth factor, beta polypeptide (oncogene SIS);NotRelevant;fused with COL1A1 in DFSP;Basal ganglia calcification, idiopathic, 5, 615483 (3), Autosomal dominantMeningioma, SIS-related, 607174 (3);chr22;PDGFB, SIS, IBGC5;True
ENSG00000239900;Adenylosuccinate lyase;NotRelevant;ade(-)I; bifunctionalAdenylosuccinase deficiency, 103050 (3);chr22;ADSL;False
ENSG00000196588;Megakaryoblastic leukemia 1 gene;NotRelevant;fusion with RBM15;Megakaryoblastic leukemia, acute (3)Megakaryoblastic leukemia, acute (3);chr22;MKL1, AMKL, MAL;False
ENSG00000196236;X-prolyl aminopeptidase 3;NotRelevant;;Nephronophthisis-like nephropathy 1, 613159 (3), Autosomal recessiveNephronophthisis-like nephropathy 1, 613159 (3);chr22;XPNPEP3, APP3, NPHPL1;True
ENSG00000100393;E1A-binding protein, 300kD;NotRelevant;;Colorectal cancer, somatic, 114500 (3)Rubinstein-Taybi syndrome 2, 613684 (3);chr22;EP300, RSTS2;False
ENSG00000100412;Aconitase, mitochondrial;NotRelevant;distal to Ph1 break; mutation identified in 1 OPA9 familyInfantile cerebellar-retinal degeneration, 614559 (3);chr22;ACO2, ICRD, OPA9;False
ENSG00000159958;Tumor necrosis factor receptor superfamily, member 13C;NotRelevant;;Immunodeficiency, common variable, 4, 613494 (3), Autosomal recessiveImmunodeficiency, common variable, 4, 613494 (3);chr22;TNFRSF13C, BAFFR, CVID4;True
ENSG00000198951;Acetylgalactosaminidase, alpha-N- (alpha-galactosidase B);NotRelevant;proximal to Ph1 break;Kanzaki disease, 609242 (3), Autosomal recessiveSchindler disease, type III, 609241 (3);chr22;NAGA;True
ENSG00000184983;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 6;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 33, 618253 (3)Mitochondrial complex I deficiency, nuclear type 33, 618253 (3);chr22;NDUFA6, MC1DN33;False
ENSG00000100197;Cytochrome P450, subfamily IID, polypeptide 6;NotRelevant;;{Codeine sensitivity}, 608902 (3), Autosomal recessive{Debrisoquine sensitivity}, 608902 (3);chr22;CYP2D6, CPD6, P450DB1;True
ENSG00000100243;Cytochrome b5 reductase 3;NotRelevant;;Methemoglobinemia, type I, 250800 (3), Autosomal recessiveMethemoglobinemia, type II, 250800 (3);chr22;CYB5R3, DIA1, B5R;True
ENSG00000128274;Alpha 1,4-galactosyltransferase;NotRelevant;;[Blood group, P1Pk system, P(2) phenotype], 111400 (3)[Blood group, P1Pk system, p phenotype], 111400 (3);chr22;A4GALT, P1PK;False
ENSG00000077942;Fibulin 1;NotRelevant;;Synpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4), Autosomal dominantSynpolydactyly, 3/3'4, associated with metacarpal and metatarsal synostoses, 608180 (4);chr22;FBLN1;True
ENSG00000130638;Ataxin 10;NotRelevant;ATTCTn repeat in intron 9;Spinocerebellar ataxia 10, 603516 (3), Autosomal dominantSpinocerebellar ataxia 10, 603516 (3);chr22;ATXN10, SCA10;True
ENSG00000186951;Peroxisome proliferator-activated receptor-alpha;NotRelevant;;{Hyperapobetalipoproteinemia, susceptibility to} (3){Hyperapobetalipoproteinemia, susceptibility to} (3);chr22;PPARA, PPAR;False
ENSG00000100416;tRNA 5-methylaminomethyl-2-thiouridylate methyltransferase;NotRelevant;;{Deafness, mitochondrial, modifier of}, 580000 (3), Mitochondrial{Deafness, mitochondrial, modifier of}, 580000 (3);chr22;TRMU, MTO2;False
ENSG00000182858;Dolichyl-P-mannose:Man-7-GlcNAc-2-PP-dolichyl-alpha-6- mannosyltransferase;NotRelevant;;Congenital disorder of glycosylation, type Ig, 607143 (3), Autosomal recessiveCongenital disorder of glycosylation, type Ig, 607143 (3);chr22;ALG12, CDG1G;True
ENSG00000100427;MLC1 gene;NotRelevant;;Megalencephalic leukoencephalopathy with subcortical cysts, 604004 (3), Autosomal recessiveMegalencephalic leukoencephalopathy with subcortical cysts, 604004 (3);chr22;MLC1, LVM, VL;True
ENSG00000128159;Tubulin-gamma complex-associated protein 6;NotRelevant;;Microcephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3), Autosomal recessiveMicrocephaly and chorioretinopathy, autosomal recessive, 1, 251270 (3);chr22;TUBGCP6, GCP6, KIAA1669, MCCRP1;True
ENSG00000100241;SET-binding factor 1 (myotubularin-related protein 5);NotRelevant;;Charcot-Marie-Tooth disease, type 4B3, 615284 (3), Autosomal recessiveCharcot-Marie-Tooth disease, type 4B3, 615284 (3);chr22;SBF1, MTMR5, CMT4B3;True
ENSG00000130489;SCO2 cytochrome c oxidase assembly protein;NotRelevant;;Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency 1, 604377 (3), Autosomal recessiveMyopia 6, 608908 (3);chr22;SCO2, CEMCOX1, MYP6;True
ENSG00000025708;Thymidine phosphorylase;NotRelevant;;Mitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3), Autosomal recessiveMitochondrial DNA depletion syndrome 1 (MNGIE type), 603041 (3);chr22;TYMP, ECGF1, MNGIE, PDECGF, MEDPS1, MTDPS1;True
ENSG00000100288;Choline kinase, beta;NotRelevant;;Muscular dystrophy, congenital, megaconial type, 602541 (3), Autosomal recessiveMuscular dystrophy, congenital, megaconial type, 602541 (3);chr22;CHKB, CHKL, CKEKB, EKB, MDCMC;True
ENSG00000100299;Arylsulfatase A;NotRelevant;;Metachromatic leukodystrophy, 250100 (3), Autosomal recessiveMetachromatic leukodystrophy, 250100 (3);chr22;ARSA;True
ENSG00000251322;SH3 and multiple ankyrin repeat domains 3;NotRelevant;;Phelan-McDermid syndrome, 606232 (3), Autosomal dominant{Schizophrenia 15}, 613950 (3);chr22;SHANK3, PSAP2, PROSAP2, KIAA1650, DEL22q13.3, SCZD15;True
ENSG00000100312;Acrosin;NotRelevant;;?Male infertility due to acrosin deficiency, 102480 (2)?Male infertility due to acrosin deficiency (2);chr22;ACR;False
ENSG00000185960;Short stature homeo box;NotRelevant;pseudoautosomal; ?gene causing short stature in Turner syndromeShort stature, idiopathic familial, 300582 (3);chrX;SHOX, GCFX, SS, PHOG;False
ENSG00000198223;Colony-stimulating factor-2 receptor, alpha, low-affinity, granulocyte-macrophage;NotRelevant;order in PAR: pter-CSF2RA-IL3RA-ANT3-ASMT-MIC2-cen;Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3)Surfactant metabolism dysfunction, pulmonary, 4, 300770 (3);chrX;CSF2RA, SMDP4;False
ENSG00000169100;Solute carrier family 25 (mitochondrial carrier), member 6 (adenine nucleotide translocator-3, liver);NotRelevant;1st intron ~1.3Mb from Xqter; nonlyonized;chrX;SLC25A6, ANT3;False
ENSG00000157399;Arylsulfatase E;NotRelevant;CDPX1 in contiguous gene syndrome with STS;Chondrodysplasia punctata, X-linked recessive, 302950 (3), X-linked recessiveChondrodysplasia punctata, X-linked recessive, 302950 (3);chrX;ARSE, CDPX1, CDPXR;True
ENSG00000146938;Neuroligin 4;NotRelevant;;{Asperger syndrome susceptibility, X-linked 2}, 300497 (3), Isolated cases, X-linked, Multifactorial{Autism susceptibility, X-linked 2}, 300495 (3);chrX;NLGN4, KIAA1260, AUTSX2, ASPGX2;False
ENSG00000130021;Haloacid dehalogenase-like hydrolase domain-containing 1A;NotRelevant;escapes X-inactivation; 100kb telomeric to STS;chrX;HDHD1A, DXF68S1E, GS1;False
ENSG00000101846;Steroid sulfatase, microsomal (arylsulfatase C, isozyme S);NotRelevant;nonlyonizing;Ichthyosis, X-linked, 308100 (3), X-linked recessiveIchthyosis, X-linked, 308100 (3);chrX;STS, ARSC1, ARSC, SSDD, XLI;True
ENSG00000011201;Kallmann syndrome-1 sequence (anosmin-1);NotRelevant;with ichthyosis in probable microdeletion syndrome;Hypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3), X-linked recessiveHypogonadotropic hypogonadism 1 with or without anosmia (Kallmann syndrome 1), 308700 (3);chrX;KAL1, KMS, ADMLX, HH1;True
ENSG00000101850;G protein-coupled receptor 143;NotRelevant;linked to XG;Nystagmus 6, congenital, X-linked, 300814 (3)Ocular albinism, type I, Nettleship-Falls type, 300500 (3);chrX;GPR143, OA1, NYS6;False
ENSG00000073464;Chloride channel-4;NotRelevant;;Raynaud-Claes syndrome, 300114 (3), X-linked dominantRaynaud-Claes syndrome, 300114 (3);chrX;CLCN4, MRX49, MRX15, MRXSRC;True
ENSG00000101871;Midline-1;NotRelevant;type II defect on chr.22;Opitz GBBB syndrome, type I, 300000 (3), X-linked recessiveOpitz GBBB syndrome, type I, 300000 (3);chrX;MID1, OGS1, BBBG1, FXY, OSX;True
ENSG00000004961;Holocytochrome c synthase (cytochrome c heme-lyase);NotRelevant;;Linear skin defects with multiple congenital anomalies 1, 309801 (3), X-linked dominantLinear skin defects with multiple congenital anomalies 1, 309801 (3);chrX;HCCS, MCOPS7, LSDMCA1;True
ENSG00000125363;Amelogenin;NotRelevant;also Y;Amelogenesis imperfecta, type 1E, 301200 (3), X-linked dominantAmelogenesis imperfecta, type 1E, 301200 (3);chrX;AMELX, AMG, AIH1, AMGX, AI1E;True
ENSG00000169933;FERM and PDZ domains-containing protein 4;NotRelevant;;Mental retardation, X-linked 104, 300983 (3), X-linkedMental retardation, X-linked 104, 300983 (3);chrX;FRMPD4, PRESO, KIAA0316, MRX104;False
ENSG00000196459;Trafficking protein particle complex 2 (sedlin);NotRelevant;;Spondyloepiphyseal dysplasia tarda, 313400 (3), X-linked recessiveSpondyloepiphyseal dysplasia tarda, 313400 (3);chrX;TRAPPC2, SEDL, SEDT;True
ENSG00000046651;OFD1 protein;NotRelevant;mutation identified in 1 RP23 family;Joubert syndrome 10, 300804 (3), X-linked recessiveSimpson-Golabi-Behmel syndrome, type 2, 300209 (3);chrX;OFD1, CXorf5, SGBS2, JBTS10, RP23;True
ENSG00000181544;Fanconi anemia, complementation group B gene;NotRelevant;;Fanconi anemia, complementation group B, 300514 (3), X-linked recessiveFanconi anemia, complementation group B, 300514 (3);chrX;FANCB, FAAP95, FAAP90, FLJ34064;True
ENSG00000165195;Phosphatidylinositol glycan, class A;NotRelevant;pseudogene on chr.12;Multiple congenital anomalies-hypotonia-seizures syndrome 2, 300868 (3), X-linked recessiveParoxysmal nocturnal hemoglobinuria, somatic, 300818 (3);chrX;PIGA, PNH1, MCAHS2;True
ENSG00000182287;Adaptor-related protein complex 1, sigma-2 subunit;NotRelevant;;Mental retardation, X-linked syndromic 5, 304340 (3), X-linked recessiveMental retardation, X-linked syndromic 5, 304340 (3);chrX;AP1S2, MRX59, MRXSF, MRXS21, MRXS5, PGS;True
ENSG00000188158;NHS gene;NotRelevant;;Cataract 40, X-linked, 302200 (3), X-linkedNance-Horan syndrome, 302350 (3);chrX;NHS, CXN, CTRCT40;False
ENSG00000008086;Cyclin-dependent kinase-like 5 (serine/threonine protein kinase 9);NotRelevant;;Epileptic encephalopathy, early infantile, 2, 300672 (3), X-linked dominantEpileptic encephalopathy, early infantile, 2, 300672 (3);chrX;CDKL5, STK9, ISSX, EIEE2;True
ENSG00000102104;Retinoschisin;NotRelevant;25cM from XG;Retinoschisis, 312700 (3), X-linked recessiveRetinoschisis, 312700 (3);chrX;RS1, XLRS1;True
ENSG00000044446;Phosphorylase kinase, liver, alpha-2 subunit;NotRelevant;;Glycogen storage disease, type IXa1, 306000 (3), X-linked recessiveGlycogen storage disease, type IXa2, 306000 (3);chrX;PHKA2, PHK, XLG, PYKL, GSD9A;True
ENSG00000173698;Adhesion G protein-coupled receptor G2;NotRelevant;;Congenital bilateral absence of vas deferens, X-linked, 300985 (3), X-linkedCongenital bilateral absence of vas deferens, X-linked, 300985 (3);chrX;ADGRG2, GPR64, HE6, CBAVDX;False
ENSG00000131828;Pyruvate dehydrogenase, E1-alpha polypeptide-1;NotRelevant;;Pyruvate dehydrogenase E1-alpha deficiency, 312170 (3), X-linked dominantPyruvate dehydrogenase E1-alpha deficiency, 312170 (3);chrX;PDHA1, PHE1A, PDHAD;True
ENSG00000177189;Ribosomal protein S6 kinase, 90kD, polypeptide 3;NotRelevant;;Coffin-Lowry syndrome, 303600 (3), X-linked dominant, Isolated casesMental retardation, X-linked 19, 300844 (3);chrX;RPS6KA3, RSK2, MRX19;True
ENSG00000149970;connector enhancer of KSR 2;NotRelevant;conflicting assignment to chr.1;Mental retardation, X-linked, syndromic, Houge type, 301008 (3), X-linkedMental retardation, X-linked, syndromic, Houge type, 301008 (3);chrX;CNKSR2, CNK2, KIAA0902, MRXSHG;False
ENSG00000091482;Small muscle protein, X-linked;NotRelevant;;Deafness, X-linked 4, 300066 (3), X-linked dominantDeafness, X-linked 4, 300066 (3);chrX;SMPX, DFNX4;True
ENSG00000012174;Membrane-bound transcription factor protease, site 2;NotRelevant;mutation identified in 1 OLMSX family;IFAP syndrome with or without BRESHECK syndrome, 308205 (3), X-linked recessiveOsteogenesis imperfecta, type XIX, 301014 (3);chrX;MBTPS2, S2P, IFAP, KFSDX, OLMSX, OI19;True
ENSG00000102172;Spermine synthase;NotRelevant;;Mental retardation, X-linked, Snyder-Robinson type, 309583 (3), X-linked recessiveMental retardation, X-linked, Snyder-Robinson type, 309583 (3);chrX;SMS, SRS, MRSR;True
ENSG00000102174;Phosphate regulating endopeptidase homolog, X-linked;NotRelevant;;Hypophosphatemic rickets, X-linked dominant, 307800 (3), X-linked dominantHypophosphatemic rickets, X-linked dominant, 307800 (3);chrX;PHEX, HYP, HPDR1, LXHR;True
ENSG00000165186;Patched domain-containing protein 1;NotRelevant;;{Autism, susceptibility to, X-linked 4}, 300830 (3), X-linked recessive{Autism, susceptibility to, X-linked 4}, 300830 (3);chrX;PTCHD1, AUTSX4;True
ENSG00000174010;Kelch-like 15;NotRelevant;;Mental retardation, X-linked 103, 300982 (3), X-linked recessiveMental retardation, X-linked 103, 300982 (3);chrX;KLHL15, KIAA1677;True
ENSG00000130741;Eukaryotic translation initiation factor 2, subunit 3;NotRelevant;;MEHMO syndrome, 300148 (3), X-linked recessiveMEHMO syndrome, 300148 (3);chrX;EIF2S3, EIF2G, MEHMO, MRXSBRK;True
ENSG00000067992;Pyruvate dehydrogenase kinase, isoenzyme 3;NotRelevant;1 family identified with mutation;?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3), X-linked dominant?Charcot-Marie-Tooth disease, X-linked dominant, 6, 300905 (3);chrX;PDK3, CMTX6;True
ENSG00000101868;Polymerase, DNA, alpha-1;NotRelevant;;Pigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3), X-linked recessivePigmentary disorder, reticulate, with systemic manifestations, X-linked, 301220 (3);chrX;POLA1;True
ENSG00000004848;Aristaless-related homeobox, X-linked;NotRelevant;;Epileptic encephalopathy, early infantile, 1, 308350 (3), X-linked recessiveProud syndrome, 300004 (3);chrX;ARX, ISSX, PRTS, MRXS1, MRX36, MRX54, MRX43, MRX87, MRX29, MRX32;True
ENSG00000169306;Il-1 receptor accessory protein-like 1;NotRelevant;;Mental retardation, X-linked 21/34, 300143 (3), X-linked recessiveMental retardation, X-linked 21/34, 300143 (3);chrX;IL1RAPL1, IL1R8, MRX21, MRX34;True
ENSG00000169297;Nuclear receptor subfamily 0, group B, member 1;NotRelevant;distal to GK;Adrenal hypoplasia, congenital, 300200 (3), X-linked recessiveAdrenal hypoplasia, congenital, 300200 (3);chrX;NR0B1, DAX1, AHC, AHX, SRXY2;True
ENSG00000198814;Glycerol kinase;NotRelevant;2Mb distal to DMD; pseudogene on 4q32Glycerol kinase deficiency, 307030 (3);chrX;GK;False
ENSG00000198947;Dystrophin;NotRelevant;dystrophin gene; cen-5'-3'-pterDuchenne muscular dystrophy, 310200 (3);chrX;DMD, BMD, CMD3B;False
ENSG00000047597;Kell blood group precursor;NotRelevant;~500kb distal to CGD;McLeod syndrome with or without chronic granulomatous disease, 300842 (3), X-linkedMcLeod syndrome with or without chronic granulomatous disease, 300842 (3);chrX;XK, MCLDS;False
ENSG00000165168;Cytochrome b-245, beta polypeptide;NotRelevant;proximal to DMD;Chronic granulomatous disease, X-linked, 306400 (3), X-linked recessiveImmunodeficiency 34, mycobacteriosis, X-linked, 300645 (3);chrX;CYBB, CGD, AMCBX2, IMD34;True
ENSG00000156313;Retinitis pigmentosa GTPase regulator;NotRelevant;;Cone-rod dystrophy, X-linked, 1, 304020 (3), X-linkedRetinitis pigmentosa, X-linked, and sinorespiratory infections, with or without deafness, 300455 (3);chrX;RPGR, RP3, CRD, RP15, COD1, CORDX1;False
ENSG00000036473;Ornithine transcarbamylase;NotRelevant;proximal to DMD, CGD;Ornithine transcarbamylase deficiency, 311250 (3), X-linked recessiveOrnithine transcarbamylase deficiency, 311250 (3);chrX;OTC;True
ENSG00000156298;Tetraspanin 7;NotRelevant;;Mental retardation, X-linked 58, 300210 (3), X-linked recessiveMental retardation, X-linked 58, 300210 (3);chrX;TSPAN7, TM4SF2, MXS1, A15, MRX58;True
ENSG00000183337;BCL6 corepressor;NotRelevant;;Microphthalmia, syndromic 2, 300166 (3), X-linked dominantMicrophthalmia, syndromic 2, 300166 (3);chrX;BCOR, KIAA1575, MCOPS2, MAA2, ANOP2;True
ENSG00000182220;ATPase, H+ transporting, lysosomal, accessory protein 2;NotRelevant;mutation identified in 1 XPDS family;Mental retardation, X-linked, syndromic, Hedera type, 300423 (3), X-linked recessiveMental retardation, X-linked, syndromic, Hedera type, 300423 (3);chrX;ATP6AP2, ATP6M8-9, XMRE, MRXSH, XPDS;True
ENSG00000124486;Ubiquitin-specific protease-9, X chromosome (Drosophila fat facets related, X-linked);NotRelevant;;Mental retardation, X-linked 99, 300919 (3), X-linked recessiveMental retardation, X-linked 99, syndromic, female-restricted, 300968 (3);chrX;USP9X, DFFRX, MRX99, MRXS99F;True
ENSG00000215301;DEAD/H box-3, X-linked;NotRelevant;;Mental retardation, X-linked 102, 300958 (3), X-linked recessive, X-linked dominantMental retardation, X-linked 102, 300958 (3);chrX;DDX3X, DDX3, DBX, MRX102;True
ENSG00000188937;Nyctalopin;NotRelevant;;Night blindness, congenital stationary (complete), 1A, X-linked, 310500 (3), X-linked recessiveNight blindness, congenital stationary (complete), 1A, X-linked, 310500 (3);chrX;NYX, CSNB1A, NBM1;True
ENSG00000147044;Calcium/calmodulin-dependent serine protein kinase;NotRelevant;;FG syndrome 4, 300422 (3)Mental retardation, with or without nystagmus, 300422 (3);chrX;CASK, MICPCH, FGS4, CMG, MRXSNA;False
ENSG00000189221;Monoamine oxidase A;NotRelevant;NDP, MAOA, MAOB closely linked;{Antisocial behavior}, 300615 (3), X-linked recessive{Antisocial behavior}, 300615 (3);chrX;MAOA, BRNRS;True
ENSG00000124479;Norrin;NotRelevant;;Exudative vitreoretinopathy 2, X-linked, 305390 (3)Norrie disease, 310600 (3);chrX;NDP, ND, EVR2;False
ENSG00000147050;Lysine (K)-specific demethylase 6A;NotRelevant;UTY also in mouse and man; escapes inactivationKabuki syndrome 2, 300867 (3);chrX;KDM6A, UTX, KABUK2;False
ENSG00000102218;Retinitis pigmentosa-2, X-linked recessive;NotRelevant;;Retinitis pigmentosa 2, 312600 (3), X-linkedRetinitis pigmentosa 2, 312600 (3);chrX;RP2;False
ENSG00000147123;NADH-dehydrogenase 1 beta subcomplex, 11;NotRelevant;mutation identified in 1 MC1DN30 patient;Linear skin defects with multiple congenital anomalies 3, 300952 (3), X-linked dominantLinear skin defects with multiple congenital anomalies 3, 300952 (3);chrX;NDUFB11, LSDMCA3, MC1DN30;True
ENSG00000182872;RNA-binding motif protein 10;NotRelevant;;TARP syndrome, 311900 (3), X-linked recessiveTARP syndrome, 311900 (3);chrX;RBM10, DXS8237E, KIAA0122, TARPS;True
ENSG00000130985;Ubiquitin-like modifier-activating enzyme 1;NotRelevant;escapes inactivation;Spinal muscular atrophy, X-linked 2, infantile, 301830 (3), X-linked recessiveSpinal muscular atrophy, X-linked 2, infantile, 301830 (3);chrX;UBA1, UBE1, GXP1, A1ST, SMAX2, AMCX1;True
ENSG00000008056;Synapsin I;NotRelevant;5kb from PFC;Epilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3), X-linked recessive, X-linked dominantEpilepsy, X-linked, with variable learning disabilities and behavior disorders, 300491 (3);chrX;SYN1;True
ENSG00000126759;Properdin P factor, complement;NotRelevant;;Properdin deficiency, X-linked, 312060 (3), X-linked recessiveProperdin deficiency, X-linked, 312060 (3);chrX;PFC, PFD;True
ENSG00000126752;Synovial sarcoma, X breakpoint 1;NotRelevant;fused with SYT in synovial sarcoma;?Sarcoma, synovial, 300813 (3)?Sarcoma, synovial, 300813 (3);chrX;SSX1, SSRC;False
ENSG00000068438;FTSJ homolog 1;NotRelevant;;Mental retardation, X-linked 9/44, 309549 (3), X-linked recessiveMental retardation, X-linked 9/44, 309549 (3);chrX;FTSJ1, JM23, SPB1, MRX44, MRX9;True
ENSG00000102312;Porcupine, Drosophila, homolog of;NotRelevant;;Focal dermal hypoplasia, 305600 (3), X-linked dominantFocal dermal hypoplasia, 305600 (3);chrX;PORCN, PORC, DHOF, FODH;True
ENSG00000147155;Emopamil-binding protein;NotRelevant;;Chondrodysplasia punctata, X-linked dominant, 302960 (3), X-linked dominantMEND syndrome, 300960 (3);chrX;EBP, CDPX2, CPXD, CPX, MEND;True
ENSG00000015285;Wiskott-Aldrich syndrome gene;NotRelevant;t(18;X)(q11.2Wiskott-Aldrich syndrome, 301000 (3);chrX;WAS, IMD2, THC1, SCNX;False
ENSG00000102145;GATA-binding protein-1 (globin transcription factor-1);NotRelevant;;Anemia, X-linked, with/without neutropenia and/or platelet abnormalities, 300835 (3), X-linked recessiveThrombocytopenia, X-linked, with or without dyserythropoietic anemia, 300367 (3);chrX;GATA1, GF1, ERYF1, NFE1, XLTDA, XLTT, XLANP;True
ENSG00000094631;Histone deacetylase 6;NotRelevant;mutation identified in 1 CPBHM family;?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3), X-linked dominant?Chondrodysplasia with platyspondyly, distinctive brachydactyly, hydrocephaly, and microphthalmia, 300863 (3);chrX;HDAC6, CPBHM;True
ENSG00000102103;Polyglutamine-binding protein 1;NotRelevant;;Renpenning syndrome, 309500 (3), X-linked recessiveRenpenning syndrome, 309500 (3);chrX;PQBP1, NPW38, SHS, MRX55, MRXS3, RENS1, MRXS8;True
ENSG00000102100;Solute carrier family 35 (UDP-galactose transporter), member 2;NotRelevant;;Congenital disorder of glycosylation, type IIm, 300896 (3), X-linked dominant, Somatic mosaicismCongenital disorder of glycosylation, type IIm, 300896 (3);chrX;SLC35A2, UGALT, UGTL, UGT2, CDGX, CDG2M;True
ENSG00000068323;Transcription factor for IgH enhancer;NotRelevant;fuses with PRCC in RCCP;Renal cell carcinoma, papillary, 1, 300854 (3)Renal cell carcinoma, papillary, 1, 300854 (3);chrX;TFE3, RCCX1;False
ENSG00000196998;WD repeat-containing protein 45;NotRelevant;?pseudogene on 4q31.3;Neurodegeneration with brain iron accumulation 5, 300894 (3), X-linked dominantNeurodegeneration with brain iron accumulation 5, 300894 (3);chrX;WDR45, WIPI4, NBIA5;True
ENSG00000102003;Synaptophysin;NotRelevant;;Mental retardation, X-linked 96, 300802 (3), X-linked recessiveMental retardation, X-linked 96, 300802 (3);chrX;SYP, MRXSYP;True
ENSG00000102001;Calcium channel, voltage-dependent, alpha-1F subunit;NotRelevant;;Aland Island eye disease, 300600 (3), X-linkedNight blindness, congenital stationary (incomplete), 2A, X-linked, 300071 (3);chrX;CACNA1F, CSNB2, CORDX3, CSNB2A, AIED, OA2;False
ENSG00000101997;Coiled-coil domain-containing protein 22;NotRelevant;;Ritscher-Schinzel syndrome 2, 300963 (3), X-linked recessiveRitscher-Schinzel syndrome 2, 300963 (3);chrX;CCDC22, RTSC2;True
ENSG00000049768;Forkhead box P3 (scurfin);NotRelevant;;{Diabetes mellitus, type I, susceptibility to}, 222100 (3), Autosomal recessive{Diabetes mellitus, type I, susceptibility to}, 222100 (3);chrX;FOXP3, IPEX, AIID, XPID, PIDX;True
ENSG00000273820;Ubiquitin-specific protease 27, X-linked;NotRelevant;;Mental retardation, X-linked 105, 300984 (3), X-linked recessiveMental retardation, X-linked 105, 300984 (3);chrX;USP27X, USP22L, MRX105;True
ENSG00000171365;Chloride channel-5;NotRelevant;;Dent disease, 300009 (3), X-linked recessiveProteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3);chrX;CLCN5, CLCK2, NPHL2, DENTS, NPHL1;True
ENSG00000158352;Shroom family member 4;NotRelevant;;Stocco dos Santos X-linked mental retardation syndrome, 300434 (3), X-linkedStocco dos Santos X-linked mental retardation syndrome, 300434 (3);chrX;SHROOM4, KIAA1202, SDSX;False
ENSG00000130385;Bone morphogenetic protein 15;NotRelevant;;Ovarian dysgenesis 2, 300510 (3), X-linkedPremature ovarian failure 4, 300510 (3);chrX;BMP15, GDF9B, ODG2, POF4;False
ENSG00000241476;Sarcoma, synovial, X breakpoint 2;NotRelevant;;?Sarcoma, synovial, 300813 (3)?Sarcoma, synovial, 300813 (3);chrX;SSX2;False
ENSG00000126012;Lysine-specific demethylase 5C (Jumonji, AT-rich interactive domain 1C);NotRelevant;escapes inactivation;Mental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3), X-linked recessiveMental retardation, X-linked, syndromic, Claes-Jensen type, 300534 (3);chrX;KDM5C, JARID1C, SMCX, DXS1272E, XE169, MRXSCJ;True
ENSG00000124313;IQ motif- and Sec7 domain-containing protein 2;NotRelevant;;Mental retardation, X-linked 1/78, 309530 (3), X-linked dominantMental retardation, X-linked 1/78, 309530 (3);chrX;IQSEC2, KIAA0522, MRX1, MRX78;True
ENSG00000072501;Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of;NotRelevant;8243;ENSG00000072501Cornelia de Lange syndrome 2, 300590 (3);chrX;SMC1A, SMC1L1, SMC1, DXS423E, KIAA0178, CDLS2;False
ENSG00000072506;17-beta-hydroxysteroid dehydrogenase X;NotRelevant;;HSD10 mitochondrial disease, 300438 (3), X-linked dominantHSD10 mitochondrial disease, 300438 (3);chrX;HSD17B10, HADH2, ERAB, MRXS10, HSD10MD;True
ENSG00000086758;HECT, UBA, and WWE domains-containing protein 1;NotRelevant;;Mental retardation, X-linked syndromic, Turner type, 300706 (3)Mental retardation, X-linked syndromic, Turner type, 300706 (3);chrX;HUWE1, UREB1, KIAA0312, LASU1;False
ENSG00000172943;PHD finger protein 8;NotRelevant;;Mental retardation syndrome, X-linked, Siderius type, 300263 (3), X-linked recessiveMental retardation syndrome, X-linked, Siderius type, 300263 (3);chrX;PHF8, ZNF422, KIAA1111, MRXSSD;True
ENSG00000158526;TSR2, 20S rRNA accumulation, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 DBA14 family;?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3), X-linked recessive?Diamond-Blackfan anemia 14 with mandibulofacial dysostosis, 300946 (3);chrX;TSR2, WGG1, DBA14;True
ENSG00000102302;FYVE, RhoGEF, and PH domain-containing protein 1;NotRelevant;;Aarskog-Scott syndrome, 305400 (3), X-linked recessiveMental retardation, X-linked syndromic 16, 305400 (3);chrX;FGD1, FGDY, AAS, MRXS16;True
ENSG00000102316;Melanoma antigen, family D, 2;NotRelevant;;Bartter syndrome, type 5, antenatal, transient, 300971 (3), X-linked recessiveBartter syndrome, type 5, antenatal, transient, 300971 (3);chrX;MAGED2, MAGED, BARTS5;True
ENSG00000158571;Fructose-2,6-bisphosphatase;NotRelevant;?Xq27-q25; ?Xcen-q13;chrX;PFKFB1, PFRX;False
ENSG00000158578;Aminolevulinate, delta-, synthase-2;NotRelevant;;Anemia, sideroblastic, 1, 300751 (3), X-linked recessiveProtoporphyria, erythropoietic, X-linked, 300752 (3);chrX;ALAS2, ANH1, ASB, XLEPP, XLSA, SIDBA1;True
ENSG00000188021;Ubiquilin 2;NotRelevant;;Amyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3), X-linked dominantAmyotrophic lateral sclerosis 15, with or without frontotemporal dementia, 300857 (3);chrX;UBQLN2, PLIC2, CHAP1, ALS15;True
ENSG00000131089;Rho guanine nucleotide exchange factor 9;NotRelevant;;Epileptic encephalopathy, early infantile, 8, 300607 (3), X-linked recessiveEpileptic encephalopathy, early infantile, 8, 300607 (3);chrX;ARHGEF9, PEM2, KIAA0424, EIEE8;True
ENSG00000184675;APC membrane recruitment protein 1;NotRelevant;;Osteopathia striata with cranial sclerosis, 300373 (3), X-linked dominantOsteopathia striata with cranial sclerosis, 300373 (3);chrX;AMER1, FAM123B, WTX, OSCS;True
ENSG00000126970;Zinc finger C4H2 domain-containing protein;NotRelevant;;Wieacker-Wolff syndrome, 314580 (3), X-linked recessiveWieacker-Wolff syndrome, 314580 (3);chrX;ZC4H2, KIAA1166, WRWF;True
ENSG00000001497;Las1-like ribosome biogenesis factor;NotRelevant;;Wilson-Turner syndrome, 309585 (3), X-linked recessiveWilson-Turner syndrome, 309585 (3);chrX;LAS1L, WTS;True
ENSG00000147065;Moesin;NotRelevant;;Immunodeficiency 50, 300988 (3), X-linked recessiveImmunodeficiency 50, 300988 (3);chrX;MSN, IMD50;True
ENSG00000169083;Androgen receptor (dihydrotestosterone receptor);NotRelevant;;Androgen insensitivity, 300068 (3), X-linked recessive{Prostate cancer, susceptibility to}, 176807 (3);chrX;AR, DHTR, TFM, SBMA, KD, SMAX1, HYSP1;True
ENSG00000079482;Oligophrenin-1;NotRelevant;;Mental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3), X-linked recessiveMental retardation, X-linked, with cerebellar hypoplasia and distinctive facial appearance, 300486 (3);chrX;OPHN1, MRX60;True
ENSG00000090776;eph-related receptor tyrosine kinase ligand 2 (ephrin B1);NotRelevant;?CFNS also on Xp22;Craniofrontonasal dysplasia, 304110 (3), X-linked dominantCraniofrontonasal dysplasia, 304110 (3);chrX;EFNB1, EPLG2, CFNS, CFND;True
ENSG00000158813;Ectodysplasin A;NotRelevant;;Ectodermal dysplasia 1, hypohidrotic, X-linked, 305100 (3), X-linked recessiveTooth agenesis, selective, X-linked 1, 313500 (3);chrX;EDA, ED1, ECTD1, HED1, STHAGX1;True
ENSG00000089289;Immunoglobulin-binding protein 1;NotRelevant;;Corpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3), X-linked recessiveCorpus callosum, agenesis of, with mental retardation, ocular coloboma and micrognathia, 300472 (3);chrX;IGBP1;True
ENSG00000120500;Arrestin 3, retinal;NotRelevant;;Myopia 26, X-linked, female-limited, 301010 (3), X-linkedMyopia 26, X-linked, female-limited, 301010 (3);chrX;ARR3, MYP26;False
ENSG00000090889;Kinesin family member 4A;NotRelevant;mutation identified in 1 MRX100 family;?Mental retardation, X-linked 100, 300923 (3), X-linked recessive?Mental retardation, X-linked 100, 300923 (3);chrX;KIF4A, KIF4, MRX100;True
ENSG00000082458;Discs large, Drosophila, homolog of, 3;NotRelevant;;Mental retardation, X-linked 90, 300850 (3), X-linked recessiveMental retardation, X-linked 90, 300850 (3);chrX;DLG3, NEDLG, SAP102, MRX90;True
ENSG00000120498;Testis-expressed gene 11;NotRelevant;;Spermatogenic failure, X-linked, 2, 309120 (3), X-linked recessiveSpermatogenic failure, X-linked, 2, 309120 (3);chrX;TEX11, SPGFX2;True
ENSG00000147168;Interleukin-2 receptor, gamma;NotRelevant;linked to DXS159;Combined immunodeficiency, X-linked, moderate, 312863 (3), X-linked recessiveSevere combined immunodeficiency, X-linked, 300400 (3);chrX;IL2RG, SCIDX1, SCIDX, IMD4;True
ENSG00000184634;Mediator of RNA polymerase II transcription, subunit 12, S. cerevisiae, homolog of;NotRelevant;;Lujan-Fryns syndrome, 309520 (3), X-linked recessiveOpitz-Kaveggia syndrome, 305450 (3);chrX;MED12, TNRC11, TRAP230, HOPA, KIAA0192, OKS, FGS1, OHDOX;True
ENSG00000196338;Neuroligin 3;NotRelevant;;{Asperger syndrome susceptibility, X-linked 1}, 300494 (3), Isolated cases, X-linked, Multifactorial{Autism susceptibility, X-linked 1}, 300425 (3);chrX;NLGN3, ASPGX1, AUTSX1;False
ENSG00000169562;Gap junction protein, beta-1, 32kD (connexin 32);NotRelevant;;Charcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3), X-linked dominantCharcot-Marie-Tooth neuropathy, X-linked dominant, 1, 302800 (3);chrX;GJB1, CX32, CMTX1;True
ENSG00000147140;Non-Pou domain-containing octamer (ATGCAAAT) binding protein (nuclear RNA-binding protein, 54-kD);NotRelevant;2Mb proximal to PHKA1;Mental retardation, X-linked, syndromic 34, 300967 (3), X-linkedMental retardation, X-linked, syndromic 34, 300967 (3);chrX;NONO, NRB54, MRXS34;False
ENSG00000147133;TAF1 RNA polymerase II, TATA box-binding protein-associated factor, 250kD;NotRelevant;SVA retrotransposon insertion;Dystonia-Parkinsonism, X-linked, 314250 (3), X-linked recessiveMental retardation, X-linked, syndromic 33, 300966 (3);chrX;TAF1, TAF2A, CCG1, BA2R, DYT3, MRXS33;True
ENSG00000147162;O-linked N-acetylglucosamine transferase;NotRelevant;;Mental retardation, X-linked 106, 300997 (3), X-linked recessiveMental retardation, X-linked 106, 300997 (3);chrX;OGT, MRX106;True
ENSG00000147099;Histone deacetylase 8;NotRelevant;;Cornelia de Lange syndrome 5, 300882 (3), X-linked dominantCornelia de Lange syndrome 5, 300882 (3);chrX;HDAC8, MRXS6, CDLS5;True
ENSG00000067177;Phosphorylase kinase, muscle, alpha polypeptide;NotRelevant;?proximal and close to PGKA;Muscle glycogenosis, 300559 (3);chrX;PHKA1;False
ENSG00000229807;X chromosome controlling element (X-inactivation center);NotRelevant;q13-q21; metaphase bend, or fold, at q13.3-q21.1X-inactivation, familial skewed, 300087 (3);chrX;XIC, XCE, XIST, SXI1;False
ENSG00000147100;Solute carrier family 16 (monocarboxylic acid transporters), member 2;NotRelevant;;Allan-Herndon-Dudley syndrome, 300523 (3), X-linkedAllan-Herndon-Dudley syndrome, 300523 (3);chrX;SLC16A2, DXS128, XPCT;False
ENSG00000131263;RING finger protein, LIM domain-interacting;NotRelevant;;Tonne-Kalscheuer syndrome, 300978 (3), X-linkedTonne-Kalscheuer syndrome, 300978 (3);chrX;RLIM, RNF12, TOKAS;False
ENSG00000050030;Neurite extension and migration factor;NotRelevant;inv(X)(q13;p22)Mental retardation, X-linked 98, 300912 (3);chrX;NEXMIF, KIAA2022, MRX98;False
ENSG00000131269;ATP-binding cassette-7;NotRelevant;;Anemia, sideroblastic, with ataxia, 301310 (3), X-linked recessiveAnemia, sideroblastic, with ataxia, 301310 (3);chrX;ABCB7, ABC7, ASAT;True
ENSG00000102383;Zinc finger DHHC domain-containing protein 15;NotRelevant;disruption of ZDHHC15 identified in 1 patient;?Mental retardation, X-linked 91, 300577 (3), X-linked dominant?Mental retardation, X-linked 91, 300577 (3);chrX;ZDHHC15, MRX91;True
ENSG00000196468;Fibroblast growth factor 16;NotRelevant;previously mapped to 8q21.3;Metacarpal 4-5 fusion, 309630 (3), X-linked recessiveMetacarpal 4-5 fusion, 309630 (3);chrX;FGF16, MF4;True
ENSG00000085224;ATR-X gene (helicase 2;NotRelevant;ENSG00000085224;Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3);chrX;ATRX, XH2, XNP, SHS, SFM1, MRXHF1;False
ENSG00000102158;Magnesium transporter 1;NotRelevant;;Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3)Immunodeficiency, X-linked, with magnesium defect, Epstein-Barr virus infection and neoplasia, 300853 (3);chrX;MAGT1, IAP, XMEN;False
ENSG00000131174;Cytochrome c oxidase, subunit VIIb;NotRelevant;;Linear skin defects with multiple congenital anomalies 2, 300887 (3), X-linked dominantLinear skin defects with multiple congenital anomalies 2, 300887 (3);chrX;COX7B, LSDMCA2;True
ENSG00000165240;ATPase, Cu++ transporting, alpha polypeptide;NotRelevant;probably Xq13.2-q13.3, ~150kb prox. to PGK1;Menkes disease, 309400 (3), X-linked recessiveSpinal muscular atrophy, distal, X-linked 3, 300489 (3);chrX;ATP7A, MNK, MK, OHS, SMAX3;True
ENSG00000102144;Phosphoglycerate kinase-1;NotRelevant;?Xq13.3; pseudogenes PGK1P1 on Xq, PGK1P2 on chr. 6Phosphoglycerate kinase 1 deficiency, 300653 (3);chrX;PGK1, PGKA;False
ENSG00000122145;T-box 22;NotRelevant;1 ABERS family identified with mutation;?Abruzzo-Erickson syndrome, 302905 (3), X-linkedCleft palate with ankyloglossia, 303400 (3);chrX;TBX22, CPX, ABERS;False
ENSG00000165288;Bromodomain-and WD repeat-containing protein 3;NotRelevant;;Mental retardation, X-linked 93, 300659 (3), X-linked recessiveMental retardation, X-linked 93, 300659 (3);chrX;BRWD3, MRX93;True
ENSG00000196767;POU domain, class 3, transcription factor 4;NotRelevant;;Deafness, X-linked 2, 304400 (3), X-linked recessiveDeafness, X-linked 2, 304400 (3);chrX;POU3F4, DFN3, DFNX2;True
ENSG00000147180;Zinc finger protein-711;NotRelevant;;Mental retardation, X-linked 97, 300803 (3), X-linkedMental retardation, X-linked 97, 300803 (3);chrX;ZNF711, ZNF6, CMPX1, MRX97;False
ENSG00000124429;FLJ22792 gene;NotRelevant;mutation identified in 1 POF2B family;?Premature ovarian failure 2B, 300604 (3), X-linked recessive?Premature ovarian failure 2B, 300604 (3);chrX;FLJ22792, POF1B, POF2B;True
ENSG00000188419;Rab escort protein 1;NotRelevant;;Choroideremia, 303100 (3), X-linked dominantChoroideremia, 303100 (3);chrX;CHM, TCD;True
ENSG00000147202;Diaphanous, Drosophila, homolog of, 2;NotRelevant;mutation identified in 1 POF2A family;?Premature ovarian failure 2A, 300511 (3), X-linked dominant?Premature ovarian failure 2A, 300511 (3);chrX;DIAPH2, DIA, POF2A;True
ENSG00000165194;Protocadherin 19;NotRelevant;;Epileptic encephalopathy, early infantile, 9, 300088 (3), X-linkedEpileptic encephalopathy, early infantile, 9, 300088 (3);chrX;PCDH19, KIAA1313, EFMR, EIEE9;False
ENSG00000102359;SUSHI repeat-containing protein, X-linked, 2;NotRelevant;mutation identified in 1 RESDX family;?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3)?Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643 (3);chrX;SRPX2, SRPUL, RESDX;False
ENSG00000126953;Translocase of inner mitochondrial membrane 8, yeast, homolog of, A;NotRelevant;;Mohr-Tranebjaerg syndrome, 304700 (3), X-linked recessiveMohr-Tranebjaerg syndrome, 304700 (3);chrX;TIMM8A, DFN1, DDP, MTS, DDP1;True
ENSG00000010671;Bruton agammaglobulinemia tyrosine kinase;NotRelevant;;Agammaglobulinemia, X-linked 1, 300755 (3), X-linked recessiveIsolated growth hormone deficiency, type III, with agammaglobulinemia, 307200 (3);chrX;BTK, AGMX1, IMD1, XLA, AT, IGHD3;True
ENSG00000102393;Galactosidase, alpha;NotRelevant;;Fabry disease, 301500 (3), X-linkedFabry disease, cardiac variant, 301500 (3);chrX;GLA;False
ENSG00000126945;Heterogeneous nuclear ribonucleoprotein H2;NotRelevant;second signal at 6q25.3-q26, pseudogene?;Mental retardation, X-linked, syndromic, Bain type, 300986 (3), X-linked dominantMental retardation, X-linked, syndromic, Bain type, 300986 (3);chrX;HNRNPH2, NRPH2, MRXSB;True
ENSG00000158301;G protein-coupled receptor-associated sorting protein 2;NotRelevant;mutation identified in 1 DFNX7 family;?Deafness, X-linked 7, 301018 (3), X-linked recessive?Deafness, X-linked 7, 301018 (3);chrX;GPRASP2, GASP2, DFNX7;True
ENSG00000123560;Proteolipid protein 1;NotRelevant;;Pelizaeus-Merzbacher disease, 312080 (3), X-linked recessiveSpastic paraplegia 2, X-linked, 312920 (3);chrX;PLP1, PMD, HLD1, SPG2;True
ENSG00000123561;Thyroxine-binding globulin;NotRelevant;;[Thyroxine-binding globulin QTL], 300932 (3)[Thyroxine-binding globulin QTL], 300932 (3);chrX;TBG, TBGQTL;False
ENSG00000080572;PIH1 domain-containing protein 3;NotRelevant;;Ciliary dyskinesia, primary, 36, X-linked, 300991 (3), X-linked recessiveCiliary dyskinesia, primary, 36, X-linked, 300991 (3);chrX;PIH1D3, CILD36;True
ENSG00000147224;Phosphoribosyl pyrophosphate synthetase-1;NotRelevant;;Arts syndrome, 301835 (3), X-linked recessivePhosphoribosylpyrophosphate synthetase superactivity, 300661 (3);chrX;PRPS1, CMTX5, DFNX1, DFN2;True
ENSG00000080561;Midline 2;NotRelevant;mutation identified in 1 MRX101 family;?Mental retardation, X-linked 101, 300928 (3), X-linked recessive?Mental retardation, X-linked 101, 300928 (3);chrX;MID2, MRX101;True
ENSG00000197565;Collagen IV, alpha-6 polypeptide;NotRelevant;mutation identified in 1 DFNX6 family;?Deafness, X-linked 6, 300914 (3), X-linked recessive?Deafness, X-linked 6, 300914 (3);chrX;COL4A6, DELXq22.3, CXDELq22.3, DFNX6;True
ENSG00000188153;Collagen IV, alpha-5 polypeptide;NotRelevant;diffuse leiomyomatosis with Alport syndrome = contiguous gene syndrome with COL4A6;Alport syndrome, 301050 (3), X-linked dominantAlport syndrome, 301050 (3);chrX;COL4A5, ATS, ASLN;True
ENSG00000068366;Acyl-CoA synthetase long-chain family member 4;NotRelevant;;Mental retardation, X-linked 63, 300387 (3), X-linked dominantMental retardation, X-linked 63, 300387 (3);chrX;ACSL4, FACL4, ACS4, MRX63;True
ENSG00000101935;Alport syndrome, mental retardation, midface hypoplasia, and elliptocytosis chromosomal region gene 1;NotRelevant;;Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3), X-linked recessiveMidface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis, 300990 (3);chrX;AMMECR1, MFHIEN;True
ENSG00000101938;Chordin-like 1;NotRelevant;;Megalocornea 1, X-linked, 309300 (3), X-linked recessiveMegalocornea 1, X-linked 309300 (3);chrX;CHRDL1, VOPT, MGC1;True
ENSG00000077264;p21-activated kinase-3;NotRelevant;;Mental retardation, X-linked 30/47, 300558 (3), X-linked recessiveMental retardation, X-linked 30/47, 300558 (3);chrX;PAK3, MRX30, MRX47;True
ENSG00000077279;Doublecortin;NotRelevant;;Lissencephaly, X-linked, 300067 (3), X-linkedSubcortical laminal heterotopia, X-linked, 300067 (3);chrX;DCX, DBCN, LISX;False
ENSG00000101901;Alg13, S. cerevisiae, homolog of;NotRelevant;mutation identified in 1 CDG1S male patient;?Congenital disorder of glycosylation, type Is, 300884 (3), X-linked dominantEpileptic encephalopathy, early infantile, 36, 300884 (3);chrX;ALG13, GLT28D1, CDG1S, EIEE36;True
ENSG00000102024;Plastin 3;NotRelevant;;Bone mineral density QTL18, osteoporosis, 300910 (3), X-linked dominantBone mineral density QTL18, osteoporosis, 300910 (3);chrX;PLS3, BMND18;True
ENSG00000268104;Solute carrier family 6 (neurotransmitter transporter), member 14;NotRelevant;;{Obesity, susceptibility to, BMIQ11}, 300306 (3){Obesity, susceptibility to, BMIQ11}, 300306 (3);chrX;SLC6A14, OBX, BMIQ11;False
ENSG00000018610;Chromosome X open reading frame 56;NotRelevant;mutation identified in 1 MRX107 family;?Mental retardation, X-linked 107, 301013 (3), X-linked?Mental retardation, X-linked 107, 301013 (3);chrX;CXorf56, MRX107;False
ENSG00000077721;Ubiquitin-conjugating enzyme E2A (RAD6 homolog);NotRelevant;;Mental retardation, X-linked syndromic, Nascimento-type, 300860 (3), X-linked recessiveMental retardation, X-linked syndromic, Nascimento-type, 300860 (3);chrX;UBE2A, RAD6A, MRXSN, MRXS30;True
ENSG00000125351;UPF3 regulator of nonsense transcripts, yeast, homolog of, B;NotRelevant;;Mental retardation, X-linked, syndromic 14, 300676 (3), X-linked recessiveMental retardation, X-linked, syndromic 14, 300676 (3);chrX;UPF3B, RENT3B, MRXS14;True
ENSG00000125352;RING finger protein 113A;NotRelevant;mutation identified in 1 TTD5 family;?Trichothiodystrophy 5, nonphotosensitive, 300953 (3), X-linked dominant?Trichothiodystrophy 5, nonphotosensitive, 300953 (3);chrX;RNF113A, ZNF183, TTD5;True
ENSG00000125356;NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kD;NotRelevant;;Mitochondrial complex I deficiency, nuclear type 12, 301020 (3)Mitochondrial complex I deficiency, nuclear type 12, 301020 (3);chrX;NDUFA1, MWFE, MC1DN12;False
ENSG00000005893;Lysosome-associated membrane protein-2;NotRelevant;;Danon disease, 300257 (3), X-linked dominantDanon disease, 300257 (3);chrX;LAMP2, LAMPB, LGP110;True
ENSG00000158290;Cullin-4B;NotRelevant;;Mental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3), X-linked recessiveMental retardation, X-linked, syndromic 15 (Cabezas type), 300354 (3);chrX;CUL4B, MRXSC, MRXHF2, SFM2, MRXS15;True
ENSG00000171155;C1GALT1-specific chaperone 1;NotRelevant;;Tn polyagglutination syndrome, somatic, 300622 (3)Tn polyagglutination syndrome, somatic, 300622 (3);chrX;C1GALT1C1, COSMC, C1GALT2, TNPS;False
ENSG00000182890;Glutamate dehydrogenase-2;NotRelevant;;{Parkinson disease, age of onset, modifier}, 168600 (3), Isolated cases, Multifactorial{Parkinson disease, age of onset, modifier}, 168600 (3);chrX;GLUD2;False
ENSG00000125675;Glutamate receptor, ionotropic, AMPA 3;NotRelevant;;Mental retardation, X-linked 94, 300699 (3), X-linked recessiveMental retardation, X-linked 94, 300699 (3);chrX;GRIA3, GLUR3, MRX94;True
ENSG00000125676;THO complex 2 (Tho2, yeast, homolog of);NotRelevant;;Mental retardation, X-linked 12/35, 300957 (3), X-linked recessiveMental retardation, X-linked 12/35, 300957 (3);chrX;THOC2, THO2, MRX12, MRX35;True
ENSG00000101966;Inhibitor of apoptosis, X-linked;NotRelevant;;Lymphoproliferative syndrome, X-linked, 2, 300635 (3), X-linked recessiveLymphoproliferative syndrome, X-linked, 2, 300635 (3);chrX;XIAP, BIRC4, API3, XLP2;True
ENSG00000183918;SH2 domain protein 1A;NotRelevant;1cM from DXS42; no recombination with DXS37Lymphoproliferative syndrome, X-linked, 1, 308240 (3);chrX;SH2D1A, LYP, IMD5, XLP, XLPD1;False
ENSG00000122126;Phosphatidylinositol polyphosphate 5-phosphatase (OCRL gene);NotRelevant;;Dent disease 2, 300555 (3), X-linked recessiveLowe syndrome, 309000 (3);chrX;OCRL, LOCR, OCRL1, NPHL2;True
ENSG00000122121;X-prolyl aminopeptidase 2 (aminopeptidase P);NotRelevant;;{Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3){Angioedema induced by ACE inhibitors, susceptibility to}, 300909 (3);chrX;XPNPEP2, AEACEI;False
ENSG00000188706;Zinc finger DHHC domain-containing protein 9;NotRelevant;;Mental retardation, X-linked syndromic, Raymond type, 300799 (3)Mental retardation, X-linked syndromic, Raymond type, 300799 (3);chrX;ZDHHC9, DHHC9, MRXSZ;False
ENSG00000156709;Apoptosis-inducing factor, mitochondrion-associated, 1;NotRelevant;;Combined oxidative phosphorylation deficiency 6, 300816 (3), X-linked recessiveDeafness, X-linked 5, 300614 (3);chrX;AIFM1, PDCD8, AIF, COXPD6, COWCK, CMTX4, DFNX5;True
ENSG00000147255;Immunoglobulin superfamily, member 1;NotRelevant;;Hypothyroidism, central, and testicular enlargement, 300888 (3), X-linked recessiveHypothyroidism, central, and testicular enlargement, 300888 (3);chrX;IGSF1, IGDC1, CHTE;True
ENSG00000165694;FERM domain-containing 7;NotRelevant;;Nystagmus 1, congenital, X-linked, 310700 (3), X-linkedNystagmus, infantile periodic alternating, X-linked, 310700 (3);chrX;FRMD7, NYS1, XIPAN;False
ENSG00000147257;Glypican 3;NotRelevant;;Simpson-Golabi-Behmel syndrome, type 1, 312870 (3), X-linked recessiveWilms tumor, somatic, 194070 (3);chrX;GPC3, SDYS, SGBS1;True
ENSG00000156531;PHD finger protein 6;NotRelevant;;Borjeson-Forssman-Lehmann syndrome, 301900 (3), X-linked recessiveBorjeson-Forssman-Lehmann syndrome, 301900 (3);chrX;PHF6, BFLS;True
ENSG00000165704;Hypoxanthine phosphoribosyltransferase 1;NotRelevant;;HPRT-related gout, 300323 (3), X-linked recessiveLesch-Nyhan syndrome, 300322 (3);chrX;HPRT1, HPRT;True
ENSG00000198689;Solute carrier family 9 (sodium/hydrogen exchanger), member 6;NotRelevant;;Mental retardation, X-linked syndromic, Christianson type, 300243 (3), X-linked dominantMental retardation, X-linked syndromic, Christianson type, 300243 (3);chrX;SLC9A6, NHE6;True
ENSG00000022267;Four-and-a-half LIM domains 1;NotRelevant;mutation identified in 1 FCMSU family;Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3), X-linked recessiveScapuloperoneal myopathy, X-linked dominant, 300695 (3);chrX;FHL1, SLIM1, XMPMA, KYOT, FHL1A, FHL1B, RBMX1A, RBMX1B, FCMSU;True
ENSG00000102245;Tumor necrosis factor ligand superfamily, member 5;NotRelevant;Between DSX144E and DSX300;Immunodeficiency, X-linked, with hyper-IgM, 308230 (3), X-linked recessiveImmunodeficiency, X-linked, with hyper-IgM, 308230 (3);chrX;TNFSF5, CD40LG, HIGM1, IGM;True
ENSG00000147274;RNA-binding motif protein, X chromosome;NotRelevant;mutation identified in 1 MRXS11 family;?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3), X-linked recessive?Mental retardation, X-linked, syndromic 11, Shashi type, 300238 (3);chrX;RBMX, MRXS11;True
ENSG00000165370;G protein-coupled receptor 101;NotRelevant;;Pituitary adenoma 2, GH-secreting, 300943 (3), X-linkedPituitary adenoma 2, GH-secreting, 300943 (3);chrX;GPR101, PAGH2, PITA2;False
ENSG00000156925;Zic family, member 3;NotRelevant;;Congenital heart defects, nonsyndromic, 1, X-linked, 306955 (3), X-linked recessiveVACTERL association, X-linked, 314390 (3);chrX;ZIC3, HTX1, HTX, VACTERLX;True
ENSG00000101981;Coagulation factor IX (plasma thromboplastic component);NotRelevant;distal to HPRT; proximal part of Xq27{Warfarin sensitivity}, 122700 (3);chrX;F9, HEMB, THPH8;False
ENSG00000101977;Oncogene MCF2 (oncogene DBL);NotRelevant;~60kb telomeric to F9; 5' replacement by chr.15 segment;chrX;MCF2, DBL;False
ENSG00000101974;ATPase, class VI, type 11C;NotRelevant;mutation identified in 1 HACXL patient;?Hemolytic anemia, congenital, X-linked, 301015 (3), X-linked recessive?Hemolytic anemia, congenital, X-linked, 301015 (3);chrX;ATP11C, ATPIQ, ATPIG, HACXL;True
ENSG00000134595;SRY (sex determining region Y)-box 3;NotRelevant;P mutant in BFLS;Mental retardation, X-linked, with isolated growth hormone deficiency, 300123 (3)Panhypopituitarism, X-linked, 312000 (3);chrX;SOX3, MRGH;False
ENSG00000102081;FMR1 gene;NotRelevant;8-8.7Mb from telomere;Fragile X syndrome, 300624 (3), X-linked dominantPremature ovarian failure 1, 311360 (3);chrX;FMR1, FRAXA, POF1;True
ENSG00000155966;AF4/FMR2 family, member 2 (fragile site, X-linked, E);NotRelevant;;Mental retardation, X-linked, FRAXE type, 309548 (3), X-linked recessiveMental retardation, X-linked, FRAXE type, 309548 (3);chrX;AFF2, FMR2, FRAXE, MRX2;True
ENSG00000010404;Iduronate 2-sulfatase (Hunter syndrome);NotRelevant;telomeric IDS2 source of inversion in IDS;Mucopolysaccharidosis II, 309900 (3), X-linked recessiveMucopolysaccharidosis II, 309900 (3);chrX;IDS, MPS2, SIDS;True
ENSG00000013619;Mastermind-like domain containing 1;NotRelevant;near MTM1 in microdeletion;Hypospadias 2, X-linked, 300758 (3), X-linked recessiveHypospadias 2, X-linked, 300758 (3);chrX;MAMLD1, CXorf6, F18, HYSP2;True
ENSG00000171100;Myotubularin;NotRelevant;close to F8;Myotubular myopathy, X-linked, 310400 (3), X-linked recessiveMyotubular myopathy, X-linked, 310400 (3);chrX;MTM1, MTMX;True
ENSG00000029993;High-mobility group box 3 (high mobility group protein 4);NotRelevant;mutation identified in 1 MCOPS13 family;?Microphthalmia, syndromic 13, 300915 (3), X-linked?Microphthalmia, syndromic 13, 300915 (3);chrX;HMGB3, HMG4, HMG2A, MCOPS13;False
ENSG00000160131;Vma21, S. cerevisiae, homolog of;NotRelevant;;Myopathy, X-linked, with excessive autophagy, 310440 (3), X-linked recessiveMyopathy, X-linked, with excessive autophagy, 310440 (3);chrX;VMA21, XMEA;True
ENSG00000147383;NAD(P)H steroid dehydrogenase-like protein;NotRelevant;;CHILD syndrome, 308050 (3), X-linked dominantCK syndrome, 300831 (3);chrX;NSDHL;True
ENSG00000182492;Biglycan;NotRelevant;proximal Xq28;Meester-Loeys syndrome, 300989 (3), X-linkedSpondyloepimetaphyseal dysplasia, X-linked, 300106 (3);chrX;BGN, SEMDX, MRLS;False
ENSG00000067842;ATPase, Ca++ transporting, plasma membrane, 3;NotRelevant;mutation identified in 1 family;?Spinocerebellar ataxia, X-linked 1, 302500 (3), X-linked recessive?Spinocerebellar ataxia, X-linked 1, 302500 (3);chrX;ATP2B3, PMCA3, SCAX1;True
ENSG00000262919;Family with sequence similarity 58, member A;NotRelevant;;STAR syndrome, 300707 (3), X-linked dominantSTAR syndrome, 300707 (3);chrX;FAM58A, STAR;True
ENSG00000130821;Solute carrier family 6 (neurotransmitter transporter, creatine), member 8;NotRelevant;distal to G6PD;Cerebral creatine deficiency syndrome 1, 300352 (3), X-linked recessiveCerebral creatine deficiency syndrome 1, 300352 (3);chrX;SLC6A8, CRTR, CCDS1;True
ENSG00000185825;B-cell receptor-associated protein 31;NotRelevant;;Deafness, dystonia, and cerebral hypomyelination, 300475 (3), X-linked recessiveDeafness, dystonia, and cerebral hypomyelination, 300475 (3);chrX;BCAP31, BAP31, DXS1357E, DDCH;True
ENSG00000101986;ATP-binding cassette, subfamily D, member 1;NotRelevant;about 650kb from GCP/RCP;Adrenoleukodystrophy, 300100 (3), X-linked recessiveAdrenomyeloneuropathy, adult, 300100 (3);chrX;ABCD1, ALD, AMN;True
ENSG00000180879;Signal sequence receptor, delta;NotRelevant;;Congenital disorder of glycosylation, type Iy, 300934 (3), X-linked recessiveCongenital disorder of glycosylation, type Iy, 300934 (3);chrX;SSR4, TRAPD, CDG1Y;True
ENSG00000198910;L1 cell adhesion molecule;NotRelevant;between RCP/GCP cluster and G6PD;CRASH syndrome, 303350 (3), X-linked recessiveMASA syndrome, 303350 (3);chrX;L1CAM, CAML1, HSAS1, MASA, SPG1;True
ENSG00000126895;Arginine vasopressin receptor-2;NotRelevant;;Diabetes insipidus, nephrogenic, 304800 (3), X-linked recessiveNephrogenic syndrome of inappropriate antidiuresis, 300539 (3);chrX;AVPR2, DIR, DI1, ADHR;True
ENSG00000102030;N-alpha-acetyltransferase 10, NatA catalytic subunit;NotRelevant;mutation identified in 1 MCOPS1 family;?Microphthalmia, syndromic 1, 309800 (3), X-linkedOgden syndrome, 300855 (3);chrX;NAA10, ARD1A, ARD1, TE2, NATD, OGDNS, MCOPS1;False
ENSG00000172534;Host cell factor C1 (VP16-accessory protein);NotRelevant;50kb distal to V2R;Mental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3), X-linked recessiveMental retardation, X-linked 3 (methylmalonic acidemia and homocysteinemia, cblX type ), 309541 (3);chrX;HCFC1, HCF1, MRX3;True
ENSG00000169057;Methyl-CpG-binding protein-2;NotRelevant;70kb centromeric of RCP/GCP;{Autism susceptibility, X-linked 3}, 300496 (3), Isolated cases, X-linked, Multifactorial{Autism susceptibility, X-linked 3}, 300496 (3);chrX;MECP2, RTT, PPMX, MRX16, MRX79, AUTSX3, MRXSL, MRXS13;False
ENSG00000102076;Red cone pigment (opsin 1, long-wave-sensitive);NotRelevant;5' to CBD;Blue cone monochromacy, 303700 (3), X-linked recessiveColorblindness, protan, 303900 (3);chrX;OPN1LW, RCP, CBP, CBBM;True
ENSG00000268221;Green cone pigment (opsin 1, medium-wave-sensitive);NotRelevant;linked to G6PD; multiple genesColorblindness, deutan, 303800 (3);chrX;OPN1MW, GCP, CBD, CBBM;False
ENSG00000196924;Filamin A, alpha (actin-binding protein-280);NotRelevant;mutation identified in 1 FGS2 patient;Cardiac valvular dysplasia, X-linked, 314400 (3), X-linked recessiveTerminal osseous dysplasia, 300244 (3);chrX;FLNA, FLN1, NHBP, OPD1, OPD2, FMD, MNS, CVD1, CSBS, FGS2;True
ENSG00000102119;Emerin;NotRelevant;in distal Xq28;Emery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3), X-linked recessiveEmery-Dreifuss muscular dystrophy 1, X-linked, 310300 (3);chrX;EMD, EDMD, STA;True
ENSG00000147403;Ribosomal protein L10;NotRelevant;;{Autism, susceptibility to, X-linked 5}, 300847 (3){Autism, susceptibility to, X-linked 5}, 300847 (3);chrX;RPL10, DXS648, QM, AUTSX5, MRXS35;False
ENSG00000102125;Tafazzin;NotRelevant;;Barth syndrome, 302060 (3), X-linked recessiveBarth syndrome, 302060 (3);chrX;TAZ, EFE2, BTHS, CMD3A, LVNCX;True
ENSG00000071553;ATPase, H+ transporting, lysosomal, accessory protein 1;NotRelevant;;Immunodeficiency 47, 300972 (3), X-linked recessiveImmunodeficiency 47, 300972 (3);chrX;ATP6AP1, ATP6IP1, ATP6S1, VATPS1;True
ENSG00000203879;GDP dissociation inhibitor 1;NotRelevant;;Mental retardation, X-linked 41, 300849 (3), X-linked dominantMental retardation, X-linked 41, 300849 (3);chrX;GDI1, RABGD1A, MRX41, MRX48;True
ENSG00000196976;L antigen family member 3;NotRelevant;;Galloway-Mowat syndrome 2, X-linked, 301006 (3), X-linked recessiveGalloway-Mowat syndrome 2, X-linked, 301006 (3);chrX;LAGE3, ITBA2, GAMOS2;True
ENSG00000160211;Glucose-6-phosphate dehydrogenase;NotRelevant;;Hemolytic anemia, G6PD deficient (favism), 300908 (3), X-linked dominant{Resistance to malaria due to G6PD deficiency}, 611162 (3);chrX;G6PD, G6PD1;True
ENSG00000269335;Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase of, gamma (NF-kappa-B essential modulator);NotRelevant;;Ectodermal dysplasia and immunodeficiency 1, 300291 (3)Invasive pneumococcal disease, recurrent isolated, 2, 300640 (3);chrX;IKBKG, NEMO, FIP3, IP, IPD2, AMCBX1, IMD33, EDAID1;False
ENSG00000130826;Dyskerin;NotRelevant;;Dyskeratosis congenita, X-linked, 305000 (3), X-linked recessiveDyskeratosis congenita, X-linked, 305000 (3);chrX;DKC1, DKCX;True
ENSG00000185010;Coagulation factor VIII, procoagulant component;NotRelevant;cen-G6PD-3' end of F8C-5'-ter; 1.1Mb from telomereHemophilia A, 306700 (3);chrX;F8, F8C, HEMA;False
ENSG00000155961;Ras-associated protein RAB39B;NotRelevant;mutation identified in 1 WSMN family;Mental retardation, X-linked 72, 300271 (3), X-linked recessiveMental retardation, X-linked 72, 300271 (3);chrX;RAB39B, MRX72, WSMN;True
ENSG00000155962;Chloride intracellular channel 2;NotRelevant;mutation identified in 1 MRXS32 family;?Mental retardation, X-linked, syndromic 32, 300886 (3), X-linked recessive?Mental retardation, X-linked, syndromic 32, 300886 (3);chrX;CLIC2, XAP121, MRXS32;True
ENSG00000185973;Epsilon-trimethyllysine hydroxylase;NotRelevant;;{Autism, susceptibility to, X-linked 6}, 300872 (3), X-linked recessive{Autism, susceptibility to, X-linked 6}, 300872 (3);chrX;TMLHE, BBOX2, TMLH, TMLHED, AUTSX6;True
ENSG00000185960;Short stature homeo box, Y-linked;NotRelevant;pseudoautosomal;Langer mesomelic dysplasia, 249700 (3)Short stature, idiopathic familial, 300582 (3);chrY;SHOXY;False
ENSG00000198223;Granulocyte-macrophage colony-stimulating factor receptor, alpha subunit (Y chromosome);NotRelevant;306250 = X homolog; distal to MIC2Y;chrY;CSF2RY;False
ENSG00000185291;Interleukin-3 receptor (Y chromosome);NotRelevant;308385 = X homolog; pseudoautosomal;chrY;IL3RA, IL3RY, IL3RAY;False
ENSG00000169100;Adenine nucleotide translocator-3 (Y chromosome);NotRelevant;300151 = X homolog; proximal to CSF2RY;chrY;ANT3Y;False
ENSG00000184895;Sex-determining region Y (testis determining factor);NotRelevant;;46XX sex reversal 1, 400045 (3)46XY sex reversal 1, 400044 (3);chrY;SRY, TDF, TDY, SRXX1, SRXY1;False
ENSG00000114374;Ubiquitin-specific protease-9, Y chromosome (Drosophila fat facets related, Y-linked);NotRelevant;;Spermatogenic failure, Y-linked, 2, 415000 (3), Y-linkedSpermatogenic failure, Y-linked, 2, 415000 (3);chrY;USP9Y, DFFRY, SPGFY2;False
ENSG00000188120;Deleted in azoospermia;NotRelevant;?same as AZF;?Sertoli-cell-only syndrome (1)?Sertoli-cell-only syndrome (1);chrY;DAZ;False
